<SEC-DOCUMENT>0000721371-17-000145.txt : 20171107
<SEC-HEADER>0000721371-17-000145.hdr.sgml : 20171107
<ACCEPTANCE-DATETIME>20171107162215
ACCESSION NUMBER:		0000721371-17-000145
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20170930
FILED AS OF DATE:		20171107
DATE AS OF CHANGE:		20171107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		171183659

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>a18q1_10qx093017xform10-q.htm
<DESCRIPTION>10-Q
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF446805551FC52BE8C0030C88C518177"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;" href="#s3D68712F08245367A1A429F89E7E3C3D"><font style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:100%;padding-bottom:4px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Washington,&#160;D.C. 20549</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Form </font><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">10-Q</font><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">For the quarterly period ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">or</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">For the transition period from ________ to ________</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Commission File Number:&#160;1-11373</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:24pt;"><font style="font-family:Arial Narrow;font-size:24pt;font-weight:bold;">Cardinal Health, Inc.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Ohio</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">31-0958666</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:middle;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">(State or other jurisdiction of</font></div><div style="text-align:center;vertical-align:middle;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">incorporation or organization)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:middle;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">(IRS Employer</font></div><div style="text-align:center;vertical-align:middle;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;vertical-align:middle;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">7000 Cardinal Place, Dublin, Ohio</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">43017</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Address of principal executive offices)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(614)&#160;757-5000</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;Yes&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Large accelerated filer&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Accelerated filer&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Non-accelerated filer&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;(Do not check if a smaller reporting company)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Smaller&#160;reporting&#160;company&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Emerging growth&#160;company&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). &#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;No&#160;</font><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;padding-bottom:1px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The number of the registrant&#8217;s common shares, without par value, outstanding as of </font><font style="font-family:Arial Narrow;font-size:10pt;">October&#160;31, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, was the following: </font><font style="font-family:Arial Narrow;font-size:10pt;">314,603,641</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s3D68712F08245367A1A429F89E7E3C3D"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:22pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:22pt;"><font style="font-family:Arial Narrow;font-size:22pt;font-weight:bold;color:#ee2724;">Cardinal Health</font><font style="font-family:Arial Narrow;font-size:20pt;font-weight:bold;color:#ee2724;">&#160;</font><font style="font-family:Arial Narrow;font-size:18pt;font-weight:bold;color:#ee2724;">&#160;</font></div><div style="text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Q1 Fiscal 2018 Form 10-Q                                                                                                                                   </font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Table of Contents</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:92%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s88A4624FCE1256ADA158D8A423F9999B"><font style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s88A4624FCE1256ADA158D8A423F9999B">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s9C68C5BDF50152929AB10631AB1A5222"><font style="font-family:Arial Narrow;font-size:10pt;">Explanation and Reconciliation of Non-GAAP Financial Measures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s9C68C5BDF50152929AB10631AB1A5222">13</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s1DECF1C5B97E5F96A999A2D90040BBEB"><font style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s1DECF1C5B97E5F96A999A2D90040BBEB">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sEDD569F795635095B9F489368026165F"><font style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sEDD569F795635095B9F489368026165F">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sBD1DBEA2BCB6524687D9D966ADD451B9"><font style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sBD1DBEA2BCB6524687D9D966ADD451B9">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sCD6BF2B8B2085D8B94D7C026DFBBA515"><font style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sCD6BF2B8B2085D8B94D7C026DFBBA515">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s19CE0DCC8CCE574DA5E6553DA1951275"><font style="font-family:Arial Narrow;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s19CE0DCC8CCE574DA5E6553DA1951275">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s618EAEA240085987BDA03F08EFD605D6"><font style="font-family:Arial Narrow;font-size:10pt;">Financial Statements and Supplementary Data</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s618EAEA240085987BDA03F08EFD605D6">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s00A4021DB014500A94720A8D20061A3F"><font style="font-family:Arial Narrow;font-size:10pt;">Exhibits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s00A4021DB014500A94720A8D20061A3F">30</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sCD6F275FF86A56AEA1A7555DB594265C"><font style="font-family:Arial Narrow;font-size:10pt;">Form 10-Q Cross Reference Index</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sCD6F275FF86A56AEA1A7555DB594265C">31</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s9E4598B78DFC5579846A3E95D6288443"><font style="font-family:Arial Narrow;font-size:10pt;">Signatures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s9E4598B78DFC5579846A3E95D6288443">32</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">About Cardinal Health</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is an Ohio corporation formed in 1979 and is a global, integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. We manage our business and report our financial results in two segments: Pharmaceutical and Medical. As used in this report, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our fiscal year ends on June 30. References to fiscal 2018 and fiscal 2017 and to FY18 and FY17 are to the fiscal years ending or ended June 30, 2018 and June 30, 2017, respectively. </font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">This Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 (this "Form 10-Q") (including information incorporated by reference) includes "forward-looking statements" addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Many forward-looking statements appear in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), but there are others in this Form 10-Q, which may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results, trends or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those made, projected or implied. The most significant of these risks and uncertainties are described in Exhibit 99.1 to this Form 10-Q and in "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2017 (our &#8220;2017 Form 10-K&#8221;). Forward-looking statements in this Form 10-Q speak only as of the date of this document. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Non-GAAP Financial Measures</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In the "Overview of Consolidated Results" section of MD&amp;A, we use financial measures that are derived from our consolidated financial data but are not presented in our condensed consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). These measures are considered "non-GAAP financial measures" under the Securities and Exchange Commission ("SEC") rules. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in the &#8220;Explanation and Reconciliation of Non-GAAP Financial Measures&#8221; section following MD&amp;A in this Form 10-Q. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s88A4624FCE1256ADA158D8A423F9999B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div><a name="s7324D81EBFB85576B926C71B1EEE104D"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Management's Discussion and Analysis of Financial Condition and Results of Operations</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The discussion and analysis presented below is concerned with material changes in financial condition and results of operations between the periods specified in our condensed consolidated balance sheets at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and in our condensed consolidated statements of earnings for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. All comparisons presented are with respect to the prior-year period, unless stated otherwise. This discussion and analysis should be read in conjunction with the MD&amp;A included in our </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;Form 10-K. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><a name="s292B3EFA471056CAA4B9975DF080351F"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><font style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Overview of Consolidated Results</font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Revenue</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="a18q1_10qx093xchart-08965.jpg" alt="a18q1_10qx093xchart-08965.jpg" style="height:200px;width:213px;"></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Revenue for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;increased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$32.6 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;due to sales growth from specialty and pharmaceutical distribution customers, which was partially offset by the previously announced May 2017 expiration of a large pharmaceutical distribution mail order customer contract. Medical segment acquisitions also contributed to the increase in revenue during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">GAAP and Non-GAAP Operating Earnings</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><img src="a18q1_10qx093xchart-10113.jpg" alt="a18q1_10qx093xchart-10113.jpg" style="height:200px;width:213px;"><img src="a18q1_10qx093xchart-10785.jpg" alt="a18q1_10qx093xchart-10785.jpg" style="height:200px;width:213px;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(51</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">183</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">122</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">610</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">669</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(9</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, GAAP operating earnings decreased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">51 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$262 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and non-GAAP operating earnings decreased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">9 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$610 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The decrease in GAAP operating earnings was primarily due to contract termination restructuring costs to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model, increased amortization of acquisition-related intangible assets as a result of the Patient Recovery Business acquisition, and litigation charges. Our Pharmaceutical segment generics program performance, which includes the negative impact of generic pharmaceutical customer pricing changes offset by the benefits of Red Oak Sourcing, also contributed to the decrease in GAAP and non-GAAP operating earnings during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">GAAP and Non-GAAP Diluted EPS </font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><img src="a18q1_10qx093xchart-11509.jpg" alt="a18q1_10qx093xchart-11509.jpg" style="height:200px;width:213px;"><img src="a18q1_10qx093xchart-12206.jpg" alt="a18q1_10qx093xchart-12206.jpg" style="height:200px;width:213px;"><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">($ per share)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.36</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.96</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(63</font></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.02</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.40</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.25</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.01</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.06</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.09</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1.24</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, GAAP diluted earnings per share attributable to Cardinal Health, Inc. ("diluted EPS") decreased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">63 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$0.36</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;per share and non-GAAP diluted EPS decreased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">12 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.09</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;per share. GAAP and non-GAAP diluted EPS decreased primarily due to the factors impacting GAAP and non-GAAP operating earnings and partly due to an increase in interest expense. The decrease in GAAP and non-GAAP diluted EPS was partially offset by a lower effective tax rate.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cash and Equivalents</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our cash and equivalents balance was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;compared to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$6.9 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The decrease in cash and equivalents during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was driven by $6.1 billion paid for acquisitions, net of cash acquired, $403 million to redeem our 1.7% notes due 2018, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;paid for share repurchases and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;paid in dividends, offset in part by net cash provided by operating activities of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">4</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Significant Developments in Fiscal 2018 and Trends</font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">On July 29, 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for $6.1 billion in cash. The Patient Recovery Business manufactures 23 categories of medical products that are sold into multiple healthcare channels, and includes numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo. The acquisition further expands the Medical segment's portfolio of self-manufactured products. We funded the acquisition through $4.5 billion in new long-term debt, the use of existing cash, and borrowings under our existing credit arrangements. </font></div><div style="line-height:120%;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Trends</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Within our Pharmaceutical segment, we expect fiscal 2018 segment profit to be less than our fiscal 2017 segment profit due primarily to generic pharmaceutical customer pricing changes. However, as is generally the case, the frequency, timing, magnitude, and profit impact of pharmaceutical customer pricing changes and branded and generic pharmaceutical manufacturer pricing changes remain uncertain and their impact on Pharmaceutical segment profit and consolidated operating earnings in fiscal 2018 could be more or less than we expect. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The acquisition of the Patient Recovery Business increased Medical segment revenue and profit during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Since the acquisition, which closed on July 29, 2017, only contributed to results for two months and also reflects an unfavorable impact from a fair value inventory step up, we expect the acquisition to increase Medical segment profit more significantly during the remainder of fiscal 2018 than it did during the three months ended September 30, 2017. During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the acquisition also increased amortization and other acquisition-related costs due to the size and complexity of the acquisition, and we expect increased amortization and other acquisition-related costs during the remainder of fiscal 2018. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the debt issued in June 2017 to fund a portion of the purchase price of the Patient Recovery Business acquisition increased our interest expense and we expect increased interest expense during the remainder of fiscal 2018.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exploring strategic alternatives for our China products and services distribution business. If we agree to sell the business, it is possible that we could recognize an impairment or loss. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s1088FD65BB5F50CCBCD1249498EA8FC3"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><font style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Results of Operations</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Revenue</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="a18q1_10qx093xchart-09340.jpg" alt="a18q1_10qx093xchart-09340.jpg" style="height:200px;width:213px;"><img src="a18q1_10qx093xchart-10263.jpg" alt="a18q1_10qx093xchart-10263.jpg" style="height:200px;width:213px;"></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">28,920</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">28,762</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,644</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,041</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,641</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,039</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pharmaceutical Segment </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pharmaceutical segment revenue increased slightly during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;due to sales growth from specialty and pharmaceutical distribution customers, which was partially offset by the previously announced May 2017 expiration of a large pharmaceutical distribution mail order customer contract.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Segment</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Medical segment revenue growth for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;was primarily due to contributions from acquisitions of $333 million, including the Patient Recovery Business.</font></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cost of Products Sold</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cost of products sold increased to $</font><font style="font-family:Arial Narrow;font-size:10pt;">31.0 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:Arial Narrow;font-size:10pt;">(</font><font style="font-family:Arial Narrow;font-size:10pt;">2 percent</font><font style="font-family:Arial Narrow;font-size:10pt;">) compared to the prior-year period, as a result of the same factors affecting the change in revenue and gross margin.</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;"><br></font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">6</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Gross Margin</font></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><img src="a18q1_10qx093xchart-11273.jpg" alt="a18q1_10qx093xchart-11273.jpg" style="height:200px;width:213px;"><img src="a18q1_10qx093xchart-12335.jpg" alt="a18q1_10qx093xchart-12335.jpg" style="height:200px;width:213px;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gross margin</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,672</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,590</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;increased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$82 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;(</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">5 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) versus the prior-year period. Acquisitions, including the Patient Recovery Business, increased gross margin by $97 million.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin rate grew 16 basis points during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;due to acquisitions, including the Patient Recovery Business, and Pharmaceutical segment generics program performance. Gross margin rate was negatively impacted by changes in pharmaceutical distribution product mix. </font></div></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Distribution, Selling, General, and Administrative ("SG&amp;A") Expenses</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:74%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">SG&amp;A expenses</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,062</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">920</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">15</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in SG&amp;A expenses during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was due to acquisitions ($92 million), including the Patient Recovery Business, and the costs related to a multi-year project to replace certain Pharmaceutical segment finance and operating information systems.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">7</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Segment Profit</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. See </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Note 14</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of the "Notes to Condensed Consolidated Financial Statements" for additional information on segment profit.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:center;font-size:10pt;"><img src="a18q1_10qx093xchart-13246.jpg" alt="a18q1_10qx093xchart-13246.jpg" style="height:200px;width:213px;"><img src="a18q1_10qx093xchart-14374.jpg" alt="a18q1_10qx093xchart-14374.jpg" style="height:200px;width:213px;"><img src="a18q1_10qx093xchart-17408.jpg" alt="a18q1_10qx093xchart-17408.jpg" style="height:200px;width:213px;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">467</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">534</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">596</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">661</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total consolidated operating earnings</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(51</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pharmaceutical Segment Profit</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The decrease in Pharmaceutical segment profit during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was primarily due to our generic program performance, which includes the negative impact of generic pharmaceutical customer pricing changes offset by the benefits of Red Oak Sourcing. The costs related to a multi-year project to replace certain Pharmaceutical segment finance and operating information systems also contributed to the decrease in Pharmaceutical Segment profit during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Segment Profit</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Medical segment profit grew slightly during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Acquisitions, which included the unfavorable cost of products sold impact from the fair value step up of inventory acquired with the Patient Recovery business, contributed to segment profit growth. The increase was mostly offset by the previously announced loss of a portion of a large distribution customer contract.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Corporate</font></div><div style="line-height:120%;padding-bottom:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As discussed further in sections that follow, the change in Corporate during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was due to contract termination restructuring costs to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model, amortization and other acquisition-related costs due to the Patient Recovery Business acquisition, and litigation charges.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">8</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Other Components of Consolidated Operating Earnings</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In addition to revenue, gross margin, and SG&amp;A expenses discussed previously, consolidated operating earnings were impacted by the following:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">183</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">122</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Restructuring and Employee Severance</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in restructuring and employee severance during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was primarily due to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$125 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;in contract termination costs to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. </font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Amortization and Other Acquisition-Related Costs</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Amortization of acquisition-related intangible assets was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$135 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$101 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The increase in amortization of acquisition-related </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">intangible assets during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was largely due to the Patient Recovery Business acquisition. Transaction and integration costs associated with the Patient Recovery Business acquisition were $37 million for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Litigation (Recoveries)/Charges, Net</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in litigation charges during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;was due to an increase in estimated losses and legal defense costs associated with inferior vena cava (IVC) filter product liability claims. </font></div></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Earnings Before Income Taxes</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition to the items discussed above, earnings before income taxes was impacted by the following:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">81</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">84</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M.</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Interest Expense, Net</font></div></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Interest expense increased during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;primarily due to $5.2 billion&#160;of new long-term debt issued in June 2017, $4.5 billion of which was used to fund the acquisition of the Patient Recovery Business in July 2017.&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Provision for Income Taxes</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was 34.2 percent and 37.3 percent, respectively. The decrease in the effective tax rate was due to the impact of discrete items.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">9</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s1CC88202B6435BADB79ACC6521E79191"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><font style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Liquidity and Capital Resources</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We currently believe that, based on available capital resources (cash on hand and committed credit facilities) and projected operating cash flow, we have adequate capital resources to fund working capital needs; currently anticipated capital expenditures; currently anticipated business growth and expansion; contractual obligations; tax payments; and current and projected debt service requirements, dividends, and share repurchases. If we were to decide to engage in one or more additional acquisitions, depending on the size and timing of such transactions, we might need to access capital markets for additional financing.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cash and Equivalents</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Our cash and equivalents balance was </font><font style="font-family:Arial Narrow;font-size:10pt;">$1.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;at </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;compared to </font><font style="font-family:Arial Narrow;font-size:10pt;">$6.9 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;at </font><font style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">. At </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, our cash and equivalents were held in cash depository accounts with major banks or invested in high quality, short-term liquid investments. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we deployed $6.1 billion for acquisitions, net of cash acquired, $403 million to redeem </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">our 1.7% notes due 2018,</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font><font style="font-family:Arial Narrow;font-size:10pt;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;for share repurchases and </font><font style="font-family:Arial Narrow;font-size:10pt;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;for cash dividends; net cash provided by operating activities was </font><font style="font-family:Arial Narrow;font-size:10pt;">$1.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">, driven by the timing of certain vendor payments and other changes in working capital.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The cash and equivalents balance at </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;included $576 million of cash held by subsidiaries outside of the United States. </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Although the vast majority of this cash is available for repatriation, bringing the cash into the United States could trigger U.S federal, state and local income tax obligations. Because the earnings are considered permanently reinvested, no U.S. tax provision has been accrued related to the repatriation of these earnings. It is not practicable to evaluate the amount of U.S. tax that might be payable on the remittance of such earnings.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Changes in working capital, which impact operating cash flow, can vary significantly depending on factors such as the timing of customer payments, inventory purchases and payments to vendors in the regular course of business, as well as fluctuating working capital needs driven by customer and product mix.</font></div></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Other Financing Arrangements and Financial Instruments</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Credit Facilities and Commercial Paper</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;revolving credit facility and a </font><font style="font-family:Arial Narrow;font-size:10pt;">$1.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;committed receivables sales facility program. We also have a commercial paper program of up to </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">, backed by the revolving credit facility. In August 2017, we increased our revolving credit facility from $1.75 billion to $2.0 billion and in September 2017, we completed a corresponding increase to our commercial paper program from $1.75 billion to $2.0 billion. In August 2017, we also increased our committed receivables sales facility program from $700 million to $1.0 billion.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;">no</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;amounts outstanding under the revolving credit facility or the committed receivables sales facility program. During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we had maximum amounts outstanding under our committed receivables program and commercial paper program of $1.3 billion and an average daily amount outstanding of $405 million.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Our revolving credit facility and committed receivables sales facility program require us to maintain, as of the end of any calendar quarter, </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">a consolidated leverage ratio of </font><font style="font-family:Arial Narrow;font-size:10pt;">no more than 4.25-to-1</font><font style="font-family:Arial Narrow;font-size:10pt;">, which will be reduced over eighteen months back to 3.25-to-1. The ratio temporarily increased as result of our acquisition of the Patient Recovery Business. As of </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we were in compliance with this financial covenant.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Long-Term Obligations</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we redeemed our </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">1.7% notes due 2018 for $403 million. </font><font style="font-family:Arial Narrow;font-size:10pt;">At&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we had total long-term obligations of&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">$10.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">. We plan to reduce our long-term obligations by approximately $500 million each year during fiscal 2018, 2019 and 2020 by paying off long-term obligations.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Funding for Acquisition of Patient Recovery Business</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">On&#160;July&#160;29, 2017, we acquired the&#160;Patient Recovery Business from Medtronic plc&#160;for&#160;$6.1 billion&#160;in cash. We funded the acquisition through&#160;$4.5 billion in new long-term debt issued in June 2017, the use of existing cash and borrowings under existing credit arrangements.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">10</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Capital Deployment</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Capital Expenditures</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Capital expenditures during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;were </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$67 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$100 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Dividends</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">On August 9, 2017, our Board of Directors approved a quarterly dividend of </font><font style="font-family:Arial Narrow;font-size:10pt;">$0.4624</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;per share, or </font><font style="font-family:Arial Narrow;font-size:10pt;">$1.85</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;per share on an annualized basis, payable on October 15, 2017 to shareholders of record on October 2, 2017.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of our common shares. We funded the repurchases with available cash and short-term borrowings. At </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$293 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;remaining under our existing share repurchase program.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Acquisition of Patient Recovery Business</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Described above under "Funding for Acquisition of Patient Recovery Business."</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s2B297FC2125B553CB01A789B3A33B7FF"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Items</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:17pt;"><font style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Other Items</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The MD&amp;A in our 2017 Form 10-K addresses our contractual obligations, critical accounting policies and sensitive accounting estimates, and off-balance sheet arrangements, as of and for the fiscal year ended June 30, 2017. There have been no subsequent material changes outside of the ordinary course of business to those items.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">12</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s9C68C5BDF50152929AB10631AB1A5222"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ff0000;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The "Overview of Consolidated Results" section within MD&amp;A in this Form 10-Q contains financial measures that are not calculated in accordance with GAAP. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition to analyzing our business based on financial information prepared in accordance with GAAP, we use these non-GAAP financial measures internally to evaluate our performance, engage in financial and operational planning and determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business. We provide these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results on a year-over-year basis and in comparing our performance to that of our competitors. However, the non-GAAP financial measures that we use may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth below should be carefully evaluated.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Exclusions from Non-GAAP Financial Measures</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Management believes it is useful to exclude the following items from the non-GAAP measures presented in this report for its own and for investors&#8217; assessment of the business for the reasons identified below:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-decoration:underline;">LIFO charges and credits</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;are excluded because the factors that drive last-in first-out ("LIFO") inventory charges or credits, such as pharmaceutical manufacturer price appreciation or deflation and year-end inventory levels (which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end), are largely out of our control and cannot be accurately predicted. The exclusion of LIFO charges from non-GAAP metrics facilitates comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-decoration:underline;">Restructuring and employee severance costs</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;are excluded because they relate to programs in which we fundamentally change our operations and because they are not part of the ongoing operations of our underlying business.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-decoration:underline;">Amortization and other acquisition-related costs</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;are excluded primarily for consistency with the presentation of the financial results of our peer group companies. Additionally, costs for amortization of acquisition-related intangible assets are non-cash amounts, which are variable in amount and frequency and are significantly impacted by the timing and size of acquisitions, so their exclusion facilitates comparison of historical, current and forecasted financial results. We also exclude other acquisition-related costs, which are directly related to an acquisition but do not meet the criteria to be recognized on the acquired entity&#8217;s initial balance sheet as part of the purchase price allocation. These costs are also significantly impacted by the timing, complexity and size of acquisitions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-decoration:underline;">Impairments and gain or loss on disposal of assets</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and are inherently unpredictable in timing and amount, and in the case of impairments, are non-cash amounts, so their exclusion facilitates comparison of historical, current and forecasted financial results.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-decoration:underline;">Litigation recoveries or charges, net</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;are excluded because they often relate to events that may have occurred in prior or multiple periods, do not occur in or reflect the ordinary course of our business and are inherently unpredictable in timing and amount. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-decoration:underline;">Loss on extinguishment of debt</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;is excluded because it does not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of this type of charge is not consistent and is significantly impacted by the timing and size of debt financing transactions.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The tax effect for each of the items listed above is generally determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded. The gross, tax and net impact of each item are presented with our GAAP to non-GAAP reconciliations.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">13</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><font style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Definitions</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Growth rate calculation</font><font style="font-family:Arial Narrow;font-size:10pt;">: growth rates in this Form 10-Q are determined by dividing the difference between current-period results and prior-period results by prior-period results.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP operating earnings</font><font style="font-family:Arial Narrow;font-size:10pt;">: operating earnings excluding (1) LIFO charges/(credits), (2) restructuring and employee severance, (3) amortization and other acquisition-related costs, (4) impairments and (gain)/loss on disposal of assets, and (5) litigation (recoveries)/charges, net.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP earnings before income taxes</font><font style="font-family:Arial Narrow;font-size:10pt;">: earnings before income taxes excluding (1) LIFO charges/(credits), (2) restructuring and employee severance, (3) amortization and other acquisition-related costs, (4) impairments and (gain)/loss on disposal of assets, (5) litigation (recoveries)/charges, net, and (6) loss on extinguishment of debt.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP net earnings attributable to Cardinal Health, Inc.</font><font style="font-family:Arial Narrow;font-size:10pt;">: net earnings attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) restructuring and employee severance, (3) amortization and other acquisition-related costs, (4) impairments and (gain)/loss on disposal of assets, (5) litigation (recoveries)/charges, net, and (6) loss on extinguishment of debt, each net of tax.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Non-GAAP diluted EPS attributable to Cardinal Health, Inc.</font><font style="font-family:Arial Narrow;font-size:10pt;">: non-GAAP net earnings attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">14</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s3210609292675A2FA3E548DAA34E506B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">GAAP to Non-GAAP Reconciliations</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings Growth Rate</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings Before Income Taxes</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for Income Taxes</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="21" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">First Quarter Fiscal 2018</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(51</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">178</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">115</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(63</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.36</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(63</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">47</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">85</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">183</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">183</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">58</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">125</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.40</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">19</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.06</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">610</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(9</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">527</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">180</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">346</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(13</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.09</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="21" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">First Quarter Fiscal 2017</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">GAAP</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(14</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">494</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">184</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">309</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(19</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)%</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.96</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(17</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)%</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.02</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">122</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">122</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">82</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Non-GAAP</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">669</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)%</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">629</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">229</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">399</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(13</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)%</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1.24</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(10</font></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)%</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup>&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">attributable to Cardinal Health, Inc.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The sum of the components may not equal the total due to rounding.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">There were no LIFO charges/(credits) during the periods presented.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">15</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s17E464C59962598EB78348CCACF7F690"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div><a name="s1DECF1C5B97E5F96A999A2D90040BBEB"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As previously disclosed in our </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;Form 10-K, as a result of the completion of the acquisition of the Patient Recovery Business, our exposure to market price changes for certain commodities as well as to both translational and transactional foreign exchange rate fluctuations has increased since the end of fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. At the time of filing this Form 10-Q, we have not completed our analysis to quantify these impacts.</font></div><div><a name="sEDD569F795635095B9F489368026165F"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Controls and Procedures</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Based on this evaluation, our principal executive officer and principal financial officer have concluded that as of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Changes in Internal Control Over Financial Reporting</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">There were no changes in our internal control over financial reporting during the quarter ended&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div><div><a name="sBD1DBEA2BCB6524687D9D966ADD451B9"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ff0000;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The legal proceedings described in </font><font style="font-family:Arial Narrow;font-size:10pt;">Note 8</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;of the "Notes to Condensed Consolidated Financial Statements" are incorporated in this "Legal Proceedings" section by reference.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">16</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sCD6BF2B8B2085D8B94D7C026DFBBA515"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Risk Factors</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">You should carefully consider the information in this Form 10-Q and the risk factors discussed in "Risk Factors" and other risks discussed in our 2017 Form 10-K and our filings with the SEC since June&#160;30, 2017. These risks could materially and adversely affect our results of operations, financial condition, liquidity, and cash flows. Our business also could be affected by risks that we are not presently aware of or that we currently consider immaterial to our operations.</font></div><div><a name="s19CE0DCC8CCE574DA5E6553DA1951275"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Unregistered Sales of Equity Securities and Use of Proceeds</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Issuer Purchases of Equity Securities</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:17%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number<br>of Shares<br>Purchased&#160;(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Average Price Paid&#160;per Share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number of Shares<br>Purchased<br>as Part of Publicly Announced Programs&#160;(2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Approximate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Dollar Value of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shares That May</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Yet be Purchased</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Under the Program&#160;(2)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">July 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">183</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">77.88</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">443</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">August 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">776,376</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.79</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">776,254</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">426</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">September 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,433,328</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">68.50</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,432,736</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">293</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,209,887</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">67.90</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,208,990</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Reflects </font><font style="font-family:Arial Narrow;font-size:8pt;">183</font><font style="font-family:Arial Narrow;font-size:8pt;">, </font><font style="font-family:Arial Narrow;font-size:8pt;">122</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;and </font><font style="font-family:Arial Narrow;font-size:8pt;">592</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;common shares purchased in July, August and September 2017, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">On May 4, 2016, our Board of Directors approved a $1.0 billion share repurchase program that expires on December 31, 2019. During the three months ended </font><font style="font-family:Arial Narrow;font-size:8pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:8pt;">, we repurchased </font><font style="font-family:Arial Narrow;font-size:8pt;">2.2 million</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;common shares under this program. After these repurchases, we have </font><font style="font-family:Arial Narrow;font-size:8pt;">$293 million</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;available under this program.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div><a name="s5E628B0B01B25604904C6AA6DDF84474"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">17</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s618EAEA240085987BDA03F08EFD605D6"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Earnings</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</font></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,641</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,039</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cost of products sold</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30,969</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30,449</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gross margin</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,672</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,590</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,062</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">920</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">183</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">122</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Operating earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">81</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Earnings before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">178</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">494</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">184</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">117</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">310</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings attributable to Cardinal Health, Inc. </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">115</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">309</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings per common share attributable to Cardinal Health, Inc.:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.36</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.97</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.36</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.96</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average number of common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">316</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">320</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">318</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">322</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash dividends declared per common share</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.4624</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.4489</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">18</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s5EFCBEEBBD5F59BA86695490F758FF4E"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Comprehensive Income</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">117</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">310</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Other comprehensive income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net unrealized gain/(loss) on derivative instruments, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">156</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">310</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Less: comprehensive income attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total comprehensive income attributable to Cardinal Health, Inc. </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">154</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">309</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">19</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s60E3309528CD58199DDAB223E1EDD933"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Balance Sheets</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,181</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6,879</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trade receivables, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8,382</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">8,048</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Inventories, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12,121</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">11,301</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,041</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">23,725</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">28,345</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,651</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,879</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">14,926</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9,207</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">638</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">681</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41,940</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40,112</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities, Redeemable Noncontrolling Interests and Shareholders&#8217; Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">19,202</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">17,906</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations and other short-term borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">935</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,327</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,988</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22,407</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">21,221</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">9,068</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9,068</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,758</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,877</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">118</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shareholders&#8217; equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Preferred shares, without par value:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">500&#160;thousand</font><font style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">none</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Common shares, without par value:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">755&#160;million</font><font style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">327 million</font><font style="font-family:Arial Narrow;font-size:8pt;">&#160;shares and 327 million shares at</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;September 30, 2017 </font><font style="font-family:Arial Narrow;font-size:8pt;">and June 30, 2017, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,674</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,697</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,943</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4,967</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Common shares in treasury, at cost:</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;12&#160;million</font><font style="font-family:Arial Narrow;font-size:8pt;">&#160;shares and 11&#160;million shares at</font><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;September 30, 2017</font><font style="font-family:Arial Narrow;font-size:8pt;">&#160;and June 30, 2017, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(853</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(731</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(86</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(125</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Cardinal Health, Inc. shareholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,678</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6,808</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total shareholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,695</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6,828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities, redeemable noncontrolling interests and shareholders&#8217; equity</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41,940</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40,112</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div><font style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">20</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s78D41703CFD65285B5C3C9EDD5517B2B"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Cash Flows</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(Unaudited)</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">117</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">310</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustments to reconcile net earnings to net cash provided by operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">229</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">173</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and loss on sale of other investments</font></div><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Impairments and loss on disposal of assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Provision for bad debts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Change in operating assets and liabilities, net of effects from acquisitions:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Increase in trade receivables</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(359</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(306</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Increase in inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(381</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(298</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Increase in accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,296</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">279</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities and operating items, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(87</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,181</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">104</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Acquisition of subsidiaries, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6,139</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions to property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(67</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Purchase of available-for-sale securities and other investments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(52</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Proceeds from sale of available-for-sale securities and other investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">64</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">34</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Proceeds from disposal of property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Proceeds from maturities of available-for-sale securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6,144</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(110</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from financing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payment of contingent consideration obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net change in short-term borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Purchase of noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Reduction of long-term obligations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(402</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Proceeds from interest rate swap terminations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net tax withholdings from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(18</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Excess tax benefits from share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Dividends on common shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(150</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(149</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Purchase of treasury shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(150</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(250</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net cash used in financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(744</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(350</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Effect of exchange rates changes on cash and equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net decrease in cash and equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(5,698</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(355</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents at beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,356</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash and equivalents at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,181</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,001</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">21</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s8EB7073231CA5A9A8E4AE7E2FC416380"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Notes to Condensed Consolidated Financial Statements </font></div><div style="line-height:120%;padding-bottom:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div><a name="sFEA9FDCC4809536E90DEDE57610985BD"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;(this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal 2018 and 2017 in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, 2018 and June 30, 2017, respectively.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. In addition, financial results presented for this fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;(the "</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;Form 10-K"). </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recent Financial Accounting Standards</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In August 2017, the Financial Accounting Standards Board (the "FASB") issued&#160;accounting guidance which is intended to improve and simplify accounting rules around hedge accounting. The guidance will be effective for us in the first quarter of fiscal 2020 and early adoption is permitted. We are currently evaluating the impact of this standard on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In March 2016, the FASB issued amended accounting guidance that changed the accounting for certain aspects of share-based compensation to employees. The guidance requires all income tax effects of share-based awards to be recognized in the statement of earnings as awards vest or are settled. Additionally, the guidance increases the amount employers can withhold in shares to cover employee income taxes without requiring liability classification and </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">allows a policy election for accounting for forfeitures. The primary impact of adoption resulted in the recognition of excess tax benefits in the statement of earnings on a prospective basis, rather than as a component of equity. The impact on the presentation in the condensed consolidated statement of cash flows is also prospective. We adopted this guidance in the first quarter of fiscal 2018. The impact of adoption on the provision for income taxes on our condensed consolidated statement of earnings was immaterial. The inclusion of excess tax benefits and deficiencies as a component of our income tax expense will increase volatility within our provision for income taxes as the amount of excess tax benefits or deficiencies from share-</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">based compensation awards depends on our stock price at the date the awards vest.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In May 2014, the FASB issued amended accounting guidance related to revenue recognition. This guidance is based on the principle that revenue is recognized in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the transfer of goods or services to customers. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The FASB also subsequently issued several amendments to the standard, including clarification on principal versus agent considerations, performance obligations and licensing, and certain scope improvements and practical expedients.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We continue to make progress on our evaluation of the amended revenue recognition guidance, including identification of revenue streams and customer contract reviews. Our revenue is primarily distribution revenue, which we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Although we are continuing to assess the impact of the amended guidance, we generally anticipate that the timing of recognition of distribution revenue will be substantially unchanged under the amended guidance.</font></div><div><a name="sCE42978A83D55C7FA4A78B028DD59F44"></a></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Acquisitions</font><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">&#32;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Patient Recovery Business</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">On July 29, 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$6.1 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;in cash. The Patient Recovery Business manufactures </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">23</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;categories of medical products sold into multiple healthcare channels, and includes numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo. The acquisition further expands the Medical segment's portfolio of self-manufactured products. We closed the Patient Recovery Business acquisition in&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">28</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;principal countries on&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">July&#160;29, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and acquired control of, as described in GAAP, and the rights to, the net economic benefit from the entire Patient Recovery Business in the remaining countries at the closing. We are in the process of transitioning legal ownership in the remaining non-</font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">22</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">principal countries, which we expect to complete by the end of calendar 2018. The results for the entire Patient Recovery Business in all countries are included in the condensed consolidated financial statements beginning&#160;July 29, 2017. We funded the acquisition through </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$4.5 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;in new long-term debt, the use of existing cash and borrowings under our existing credit arrangements. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Transaction and integration costs associated with the acquisition of the Patient Recovery business were </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$37 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and are included in amortization and other acquisition-related costs in the condensed consolidated statements of earnings. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Fair Value of Assets Acquired and Liabilities Assumed</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The allocation of the purchase price for the acquisition of the Patient Recovery Business is not yet finalized and is subject to adjustment as we complete the valuation analysis for this acquisition. The purchase price is subject to adjustment based on working capital requirements as set forth in the acquisition agreement. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The valuation of identifiable intangible assets utilizes significant unobservable inputs and thus represents a Level 3 nonrecurring fair value measurement. The estimated fair value of the identifiable intangible assets was determined using income-based approaches, which includes market participant expectations of the cash flows that an asset could generate over its economic life, discounted back to present value using an appropriate rate of return. The weighted- average discount rate used to arrive at the present value of the identifiable intangible assets was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">8.2 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and considers the inherent risk of each intangible asset relative to the internal rate of return and weighted-average cost of capital. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of the assets acquired and liabilities assumed as of the acquisition date for the Patient Recovery Business:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Patient Recovery Business</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,712</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trade names (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">186</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other (3)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total identifiable intangible assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,630</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">434</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">807</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(153</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(873</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total identifiable net assets acquired/(liabilities) assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,975</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,078</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The range of useful lives for customer relationships is </font><font style="font-family:Arial Narrow;font-size:8pt;">10</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;to </font><font style="font-family:Arial Narrow;font-size:8pt;">18</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The useful life of trade names is </font><font style="font-family:Arial Narrow;font-size:8pt;">15</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The useful life of developed technology is </font><font style="font-family:Arial Narrow;font-size:8pt;">15</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;years.</font></div></td></tr></table></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a name="s58351480843A5B348D7C5AA36601E99E"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Restructuring and Employee Severance </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance costs:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs (2)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In September 2017, we entered into an agreement to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. The expected costs with this restructuring include </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$125 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, on a pre-tax basis, in contract termination costs. These costs are reflected in facility exit and other costs in the condensed consolidated statements of earnings during the three months ended September 30, 2017. The contract termination costs are expected to be paid before the end of fiscal 2018. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Related Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">34</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">127</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">161</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><a name="s6CD83BAD3BC95C51AFE412E28BFFC40D"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Goodwill and Other Intangible Assets</font><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">&#32;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,939</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4,282</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7,221</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,156</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,157</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,951</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7,468</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,419</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in the Medical segment goodwill is primarily due to the Patient Recovery Business acquisition. Goodwill recognized in connection with the Patient Recovery Business acquisition primarily represents the expected benefits from certain synergies of integrating the business, the existing workforce of the</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">acquired entity, and the expected growth from new customers.</font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">23</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,705</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,046</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,659</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">697</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">212</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">485</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">346</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,050</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,446</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,111</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,507</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,966</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">967</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">999</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">509</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">195</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">314</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">916</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">304</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">612</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,925</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,452</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,986</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in definite-life intangibles is primarily due to the Patient Recovery Business acquisition. Total amortization of intangible assets was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$135 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$101 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;through</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;2022</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;is as follows: </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$444 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$563 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$531 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$458 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$421 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a name="sCFC5C8C4ED1456309C3BE966E76C09EE"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Available-for-Sale Securities</font><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">&#32;</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. We held the following investments in marketable securities at fair value at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Treasury bills</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">International bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">U.S. agency bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">International equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In July 2017, we liquidated our marketable securities. There were no unrealized gains or loss at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and gross unrealized gains and losses were immaterial at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and 2016, gross realized gains and losses were immaterial and we did not recognize any other-than-temporary impairments. </font></div><div><a name="sd15e85440a2f4416a932b61f8b5aecb9"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;">6. Long-Term Obligations and Other Short-Term Borrowings </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had total long term obligations, including the current portion, of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$10.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$10.4 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </font><font style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </font><font style="font-family:Arial Narrow;font-size:10pt;">$19.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In June 2017, we issued additional debt with the aggregate principal amount of </font><font style="font-family:Arial Narrow;font-size:10pt;">$5.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;to fund a portion of the acquisition of the Patient Recovery Business, to redeem the </font><font style="font-family:Arial Narrow;font-size:10pt;">$400 million</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font><font style="font-family:Arial Narrow;font-size:10pt;">1.7%</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;Notes due 2018</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;and for general corporate purposes. In July 2017, we redeemed the </font><font style="font-family:Arial Narrow;font-size:10pt;">$400 million</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font><font style="font-family:Arial Narrow;font-size:10pt;">1.7%</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;Notes due 2018.</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;The notes issued in June 2017 were </font><font style="font-family:Arial Narrow;font-size:10pt;">1.948%</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;Notes due 2019, </font><font style="font-family:Arial Narrow;font-size:10pt;">2.616%</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;Notes due 2022, </font><font style="font-family:Arial Narrow;font-size:10pt;">3.079%</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;Notes due 2024, </font><font style="font-family:Arial Narrow;font-size:10pt;">3.410%</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;Notes due 2027, </font><font style="font-family:Arial Narrow;font-size:10pt;">4.368%</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;Notes due 2047, and floating rate Notes due 2022.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;revolving credit facility and a </font><font style="font-family:Arial Narrow;font-size:10pt;">$1.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;committed receivables sales facility program. At </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;">no</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;amounts outstanding under the revolving credit facility or the committed receivables sales facility program.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In November 2016, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through November 1, 2019. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers.  Although consolidated with </font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">24</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors.</font></div><div><a name="s534DA4570301511E8A8BC490AF0E3737"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Income Taxes</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fluctuations in our provision for income taxes as a percentage of pretax earnings (&#8220;effective tax rate&#8221;) are due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">34.2 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">37.3 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The decrease in the effective tax rate was due to the impact of discrete items.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$410 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$417 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of unrecognized tax benefits, respectively. The </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;balances include </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$266 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$268 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of unrecognized tax benefits, respectively, that if recognized, would have an impact on the effective tax rate. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$97 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$99 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for income taxes in the condensed consolidated statements of earnings. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">zero</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and a net decrease of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$35 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, exclusive of penalties and interest.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$144 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$142 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheets.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a name="s432D3548232F5310BFDCB271429EE680"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Commitments, Contingent Liabilities and Litigation </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">July 2014</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">10 years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of both companies. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$45.6 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to CVS Health for the remainder of the initial term.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We become involved from time to time in disputes, litigation, and regulatory matters.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We may be named from time to time in </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">From time to time, we may determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred </font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">25</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges, net in our condensed consolidated statements of earnings.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Opioid Lawsuits </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As of October 30, 2017, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">98</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;counties and municipalities, one state attorney general and one tribal entity have filed lawsuits against pharmaceutical wholesale distributors (including us) relating to the distribution of prescription opioid pain medications. Many of the lawsuits also include pharmaceutical manufacturers and retail chains. We are also a defendant in a purported class action lawsuit brought on behalf of unions and other health and welfare funds that paid for certain opioid prescriptions on behalf of their members. These lawsuits, which have been filed in various federal, state and other courts, allege violations of controlled substance laws and various other statutes as well as common law claims, including negligence, public nuisance and unjust enrichment, and seek equitable relief and monetary damages. We are vigorously defending ourselves in these lawsuits. Since these lawsuits are in early stages, we are unable to predict their outcome or estimate a range of reasonably possible losses.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In September 2017, we, along with other distributors, received a request for information related to an investigation being conducted by a group of approximately </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">40</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;U.S. state attorneys general. We also have received civil investigative demands, subpoenas or requests for information from several individual state attorneys general offices. These investigations are focused on the distribution of opioid medication. We are currently evaluating and responding to their requests.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Product Liability Lawsuits</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As of October 30, 2017, we are named as a defendant in </font><font style="font-family:Arial Narrow;font-size:10pt;">90</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;product liability lawsuits filed in Alameda County Superior Court in California involving claims by approximately </font><font style="font-family:Arial Narrow;font-size:10pt;">1,030</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </font><font style="font-family:Arial Narrow;font-size:10pt;">15</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;similar lawsuits involving claims by approximately </font><font style="font-family:Arial Narrow;font-size:10pt;">25</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.</font><font style="font-family:Arial Narrow;font-size:10pt;color:#5b9bd5;">&#32;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At September 30, 2017, we had a total of $</font><font style="font-family:Arial Narrow;font-size:10pt;">129 million</font><font style="font-family:Arial Narrow;font-size:10pt;">, net of expected insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits. While we have recorded accruals based on our assessment of these matters, because these lawsuits are in early stages, we are unable to estimate a range of reasonably possible losses in excess of this accrued amount.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a name="s77D38A7A910E5544B9A9143CB621E5CD"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,162</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,162</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Available-for-sale securities (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other investments (3)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration (4)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">739</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">739</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Available-for-sale securities (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other investments (3)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">116</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">116</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration (4)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The fair value of interest rate swaps, foreign currency contracts and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in the condensed consolidated balance sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. Observable Level 2 inputs such as quoted prices for similar securities, interest rate spreads, yield curves and credit risk are used to determine the fair value. See </font><font style="font-family:Arial Narrow;font-size:8pt;">Note 5</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;for additional information regarding available-for-sale securities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds primarily invest in the equity securities of companies with large market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration represents the obligations incurred in connection with acquisitions. We do not deem the fair value of the contingent consideration obligations under any single acquisition to be significant. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding future business results, discount rates, discount periods, and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">26</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following table presents those liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Contingent Consideration Obligation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions from acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Changes in fair value of contingent consideration (1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payment of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">23</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amount is included in amortization and other acquisition-related costs in the   condensed consolidated statements of earnings.</font></div></td></tr></table><div><a name="s93E1025C1AD159EAABA4E1DFE7D50B08"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. Our derivative and hedging programs are consistent with those described in the 2017 Form 10-K. The amount of ineffectiveness associated with these derivative instruments was immaterial for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, accounts payable, and other accrued liabilities at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;approximate fair value due to their short-term maturities.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:26%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,333</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,713</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,003</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,395</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</font></div><div><a name="s765F719E83A256A0B96C1E749EEE2ADD"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Redeemable Noncontrolling Interests </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the acquisition of a </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">71 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;ownership interest in naviHealth during fiscal 2016, we recognized redeemable noncontrolling interest with a fair value of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$119 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;at the acquisition date. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The noncontrolling interests are redeemable at the option of the third-party noncontrolling interests holders at any time after the two-year </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">anniversary of the closing.&#160;During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, certain third-party noncontrolling interest holders notified us of their intent to exercise their put right on the noncontrolling interest representing </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">16 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of naviHealth with a carrying value of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$103 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and a redemption value of $</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">109 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Upon notification of the intent to exercise the put, the carrying value of the </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">16 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of naviHealth became mandatorily redeemable and was reclassified to other accrued liabilities in the condensed consolidated balance sheet.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The reconciliation of the changes in redeemable noncontrolling interests are as follows: </font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:77%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Redeemable Noncontrolling Interest</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">118</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net earnings attributable to redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net purchase of redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(103</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustment of redeemable noncontrolling interests to redemption value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2017, we settled the </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$103 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;mandatorily redeemable liability with cash, which resulted in our ownership interest in naviHealth increasing to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">98 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div><a name="sC526EADD84B1597F8B90C3856CF3F1FC"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Shareholders' Equity </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2.2 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;common shares having an aggregate cost of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$67.92</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We funded the repurchases with available cash and short-term borrowings.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">3.1 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;common shares having an aggregate cost of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$250 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$81.37</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We funded the repurchases with available cash </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The common shares repurchased are held in treasury to be used for general corporate purposes.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Currency</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Translation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(125</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(108</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(86</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr></table></div></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">27</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Activity related to realized gains and losses on available-for-sale securities, as described in </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Note 5</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, was immaterial during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. There were no unrealized gains and losses on available-for-sale securities at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div><a name="s1F376B71F409558281BB3A3B2F09A929"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Earnings Per Share Attributable to Cardinal Health, Inc.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:70%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">316</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">318</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">322</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units, and performance share units that were antidilutive for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;were </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">5 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">3 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</font></div><div><a name="s5AAC1CDC157D50AD94C061D26722D312"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Segment Information</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment and Corporate:</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">28,920</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">28,762</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,644</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,041</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,641</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,039</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance. The results attributable to noncontrolling interests are </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">recorded within segment profit. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; other income, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation, and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. We encourage our segments and corporate functions to identify investment projects that will promote innovation and provide future returns. As approval decisions for such projects are dependent upon executive management, the expenses for such projects are often retained at Corporate. Investment spending within Corporate was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents segment profit by reportable segment and Corporate:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">467</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">534</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">596</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">661</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June 30, <br>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22,220</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">21,848</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18,055</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,688</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,665</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7,576</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41,940</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40,112</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><a name="sAA02ABA5C6485141BFD2BE648FDD509B"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">15. Share-Based Compensation </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">28</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The total tax benefit related to share-based compensation was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$6 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$8 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. As of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">July&#160;1, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, under ASU 2016-09, excess tax benefits, which are immaterial for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, are prospectively recognized within the provision for income taxes on our condensed consolidated statements of earnings and prospectively recognized as operating activity on our condensed consolidated statement of cash flows.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:52%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">76.72</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">79.53</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">71.60</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$117 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;and are exercisable for  </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">ten years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:57%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">63.44</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">64.30</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">59.19</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$35 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">109</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:58%;"></td><td style="width:21%;"></td><td style="width:2%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units vest over a </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">zero</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">200 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:51%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">77.83</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.43</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vested (1)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">71.57</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">75.39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)    Vested based on achievement of </font><font style="font-family:Arial Narrow;font-size:8pt;">133 percent</font><font style="font-family:Arial Narrow;font-size:8pt;">&#32;of the target performance goal.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$18 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#32;if the performance goals are achieved.</font></div></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s00A4021DB014500A94720A8D20061A3F"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:left;-sec-extract:summary;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-weight:bold;">Exhibits</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Exhibit</font></div><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Exhibit Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit222.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 1, dated as of July 28, 2017, to Stock and Asset Purchase Agreement, dated April 18, 2017, between Cardinal Health, Inc. and Medtronic plc (incorporated by reference to Exhibit 2.2.2 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 3017, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx93017xexhibit22.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 2, dated as of October 2, 2017, to Stock and Asset Purchase Agreement, dated as of March 2, 2015, by and between Ethicon, Inc. and Cardinal Health, Inc.</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex31.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137116000243/exhibit32-restatedcodeofre.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on June 30, 2016, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.1.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1022.htm"><font style="font-family:Arial Narrow;font-size:8pt;">First Amendment to Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.2 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 3017, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.1.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1023.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Form of Nonqualified Stock Option Agreement under the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.3 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 3017, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.1.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1024.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Form of Restricted Share Units Agreement under the Amended Cardinal Health 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.4 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 3017, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.1.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000083/a17q4_10kx063017xexhibit1025.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Form of Performance Share Units Agreement under the Amended Cardinal Health 2011 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2.5 to Cardinal Health's Annual Report on Form 10-K for the year ended June 30, 3017, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx93017xexhibit102.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Third Amendment to Issuing and Paying Agency Agreement, dated September 15, 2017, by and between Cardinal Health, Inc., and the Bank of New York Mellon</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx93017xexhibit103.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 2 to Amended and Restated Five-Year Credit Agreement, dated as of August 26, 2017, by and between Cardinal Health, Inc. and JPMorgan Chase Bank, N.A., individually and as administrative agent</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.4.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137113000179/a14q1_10qx093013xexhibit101.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013, among Cardinal Health Funding, LLC, as Seller, Griffin Capital, LLC, as Servicer, the Conduits party thereto, the Financial Institutions Party thereto, the Managing Agents party thereto, and LC Banks party thereto and the Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Agent (incorporated by reference to Exhibit 10.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.4.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137114000235/a15q1_10qx093014xexhibit103.htm"><font style="font-family:Arial Narrow;font-size:8pt;">First Amendment and Joinder, dated as of November 3, 2014, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.3 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.4.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit1043.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Second Amendment, dated as of November 14, 2016, to the Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.4.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137117000110/a83117_8kxex101.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Third Amendment, dated as of August 30, 2017, to the Fourth Amended and Receivables Purchase Agreement, dated as of November 1, 2013 (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on August 31, 2017, File No. 1-11373)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.5.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit1051.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016, executed by Cardinal Health, Inc. in favor of Cardinal Health Funding, LLC</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10.5.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx93017xexhibit1052.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Amendment No. 1, dated May 1, 2017, to Seventh Amended and Restated Performance Guaranty, dated as of November 14, 2016</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">12.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit121.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Computation of Earnings to Fixed Charges</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">31.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit311.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">31.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit312.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit321.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">99.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a18q1_10qx093017xexhibit991.htm"><font style="font-family:Arial Narrow;font-size:8pt;">Statement Regarding Forward-Looking Information</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">101.INS</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">XBRL Instance Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">101.SCH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">XBRL Taxonomy Extension Schema Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">101.CAL</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">XBRL Taxonomy Extension Calculation Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">101.DEF</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">XBRL Taxonomy Definition Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">101.LAB</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">XBRL Taxonomy Extension Label Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">101.PRE</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">XBRL Taxonomy Extension Presentation Linkbase Document</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">Cardinal Health Website</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cardinal Health&#160;uses its website as a channel of distribution for material company information. Important information, including news releases, financial information, earnings and analyst presentations, and information about upcoming presentations and events is routinely posted and accessible at ir.cardinalhealth.com. In addition, the website allows investors and other interested persons to sign up automatically to receive e-mail alerts when the company posts news releases,&#160;SEC filings and certain other information on its website.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">30</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sCD6F275FF86A56AEA1A7555DB594265C"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:29%;"></td><td style="width:47%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Form 10-Q Cross Reference Index</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Form 10-Q Cross Reference Index</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:85%;"></td><td style="width:7%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part I. Financial Information</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s5E628B0B01B25604904C6AA6DDF84474"><font style="font-family:Arial Narrow;font-size:10pt;">Financial Statements </font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s618EAEA240085987BDA03F08EFD605D6">18</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s88A4624FCE1256ADA158D8A423F9999B"><font style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s88A4624FCE1256ADA158D8A423F9999B">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s1DECF1C5B97E5F96A999A2D90040BBEB"><font style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk </font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s1DECF1C5B97E5F96A999A2D90040BBEB">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sEDD569F795635095B9F489368026165F"><font style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sEDD569F795635095B9F489368026165F">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part II. Other Information</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sBD1DBEA2BCB6524687D9D966ADD451B9"><font style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sBD1DBEA2BCB6524687D9D966ADD451B9">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 1A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sCD6BF2B8B2085D8B94D7C026DFBBA515"><font style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sCD6BF2B8B2085D8B94D7C026DFBBA515">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s19CE0DCC8CCE574DA5E6553DA1951275"><font style="font-family:Arial Narrow;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s19CE0DCC8CCE574DA5E6553DA1951275">17</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Defaults Upon Senior Securities </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Mine Safety Disclosures </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other Information</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Item 6</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s00A4021DB014500A94720A8D20061A3F"><font style="font-family:Arial Narrow;font-size:10pt;">Exhibits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s00A4021DB014500A94720A8D20061A3F">30</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s9E4598B78DFC5579846A3E95D6288443"><font style="font-family:Arial Narrow;font-size:10pt;">Signatures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s9E4598B78DFC5579846A3E95D6288443">32</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:48%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Not applicable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.4609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">31</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </font><font style="font-family:Arial Narrow;font-size:10pt;">Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="s9E4598B78DFC5579846A3E95D6288443"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Additional Information</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Signatures</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.04761904761905%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:50%;"></td><td style="width:44%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;GEORGE S. BARRETT</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">George S. Barrett</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chairman and Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;Q1</font><font style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2018 Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">32</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>a18q1_10qx93017xexhibit22.htm
<DESCRIPTION>EXHIBIT 2.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s9247dfd8b7f94f7bbeabf23ee7ae2011"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Exhibit 2.2</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;font-weight:bold;">AMENDMENT NO. 2</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;font-weight:bold;">TO</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;font-weight:bold;">STOCK AND ASSET PURCHASE AGREEMENT</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">This AMENDMENT NO. 2, dated as of October 2, 2017 (this &#8220;</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Amendment</font><font style="font-family:Times New Roman;font-size:12pt;">&#8221;), to the Stock and Asset Purchase Agreement, dated as of March 1, 2015, as amended (the &#8220;</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Purchase Agreement</font><font style="font-family:Times New Roman;font-size:12pt;">&#8221;), by and between Ethicon, Inc., a Delaware corporation (&#8220;</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Seller</font><font style="font-family:Times New Roman;font-size:12pt;">&#8221;) and Cardinal Health, Inc., a Delaware corporation (&#8220;</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Buyer</font><font style="font-family:Times New Roman;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">WHEREAS, the parties desire to amend certain provisions of the Purchase Agreement as described herein;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">NOW, THEREFORE, in consideration of the mutual agreements set forth in the Purchase Agreement and this Amendment, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Buyer and Seller hereby agree as follows:</font></div><div style="line-height:120%;padding-left:48px;text-align:left;text-indent:0px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">1.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Definitions</font><font style="font-family:Times New Roman;font-size:12pt;">. Terms used herein and not defined shall have the meanings ascribed thereto in the Purchase Agreement.</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">2.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Use of Trademarks</font><font style="font-family:Times New Roman;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:120px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:96px;"><font style="font-family:Times New Roman;font-size:12pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">Section 7.01(b) of the Purchase Agreement is hereby amended and restated in its entirety as follows: </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:120px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:120px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">&#8220;Seller hereby grants, and shall cause its Affiliates to grant, to Buyer and its Affiliates permission to use the Trademarks currently used in the Business as of the Applicable Closing Date (other than the Trademarks included in the Transferred IP) as specifically set forth on </font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Schedules&#160;3.04</font><font style="font-family:Times New Roman;font-size:12pt;">&#32;and </font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">3.10(a)(ii)</font><font style="font-family:Times New Roman;font-size:12pt;">&#32;&#32;to the Disclosure Letter, solely to the extent that such Trademark appears on any Transferred Asset conveyed pursuant hereto, including Inventory (collectively, the &#8220;</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Seller Trademarked Items</font><font style="font-family:Times New Roman;font-size:12pt;">&#8221;) until (i) the depletion of such Seller Trademarked Items for finished goods inventory produced prior to October 2, 2018 and (ii) in the case of any other Transferred Asset, including any other Inventory, until October 2, 2018 (such date, the &#8220;</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Expiration Period</font><font style="font-family:Times New Roman;font-size:12pt;">&#8221;).  When the Expiration Period expires, Buyer is responsible for the destruction and disposal of any remaining Seller Trademarked Items bearing the name or trademark of Seller or its Affiliates then in Buyer&#8217;s possession or returned to Buyer after the Expiration Period.  Buyer and its Affiliates hereby agree to indemnify Seller and the other Seller Indemnitees from and against any and all Damages incurred or suffered as a result of such permitted use of Seller Trademarked Items in this Section 7.01(b), except to the extent that any such Damages result from the fraud or willful misconduct of Seller or any of its Affiliates.</font></div><div style="line-height:120%;text-align:left;padding-left:120px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">Buyer will use commercially reasonable efforts to include representatives of Seller and/or its Affiliates in all local country meetings and conversations with regulatory and health authorities related to Product license renewals, label changes and BSI certificates and will keep Seller updated on the status of the transition from Seller labeling and certificates to Buyer labeling and certificates in such countries.&#160; In the event representatives of Seller and/or its Affiliates are not present during any meetings described above, Buyer will, at the request of Seller, provide a written summary of such meetings to Seller&#8221; </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">3.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Dispute Resolution</font><font style="font-family:Times New Roman;font-size:12pt;">. Notwithstanding anything to the contrary in any Country Transfer Agreement, all disputes arising in connection with any Country Transfer Agreement will be resolved pursuant to the applicable provisions of the Purchase Agreement.</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">4.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Effect of Amendment</font><font style="font-family:Times New Roman;font-size:12pt;">.  This Amendment shall not constitute an amendment or waiver of any provision of the Purchase Agreement not expressly amended or waived herein and shall not be construed as an amendment, waiver or consent to any action that would require an amendment, waiver or consent except as expressly stated herein.  The Purchase Agreement, as amended by this Amendment, is and shall continue to be in full force and effect and is in all respects ratified and confirmed hereby. </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">5.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Counterparts</font><font style="font-family:Times New Roman;font-size:12pt;">.  This Amendment may be executed in two or more counterparts and such counterparts may be delivered in electronic format (including by fax or in portable document format (.pdf)), each of which shall be deemed to be an original and all of which shall be deemed to constitute the same Amendment.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">6.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Governing Law</font><font style="font-family:Times New Roman;font-size:12pt;">.  This Amendment shall be governed by the law of the State of New York without reference to the choice of law doctrine of such state.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:left;text-indent:48px;"><font style="text-align:left;font-family:Times New Roman;font-size:12pt;padding-right:48px;">7.</font><font style="font-family:Times New Roman;font-size:12pt;text-decoration:underline;">Other Miscellaneous Terms</font><font style="font-family:Times New Roman;font-size:12pt;">.  The provisions of Article XI (Miscellaneous) shall apply mutatis mutandis to this Amendment, and to the Purchase Agreement, taken together as a single agreement, reflecting the terms as modified hereby.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">[SIGNATURE PAGES FOLLOW]</font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;">IN WITNESS WHEREOF, the parties have duly executed this Amendment as of the date first above written.</font></div><div style="line-height:120%;text-align:center;padding-left:281px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:281px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CARDINAL HEALTH, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William Owad</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William Owad</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SVP, Integration</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;padding-left:281px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:281px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ETHICON, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Alan Rae</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Alan Rae</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President, Business Development</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:281px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:281px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:317px;font-size:12pt;"><font style="font-family:Times New Roman;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a18q1_10qx93017xexhibit102.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s81d723960752404eac1108f3893fcd0d"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Exhibit 10.2</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">THIRD AMENDMENT TO ISSUING AND PAYING AGENCY AGREEMENT</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Bank of New York Mellon, as Issuing and Paying Agent</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">101 Barclay Street, Floor 8 West</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">New York, New York 10286</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Attn:  Corporate Trust Administration</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;">Re:  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cardinal Health, Inc.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;">This letter (the &#8220;Third Amendment&#8221;) sets forth the understanding between you and Cardinal Health, Inc. (the &#8220;Company&#8221;), whereby we have agreed to amend that certain Issuing and Paying Agency Agreement by and between you (formerly known as The Bank of New York) and the Company dated August 9, 2006, amended February 28, 2007 and November 23, 2016 (the &#8220;Issuing and Paying Agency Agreement&#8221;) in order to increase to $2,000,000,000 the limit as to the aggregate principal amount of commercial paper notes which may be outstanding at any given time pursuant to such agreement.  </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:37px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Defined Terms</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.  </font><font style="font-family:inherit;font-size:12pt;">Unless the context as used herein requires otherwise, capitalized terms used but not defined in this Third Amendment shall have the meaning given to them in the Issuing and Paying Agency Agreement.</font></div><div style="line-height:120%;text-align:justify;text-indent:37px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:37px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.  </font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Amendment</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.  </font><font style="font-family:inherit;font-size:12pt;">Paragraph 4(a)(i) of the Issuing and Paying Agency Agreement is hereby deleted in its entirety and restated as follows: </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;">(i)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">date each such Certificated CP Note the date of issuance thereof (which shall be a Business Day) and insert the maturity date thereof (provided that the Authorized Representative or Dealer Representative shall ensure that such date is a Business Day and that it shall not be more than 364 days from the date of issue and that the aggregate principal amount of CP Notes outstanding shall not exceed $2,000,000,000) and the face amount (provided that the Authorized Representative or the Dealer Representative shall ensure that such face amount is not less than $250,000) thereof in figures; </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">No Other Modifications</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;Except as expressly provided in this Third Amendment, all of the terms and conditions of the Issuing and Paying Agency Agreement shall remain unchanged and in full force and effect.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;">4.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Binding Effect</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;This Third Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"></font><font style="font-family:inherit;font-size:12pt;">5.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Governing Law</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.  </font><font style="font-family:inherit;font-size:12pt;">This Third Amendment shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Conflict</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.  </font><font style="font-family:inherit;font-size:12pt;">In the event of any inconsistency or conflict between this Third Amendment and the Issuing and Paying Agency Agreement, the terms, provisions and conditions of this Third Amendment shall govern and control.</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Counterparts</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;This Third Amendment may be executed in separate counterparts, each of which shall be deemed to be an original but all of which shall constitute one and the same instrument.  </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">Concerning the Issuing and Paying Agent</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">.</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;All of the provisions contained in the Issuing and Paying Agency Agreement in respect of  the rights, privileges, protections, immunities, powers and duties of the Issuing and Paying Agent shall be applicable in respect of this Third Amendment as fully and with like force and effect as though fully set forth in full herein.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">(Signatures on following page.)</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If the foregoing is acceptable to you, please indicate your agreement therewith by signing one or more counterparts of this Third Amendment in the space provided below, and returning such signed counterpart(s) to the Company, whereupon this letter when signed by you and the Company, will become a binding agreement between us.  </font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:336px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:336px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:336px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:336px;text-indent:240px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;padding-left:336px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agreed to and Accepted</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This 15th day of September, 2017</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:60.546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:14%;"></td><td style="width:43%;"></td><td style="width:43%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Bank of New York Mellon, as Issuing and Paying Agent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Laurence J. O'Brien</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Laurence J. O'Brien</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a18q1_10qx93017xexhibit103.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1d624017180a4e85b5efafcd621d2da5"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Exhibit 10.3</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:32px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">AMENDMENT NO. 2 TO AMENDED AND RESTATED FIVE-YEAR CREDIT AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Amendment No. 2 to Amended and Restated Five-Year Credit Agreement (this &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment</font><font style="font-family:inherit;font-size:12pt;">&#8221;) is entered into as of August 25, 2017 by and among Cardinal Health, Inc., an Ohio corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Company</font><font style="font-family:inherit;font-size:12pt;">&#8221;), JPMorgan Chase Bank, N.A., individually and as administrative agent (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Administrative Agent</font><font style="font-family:inherit;font-size:12pt;">&#8221;), and the other financial institutions signatory hereto.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">RECITALS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Company, the Subsidiary Borrowers from time to time party thereto, the Administrative Agent and the Lenders are party to that certain Amended and Restated Five-Year Credit Agreement dated as of June 16, 2016 (as amended, restated, supplemented, or otherwise modified from time to time, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credit Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  Unless otherwise specified herein, capitalized terms used in this Amendment shall have the meanings ascribed to them by the Credit Agreement.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">The Company, the Administrative Agent and the undersigned Lenders wish to amend the Credit Agreement on the terms and conditions set forth below.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Now, therefore, in consideration of the mutual execution hereof and other good and valuable consideration, the parties hereto agree as follows:</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">1.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment to Credit Agreement</font><font style="font-family:inherit;font-size:12pt;">.  Upon the &#8220;Effective Date&#8221; (as defined below), the Credit Agreement shall be amended as follows:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:96px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(a)</font><font style="font-family:inherit;font-size:12pt;">Section 1.1 of the Credit Agreement is hereby amended by adding the following definition in the appropriate alphabetical order:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment No. 2 Effective Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; means August 25, 2017.</font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:96px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(b)</font><font style="font-family:inherit;font-size:12pt;">The definition of &#8220;Aggregate Commitment&#8221; set forth in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate Commitment</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the aggregate of the Commitments of all the Lenders, as increased or reduced from time to time pursuant to the terms hereof.  As of the Amendment No. 2 Effective Date, the Aggregate Commitment is $2,000,000,000.</font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:96px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(c)</font><font style="font-family:inherit;font-size:12pt;">The definition of &#8220;Aggregate Dollar Commitment&#8221; set forth in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate Dollar Commitment</font><font style="font-family:inherit;font-size:12pt;">&#8221; means at any date of determination with respect to all Lenders, an amount equal to the Dollar Commitments of all Lenders on such date.  </font><font style="font-family:inherit;font-size:12pt;">As of the Amendment No. 2 Effective Date, the Aggregate Dollar Commitment is $1,500,000,000.  </font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:96px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(d)</font><font style="font-family:inherit;font-size:12pt;">Schedule 2.1(a) of the Credit Agreement is hereby deleted and replaced with Schedule 2.1(a) attached hereto as </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit A</font><font style="font-family:inherit;font-size:12pt;">&#32;(which Exhibit reflects the $250,000,000 increase in the Aggregate Dollar Commitment contemplated hereby).</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">2.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties of the Company</font><font style="font-family:inherit;font-size:12pt;">.  The Company represents and warrants that as of the Effective Date:</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(a)</font><font style="font-family:inherit;font-size:12pt;">the execution, delivery and performance by the Company of this Amendment have been duly authorized by all necessary corporate action and that this Amendment is a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, or similar Laws affecting creditors&#8217; rights generally;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(b)</font><font style="font-family:inherit;font-size:12pt;">the representations and warranties contained in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article V</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Credit Agreement (other than </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 5</font><font style="font-family:inherit;font-size:12pt;">.5, 5.7 and 5.15) and in each other Loan Document are true and correct in all material respects except to the extent any such representation or warranty is stated to relate solely to an earlier date, in which case such representation or warranty was true and correct in all material respects on and as of such earlier date; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">&#32;that, any representation and warranty that is qualified as to materiality, &#8220;Material Adverse Effect&#8221; or similar language is true and correct (after giving effect to any such qualification therein) in all respects; and </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(c)</font><font style="font-family:inherit;font-size:12pt;">there exists no Default or Unmatured Default, nor would a Default or Unmatured Default result from the increase in Commitments contemplated hereby.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">3.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effective Date</font><font style="font-family:inherit;font-size:12pt;">.  This Amendment shall become effective on the date and at the time (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effective Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;) upon which all of the following conditions have been satisfied:</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(a)</font><font style="font-family:inherit;font-size:12pt;">the execution and delivery of this Amendment by the Company, the Administrative Agent and each of the financial institutions identified on the signature pages hereto (including a signature page for each Lender increasing its Commitment in connection herewith);</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(b)</font><font style="font-family:inherit;font-size:12pt;">the Administrative Agent (or its counsel) shall have received such documents and certificates as are customary for a transaction of this kind relating to the organization, existence and good standing of the Company, the authorization of this Amendment and other legal matters relating to the Company, all in form and substance reasonably satisfactory to the Administrative Agent and its counsel;</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(c)</font><font style="font-family:inherit;font-size:12pt;">the Administrative Agent (or its counsel) shall have received a certificate signed by the Chief Financial Officer or Treasurer of the Company dated the Effective Date, certifying as to the matters set forth in Section 2(b) and (c) above; </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(d)</font><font style="font-family:inherit;font-size:12pt;">the Lenders, the Administrative Agent and the lead arrangers shall have received all fees required to be paid, and all reasonable expenses for which invoices have been presented by the Administrative Agent, on or before the Effective Date.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event the Effective Date has not occurred on or before September 15, 2017, this Amendment shall not become operative and shall be of no force or effect.</font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">4.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reference to and Effect Upon the Credit Agreement; Other</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(a)</font><font style="font-family:inherit;font-size:12pt;">Except as specifically amended above, the Credit Agreement and the other Loan Documents shall remain in full force and effect and are hereby ratified and confirmed.  This Amendment shall constitute a Loan Document.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(b)</font><font style="font-family:inherit;font-size:12pt;">The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Administrative Agent or any Lender under the Credit Agreement or any other Loan Document, nor constitute a waiver of any provision of the Credit Agreement or any other Loan Document, except as specifically set forth herein.  Upon the effectiveness of this Amendment, each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of similar import shall mean and be a reference to the Credit Agreement as amended hereby and each reference in any other Loan Document to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended hereby.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(c)</font><font style="font-family:inherit;font-size:12pt;">For the avoidance of doubt, it is understood and agreed that the increase in the amount of the Aggregate Commitments effectuated hereby constitutes a utilization of the $250,000,000 basket for increases to the Aggregate Commitment pursuant to and as set forth in Section 2.2 of the Credit Agreement and that, after giving effect hereto, no further increases in the Aggregate Commitment pursuant to Section 2.2 shall be permitted.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(d)</font><font style="font-family:inherit;font-size:12pt;">As of the Effective Date, participations in all outstanding Facility LC&#8217;s shall be reallocated such that each Lender shall have a participation in each Facility LC (and each Modification thereof) and the related LC Obligations in proportion to its Pro Rata Share of the Aggregate Commitment (determined after giving effect to any changes in Commitments on the Effective Date).</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">5.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Costs and Expenses</font><font style="font-family:inherit;font-size:12pt;">.  The Company hereby affirms its obligation under Section 9.6 of the Credit Agreement to reimburse the Administrative Agent for all reasonable out-of-pocket expenses incurred by the Administrative Agent in connection with the preparation, negotiation, execution and delivery of this Amendment, including but not limited to the reasonable fees, charges and disbursements of attorneys for the Administrative Agent with respect thereto.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">6.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law</font><font style="font-family:inherit;font-size:12pt;">.  This Amendment shall be governed by, construed and enforced in accordance with the laws of the State of New York, including Section 5-1401 and Section 5-1402 of the general obligation law of the State of New York, without reference to any other conflicts of law principles thereof.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">7.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Headings</font><font style="font-family:inherit;font-size:12pt;">.  Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purposes.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">8.</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts</font><font style="font-family:inherit;font-size:12pt;">.  This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed an original but all such counterparts shall constitute one and the same instrument.  Delivery of an executed signature page of this Amendment by facsimile transmission or electronic mail shall be effective as delivery of manually executed counterpart hereof.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[signature pages follow]</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="sbce9544d6a4d4b4f97fb18588effab1f"></a></div><div style="line-height:120%;padding-bottom:32px;text-align:justify;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the parties have executed this Amendment as of the date and year first above written.</font></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH, INC., as Company</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">JPMORGAN CHASE BANK, N.A., as Administrative Agent and a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Eric B. Bergeson</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eric Bergeson</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Authorized Officer</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Bank of America, N.A., as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Joseph L. Corah</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Joseph L. Corah</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Brian McNany</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brian McNany</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Barclays Bank PLC, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Christopher Aitkin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Christopher Aitkin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assistant Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DEUTSCHE BANK AG NEW YORK BRANCH, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Ming K. Chu</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ming K. Chu</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Virginia Cosenza</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Virginia Cosenza</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Goldman Sachs Bank USA, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Annie Carr</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Annie Carr</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Authorized Signatory</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">HSBC BANK USA, N.A., as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Iain P. Stewart</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Iain P. Stewart</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">MORGAN STANLEY BANK, N.A., as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael King</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael King</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Authorized Signatory</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Wells Fargo Bank, National Association, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Andrea S. Chen</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Andrea S. Chen</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">U.S. Bank National Association, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Jennifer Hwang</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jennifer Hwang</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Credit Agricole Corporate and Investment Bank, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Gordon Yip</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gordon Yip</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Mark Koneval</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark Koneval</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF NOVA SCOTIA, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michelle C. Phillips</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michelle C. Phillips</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Execution Head &amp; Director</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE HUNTINGTON NATIONAL BANK, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Peter M. Kakoules</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Peter M. Kakoules</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PNC BANK NATIONAL ASSOCATION, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Douglas H. Klamfoth</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Douglas H. Klamfoth</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:32px;text-align:center;padding-left:372px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Standard Chartered Bank, as a Lender</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Daniel Mattern</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Daniel Mattern</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Associate Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Standard Chartered Bank</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:32px;text-align:left;padding-left:372px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="s8a7f7591131c4f75944bb93fbc429073"></a></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">[Signature Page to Amendment No. 2 to Amended and Restated Five-Year Credit Agreement]</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">EXHIBIT A</font></div><div style="line-height:120%;padding-bottom:16px;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">SCHEDULE 2.1(a)</font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">COMMITMENTS</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:29%;"></td><td style="width:23%;"></td><td style="width:24%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Lender</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Dollar</font></div><div style="padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Commitment</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">1</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Multicurrency</font></div><div style="padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Commitment</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Total</font></div><div style="padding-bottom:4px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Commitment</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">JPMorgan Chase Bank, N.A.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$158,571,428.61</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($30,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$51,428,571.39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$210,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bank of America, N.A.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$152,500,000.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($27,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$50,000,000.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$202,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Bank of Tokyo-Mitsubishi UFJ, Ltd. </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$152,500,000.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($27,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$50,000,000.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$202,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Barclays Bank Plc </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$123,571,428.57</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($20,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$41,428,571.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$165,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deutsche Bank AG New York Branch </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$123,571,428.57<br>($20,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$41,428,571.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$165,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goldman Sachs Bank USA</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$123,571,428.57<br>($20,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$41,428,571.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$165,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HSBC Bank USA, National Association </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$123,571,428.57<br>($20,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$41,428,571.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$165,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Morgan Stanley Bank, N.A. </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$123,571,428.57<br>($20,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$41,428,571.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$165,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Wells Fargo Bank, National Association </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$123,571,428.57<br>($20,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$41,428,571.43</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$165,000,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Bank National Association </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$43,214,285.71</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($7,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$57,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Agricole Corporate and Investment Bank</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$43,214,285.71<br>($7,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$57,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Bank of Nova Scotia</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$43,214,285.71<br>($7,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$57,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Huntington National Bank</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$43,214,285.71<br>($7,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$57,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PNC Bank, National Association </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$43,214,285.71<br>($7,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$57,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Standard Chartered Bank</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$43,214,285.71<br>($7,500,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$57,500,000</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SunTrust Bank</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$35,714,285.71</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">($0.00)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,285,714.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$50,000,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;height:21px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total: $1,500,000,000</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">( $250,000,000)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total: $500,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Total: $2,000,000,000</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup></font><font style="font-family:inherit;font-size:9pt;">&#32;The first numbers in this column reflect Dollar Commitment amounts inclusive of the Amendment No. 2 Increases.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#32;&#32;&#32;The second numbers in this column, in parenthesis, reflect the amount of the Amendment No. 2 Increases.</font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4.3
<SEQUENCE>5
<FILENAME>a18q1_10qx093017xexhibit1043.htm
<DESCRIPTION>EXHIBIT 10.4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5213b42bd35142a8b9f8e1a9fa2e387e"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Exhibit 10.4.3</font></div></div><div><br></div><div style="line-height:120%;padding-top:1px;text-align:center;padding-left:230px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">SECOND AMENDMENT</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">TO THE</font></div><div style="line-height:120%;text-align:center;padding-left:28px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">FOURTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This SECOND AMENDMENT TO THE FOURTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment</font><font style="font-family:inherit;font-size:12pt;">&#8221;), dated as of November 14,</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2016, is entered into by and among the following parties:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)&#160;&#160;&#160;&#160;CARDINAL HEALTH FUNDING, LLC, a Nevada limited liability company (the</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)      GRIFFIN CAPITAL, LLC, a Nevada limited liability company (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Griffin</font><font style="font-family:inherit;font-size:12pt;">&#8221; and, together with the Seller, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller Parties</font><font style="font-family:inherit;font-size:12pt;">&#8221; and each, a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller Party</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)&#160;&#160;&#160;&#160;WELLS  FARGO  BANK,  N.A.  (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">WF</font><font style="font-family:inherit;font-size:12pt;">&#8221;)  as  a  Financial  Institution  and  as  the</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Managing Agent for WF&#8217;s Purchaser Group;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)&#160;&#160;&#160;&#160;LIBERTY STREET FUNDING LLC (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Liberty Street</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as a Conduit;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       THE BANK OF NOVA SCOTIA (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">BNS</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as the Related Financial Institution for Liberty Street and as the Managing Agent for Liberty Street&#8217;s Purchaser Group;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)&#160;&#160;&#160;&#160;ATLANTIC ASSET SECURITIZATION LLC (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Atlantic</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as a Conduit;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)     CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK NEW YORK BRANCH (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credit Agricole&#8221;</font><font style="font-family:inherit;font-size:12pt;">), as the Related Financial Institution for Atlantic and as the Managing Agent for Atlantic&#8217;s Purchaser Group;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)    PNC BANK, NATIONAL ASSOCIATION (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">PNC</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as a Financial Institution, as the Managing Agent for PNC&#8217;s Purchaser Group and as an LC Bank;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ix)&#160;&#160;&#160;&#160;VICTORY RECEIVABLES CORPORATION (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Victory</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as a Conduit; and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(x)      THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">BTMUNY</font><font style="font-family:inherit;font-size:12pt;">&#8221;), as the Related Financial Institution for Victory, as Managing Agent for Victory&#8217;s Purchaser Group and as the Agent.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:200px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PRELIMINARY STATEMENTS</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, the parties hereto are parties to that certain Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013 (as amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Receivables Purchase Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, concurrently herewith, Cardinal Health 110, LLC, a Delaware limited liability company, and Medicap Pharmacies Incorporated, an Iowa corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">New Sub-Origintor</font><font style="font-family:inherit;font-size:12pt;">&#8221;) are entering into that certain Receivables Sale Agreement, dated as of the date hereof (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Receivables Sale Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, concurrently herewith, Allegiance Corporation, a Delaware corporation (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Allegiance</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and Griffin are entering into that certain Termination Agreement, dated as of the date hereof (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Allegiance RPA Termination Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;) terminating that certain Receivables Purchase and Sale Agreement, dated as of November 3, 2014, by and between Allegiance and Griffin;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS,  concurrently  herewith,  Allegiance  and  Cardinal  Health  200,  LLC,  a Delaware limited liability company (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CH-200</font><font style="font-family:inherit;font-size:12pt;">&#8221;) are entering into that certain Termination Agreement, dated as of the date hereof (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CH-200 RSA Termination Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;) terminating that certain Receivables Sale Agreement, dated as of November 3, 2014, by and between Allegiance and CH-200;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, concurrently herewith, the Performance Guarantor is executing and delivering that certain Seventh Amended and Restated Performance Guaranty, dated as of the date hereof (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">New Performance Guaranty</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, the Seller Parties, the Agent and JPMorgan Chase Bank, N.A. are entering into that certain Amendment No. 2 to the Blocked Account Control Agreement (&#8220;Shifting Control&#8221;), dated as of the date hereof (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">JPM Blocked Account Agreement Amendment</font><font style="font-family:inherit;font-size:12pt;">&#8221;);</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, concurrently herewith, each of the parties hereto (other than Griffin) are entering into that certain Amended and Restated Fee Letter, dated as of the date hereof (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">A&amp;R Fee Letter</font><font style="font-family:inherit;font-size:12pt;">&#8221;; together with the Receivables Sale Agreement, the Allegiance RPA Termination Agreement, the CH-200 RSA Termination Agreement, the New Performance Guaranty, the JPM Blocked Account Agreement, collectively, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Related Agreements</font><font style="font-family:inherit;font-size:12pt;">&#8221;); and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, the parties hereto desire to amend the Receivables Purchase Agreement as set forth herein.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, in consideration of the premises herein contained and for other good and valuable consideration, the receipt and adequacy of which the parties hereto hereby acknowledge, the parties hereto agree as follows:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Definitions</font><font style="font-family:inherit;font-size:12pt;">.    Capitalized  terms  used  herein  and  not  otherwise  defined herein shall have the respective meanings assigned thereto in the Receivables Purchase Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendments  to  the  Receivables  Purchase  Agreement</font><font style="font-family:inherit;font-size:12pt;">.  Subject  to  the satisfaction  of  the  conditions  precedent  set  forth  in  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  6</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;of  this  Amendment,  the Receivables Purchase Agreement is hereby amended to reflect the changes shown on the marked pages attached as </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit A</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Pro Rata Shares</font><font style="font-family:inherit;font-size:12pt;">.  For the avoidance of doubt, each of the parties hereto hereby acknowledge and agree that (i) as of the date hereof, the LC Exposure is an amount equal to $38,328,389.00 and (ii) after giving effect to this Amendment, as of the date hereof each Purchaser Group&#8217;s Pro Rata Share and Pro Rata Share of the LC Exposure are as set forth in the following table:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:46%;"></td><td style="width:27%;"></td><td style="width:27%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Purchaser Group</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Pro Rata Share</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-top:3px;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Pro Rata Share of</font></div><div style="padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">LC Exposure</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Victory Receivables Corporation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.14%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$14,236,258.78</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Wells Fargo Bank, N.A.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.29%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7,008,619.70</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liberty Street Funding LLC</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.29%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7,008,619.70</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PNC Bank, National Association</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.14%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5,037,445.41</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Atlantic Asset Securitization LLC</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.14%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5,037,445.41</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Consent  to  Related  Agreements</font><font style="font-family:inherit;font-size:12pt;">.    Each  of  the  parties  hereto  hereby acknowledges, agrees and consents to the execution and delivery of each of the Related Agreements.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties</font><font style="font-family:inherit;font-size:12pt;">. On the date hereof, each Seller Party hereby represents and warrants (as to itself) to the Purchasers, the Managing Agents and the Agent as follows:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       after   giving   effect   to   this   Amendment   and   each   of   the   Related Agreements, no event or condition has occurred and is continuing which constitutes an Amortization Event or Potential Amortization Event;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       after   giving   effect   to   this   Amendment   and   each   of   the   Related Agreements, the representations and warranties of such Person set forth in the Receivables Purchase Agreement and each other Transaction Document are true and correct as of the date hereof, as though made on and as of such date (except to the extent such representations and warranties relate solely to an earlier date and then as of such earlier date); and</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       this  Amendment  and  each  of  the  Related  Agreements  to  which  such Person is a party, constitutes the valid and binding obligation of such Person, enforceable against such Person in accordance with its terms.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conditions to Effectiveness of this Amendment</font><font style="font-family:inherit;font-size:12pt;">.   This Amendment shall become effective as of the date hereof upon receipt by the Agent of each of the following, in each case, in form and substance reasonably satisfactory to the Agent:</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:12px;text-indent:90px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)&#160;&#160;&#160;&#160;counterparts of this Amendment, duly executed by each of the parties hereto;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       counterparts of each of the Related Agreements, duly executed by each of the parties thereto; and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       confirmation  that  each  of  the  Financial  Institutions  has  received  its respective &#8220;Amendment Fee&#8221; (under and as defined in the A&amp;R Fee Letter) in accordance with the A&amp;R Fee Letter.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Post-Closing Covenant</font><font style="font-family:inherit;font-size:12pt;">.  On or prior to December 31, 2016 (or such later day as agreed to in writing by the Agent), the Servicer shall (or shall cause the applicable Originator to) either: (i) (A) transfer ownership of deposit account number 9429248747 maintained at Bank of America, NA, to Griffin (such account, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">New BOA Lock-Box</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Account</font><font style="font-family:inherit;font-size:12pt;">&#8221;), (B) deliver to the Agent a duly executed amendment to the Collection Account Agreement entered into with Bank of America, N.A. as Collection Bank reflecting the addition of the New BOA Lock-Box Account reasonably satisfactory to the Agent, and (C) deliver to the Agent a duly executed restatement of the Collection Account Disclosure Letter reflecting the addition of the New BOA Lock-Box Account reasonably satisfactory to the Agent or (ii) direct Obligors </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">to cease remitting payments to the New BOA Lock-Box Account and begin remitting payments to another Lock-Box Account.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Miscellaneous</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effect of Amendment; Ratification</font><font style="font-family:inherit;font-size:12pt;">.  Except as specifically set forth herein, the Receivables Purchase Agreement (as amended hereby) is hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect.  After this Amendment becomes effective, all references in the Receivables Purchase Agreement (or in any other Transaction Document) to &#8220;the Receivables Purchase Agreement&#8221;, &#8220;this Agreement&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221;, or words of similar effect, in each case referring to the Receivables Purchase Agreement,  shall  be  deemed  to  be  references  to  the  Receivables  Purchase  Agreement  as amended hereby.  This Amendment shall not be deemed to expressly or impliedly waive, amend, or supplement any provision of the Receivables Purchase Agreement other than as specifically set forth herein.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Costs, Fees and Expenses</font><font style="font-family:inherit;font-size:12pt;">.   The Seller agrees to reimburse each of the parties hereto (other than Griffin) on demand for all reasonable costs, fees and expenses incurred by such parties (including, without limitation, their reasonable fees and expenses of counsel) incurred in connection with the preparation, execution and delivery of this Amendment and each of the Related Agreements.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts; Delivery</font><font style="font-family:inherit;font-size:12pt;">. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.  Delivery of an executed counterpart of a signature page to this Amendment by facsimile or other electronic means shall be effective as delivery of a manually executed counterpart of this Amendment.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Severability</font><font style="font-family:inherit;font-size:12pt;">.  Any provision contained in this Amendment which is held to be inoperative, unenforceable or invalid in any jurisdiction shall, as to that jurisdiction, be inoperative, unenforceable or invalid without affecting the remaining provisions of this Amendment in that jurisdiction or the operation, enforceability or validity of such provision in any other jurisdiction.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section Headings</font><font style="font-family:inherit;font-size:12pt;">. The various headings of this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Receivables Purchase Agreement or any provision hereof or thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">GOVERNING LAW</font><font style="font-family:inherit;font-size:12pt;">.   THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF ILLINOIS.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">WAIVER OF TRIAL BY JURY</font><font style="font-family:inherit;font-size:12pt;">.  EACH PARTY HERETO HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AMENDMENT, ANY DOCUMENT EXECUTED BY ANY SELLER PARTY PURSUANT TO THIS AMENDMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER OR THEREUNDER.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:233px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Signature Pages Follow</font><font style="font-family:inherit;font-size:12pt;">)</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="saca571ec5ab34307a05725f3cb6b53a2"></a></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:5px;text-align:left;padding-left:9px;text-indent:46px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be executed as of the date first above written.</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH FUNDING, LLC, as Seller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Scott B. Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Scott B. Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">GRIFFIN CAPITAL, LLC, as Servicer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Scott B. Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Scott B. Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2nd Amendment to Fourth </font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">A&amp;R Receivables Purchase Agreement</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WELLS FARGO BANK, N.A., as a Financial Institution and as Managing Agent for WF's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Elizabeth R. Wagner</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Elizabeth R. Wagner</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2nd Amendment to Fourth </font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">A&amp;R Receivables Purchase Agreement</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ATLANTIC ASSET SECURITIZATION LLC, as a Conduit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Sam Pilcer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sam Pilcer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Konstantina Kourmpetis</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Konstantina Kourmpetis </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director </font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK NEW YORK BRANCH, as Related Financial Institution for Atlantic and as Managing Agent for Atlantic's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Sam Pilcer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sam Pilcer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Konstantina Kourmpetis</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Konstantina Kourmpetis </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director </font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2nd Amendment to Fourth </font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">A&amp;R Receivables Purchase Agreement</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PNC BANK, NATIONAL ASSOCIATION, as a Financial Institution and as Managing Agent for PNC's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael Brown</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael Brown</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PNC BANK, NATIONAL ASSOCIATION, as an LC Bank</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael Brown</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael Brown</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2nd Amendment to Fourth </font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">A&amp;R Receivables Purchase Agreement</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">VICTORY RECEIVABLES CORPORATION, as a Conduit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ David V. DeAngelis</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David V. DeAngelis</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Related Financial Institution for Victory</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Luna Mills</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Luna Mills</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Managing Agent for Victory's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Luna Mills</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Luna Mills</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Agent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Luna Mills</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Luna Mills</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2nd Amendment to Fourth </font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">A&amp;R Receivables Purchase Agreement</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">LIBERTY STREET FUNDING LLC, as a Conduit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Jill A. Russo</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jill A. Russo</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vice President</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF NOVA SCOTIA, as Related Financial Institution for Liberty Street and as Managing Agent for Liberty Street's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Diane Emanuel</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diane Emanuel</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="sce1d4f2bfacb4360930a94fafe6c3658"></a></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">2nd Amendment to Fourth </font></div><div style="line-height:120%;text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">A&amp;R Receivables Purchase Agreement</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EXHIBIT A </font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">MARKED RECEIVABLES PURCHASE AGREEMENT</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(Attached)</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:right;text-indent:122px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CONFORMED COPY</font></div><div style="line-height:120%;text-align:right;text-indent:122px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(Original is on document No. 707698660)</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Conformed to:</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">First Amendment and Joinder, dated as of November 3, 2014. </font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Second Amendment, dated as of November 14, 2016</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:center;padding-left:166px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">FOURTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:center;padding-left:220px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">dated as of November 1, 2013 among</font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:182px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH FUNDING, LLC, as Seller,</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:228px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">GRIFFIN CAPITAL, LLC, as Servicer,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:193px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE CONDUITS PARTY HERETO,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:center;padding-left:136px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE FINANCIAL INSTITUTIONS PARTY HERETO, THE MANAGING AGENTS PARTY HERETO, THE LC BANKS PARTY HERETO,</font></div><div style="line-height:120%;padding-top:1px;text-align:center;padding-left:304px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">and</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:64px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Agent</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:64px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:5px;text-align:center;padding-left:229px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TABLE OF CONTENTS</font></div><div style="line-height:120%;padding-top:1px;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:570px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Page</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE I.&#160;&#160;&#160;&#160;PURCHASE ARRANGEMENTS................................................................... 2</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.1&#160;&#160;&#160;&#160;Purchase Facility ..................................................................................2</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.2&#160;&#160;&#160;&#160;Increases............................................................................................... 3</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.3&#160;&#160;&#160;&#160;Decreases ............................................................................................. 4</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.4&#160;&#160;&#160;&#160;Payment Requirements ........................................................................ 4</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.5&#160;&#160;&#160;&#160;Letters of Credit .................................................................................. 5</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.6&#160;&#160;&#160;&#160;Issuance of Letters of Credit; Participations ........................................ 5</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.7&#160;&#160;&#160;&#160;Requirements For Issuance of Letters of Credit .................................. 6</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.8&#160;&#160;&#160;&#160;Disbursements, Reimbursement .......................................................... 6</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.9&#160;&#160;&#160;&#160;Repayment of LC Participation Advances........................................... 8</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.10&#160;&#160;&#160;&#160;Documentation .................................................................................... 9</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.11&#160;&#160;&#160;&#160;Determination to Honor Drawing Request .......................................... 9</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.12&#160;&#160;&#160;&#160;Nature of LC Participations and LC Reimbursement</font></div><div style="line-height:120%;text-align:left;padding-left:174px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Obligations ................................................................................... 9</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.13&#160;&#160;&#160;&#160;Liability for Acts and Omissions ....................................................... 11</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.14&#160;&#160;&#160;&#160;Defaulting Financial Institutions........................................................ 12</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE II.&#160;&#160;&#160;&#160;PAYMENTS AND COLLECTIONS ............................................................ 13</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.1&#160;&#160;&#160;&#160;Payments ............................................................................................ 13</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.2&#160;&#160;&#160;&#160;Collections Prior to Amortization ...................................................... 13</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.3&#160;&#160;&#160;&#160;Collections Following Amortization.................................................. 15</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.4&#160;&#160;&#160;&#160;Application of Collections ................................................................. 15</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.5&#160;&#160;&#160;&#160;Payment Rescission ........................................................................... 16</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.6&#160;&#160;&#160;&#160;Maximum Purchaser Interests............................................................ 16</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.7&#160;&#160;&#160;&#160;Clean Up Call..................................................................................... 16</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.8&#160;&#160;&#160;&#160;Demand for Payment of Demand Loans............................................ 16</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE III.&#160;&#160;&#160;&#160;CONDUIT FUNDING....................................................................... 17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.1&#160;&#160;&#160;&#160;CP Costs............................................................................................. 17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.2&#160;&#160;&#160;&#160;CP Costs Payments ............................................................................ 17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.3&#160;&#160;&#160;&#160;Calculation of CP Costs .....................................................................17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE IV.&#160;&#160;&#160;&#160;FINANCIAL INSTITUTION FUNDING .........................................17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.1&#160;&#160;&#160;&#160;Financial Institution Funding ............................................................17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.2&#160;&#160;&#160;&#160;Calculation of Yield; Yield Payments ............................................... 17</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.3&#160;&#160;&#160;&#160;Selection and Continuation of Tranche Periods................................. 18</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.4&#160;&#160;&#160;&#160;Financial Institution Discount Rates ..................................................18</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.5&#160;&#160;&#160;&#160;Suspension of the LIBO Rate ............................................................18</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.6&#160;&#160;&#160;&#160;Extension of Scheduled Facility Termination Date ...........................19</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE V.&#160;&#160;&#160;&#160;REPRESENTATIONS AND WARRANTIES............................................... 21</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.1&#160;&#160;&#160;&#160;Representations and Warranties of the Seller Parties ........................21</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.2&#160;&#160;&#160;&#160;Additional Representations and Warranties of Seller ........................24</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.3&#160;&#160;&#160;&#160;Financial Institution Representations and Warranties ....................... 25</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE VI.&#160;&#160;&#160;&#160;CONDITIONS OF PURCHASES ..................................................... 26</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.1&#160;&#160;&#160;&#160;Conditions Precedent to Initial Incremental Purchase ....................... 26</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.2&#160;&#160;&#160;&#160;Conditions Precedent to All Incremental Purchases and</font></div><div style="line-height:120%;text-align:left;padding-left:174px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Reinvestments ............................................................................ 26</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE VII.&#160;&#160;&#160;&#160;COVENANTS ................................................................................... 27</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.1&#160;&#160;&#160;&#160;Affirmative Covenants of the Seller Parties ...................................... 27</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.2&#160;&#160;&#160;&#160;Negative Covenants of the Seller Parties ........................................... 35</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE VIII.&#160;&#160;&#160;&#160;ADMINISTRATION AND COLLECTION ..................................... 37</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.1&#160;&#160;&#160;&#160;Designation of Servicer...................................................................... 37</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.2&#160;&#160;&#160;&#160;Duties of Servicer .............................................................................. 38</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.3&#160;&#160;&#160;&#160;Collection Notices; Power-of-Attorney ............................................. 39</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.4&#160;&#160;&#160;&#160;Responsibilities of Seller ................................................................... 40</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.5&#160;&#160;&#160;&#160;Reports ............................................................................................... 40</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.6&#160;&#160;&#160;&#160;Servicing Fees .................................................................................... 41</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE IX.&#160;&#160;&#160;&#160;AMORTIZATION EVENTS.............................................................. 41</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.1&#160;&#160;&#160;&#160;Amortization Events .......................................................................... 41</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.2&#160;&#160;&#160;&#160;Remedies............................................................................................ 43</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE X.&#160;&#160;&#160;&#160;INDEMNIFICATION.................................................................................... 44</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.1&#160;&#160;&#160;&#160;Indemnities by the Seller Parties........................................................ 44</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.2&#160;&#160;&#160;&#160;Increased Cost and Reduced Return; Accounting Based</font></div><div style="line-height:120%;text-align:left;padding-left:174px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Consolidation Events ................................................................. 47</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.3&#160;&#160;&#160;&#160;Other Costs and Expenses.................................................................. 49</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.4&#160;&#160;&#160;&#160;Taxes .................................................................................................. 50</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XI.&#160;&#160;&#160;&#160;THE AGENT ...................................................................................... 53</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.1&#160;&#160;&#160;&#160;Authorization and Action.................................................................... 53</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.2&#160;&#160;&#160;&#160;Delegation of Duties ........................................................................... 53</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.3&#160;&#160;&#160;&#160;Exculpatory Provisions ....................................................................... 53</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.4&#160;&#160;&#160;&#160;Reliance by Agent ............................................................................... 54</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.5&#160;&#160;&#160;&#160;Non-Reliance on Agent and Other Purchasers .................................... 54</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.6&#160;&#160;&#160;&#160;Reimbursement and Indemnification .................................................. 54</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.7&#160;&#160;&#160;&#160;Agent in its Individual Capacity ......................................................... 55</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.8&#160;&#160;&#160;&#160;Successor Agent................................................................................... 55</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XII.&#160;&#160;&#160;&#160;ASSIGNMENTS; PARTICIPATIONS ............................................... 55</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.1&#160;&#160;&#160;&#160;Assignments ....................................................................................... 55</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.2&#160;&#160;&#160;&#160;Participations........................................................................................ 57</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XIII.&#160;&#160;&#160;&#160;MANAGING AGENTS........................................................................58</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 13.1&#160;&#160;&#160;&#160;Managing Agents ................................................................................. 58</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XIV.&#160;&#160;&#160;&#160;MISCELLANEOUS ........................................................................... 58</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.1&#160;&#160;&#160;&#160;Waivers and Amendments ................................................................. 58</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.2&#160;&#160;&#160;&#160;Notices ............................................................................................... 59</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.3&#160;&#160;&#160;&#160;Ratable Payments............................................................................... 60</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.4&#160;&#160;&#160;&#160;Protection of Ownership Interests of the Purchasers ......................... 60</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.5&#160;&#160;&#160;&#160;Confidentiality ................................................................................... 61</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.6&#160;&#160;&#160;&#160;Bankruptcy Petition ........................................................................... 61</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.7&#160;&#160;&#160;&#160;Limitation of Liability........................................................................ 62</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.8&#160;&#160;&#160;&#160;CHOICE OF LAW ............................................................................ 62</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.9&#160;&#160;&#160;&#160;CONSENT TO JURISDICTION....................................................... 62</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.10&#160;&#160;&#160;&#160;WAIVER OF JURY TRIAL.............................................................. 63</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.11&#160;&#160;&#160;&#160;Integration; Binding Effect; Survival of Terms ................................. 63</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.12&#160;&#160;&#160;&#160;Counterparts; Severability; Section References................................. 63</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.13&#160;&#160;&#160;&#160;Agent Roles........................................................................................ 63</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.14&#160;&#160;&#160;&#160;Characterization ................................................................................. 64</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.15&#160;&#160;&#160;&#160;Confirmation and Ratification of Terms ............................................ 64</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.16&#160;&#160;&#160;&#160;Excess Funds...................................................................................... 65</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.17&#160;&#160;&#160;&#160;Patriot Act .......................................................................................... 65</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.18&#160;&#160;&#160;&#160;Acknowledgement and Consent to Bail-In of EEA Financial</font></div><div style="line-height:120%;text-align:left;padding-left:174px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Institutions.................................................................................. 65</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:4px;text-align:center;padding-left:241px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Exhibits and Schedules</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:69.00584795321637%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:28%;"></td><td style="width:72%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Definitions</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Purchase Notice</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal Names; Jurisdictions of Organization; Locations of Records; Federal Employer Identification Numbers; State Organizational Identification Numbers</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit IV</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[Reserved]</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit V</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Compliance Certificate</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit VI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Assignment Agreement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit VII</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit and Collection Policy</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit VIII</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[Reserved]</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit IX</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Monthly Report</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit X</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">[Reserved]</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit XI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Reduction Notice</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit XII</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Letter of Credit Application</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commitments, Wiring Instructions, Related Financial Institutions, LC Banks, Conduits and Managing Agents</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Documents to be Delivered to the Agent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule C</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notice Address</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Concentration Limit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule E</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject Conversion Condition Documents</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule F</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Documents to be Delivered to the Agent following the date hereof</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:center;padding-left:166px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">FOURTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013, is entered into by and among Cardinal Health Funding, LLC, a Nevada limited liability company (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller</font><font style="font-family:inherit;font-size:12pt;">&#8221;), Griffin Capital, LLC, a Nevada limited liability company (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Griffin</font><font style="font-family:inherit;font-size:12pt;">&#8221;), not in its individual capacity but solely as initial Servicer (the Servicer together with Seller, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller Parties</font><font style="font-family:inherit;font-size:12pt;">&#8221; and each a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller Party</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the entities listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement under the heading &#8220;Financial Institutions&#8221; (together with their respective successors and assigns hereunder, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Institutions</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the entities listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement under the heading &#8220;LC Banks&#8221; (together with their respective successors and assigns hereunder, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Banks</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the entities listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement under the heading &#8220;Conduits&#8221; (together with any of their respective successors and assigns hereunder, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conduits</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the entities listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement under the heading &#8220;Managing Agents&#8221; (together with any of their respective successors and assigns hereunder, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Managing</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agents</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as agent for the Purchasers hereunder or any successor agent hereunder (together with its successors and assigns hereunder, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agent</font><font style="font-family:inherit;font-size:12pt;">&#8221;).   Unless defined elsewhere herein, capitalized terms used in this Agreement shall have the meanings assigned to such terms in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit I</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:206px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PRELIMINARY STATEMENTS</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The parties hereto (other than PNC in its capacity as an LC Bank) have entered into that certain Third Amended and Restated Receivables Purchase Agreement, dated as of November</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">19, 2007 (as amended up to the date hereof, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Existing Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Seller has transferred and assigned to the Purchasers pursuant to the Existing Agreement, and desires to continue to transfer and assign to the Purchaser&#8217;s pursuant to this Agreement, Purchaser Interests from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Each Conduit may, in its absolute and sole discretion, purchase the Purchaser Interests from Seller from time to time.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event that any Conduit declines to make any purchase of Purchaser Interests or if the related Purchaser Group does not include a Conduit, the applicable Related Financial Institution(s) will, at the request of Seller, purchase such Purchaser Interests from time to time on the terms and subject to the conditions set forth herein.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On the terms and subject to the conditions set forth herein, the LC Banks have agreed to issue Letters of Credit, and each Financial Institution has agreed to acquire risk participations in such Letters of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">BTMUNY has been requested and is willing to act as Agent on behalf of the Purchasers and Managing Agents in accordance with the terms hereof.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The parties hereto now desire to amend and restate the Existing Agreement in its entirety to read as set forth herein.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:center;padding-left:266px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AGREEMENT</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Now therefore, in consideration of the foregoing and for other valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto hereby agree that, the Existing Agreement is hereby amended and restated in its entirety to read as follows:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:206px;text-indent:-2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE I. PURCHASE ARRANGEMENTS</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.1&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchase Facility</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       On the terms and subject to the conditions set forth herein, the Seller may, from time to time prior to the Amortization Date (but not more often than six times per calendar month), instruct (i) the Purchaser Groups ratably (based on the Commitments of their respective Related Financial Institutions) to make purchases of and reinvestments in Purchaser Interests, and each such purchase or reinvestment by a Purchaser Group shall be funded by (x) a Conduit (if any) in such Purchaser Group if such Conduit elects to make such purchase or reinvestment in its sole and absolute discretion (it being understood and agreed that no Conduit shall have any obligation to fund any purchase or reinvestment hereunder), or (y) by the Related Financial Institution(s) in such Purchaser Group if such Purchaser Group does not include a Conduit or if the Conduit(s) in such Purchaser Group decline(s) to make such purchase or reinvestment, or (ii) any LC Bank to issue Letters of Credit in return for Purchaser Interests, and upon each such issuance, each Financial Institution shall (and shall be deemed to) purchase a risk participation in such Letters of Credit and shall be required to make LC Participation Advances in connection with any draws under such Letters of Credit equal to such Financial Institution&#8217;s Pro Rata Share of such draws.  In connection with each such purchase, reinvestment or issuance, the Seller shall (and shall be deemed to) sell and assign the related Purchaser Interests to the Agent for the benefit of the Purchasers.  Notwithstanding anything set forth in this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;or otherwise herein to the contrary, under no circumstances shall any Purchaser be obligated to fund any purchase  of,  or  reinvestment  in,  any  Purchaser  Interest  or  issue  any  Letter  of  Credit,  as applicable, if, after giving effect thereto:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)&#160;&#160;&#160;&#160;the sum of the Aggregate Capital </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;the LC Exposure, would exceed the</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Purchase Limit;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)&#160;&#160;&#160;&#160;the LC Exposure would exceed the LC Facility Limit;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      the  sum  of  (A)  such  Purchaser&#8217;s  outstanding  Capital,  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;(B)  the outstanding Capital of all other Purchasers in such Purchaser&#8217;s Purchaser Group, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;(C) such Purchaser&#8217;s Purchaser Group&#8217;s Pro Rata Share of the LC Exposure, would exceed the Purchaser Group Commitment of such Purchaser Group;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)     if such Purchaser is a Financial Institution, the sum of such Financial Institution&#8217;s outstanding Capital </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;such Financial Institution&#8217;s Pro Rata Share of the LC Exposure, would exceed such Financial Institution&#8217;s Commitment;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)&#160;&#160;&#160;&#160;the amounts then available to be drawn under all outstanding Letters of</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Credit issued by any LC Bank would exceed its LC Limit; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)&#160;&#160;&#160;&#160;the aggregate of all Purchaser Interests would exceed 100%;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that, for the avoidance of doubt, none of the foregoing conditions shall apply to any </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Financial Institution&#8217;s obligation to fund LC Participation Advances hereunder.   The Seller may, subject to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (a)</font><font style="font-family:inherit;font-size:12pt;">&#32;and the other requirements and conditions herein, use the proceeds of any purchase by the Purchasers hereunder to satisfy any LC Reimbursement Obligation to the LC Bank and the Financial Institutions pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8</font><font style="font-family:inherit;font-size:12pt;">&#32;below.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding  anything  herein  to  the  contrary,  no  LC  Bank  shall  have  any  obligation hereunder to issue, and shall not issue, any Letters of Credit the proceeds of which would be made available to any Person (i) to fund any activity or business of or with any Sanctioned Person, or in any Sanctioned Country, except, in each case, to the extent such use is licensed by OFAC and otherwise authorized under applicable law or (ii) in any manner that would result in a violation of any Sanctions by any party to this Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Seller  may,  upon  at  least  10  Business  Days&#8217;  notice  to  the  Agent  and  each Managing Agent, terminate in whole or reduce in part, ratably among the Financial Institutions, the unused portion of the Purchase Limit (but not below the amount that would cause the Aggregate Capital </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;the LC Exposure to exceed the Purchase Limit or the LC Exposure to exceed the LC Facility Limit); </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that (i) each partial reduction of the Purchase Limit shall be in an amount equal to $5,000,000 or an integral multiple thereof and (ii) in connection with each such termination or reduction of the Purchase Limit, the Financial Institutions&#8217; respective Commitments and the Purchaser Groups&#8217; respective Purchaser Group Commitments, in each case, shall be automatically terminated in whole or ratably reduced in part (as the case may be) by an amount (in the aggregate for all Financial Institutions and Purchaser Groups) equal to such termination or reduction in the Purchase Limit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Increases</font><font style="font-family:inherit;font-size:12pt;">.  Seller will provide the Agent and each Managing Agent with notice by at least 12:00 noon (New York time) one Business Day (or, with respect to the issuance of a Letter of Credit, three Business Days) prior in a form set forth as </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit II</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto of each Incremental Purchase (other than an LC Reimbursement Purchase deemed requested pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8</font><font style="font-family:inherit;font-size:12pt;">) (each such notice, a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchase Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  Each Purchase Notice shall be subject to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 6.2</font><font style="font-family:inherit;font-size:12pt;">&#32;hereof and, except as set forth below, shall be irrevocable and shall specify the requested Purchase Price (which shall not be less than $1,000,000 and shall be in integral multiples of $100,000 thereafter), whether the issuance of a Letter of Credit is being requested (in which case, the Purchase Notice shall specify the applicable LC Bank and shall include the related documents and information specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.6(a)</font><font style="font-family:inherit;font-size:12pt;">) and date of purchase and, in the case of an Incremental Purchase to be funded by any of the Financial Institutions, the requested Discount  Rate and  Tranche Period.    Following  receipt  of  a Purchase  Notice (other than  a Purchase Notice that requests only the issuance of a Letter of Credit), each Managing Agent will promptly notify the Purchasers in its Purchaser Group of such Purchase Notice.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On the date of each Incremental Purchase (other than an LC Reimbursement Purchase deemed requested pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8</font><font style="font-family:inherit;font-size:12pt;">, which shall be funded in accordance with such Section), subject to satisfaction of the applicable conditions set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">, this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.2</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article VI</font><font style="font-family:inherit;font-size:12pt;">, (i) in the case of any Incremental Purchase other than the issuance of a Letter of Credit, the Purchasers in each Purchaser Group (which may be Conduits and/or Financial Institutions, as determined in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">) will deposit (or will initiate a deposit and, if requested, will provide the Seller the related wire confirmation number) to the Facility Account, in immediately available funds, no later than 1:00 p.m. (New York time), an amount equal to such Purchaser Group&#8217;s Pro Rata Share of the aggregate Purchase Price of such Incremental Purchase, and (ii) in the case of the issuance of a Letter of Credit, such Letter of Credit shall be issued in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 1.5</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">1.6</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Each Purchaser&#8217;s obligations hereunder shall be several, such that the failure of any Purchaser to make available to Seller any funds in connection with any purchase shall not relieve any other Purchaser </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">of its obligation, if any, hereunder to make funds available on the date of such purchase, but no Purchaser shall be responsible for the failure of any other Purchaser to make funds available in connection with any purchase.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.3      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Decreases</font><font style="font-family:inherit;font-size:12pt;">.  Seller will provide the Agent and each Managing Agent with prior written notice substantially in the form of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit XI</font><font style="font-family:inherit;font-size:12pt;">&#32;(a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reduction Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221;) in conformity with the Required Notice Period of any proposed reduction of Aggregate Capital on any Settlement Date from Collections and each Managing Agent will promptly notify each Purchaser in such Managing Agent&#8217;s Purchaser Group of such Reduction Notice after such Managing Agent&#8217;s receipt thereof.  Such Reduction Notice shall designate (i) the date (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Proposed</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reduction Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;) upon which any such reduction of the Aggregate Capital shall occur (which date shall give effect to the applicable Required Notice Period), and (ii) the aggregate amount by which  the Aggregate  Capital  will  be reduced  (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate  Reduction</font><font style="font-family:inherit;font-size:12pt;">&#8221;),  which  shall  be applied to reduce the Capital of the various Purchasers ratably (based on the amount of their respective outstanding Capital).  Only one (1) Reduction Notice shall be outstanding at any time. Notwithstanding the foregoing, the Aggregate Reduction will not be made if the Amortization Date  shall  have  occurred  for  any  reason  on  or  prior  to  the  Proposed  Reduction  Date. Concurrently with any reduction of Aggregate Capital pursuant to this Section, Seller shall pay to the applicable Purchasers all Broken Funding Costs (if any) arising as a result of such reduction.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.4      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payment Requirements</font><font style="font-family:inherit;font-size:12pt;">.  All amounts to be paid or deposited by any Seller Party pursuant to any provision of this Agreement or any other Transaction Documents shall be paid or deposited (or such Seller Party shall initiate a payment or deposit and, if requested, will provide the Agent or any Managing Agent the related wire confirmation number) in accordance with the terms hereof no later than 12:00 noon (New York time) on the day when due in immediately available funds, and if not received (or if such payment or deposit is not initiated) before 12:00 noon (New York time) shall be deemed to be received on the next succeeding Business Day.  If such amounts are payable to a Purchaser, they shall be paid to such Purchaser by wire transfer of immediately available funds in accordance with the &#8220;Wiring Instructions&#8221; specified for such Purchaser on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;or in accordance with such other wiring instructions specified by such Purchaser (or its Managing Agent) in writing to each other party hereto.   If such amounts are payable to the Agent, they shall be paid to the Agent with the &#8220;Wiring Instructions&#8221; specified for the Agent on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;or in accordance with such other wiring instructions specified by the Agent in writing to each other party hereto.  All computations of Yield, per annum fees or discount calculated as part of any CP Costs, per annum fees hereunder and per annum fees under any Fee Letter shall be made on the basis of a year of 360 days (or, if calculated by reference to the Prime Rate, 365 or 366 days, as applicable) for the actual number of days elapsed.   If any amount hereunder or under any other Transaction Document shall be payable on a day which is not a Business Day, such amount shall be payable on the next succeeding Business Day.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.5       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Letters of Credit</font><font style="font-family:inherit;font-size:12pt;">.  Upon the request of the Seller pursuant to a Purchase Notice  delivered  in  accordance  with  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  1.2</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;and  subject  to  all  applicable  terms  and conditions set forth herein (including, without limitation, those conditions set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.2</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.6</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article VI</font><font style="font-family:inherit;font-size:12pt;">), the applicable LC Bank shall issue or cause the issuance of Letters of Credit on behalf of the Seller or its assignee or subassignees (and, if applicable, on behalf of, or for the account of, the Performance Guarantor, an Originator or an Affiliate of an Originator in favor of such beneficiaries as the Performance Guarantor, such Originator or such Affiliate may elect).  For the avoidance of doubt, Yield shall accrue on all amounts drawn under Letters of Credit for each day on and after the applicable LC Reimbursement Date so long as such drawn amounts shall have not been reimbursed to the applicable LC Bank pursuant to the terms hereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.6&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Issuance of Letters of Credit; Participations</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       In accordance with Section 1.2, the Seller may from time to time request that an LC Bank issue a Letter of Credit by completing and delivering to the Agent and such LC Bank a Purchase Notice together with (i) a Letter of Credit Application completed to the satisfaction of the Agent and such LC Bank, and (ii) such other certificates, documents and other papers and information as the Agent and such LC Bank may reasonably request.  The Seller will also have the  right  to  give  instructions  and  make  agreements  with  respect  to  any  Letter  of  Credit Application and the disposition of documents, and to agree with the LC Bank upon any amendment, extension or renewal of any Letter of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Each Letter of Credit will, among other things, (i) provide for the payment of sight drafts or other written demands for payment when presented for honor thereunder in accordance with the terms thereof and when accompanied by the documents described therein and  (ii) have  an  expiry date  not  later than  twelve (12)  months  after  the date of  issuance, extension or renewal, as the case may be, of such Letter of Credit and in no event later than twelve (12) months after the Scheduled Facility Termination Date.  The terms of each Letter of Credit may include customary &#8220;evergreen&#8221; provisions providing that such Letter of Credit&#8217;s expiry date shall automatically be extended for additional periods not to exceed twelve (12) months unless, not less than thirty (30) days (or such longer period as may be specified in such Letter of Credit) (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Expiry Notice Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;) prior to the applicable expiry date, the applicable LC  Bank  delivers  written  notice  to  the  Seller  and  the  beneficiary  thereof  declining  such extension; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that if (x) any such extension would cause the expiry date of such Letter of Credit to occur after the date that is twelve (12) months after the Scheduled Facility Termination Date or (y) the   applicable LC Bank determines that any condition precedent (including, without limitation, those set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit VI</font><font style="font-family:inherit;font-size:12pt;">) to issuing such Letter of Credit hereunder (as if such Letter of Credit were then being first issued) is not satisfied (other than any such condition requiring the Seller to submit a Purchase Notice or Letter of Credit Application in respect thereof), then such LC Bank, in the case of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (x)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, may (or, at the written direction of any Financial Institution, shall) or, in the case of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (y)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, shall, use reasonable efforts in accordance with (and to the extent permitted by) the terms of such Letter of Credit to prevent the extension of such expiry date (including notifying the Seller and the beneficiary of such Letter of Credit in writing prior to the LC Expiry Notice Date that such expiry date will not be so extended).  Each Letter of Credit shall be subject either to the Uniform Customs and Practice for Documentary Credits (2007 Revision), International Chamber of Commerce Publication No. 600, and any amendments or revisions thereof adhered to by the applicable LC Bank or the International Standby Practices (ISP98-International Chamber of Commerce Publication Number 590), and any amendments or revisions thereof adhered to by such LC Bank, as determined by such LC Bank.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       Immediately upon the issuance by an LC Bank of any Letter of Credit (or any amendment to a Letter of Credit increasing the amount thereof), such LC Bank shall be deemed to have sold and transferred to each Financial Institution, and each Financial Institution shall be deemed irrevocably and unconditionally to have purchased and received from such LC Bank, without recourse or warranty, an undivided interest and participation, to the extent of such Financial Institution&#8217;s Pro Rata Share, in such Letter of Credit, each drawing made thereunder and the obligations of the Seller hereunder with respect thereto, and any security therefor or guaranty pertaining thereto. Upon any change in the Commitments or Pro Rata Shares of the Financial Institutions pursuant to this Agreement, it is hereby agreed that, with respect to all outstanding Letters of Credit and unreimbursed drawings thereunder, there shall be an automatic adjustment to the participations pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.6(c)</font><font style="font-family:inherit;font-size:12pt;">&#32;to reflect the new Pro Rata Shares of the assignor and assignee Financial Institutions or of all Financial Institutions with Commitments, as the case may be.  In the event that an LC Bank makes any payment under any Letter of Credit and the Seller shall not have reimbursed such amount in full to such LC Bank pursuant  to  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;or  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">1.8(b)</font><font style="font-family:inherit;font-size:12pt;">,  each  </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Financial  Institution  that  has  not  made  an  LC Reimbursement Purchase in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;will be obligated to make LC Participation Advances with respect to such Letter of Credit in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(c)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.7      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Requirements For Issuance of Letters of Credit</font><font style="font-family:inherit;font-size:12pt;">.  The Seller shall authorize and direct the LC Bank to name the Seller, the Performance Guarantor, an Originator or an Affiliate of an Originator as the &#8220;Applicant&#8221; or &#8220;Account Party&#8221; of each Letter of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.8&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Disbursements, Reimbursement</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       In  the  event  of  any  request  for  a  drawing  under  a  Letter  of  Credit  by  the beneficiary or transferee thereof, the applicable LC Bank will promptly notify the Agent who will notify the Seller and each Managing Agent of such request, and the applicable LC Bank will honor such drawing if and when required pursuant to the terms of the applicable Letter of Credit (the date on which an LC Bank honors a drawing on a Letter of Credit, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Honor Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  The Seller shall reimburse (such obligation to reimburse the LC Bank, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Reimbursement</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Obligation</font><font style="font-family:inherit;font-size:12pt;">&#8221;) the LC Bank (i) if the Seller shall have received notice of such drawing prior to 10:00 a.m. (New York time) on any Business Day, by no later than 2:00 p.m. (New York time) on such Business Day or (ii) otherwise, by noon   (New York time) on the Business Day immediately following the day that the Seller receives such notice (each such date for reimbursement, an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Reimbursement Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;) in an amount equal to the amount so paid by such LC Bank; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that recourse to the Seller for the LC Reimbursement Obligation shall be limited to the Collateral and all of the other rights, interests and assets from time to time owned by the Seller (including all rights and interests of the Seller under or in connection with the Transaction Documents).  For the avoidance of doubt, no Cardinal Entity (other than the Seller) or any other account party on a Letter of Credit (unless such account party is the Seller) shall have any obligation to reimburse the LC Bank or any other Person for a drawing under a Letter of Credit or shall otherwise be required to fund or perform the Reimbursement Obligation hereunder on behalf of the Seller or otherwise.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Upon receipt of a notice of a drawing under a Letter of Credit pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, unless the Seller shall have already satisfied the Reimbursement Obligation from its own funds, (i) the Seller will be deemed (without further action or notice) to have requested that an Incremental Purchase (each such Incremental Purchase, an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Reimbursement Purchase</font><font style="font-family:inherit;font-size:12pt;">&#8221;) be made on the applicable LC Reimbursement Date in an amount equal to such LC Reimbursement Obligation, (ii) the Agent will notify each Managing Agent of such requested LC Reimbursement Purchase and (iii) interest shall accrue and be owing by the Seller to the LC Bank on such amount so paid by such LC Bank between such Honor Date and the LC Reimbursement Date at a rate per annum equal to the Discount Rate at such time; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that recourse to the Seller for such interest payment obligations shall be limited to the Collateral and all of the other rights, interests and assets from time to time owned by the Seller (including all rights and interests of the Seller under or in connection with the Transaction Documents).  Subject to satisfaction of the conditions set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article VI</font><font style="font-family:inherit;font-size:12pt;">, a Reimbursement Purchase will be made on the LC Reimbursement Date by the Purchasers in each Purchaser Group (which may be Conduits and/or Financial Institutions, as determined in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(a)</font><font style="font-family:inherit;font-size:12pt;">) by delivering their respective Pro Rata Shares of such LC Reimbursement Purchase (or, in the case of a Defaulting Financial Institution, by the Agent using funds in the LC Collateral Account, if available, to fund such Defaulting Financial Institution&#8217;s Pro Rata Share of the Reimbursement Purchase) directly to the applicable LC Bank on behalf of the Seller in respect of the Seller&#8217;s LC Reimbursement Obligation.  In the event an LC Bank is not reimbursed for the full amount of any drawing under any Letter of Credit by the applicable time on any LC Reimbursement Date (including, without limitation, because the conditions precedent to an LC Reimbursement Purchase deemed to have been requested by the Seller pursuant to this Section are not </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">satisfied), such LC Bank will promptly notify the Agent who will promptly notify each Financial Institution (or its Managing Agent) thereof (which notice may be delivered in writing, orally or by e-mail).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)      Upon its (or its Managing Agent&#8217;s) receipt of any notice (including, without limitation, oral notice) pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;that an LC Bank has not been reimbursed for the full  amount  of any drawing  under  any  Letter of Credit  by the  applicable time on  the applicable LC Reimbursement Date, each Financial Institution shall make available to such LC Bank an amount in immediately available funds equal to its Pro Rata Share of the amount of the drawing  (an  &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC  Participation  Advance</font><font style="font-family:inherit;font-size:12pt;">&#8221;).     For  the  avoidance  of  doubt,  each  Financial Institutions obligation under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (c)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall be binding upon such Financial Institution notwithstanding the limitation on recourse to the Seller set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(a)</font><font style="font-family:inherit;font-size:12pt;">.   If any Financial Institution so notified fails to make available to the applicable LC Bank the amount of such Financial Institution&#8217;s Pro Rata Share of such amount by 4:00 p.m. (New York time) on the LC Reimbursement Date, then interest shall accrue on such Financial Institution&#8217;s obligation to make such payment, from the LC Reimbursement Date to the date on which such Financial Institution makes such payment (i) at a rate per annum equal to the Federal Funds Rate during the first three days following the LC Reimbursement Date and (ii) at a rate per annum equal to the Prime Rate on and after the fourth day following the LC Reimbursement Date.   Each Financial Institution&#8217;s Commitment to make LC Participation Advances to the LC Banks in respect of participation interests acquired by it pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.6(c)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall survive and continue (notwithstanding the occurrence of the Amortization Date or any other termination of the purchase facility evidenced by this Agreement) until the last to occur of the following events: (i) the applicable LC Bank ceases to be obligated to issue or cause to be issued Letters of Credit hereunder, (ii) no Letter of Credit issued hereunder remains outstanding and un-cancelled or (iii) all Persons (other than the Seller) have been fully reimbursed for all payments made under or relating to Letters of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.9&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Repayment of LC Participation Advances</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       Upon receipt by an LC Bank for its account of immediately available funds from or for the account of the Seller (i) in reimbursement of any payment made by such LC Bank under a Letter of Credit with respect to which any Financial Institution has made an LC Participation Advance to such LC Bank, or (ii) in payment of Yield on the LC Reimbursement Purchases made or deemed to have been requested in connection with any such draw, such LC Bank will pay to each Financial Institution, ratably (based on the outstanding drawn amounts funded by each Financial Institution in respect of such Letter of Credit), in the same funds as those received by the LC Bank.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       If an LC Bank is required at any time to return to the Seller, or to a trustee, receiver, liquidator, custodian, or any official in any insolvency proceeding, any portion of the payments made by the Seller to such LC Bank pursuant to this Agreement in reimbursement of a payment made under a Letter of Credit or interest or fee thereon, each Financial Institution shall, on demand of the LC Bank, forthwith return to such LC Bank the amount of its Pro Rata Share of any amounts so returned by such LC Bank (including any interest on such amounts owing by such LC Bank to the Seller, or to a trustee, receiver, liquidator, custodian, or any official in any insolvency proceeding) </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;interest at the Federal Funds Rate, from the date the payment was returned by such LC Bank through, but not including, the date the payment is returned by such Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       If any Letters of Credit are outstanding and undrawn on the Amortization Date, the LC Collateral Account shall be funded from Collections (or, in the Seller&#8217;s sole discretion, by other funds available to the Seller) in an amount equal to the aggregate undrawn face amount of such Letters of Credit plus all related fees to accrue through the stated expiration dates thereof (such fees to accrue, as reasonably estimated by the applicable LC Bank, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Fee</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Expectation</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       Funds in the LC Collateral Account will be used to reimburse the LC Banks and (to the extent they have unreimbursed LC Participation Advances) the Financial Institutions for fees related to the Letters of Credit and for any draws on the Letters of Credit and LC Participation Advances which have not been reimbursed by the Seller or repaid from Collections. On each Settlement Date funds (if any) then on deposit in the LC Collateral Account shall be released to the Servicer for application as Collections in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">&#32;to the extent that, after giving effect to such release and all distributions of Collections and any Purchases on such Settlement Date, (i) the Purchaser Interest will not exceed 100%, and (ii) only if the Amortization  Date  has  occurred,  the  amount  of  the  funds  on  deposit  in  the  LC  Collateral Account will not be less than 100% of the LC Exposure at such time, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;the amount of the LC Fee Expectation at such time.  Any funds on deposit in the LC Cash Collateral Account after all Letters of Credit have expired, all draws on the Letters of Credit have been reimbursed, all LC Participation Advances have been repaid, all fees due with respect to the Letters of Credit have been paid in full, and the Amortization Date has occurred, shall be applied as Collections in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.10     </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Documentation</font><font style="font-family:inherit;font-size:12pt;">.   The Seller agrees to be bound by the terms of each Letter of Credit Application and by the applicable LC Bank&#8217;s reasonable interpretations of any Letter of Credit issued hereunder and by each LC Bank&#8217;s written regulations and customary practices relating to letters of credit, though the LC Bank&#8217;s reasonable interpretation of such regulations and practices may be different from the Seller&#8217;s own.  In the event of a conflict between the Letter of Credit Application and this Agreement, this Agreement shall govern.  It is understood and agreed that, except in the case of gross negligence or willful misconduct by an LC Bank, such LC Bank shall not be liable for any error, negligence and/or mistakes, whether of omission or commission, in following the Seller&#8217;s or the account party&#8217;s instructions or those contained in the Letters of Credit or any modifications, amendments or supplements thereto.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.11    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Determination to Honor Drawing Request</font><font style="font-family:inherit;font-size:12pt;">.   In determining whether to honor any request for drawing under any Letter of Credit by the beneficiary thereof, an LC Bank shall  be  responsible  only  to  determine  that  the  documents  and  certificates  required  to  be delivered under such Letter of Credit have been delivered and that they comply on their face with the requirements of such Letter of Credit and that any other drawing condition appearing on the face of such Letter of Credit has been satisfied in the manner so set forth.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.12    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Nature of LC Participations and LC Reimbursement Obligations</font><font style="font-family:inherit;font-size:12pt;">.   Each Financial Institution&#8217;s obligation in accordance with this Agreement to make LC Participation Advances as a result of a drawing under a Letter of Credit, and the obligations of the Seller to reimburse the applicable LC Bank upon a draw under a Letter of Credit, shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article I</font><font style="font-family:inherit;font-size:12pt;">&#32;under all circumstances, including the following circumstances:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        any set-off, counterclaim, recoupment, defense or other right which such Financial Institution may have against any LC Bank, the Agent, any Managing Agent, any Purchaser, any Seller Party or any other Person for any reason whatsoever;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)      the failure of any Seller Party or any other Person to comply with the conditions set forth in this Agreement for the making of a purchase, reinvestments, requests for Letters of Credit or otherwise, it being acknowledged that such conditions are not required for the making of LC Participation Advances hereunder;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      any lack of validity or enforceability of any Letter of Credit or any set-off, counterclaim, </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">recoupment, defense or other right which any Seller Party, any Originator or any Affiliate thereof on behalf of which a Letter of Credit has been issued may have against any LC Bank, the Agent, any Managing Agent, any Purchaser, any Seller Party or any other Person for any reason whatsoever;</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)      any claim of breach of warranty that might be made by any Seller Party, any LC Bank, any Financial Institution, any other Purchaser, the Agent, any Managing Agent or any other Person against the beneficiary of a Letter of Credit, or the existence of any claim, set-off, defense or other right which any Seller Party, any LC Bank, any Financial Institution, any other Purchaser, the Agent, any Managing Agent or any other Person may have at any time against a beneficiary, any successor beneficiary or any transferee of any Letter of Credit or the proceeds thereof (or any Persons for whom any such transferee may be acting), any LC Bank, any Financial Institution, the Agent, any Purchaser or any Managing Agent or any other Person, whether in connection with this Agreement, the transactions contemplated herein or any unrelated transaction (including any underlying transaction between any Seller Party or any Affiliate of any Seller Party and the beneficiary for which any Letter of Credit was procured);</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       the  lack  of  power  or  authority  of  any  signer  of,  or  lack  of  validity, sufficiency, accuracy, enforceability or genuineness of, any draft, demand, instrument, certificate or other document presented under any Letter of Credit, or any such draft, demand, instrument, certificate or other document proving to be forged, fraudulent, invalid, defective or insufficient in any respect or any statement therein being untrue or inaccurate in any respect, even if the Agent, any LC Bank, any Financial Institution, any Managing Agent, any Purchaser or any Seller Party has been notified thereof;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)      payment by an LC Bank under any Letter of Credit against presentation of a demand, draft or certificate or other document which does not comply with the terms of such Letter of Credit other than as a result of the gross negligence or willful misconduct of such LC Bank;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)     the solvency of, or any acts or omissions by, any beneficiary of any Letter of Credit, or any other Person having a role in any transaction or obligation relating to a Letter of Credit, or the existence, nature, quality, quantity, condition, value or other characteristic of any property or services relating to a Letter of Credit;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)    any failure by an LC Bank or any of its Affiliates to issue any Letter of Credit in the form requested by the Seller, unless such LC Bank has received written notice from the Seller of such failure within three Business Days after the LC Bank shall have furnished the Seller a copy of such Letter of Credit and such error is material and no drawing has been made thereon prior to receipt of such notice;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ix)&#160;&#160;&#160;&#160;any Material Adverse Effect;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(x)       any breach of this Agreement or any other Transaction Document by any party thereto;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xi)&#160;&#160;&#160;&#160;the bankruptcy or insolvency of any Seller Party, any Originator or any</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Affiliate of the foregoing;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xii)     the fact that an Amortization Event or a Potential Amortization Event shall have occurred and be continuing;</font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiii)&#160;&#160;&#160;&#160;the  fact  that  this  Agreement,  any  other  Transaction  Document  or  the obligations of any Seller Party hereunder or thereunder shall have been terminated; and</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiv)&#160;&#160;&#160;&#160;any other circumstance or happening whatsoever, whether or not similar to any of the foregoing.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.13    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Liability for Acts and Omissions</font><font style="font-family:inherit;font-size:12pt;">.  As between the Seller, on the one hand, and  the  Agent,  the  LC  Banks,  the  Financial  Institutions,  the  Managing  Agents  and  the Purchasers, on the other, the Seller assumes all risks of the acts and omissions of, or misuse of any Letter of Credit by, the respective beneficiaries of such Letter of Credit.  In furtherance and not in limitation of the foregoing, none of the Agent, the LC Banks, the Financial Institutions, the Managing Agents or the Purchasers shall be responsible for: (i) the form, validity, sufficiency, accuracy, genuineness or legal effect of any document submitted by any party in connection with the application for an issuance of any such Letter of Credit, even if it should in fact prove to be in any or all respects invalid, insufficient, inaccurate, fraudulent or forged (even if any LC Bank or any Financial Institution shall have been notified thereof); (ii) the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign any such Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, which may prove to be invalid or ineffective for any reason; (iii) the failure of the beneficiary of any such Letter of Credit, or any other party to which such Letter of Credit may be transferred, to comply fully with any conditions required in order to draw upon such Letter of Credit or any other claim of the Seller against any beneficiary of such Letter of Credit, or any such transferee, or any dispute between or among the Seller and any beneficiary of any Letter of Credit or any such transferee; (iv) errors, omissions, interruptions or delays in transmission or delivery of any messages, by mail, electronic mail, cable, telegraph, telex, facsimile or otherwise, whether or not they be encrypted; (v) errors in interpretation of technical terms; (vi) any loss or delay in the transmission or otherwise of any document required in order to make a drawing under any such Letter of Credit or of the proceeds thereof; (vii) the misapplication by the beneficiary of any such Letter of Credit of the proceeds of any drawing under such Letter of Credit; or (viii) any consequences arising from causes beyond the control of the Agent, the LC Banks, the Financial Institutions, the Managing Agents and the Purchasers, including any governmental acts, and none of the above shall affect or impair, or prevent the vesting of, any of any LC Bank&#8217;s rights or powers hereunder.  Nothing in the preceding sentence shall relieve any LC Bank from liability for its gross negligence or willful misconduct, as determined by a final non-appealable judgment of a court of competent jurisdiction, in connection with actions or omissions described in such </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clauses (i)</font><font style="font-family:inherit;font-size:12pt;">&#32;through </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(viii)</font><font style="font-family:inherit;font-size:12pt;">&#32;of such sentence.  In no event shall the Agent, the LC Banks, the Financial Institutions, the Managing Agents or the Purchasers or their respective Affiliates, be liable to any Seller Party or any other Person for any indirect, consequential, incidental, punitive, exemplary or special damages or expenses (including without limitation attorneys&#8217; fees), or for any damages resulting from any change in the value of any property relating to a Letter of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Without limiting the generality of the foregoing, the Agent, the LC Banks, the Financial Institutions, the Managing Agents and the Purchasers and each of its Affiliates (i) may rely on any written communication believed in good faith by such Person to have been authorized or given by or on behalf of the applicant for a Letter of Credit; (ii) may honor any presentation if the documents presented appear on their face to comply with the terms and conditions of the relevant Letter of Credit; (iii) may honor a previously dishonored presentation under a Letter of Credit, whether such dishonor was pursuant to a court order, to settle or compromise any claim of wrongful dishonor, or otherwise, and shall be entitled to reimbursement to the same extent as if such presentation had initially been honored, together with any interest paid by the applicable LC Bank or its Affiliates; (iv) may honor any drawing that is payable upon presentation of a statement  advising  negotiation  or  payment,  upon  receipt  of  such  statement  (even  if  such statement indicates that a draft or other document is being delivered separately), and shall not be liable for any failure </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">of any such draft or other document to arrive, or to conform in any way with the relevant Letter of Credit; (v) may pay any paying or negotiating bank claiming that it rightfully honored under the laws or practices of the place where such bank is located; and (vi) may settle or adjust any claim or demand made on the Agent, the LC Banks, the Financial Institutions, the Managing Agents or the Purchasers or their respective Affiliates, in any way related to any order issued at the applicant&#8217;s request to an air carrier, a letter of guarantee or of indemnity issued to a carrier or any similar document (each an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Order</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and may honor any drawing  in  connection  with  any  Letter  of  Credit  that  is  the  subject  of  such  Order, notwithstanding that any drafts or other documents presented in connection with such Letter of Credit fail to conform in any way with such Letter of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In furtherance and extension and not in limitation of the specific provisions set forth above, any action taken or omitted by any LC Bank under or in connection with any Letter of Credit issued by it or any documents and certificates delivered thereunder, if taken or omitted in good faith and without gross negligence or willful misconduct, as determined by a final non- appealable judgment of a court of competent jurisdiction, shall not put such LC Bank under any resulting liability to any Seller Party, the Agent, any Financial Institution, any other Purchaser, any Managing Agent or any other Person.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.14&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Defaulting Financial Institutions</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       If any Financial Institution becomes a Defaulting Financial Institution at any time when there are undrawn Letters of Credit outstanding, then such Defaulting Financial Institution shall (i) within two (2) Business Days following notice by any LC Bank, cash collateralize for the benefit of the LC Banks a portion of the amount of the then outstanding Letters of Credit equal to such Defaulting Financial Institution&#8217;s Pro Rata Share of the undrawn stated amount of outstanding Letters of Credit by depositing such amount into the Defaulting Financial Institution Account, and (ii) maintain funds in the Defaulting Financial Institution Account to cash collateralize such Defaulting Financial Institution&#8217;s Pro Rata Share of the undrawn stated amount of outstanding Letters of Credit.  The Agent shall apply funds deposited into the Defaulting Financial Institution Account to satisfy a Defaulting Financial Institution&#8217;s obligation to fund its portion of an LC Participation Advance required to be made by such Defaulting Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       No  amount  payable  by  the  Seller  for  the  account  of  a  Defaulting  Financial Institution (whether on account of Capital, Yield, fees, indemnity payments or other amounts) shall be paid or distributed to such Defaulting Financial Institution (or its Managing Agent), but instead  shall  be deposited  to  the Defaulting Financial  Institution  Account  until the amount therein is equal to the amount of such Defaulting Financial Institution&#8217;s Pro Rata Share of the stated amount of the undrawn Letters of Credit that is not cash collateralized, and to the extent of any remaining amounts, to pay to such Defaulting Financial Institution amounts owed to it.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       Any funds on deposit in the Defaulting Financial Institution Account after all Letters of Credit have expired, all draws on the Letters of Credit have been reimbursed, all LC Participation Advances have been repaid, all fees due with respect to the Letters of Credit have been paid in full, and the Amortization Date has occurred, shall be applied as Collections in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       No Defaulting Financial Institution shall have any right to approve or disapprove any  amendment,  waiver  or  consent  under  this  Agreement  (and  any  amendment,  waiver  or consent which by its terms requires the consent of all Financial Institutions or each affected Financial Institution may be effected with the consent of the applicable Financial Institutions other than Defaulting Financial Institutions), except that (x) the Commitment of any Defaulting Financial Institution may not be increased or extended without the consent of such Financial Institution and (y) any waiver, amendment or modification requiring the consent of all Financial Institutions  or  each  affected  Financial  Institution  that  by  its  terms  affects  </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">any  Defaulting Financial Institution more adversely than other affected Financial Institutions shall require the consent of such Defaulting Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE II. PAYMENTS AND COLLECTIONS</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payments</font><font style="font-family:inherit;font-size:12pt;">.   Notwithstanding any limitation on recourse contained in this Agreement, Seller will immediately pay to the Agent or relevant Purchaser or Purchasers, as applicable, when due, for the account of the Agent or the relevant Purchaser or Purchasers on a full recourse basis, (i) such fees as set forth in each Fee Letter, (ii) all CP Costs, (iii) all amounts payable as Yield, (iv) all amounts payable as Deemed Collections (which shall be due and payable by Seller and applied to reduce the outstanding Aggregate Capital or the LC Adjusted Exposure in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 2.2</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">2.3</font><font style="font-family:inherit;font-size:12pt;">&#32;hereof), (v) all amounts payable, if required, pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.6</font><font style="font-family:inherit;font-size:12pt;">, (vi) all amounts payable pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article X</font><font style="font-family:inherit;font-size:12pt;">, if any, (vii) all Servicer costs and expenses, including the Servicing Fee, in connection with servicing, administering and collecting the Receivables, (viii) all Broken Funding Costs and (ix) all Default Fees (collectively, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Obligations</font><font style="font-family:inherit;font-size:12pt;">&#8221;).   If any Person fails to pay any of the Obligations when due, such Person agrees to pay, on demand, the Default Fee in respect thereof until paid.  Notwithstanding the foregoing, no provision of this Agreement or any Fee Letter shall require the payment or permit the collection of any amounts hereunder in excess of the maximum permitted by applicable law. If at any time Seller receives any Collections or is deemed to receive any Collections, Seller will immediately pay such Collections or Deemed Collections to the Servicer for application in accordance with the terms and conditions hereof and, at all times prior to such payment, such Collections shall be held in trust by Seller for the exclusive benefit of the Purchasers and the Agent.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collections Prior to Amortization</font><font style="font-family:inherit;font-size:12pt;">.   Prior to the Amortization Date, any Collections and/or Deemed Collections received by the Servicer shall be set aside and held in trust by the Servicer for the benefit of the Agent and the Purchasers for the payment of any accrued and unpaid Aggregate Unpaids or for a Reinvestment as provided in this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.2</font><font style="font-family:inherit;font-size:12pt;">.  If at any time any Collections and/or Deemed Collections are received by the Servicer prior to the Amortization Date, (i) the Servicer shall set aside (x) the Termination Percentage (hereinafter defined) of Collections evidenced by the Purchaser Interests of each Terminating Financial Institution and its related Conduit(s), if any, (y) Collections to be used to effect any Aggregate Reduction in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.3</font><font style="font-family:inherit;font-size:12pt;">&#32;and (z) amounts necessary to pay Obligations due on the next succeeding Settlement Date and (ii) Seller hereby requests and, subject to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 6.2</font><font style="font-family:inherit;font-size:12pt;">, the Purchasers (other than any Terminating Financial Institutions and their related Conduits, if any) hereby agree to make, simultaneously with such receipt, a reinvestment (each a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reinvestment</font><font style="font-family:inherit;font-size:12pt;">&#8221;) with that portion of the balance of each and every Collection and Deemed Collection  received  by  the  Servicer  that  is  part  of  any  Purchaser  Interest  (other  than  any Purchaser Interests of Terminating Financial Institutions and their related Conduits, if any), such that after giving effect to such Reinvestment, the amount of Capital of such Purchaser Interest and the LC Adjusted Exposure, in each case, immediately after such receipt and corresponding Reinvestment shall be equal to the amount of Capital and the LC Adjusted Exposure, in each case, immediately prior to such receipt (but giving effect to any reduction thereof pursuant to application of an Aggregate Reduction).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On each Settlement Date prior to the occurrence of the Amortization Date, the Servicer shall remit to the Agent&#8217;s or the applicable Purchaser&#8217;s account (or, in the case of any amount to be applied in reduction of the LC Adjusted Exposure, to the LC Collateral Account), no later than 12:00 noon (New York time), the amounts set aside during the preceding Settlement Period that have not been subject to a Reinvestment to be applied in the following order of priority (if not previously paid in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.1</font><font style="font-family:inherit;font-size:12pt;">):</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">first</font><font style="font-family:inherit;font-size:12pt;">, to reduce unpaid Obligations,</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">second</font><font style="font-family:inherit;font-size:12pt;">, to reduce the Capital of all Purchaser Interests of Terminating Financial Institutions and their respective related Conduits (if any), applied ratably to each Terminating Financial Institution (and its related Conduit(s), if any) according to its respective Termination Percentage,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">third</font><font style="font-family:inherit;font-size:12pt;">, if applicable, to ratably reduce the Aggregate Capital of all Purchasers (other than any Terminating Financial Institutions) and/or to reduce the LC Adjusted Exposure by deposit of funds to the LC Collateral Account, in each case, to the extent required to fund any Aggregate Reduction on such Settlement Date in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.3</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">2.6</font><font style="font-family:inherit;font-size:12pt;">, as applicable, and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">fourth</font><font style="font-family:inherit;font-size:12pt;">, the balance, if any, to Seller on such Settlement Date.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Prior to the occurrence of the Amortization Date, each Terminating Financial Institution (and its related Conduit(s), if any) shall be allocated a ratable portion of Collections received from and after the Scheduled Facility Termination Date that such Terminating Financial Institution did not consent to extend (as to such Terminating Financial Institution and its related Conduit(s),  if  any,  the  &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial  Institution  Termination  Date</font><font style="font-family:inherit;font-size:12pt;">&#8221;),  until  such  Terminating Financial Institution&#8217;s and its related Conduit(s)&#8217;s (if any) Capital shall be paid in full.  This ratable portion shall be calculated on the Financial Institution Termination Date of such Terminating Financial Institution as a percentage (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination Percentage</font><font style="font-family:inherit;font-size:12pt;">&#8221;) equal to (i) Capital of such Terminating Financial Institution outstanding on its Financial Institution Termination Date, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">divided</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">by</font><font style="font-family:inherit;font-size:12pt;">&#32;(ii) the sum of (x) the Aggregate Capital outstanding on such Financial Institution Termination Date and (y) the LC Adjusted Exposure on such Financial</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Institution Termination Date.  Each Terminating Financial Institution&#8217;s Termination Percentage shall remain constant prior to the Amortization Date.  On and after the Amortization Date, each Termination  Percentage  shall  be  disregarded,  and  each  Terminating  Financial  Institution&#8217;s Capital shall be reduced ratably with all Financial Institutions in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.3</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.3      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collections Following Amortization</font><font style="font-family:inherit;font-size:12pt;">.   On the Amortization Date and on each day thereafter, the Servicer will set aside and hold in trust, for the holder of each Purchaser Interest, (a) the percentage evidenced by such Purchaser Interest of all Collections and Deemed Collections received on such day, (b) to the extent not set aside and held in trust pursuant to the immediately  preceding  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause  (a)</font><font style="font-family:inherit;font-size:12pt;">,  an  additional  amount  for  payment  to  the  LC  Collateral Account equal to the sum of (i) an amount necessary to reduce the LC Adjusted Exposure to zero and (ii) an amount equal to the LC Fee Expectation at such time, (c) an additional amount of Collections and Deemed Collections for the payment of any Aggregate Unpaids owed by Seller and not previously paid by Seller in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.1</font><font style="font-family:inherit;font-size:12pt;">&#32;and (d) to the extent not set aside and held in trust pursuant to the immediately preceding </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (c)</font><font style="font-family:inherit;font-size:12pt;">, an additional amount for the payment of any amounts payable pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article X</font><font style="font-family:inherit;font-size:12pt;">&#32;owed by Seller and not previously paid by Seller in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.1</font><font style="font-family:inherit;font-size:12pt;">.  On and after the Amortization Date, the Servicer will, at any time upon the request from time to time by (or pursuant to standing instructions from) the Agent (i) remit to the Agent&#8217;s or applicable Purchaser&#8217;s account (or in the case of amounts applied in reduction of the LC Adjusted Exposure, to the LC Collateral Account) the amounts set aside pursuant to the preceding sentence, and (ii) apply such amounts to reduce the Capital associated with each such Purchaser Interest, the LC Adjusted Exposure and any other Aggregate Unpaids.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.4      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Application of Collections</font><font style="font-family:inherit;font-size:12pt;">.   If the amount of funds held in trust by the Servicer are not sufficient to pay in full of the aforementioned amounts pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.2</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">2.3</font><font style="font-family:inherit;font-size:12pt;">&#32;(as applicable), the Servicer will distribute such funds in the following order of priority:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">first</font><font style="font-family:inherit;font-size:12pt;">, to the payment of the Servicer&#8217;s reasonable out-of-pocket costs and expenses in </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">connection with servicing, administering and collecting the Receivables, including the Servicing Fee, if Seller or one of its Affiliates is not then acting as the Servicer,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">second</font><font style="font-family:inherit;font-size:12pt;">, to the reimbursement of the Agent&#8217;s, the Purchasers&#8217; and the Managing</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agents&#8217; costs of collection and enforcement of this Agreement,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">third</font><font style="font-family:inherit;font-size:12pt;">, ratably to the payment of all accrued and unpaid fees under any Fee Letter, CP Costs and Yield,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">fourth</font><font style="font-family:inherit;font-size:12pt;">,  to  the  ratable  reduction  of  Aggregate  Capital  (without  regard  to  any</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Termination Percentage) until reduced to zero,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">fifth</font><font style="font-family:inherit;font-size:12pt;">, to the LC Collateral Account (i) the amount necessary to reduce the LC Adjusted Exposure to zero and (ii) an amount equal to the LC Fee Expectation at such time,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">sixth</font><font style="font-family:inherit;font-size:12pt;">, for the ratable payment of all other unpaid Obligations, provided that to the extent such Obligations relate to the payment of Servicer costs and expenses, including the Servicing Fee, when Seller or one of its Affiliates is acting as the Servicer, such costs and expenses will not be paid until after the payment in full of all other Obligations, and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">seventh</font><font style="font-family:inherit;font-size:12pt;">, after the Aggregate Unpaids have been indefeasibly reduced to zero, to Seller.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Collections applied to the payment of Aggregate Unpaids shall be distributed in accordance with the aforementioned provisions, and, giving effect to each of the priorities set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.4</font><font style="font-family:inherit;font-size:12pt;">&#32;above, shall be shared ratably (within each priority) among the Agent and the Purchasers in accordance with the amount of such Aggregate Unpaids owing to each of them in respect of each such priority.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.5      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payment Rescission</font><font style="font-family:inherit;font-size:12pt;">.  No payment of any of the Aggregate Unpaids shall be considered paid or applied hereunder to the extent that, at any time, all or any portion of such payment or application is rescinded by application of law or judicial authority, or must otherwise be returned or refunded for any reason.  Seller will remain obligated for the amount of any payment or application so rescinded, returned or refunded, and will promptly pay to the Agent or applicable Managing Agent(s) (for application to the Person or Persons who suffered such rescission, return or refund) the full amount thereof, plus the Default Fee from the date of any such rescission, return or refunding.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.6      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Maximum  Purchaser  Interests</font><font style="font-family:inherit;font-size:12pt;">.    Seller  shall  ensure  that  the  Purchaser Interests of the Purchasers shall at no time exceed in the aggregate 100%.  If the aggregate of the Purchaser Interests of the Purchasers exceeds 100%, Seller will pay to the Purchasers (ratably based on the ratio of each Purchaser&#8217;s Capital at such time to the Aggregate Capital at such time) and/or, to the extent the LC Adjusted Exposure is greater than zero, shall deposit to the LC Collateral Account, in either case, within one (1) Business Day, an amount or amounts to be applied to reduce the Aggregate Capital or to reduce the LC Adjusted Exposure (as the case may be), such that after giving effect to such payment and/or deposit the aggregate of the Purchaser Interests equals or is less than 100%.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.7      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Clean Up Call</font><font style="font-family:inherit;font-size:12pt;">.  In addition to Seller&#8217;s rights pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.3</font><font style="font-family:inherit;font-size:12pt;">, Seller shall have the right (after providing written notice to the Agent and each Managing Agent in accordance with the Required Notice Period), at any time when the sum of the Aggregate Capital plus the LC Adjusted Exposure is less than an amount equal to 10.0% of the maximum sum of the Aggregate Capital plus the LC </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Adjusted Exposure at any time since November 19, 2007, to repurchase from the Purchasers all, but not less than all, of the then outstanding Purchaser Interests.  The purchase price in respect thereof shall be an amount equal to the Aggregate Unpaids through the date of such repurchase, payable in immediately available funds.  Such repurchase shall be without representation, warranty or recourse of any kind by, on the part of, or against any Purchaser, any Managing Agent or the Agent.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.8      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Demand for Payment of Demand Loans</font><font style="font-family:inherit;font-size:12pt;">.   At any time when any Seller Party is required to make any payment hereunder and such Seller Party does not have sufficient funds to make such payment, Seller shall demand payment of the Demand Loans (or such portion of the Demand Loans as would be sufficient to make such payment) and remit the amount received as a result of such demand to the Servicer, the Purchasers or the Agent (as applicable) for disposition as provided herein.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:242px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE III. CONDUIT FUNDING</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CP Costs</font><font style="font-family:inherit;font-size:12pt;">.  Seller will pay CP Costs with respect to the Capital associated with each Purchaser Interest of the Conduits for each day that any Capital in respect of any such Purchaser Interest is outstanding.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CP Costs Payments</font><font style="font-family:inherit;font-size:12pt;">.   On each Settlement Date, Seller will pay to each Conduit an aggregate amount equal to all accrued and unpaid CP Costs in respect of the Capital associated with all Purchaser Interests of such Conduit for the immediately preceding Accrual Period in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.3      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Calculation of CP Costs</font><font style="font-family:inherit;font-size:12pt;">.  On each Determination Date, each Conduit will calculate the aggregate amount of its CP Costs for the applicable Accrual Period and will notify the Seller of such aggregate amount.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:269px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE IV.</font></div><div style="line-height:120%;text-align:center;padding-left:182px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">FINANCIAL INSTITUTION FUNDING</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Institution Funding</font><font style="font-family:inherit;font-size:12pt;">.   Each Purchaser Interest of the Financial Institutions shall accrue Yield for each day during its Tranche Period at either the LIBO Rate or the Prime Rate in accordance with the terms and conditions hereof.  Until Seller gives notice to the Agent and the applicable Managing Agent(s) of another Discount Rate in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.4</font><font style="font-family:inherit;font-size:12pt;">, the initial Discount Rate for any Purchaser Interest transferred to the Financial Institutions pursuant to the terms and conditions hereof shall be the Prime Rate.  If any Purchaser Interest of any Conduit is assigned or transferred to, or funded by, any Related Financial Institution of such Conduit pursuant to any Funding Agreement or to or by any other Person, each such Purchaser Interest so assigned, transferred or funded shall each be deemed to have a new Tranche Period commencing on the date of any such transfer or funding and shall accrue Yield for each day during its Tranche Period at either the LIBO Rate or the Prime Rate in accordance with the terms and conditions hereof as if each such Purchaser Interest was held by a Financial Institution, and with respect to each such Purchaser Interest, the assignee or transferee thereof or lender with respect thereto shall be deemed to be a Financial Institution in the transferring Conduit&#8217;s Purchaser Group solely for the purposes of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 4.1</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">4.2</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">4.3</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">4.4</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">4.5</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Calculation of Yield; Yield Payments</font><font style="font-family:inherit;font-size:12pt;">.  On each Determination Date, each Financial Institution shall notify the Agent or its Managing Agent, as applicable (and the Agent and Managing Agents shall promptly notify Seller), of the aggregate amount of accrued and unpaid Yield owing in respect of such </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Financial Institution&#8217;s Purchaser Interests which is to be paid on the next occurring Settlement Date.  On the Settlement Date for each Purchaser Interest of the Financial Institutions, Seller will pay to each Financial Institution an aggregate amount equal to all accrued and unpaid Yield for the entire Tranche Period of each Purchaser Interest funded by such Financial Institution in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.3      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Selection and Continuation of Tranche Periods</font><font style="font-family:inherit;font-size:12pt;">.   (a)   With consultation from (and approval by) the Agent and the applicable Managing Agent, Seller will from time to time request Tranche Periods for the Purchaser Interests of the Financial Institutions, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that, if at any time the Financial Institutions shall have a Purchaser Interest, Seller shall always request Tranche Periods such that at least one Tranche Period shall end on the date specified in clause (A) of the definition of Settlement Date.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Seller, the Agent or the applicable Managing Agent, upon notice to and consent by the other received at least three (3) Business Days prior to the last day of a Tranche Period (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terminating Tranche</font><font style="font-family:inherit;font-size:12pt;">&#8221;) for any Purchaser Interest, may, effective on such last day, divide any such  Purchaser  Interest  into  multiple Purchaser  Interests  by subdividing the associated Capital  for  such  Purchaser  Interest  into  smaller  amounts  of  Capital  or  combine  any  such Purchaser Interest with one or more other Purchaser Interests which either have a Terminating Tranche ending on such day or are newly created on such day by combining the associated Capital for such Purchaser Interests, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that in no event may a Purchaser Interest of any Purchaser be combined with a Purchaser Interest of any other Purchaser.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.4      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Institution Discount Rates</font><font style="font-family:inherit;font-size:12pt;">.  Seller may select the LIBO Rate or the Prime Rate for each Purchaser Interest of the Financial Institutions.  Seller shall by 12:00 noon (New York time): (i) at least three (3) Business Days prior to the expiration of any Terminating Tranche with respect to which the LIBO Rate is being requested as a new Discount Rate and (ii) at least one (1) Business Day prior to the expiration of any Terminating Tranche with respect to which the Prime Rate is being requested as a new Discount Rate, give the Agent or the applicable Managing Agent irrevocable notice of the new Discount Rate for the Purchaser Interest associated with such Terminating Tranche.  Until Seller gives notice to the Agent or the applicable Managing Agent of another Discount Rate, the initial Discount Rate for any Purchaser Interest transferred to the Financial Institutions pursuant to the terms and conditions hereof (or assigned  or transferred  to,  or  funded  by,  any  Related  Financial  Institution  pursuant  to  any Funding Agreement or to or by any other Person) shall be the Prime Rate.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.5&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Suspension of the LIBO Rate</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       If  any  Financial  Institution  notifies  the  Agent  or  its  Managing  Agent,  as applicable, that it has determined that funding its Pro Rata Share of the Purchaser Interests of the Financial Institutions in such Financial Institution&#8217;s Purchaser Group at the LIBO Rate would violate any applicable law, rule, regulation, or directive of any governmental or regulatory authority, whether or not having the force of law, or that (i) deposits of a type and maturity appropriate to match fund its Purchaser Interests at the LIBO Rate are not available or (ii) the LIBO Rate does not accurately reflect the cost of acquiring or maintaining a Purchaser Interest at the LIBO Rate, then the Agent or such Managing Agent, as applicable, shall suspend the availability of the LIBO Rate for the Financial Institutions in such Financial Institution&#8217;s Purchaser Group and require Seller to select the Prime Rate for any Purchaser Interest funded by the Financial Institutions in such Financial Institution&#8217;s Purchaser Group accruing Yield at the LIBO Rate.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)&#160;&#160;&#160;&#160;If  less  than  all  of  the  Financial  Institutions  in  such  Financial  Institution&#8217;s</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Purchaser Group give a notice to the Agent or such Purchaser Group&#8217;s Managing Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.5(a)</font><font style="font-family:inherit;font-size:12pt;">, each Financial Institution which gave such a notice shall be obliged, at the request of Seller, the Conduit in such Financial Institution&#8217;s Purchaser Group or the Agent or such Managing Agent, </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">to assign all of its rights and obligations hereunder to (i) another Financial Institution  in  such  Financial  Institution&#8217;s  Purchaser  Group  or  (ii)  another  funding  entity nominated by Seller or the Agent or such Managing Agent that is acceptable to the Conduit in such Financial Institution&#8217;s Purchaser Group and willing to participate in this Agreement through the Scheduled Facility Termination Date in the place of such notifying Financial Institution; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that (i) the notifying Financial Institution receives payment in full, pursuant to an Assignment Agreement, of an amount equal to such notifying Financial Institution&#8217;s Pro Rata Share of the Capital and Yield owing to all of the Financial Institutions in such Financial Institution&#8217;s Purchaser Group and all accrued but unpaid fees and other costs and expenses payable in respect of its Pro Rata Share of the Purchaser Interests of the Financial Institutions in such Financial Institution&#8217;s Purchaser Group, and (ii) the replacement Financial Institution otherwise satisfies the requirements of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.6&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Extension of Scheduled Facility Termination Date</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)      Seller may request one or more 364-day extensions of the Scheduled Facility Termination Date then in effect by giving written notice of such request to the Agent (each such notice an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Extension Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221;) at least 60 days prior to the Scheduled Facility Termination Date then in effect.   After the Agent&#8217;s receipt of any Extension Notice, the Agent shall promptly advise each Financial Institution of such Extension Notice.  Each Financial Institution may, in its sole discretion, by a revocable notice (a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Consent Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221;) given to the Agent on or prior to the 30</font><font style="font-family:inherit;font-size:8pt;">th  </font><font style="font-family:inherit;font-size:12pt;">day prior to the Scheduled Facility Termination Date then in effect (such period from the date of the Extension Notice to such 30th day being referred to herein as the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Consent Period</font><font style="font-family:inherit;font-size:12pt;">&#8221;), consent to such extension of such Scheduled Facility Termination Date; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that, except as provided in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(b)</font><font style="font-family:inherit;font-size:12pt;">, such extension shall not be effective with respect to any of the Financial Institutions if any one or more Financial Institutions:  (i) notifies the Agent during the Consent  Period  that  such  Financial  Institution  either does  not  wish  to  consent  to  such extension or wishes to revoke its prior Consent Notice or (ii) fails to respond to the Agent within the Consent Period (each Financial Institution that does not wish to consent to such extension or wishes to revoke its prior Consent Notice or fails to respond to the Agent within the Consent Period is herein referred to as a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-Renewing Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  If none of the events described in the foregoing </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clauses (i)</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(ii)</font><font style="font-family:inherit;font-size:12pt;">&#32;occurs during the Consent Period and all Consent Notices have been received, then, the Scheduled Facility Termination Date shall be irrevocably extended until the date that is 364 days after the Scheduled Facility Termination Date then in effect.  The Agent shall promptly notify Seller of any Consent Notice or other notice received by the Agent pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(a)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)      Upon receipt of notice from the Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;of any Non- Renewing Financial Institution or that the Scheduled Facility Termination Date has not been extended, one or more of the Financial Institutions (including any Non-Renewing Financial Institution) may proffer to the Agent the names of one or more institutions meeting the criteria set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1(b)(i)</font><font style="font-family:inherit;font-size:12pt;">&#32;that are willing to accept assignments of and assume the rights and obligations under this Agreement and the other applicable Transaction Documents of the Non- Renewing Financial Institution and of the Conduit(s) (if any) in its Purchaser Group.  Provided the proffered name(s) are acceptable to the Agent and the LC Banks (in their sole discretion), the Agent shall notify the remaining Financial Institutions of such fact, and, subject to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (d)</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;">below, the then existing Scheduled Facility Termination Date shall be extended for an additional</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">364 days upon satisfaction of the conditions for an assignment in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1</font><font style="font-family:inherit;font-size:12pt;">&#32;and the Commitment of each Non-Renewing Financial Institution shall be reduced to zero.  If the rights and obligations under this Agreement and the other applicable Transaction Documents of each Non-Renewing Financial Institution and of the Conduit(s) (if any) in each of their Purchaser Groups are not assigned as contemplated by this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;(each such Non-Renewing Financial Institution whose (or whose related Conduit&#8217;s) rights and obligations under this Agreement and the other applicable Transaction Documents </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">are not so assigned is herein referred to as a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terminating Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and at least one Financial Institution is not a Non- Renewing Financial Institution, the then existing Scheduled Facility Termination Date shall be extended for an additional 364 days; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that (i) the Purchase Limit shall be reduced on the Financial Institution Termination Date applicable to each Terminating Financial Institution by an aggregate amount equal to the Terminating Commitment Availability of each Terminating Financial Institution as of such date and shall thereafter continue to be reduced by amounts equal to any reduction in the Capital of any Terminating Financial Institution (after application  of  Collections  pursuant  to  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections  2.2</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;and  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">2.3</font><font style="font-family:inherit;font-size:12pt;">),  (ii)  the  Purchaser  Group Commitment of each Purchaser Group shall be reduced by the aggregate amount of the Terminating Commitment Amount of each Terminating Financial Institution in such Purchaser Group and (iii) the Commitment of each Terminating Financial Institution shall be reduced to zero on the Financial Institution Termination Date applicable to such Terminating Financial Institution.  Subject to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (d)</font><font style="font-family:inherit;font-size:12pt;">&#32;below, upon reduction to zero of all of the Purchaser Interests of a Terminating Financial Institution and of its related Conduit(s) (is any) (after application of Collections thereto pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 2.2</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">2.3</font><font style="font-family:inherit;font-size:12pt;">) and payment in full of all other amounts required to be paid to such Terminating Financial Institution and such Conduit(s) (if any) hereunder,  all  rights  and  obligations  of  such  Terminating  Financial  Institution  and  such Conduit(s) (if any) hereunder shall be terminated and such Terminating Financial Institution and each such Conduit (if any) shall no longer be a &#8220;Financial Institution&#8221; or a &#8220;Conduit&#8221;, as applicable; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that the provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article X</font><font style="font-family:inherit;font-size:12pt;">&#32;shall continue in effect for its benefit with respect to  Purchaser  Interests held  by such  Financial  Institution and any such Conduit prior to its termination as a Financial Institution or Conduit, as applicable.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       Any  requested  extension  may  be  approved  or  disapproved  by  a  Financial Institution in its sole discretion.   In the event that the Commitments are not extended in accordance with the provisions of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6</font><font style="font-family:inherit;font-size:12pt;">, the Commitment of each Financial Institution (other than its commitment to make LC Participation Advances hereunder) shall be reduced to zero on the Scheduled Facility Termination Date.  Upon reduction to zero of the Commitment of a Financial Institution, reduction of the LC Exposure to zero, reduction to zero of the Capital of all of the Purchaser Interests of such Financial Institution and of each Conduit (if any) in its Purchaser Group and payment in full of all other amounts required to be paid to such Financial Institution and any such Conduit hereunder all rights and obligations of such Financial Institution and any such Conduit hereunder shall be terminated and such Financial Institution and any such Conduit shall no longer be a &#8220;Financial Institution&#8221; or &#8220;Conduit&#8221;, as applicable; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that the provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article X</font><font style="font-family:inherit;font-size:12pt;">&#32;shall continue in effect for its benefit with respect to Purchaser  Interests  held  by  such  Financial  Institution  and  any  such  Conduit  prior  to  its termination as a Financial Institution or Conduit, as applicable.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       Notwithstanding   the   foregoing,   no   extension   of   the   Scheduled   Facility Termination Date pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall occur at any time when the LC Exposure is greater than  zero unless  each  LC  Bank has  consented in writing to such extension, which consents may be granted or withheld in each LC Bank&#8217;s sole discretion.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE V. </font></div><div style="line-height:120%;text-align:center;padding-left:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">REPRESENTATIONS AND WARRANTIES</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties of the Seller Parties</font><font style="font-family:inherit;font-size:12pt;">.   Each Seller Party hereby represents and warrants to the Agent, the Managing Agents and the Purchasers, only as to itself and as applicable to it (on a several basis and not jointly), subject to the last paragraph of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 5.1</font><font style="font-family:inherit;font-size:12pt;">&#32;and subject to the limitations set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 6.2(i)</font><font style="font-family:inherit;font-size:12pt;">, on and as of the date hereof, the date of each Incremental Purchase and the date of each Reinvestment that:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Limited Liability Company Existence and Power</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party is a limited liability </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">company duly organized, validly existing and in good standing under the laws of its state of organization, and is duly qualified to do business and is in good standing as a foreign entity, and has and holds all limited liability company power and all governmental licenses, authorizations, consents and approvals required to carry on its business in each jurisdiction in which its business is conducted except where the failure to so qualify or so hold could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Power and Authority; Due Authorization, Execution and Delivery</font><font style="font-family:inherit;font-size:12pt;">.  The execution and delivery by such Seller Party of this Agreement and each other Transaction Document to which it is a party, and the performance of its obligations hereunder and thereunder and, in the case of Seller, Seller&#8217;s use of the proceeds of purchases made hereunder, are within its limited liability company powers and authority and have been duly authorized by all necessary limited liability company action on its part.  This Agreement and each other Transaction Document to which such Seller Party is a party has been duly executed and delivered by such Seller Party.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Conflict</font><font style="font-family:inherit;font-size:12pt;">.  The execution and delivery by such Seller Party of this Agreement and  each  other  Transaction  Document  to  which  it  is  a  party,  and  the  performance  of  its obligations hereunder and thereunder do not contravene or violate (i) its articles of organization or operating agreement (or equivalent organizational documents), (ii) any law, rule or regulation applicable to it, (iii) any restrictions under any agreement, contract or instrument to which it is a party or by which it or any of its property is bound, or (iv) any order, writ, judgment, award, injunction or decree binding on or affecting it or its property, and do not result in the creation or imposition of any Adverse Claim on assets of such Seller Party or its Subsidiaries (except as created hereunder) except, in any case, where such contravention or violation could not reasonably be expected to have a Material Adverse Effect; and no transaction contemplated hereby requires compliance with any bulk sales act or similar law.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governmental Authorization</font><font style="font-family:inherit;font-size:12pt;">.  Other than the filing of the financing statements required hereunder, no authorization or approval or other action by, and no notice to or filing with, any Governmental Authority or regulatory body is required for the due execution and delivery by such Seller Party of this Agreement and each other Transaction Document to which it is a party and the performance of its obligations hereunder and thereunder.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Actions, Suits</font><font style="font-family:inherit;font-size:12pt;">.  There are no actions, suits or proceedings pending, or to the best of such Seller Party&#8217;s knowledge, threatened, against or affecting such Seller Party, or any of its properties, in or before any court, arbitrator or other body, that could reasonably be expected to have a Material Adverse Effect.  Such Seller Party is not in default with respect to any order of any court, arbitrator or governmental body.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Binding Effect</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement and each other Transaction Document to which such Seller Party is a party constitute the legal, valid and binding obligations of such Seller Party enforceable against such Seller Party in accordance with their respective terms, except as such enforcement  may  be  limited  by  applicable  bankruptcy,  insolvency,  reorganization  or  other similar laws relating to or limiting creditors&#8217; rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Accuracy of Information</font><font style="font-family:inherit;font-size:12pt;">.   All information heretofore furnished by such Seller Party or any of its Affiliates to the Agent, the Managing Agents or the Purchasers for purposes of or in connection with this Agreement, any of the other Transaction Documents or any transaction contemplated hereby or thereby is, and all such information hereafter furnished by such Seller Party or any of its Affiliates to the Agent, the Managing Agents or the Purchasers will be, true and accurate in every material respect on the date such information is stated or certified and does not and will not contain any material misstatement of fact or omit </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">to state a material fact or any fact necessary to make the statements contained therein not misleading.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Jurisdiction of Organization; Places of Business, etc</font><font style="font-family:inherit;font-size:12pt;">.   </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit III</font><font style="font-family:inherit;font-size:12pt;">&#32;correctly sets forth such Seller Party&#8217;s legal name, jurisdiction of organization, Federal Employer&#8217;s Identification Number and State Organizational Identification Number.  The offices where such Seller Party keeps all of its Records are located at the address(es) listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit III</font><font style="font-family:inherit;font-size:12pt;">, or such other location of which the Agent and each Managing Agent have been notified in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.2(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;in jurisdictions where all action required by </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.4(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;has been taken and completed.  Seller is a Nevada limited liability company and is a &#8220;registered organization&#8221; (within the meaning of Section 9-102 of the UCC as in effect in the State of Nevada).</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collections</font><font style="font-family:inherit;font-size:12pt;">.   The conditions and requirements set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.1(j)</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.2</font><font style="font-family:inherit;font-size:12pt;">&#32;have at all times been satisfied and duly performed.  The names and addresses of all Collection Banks, together with the account numbers of the Collection Accounts of Seller at each Collection Bank and the post office box number or bank departmental number of each Lock- Box, are listed in the Collection Account Disclosure Letter or have been provided to the Agent in a written notice that complies with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.2(b)</font><font style="font-family:inherit;font-size:12pt;">.  Seller has not granted any Person, other than the Agent as contemplated by this Agreement, dominion and control or &#8220;control&#8221; (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) of any Lock-Box or Collection Account, or the right to take dominion and control or &#8220;control&#8221; (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) of any such Lock-Box or Collection Account at a future time or upon the occurrence of a future event.  Each Seller Party has taken all steps necessary to ensure that the Agent has &#8220;control&#8221; (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) over all Lock-Boxes and Collection Accounts.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Material Adverse Effect</font><font style="font-family:inherit;font-size:12pt;">.   (i) The initial Servicer represents and warrants that since June 30, 2013, no event has occurred that would have a material adverse effect on (x) the financial condition or operations of the initial Servicer and its Subsidiaries or (y) the ability of the initial Servicer to perform its obligations under this Agreement, and (ii) Seller represents and warrants that since June 30, 2013, no event has occurred that would have a material adverse effect on (A) the financial condition or operations of Seller, (B) the ability of Seller to perform its obligations under the Transaction Documents, or (C) the collectibility of the Receivables generally or any material portion of the Receivables.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Not an Investment Company</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party is neither (i) an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended, or any successor statute nor (ii) a &#8220;covered fund&#8221; under Section 619 of the Dodd-Frank Wall Street Reform and Consumer Protection Act.  In determining that it is not a &#8220;covered fund&#8221; under Section 619 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, the Seller relies on the exemption from the definition of &#8220;investment company&#8221; set forth in Section 3(c)(5) of the Investment Company Act of 1940, as amended, or any successor statute.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance with Law</font><font style="font-family:inherit;font-size:12pt;">.   Such Seller Party has complied in all respects with all applicable laws, rules, regulations, orders, writs, judgments, injunctions, decrees or awards to which it may be subject, except where the failure to so comply could not reasonably be expected to have a Material Adverse Effect.  Each Receivable, together with the Contract related thereto, does not contravene any laws, rules or regulations applicable thereto (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, laws, rules and regulations relating to truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and privacy), and no part of such Contract is in violation of any such law, rule or regulation, except where such contravention or violation could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(m)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance with Credit and Collection Policy</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party has complied in all material </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">respects with the Credit and Collection Policy with regard to each Receivable and the related Contract, and has not made any material change to such Credit and Collection Policy, except such material change as to which the Agent and each Managing Agent have been notified in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.1(a)(vii)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(n)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Eligible Receivables</font><font style="font-family:inherit;font-size:12pt;">.  Each Receivable included in the Net Receivables Balance as an Eligible Receivable on the date of its purchase under the Receivables Sale Agreement or in any calculation of the Net Receivables Balance contained in any report delivered to the Agent was an Eligible Receivable on such purchase date or date of such report, as the case may be.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(o)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Accounting</font><font style="font-family:inherit;font-size:12pt;">.  The manner in which such Seller Party accounts for the transactions contemplated by this Agreement and the Receivables Sale Agreement does not jeopardize the true sale analysis with respect to the Seller&#8217;s acquisition of Receivables.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(p)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Anti-Corruption  Laws  and  Sanctions</font><font style="font-family:inherit;font-size:12pt;">.     Such  Seller  Party  (or  Performance Guarantor on its behalf) has implemented and maintains in effect policies and procedures designed  to  promote  compliance  by  each  Seller  Party,  its  Subsidiaries  and  its  respective directors, officers and employees with Anti-Corruption Laws and applicable Sanctions, and such Seller Party, its Subsidiaries and to the knowledge of such Seller Party, its respective employees, officers,  directors  and  agents  (in  their  capacity  as  such)  that  will  act  in  any  capacity  in connection with or benefit from the facility established hereby, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects and are not engaged in any activity that would reasonably be expected to result in such Seller Party being designated as a Sanctioned Person. No Seller Party or any Subsidiary is a Sanctioned Person.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(q)       Except for the Permitted Linked Accounts, there are no &#8220;Linked Accounts&#8221; (as defined in the Collection Account Agreement with Bank of America, National Association) with respect  to  any  Lock-Box  Account  or  Collection  Account  maintained  at  Bank  of  America, National Association.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Additional Representations and Warranties of Seller</font><font style="font-family:inherit;font-size:12pt;">.  Seller hereby further represents and warrants to the Agent, the Managing Agents and the Purchasers, on and as of the date hereof, the date of each Incremental Purchase and the date of each Reinvestment that:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Use of Proceeds</font><font style="font-family:inherit;font-size:12pt;">.  No proceeds of any purchase hereunder will be used (i) for a purpose that violates, or would be inconsistent with, Regulation T, U or X promulgated by the Board of Governors of the Federal Reserve System from time to time or (ii) to acquire any security in any transaction which is subject to Section 12, 13 or 14 of the Securities Exchange Act of 1934, as amended.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Good Title</font><font style="font-family:inherit;font-size:12pt;">.   Immediately prior to each purchase hereunder, Seller shall be the legal and beneficial owner of the Receivables and the Related Security and Collections with respect thereto, free and clear of any Adverse Claim, except as created by the Transaction Documents.  There have been duly filed all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect Seller&#8217;s ownership interest in each Receivable, its Collections and the Related Security, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that prior to the occurrence of an Amortization Event, Seller&#8217;s interest in the Related Security shall be perfected only to the extent that such Related Security is subject to Article 9 of the UCC and such interest may be perfected by the filing of a financing statement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)          </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Perfection</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement, together with the filing of the financing statements contemplated hereby, is effective to, and shall, upon each purchase hereunder, transfer to the Agent for the benefit of the relevant Purchaser or Purchasers (and the Agent for the benefit of such Purchaser or Purchasers shall acquire from Seller) a valid and perfected first priority undivided percentage ownership or security interest in each </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Receivable existing or hereafter arising and in the Related Security and Collections with respect thereto, free and clear of any Adverse Claim, except as created by the Transaction Documents, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that prior to the occurrence of an Amortization Event, the Agent&#8217;s interest in the Related Security shall be perfected only to the extent that such Related Security is subject to Article 9 of the UCC and such interest may be perfected by the filing of a financing statement.  There have been duly filed all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect the Agent&#8217;s (on behalf of the Purchasers) ownership or security interest in the Receivables, the Collections and the Related Security, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that prior to the occurrence of an Amortization Event, Agent&#8217;s interest in the Related Security shall be perfected only to the extent that such Related Security is subject to Article 9 of the UCC and such interest may be perfected by the filing of a financing statement).</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Names</font><font style="font-family:inherit;font-size:12pt;">.  In the past five (5) years, Seller has not used any corporate names, trade names or assumed names other than the name in which it has executed this Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Ownership of Seller</font><font style="font-family:inherit;font-size:12pt;">.  Griffin owns, directly or indirectly, 100% of the issued and outstanding membership or other equity interests of Seller, free and clear of any Adverse Claim. Such membership and equity interests are validly issued, fully paid and nonassessable, and there are no options, warrants or other rights to acquire securities of Seller or any other equity interest in Seller.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payments to Griffin; Collections</font><font style="font-family:inherit;font-size:12pt;">.  With respect to each Receivable transferred to Seller under the Receivables Sale Agreement, Seller has given reasonably equivalent value to Griffin in consideration therefor and such transfer was not made for or on account of an antecedent  debt.    No  transfer  by  Griffin  of  any  Receivable  under  the  Receivables  Sale Agreement is or may be voidable under any section of the Bankruptcy Reform Act of 1978 (11 U.S.C.  &#167;&#167;  101  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">et</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">seq.</font><font style="font-family:inherit;font-size:12pt;">),  as  amended.    In  the  case  of  this  Agreement,  each  remittance  of Collections by the Seller to the Agent or any Purchaser hereunder will have been (i) in payment of a debt incurred by the Seller in the ordinary course of business or financial affairs of the Seller and (ii) made in the ordinary course of business or financial affairs of the Seller.  In the case of the Receivables Sale Agreement, each remittance of Collections by Griffin to the Seller thereunder will have been (i) in payment of a debt incurred by Griffin in the ordinary course of business or financial affairs of Griffin and (ii) made in the ordinary course of business or financial affairs of the Griffin.  In the case of any Griffin RPA, each remittance of Collections by the applicable Originator to Griffin thereunder will have been (i) in payment of a debt incurred by such Originator in the ordinary course of business or financial affairs of such Originator and (ii) made in the ordinary course of business or financial affairs of such Originator.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Net Receivables Balance</font><font style="font-family:inherit;font-size:12pt;">.   Seller has determined that, immediately after giving effect to each purchase under the Existing Agreement and each purchase hereunder, the Net Receivables Balance is at least equal to the sum of (i) the Aggregate Capital, plus (ii) the LC Adjusted Exposure, plus (iii) the Aggregate Reserves.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Enforceability of Contracts</font><font style="font-family:inherit;font-size:12pt;">.  Each Contract with respect to each Receivable is effective to create, and has created, a legal, valid and binding obligation of the related Obligor to pay the Outstanding Balance of the Receivable created thereunder and any accrued interest thereon,  enforceable  against  the  Obligor  in  accordance  with  its  terms,  except  as  such enforcement  may  be  limited  by  applicable  bankruptcy,  insolvency,  reorganization  or  other similar laws relating to or limiting creditors&#8217; rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law).</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.3      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial  Institution  Representations  and  Warranties</font><font style="font-family:inherit;font-size:12pt;">.    Each  Financial Institution hereby represents and warrants to the Agent, to the LC Bank and to the Conduit (if any) and the Managing Agent in such Financial Institution&#8217;s Purchaser Group that:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Existence and Power</font><font style="font-family:inherit;font-size:12pt;">.  Such Financial Institution is a corporation or a banking association  duly  organized,  validly  existing  and  in  good  standing  under  the  laws  of  its jurisdiction of incorporation or organization, and has all corporate power to perform its obligations hereunder.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Conflict</font><font style="font-family:inherit;font-size:12pt;">.  The execution and delivery by such Financial Institution of this Agreement and the performance of its obligations hereunder are within its corporate powers, have been duly authorized by all necessary corporate action, do not contravene or violate (i) its certificate or articles of incorporation or association or by-laws, (ii) any law, rule or regulation applicable to it, (iii) any restrictions under any agreement, contract or instrument to which it is a party or by which  any of its  property is  bound, or  (iv) any order,  writ,  judgment,  award, injunction or decree binding on or affecting it or its property, and do not result in the creation or imposition of any Adverse Claim on its assets.  This Agreement has been duly authorized, executed and delivered by such Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governmental Authorization</font><font style="font-family:inherit;font-size:12pt;">.   No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority or regulatory body is required for the due execution and delivery by such Financial Institution of this Agreement and the performance of its obligations hereunder, except that has already been received.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Binding  Effect</font><font style="font-family:inherit;font-size:12pt;">.     This  Agreement  constitutes  the  legal,  valid  and  binding obligation of such Financial Institution enforceable against such Financial Institution in accordance with its terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization or other similar laws relating to or limiting creditors&#8217; rights generally and by general principles of equity (regardless of whether such enforcement is sought in a proceeding in equity or at law).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE VI. </font></div><div style="line-height:120%;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CONDITIONS OF PURCHASES</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conditions  Precedent   to   Initial   Incremental   Purchase</font><font style="font-family:inherit;font-size:12pt;">.      The  initial Incremental Purchase of a Purchaser Interest under, and the effectiveness of, this Agreement is subject to the conditions precedent that (a) the Agent shall have received on or before the date of such purchase those documents listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule B</font><font style="font-family:inherit;font-size:12pt;">&#32;and (b) the Agent, each LC Bank and each Managing Agent shall have received all fees and expenses required to be paid on or prior to the date hereof pursuant to the terms of this Agreement and each Fee Letter.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conditions Precedent to All Incremental Purchases and Reinvestments</font><font style="font-family:inherit;font-size:12pt;">. Each Incremental Purchase of a Purchaser Interest and each Reinvestment (in each case, for the avoidance of doubt, excluding any LC Participation Advance) shall be subject to the further conditions precedent that (a) in the case of each such Incremental Purchase or Reinvestment, Servicer shall have delivered to the Agent and each Managing Agent on or prior to the date of such purchase, in form and substance satisfactory to the Agent and such Managing Agent, all Monthly Reports as and when due under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.5</font><font style="font-family:inherit;font-size:12pt;">&#32;and all Weekly Reports and Daily Reports, if  required,  as  and  when due under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  8.5</font><font style="font-family:inherit;font-size:12pt;">;  (b) the Amortization Date shall  not  have occurred; (c) the Agent and each Managing Agent shall have received such other approvals, opinions or documents as it may reasonably request and (d) on the date of each such Incremental Purchase or Reinvestment, the following statements shall be true (and acceptance of the proceeds of such </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Incremental Purchase or Reinvestment shall be deemed a representation and warranty by Seller that such statements are then true):</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        the representations and warranties set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 5.1</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">5.2</font><font style="font-family:inherit;font-size:12pt;">&#32;are true and correct in all material respects on and as of the date of such Incremental Purchase or Reinvestment as though made on and as of such date (other than the representation and warranty set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 5.1(j)</font><font style="font-family:inherit;font-size:12pt;">, which representation and warranty shall be true and correct on the date of the Initial Incremental Purchase as though made on and as of such date);</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)     no event has occurred and is continuing, or would result from such Incremental Purchase or Reinvestment, that will constitute an Amortization Event or a Potential Amortization Event; and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      none  of  the  conditions  or  circumstances  listed  in  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">sub-paragraphs  (i)</font><font style="font-family:inherit;font-size:12pt;">&#32;through  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(vi)</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;of  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  1.1(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;exist  at  the  time  of,  or  would  be  caused  to  exist  by,  such Incremental Purchase or Reinvestment. It is expressly understood that each Reinvestment shall, unless otherwise directed by the Agent or any Purchaser, occur automatically on each day that the Servicer shall receive any Collections without the requirement that any further action be taken on the part of any Person and notwithstanding the failure of Seller to satisfy any of the foregoing conditions precedent in respect of such Reinvestment.  The failure of Seller to satisfy any of the foregoing conditions precedent in respect of any Reinvestment shall give rise to a right of the Agent, which right may be exercised at any time on demand of the Agent, to rescind the related purchase and direct Seller to pay to the Agent for the benefit of the Purchasers an amount equal to the Collections prior to the Amortization Date that shall have been applied to the affected Reinvestment.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:268px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE VII. COVENANTS</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Affirmative Covenants of the Seller Parties</font><font style="font-family:inherit;font-size:12pt;">.  Until the date on which the Aggregate Unpaids have been indefeasibly paid in full and this Agreement terminates in accordance with its terms, each Seller Party hereby covenants, only as to itself and as applicable to it (on a several basis and not jointly), as set forth below:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Reporting</font><font style="font-family:inherit;font-size:12pt;">.   Such Seller Party will maintain, for itself and each of its Subsidiaries, a system of accounting established and administered in accordance with generally accepted accounting principles, and furnish or cause to be furnished to the Agent, each LC Bank and each Managing Agent (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that, for purposes of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clauses (i)</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(ii)</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(iv)</font><font style="font-family:inherit;font-size:12pt;">, and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(v)</font><font style="font-family:inherit;font-size:12pt;">&#32;hereof, posting to EDGAR or on the website of Cardinal Health, Inc. shall constitute delivery of such reports, notices or filings to the Agent, each LC Bank and each Managing Agent):</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Annual Reporting</font><font style="font-family:inherit;font-size:12pt;">.  In the case of the Performance Guarantor, within one hundred twenty (120) days after the close of each of its fiscal years, audited, unqualified financial  statements  (which  shall  include  balance  sheets,  statements  of  income  and retained earnings and a statement of cash flows) for Performance Guarantor for such fiscal year certified in a manner reasonably acceptable to the Agent by independent public accountants reasonably acceptable to the Agent.  In the case of the Seller, within one hundred twenty (120) days after the close of each of its fiscal years, unaudited financial statements (which shall include a balance sheet and a profit and loss statement).</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Quarterly Reporting</font><font style="font-family:inherit;font-size:12pt;">.   In the case of the Performance Guarantor, within sixty (60) days after the close of the first three (3) quarterly periods of each of its fiscal years, balance sheets of Performance Guarantor as at the close of each such period and statements  of  income  and  retained  </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">earnings  and  a  statement  of  cash  flows  for Performance Guarantor for the period from the beginning of such fiscal year to the end of such quarter, all certified in a manner reasonably acceptable to the Agent by Performance Guarantor&#8217;s chief financial officer.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance Certificate</font><font style="font-family:inherit;font-size:12pt;">.   Together with the documents required to be delivered pursuant to clauses (i) and (ii) above, a compliance certificate in substantially the form of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit V</font><font style="font-family:inherit;font-size:12pt;">&#32;signed by an Authorized Officer of Performance Guarantor.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Shareholders  Statements  and  Reports</font><font style="font-family:inherit;font-size:12pt;">.    Promptly  upon  the  furnishing thereof to the shareholders of Performance Guarantor copies of all financial statements, reports and proxy statements so furnished.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">S.E.C. Filings</font><font style="font-family:inherit;font-size:12pt;">.  Promptly upon the filing thereof, copies of all registration statements and annual, quarterly, monthly or other regular reports which Performance Guarantor or any of its Subsidiaries files with the Securities and Exchange Commission.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Copies of Notices</font><font style="font-family:inherit;font-size:12pt;">.   Promptly upon its receipt of any notice, request for consent, financial statements, certification, report or other communication under or in connection with any Transaction Document from any Person other than the Agent, any Managing  Agent  (so  long  as  the  Agent  is  copied  on  such  communication)  or  any Purchaser (so long as each other Purchaser is copied on such communication), copies of the same.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)     </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Change in Credit and Collection Policy</font><font style="font-family:inherit;font-size:12pt;">.  At least thirty (30) days prior to the effectiveness of any material change in or material amendment to the Credit and Collection Policy, a copy of the Credit and Collection Policy then in effect and a notice (A)  indicating  such  change  or  amendment  and  (B)  if  such  proposed  change  or amendment would be reasonably likely to materially adversely affect the collectibility of the  Receivables  or  materially  decrease  the  credit  quality  of  any  newly  created Receivables,  requesting  the  Agent&#8217;s,  each  LC  Bank&#8217;s  and  each  Managing  Agent&#8217;s consent thereto.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Information</font><font style="font-family:inherit;font-size:12pt;">.  Promptly, from time to time, such other information, documents, records or reports relating to the Receivables or the condition or operations, financial  or  otherwise,  of  such  Seller  Party  as  the  Agent  may  from  time  to  time reasonably request (taking into consideration the burden and expense, if any, imposed upon such Seller Party) in order to protect the interests of the Agent and the Purchasers under or as contemplated by this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices</font><font style="font-family:inherit;font-size:12pt;">.    Such  Seller  Party  will  notify  the  Agent,  each  LC  Bank  and  each Managing Agent in writing of any of the following promptly upon learning of the occurrence thereof, describing the same and, if applicable, the steps being taken with respect thereto:</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amortization Events or Potential Amortization Events</font><font style="font-family:inherit;font-size:12pt;">.  The occurrence of each Amortization Event and each Potential Amortization Event, by a statement of an Authorized Officer of such Seller Party.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Judgment and Proceedings</font><font style="font-family:inherit;font-size:12pt;">.   (A) The entry of any judgment or decree against Servicer or any of its respective Subsidiaries if the aggregate amount of all judgments and decrees then outstanding against Servicer and its Subsidiaries exceeds $250,000 and (B) the entry of any judgment or decree or the institution of any litigation, arbitration proceeding or governmental proceeding against Seller.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Material Adverse Effect</font><font style="font-family:inherit;font-size:12pt;">.   The occurrence of any event or condition that has had, or could reasonably be expected to have, a Material Adverse Effect.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination Date</font><font style="font-family:inherit;font-size:12pt;">.   Subject to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.2(f)</font><font style="font-family:inherit;font-size:12pt;">, the occurrence of the &#8220;Termination Date&#8221; under and as defined in the Receivables Sale Agreement and the termination of any Griffin RPA in accordance with its terms or otherwise.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Defaults Under Other Agreements</font><font style="font-family:inherit;font-size:12pt;">.   The occurrence of a default or an event of default under any other financing arrangement pursuant to which such Seller Party is a debtor or an obligor.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance with Laws and Preservation of Corporate Existence</font><font style="font-family:inherit;font-size:12pt;">.   Such Seller Party will comply in all respects with all applicable laws, rules, regulations, orders, writs, judgments, injunctions, decrees or awards to which it may be subject except where the failure to so comply could not reasonably be expected to have a Material Adverse Effect.   Such Seller Party will preserve and maintain its existence, rights, franchises and privileges in the jurisdiction of its organization, and qualify and remain qualified in good standing as a foreign entity in each jurisdiction where its business is conducted, except where the failure to so preserve and maintain or qualify could not reasonably be expected to have a Material Adverse Effect. Such Seller Party (or Performance Guarantor on its behalf) will maintain in effect and enforce, in all material respects, policies and procedures designed to promote compliance by each Seller Party, its Subsidiaries and its respective directors, officers and employees with applicable Anti-Corruption Laws and applicable Sanctions.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Audits</font><font style="font-family:inherit;font-size:12pt;">.   Such Seller Party will furnish to the Agent, each LC Bank and each Managing Agent from time to time such information with respect to it and the Receivables as the Agent, each LC Bank or each Managing Agent may reasonably request.  Such Seller Party will, from time to time during regular business hours as requested by the Agent upon reasonable notice and at the sole cost of such Seller Party, subject to the penultimate sentence of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.1(d)</font><font style="font-family:inherit;font-size:12pt;">, permit the Agent, or its agents or representatives, (i) to examine and make copies of and abstracts from all Records in the possession or under the control of such Person relating to the Receivables and the Related Security, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the related Contracts, and (ii) to visit the offices and properties of such Person for the purpose of examining such materials described in clause (i) above, and to discuss matters relating to such Person&#8217;s financial condition or the Receivables and the Related Security or any Person&#8217;s performance under any of the Transaction Documents or any Person&#8217;s performance under the Contracts and, in each case, with any of the officers or employees of Seller or the Servicer having knowledge of such matters (the procedures described in the foregoing clauses (i) and (ii) are referred to herein as an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Audit</font><font style="font-family:inherit;font-size:12pt;">&#8221;). All such examinations and visits shall be at the sole cost of such Seller Party; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that (i) (A) for so long as no Amortization Event has occurred and is continuing, (B) the Ratings Level then in effect is either Ratings Level 1 or Ratings Level 2 and (C) the immediately preceding Audit was satisfactory to the Agent and each Managing Agent in all material respects, such cost shall be borne by such Seller Party not more than once per calendar year, and (ii) (A) for so long as no Amortization Event has occurred and is continuing, (B) the Ratings Level then in effect is either Ratings Level 3 or Ratings Level 4 and (C) the immediately preceding Audit was satisfactory to the Agent and each Managing Agent in all material respects, such cost shall be borne by such Seller Party not more than twice per calendar year (although in no event shall the foregoing proviso be construed to limit the Agent or its agents or representatives to one or two, as applicable, Audits during any calendar year period).  The Agent will use commercially reasonable efforts to determine if the costs and expenses to be incurred by the Agent in connection  with  any  Audit  are  estimated  to  exceed  $35,000  and,  if  so,  will  so  notify the applicable Seller Party promptly after knowledge thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Keeping and Marking of Records and Books</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        Servicer  will  maintain  and  implement  administrative  and  operating procedures (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, an ability to recreate records evidencing Receivables  in  the  event  of  the  destruction  of  the  originals  thereof),  and  keep  and maintain all documents, books, records and other information reasonably necessary or advisable for the collection of all Receivables (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, records adequate to permit the immediate identification of each new Receivable and all Collections of and adjustments to each existing Receivable).  The Servicer will give the Agent notice of any material change in the administrative and operating procedures referred to in the previous sentence.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       Such Seller Party will, (A) on or prior to June 29, 2000, mark its master data processing records and other books and records relating to the Purchaser Interests with a legend, acceptable to the Agent, describing the Purchaser Interests and (B) upon the request of the Agent following the occurrence of an Amortization Event, (x) mark each Contract with a legend describing the Purchaser Interests and (y) deliver to the Agent all Contracts (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, all multiple originals of any such Contract) relating to the Receivables.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance with Contracts and Credit and Collection Policy</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party will timely and fully (i) perform and comply with all provisions, covenants and other promises required to be observed by it under the Contracts related to the Receivables, and (ii) comply in all respects with the Credit and Collection Policy in regard to each Receivable and the related Contract.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance and Enforcement of Receivables Sale Agreement</font><font style="font-family:inherit;font-size:12pt;">.  Seller will, and will require Griffin to, perform each of their respective obligations and undertakings under and pursuant to the Receivables Sale Agreement, will purchase Receivables thereunder in strict compliance with the terms thereof and will use commercially reasonable efforts to enforce the rights and remedies accorded to Seller under the Receivables Sale Agreement.  Seller will take all actions to perfect and enforce its rights and interests (and the rights and interests of the Agent and the Purchasers as assignees of Seller) under the Receivables Sale Agreement as the Agent may from time to time reasonably request, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, making claims to which it may be entitled under any indemnity, reimbursement or similar provision contained in the Receivables Sale Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Ownership</font><font style="font-family:inherit;font-size:12pt;">. Seller will take all necessary action to (i) vest legal and equitable title to the Receivables, the Related Security and the Collections purchased under the Receivables Sale Agreement irrevocably in Seller, free and clear of any Adverse Claims other than Adverse Claims in favor of the Agent and the Purchasers (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the filing of all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect Seller&#8217;s interest in such Receivables, Related Security and Collections and such other action to perfect, protect or more fully evidence the interest of Seller therein as the Agent may reasonably request), provided, that prior to the occurrence of an Amortization Event, Seller&#8217;s interest in the Related Security shall be perfected only to the extent that such Related Security is subject to Article 9 of the UCC and such interest may be perfected by the filing of a financing statement; and (ii) establish and maintain, in favor of the Agent, for the benefit of the Purchasers, a valid and perfected first priority undivided percentage ownership interest (and/or a valid and perfected first priority security interest) in all Receivables, Related Security and Collections to the full extent contemplated herein, free and clear of any Adverse Claims other than Adverse Claims in favor of the Agent for the benefit of the Purchasers (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the filing of all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect the Agent&#8217;s (for the benefit of the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Purchasers) interest in such Receivables, Related Security and Collections and such other action to perfect, protect or more fully evidence the interest of the Agent for the benefit of the Purchasers as the Agent may reasonably request), provided, that prior to the occurrence of an Amortization Event, the Agent&#8217;s interest in the Related Security shall be perfected only to the extent that such Related Security is subject to Article 9 of the UCC and such interest may be perfected by the filing of a financing statement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchasers&#8217; Reliance</font><font style="font-family:inherit;font-size:12pt;">.  Seller acknowledges that the Purchasers are entering into the transactions contemplated by this Agreement in reliance upon Seller&#8217;s identity as a legal entity that is separate from each Cardinal Entity and their respective Affiliates.  Therefore, from and after June 29, 2000, Seller will take all reasonable steps, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, all steps that the Agent or any Purchaser may from time to time reasonably request, to maintain Seller&#8217;s identity as a separate legal entity and to make it manifest to third parties that Seller is an entity with assets and liabilities distinct from those of each Cardinal Entity and any Affiliates thereof and not just a division of any Cardinal Entity.   Without limiting the generality of the foregoing and in addition to the other covenants set forth herein, Seller will:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)       conduct its own business in its own name and require that all full-time employees of Seller, if any, identify themselves as such and not as employees of any Cardinal Entity (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, by means of providing appropriate employees with business or identification cards identifying such employees as Seller&#8217;s employees);</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       compensate all employees, consultants and agents directly, from Seller&#8217;s own funds, for services provided to Seller by such employees, consultants and agents and, to the extent any employee, consultant or agent of Seller is also an employee, consultant or agent of any Cardinal Entity or any Affiliate thereof, allocate the compensation of such employee, consultant or agent between Seller and such Cardinal Entity or such Affiliate, as applicable on a basis that reflects the services rendered to Seller and such Cardinal Entity or such Affiliate, as applicable;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      clearly identify its offices (by signage or otherwise) as its offices and, if such office is located in the offices of any Cardinal Entity, Seller will lease such office at a fair market rent;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)      have a separate telephone number, which will be answered only in its name and separate stationery, invoices and checks in its own name;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       conduct  all  transactions  with  each  Cardinal  Entity  and  the  Servicer (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, any delegation of its obligations hereunder as Servicer) strictly on an arm&#8217;s-length basis, allocate all overhead expenses (including, without limitation, telephone and other utility charges) for items shared between Seller and any Cardinal Entity on the basis of actual use to the extent practicable and, to the extent such allocation is not practicable, on a basis reasonably related to actual use;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)      (A) at all times have a Board of Managers consisting of three members, at least one member of which is an Independent Manager reasonably acceptable to the Agent; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that any Independent Manager that is employed by Global Securitization Services, LLC, Lord Securities Corporation or Amacar Group LLC for the purpose of providing director services to special purpose entities and that meets the other requirements of an Independent Manager set forth herein shall be deemed approved by the Agent and (B) not remove any Independent Manager or replace any Independent Manager (other than a replacement by an individual employed by Global Securitization Services, LLC, Lord Securities Corporation or Amacar Group LLC for the purpose of providing director services to special purpose entities and who otherwise meets the other requirements of an </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Independent Manager set forth herein; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;">&#32;that written notice of the replacement of the current Independent Manager with an Independent Manager employed by one of the entities specifically referred to herein will be furnished to the Agent), in each case without the prior written consent of the Agent;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)     observe all corporate formalities as a distinct entity, and ensure that (I) all limited liability company actions relating to (1) the dissolution or liquidation of Seller or (2) the initiation of, participation in, acquiescence in or consent to any bankruptcy, insolvency, reorganization or similar proceeding involving Seller, are duly authorized by unanimous vote of its Board of Managers (including the Independent Manager) and (II) all limited liability company actions relating to the selection, maintenance or replacement of the Independent Manager are duly authorized in compliance with Seller&#8217;s articles of organization and operating agreement;</font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)    maintain Seller&#8217;s books and records separate from those of each Cardinal Entity and any Affiliate thereof and otherwise readily identifiable as its own assets rather than assets of any Cardinal Entity and any Affiliate thereof;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ix)      prepare its financial statements separately from those of each Cardinal Entity and insure that any consolidated financial statements of any Cardinal Entity or any Affiliate thereof that include Seller and that are filed with the Securities and Exchange Commission or any other governmental agency have notes clearly stating that Seller is a separate legal entity and that its assets will be available first and foremost to satisfy the claims of the creditors of Seller;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(x)      except to the extent funds of Seller and Griffin and funds of Seller and Cardinal may be commingled in connection with the performance by Griffin and Cardinal of their respective servicing obligations hereunder as Servicer and Permitted Sub- Servicer, respectively, maintain the funds or other assets of Seller separate from, and not commingled with, those of any Cardinal Entity or any Affiliate thereof and only maintain bank accounts or other depository accounts to which Seller alone is the account party, into which Seller alone makes deposits and from which Seller alone (or the Agent hereunder) has the power to make withdrawals;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xi)      pay all of Seller&#8217;s operating expenses from Seller&#8217;s own assets (except for certain payments by any Cardinal Entity or other Persons pursuant to allocation arrangements that comply with the requirements of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.1(i)</font><font style="font-family:inherit;font-size:12pt;">);</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xii)    operate its business and activities such that:  it does not engage in any business or activity of any kind, or enter into any transaction or indenture, mortgage, instrument, agreement, contract, lease or other undertaking, other than the transactions contemplated and authorized by this Agreement and the Receivables Sale Agreement (it being understood that Seller may make the Demand Loans to Cardinal pursuant to and in accordance with the terms of the Cash Management Agreement); and does not create, incur, guarantee, assume or suffer to exist any indebtedness or other liabilities, whether direct  or  contingent,  other  than  (1)  as  a  result  of  the  endorsement  of  negotiable instruments for deposit or collection or similar transactions in the ordinary course of business, (2) the incurrence of obligations under this Agreement, (3) the incurrence of obligations, as expressly contemplated in the Receivables Sale Agreement, to make payment to Griffin thereunder for the purchase of Receivables from Griffin under the Receivables Sale Agreement, and (4) the incurrence of operating expenses in the ordinary course of business of the type otherwise contemplated by this Agreement;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiii)  maintain its limited liability company charter in conformity with this Agreement, such that it does not amend, restate, supplement or otherwise modify its articles of organization and operating agreement in any respect that would impair its ability to comply with the terms or provisions of any of the Transaction Documents, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.1(i)</font><font style="font-family:inherit;font-size:12pt;">&#32;of this Agreement;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiv)    maintain the effectiveness of, and continue to perform and require Griffin, the Originators and the Approved Sub-Originators to perform under the Receivables Sale</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agreement, each Griffin RPA, each Sub-Originator Sale Agreement, the Cash Management Agreement and the Performance Guaranty, such that it does not amend, restate, supplement, cancel, terminate or otherwise modify the Receivables Sale Agreement, each Griffin RPA, each Sub-Originator Sale Agreement,   the Cash Management Agreement or the Performance Guaranty, or give any consent, waiver, directive or approval thereunder or waive any default, action, omission or breach thereunder or otherwise grant any indulgence thereunder, without (in each case) the prior written consent of the Agent and the Required Financial Institutions;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xv)     maintain its limited liability company separateness such that it does not merge or consolidate with or into, or convey, transfer, lease or otherwise dispose of (whether in one transaction or in a series of transactions, and except as otherwise contemplated herein) all or substantially all of its assets (whether now owned or hereafter acquired) to, or acquire all or substantially all of the assets of, any Person, nor at any time create, have, acquire, maintain or hold any interest in any Subsidiary;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xvi)   maintain at all times the Required Capital Amount (as defined in the Receivables Sale Agreement) and refrain from making any dividend, distribution, redemption of capital stock or membership interest or payment of any subordinated indebtedness which would cause the Required Capital Amount to cease to be so maintained; and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xvii)   take such other actions as are necessary on its part to ensure that the facts and assumptions set forth in the opinion issued by counsel for Seller, in connection with the closing the Existing Agreement or any amendment thereto and relating to substantive consolidation issues, and in the certificates accompanying such opinion, remain true and correct in all material respects at all times.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collections</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        Such Seller Party will (A) instruct all Obligors to remit all Collections directly to a Lock-Box or Collection Account, (B) cause all proceeds from all Lock- Boxes to be directly deposited by a Collection Bank into a Lock-Box Account or Collection  Account,  (C)  cause  each  Lock-Box,  Lock-Box  Account  and  Collection Account to be subject at all times to a Collection Account Agreement that is in full force and effect, (D) cause the Cash Management Agreement to be in full force and effect and (E) not, and will not permit any other Person to, remit, deposit, credit or otherwise transfer any funds other than Collections, Brokerage Receivables, Permitted Commingled Collections and immaterial amounts of other receipts not constituting Collections to any Lock-Box or Collection Account.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       At  all  times,  in  the  event  any  payments  relating  to  Receivables  are remitted directly to such Seller Party or any Affiliate of such Seller Party, such Seller Party will remit (or will cause all such payments to be remitted) directly to a Collection Bank and deposited into a Collection Account within two (2) Business Days following receipt thereof and, at all times prior </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">to such remittance, such Seller Party will itself hold or, if applicable, will cause such payments to be held in trust for the exclusive benefit of the Agent and the Purchasers.  Seller will maintain exclusive ownership, dominion and control or &#8220;control&#8221; (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) (subject to the terms of this Agreement) of each Lock-Box Account and Collection Account and will not grant the right to take dominion and control or &#8220;control&#8221; (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) of any Lock-Box or Collection Account at a future time or upon the occurrence of a future event to any Person, except to the Agent as contemplated by this Agreement.  All Collections from time to time deposited to any Collection Account, shall be held in trust, for the exclusive benefit of the Agent and the Purchasers.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Taxes</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party will file all Tax returns and reports required by law to be filed by it and will promptly pay all Taxes and governmental charges at any time owing and required by law to be paid by it including with respect to the Receivables, except any such Taxes which are not yet delinquent or are being diligently contested in good faith by appropriate proceedings and for which adequate reserves in accordance with generally accepted accounting principles shall have been set aside on its books.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Insurance</font><font style="font-family:inherit;font-size:12pt;">.  Seller will maintain in effect, or cause to be maintained in effect, at Seller&#8217;s own expense, commercial general liability insurance.  The Agent, for the benefit of the Purchasers, shall be named on such insurance policies as an additional insured with respect to all such liability insurance maintained by Seller.  Seller will pay or cause to be paid, the premiums therefor and deliver to the Agent a certificate of insurance evidencing such insurance.  The foregoing requirements shall not be construed to negate, reduce or modify, and are in addition to Seller&#8217;s obligations hereunder.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(m)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Payment to Griffin</font><font style="font-family:inherit;font-size:12pt;">.   With respect to any Receivable purchased by Seller from Griffin, such sale shall be effected under, and in strict compliance with the terms of, the Receivables Sale Agreement, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the terms relating to the amount and timing of payments to be made to Griffin in respect of the purchase price for such Receivable.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Negative Covenants of the Seller Parties</font><font style="font-family:inherit;font-size:12pt;">.   Until the date on which the Aggregate Unpaids have been indefeasibly paid in full and this Agreement terminates in accordance with its terms, each Seller Party hereby covenants, only as to itself and as applicable to it (on a several basis and not jointly), that:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Name Change, Jurisdiction of Organization, Offices, Records and Books of</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Accounts</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party will not change its name, identity, corporate or other organizational structure or jurisdiction of organization (within the meaning of Section 9-503 or 9-507 of the UCC of all applicable jurisdictions) or relocate any office where Records are kept unless it shall have:  (i) given the Agent at least forty-five (45) days&#8217; prior written notice thereof and (ii) delivered to the Agent all financing statements, instruments and other documents requested by the Agent in connection with such change or relocation.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Change in Payment Instructions to Obligors</font><font style="font-family:inherit;font-size:12pt;">.  Except as may be required by the Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.2(b)</font><font style="font-family:inherit;font-size:12pt;">, such Seller Party will not add or terminate any bank as a Collection Bank, or make any change in the instructions to Obligors regarding payments to be made to any Lock-Box or Collection Account, unless the Agent shall have received, at least ten</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(10) days before the proposed effective date therefor, (i) written notice of such addition, termination or change and (ii) with respect to the addition of a Collection Bank or a Collection Account or Lock-Box, an executed Collection Account Agreement with respect to the new Collection Account or Lock-Box; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that the Servicer may make changes in instructions to Obligors regarding payments if such new instructions require such Obligor to make payments to another existing Collection Account that is subject to a Collection Account Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Modifications to Contracts and Credit and Collection Policy</font><font style="font-family:inherit;font-size:12pt;">.  Such Seller Party will not make any change to the Credit and Collection Policy that could materially adversely affect the collectibility of the Receivables or materially decrease the credit quality of any newly created Receivables.   Except as provided in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.2(d)</font><font style="font-family:inherit;font-size:12pt;">, such Seller Party will not extend, amend or otherwise modify the terms of any Receivable or any Contract related thereto other than in accordance with the Credit and Collection Policy.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sales, Liens</font><font style="font-family:inherit;font-size:12pt;">.   Seller will not sell, assign (by operation of law or otherwise) or otherwise dispose of, or grant any option with respect to, or create or suffer to exist any Adverse Claim upon (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the filing of any financing statement) or with respect to, any Receivable, Related Security (other than an Adverse Claim arising through or under an Obligor) or Collections, or upon or with respect to any Contract under which any Receivable arises, or any Lock-Box or Collection Account, or assign any right to receive income with respect thereto (other than, in each case, the creation of the interests therein in favor of the Agent and the Purchasers provided for herein), and Seller will defend the right, title and interest of the Agent and the Purchasers in, to and under any of the foregoing property, against all claims of third parties claiming through or under Seller or any Cardinal Entity.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Net Receivables Balance</font><font style="font-family:inherit;font-size:12pt;">.  Seller will not at any time permit the Net Receivables Balance to be less than an amount equal to the sum of (i) the Aggregate Capital, plus (ii) the LC Adjusted Exposure, plus (iii) the Aggregate Reserves.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination Date Determination</font><font style="font-family:inherit;font-size:12pt;">.  Seller will not designate the Termination Date (as defined in the Receivables Sale Agreement), or send any written notice to Griffin in respect thereof, without the prior written consent of the Agent, except with respect to the occurrence of such Termination Date arising pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 5.1(d)</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Receivables Sale Agreement, and any such designation of the Termination Date or provision of notice in respect thereof not in compliance with this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (f)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall be void </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ab initio</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Griffin RPA Termination</font><font style="font-family:inherit;font-size:12pt;">.  Griffin will not terminate any Griffin RPA, nor send any written notice to the applicable Originator in respect thereof, without providing 10 Business Days&#8217; prior written notice thereof to the Agent, except with respect to (i) the occurrence of a termination  pursuant  to  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  7.2</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;of  the  applicable  Griffin  RPA  and  (ii)  a  termination permitted under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;hereunder, and any such termination of any Griffin RPA or provision of notice to any Originator in respect thereof not in compliance with this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (g)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall be void </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ab initio</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h)&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sub-Originator Sale Agreement Termination</font><font style="font-family:inherit;font-size:12pt;">. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sub-Originator Sale Agreement</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination</font><font style="font-family:inherit;font-size:12pt;">.  The Seller Parties shall not permit any Originator to terminate any Sub-Originator Sale Agreement, nor send (or permit any Originator to send) any written notice to the applicable Approved Sub-Originator in respect thereof, without providing 10 Business Days&#8217; prior written notice thereof to the Agent, except with respect to (i) the occurrence of a termination pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.2</font><font style="font-family:inherit;font-size:12pt;">&#32;of the applicable Sub-Originator Sale Agreement and (ii) a termination permitted under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.1(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;hereunder, and any such termination of any Sub-Originator Sale Agreement or provision of notice to any Approved Sub-Originator in respect thereof not in compliance with this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (h)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall be void </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ab initio</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Anti-Corruption Laws and Sanctions</font><font style="font-family:inherit;font-size:12pt;">.  No Seller Party will permit the proceeds of any Incremental Purchase or Reinvestment to be used directly or, to the knowledge of Seller, indirectly,  (i)  in  furtherance  of  an  offer,  payment,  promise  to  pay,  or  authorization  of  the payment or giving of anything </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">else of value, to any Person in violation of any Anti-Corruption Laws, (ii) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, in each case, except to the extent such use is licensed by OFAC and otherwise authorized under applicable law, or (iii) in any manner that would result in the violation of any Sanctions applicable to any party hereto.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Linked Accounts</font><font style="font-family:inherit;font-size:12pt;">.   Except for the Permitted Linked Accounts, no Seller Party shall permit any &#8220;Linked Account&#8221; (as defined in the Collection Account Agreement with Bank of America, National Association) to exist with respect to any Lock-Box Account or Collection Account maintained at Bank of America, National Association; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that at any time (x) during the continuance of an Amortization Event, (y) during the continuance of a Potential Amortization Event or (z) the Ratings Level then in effect is either Ratings Level 3 or Ratings Level 4, any Seller Party shall, if so instructed by the Agent (in its sole discretion), cause the Permitted Linked Accounts to cease being a &#8220;Linked Accounts&#8221; promptly, but not later than five (5) Business Days following such Seller Party&#8217;s receipt of such instruction.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE VIII. </font></div><div style="line-height:120%;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ADMINISTRATION AND COLLECTION</font></div><div style="line-height:120%;padding-top:1px;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Designation of Servicer</font><font style="font-family:inherit;font-size:12pt;">.  (a)  The servicing, administration and collection of the Receivables shall be conducted by such Person (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Servicer</font><font style="font-family:inherit;font-size:12pt;">&#8221;) so designated from time to time in accordance with this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.1</font><font style="font-family:inherit;font-size:12pt;">.  Griffin is hereby designated as, and hereby agrees to perform the duties and obligations of, the Servicer pursuant to the terms of this Agreement.  The Agent (on behalf of the Purchasers) may, and at the direction of the Required Financial Institutions shall, at any time following the occurrence of a Collection Notice Event, by notice to Griffin and Seller designate any Person to succeed Griffin as Servicer or any successor Servicer.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Without the prior written consent of the Agent and each Managing Agent, Griffin will not delegate any of its duties or responsibilities as Servicer to any Person other than (i) an Originator  (with  respect  to  Receivables  originated  by  such  Originator),  (ii)  Cardinal,  (iii) Cardinal Health 2, Inc. a Nevada corporation, (iv) Cardinal Health 7, LLC and (v) with respect to certain Receivables that are Charged-Off Receivables, outside collection agencies in accordance with its customary practices (each, a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Permitted Sub-Servicer</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  No Permitted Sub-Servicer will further delegate to any other Person, other than another Permitted Sub-Servicer, any of the duties or responsibilities of the Servicer delegated to it by Griffin.  If the Agent shall, in accordance with this Agreement, designate as Servicer any Person other than Griffin, all duties and responsibilities theretofore delegated by Griffin to each Permitted Sub-Servicer may, at the discretion of the Agent, be terminated forthwith on notice given by the Agent to Griffin and to Seller (and, at the Agent&#8217;s discretion, any Permitted Sub-Servicer).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)      Notwithstanding the foregoing </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">subsection (b)</font><font style="font-family:inherit;font-size:12pt;">, (i) Griffin shall be and remain primarily liable to the Agent and the Purchasers for the full and prompt performance of all duties and responsibilities of the Servicer hereunder and (ii) the Agent and the Purchasers shall be entitled to deal exclusively with Griffin in matters relating to the discharge by the Servicer of its duties and responsibilities hereunder.  The Agent and the Purchasers shall not be required to (but may at their sole option) give notice, demand or other communication to any Person other than Griffin in order for communication to the Servicer and any of its Permitted Sub-Servicers with respect  thereto  to  be  accomplished.    Griffin,  at  all  times  that  it  is  the  Servicer,  shall  be responsible for providing any Permitted Sub-Servicer or other delegate of the Servicer with any notice given to the Servicer under this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Duties of Servicer</font><font style="font-family:inherit;font-size:12pt;">.   (a)   The Servicer will take or cause to be taken all such actions </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">as may be necessary or advisable to collect each Receivable from time to time, all in accordance with applicable laws, rules and regulations, with reasonable care and diligence, and in accordance with the Credit and Collection Policy.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       The Servicer will instruct all Obligors to pay all Collections directly to a Lock- Box or Collection Account and effect a Collection Account Agreement with each bank party to a Collection Account at any time.   In the case of any remittances received in any Lock-Box or Collection Account that shall have been identified, to the satisfaction of the Servicer, to not constitute Collections or other proceeds of the Receivables or the Related Security, the Servicer will promptly remit such items to the Person identified to it as being the owner of such remittances.   From and after the date the Agent delivers to any Collection Bank a Collection Notice pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.3</font><font style="font-family:inherit;font-size:12pt;">, the Agent may request that the Servicer, and the Servicer thereupon promptly will instruct all Obligors with respect to the Receivables to, remit all payments thereon to a new depositary account specified by the Agent and, at all times thereafter, Seller and the Servicer will not deposit or otherwise credit, and will not permit any other Person to deposit or otherwise credit to such new depositary account any cash or payment item other than Collections.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       The Servicer will administer the Collections in accordance with the procedures described herein and in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.  The Servicer will set aside and hold in trust for the account of Seller and the Purchasers their respective shares of the Collections of Receivables in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.   The Servicer will, upon the request of the Agent, segregate, in a manner reasonably acceptable to the Agent, all cash, checks and other instruments received by it from time to time constituting Collections from the general funds of the Servicer or Seller prior to the remittance thereof in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.  If the Servicer shall be required to segregate Collections pursuant to the preceding sentence, the Servicer shall segregate and deposit with a bank designated by the Agent such allocable share of Collections of Receivables set aside for the Purchasers on the first Business Day following receipt by the Servicer of such Collections, duly endorsed or with duly executed instruments of transfer.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       The Servicer may, in accordance with the Credit and Collection Policy, extend the maturity of any Receivable or adjust the Outstanding Balance of any Receivable or restructure any Receivable into a Note Receivable and sell such Note Receivable and its Related Security on a non-recourse basis, as agent for and on behalf of Seller, to a third party (other than Griffin or any Originator), in each case, as the Servicer determines to be appropriate to maximize Collections thereof; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that (i) such extension or adjustment shall not alter the status of such Receivable as a Delinquent Receivable or Charged-Off Receivable or limit the rights of the Agent, the Managing Agents or the Purchasers under this Agreement and (ii) any such restructuring shall be subject to the following conditions: (A) no Amortization Event shall exist immediately before such restructuring or after giving effect thereto (unless otherwise consented to by the Agent (at the instruction of each Managing Agent) in writing), (B) prior to such restructuring or concurrently therewith, Seller shall pay a Deemed Collection to the Agent in the amount of the Outstanding Balance of such Receivable and (C) Servicer shall identify the Receivable to be restructured to the Agent in writing.  Upon and not until satisfaction of the conditions set forth in the foregoing clauses (A), (B) and (C), any Receivable restructured into a Note Receivable shall cease to be a &#8220;Receivable&#8221; for any purposes hereunder and the lien of the Agent for the benefit of the Purchasers shall be automatically released without further action. Notwithstanding anything to the contrary contained herein, the Agent shall have the right, in its reasonable discretion, to direct the Servicer to commence or settle any legal action with respect to any Receivable or to foreclose upon or repossess any Related Security.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       The Servicer will hold in trust for Seller and the Purchasers all Records that (i) evidence or relate to the Receivables, the related Contracts and Related Security or (ii) are otherwise necessary or desirable to collect the Receivables and will, upon the occurrence of a Collection Notice Event, as soon as </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">practicable upon demand of the Agent, deliver or make available to the Agent all such Records, at a place selected by the Agent.  The Servicer will, as soon as practicable following receipt thereof, turn over to Seller any cash collections or other cash proceeds received with respect to Indebtedness not constituting Receivables.  The Servicer will, from time to time at the request of any Purchaser, furnish to the Purchasers (promptly after any such request) a calculation of the amounts set aside for the Purchasers pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article II</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)       Any payment by an Obligor in respect of any indebtedness owed by it to any Originator, Griffin or Seller shall, except as otherwise specified by such Obligor or otherwise required by contract or law and unless otherwise instructed by the Agent, be applied as a Collection of any Receivable of such Obligor to the extent of any amounts then due and payable thereunder before being applied to any other receivable or other obligation of such Obligor.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.3      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection Notices; Power-of-Attorney</font><font style="font-family:inherit;font-size:12pt;">.   (a)   The Agent is authorized at any time after the occurrence of a Collection Notice Event to date and to deliver to the Collection Banks the Collection Notices.   Seller hereby transfers to the Agent for the benefit of the Purchasers, effective when the Agent delivers such notice, the exclusive ownership and sole &#8220;control&#8221; (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) of each Lock-Box and the Collection Accounts.  In case any authorized signatory of Seller whose signature appears on a Collection Account Agreement shall cease to have such authority before the delivery of such notice, such Collection Notice shall nevertheless be valid as if such authority had remained in force.  Seller hereby authorizes the Agent, and agrees that the Agent shall be entitled after the occurrence of a Collection Notice Event to (i) endorse Seller&#8217;s name on checks</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">and other instruments representing Collections, (ii) take such action as shall be necessary or desirable to cause all cash, checks and other instruments constituting Collections of Receivables to come into the possession of the Agent rather than Seller and (iii) designate any Person to succeed Griffin as Servicer and enforce the Receivables, the related Contracts and the Related Security.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       The Seller hereby authorizes the Agent, and irrevocably appoints the Agent as its attorney-in-fact with full power of substitution and with full authority in the place and stead of the Seller, which appointment is coupled with an interest, to take any and all steps in the name of the Seller and on behalf of the Seller necessary or desirable, in the reasonable determination of the Agent, after the occurrence of a Amortization Event, to collect any and all amounts or portions thereof due under any and all Receivables, related Contracts and Related Security, including endorsing the name of the Seller on checks and other instruments representing Collections   and   otherwise   enforcing   Obligations   hereunder   and   under   the   Transaction Documents. Notwithstanding anything to the contrary contained in this subsection, none of the powers conferred upon such attorney-in-fact pursuant to the preceding sentence shall subject such attorney-in-fact to any liability if any action taken by it shall prove to be inadequate or invalid, nor shall they confer any obligations upon such attorney-in-fact in any manner whatsoever.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.4      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Responsibilities    of    Seller</font><font style="font-family:inherit;font-size:12pt;">.        Anything    herein    to    the    contrary notwithstanding, the exercise by the Agent, the Managing Agents and the Purchasers of their rights hereunder shall not release the Servicer, Griffin, any Originator or Seller from any of their duties or obligations with respect to any Receivables or under the related Contracts.   The Purchasers shall have no obligation or liability with respect to any Receivables or related Contracts, nor shall any of them be obligated to perform the obligations of Seller.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.5      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reports</font><font style="font-family:inherit;font-size:12pt;">.  (a)  The Servicer will prepare and forward to the Agent and the Managing Agents (i) on the seventeenth (17th) calendar day of each month (or if such day is not a Business Day, the next succeeding Business Day) and at such times as the Agent or the Required Financial Institutions shall </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">request, a Monthly Report and (ii) at such times as the Agent or the Required Financial Institutions shall request, a listing by Obligor of all Receivables together with an aging of such Receivables.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       If on any date, less than two of S&amp;P, Moody&#8217;s and Fitch are then maintaining senior unsecured long-term debt ratings on Cardinal of at least BBB- (as determined by S&amp;P and Fitch) or Baa3 (as determined by Moody&#8217;s), then the Servicer shall prepare and forward to the Agent and each Managing Agent on the Tuesday of each week thereafter for the immediately preceding calendar week, a Weekly Report with respect to the calendar week most recently ended, which report shall be in addition to any required or requested Monthly Report.  If on any date, less than two of S&amp;P, Moody&#8217;s and Fitch are then maintaining senior unsecured long-term debt ratings on Cardinal of at least BB (as determined by S&amp;P and Fitch) or Ba2 (as determined by Moody&#8217;s), the Servicer shall prepare and forward to the Agent and each Managing Agent on each Business Day thereafter, a Daily Report with respect to the immediately preceding Business Day or such other Business Day determined by the Agent, which report shall be in addition to any required or requested Monthly Report.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.6      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Servicing Fees</font><font style="font-family:inherit;font-size:12pt;">.  In consideration of Griffin&#8217;s agreement to act as Servicer hereunder, the Purchasers hereby agree that, so long as Griffin continues to perform as Servicer hereunder, Seller will pay over to Griffin on the 20th calendar day of each month, in arrears for the preceding Calculation Period (as defined in the Receivables Sale Agreement), a fee (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Servicing Fee</font><font style="font-family:inherit;font-size:12pt;">&#8221;) equal to 1.00% per annum of the average aggregate Outstanding Balance of all Receivables during such period, as compensation for its servicing activities.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:222px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE IX. </font></div><div style="line-height:120%;text-align:center;padding-left:222px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AMORTIZATION EVENTS</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.1      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amortization Events</font><font style="font-family:inherit;font-size:12pt;">.  The occurrence of any one or more of the following events shall constitute an Amortization Event:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       (i) Any Seller  Party shall fail (A) to make any payment or deposit required hereunder when due, which failure continues for two (2) consecutive days after such Seller Party has received notice, or has actual knowledge, of such failure, or (B) to perform or observe in any material respect any term, covenant or agreement hereunder (other than as referred to in clause (i) of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">paragraph (a)</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">) and such failure, if capable of cure, shall continue for ten (10) consecutive Business Days after such Seller Party has received notice, or has actual knowledge, of such failure; or (ii) Cardinal shall fail to make any payment in respect of the Demand Loans, whether upon demand or when otherwise due and such failure continues for two (2) consecutive days after any Seller Party has received notice, or has actual knowledge, of such failure.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Any representation, warranty, certification or statement made by any Seller Party in this Agreement, any other Transaction Document or in any other document delivered pursuant hereto or thereto shall prove to have been incorrect in any material respect when made or deemed made and, if capable of cure, such breach shall continue for ten (10) consecutive Business Days after such Seller Party has received notice, or has actual knowledge, of such breach.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       (i)        Failure of Seller to pay any Indebtedness when due in excess of $15,775 (such Indebtedness being referred to hereinafter as &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller&#8217;s Material Indebtedness</font><font style="font-family:inherit;font-size:12pt;">&#8221;); or the default by Seller in the performance of any term, provision or condition contained in any agreement under which any Seller&#8217;s Material Indebtedness was created or is governed, the effect of which is to cause, or to permit the holder or holders of such Seller&#8217;s Material Indebtedness to cause, such Seller&#8217;s Material Indebtedness to become </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">due prior to its stated maturity; or any Seller&#8217;s Material Indebtedness shall be declared to be due and payable or required to be prepaid (other than by a regularly scheduled payment) prior to the date of maturity thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       Failure of Servicer to pay Indebtedness when due in excess of $250,000 (such Indebtedness being referred to hereinafter as &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Material Indebtedness</font><font style="font-family:inherit;font-size:12pt;">&#8221;); or the default by Servicer in the performance of any term, provision or condition contained in any agreement under which any Material Indebtedness of Servicer was created or is governed, the effect of which is to cause, or to permit the holder or holders of such Material Indebtedness to cause, such Material Indebtedness to become due prior to its stated maturity; or any Material Indebtedness of Servicer shall be declared to be due and payable or required to be prepaid (other than by a regularly scheduled payment) prior to the date of maturity thereof.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      The Performance Guarantor or any Originator (a) shall fail to make any payment when due (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise) in respect of any Indebtedness having an aggregate principal amount (excluding undrawn committed amounts, but including amounts owing to all creditors under any combined or syndicated credit arrangement) of more than $100,000,000 and such failure shall continue beyond any applicable grace period (or, in the event such Indebtedness does not have a grace period for non-payment of non-principal amounts, such failure with respect to any non-principal amount shall continue for three Business Days) or (b) shall fail to observe or perform any other agreement, or any circumstance or condition shall exist, in either case relating to Indebtedness having an aggregate principal amount (excluding undrawn committed amounts, but including amounts owing to all creditors under any combined syndicated credit arrangement) of more than</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">$100,000,000 or contained in any instrument or other agreement evidencing, securing or relating thereto, the effect of which failure, circumstance or condition is to cause such Indebtedness to become due or to be repurchased, prepaid, defeased or redeemed (in each case automatically or otherwise), prior to its stated maturity.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       (i)     Any  Seller  Party,  Performance  Guarantor  or  any  of  their  respective Subsidiaries shall generally not pay its debts as such debts become due; or (ii) any Seller Party, Performance Guarantor or any of their respective Subsidiaries shall admit in writing its inability to pay its debts generally or shall make a general assignment for the benefit of creditors; or (iii) any proceeding shall be instituted against Seller or by any Seller Party, Performance Guarantor or any of their respective Subsidiaries seeking to adjudicate it bankrupt or insolvent, or seeking liquidation, winding up, reorganization, arrangement, adjustment, protection, relief or composition of it or its debts under any law relating to bankruptcy, insolvency or reorganization or relief of debtors, or seeking the entry of an order for relief or the appointment of a receiver, trustee or other similar official for it or any substantial part of its property; or (iv) any Seller Party, Performance Guarantor or any of their respective Subsidiaries shall take any corporate action to authorize any of the actions set forth in clause (i), (ii) or (iii) above in this subsection (d); or (v) any proceeding of the type described in clause (iii) of this subsection (d) shall be instituted against Servicer or Performance Guarantor and shall not be withdrawn, vacated or dismissed within 60 days after the commencement thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       The Purchaser Interests of the Purchasers shall exceed in the aggregate 100% for a period of two (2) consecutive Business Days.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)&#160;&#160;&#160;&#160;As  at  the  end  of  any  calendar  month  occurring  after  the  date  hereof,  the</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Delinquency Ratio shall exceed 5.75%.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)&#160;&#160;&#160;&#160;As at the end of any calendar month:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        (x) the Collections-to-Sales Ratio for such calendar month shall be less than 75% or </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(y) the Collections-to-Sales Ratios for each of such calendar month and the immediately preceding calendar month shall be less than 80%; or</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)&#160;&#160;&#160;&#160;the  three-month  rolling  average  Dilution-to-Sales  Ratio  shall  exceed 5.50%.</font></div><div style="line-height:120%;text-align:left;text-indent:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h)       (i)   A Change of Control shall occur with respect to any Seller Party; or (ii) a Change of Control shall occur with respect to Performance Guarantor and shall result in a Material Adverse Effect.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        (i)   One or more final judgments for the payment of money shall be entered against Seller; or (ii) one or more final judgments for the payment of money shall be entered against Servicer in excess of $250,000 on claims not covered by insurance or as to which the insurance carrier has denied its responsibility, and such judgment shall continue unsatisfied and in effect for thirty (30) consecutive days without a stay of execution; or (iii) one or more final judgments for the payment of money shall be entered against Performance Guarantor or any Originator in excess of $25,000,000 on claims not covered by insurance or as to which the insurance carrier has denied its responsibility, and such judgment shall continue unsatisfied and in effect for thirty (30) consecutive days without a stay of execution.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(j)        The Termination Date (as defined in the Receivables Sale Agreement) shall occur under the Receivables Sale Agreement; or Griffin shall for any reason cease to transfer, or cease to have the legal capacity to transfer, or otherwise be incapable of transferring Receivables to Seller under the Receivables Sale Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(k)       This Agreement shall terminate in whole or in part (except in accordance with its terms), or shall cease to be effective or to be the legally valid, binding and enforceable obligation of Seller, or any Obligor shall directly or indirectly contest in any manner such effectiveness, validity, binding nature or enforceability, or the Agent for the benefit of the Purchasers shall cease to have a valid and perfected first priority security interest in the Receivables, the Related Security and the Collections with respect thereto and the Collection Accounts.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(l)        Any Griffin RPA shall terminate in accordance with its terms or otherwise; or any Originator shall for any reason cease to transfer, or cease to have the legal capacity to transfer, or otherwise be incapable of transferring Receivables (as defined in the applicable Griffin RPA) to Griffin under the applicable Griffin RPA.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(m)      Performance Guarantor shall fail to perform or observe in any material respect any term, covenant or agreement required to be performed by it under the Performance Guaranty and, if capable of cure, such failure shall continue for ten (10) consecutive Business Days after such  Seller  Party  has  received  notice,  or  has  actual  knowledge,  of  such  failure,  or  the Performance Guaranty shall cease to be effective or to be the legally valid, binding and enforceable obligation of Performance Guarantor, or Performance Guarantor shall directly or indirectly contest in any manner such effectiveness, validity, binding nature or enforceability.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(n)       Any  Letter  of  Credit  is  drawn  upon  and  is  not  fully  reimbursed  (including, pursuant to an LC Reimbursement Purchase) by the Seller for any reason (including, because of any limitation on recourse to the Seller pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(a)</font><font style="font-family:inherit;font-size:12pt;">) within two (2) Business Days following the applicable LC Reimbursement Date.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.2      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Remedies</font><font style="font-family:inherit;font-size:12pt;">.    Upon  the  occurrence  and  during  the  continuation  of  an Amortization Event, the Agent may, or upon the direction of the Required Financial Institutions shall, take any of the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">following actions: (i) replace the Person then acting as Servicer, (ii) declare the Amortization Date to have occurred, whereupon the Amortization Date shall forthwith occur, without demand, protest or further notice of any kind, all of which are hereby expressly waived by each Seller Party; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that upon the occurrence of an Amortization Event described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">, or of an actual or deemed entry of an order for relief with respect to any Seller Party under the federal bankruptcy code, the Amortization Date shall automatically occur, without demand, protest or any notice of any kind, all of which are hereby expressly waived by each Seller Party, (iii) to the fullest extent permitted by applicable law, declare that the Default Fee shall accrue with respect to any of the Aggregate Unpaids outstanding at such time, (iv) deliver the Collection Notices to the Collection Banks, (v) notify Obligors of the Purchasers&#8217; interest in the Receivables and (vi) make demand on Cardinal for payment of the Demand Loans.  The aforementioned rights and remedies shall be without limitation, and shall be in addition to all other rights and remedies of the Agent, the Managing Agents and the Purchasers otherwise available under any other provision of this Agreement, by operation of law, at equity or otherwise, all of which are hereby expressly preserved, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, all rights and remedies provided under the UCC, all of which rights shall be cumulative.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:244px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE X. INDEMNIFICATION</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.1    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indemnities by the Seller Parties</font><font style="font-family:inherit;font-size:12pt;">.  Without limiting any other rights that the Agent, any Managing Agent, any Purchaser, any Funding Source or any of their respective Affiliates may have hereunder or under applicable law, (A) Seller hereby agrees to indemnify (and  pay  upon  demand  to)  the  Agent,  each  Managing  Agent,  each  Funding  Source,  each Purchaser and their respective Affiliates, assigns, officers, directors, agents and employees (each an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indemnified Party</font><font style="font-family:inherit;font-size:12pt;">&#8221;) from and against any and all damages, losses, claims, liabilities, costs, expenses  and  for  all  other  amounts  payable,  including  reasonable  attorneys&#8217;  fees  (which attorneys may be employees of the Agent or such Purchaser) and disbursements (all of the foregoing being collectively referred to as &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indemnified Amounts</font><font style="font-family:inherit;font-size:12pt;">&#8221;) awarded against or incurred by any of them arising out of or as a result of this Agreement, or the use of the proceeds of any purchase hereunder, or the acquisition, funding or ownership either directly or indirectly, by a Purchaser or a Funding Source of a Purchaser Interest or of an interest in the Receivables, or any Receivable or any Contract or any Related Security, the issuance of or any drawing under any Letter of Credit, participating such Letter of Credit (or a portion thereof) to another Financial Institution hereunder, acquiring a participation in or funding an LC Participation Advance in respect of a Letter of Credit hereunder, the maintenance of any LC Collateral Account, or any action of any Seller Party or any Affiliate of any Seller Party, and (B) the Servicer hereby agrees to indemnify (and pay upon demand to) each Indemnified Party for Indemnified Amounts awarded against or incurred by any of them arising out of the Servicer&#8217;s activities as Servicer hereunder excluding, however, in all of the foregoing instances under the preceding </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clauses (A)</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(B)</font><font style="font-family:inherit;font-size:12pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        Indemnified  Amounts  to  the  extent  a  final  judgment  of  a  court  of competent jurisdiction holds that such Indemnified Amounts resulted from gross negligence or willful misconduct on the part of the Indemnified Party seeking indemnification;</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       Indemnified Amounts to the extent the same includes losses in respect of Receivables that are uncollectible on account of the insolvency, bankruptcy or lack of creditworthiness of the related Obligor; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)&#160;&#160;&#160;&#160;Excluded Taxes and Taxes;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that nothing contained in this sentence shall limit the liability of any Seller Party or </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">limit the recourse of any Indemnified Party to any Seller Party for amounts otherwise specifically provided to be paid by such Seller Party under the terms of this Agreement.  Without limiting the generality of the foregoing indemnification, Seller will indemnify each Indemnified Party for Indemnified Amounts (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, losses in respect of uncollectible receivables, regardless of whether reimbursement therefor would constitute recourse to Seller or the Servicer) relating to or resulting from:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        any representation or warranty made by any Seller Party or any Cardinal Entity (or any officers of any such Person) under or in connection with this Agreement, any other Transaction Document or any other information or report delivered by any such Person pursuant hereto or thereto, that shall have been false or incorrect when made or deemed made;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       the failure by any Seller Party or any Cardinal Entity to comply with any applicable law, rule or regulation with respect to any Receivable or Contract related thereto, or the nonconformity of any Receivable or Contract included therein with any such applicable law, rule or regulation or any failure of Seller or any Cardinal Entity to keep or perform any of its obligations, express or implied, with respect to any Contract;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      any failure of any Seller Party or any Cardinal Entity to perform its duties, covenants or other obligations in accordance with the provisions of this Agreement or any other Transaction Document;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)      any products liability, personal injury or damage suit, or other similar claim arising out of or in connection with merchandise, insurance or services that are the subject of any Contract;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       any dispute, claim, offset or defense (other than discharge in bankruptcy of the Obligor) of the Obligor to the payment of any Receivable (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, (A) a defense based on such Receivable or the related Contract not being a legal, valid and binding obligation of such Obligor enforceable against it in accordance with its terms and/or (B) a claim that the sale or other assignment of all or any part of the applicable Originator&#8217;s (or any of its assignees&#8217;) rights under the related Contract violates any anti-assignment clause contained therein), or any other claim resulting from the sale of the merchandise or service related to such Receivable or the furnishing or failure to furnish such merchandise or services;</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)&#160;&#160;&#160;&#160;the commingling of Collections of Receivables at any time with other funds; </font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)     any investigation, litigation or proceeding related to or arising from this Agreement or any other Transaction Document, the transactions contemplated hereby, the use of the proceeds of an Incremental Purchase or Reinvestment (including any Letter of Credit), the ownership of the Purchaser Interests or any other investigation, litigation or proceeding relating to any Seller Party or any Cardinal Entity in which any Indemnified Party becomes involved as a result of any of the transactions contemplated hereby;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)    any inability to litigate any claim against any Obligor in respect of any Receivable as a result of such Obligor being immune from civil and commercial law and suit on the grounds of sovereignty or otherwise from any legal action, suit or proceeding;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ix)&#160;&#160;&#160;&#160;any Amortization Event described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">; </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(x)&#160;&#160;&#160;&#160;either:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A)     any failure of the Originators to acquire and maintain legal and equitable title to, and ownership of any Receivable originated by an Approved Sub-Originator and the Related Security and Collections with respect thereto from the applicable Approved Sub-Originator, free and clear of any Adverse Claim (other than any Adverse Claim created or permitted hereunder); or any failure of the Originators to give reasonably equivalent value to any Approved Sub- Originator under any Sub-Originator Sale Agreement in consideration of the transfer by such Approved Sub-Originator of any Receivable originated by such Approved Sub-Originator, or any attempt by any Person to void such transfer under statutory provisions or common law or equitable action; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B)      any failure of Griffin to acquire and maintain legal and equitable title to, and ownership of any Receivable and the Related Security and Collections with respect thereto from the applicable Originator, free and clear of any Adverse Claim (other than any Adverse Claim created or permitted hereunder); or any failure of Griffin to give reasonably equivalent value to any Originator under any Griffin RPA in consideration of the transfer by such Originator of any Receivable, or any attempt by any Person to void such transfer under statutory provisions or common law or equitable action;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xi)      any failure of Seller to acquire and maintain legal and equitable title to, and ownership of any Receivable and the Related Security and Collections with respect thereto from Griffin, free and clear of any Adverse Claim (other than any Adverse Claim created or permitted hereunder); or any failure of Seller to give reasonably equivalent value to Griffin under the Receivables Sale Agreement in consideration of the transfer by Griffin of any Receivable, or any attempt by any Person to void such transfer under statutory provisions or common law or equitable action;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xii)     any failure to vest and maintain vested in the Agent for the benefit of the Purchasers,  or  to  transfer  to  the  Agent  for  the  benefit  of  the  Purchasers,  legal  and equitable title to, and ownership of, a first priority perfected undivided percentage ownership interest (to the extent of the Purchaser Interests contemplated hereunder) or security interest in the Receivables, the Related Security and the Collections, free and clear of any Adverse Claim (except as created by the Transaction Documents);</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiii)   the failure to have filed, or any delay in filing, financing statements or other similar instruments or documents under the UCC of any applicable jurisdiction or other  applicable  laws  with  respect  to  any  Receivable,  the  Related  Security  and Collections with respect thereto, and the proceeds of any thereof, whether at the time of any Incremental Purchase or Reinvestment or at any subsequent time;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiv)    any action or omission by any Seller Party or any Cardinal Entity which reduces  or  impairs  the  rights  of  the  Agent  or  the  Purchasers  with  respect  to  any Receivable or the value of any such Receivable;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xv)&#160;&#160;&#160;&#160;any  attempt  by  any  Person  to  void  any  Incremental  Purchase  or Reinvestment hereunder under statutory provisions or common law or equitable action;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xvi)    any inability of the Agent or any Purchaser to review any Contract or to exercise its rights under any Contract or this Agreement as a result of a confidentiality provision in any such </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Contract and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xvii)   any  and  all  losses,  claims,  damages,  liabilities  and  related  expenses incurred as a result of a breach of Section 7.2(i) hereof (including, without limitation, any civil penalties or fines assessed by OFAC).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.2&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Increased  Cost  and  Reduced  Return;  Accounting  Based  Consolidation Events</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)&#160;&#160;&#160;&#160;If any Regulatory Change occurring or implemented after November 6, 2012 or any Specified Regulation:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        shall  subject  an  Affected  Party  to  any  Taxes  (other  than  (i)  Taxes indemnified under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">, (ii) Taxes attributable to such Affected Party&#8217;s failure to comply with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)</font><font style="font-family:inherit;font-size:12pt;">, and (iii) Excluded Taxes) with respect to any Purchaser Interest owned, maintained or funded by it (or its participation in any of the foregoing), any Letter of Credit or participation therein (or any obligation to fund any drawing thereunder or to make LC Participation Advances in respect thereof) or any obligations or right to make purchases or Reinvestments, to issue or participate in any Letter of Credit or  to  provide  funding  or  maintenance  therefor  (or  its  participation  in  any  of  the foregoing), or shall change the basis of taxation of payments to the Affected Party of Purchasers&#8217; Capital or Yield, per annum fees or discount calculated as part of any CP Costs, per annum fees hereunder and per annum fees under any Fee Letter owned by, owed to, funded or maintained in whole or in part by it (or its participation in any of the foregoing) or any other amounts due under this Agreement in respect of the Purchased Interest owned, maintained or funded by it or its obligations or rights, if any, to issue or participate in any Letter of Credit, to make or participate in purchases or Reinvestments or to provide funding therefor or the maintenance thereof;</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       shall impose, modify or deem applicable any reserve, special deposit or similar requirement against assets of any Affected Party, deposits or obligations with or for the account of any Affected Party or with or for the account of any Affiliate (or entity deemed by the Federal Reserve Board or other Governmental Authority to be an affiliate) of any Affected Party, or credit extended by any Affected Party;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      shall impose any other condition affecting any Purchaser Interest owned, maintained or funded (or participated in) in whole or in part by any Affected Party, or its obligations or rights, if any, to make (or participate in) purchases or Reinvestments, to issue or participate in any Letter of Credit, or to provide (or to participate in) funding therefor or the maintenance thereof;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)     shall change the rate for, or the manner in which the Federal Deposit Insurance  Corporation  (or  a  successor  thereto)  or  similar  Person  assesses  deposit insurance premiums or similar charges; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       shall change the amount of capital maintained or required or requested or directed to be maintained by any Affected Party;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">and the result of any of the foregoing is or would be, in each case, as determined by the applicable LC Bank or Managing Agent:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A)      to increase the cost to (or impose a cost on) (1) an Affected Party funding or making, issuing or maintaining any purchases or Reinvestments, any Letter of Credit or </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">participation therein, any purchases, reinvestments, or loans or other extensions of credit under any Liquidity Agreement, any Enhancement Agreement or any commitment (hereunder or under any Liquidity Agreement or any Enhancement Agreement) of such Affected Party with respect to any of the foregoing, or (2) a Financial Institution or a LC Bank for continuing its or Seller&#8217;s relationship with any Purchaser,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B)      to reduce the amount of any sum received or receivable by an Affected Party under this Agreement, any Liquidity Agreement or any Enhancement Agreement (or its participation in any such Liquidity Agreement or Enhancement Agreement) with respect thereto, or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(C)      to reduce the rate of return on the capital of such Affected Party as a consequence of its obligations hereunder, under any Liquidity Agreement or under any Enhancement Agreement (or its participation in any such Liquidity Agreement or Enhancement Agreement), including its funding or maintenance of any portion of the Purchaser Interest, or arising in connection herewith (or therewith) to a level below that which such Affected Party could otherwise have achieved hereunder or thereunder,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">then upon demand by such Managing Agent or LC Bank, Seller shall pay to such Managing Agent or LC Bank, for benefit of the relevant Affected Party, such additional amount or amounts as will compensate such Affected Party for such additional or increased cost or such reduction; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that such fee, expense, increased cost or reduction is applicable generally to the class of institutions of which such Affected Party is a member; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">&#32;that no failure to make such demand shall adversely affect the rights of any such Affected Party to such compensation except as provided in the next sentence.  Notwithstanding the foregoing, Seller shall not be required to compensate an Affected Party for any such additional or increased cost or reduction suffered more than nine months prior to the date that such Affected Party (or its Managing Agent on its behalf) notifies the Seller of such Affected Party&#8217;s intention to claim compensation therefor (except that if a Regulatory Change or a Specified Regulation giving rise to such additional or increased cost or reduction is retroactive, then the nine month period referred to above shall be extended to include the period of retroactive effect thereof).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       In determining any amount provided for or referred to in this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2</font><font style="font-family:inherit;font-size:12pt;">, no Managing Agent may claim or receive, on behalf of the Affected Parties in, or related to, its Purchaser Group, reimbursement or compensation for amounts under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2</font><font style="font-family:inherit;font-size:12pt;">&#32;that would result in (i) the total compensation (inclusive of Yield and fees and after giving effect to the payment of such amounts under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2</font><font style="font-family:inherit;font-size:12pt;">&#32;and imposition of the related additional or increased costs or reduction in the rate of return on Capital) received, in the aggregate, by all such Affected Parties, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">exceeding</font><font style="font-family:inherit;font-size:12pt;">&#32;(ii) the total compensation (inclusive of Yield and fees) that would have been payable to all such Affected Parties immediately prior to such Regulatory Change or Specified Regulation, as the case may be.  Subject to the nine-month limitation set forth in the last sentence of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2(a)</font><font style="font-family:inherit;font-size:12pt;">, amounts payable by Seller under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;may be demanded at any time without regard to the timing of issuance of any financial statement by any Affected Party.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.3    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Costs and Expenses</font><font style="font-family:inherit;font-size:12pt;">.  Subject to any written agreement between the Agent or a Purchaser, on the one hand, and Seller, on the other hand, to the contrary, Seller will pay to the Agent, each Managing Agent and each Purchaser on demand all reasonable costs and out-of-pocket  expenses  in  connection  with  the  preparation,  execution,  delivery  and administration of this Agreement, the transactions contemplated hereby and the other documents to be delivered hereunder, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the cost of any Purchaser&#8217;s auditors auditing the books, records and procedures of Seller, reasonable fees and </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">out-of-pocket expenses of legal counsel for each Purchaser, each Managing Agent and the Agent (which such counsel may be employees of any Purchaser, any Managing Agent or the Agent) with respect thereto and with respect to advising any Purchaser, any Managing Agent and the Agent as to their respective rights and remedies under this Agreement.  Seller will pay to the Agent, each Managing Agent and each Purchaser on demand any and all reasonable costs and expenses of the Agent, the Managing Agents and the Purchasers, if any, including reasonable counsel fees and expenses in connection with the enforcement of this Agreement, the other Transaction Documents and any other documents delivered hereunder and in connection with (i) any amendment, modification, or waiver of this Agreement, any other Transaction Document or any Funding Agreement or (ii) the restructuring, workout or administration of this Agreement and the other Transaction Documents following an Amortization Event; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that the Agent, each Managing Agent and each Purchaser agree that, with respect to counsel fees and expenses incurred in connection with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (i)</font><font style="font-family:inherit;font-size:12pt;">&#32;of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.3</font><font style="font-family:inherit;font-size:12pt;">, unless an Amortization Event has occurred and is continuing, all of such entities will be represented by a single law firm.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.4&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Taxes</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       All payments by or on account of the Seller or the Servicer hereunder or under any Transaction Document shall be made free and clear of and without deduction for any and all Taxes, except as required by applicable Law. If any Law shall require the deduction or withholding of any Taxes from or in respect of any sum payable hereunder or under any Transaction Document, (i) except to the extent such Taxes are attributable to the applicable Affected Party&#8217;s failure to comply with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)</font><font style="font-family:inherit;font-size:12pt;">, the sum payable by the Seller or the Servicer, as the case may be, shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">) the applicable Affected Party receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Seller or the Servicer, as the case may be, shall make such deductions, (iii) the Seller or the Servicer, as the case may be, shall pay the full amount deducted to the relevant authority in accordance with applicable Law and (iv) the Seller or the Servicer, as the case may be, shall furnish to the Agent the original or a certified copy of a receipt or other documentation reasonably acceptable to the Agent evidencing payment thereof within thirty (30) days after such payment is made.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)      In addition, the Seller hereby agrees to pay any present or future stamp, court, documentary, intangible, recording, filing or similar Taxes and any other excise or property Taxes, charges or similar levies which arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt under, or otherwise with respect to, this Agreement or any Transaction Document (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Taxes</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       The Seller hereby agrees to indemnify each Affected Party for the full amount of Taxes or Other Taxes (including, without limitation, any Taxes or Other Taxes imposed on amounts payable under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">) withheld or deducted on payments to, or paid by, such Affected Party and any liability (including penalties, interest and expenses) arising therefrom or with respect thereto.   Notwithstanding the preceding sentence, Seller shall not be obligated to indemnify any Affected Party for any Taxes or any liability arising therefrom or with respect thereto to the extent such Taxes or liabilities are attributable to such Affected Party&#8217;s failure to comply with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)</font><font style="font-family:inherit;font-size:12pt;">.  Payments due under this indemnification shall be made within 30 days of the date the applicable Affected Party makes demand therefor pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (f)</font><font style="font-family:inherit;font-size:12pt;">&#32;of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       Any  Affected  Party  that  is  entitled  to  an  exemption  from  or  reduction  of withholding Tax with respect to payments under this Agreement or any Transaction Document pursuant to the Law of any relevant jurisdiction shall deliver to each of Seller, the Servicer and the Agent, at the time or times </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">prescribed by applicable Law, such properly completed and executed documentation prescribed by applicable Law as will permit such payments to be made without withholding or at a reduced rate. Notwithstanding anything to the contrary in the preceding sentence, the completion, execution and submission of such documentation (other than such documentation set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)(i),</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(ii)</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(iii)</font><font style="font-family:inherit;font-size:12pt;">) shall not be required if in the Affected Party&#8217;s reasonable judgment such completion, execution or submission would subject such Affected Party to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Affected Party. Without limiting the generality of the foregoing:</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)&#160;&#160;&#160;&#160;Each Affected Party this is a &#8220;United States person&#8221; as defined in Section</font></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7701(a)(30) of the Code (each a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">U.S. Affected Party</font><font style="font-family:inherit;font-size:12pt;">&#8221;), on or prior to November 6, 2012 (or, in the case of any such U.S. Affected Party that is not a party hereto on such date, on or prior to the date on which such U.S. Affected Party first becomes entitled to any payment under this Agreement or any Transaction Document), shall deliver to each of Seller, the Servicer and the Agent, a duly completed and executed copy of U.S. Internal Revenue Service Form W-9 certifying that such U.S. Affected Party is exempt from U.S. federal backup withholding Tax.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       Each Affected Party that is not a &#8220;United States person&#8221; as defined in Section 7701(a)(30) of the Code (each a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-U.S. Affected Party</font><font style="font-family:inherit;font-size:12pt;">), on or prior to November 6, 2012 (or, in the case of any such Non-U.S. Affected Party that is not a party hereto on such date, on or prior to the date on which such Non-U.S. Affected Party first becomes entitled to any payment under this Agreement or any Transaction Document), shall deliver to Seller, the Servicer and the Agent (A) a duly completed and executed copy of U.S. Internal Revenue Service Form W-8BEN certifying that such Affected Party is entitled to receive payments under this Agreement from the Seller, the Servicer and the Agent without deduction or withholding of any U.S. federal withholding Taxes; (B) a duly completed and executed copy of U.S. Internal Revenue Service Form W-8ECI certifying that such Affected Party is entitled to receive payments under this Agreement from the Seller, the Servicer and the Agent without deduction or withholding of any U.S. federal withholding Taxes; or (C) if such Non-U.S. Affected Party is not the beneficial owner, a duly completed and executed copy of U.S. Internal Revenue Service Form W-8IMY, accompanied by duly completed and executed copies of U.S. Internal Revenue Service Forms W-8ECI, W-8BEN, W-9 and/or other certification documents from the beneficial owners, as applicable.  Each Non-U.S. Affected Party, on or prior to November 6, 2012 (or, in the case of any such Non-U.S. Affected Party that is not a party hereto on such date, on or prior to the date on which such Non-U.S. Affected Party first becomes entitled  to  any payment  under this  Agreement  or any Transaction  Document),  shall deliver to Seller, the Servicer and the Agent a duly completed and executed copy of any other form or documentation prescribed by applicable Law as a basis for claiming exemption from U.S. federal withholding Tax, together with such supplementary documentation as may be prescribed by applicable Law to permit Seller, the Servicer and the Agent to determine the withholding or deduction required to be made.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      If a payment made to an Affected Party under any Transaction Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Affected Party were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such  Affected  Party  shall  deliver  to  the  Seller  and  the  Agent  at  the  time  or  times prescribed by law and at such time or times reasonably requested by the Seller or the Agent such documentation prescribed by applicable Law (including as prescribed by Section 1471(b)(3)(C)(i)  of  the  Code)  and  such  additional  documentation  reasonably requested by the Seller or the Agent as may be necessary for the Seller and the Agent to comply with their obligations under FATCA and to determine that such Affected Party has complied </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">with such Affected Party&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (h)</font><font style="font-family:inherit;font-size:12pt;">, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Each  Affected  Party  shall  promptly  deliver  to  each  of  Seller,  the  Servicer  and  the Agent updates, renewals or additional copies, duly completed and executed, of any form or other documentation (or any successor thereto) contemplated by this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)</font><font style="font-family:inherit;font-size:12pt;">&#32;(A) from time to time as reasonably requested by Seller, the Servicer or the Agent, and (B) on or before the date that such form or other documentation expires or becomes obsolete or inaccurate.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       Without limiting </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 11.6</font><font style="font-family:inherit;font-size:12pt;">, each Financial Institution, LC Bank and Managing Agent shall severally indemnify the Agent, within ten (10) days after demand therefor, for (i) any Taxes attributable to such Financial Institution or LC Bank (or to any member of its Purchaser Group or any related Affected Party) (but only to the extent that neither the Seller nor the Servicer has already indemnified the Agent for such Taxes pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">&#32;and without limiting the obligation of the Seller or the Servicer to do so), and (ii) any Excluded Taxes attributable to such Financial Institution, LC Bank or Managing Agent (or to any member of its Purchaser Group or any related Affected Party), in each case, that are payable or paid by the Agent in connection with any Transaction Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Financial Institution, LC Bank or Managing Agent by the Agent shall be conclusive absent manifest error.  Each Purchaser and Managing Agent hereby authorizes the Agent to set off and apply any and all amounts at any time owing to such Purchaser or Managing Agent under any Transaction Document or otherwise payable by the Agent to such Purchaser or Managing Agent from any other source against any amount due to the Agent under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(e)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        Each Managing Agent shall deliver a written statement to Seller, the Servicer and the Agent as to the amount due, if any, to the Purchasers in its Purchaser Group and any related Affected Parties under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">.   Such written statement shall set forth in reasonable detail the calculations upon which such Managing Agent determined such amount and shall be final, conclusive and binding on Seller, the Servicer and the Agent in the absence of manifest error.  Unless otherwise provided herein, the amount specified in such written statement shall be payable on demand after receipt by the Seller of such written statement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(g)       If any party determines, in its sole discretion (exercised in good faith), that it has received a refund of any Taxes as to which it has been indemnified pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">&#32;(including by the payment of additional amounts pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">), it shall pay to such indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by such indemnifying party under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">&#32;with respect to the Taxes giving rise to such refund), net of all reasonable out-of-pocket expenses of such indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund); </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that the indemnifying party, upon the request of the indemnified party, agrees to repay the amount paid over to it pursuant to this  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause  (g)</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;(plus  any  penalties,  interest  or  other  charges  imposed  by  the  relevant Governmental Authority) to such indemnified party in the event such indemnified party is required to repay such refund to such Governmental Authority.   This </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (g)</font><font style="font-family:inherit;font-size:12pt;">&#32;shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to any other party or Person. Notwithstanding anything herein to the contrary, in no event will any indemnified party be required to pay any amount pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (g)</font><font style="font-family:inherit;font-size:12pt;">&#32;the payment of </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">which would place such indemnified party in a less favorable net after-Tax position than the indemnified party would have been if the Taxes subject to indemnification and giving rise to such refund had not been deducted,  withheld  or  otherwise  imposed  and  the  indemnification  payments  or  additional amounts with respect to such Tax had never been paid.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(h)       Each party&#8217;s obligations under this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4</font><font style="font-family:inherit;font-size:12pt;">&#32;shall survive the resignation or replacement of the Agent or any assignment of rights by, or the replacement of, an Affected Party, subject to the provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 11.8</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1</font><font style="font-family:inherit;font-size:12pt;">, respectively, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Transaction Document.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:270px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XI. </font></div><div style="line-height:120%;text-align:center;padding-left:270px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE AGENT</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.1    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Authorization and Action</font><font style="font-family:inherit;font-size:12pt;">.  Each Purchaser hereby designates and appoints BTMUNY to act as its agent hereunder and under each other Transaction Document, and authorizes the Agent to take such actions as agent on its behalf and to exercise such powers as are delegated to the Agent by the terms of this Agreement and the other Transaction Documents together with such powers as are reasonably incidental thereto.  The Agent shall not have any duties or responsibilities, except those expressly set forth herein or in any other Transaction Document,  or  any  fiduciary  relationship  with  any  Purchaser,  and  no  implied  covenants, functions, responsibilities, duties, obligations or liabilities on the part of the Agent shall be read into this Agreement or any other Transaction Document or otherwise exist for the Agent.   In performing its functions and duties hereunder and under the other Transaction Documents, the Agent shall act solely as agent for the Purchasers and does not assume nor shall be deemed to have assumed any obligation or relationship of trust or agency with or for any Seller Party or any of such Seller Party&#8217;s successors or assigns.  The Agent shall not be required to take any action that exposes the Agent to personal liability or that is contrary to this Agreement, any other Transaction Document or applicable law.  The appointment and authority of the Agent hereunder shall terminate upon the indefeasible payment in full of all Aggregate Unpaids.  Each Purchaser hereby authorizes the Agent to file each of the Uniform Commercial Code financing or continuation statements (and amendments thereto and assignments or terminations thereof) on behalf of such Purchaser (the terms of which shall be binding on such Purchaser).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.2    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Delegation of Duties</font><font style="font-family:inherit;font-size:12pt;">.  The Agent may execute any of its duties under this Agreement and each other Transaction Document by or through agents or attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties.  The Agent shall not be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.3    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exculpatory  Provisions</font><font style="font-family:inherit;font-size:12pt;">.    Neither  the  Agent  nor  any  of  its  directors, officers, agents or employees shall be (i) liable for any action lawfully taken or omitted to be taken  by it  or  them  under or in  connection  with  this Agreement  or  any other Transaction Document (except for its, their or such Person&#8217;s own gross negligence or willful misconduct), or (ii)  responsible  in  any  manner  to  any  of  the  Purchasers  for  any  recitals,  statements, representations or warranties made by any Seller Party contained in this Agreement, any other Transaction Document or any certificate, report, statement or other document referred to or provided  for  in,  or  received  under  or  in  connection  with,  this  Agreement,  or  any  other Transaction Document or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement, or any other Transaction Document or any other document furnished in connection herewith or therewith, or for any failure of any Seller Party to perform its obligations hereunder or thereunder, or for the satisfaction of any condition specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article VI</font><font style="font-family:inherit;font-size:12pt;">, or for the perfection, priority, condition, value or sufficiency of any collateral pledged in connection herewith.   The Agent shall not be under any obligation to any Purchaser to ascertain or to inquire as to the observance or performance of any </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">of the agreements or covenants contained in, or conditions of, this Agreement or any other Transaction Document, or to inspect the properties, books or records of the Seller Parties.  The Agent shall not be deemed to have knowledge of any Amortization Event or Potential Amortization Event unless the Agent has received notice from Seller or a Purchaser.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.4    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reliance by Agent</font><font style="font-family:inherit;font-size:12pt;">.  The Agent shall in all cases be entitled to rely, and shall be fully protected in relying, upon any document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">,</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, counsel to Seller), independent accountants and other experts selected by the Agent.  The Agent shall in all cases be fully justified in failing or refusing to take any action under this Agreement or any other Transaction  Document unless it shall first receive such advice or concurrence of the Required Financial Institutions or all of the Purchasers, as applicable, as it deems appropriate and it shall first be indemnified to its satisfaction by the Purchasers, provided that unless and until the Agent shall have received such advice, the Agent may take or refrain from taking any action, as the Agent shall deem advisable and in the best interests of the Purchasers.  The Agent shall in all cases be fully protected in acting, or in refraining from acting, in accordance with a request of the Required Financial Institutions or all of the Purchasers, as applicable, and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Purchasers.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.5    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-Reliance on Agent and Other Purchasers</font><font style="font-family:inherit;font-size:12pt;">.  Each Purchaser expressly acknowledges that neither the Agent, nor any of its officers, directors, employees, agents, attorneys-in-fact or affiliates has made any representations or warranties to it and that no act by the Agent hereafter taken, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, any review of the affairs of any Seller Party,  shall  be  deemed  to  constitute  any  representation  or  warranty  by  the  Agent.    Each Purchaser represents and warrants to the Agent that it has and will, independently and without reliance upon the Agent or any other Purchaser and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, operations, property, prospects, financial and other conditions and creditworthiness of Seller and made its own decision to enter into this Agreement, the other Transaction Documents and all other documents related hereto or thereto.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.6    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reimbursement and Indemnification</font><font style="font-family:inherit;font-size:12pt;">.  Each Financial Institution and each Managing Agent agrees to reimburse and indemnify the Agent and its officers, directors, employees, representatives and agents ratably based on the ratio of each such indemnifying Financial Institution&#8217;s commitment to the aggregate Commitment (or, in the case of an indemnifying Managing Agent, ratably based on the Commitment(s) of each Financial Institution in such Managing Agent&#8217;s Purchaser Group to the aggregate Commitment), to the extent not paid or reimbursed by the Seller Parties (i) for any amounts for which the Agent, acting in its capacity as Agent, is entitled to reimbursement by the Seller Parties hereunder and (ii) except with respect to any expenses arising out of the willful misconduct or gross negligence of the Agent (to the extent a final judgment of a court of competent jurisdiction holds that the Agent was grossly negligent or engaged in willful misconduct), for any other expenses incurred by the Agent, in its capacity as Agent and acting on behalf of the Purchasers, in connection with the administration and enforcement of this Agreement and the other Transaction Documents.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.7    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agent in its Individual Capacity</font><font style="font-family:inherit;font-size:12pt;">.  The Agent and its Affiliates may make loans to, accept deposits from and generally engage in any kind of business with Seller or any Affiliate of Seller as though the Agent were not the Agent hereunder.  With respect to the acquisition of Purchaser Interests pursuant to this Agreement, the Agent shall have the same rights and powers under this Agreement in its individual capacity as any Purchaser and may exercise the same as though it were not the Agent, and the terms &#8220;Financial Institution,&#8221; &#8220;Purchaser,&#8221; &#8220;Related Financial Institution,&#8221; &#8220;Financial Institutions,&#8221; </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;Purchasers,&#8221; and &#8220;Related Financial Institutions&#8221; shall include the Agent in its individual capacity.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.8    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Successor Agent</font><font style="font-family:inherit;font-size:12pt;">.  The Agent may, upon five days&#8217; notice to Seller and the Purchasers and with the consent of Seller (such consent not to be unreasonably withheld), and the Agent will, upon the direction of all of the Purchasers (other than the Agent, in its individual capacity) and with the consent of Seller (such consent not to be unreasonably withheld), resign as Agent.  If the Agent shall resign, then the Required Financial Institutions during such five-day period shall appoint from among the Purchasers and the Managing Agents a successor agent.  If for any reason no successor Agent is appointed by the Required Financial Institutions during such five-day period, then effective upon the termination of such five-day period, the Purchasers shall  perform  all  of  the  duties  of  the  Agent  hereunder  and  under  the  other  Transaction Documents and Seller and the Servicer (as applicable) shall make all payments in respect of the Aggregate Unpaids directly to the applicable Purchasers and for all purposes shall deal directly with the Purchasers.  After the effectiveness of any retiring Agent&#8217;s resignation hereunder as Agent, the retiring Agent shall be discharged from its duties and obligations hereunder and under the other Transaction Documents and the provisions of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article XI</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article X</font><font style="font-family:inherit;font-size:12pt;">&#32;shall continue in effect for its benefit with respect to any actions taken or omitted to be taken by it while it was Agent under this Agreement and under the other Transaction Documents.</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XII. </font></div><div style="line-height:120%;text-align:center;padding-left:180px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ASSIGNMENTS; PARTICIPATIONS</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.1    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Assignments</font><font style="font-family:inherit;font-size:12pt;">.  (a)  Seller, the Agent, each Managing Agent, each LC Bank and each Financial Institution hereby agree and consent to the complete or partial assignment by any Conduit of all or any portion of its rights under, interest in, title to and/or obligations under this Agreement (or interests therein) to the Financial Institutions pursuant to any Funding Agreement or to any other Person, and upon such assignment, such Conduit shall be released from its obligations so assigned.  Further, Seller and each Financial Institution hereby agree that any assignee of any Conduit of this Agreement or of all or any of the Purchaser Interests of any Conduit shall have all of the rights and benefits under this Agreement as if the term &#8220;Conduit&#8221; explicitly referred to and included such party (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that (i) the Purchaser Interests of any such assignee that is a Conduit or a commercial paper conduit shall accrue CP Costs based on such assignee&#8217;s CP Rate, and (ii) the Purchaser Interests of any other such assignee shall accrue Yield pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.1</font><font style="font-family:inherit;font-size:12pt;">), and no such assignment shall in any way impair the rights and benefits of any Conduit hereunder.  Neither Seller nor the Servicer shall have the right to assign its rights or obligations under this Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Any Financial Institution may at any time and from time to time, upon notice to the Agent and Seller, assign to one or more Persons (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchasing Financial Institutions</font><font style="font-family:inherit;font-size:12pt;">&#8221;) all or any part of its rights and obligations under this Agreement pursuant to an assignment agreement, substantially in the form set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit VI</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Assignment Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;) executed by such Purchasing Financial Institution and such selling Financial Institution.  Each assignee of a Financial Institution must (i) have a short-term debt rating of A-1 or better by S&amp;P and P-1 by Moody&#8217;s, and (ii) be approved by the Agent, each LC Bank and the Seller (such approval not to be unreasonably withheld or delayed); </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that no such approval of the Seller shall be required (but, for the avoidance of doubt, such approval of the Agent and the LC Banks shall be required in any event) (A) in the event that Seller does not approve of the proposed Purchasing Financial Institution and Seller, the Agent, such Conduit and the selling Financial Institution fail to agree on an alternative funding entity within 15 days after the selling Financial Institution gives notice pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;of the proposed assignment or (B) if an Amortization Event or a Potential Amortization Event shall have occurred and is continuing. Upon delivery of the executed Assignment Agreement to the Agent, such selling Financial Institution shall be released from its obligations </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">hereunder (including, without limitation, the applicable obligations of a Related Financial Institution) to the extent of such assignment. Thereafter the Purchasing Financial Institution shall for all purposes be a Financial Institution party to this Agreement and shall have all the rights and obligations of a Financial Institution under this Agreement to the same extent as if it were an original party hereto and no further consent or action by Seller, the Purchasers, the Managing Agents or the Agent shall be required.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       In the event that any Financial Institution shall cease to have a short-term debt rating of A-1 or better by S&amp;P and P-1 by Moody&#8217;s (an &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Affected Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221;), such Affected Financial Institution and its related Conduit shall be obligated, upon ten (10) Business Days prior written request of the Seller, to sell and assign all of their respective rights and obligations under the Transaction Documents (including their Capital) (i) to any other Financial Institution selected by the Seller that is (x) a party to this Agreement, (y) not an Affected Financial Institution and (z) willing, in such Financial Institution&#8217;s sole discretion, to purchase and assume such rights and obligations (it being understood and agreed that no Financial Institution shall have any obligation to purchase or assume any such rights or obligations of any other Financial Institution or Conduit), or (ii) if no other Financial Institution then meets the criteria specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (i)</font><font style="font-family:inherit;font-size:12pt;">&#32;above or no Financial Institution agrees to purchase the Affected Financial Institution&#8217;s rights and obligations under the Transaction Documents, to any other commercial bank selected by the Seller and acceptable to the Agent and each LC Bank (such acceptance not to be unreasonably withheld) with short-term debt ratings of A-1 or better by S&amp;P and P-1 by Moody&#8217;s, which commercial bank is willing to purchase and assume such rights and obligations; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that the Affected Financial Institution, its related Conduit, their Managing Agent and any other related Affected Parties receive payment in full, pursuant to an</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Assignment Agreement, of all amounts then owing to them under the Transaction Documents (including, without limitation, all their outstanding Capital, accrued Yield, any fees accrued under the Fee Letter); and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">, that any such sale and assignment shall be made pursuant to an Assignment Agreement in form and substance reasonably satisfactory to the Agent, each LC Bank and the Seller; and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">, that if the Affected Financial Institution or any Affiliate thereof is the Agent, another Person shall have been appointed as a successor Agent in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 11.8</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       Notwithstanding  any  other  provision  of  this  Agreement  to  the  contrary,  any Purchaser may at any time pledge or grant a security interest in all or any portion of its rights (including, without limitation, rights to payment of principal and interest) under this Agreement to secure obligations of such Purchaser to a Federal Reserve Bank located in the United States of America, without notice to or consent of the Seller, the Agent, any LC Bank or any Managing Agent; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that no such pledge or grant of a security interest shall release a Purchaser from any of its obligations hereunder or substitute any such pledgee or grantee for such Purchaser as a party hereto.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       The Agent, acting solely for this purpose as an agent of Seller, shall maintain at one of its offices in New York a copy of each Assignment Agreement delivered to it and a register for the recordation of the names and addresses of the Purchasers, and the Commitments of, and amount of Capital owing to, each Purchaser pursuant to the terms hereof from time to time (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Register</font><font style="font-family:inherit;font-size:12pt;">&#8221;).  The entries in the Register shall be conclusive absent manifest error, and Seller, the Servicer, the Agent and each Affected Party shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Purchaser hereunder for all purposes of this Agreement, notwithstanding notice to the contrary.  The Register shall be available for inspection by Seller, the Servicer and any Affected Party at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.2    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Participations</font><font style="font-family:inherit;font-size:12pt;">.  Any Financial Institution may, in the ordinary course of its business at any time sell to one or more Persons (each a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Participant</font><font style="font-family:inherit;font-size:12pt;">&#8221;) participating interests in its Pro Rata Share of the Purchaser Interests of the Financial Institutions in such Financial Institution&#8217;s Purchaser Group or </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">any other interest of such Financial Institution hereunder. Notwithstanding  any  such  sale  by  a  Financial  Institution  of  a  participating  interest  to  a Participant, such Financial Institution&#8217;s rights and obligations under this Agreement shall remain unchanged, such Financial Institution shall remain solely responsible for the performance of its obligations hereunder, and Seller, each Purchaser, each Managing Agent and the Agent shall continue to deal solely and directly with such Financial Institution in connection with such Financial Institution&#8217;s rights and obligations under this Agreement.  Each Financial Institution agrees that any agreement between such Financial Institution and any such Participant in respect of such participating interest shall not restrict such Financial Institution&#8217;s right to agree to any amendment, supplement, waiver or modification to this Agreement, except for any amendment, supplement, waiver or modification described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.1(b)(i)</font><font style="font-family:inherit;font-size:12pt;">.  Each Financial Institution that sells a participating interest shall, acting solely for this purpose as an agent of Seller, maintain a register on which it enters the name and address of each Participant and the amount of each Participant&#8217;s participating interest in the Purchaser Interests or other obligations under this Agreement (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Participant Register</font><font style="font-family:inherit;font-size:12pt;">&#8221;); </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that no Financial Institution shall have any obligation to disclose all or any portion of the Participant Register to Seller, the Servicer, the</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agent or any other Person (including the identity of any Participant or any information relating to a Participant&#8217;s participating interest in the Purchaser Interests or other obligations) except to the extent such disclosure is necessary to establish that such Purchaser Interests or other obligations are in registered form under Section 5f.103-1(c) of the U.S. Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Financial Institution shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Agent (in its capacity as Agent) shall have no responsibility for maintaining the Participant Register.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:238px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XIII. </font></div><div style="line-height:120%;text-align:center;padding-left:238px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">MANAGING AGENTS</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 13.1    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Managing Agents</font><font style="font-family:inherit;font-size:12pt;">.   Each Purchaser Group shall designate a &#8220;Managing Agent&#8221; hereunder, which Managing Agent shall become a party to this Agreement.  Unless otherwise notified in writing to the contrary by the applicable Purchaser, the Agent and the Seller Parties shall provide all notices and payments specified to be made by the Agent or any Seller Party to a Purchaser hereunder to such Purchaser&#8217;s Managing Agent, if any, for the benefit of such Purchaser, instead of to such Purchaser.  Each Managing Agent may perform any of the obligations of, or exercise any of the rights of, any member of its Purchaser Group and such performance or exercise shall constitute performance of the obligations of, or exercise of the rights of, such member hereunder.   Each member of the BTMU Conduit&#8217;s Purchaser Group hereby  designates  BTMUNY,  and  BTMUNY  hereby  agrees  to  perform  the  duties  and obligations of, such Purchaser Group&#8217;s Managing Agent.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:249px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ARTICLE XIV. MISCELLANEOUS</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.1    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Waivers and Amendments</font><font style="font-family:inherit;font-size:12pt;">.   (a)   No failure or delay on the part of any party to this Agreement in exercising any power, right or remedy under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or remedy preclude any other further exercise thereof or the exercise of any other power, right or remedy.  The rights and remedies herein provided shall be cumulative and nonexclusive of any rights or remedies provided by law.  Any waiver of this Agreement shall be effective only in the specific instance and for the specific purpose for which given.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       No provision of this Agreement may be amended, supplemented, modified or waived except </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">in writing in accordance with the provisions of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.1(b)</font><font style="font-family:inherit;font-size:12pt;">.   No amendment or waiver of any provision of this Agreement shall be effective unless in a writing signed by the Agent, the Required Financial Institutions, all LC Banks and, in the case of an amendment, the Seller and the Servicer; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that with respect to any material modification or waiver and to the extent required pursuant to the documents governing each Conduit&#8217;s commercial paper program, the Rating Agencies then rating the Commercial Paper notes of the applicable Conduit shall have confirmed that the ratings of the Commercial Paper notes of such Conduit will not be downgraded or withdrawn as a result of such modification or waiver; and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">, that no such modification or waiver shall:</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        without the consent of each affected Purchaser, (A) extend the Scheduled Facility Termination Date (except as provided in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6</font><font style="font-family:inherit;font-size:12pt;">) or the date of any payment or deposit of Collections by Seller or the Servicer, (B) reduce the rate or extend the time of payment of Yield or any CP Costs (or any component of Yield or CP Costs), (C) reduce any fee payable to the Agent for the benefit of the Purchasers, (D) except pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article XII</font><font style="font-family:inherit;font-size:12pt;">&#32;hereof, change the amount of the Capital of any Purchaser, any Financial Institution&#8217;s Pro Rata Share, any Conduit&#8217;s Pro Rata Share, any Financial Institution&#8217;s Commitment or any Conduit&#8217;s Conduit Purchase Limit (other than, to the extent applicable, pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6</font><font style="font-family:inherit;font-size:12pt;">), (E) amend, modify or waive any provision of the definition of Required Financial Institutions or this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.1(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.6</font><font style="font-family:inherit;font-size:12pt;">, (F) consent to or permit the assignment or transfer by Seller of any of its rights and obligations under this Agreement, (G) change the definition of &#8220;Capital,&#8221; &#8220;Purchaser Interest,&#8221; &#8220;Net Receivables Balance,&#8221; &#8220;Eligible Receivable,&#8221; &#8220;Loss Reserve,&#8221; &#8220;Dilution   Reserve,&#8221;   &#8220;Carrying   Cost   Reserve,&#8221;   &#8220;Aggregate   Reserves,&#8221;   &#8220;Dynamic Reserve&#8221; or &#8220;Reserve Floor,&#8221; (H) except as expressly set forth herein and in the other Transaction Documents, (x) release all or a material portion of the Collateral from the Agent&#8217;s security interest created hereunder or (y) release or terminate the Performance Guaranty or (I) amend or modify any defined term (or any defined term used directly or indirectly in such defined term) used in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clauses (A)</font><font style="font-family:inherit;font-size:12pt;">&#32;through </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(H)</font><font style="font-family:inherit;font-size:12pt;">&#32;above in a manner that would circumvent the intention of the restrictions set forth in such clauses; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       without the written consent of the then Agent, amend, modify or waive any provision of this Agreement if the effect thereof is to affect the rights or duties of such Agent.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding the foregoing, (i) without the consent of the Financial Institutions, the Agent may, with the prior written consent of Seller and each LC Bank, amend this Agreement solely to add additional Persons with short-term debt ratings of A-1 or better by S&amp;P and P-1 by Moody&#8217;s as Financial Institutions hereunder and (ii) the Agent, all LC Banks and the Required Financial Institutions may enter into amendments to modify any of the terms or provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article XI</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article XII</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.13</font><font style="font-family:inherit;font-size:12pt;">&#32;or any other provision of this Agreement without the consent of Seller, provided that such amendment has no negative impact upon Seller; and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided,</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">further</font><font style="font-family:inherit;font-size:12pt;">, that in the case of material amendments and to the extent required pursuant to the documents governing each Conduit&#8217;s commercial paper program, the Rating Agencies then rating the Commercial Paper notes of the applicable Conduit shall have confirmed that the ratings of the Commercial Paper notes of such Conduit will not be downgraded or withdrawn as a result of such amendments.  Any modification or waiver made in accordance with this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.1</font><font style="font-family:inherit;font-size:12pt;">&#32;shall apply to each of the Purchasers equally and shall be binding upon Seller, the Purchasers, the Managing Agents and the Agent.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.2    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices</font><font style="font-family:inherit;font-size:12pt;">.  Except as provided in this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.2</font><font style="font-family:inherit;font-size:12pt;">&#32;and in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8</font><font style="font-family:inherit;font-size:12pt;">, all communications and notices provided for hereunder shall be in writing (including facsimile or electronic mail communication) and shall be given to the other parties hereto by facsimile, electronic mail or by overnight mail at their respective mailing or electronic mail addresses or facsimile numbers set forth on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule C</font><font style="font-family:inherit;font-size:12pt;">&#32;or at such other mailing or electronic mail address or facsimile number as such Person may hereafter specify for the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">purpose of notice to each of the other parties hereto.  Each such notice or other communication shall be effective (i) if delivered by overnight mail, when received, and (ii) if transmitted by facsimile or electronic mail, when sent, receipt confirmed by telephone or electronic means.  Seller hereby authorizes (i) the Agent and the Purchasers to effect purchases and (ii) the Agent or applicable Managing Agent to effect Tranche Period and Discount Rate selections, in each case, based on telephonic notices made by any Person whom the Agent or applicable Managing Agent in good faith believes to be acting on behalf of Seller.  Seller agrees to deliver promptly to the Agent and each applicable Managing Agent a written confirmation of each telephonic notice signed by an authorized officer of Seller; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, the absence of such confirmation shall not affect the validity of such notice. If the written confirmation differs from the action taken by the Agent or applicable Purchaser, the records of the Agent or applicable Managing Agent shall govern absent manifest error.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.3    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Ratable Payments</font><font style="font-family:inherit;font-size:12pt;">.  If any Purchaser, whether by setoff or otherwise, has payment  made  to  it  with  respect  to  any portion  of  the  Aggregate  Unpaids  owing  to  such Purchaser (other than payments received pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">10.3</font><font style="font-family:inherit;font-size:12pt;">) in a greater proportion than that received by any other Purchaser entitled to receive a ratable share of such Aggregate Unpaids, such Purchaser agrees, promptly upon demand, to purchase for cash without recourse or warranty a portion of such Aggregate Unpaids held by the other Purchasers so that after such purchase each Purchaser will hold its ratable proportion of such Aggregate Unpaids; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that if all or any portion of such excess amount is thereafter recovered from such Purchaser, such purchase shall be rescinded and the purchase price restored to the extent of such recovery, but without interest.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.4    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Protection of Ownership Interests of the Purchasers</font><font style="font-family:inherit;font-size:12pt;">.  (a)  Seller agrees that from time to time, at its expense, it will promptly execute and deliver all instruments and documents, and take all actions, that may be reasonably necessary or desirable, or that the Agent may reasonably request, to perfect, protect or more fully evidence the Purchaser Interests, or to enable the Agent or the Purchasers to exercise and enforce their rights and remedies hereunder. Without limiting the foregoing, Seller will, upon the request of the Agent, file (or authorize the Agent to file) such financing or continuation statements, or amendments thereto or assignments thereof, and execute and file such other instruments and documents, that may be necessary or desirable,  or  that  the  Agent  may  reasonably  request,  to  perfect,  protect  or  evidence  such Purchaser Interest.   At any time after the occurrence of a Collection Notice Event, the Agent may, or the Agent may direct Seller or the Servicer to, notify the Obligors of Receivables, at Seller&#8217;s expense, of the ownership or security interests of the Purchasers under this Agreement and may also direct that payments of all amounts due or that become due under any or all Receivables be made directly to the Agent or its designee; it being understood that the Agent shall only exercise such right after the occurrence of a Collection Notice Event notwithstanding that the terms of the Receivables Sale Agreement provide that Seller (or its assign) may notify Obligors at any time.   Seller or the Servicer (as applicable) shall, at any Purchaser&#8217;s request, withhold the identity of such Purchaser in any such notification.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       If any Seller Party fails to perform any of its obligations hereunder, the Agent or any Purchaser may (but shall not be required to) perform, or cause performance of, such obligations, and the Agent&#8217;s or such Purchaser&#8217;s costs and expenses incurred in connection therewith shall be payable by Seller as provided in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.3</font><font style="font-family:inherit;font-size:12pt;">.  Each Seller Party irrevocably authorizes the Agent at any time and from time to time in the sole discretion of the Agent, and appoints the Agent as its attorney-in-fact, to act on behalf of such Seller Party (i) to authorize on behalf of such Seller Party as debtor and to file financing statements or continuation statements (and amendments thereto and assignments thereof) necessary or desirable in the Agent&#8217;s sole discretion to perfect and to maintain the perfection and priority of the interest of the Purchasers in the Receivables and (ii) to file a carbon, photographic or other reproduction of this Agreement or any financing statement with respect to the Receivables as a financing statement in such offices as the Agent in its sole </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">discretion deems necessary or desirable to perfect and to maintain the  perfection  and  priority  of  the  interests  of  the  Purchasers  in  the  Receivables.    This appointment is coupled with an interest and is irrevocable.  The authorization set forth in the second sentence of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.4(b)</font><font style="font-family:inherit;font-size:12pt;">&#32;is intended to meet all requirements for authorization by a debtor under Article 9 of any applicable enactment of the UCC, including, without limitation, Section 9-509 thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.5    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Confidentiality</font><font style="font-family:inherit;font-size:12pt;">.  (a)  Each Seller Party and each Purchaser shall maintain and shall cause each of its employees and officers to maintain the confidentiality of this Agreement and the other confidential or proprietary information with respect to the Agent and each Purchaser and their respective businesses obtained by it or them in connection with the structuring, negotiating and execution of the transactions contemplated herein, except that such Seller Party and such Purchaser and its officers and employees may disclose such information to such Seller Party&#8217;s and such Purchaser&#8217;s external accountants and attorneys and as required by any applicable law or order of any judicial or administrative proceeding.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Anything  herein  to  the  contrary  notwithstanding,  each  Seller  Party  hereby consents to the disclosure of any nonpublic information with respect to it (i) to the Agent, any Managing Agent, any LC Bank, any Financial Institution, any Funding Source or any Conduit by each other, (ii) by the Agent, any Managing Agent, any Funding Source or the Purchasers to any prospective or actual assignee or participant of any of them, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that such assignee or participant agrees to be bound by the terms of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.5</font><font style="font-family:inherit;font-size:12pt;">&#32;and (iii) by the Agent, any Managing Agent, any Funding Source or any Purchaser to any rating agency, Funding Source, Commercial Paper dealer or provider of a surety, guaranty or credit or liquidity enhancement to any Conduit or any entity organized for the purpose of purchasing, or making loans secured by, financial assets for which the Agent or any Managing Agent acts as the administrative agent and to any officers, directors, employees, outside accountants, advisors and attorneys of any of the foregoing, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;each such Person is informed of the confidential nature of such information. In addition, the Purchasers, any Funding Source, the Managing Agents and the Agent may disclose any such nonpublic information pursuant to any law, rule, regulation, direction, request or order of any judicial, administrative or regulatory authority or proceedings (whether or not having the force or effect of law), and, without limiting the generality of the foregoing, may disclose any such nonpublic information to any nationally recognized statistical rating organization as contemplated by Section 17g-5 of the Securities Exchange  Act of 1934, as amended.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.6    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Bankruptcy  Petition</font><font style="font-family:inherit;font-size:12pt;">.    Seller,  the  Servicer,  each  Managing  Agent,  the Agent and each Purchaser hereby covenants and agrees that, prior to the date that is one year and one day after the payment in full of all outstanding senior indebtedness of any Conduit or any Funding Source that is a special purpose bankruptcy remote entity, it will not institute against, or join any other Person in instituting against, any Conduit or any such entity any bankruptcy, reorganization, arrangement, insolvency or liquidation proceedings or other similar proceeding under the laws of the United States or any state of the United States.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.7    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Limitation of Liability</font><font style="font-family:inherit;font-size:12pt;">.  (a)  Except with respect to any claim arising out of the willful misconduct or gross negligence of any Conduit, any LC Bank, the Agent, any Managing Agent or any Financial Institution, no claim may be made by any Seller Party or any other  Person  against  any  Conduit,  any  LC  Bank,  the  Agent,  any Managing  Agent  or  any Financial Institution or their respective Affiliates, directors, officers, employees, attorneys or agents for any special, indirect, consequential or punitive damages in respect of any claim for breach of contract or any other theory of liability arising out of or related to the transactions contemplated  by  this  Agreement,  or  any  act,  omission  or  event  occurring  in  connection therewith; and each Seller Party hereby waives, releases, and agrees not to sue upon any claim for any such damages, whether or not accrued and whether or not known or suspected to exist in its favor.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       Notwithstanding any provisions contained in this Agreement to the contrary, no Conduit shall, nor shall it be obligated to, pay any amount pursuant to this Agreement unless (i) such Conduit has received funds which may be used to make such payment and which funds are not  required  to  repay its  Commercial  Paper  when  due  and  (ii)  after  giving  effect  to  such payment,  either  (x)  such  Conduit  could  issue  Commercial  Paper  to  refinance  all  of  its outstanding Commercial Paper (assuming such outstanding Commercial Paper matured at such time)  in  accordance  with  the  program  documents  governing  such  Conduit&#8217;s  securitization program or (y) all of such Conduit&#8217;s Commercial Paper is paid in full.  Any amount which such Conduit does not pay pursuant to the operation of the preceding sentence shall not constitute a claim (as defined in &#167;101 of the Federal Bankruptcy Code) against or corporate obligation of such Conduit for any such insufficiency unless and until such Conduit satisfies the provisions of clauses (i) and (ii) above.  This paragraph (b) shall survive the termination of this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.8    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CHOICE  OF  LAW</font><font style="font-family:inherit;font-size:12pt;">.    THIS  AGREEMENT  SHALL  BE  GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF ILLINOIS.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.9    </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CONSENT TO JURISDICTION</font><font style="font-family:inherit;font-size:12pt;">.   EACH SELLER PARTY HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF ANY UNITED STATES FEDERAL OR ILLINOIS STATE COURT SITTING IN CHICAGO, ILLINOIS IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY DOCUMENT EXECUTED BY SUCH PERSON PURSUANT TO THIS AGREEMENT AND EACH SELLER PARTY HEREBY IRREVOCABLY AGREES THAT  ALL  CLAIMS  IN  RESPECT  OF  SUCH  ACTION  OR  PROCEEDING  MAY  BE HEARD AND DETERMINED IN ANY SUCH COURT AND  IRREVOCABLY  WAIVES ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE AS TO THE VENUE OF ANY SUCH  SUIT,  ACTION  OR  PROCEEDING  BROUGHT  IN  SUCH  A  COURT  OR  THAT SUCH COURT IS AN INCONVENIENT FORUM.  NOTHING HEREIN SHALL LIMIT THE RIGHT OF THE AGENT, ANY MANAGING AGENT OR ANY PURCHASER TO BRING PROCEEDINGS AGAINST ANY SELLER PARTY IN THE COURTS OF ANY OTHER JURISDICTION.   ANY JUDICIAL PROCEEDING BY ANY SELLER PARTY AGAINST THE AGENT, ANY MANAGING AGENT OR ANY PURCHASER OR ANY AFFILIATE OF THE   AGENT,   ANY   MANAGING   AGENT   OR   ANY   PURCHASER   INVOLVING, DIRECTLY  OR  INDIRECTLY,  ANY  MATTER  IN  ANY  WAY  ARISING  OUT  OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT OR ANY DOCUMENT EXECUTED BY SUCH SELLER PARTY PURSUANT TO THIS AGREEMENT SHALL BE BROUGHT ONLY IN A COURT IN CHICAGO, ILLINOIS.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.10  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">WAIVER  OF  JURY  TRIAL</font><font style="font-family:inherit;font-size:12pt;">.     EACH  PARTY  HERETO  HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT, ANY DOCUMENT EXECUTED BY ANY SELLER PARTY PURSUANT TO THIS AGREEMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER OR THEREUNDER.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.11  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Integration; Binding Effect; Survival of Terms</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       This  Agreement  and  each  other  Transaction  Document  contain  the  final  and complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof superseding all prior oral or written understandings.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       This Agreement shall be binding upon and inure to the benefit of the parties hereto  and  their  respective  successors  and  permitted  assigns  (including  any  trustee  in bankruptcy).  This Agreement shall create and constitute the continuing obligations of the parties hereto in accordance with its terms and shall remain in full force and effect until terminated in accordance with its terms; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that the rights and remedies with respect to (i) any breach of any representation and warranty made by any Seller Party pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article V</font><font style="font-family:inherit;font-size:12pt;">, (ii) the indemnification and payment provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article X</font><font style="font-family:inherit;font-size:12pt;">, and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 14.5</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">14.6</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">14.7</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">14.16</font><font style="font-family:inherit;font-size:12pt;">&#32;all be continuing and shall survive any termination of this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.12  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts; Severability; Section References</font><font style="font-family:inherit;font-size:12pt;">.  This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same Agreement.  Any provisions of this Agreement which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.   Unless otherwise expressly indicated, all references herein to &#8220;Article,&#8221; &#8220;Section,&#8221; &#8220;Schedule&#8221; or &#8220;Exhibit&#8221; shall mean articles and sections of, and schedules and exhibits to, this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.13  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agent Roles</font><font style="font-family:inherit;font-size:12pt;">.  In addition to its role as Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article XI</font><font style="font-family:inherit;font-size:12pt;">, each of the Purchasers and Managing Agents acknowledges that the Person acting as Agent (or any Affiliate thereof) acts, or may in the future act, (i) as a Financial Institution, an LC Bank or a Managing Agent party hereto, (ii) as administrative agent (or in a similar capacity) for a Conduit, Financial Institution, LC Bank or Managing Agent from time to time party hereto or for any other Person, (iii) as issuing and paying agent for certain Commercial Paper, (iv) to provide credit or liquidity enhancement for the timely payment for certain Commercial Paper and (v) to provide other services from time to time for a Conduit, Financial Institution, LC Bank or Managing Agent from time to time party hereto or for any other Person (collectively, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agent</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Roles</font><font style="font-family:inherit;font-size:12pt;">&#8221;).    Without  limiting  the  generality  of  this  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  14.13</font><font style="font-family:inherit;font-size:12pt;">,  each  Purchaser  and  each Managing Agent hereby acknowledges and consents to any and all Agent Roles and agrees that in connection with any Agent Role, the Person acting as Agent may take, or refrain from taking, any action that it, in its discretion, deems appropriate, including, without limitation, in its role as administrative agent for a Conduit party hereto.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.14  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Characterization</font><font style="font-family:inherit;font-size:12pt;">.   (a)   It is the intention of the parties hereto that each purchase hereunder shall constitute and be treated as an absolute and irrevocable sale, which purchase shall provide the applicable Purchaser with the full benefits of ownership of the applicable Purchaser Interest.  Except as specifically provided in this Agreement, each sale of a Purchaser Interest by Seller hereunder is made without recourse to Seller; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that (i) Seller shall be liable to each Purchaser, each Managing Agent and the Agent for all representations, warranties, covenants and indemnities made by Seller pursuant to the terms of this Agreement, and (ii) such sale does not constitute and is not intended to result in an assumption by any Purchaser, the Agent, any Managing Agent or any assignee of any of the foregoing of any obligation of Seller or any Cardinal Entity or any other Person arising in connection with the Receivables, the Related Security, or the related Contracts, or any other obligations of Seller or any Cardinal Entity.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       In addition to any ownership interest which the Agent may from time to time acquire  pursuant  hereto,  Seller  hereby  grants  to  the  Agent  for  the  ratable  benefit  of  the Purchasers a valid and perfected security interest in all of Seller&#8217;s right, title and interest in, to and under all Receivables now existing or hereafter arising, all Collections, each Lock-Box, each Collection Account, the LC Collateral Account and all funds from time to time held therein, all Related Security, all other rights and payments relating to such Receivables and all proceeds of any thereof (the forgoing, collectively, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collateral</font><font style="font-family:inherit;font-size:12pt;">&#8221;) prior to all other </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">liens on and security interests therein to secure the prompt and complete payment of the Aggregate Unpaids.  After an Amortization Event, the Agent, the Managing Agents and the Purchasers shall have, in addition to the rights and remedies that they may have under this Agreement, all other rights and remedies provided to a secured creditor after default under the UCC and other applicable law, which rights and remedies shall be cumulative.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.15  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Confirmation and Ratification of Terms</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       Upon  the  effectiveness  of  this  Agreement,  each  reference  to  the  Existing Agreement in any other Transaction Document, and any document, instrument or agreement executed and/or delivered in connection with the Existing Agreement or any other Transaction Document, shall mean and be a reference to this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       The other Transaction Documents and all agreements, instruments and documents executed or delivered in connection with the Existing Agreement or any other Transaction Document shall each be deemed to be amended to the extent necessary, if any, to give effect to the provisions of this Agreement, as the same may be amended, modified, supplemented or restated from time to time.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       The effect of this Agreement is to amend and restate the Existing Agreement in its entirety, and to the extent that any rights, benefits or provisions in favor of the Agent or any Purchaser existed in the Existing Agreement and continue to exist in this Agreement without any written waiver of any such rights, benefits or provisions prior to the date hereof, then such rights, benefits or provisions are acknowledged to be and to continue to be effective from and after June</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">29, 2000.  This Agreement is not a novation.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)       The parties hereto agree and acknowledge that any and all rights, remedies and payment provisions under the Existing Agreement, including, without limitation, any and all rights, remedies and payment provisions with respect to (i) any representation and warranty made or deemed to be made pursuant to the Existing Agreement, or (ii) any indemnification provision, shall continue and survive the execution and delivery of this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       The parties hereto agree and acknowledge that any and all amounts owing as or for Capital, Yield, CP Costs, fees, expenses or otherwise under or pursuant to the Existing Agreement, immediately prior to the effectiveness of this Agreement shall be owing as or for Capital, Yield, CP Costs, fees, expenses or otherwise, respectively, under or pursuant to this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.16  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Excess Funds</font><font style="font-family:inherit;font-size:12pt;">.     Each  of  Seller,  the  Servicer,  each  Purchaser,  each Managing Agent and the Agent agrees that each Conduit shall be liable for any claims that such party may have against such Conduit only to the extent that such Conduit has funds in excess of those funds necessary to pay matured and maturing Commercial Paper and to the extent such excess funds are insufficient to satisfy the obligations of such Conduit hereunder, such Conduit shall have no liability with respect to any amount of such obligations remaining unpaid and such unpaid amount shall not constitute a claim against such Conduit.  Any and all claims against any Conduit shall be subordinate to the claims against such Conduit of the holders of Commercial Paper and any Person providing liquidity support to such Conduit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.17  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Patriot Act</font><font style="font-family:inherit;font-size:12pt;">.  Each of the Agent and the Purchasers hereby notifies you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">PATRIOT Act</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the Agent and the Purchasers may be required to obtain,  verify  and  record  information  that  identifies  the  Seller  Parties,  which  information includes the name, address, tax </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">identification number and other information regarding the Seller Parties that will allow the Agent and the Purchasers to identify the Seller Parties in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act. Each of the Seller Parties agrees to provide the Agent and the Purchasers, from time to time prior to and after the Closing Date, with all documentation and other information required by bank regulatory authorities under &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including, without limitation, the PATRIOT Act.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.18  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Acknowledgement and Consent to Bail-In of EEA Financial Institutions</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding  anything  to  the  contrary  in  any  Transaction  Document  or  in  any  other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any Transaction Document, to the extent such liability is unsecured, may be subject to the write-down and conversion  powers  of  an  EEA  Resolution  Authority  and  agrees  and  consents  to,  and acknowledges and agrees to be bound by:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution; and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:102px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:54px;"><font style="font-family:inherit;font-size:12pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the effects of any Bail-in Action on any such liability, including, if applicable: </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)&#160;&#160;&#160;&#160;a reduction in full or in part or cancellation of any such liability;</font></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)      a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)       the variation of the terms of such liability in connection with the exercise of the write-down and conversion powers of any EEA Resolution Authority.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:234px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">Signature Pages Follow</font><font style="font-family:inherit;font-size:12pt;">)</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:234px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="saffc813f734d40679fbcf0609c3e70ee"></a></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered by their duly authorized officers as of the date hereof.</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH FUNDING, LLC, as Seller</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">GRIFFIN CAPITAL, LLC, as Servicer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WELLS FARGO BANK, N.A., as a Financial Institution and as Managing Agent for WF's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ATLANTIC ASSET SECURITIZATION LLC, as a Conduit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK NEW YORK BRANCH, as Related Financial Institution for Atlantic and as Managing Agent for Atlantic's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PNC BANK, NATIONAL ASSOCIATION, as a Financial Institution and as Managing Agent for PNC's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">PNC BANK, NATIONAL ASSOCIATION, as an LC Bank</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">VICTORY RECEIVABLES CORPORATION, as a Conduit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Related Financial Institution for Victory</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Managing Agent for Victory's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as Agent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">LIBERTY STREET FUNDING LLC, as a Conduit</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:366px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF NOVA SCOTIA, as Related Financial Institution for Liberty Street and as Managing Agent for Liberty Street's Purchaser Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="sf4fb894ee6524ffb8a8f4cf14876da90"></a></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:266px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EXHIBIT I DEFINITIONS</font></div><div style="line-height:120%;text-align:center;padding-left:266px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">As used in this Agreement, the following terms shall have the following meanings (such</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">meanings to be equally applicable to both the singular and plural forms of the terms defined):</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Accrual Period</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each calendar month, provided that the initial Accrual Period hereunder  means  the  period  from  (and  including)  November  1,  2013  to  (and  including) November 30, 2013.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Adverse Claim</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a lien, security interest, charge or encumbrance, or other right or claim in, of or on any Person&#8217;s assets or properties in favor of any other Person.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Adjusted Tangible Net Worth</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, as of any date, (i) the amount of any capital stock, paid in capital and similar equity accounts </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;(or minus in the case of deficit) the capital surplus and retained earnings of Cardinal and its consolidated Subsidiaries, but excluding the amount of any foreign currency translation adjustment account shown as a capital account, less (ii) the net book value of all items of the following character which are included in the assets of Cardinal  and  its  consolidated  Subsidiaries:    (a)  goodwill,  including,  without  limitation,  the excess of cost over book value of any asset, (b) organization or experimental expenses, (c) unamortized debt discount and expense, (d) patents, trademarks, trade names and copyrights, (e) treasury stock, (f) franchises, licenses and permits, and (g) other assets which are deemed intangible assets under generally accepted accounting principles.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Affected Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1(c)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Affected Party</font><font style="font-family:inherit;font-size:12pt;">&#8221; means  each Purchaser, each  Managing Agent, the Agent  and each</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Funding Source.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Affiliate</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under direct or indirect common control with, such Person or any Subsidiary of such Person.  A Person shall be deemed to control another Person if the controlling Person owns 10% or more </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">of any class of voting securities of the controlled Person or possesses, directly or indirectly, the power to direct or cause the direction of the management or policies of the controlled Person, whether through ownership of stock, by contract or otherwise.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agent</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble to this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate  Capital</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  on  any  date  of  determination,  the  aggregate  amount  of</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Capital of all Purchasers and Purchaser Interests outstanding on such date.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-12px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate Reduction</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.3</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate Reserves</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, an amount equal to the sum of (i) the greater of (x) the Reserve Floor and (y) the Dynamic Reserve plus (ii) the Carrying Cost Reserve.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Aggregate Unpaids</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, an amount equal to the sum of all accrued and unpaid Aggregate Capital, the LC Adjusted Exposure, any LC Reimbursement Obligation and all unpaid Obligations (whether due or accrued) at such time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">means</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">this</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Fourth</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Amended</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">and</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Restated</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Receivables</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">Purchase</font></div><div style="line-height:120%;text-align:center;padding-left:4px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agreement, as it may be amended or modified and in effect from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amortization Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the earliest to occur of (i) the Business Day immediately prior to the occurrence of an Amortization Event set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">, (ii) the Business Day specified in a written notice from the Agent following the occurrence of any other Amortization Event, (iii) (A) the date on which the Seller repurchases all of the outstanding Purchaser Interests in accordance with the terms of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.7</font><font style="font-family:inherit;font-size:12pt;">&#32;or (B) the date that is 30 Business Days after the Agent&#8217;s receipt of written notice from Seller that it wishes to terminate the facility evidenced by this Agreement and (iv) the Scheduled Facility Termination Date.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amortization Event</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article IX</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Anti-Corruption Laws</font><font style="font-family:inherit;font-size:12pt;">&#8221; means all laws, rules, and regulations of any jurisdiction applicable to the Seller Parties or any of their Subsidiaries from time to time relating to bribery or corruption.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Applicable Margin</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means (A) with respect to any Incremental Purchase funded or maintained by any Financial Institution other than WF or PNC, a per annum rate equal to 2.50% and (B) with respect to any Incremental Purchase funded or maintained by WF or PNC, a per annum rate equal to 0.00%; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that at any time when 50% or more of the Incremental Purchases (determined based on outstanding Capital and excluding any outstanding Capital funded or maintained by WF or PNC) are then being funded or maintained by Financial Institutions that are including the Applicable Margin specified in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (A)</font><font style="font-family:inherit;font-size:12pt;">&#32;above in their calculations of the LIBO Rate for such Incremental Purchases, the Applicable Margin with respect to such Incremental Purchase shall be 2.50% at such time.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:-96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Approved Sub-Originator</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each of the following Persons and their successors: </font></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:-96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)&#160;&#160;&#160;&#160;Leader Drugstores, Inc., a Delaware corporation;</font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)     Cardinal Health Pharmacy Services, LLC, a Delaware limited liability company;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)&#160;&#160;&#160;&#160;Medicine Shoppe International, Inc., a Delaware corporation;</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)&#160;&#160;&#160;&#160;Cardinal Health 108, LLC, a Delaware limited liability company; </font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)&#160;&#160;&#160;&#160;Cardinal Health Systems, Inc, an Ohio corporation; and</font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)    Medicap Pharmacies Incorporated, an Iowa corporation; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that Medicap Pharmacies Incorporated shall cease to be an &#8220;Approved Sub-Originator&#8221; if (a) any of the following events shall occur: (x) an Amortization Event or Potential Amortization Event, (y) the Ratings Level then in effect is either Ratings Level 3 or Ratings Level 4, or (z) Medicap Pharmacies Incorporated shall generate Collections in excess of $3,000,000 in a single calendar month and (b) legal counsel for the Seller Parties shall not have delivered to the Administrative Agent and each Purchaser favorable opinions, which address the following matters with respect to Medicap Pharmacies Incorporated and such other matters as the Agent may reasonably request: (x) certain corporate, authority, enforceability and no-conflict matters, (y) certain UCC attachment, perfection and priority maters and (z) true sale and non-consolidation matters, in each case, acceptable to the Administrative Agent in its sole discretion.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;any other Person approved in writing by the  Agent and the Required Financial Institutions as an &#8220;Approved Sub-Originator&#8221; from time to time. &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Assignment Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Assignment and Assumption Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means that certain Assignment and Assumption Agreement, dated as of the date hereof, by and among the parties hereto and certain parties to the Existing Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Audit</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7.1(d)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Authorized  Officer</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means,  with  respect  to  any  Person,  its  president,  corporate controller, treasurer or chief financial officer.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Bail-In Action</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Bail-In Legislation</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">BNS</font><font style="font-family:inherit;font-size:12pt;">&#8221; means The Bank of Nova Scotia, and its successors.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">BNS Conduit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Liberty Street Funding LLC, and its successors.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Broken Funding Costs</font><font style="font-family:inherit;font-size:12pt;">&#8221; means for any Purchaser Interest which: (i) has its Capital reduced without compliance by Seller with the notice requirements hereunder or (ii) does not become subject to an Aggregate Reduction following the delivery of any Reduction Notice or (iii) is assigned, transferred or funded pursuant to a Funding Agreement or otherwise transferred or terminated prior to the date on which it was originally scheduled to end; an amount equal to the excess, if any, of (A) the CP Costs or Yield (as applicable) that would have accrued during the remainder of the Tranche Periods or the tranche periods for Commercial Paper determined by the applicable Managing Agent or the Agent to relate to such Purchaser Interest (as </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">applicable) subsequent to the date of such reduction, assignment or termination (or in respect of clause (ii) above, the date such Aggregate Reduction was designated to occur pursuant to the Reduction Notice) of the Capital of such Purchaser Interest if such reduction, assignment or termination had not occurred or such Reduction Notice had not been delivered, over (B) the sum of (x) to the extent all or a portion of such Capital is allocated to another Purchaser Interest, the amount of CP Costs or Yield actually accrued during the remainder of such period on such Capital for the new Purchaser  Interest, and  (y) to the extent such Capital is not allocated to another Purchaser Interest, the income, if any, actually received net of any costs of redeployment of funds during the remainder of such period by the holder of such Purchaser Interest from investing the portion of such Capital not so allocated.  In the event that the amount referred to in clause (B) exceeds the amount referred to in clause (A), the relevant Purchaser or Purchasers agree to pay to Seller the amount of such excess.  All Broken Funding Costs shall be due and payable hereunder upon demand.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Brokerage Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means all rights to payment now or hereafter owed to any Originator for goods sold or services performed through such Originator&#8217;s brokerage division, which  receivable  is  designated  with  company  code  &#8220;20&#8221;  on  such  Originator&#8217;s  AR  2000 accounting system.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">BTMUNY</font><font style="font-family:inherit;font-size:12pt;">&#8221; means The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, and its successors.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">BTMU Conduit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Victory Receivables Corporation and its successors.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Business Day</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any day other than a Saturday, Sunday or other day on which banks are authorized or required to close in New York, New York or Chicago, Illinois and The Depository Trust Company of New York is open for business, and, if the applicable Business Day relates to any computation or payment to be made with respect to the LIBO Rate, any day on which dealings in dollar deposits are carried on in the London interbank market.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Capital</font><font style="font-family:inherit;font-size:12pt;">&#8221; of any Purchaser Interest means, at any time, (A) the Purchase Price of such Purchaser  Interest,  minus  (B)  the  sum  of  the  aggregate  amount  of  Collections  and  other payments received by the Agent or any Managing Agent which in each case are applied to reduce such Capital in accordance with the terms and conditions of this Agreement; provided that such Capital shall be restored (in accordance with </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.5</font><font style="font-family:inherit;font-size:12pt;">) in the amount of any Collections or other payments so received and applied if at any time the distribution of such Collections or payments are rescinded, returned or refunded for any reason.  For the avoidance of doubt, each Purchaser&#8217;s Capital shall include (x) any amount that such Purchaser (as a Financial Institution) pays to the LC Bank in respect of any LC Participation Advance and (y) any amount that such Purchaser (as an LC Bank) funds or pays with respect to any drawings under Letters of Credit, to the extent such LC Bank has not been reimbursed therefor by the Seller or by an LC Participation Advance.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cardinal</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Cardinal Health, Inc., an Ohio corporation.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cardinal Entity</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each of Cardinal, Griffin, each Originator and each Approved</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Sub-Originator.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Carrying Cost Reserve</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, an amount equal to the sum of (a) all accrued and unpaid CP Costs, Yield and fees and any other amounts payable by the Seller under the Fee Letters plus (b) the product of (i) the Carrying Cost Reserve Percentage multiplied by (ii) the Net Receivables Balance as of the close of business of the Servicer on such date.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Carrying Cost Reserve Percentage</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, a fraction (expressed as a percentage) (a) the numerator of which is the product of (i) 2.00 multiplied by (ii) the sum of (x) the Prime </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Rate then in effect plus (y) 5.00% multiplied by (iii) Days Sales Outstanding and (b) the denominator of which is 360.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cash Management Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means that certain Third Amended and Restated Cash Management Agreement, dated as of June 20, 2007, by and among Cardinal, Griffin, Seller, each Originator and Cardinal Health 2, Inc., a Nevada corporation, formerly known as The Griffin Group, Inc., as administrator, as such agreement may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Change of Control</font><font style="font-family:inherit;font-size:12pt;">&#8221; means (i) the acquisition by any Person, or two or more Persons acting in concert, of beneficial ownership (within the meaning of Rule 13d-3 of the Securities and Exchange Commission under the Securities Exchange Act of 1934) of 20% or more of the outstanding shares of voting stock of Performance Guarantor or (ii) Performance Guarantor shall cease to own or control, directly or indirectly, 100% of the outstanding shares of voting stock of Seller, Griffin or any Originator.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Charged-Off Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable: (i) as to which the Obligor thereof has taken any action, or suffered any event to occur, of the type described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">&#32;(as if references to Seller Party therein refer to such Obligor); (ii) as to which the Obligor thereof, if a natural person, is deceased, (iii) which, consistent with the Credit and Collection Policy, would be written off Seller&#8217;s books as uncollectible or (iv) which has been identified by Seller as uncollectible.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Code</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the Internal Revenue Code of 1986, as amended, reformed or otherwise modified from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collateral</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 14.14(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection Account</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each concentration account, depositary account, lock-box account  or  similar  account  in  which  any Collections  are  collected  or  deposited,  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, any account established for the purposes of receiving Collections which are paid by automated clearing house (ACH) or wire transfer.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection Account Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means an agreement, in form and substance satisfactory to the Agent, among the applicable Originator or Griffin and Seller, the Agent and a Collection Bank, as such agreement may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection  Account  Disclosure  Letter</font><font style="font-family:inherit;font-size:12pt;">&#8221; means  that  certain  letter between  the Seller and the Agent dated November 3, 2014 identifying, among other things, the Collection Banks and the Collection Accounts.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:58px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection Bank</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, any of the banks holding one or more Collection</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Accounts.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a notice under a Collection Account Agreement, in form and substance satisfactory to the Agent, from the Agent to a Collection Bank or any similar or analogous notice from the Agent to a Collection Bank.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collection Notice Event</font><font style="font-family:inherit;font-size:12pt;">&#8221; means (a) the occurrence of any Potential Amortization Event under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">, (b) the occurrence with respect to Servicer or Performance Guarantor of any event of the type described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">, but without regard to the 60 day grace period included in the last clause thereof, (c) the occurrence of any Amortization Event or (d) the occurrence of a Material Adverse Effect (as such term is defined herein, in the Receivables Sale Agreement or in any Griffin RPA).</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collections</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Receivable, all cash collections and other cash proceeds in respect of such Receivable, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, all principal payments, yield, Finance Charges or other related amounts accruing in respect thereof, all cash proceeds of Related Security with respect to such Receivable and all amounts received as payments in respect of the Demand Loans.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Collections-to-Sales Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, as of the last day of any calendar month, the ratio (expressed as a percentage) of (i) the aggregate amount of Collections during such month, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">divided</font><font style="font-family:inherit;font-size:12pt;">&#32;by (ii) the aggregate gross sales of the Originators during such month.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Commercial Paper</font><font style="font-family:inherit;font-size:12pt;">&#8221; means promissory notes of any Conduit issued by such Conduit in the commercial paper market.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Commitment</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, for each Financial Institution, the commitment of such Financial Institution to purchase Purchaser Interests from Seller in an amount not to exceed, (i) in the aggregate, the amount set forth opposite such Financial Institution&#8217;s name on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement, as such amount may be modified in accordance with the terms hereof (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, any termination of Commitments pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6</font><font style="font-family:inherit;font-size:12pt;">&#32;hereof) and (ii) with respect to any individual purchase hereunder, its Pro Rata Share of the Purchase Price therefor.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Commitment Availability</font><font style="font-family:inherit;font-size:12pt;">&#8221; means at any time the positive difference (if any) between (a) an amount equal to the aggregate amount of the Commitments, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">minus</font><font style="font-family:inherit;font-size:12pt;">&#32;(b) the sum of (i) the Aggregate Capital at such time, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;(ii) the LC Exposure at such time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Concentration Limit</font><font style="font-family:inherit;font-size:12pt;">&#8221; shall have the meaning set forth for such term on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule D</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto.</font></div><div style="line-height:120%;text-align:left;text-indent:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Conduit</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble to this Agreement.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Consent Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(a)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Consent Period</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(a)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Contingent Obligation</font><font style="font-family:inherit;font-size:12pt;">&#8221; of a Person means any agreement, undertaking or arrangement by which such Person assumes, guarantees, endorses, contingently agrees to purchase or provide funds for the payment of, or otherwise becomes or is contingently liable upon, the obligation or liability of any other Person, or agrees to maintain the net worth or working capital or other</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">financial condition of any other Person, or otherwise assures any creditor of such other Person against loss, including, without limitation, any comfort letter, operating agreement, take-or-pay contract or application for a letter of credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Contract</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Receivable, any and all instruments, agreements, invoices or other writings pursuant to which such Receivable arises or which evidences such Receivable.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Contractual Dilution Reserve</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, as of any date of determination and with respect to the Receivables of any Obligor, the aggregate amount of any reserves or liabilities maintained on the Seller&#8217;s books and records in accordance with generally accepted accounting principles and the Credit and Collection Policy for, or in anticipation of, volume rebates, flat fee rebates, performance-to-plan rebates, cost-plus-zero program rebates or similar rebates affecting or to affect the Receivables of such Obligor as reported on (i) prior to the Amortization Date, the most recently delivered Monthly Report, Weekly Report or Daily </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Report, as the case may be, or (ii) at any time on or after the Amortization Date, as reported on the last Monthly Report, Weekly Report or Daily Report delivered prior to the Amortization Date.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CP Costs</font><font style="font-family:inherit;font-size:12pt;">&#8221; means for each day with respect to any Purchaser Interest (or any portion thereof) of any Conduit, an amount equal to the product of (i) the applicable CP Rate, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">times</font><font style="font-family:inherit;font-size:12pt;">, (ii) the Capital of such Purchaser Interest on such day, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">times</font><font style="font-family:inherit;font-size:12pt;">&#32;(iii) 1/360; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that notwithstanding anything in this Agreement or the other Transaction Documents to the contrary, Seller agrees that any amounts payable to such Conduit in respect of CP Costs for any period with respect to any Purchaser Interests (or portion thereof) funded by such Conduit by the issuance of Commercial Paper shall include an amount equal to the portion of the face amount of the  outstanding  Commercial  Paper  issued  to  fund  or  maintain  such  Purchaser  Interests  (or portion thereof) that corresponds to the portion of the proceeds of such Commercial Paper that was  used  to  pay the  interest  component  of  maturing  Commercial  Paper  issued  to  fund  or maintain such Purchaser Interests (or portion thereof), to the extent that such Conduit had not received payments of interest in respect of such interest component prior to the maturity date of such maturing Commercial Paper (for purposes of the foregoing, the &#8220;interest component&#8221; of Commercial Paper equals the excess of the face amount thereof over the net proceeds received by such Conduit from the issuance of Commercial Paper, except that if such Commercial Paper is issued on an interest-bearing basis, its &#8220;interest component&#8221; will equal the amount of interest accruing on such Commercial Paper through maturity).</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CP Rate</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, for any period with respect to the Purchaser Interests (or portion thereof) of any Conduit then being funded by the issuance of Commercial Paper, the </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">per</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">annum</font><font style="font-family:inherit;font-size:12pt;">&#32;rate equivalent to the weighted average cost (as determined such Conduit or its Managing Agent and which shall include commissions and fees of placement agents and dealers, incremental carrying costs incurred with respect to Commercial Paper maturing on dates other than those on which corresponding funds are received by such Conduit, other borrowings by such Conduit (other than under any Liquidity Agreement) and any other costs and expenses associated with the issuance  of  Commercial  Paper)  of  or  related  to  the  issuance  of  Commercial  Paper  that  is allocated, in whole or in part, by such Conduit or its Managing Agent to fund or maintain such Purchaser Interests (and which may be also allocated in part to the funding of other assets of such Conduit (determined in the case of Commercial Paper issued on a discount by converting the discount to an interest equivalent rate </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">per</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">annum</font><font style="font-family:inherit;font-size:12pt;">).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credit Agricole</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Credit Agricole Corporate and Investment Bank New York</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Branch, and its successors.</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credit Agricole Conduit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Atlantic Asset Securitization LLC and its successors. </font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credit and Collection Policy</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Seller&#8217;s credit and collection policies and practices</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">relating to Contracts and Receivables existing on the date of this Agreement and summarized in</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit VII</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto, as modified from time to time in accordance with this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Daily Report</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a report, in form and substance acceptable to the Agent and each Managing Agent, appropriately completed and furnished by the Servicer to the Agent and each Managing Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.5</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Days Sales Outstanding</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, an amount (expressed in days) equal to the product of (a) the amount obtained by dividing (i) the aggregate Outstanding Balance of all Receivables as of the last day of the most recently ended calendar month by (ii) the aggregate Outstanding Balance of all Receivables that were originated during such calendar month multiplied by (b) 30.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Deemed  Collections</font><font style="font-family:inherit;font-size:12pt;">&#8221;    means  the  aggregate  of  all  amounts  Seller  shall  have  been deemed to have received as a Collection of a Receivable.   Seller shall be deemed to have received a Collection in full of a Receivable if at any time (i) the Outstanding Balance of any such Receivable is either (x) reduced as a result of defective or rejected goods or services, any discount or any negative adjustment or otherwise by Seller (other than cash Collections on account  of  the  Receivables</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">)</font><font style="font-family:inherit;font-size:12pt;">;  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">,  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">,  that  this  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause  (i)(x)</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;shall  exclude  any Excluded Contractual Dilutions, or (y) reduced or canceled as a result of a setoff in respect of any claim by any Person (whether such claim arises out of the same or a related transaction or an unrelated transaction), (ii) any of the representations or warranties in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article V</font><font style="font-family:inherit;font-size:12pt;">&#32;are no longer true with respect to any Receivable or (iii) any Receivable is restructured into a Note Receivable.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Default Fee</font><font style="font-family:inherit;font-size:12pt;">&#8221; means with respect to any amount due and payable by Seller in respect of any Aggregate Unpaids, an amount equal to the greater of (i) $1000 and (ii) interest on any such unpaid Aggregate Unpaids at a rate per annum equal to 2.50% above the Prime Rate.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Default Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, for any calendar month, an amount (expressed as a percentage) equal to (i) the sum of (A)  the aggregate Outstanding Balance of all Defaulted Receivables as of the  last  day  of  such  calendar  month  and  (B)  the  aggregate  Outstanding  Balance  of  all Receivables that became Charged-Off Receivables during such calendar month divided by (ii) the aggregate gross sales of the Originators during the calendar month that is four calendar months prior to such calendar month.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Defaulted Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable as to which any payment, or part thereof, remains unpaid for more than 90 but less than 121 days from the original invoice due date for such payment as set forth on the invoice or otherwise.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Defaulting Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any Financial Institution that (a) has failed to (i) perform its obligation to fund any portion of its Incremental Purchases or LC Participation Advances or (ii) pay over to the Agent or any Purchaser any other amount within two Business Days of the date required to be funded or paid by it hereunder, unless, in the case of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (i)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, such Financial Institution notifies the Agent and the Seller in writing that such failure is the result of such Financial Institution&#8217;s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied, (b) has notified the Seller, the Agent or any Purchaser in writing, or has made a public statement to the effect, that it does not intend to comply with any of its funding obligations under this Agreement or any other Transaction Document or generally under other agreements in which it commits or extends credit (unless such writing or public statement relates to such Financial Institution&#8217;s obligation to fund any portion of its Incremental Purchases or LC Participation Advances and states that such position is based on such Financial Institution&#8217;s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied), (c) has failed, within three Business Days after written request by the Agent or the Seller, to confirm in writing in a manner satisfactory to the Agent and the Seller, that it will comply with the terms of this Agreement and the other Transaction Documents relating to its obligations to fund prospective Incremental Purchases and LC Participation Advances under this Agreement (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that such Financial Institution shall cease to be a Defaulting Financial Institution pursuant to this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (c)</font><font style="font-family:inherit;font-size:12pt;">&#32;upon receipt of such written confirmation by the Agent and the Seller), (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any bankruptcy or insolvency proceeding or the subject of a Bail-In Action or (ii) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such capacity; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">&#32;that, for the avoidance of doubt, a Financial Institution shall not be a Defaulting Financial Institution solely by virtue of the ownership or acquisition of any equity interest in such Financial Institution </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Financial Institution with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Financial Institution (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Defaulting Financial Institution Account</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the account or accounts at any time designated as the Defaulting Financial Institution Account established and maintained by the Agent (for the benefit of the LC Banks and the Defaulting Financial Institutions), or such other account as may be so designated as such by the Agent (which, for the avoidance of doubt, may be one or more accounts maintained at the respective LC Banks).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Delinquency Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, a percentage equal to (i) the aggregate Outstanding Balance of all Receivables that were Delinquent Receivables at such time divided by (ii) the aggregate Outstanding Balance of all Receivables at such time, calculated on a three- month rolling average basis.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Delinquent Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable as to which any payment, or part thereof, remains unpaid for more than 60 days from the original invoice due date for such payment.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Demand Loan</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a loan of Collections made by Seller to Cardinal pursuant to and in accordance with the terms of the Cash Management Agreement, which loan is payable on demand, together with accrued and unpaid interest thereon.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Designated Obligor</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each Obligor indicated by the Agent to Seller in writing.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Determination Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the 2</font><font style="font-family:inherit;font-size:8pt;">nd </font><font style="font-family:inherit;font-size:12pt;">Business Day of each calendar month.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilution Horizon Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, as of the last day of any calendar month, a percentage equal to (i) the sum of (x) the aggregate gross sales of the Originators during the calendar month then most recently ended plus (y) 33% of the aggregate gross sales of the Originators during the calendar month immediately preceding the calendar month then most recently ended, divided by (ii) at any time, the Ratings Level then in effect is (a) Ratings Level 1, the amount equal to the Non-Defaulted Receivables Balance as of the last day of such calendar month, or (b) Ratings Level 2, Ratings Level 3 or Ratings Level 4, the Net Receivables Balance as of the last day of the most recently ended calendar month.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilution Percentage</font><font style="font-family:inherit;font-size:12pt;">&#8221; means as of the last day of any calendar month, a percentage equal to the following:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:306px;text-indent:-120px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[[SF x ED] +[ (DS - ED) x </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">DS</font><font style="font-family:inherit;font-size:12pt;">&#32;]] x DHR </font></div><div style="line-height:120%;text-align:left;padding-left:306px;text-indent:-120px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;ED</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">where:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">SF</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#32;=</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Dilution Stress Factor at such time </font></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ED</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">=</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Expected Dilution Ratio at such time </font></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DS</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#32;=</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Dilution Spike Ratio at such time </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">DHR</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">&#32;=</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Dilution Horizon Ratio at such time</font></div><div style="line-height:232%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilution-to-Sales Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, a percentage equal to (i) the aggregate amount of Dilutions which occurred during the month then most recently ended, divided by (ii) the aggregate gross sales of the Originators during the month one month prior to such month, calculated on a monthly basis.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilution Reserve</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date, an amount equal to the Dilution Percentage multiplied by the Net Receivables Balance as of the close of business of the Servicer on such date.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilution Spike Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, as of the last day of any calendar month, the highest monthly Dilution-to-Sales Ratio calculated as of the last day of each of the twelve calendar months then most recently ended.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilution Stress Factor</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, the &#8220;Dilution Stress Factor&#8221; set forth in the table below corresponding to the Ratings Level in effect at such time and set forth in the table below:</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:45%;"></td><td style="width:55%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ratings Level</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Dilution Stress Factor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dilutions</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, the aggregate amount of reductions or cancellations described in clauses (i) and (iii) of the definition of &#8220;Deemed Collections&#8221;.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Discount Rate</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, the LIBO Rate or the Prime Rate, as applicable, with respect to each Purchaser Interest of the Financial Institutions.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Dynamic Reserve</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, an amount equal to the sum of</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) the Dilution Reserve plus (ii) the Loss Reserve.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">EEA  Financial  Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  (a)  any  credit  institution  or  investment  firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">EEA  Member  Country</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  any  of  the  member  states  of  the  European  Union, Iceland, Liechtenstein, and Norway.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">EEA Resolution Authority</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Eligible Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, a Receivable:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        the Obligor of which (A) if a natural person, is a resident of the United States or, if a corporation or other business organization, is organized under the laws of the United States or any </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">political subdivision thereof and has its chief executive office in the United States, (B) is not an Affiliate of any of the parties hereto and (C) is neither (I) a Designated Obligor nor (II) a Sanctioned Person,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       the Obligor of which is not the Obligor of (i) any Charged-Off Receivable or (ii) Receivables more than 30% of which are Delinquent Receivables or (iii) any Note Receivable that was structured as a Note Receivable for credit reasons,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">which is not a Charged-Off Receivable, a Delinquent Receivable or a</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Legal Receivable,</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)     which arises under a Contract that requires payment in full of such Receivable within 45 days of the original invoice date therefor; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that (a) a Medium Term Receivable that is otherwise an &#8220;Eligible Receivable&#8221; but for this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (iv)</font><font style="font-family:inherit;font-size:12pt;">, shall be an Eligible Receivable notwithstanding this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (iv)</font><font style="font-family:inherit;font-size:12pt;">&#32;if the Outstanding Balance of such Medium Term Receivable when added to the Outstanding Balance of all other Medium Term Receivables does not exceed ten percent (10%) of the aggregate Outstanding Balance of all Receivables and (b) a Long Term Non-Trade Show Receivable that is otherwise an &#8220;Eligible Receivable&#8221; but for this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (iv)</font><font style="font-family:inherit;font-size:12pt;">, shall be an Eligible Receivable notwithstanding this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (iv)</font><font style="font-family:inherit;font-size:12pt;">&#32;if the Outstanding Balance of such Long Term Non-Trade Show Receivable when added to the Outstanding Balance of all other Long Term Non-Trade Show Receivable does not exceed five percent (5%) of the aggregate Outstanding Balance of all Receivables,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)       which  has  not  had  its  payment  terms  extended  for  credit  reasons  or otherwise been restructured for credit reasons,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)      which is an &#8220;account&#8221; or &#8220;general intangible&#8221; within the meaning of the UCC of all applicable jurisdictions or &#8220;chattel paper&#8221; within the meaning of the UCC of all applicable jurisdictions and which is not evidenced, in whole or in part, by any note, draft or other &#8220;instrument&#8221; or &#8220;document&#8221; within the meaning of Article 9 of the UCC,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">which is denominated and payable only in United States dollars in the</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">United States,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(viii)    which arises under a Contract, which, together with such Receivable, is in full force and effect and constitutes the legal, valid and binding obligation of the related Obligor enforceable against such Obligor by the applicable Originator or Approved Sub- Originator and its assignees, subject to no offset, counterclaim or other defense,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ix)      as to which all right, title and interest thereto and therein has been validly transferred (A) in the case of any Receivable originated by an Approved Sub-Originator, by such Approved Sub-Originator directly to an Originator under and in accordance with the applicable Sub-Originator Sale Agreement, (B) by the applicable Originator directly to Griffin under and in accordance with the applicable Griffin RPA and (C) by Griffin directly to Seller under and in accordance with the Receivables Sale Agreement, and as to which Seller has good and marketable title thereto free and clear of any Adverse Claim,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(x)       which arises under a Contract that contains an obligation to pay a specified sum of money and as to which the applicable Originator or Approved Sub-Originator has performed all </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">obligations due or to become due from it, and no further action is required to be performed by any Person with respect thereto other than payment thereon by the applicable Obligor,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xi)      which, together with the Contract related thereto, does not contravene any law, rule or regulation applicable thereto (</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, any law, rule and regulation relating to truth in lending, fair credit billing, fair credit reporting, equal credit</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">opportunity, fair debt collection practices and privacy) and with respect to which no part of the Contract related thereto is in violation of any such law, rule or regulation,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;text-indent:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xii)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">which satisfies all applicable requirements of the Credit and Collection Policy, </font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiii)   which was generated in the ordinary course of the applicable Originator&#8217;s or Approved Sub-Originator&#8217;s business,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xiv)    which arises solely from the sale of goods or the provision of services to the related Obligor by the applicable Originator or Approved Sub-Originator, and not by any other Person (in whole or in part),</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xv)     which is not subject to any right of rescission, set-off, counterclaim, any other  defense  (including  defenses  arising  out  of  violations  of  usury  laws)  of  the applicable Obligor against the applicable Originator or Approved Sub-Originator and which is not subject to any other Adverse Claim, and the Obligor thereon holds no right as against the applicable Originator or Approved Sub-Originator to cause such Originator or Approved Sub-Originator to repurchase the goods or merchandise the sale of which shall have given rise to such Receivable (except with respect to sale discounts effected pursuant to the Contract, or defective goods returned in accordance with the terms of the Contract or in compliance with the applicable Originator&#8217;s or Approved Sub-Originator&#8217;s returned goods policy as in effect on the date hereof),</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xvi)   the inclusion of which as an Eligible Receivable does not result in the aggregate Outstanding Balance of all Receivables having an Obligor that is a government or a governmental subdivision or agency exceeding ten percent (10%) of the aggregate Outstanding Balance of all Receivables,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xvii)  the inclusion of which as an Eligible Receivable does not result in the aggregate Outstanding Balance of all Trade Show Receivables with terms of up to six (6) months exceeding two percent (2%) of the aggregate Outstanding Balance of all Receivables,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xviii) as  to  which  the  Agent  has  not  notified  Seller  that  the  Agent  has determined that such Receivable or class of Receivables is not acceptable as an Eligible Receivable,  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">,  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">,  because  such  Receivable  arises  under  a Contract that is not acceptable to the Agent,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xix)    which does not constitute proceeds of any inventory that was pledged to any Person,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xx)     which was originated subsequent to the date hereof and the Originator or Approved Originator of which is not Allegiance Corporation, Cardinal Health 200, LLC, or any other Person that ceases to be an Approved Sub-Originator subsequent to the origination of such Receivable,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xxi)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">which does not represent Finance Charges, and</font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(xxii)   which is not a ParMed Receivable, unless and until such time, if any, that the Agent has received (A) such information and reports with respect to ParMed Receivable, in form and substance satisfactory to the Agent, as the Agent has requested from the Seller or the Servicer and (B) either (1) evidence reasonably satisfactory to the Agent that Seller (or Servicer on its behalf) has instructed all Obligors of Receivables ParMed Receivable to deliver payments on such Receivables to an existing Lock-Box Account or (2) a duly executed Collection Account Agreement (or amendment thereto) satisfactory to the Agent relating to each account to which Seller (or Servicer on its behalf) has instructed Obligors of ParMed Receivable.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Enhancement Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any agreement between a Conduit and any other Person(s), entered into to provide (directly or indirectly) credit enhancement to such Conduit&#8217;s Commercial Paper facility.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">ERISA</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">EU Bail-In Legislation Schedule</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Excluded Contractual Dilution</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any amounts that would otherwise be included in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (i)(x)</font><font style="font-family:inherit;font-size:12pt;">&#32;of &#8220;Deemed Collections&#8221; that result from volume rebates, flat fee rebates, performance-to-plan rebates, cost-plus-zero program rebates or similar rebates affecting the Receivables of any Obligor during any period solely to the extent that such amounts do not, in the aggregate, exceed the Contractual Dilution Reserve for such Obligor and such period; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">however</font><font style="font-family:inherit;font-size:12pt;">, that on and after the Amortization Date, &#8220;Excluded Contractual Dilution&#8221; shall mean any amounts that would otherwise be included in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (i)(x)</font><font style="font-family:inherit;font-size:12pt;">&#32;of &#8220;Deemed Collections&#8221; that result from volume rebates, flat fee rebates, performance-to-plan rebates, cost- plus-zero program rebates or similar rebates affecting the Receivables of any Obligor since the Amortization Date solely to the extent that such amounts do not, in the aggregate, exceed the Contractual Dilution Reserve for such Obligor and determined pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (ii)</font><font style="font-family:inherit;font-size:12pt;">&#32;of &#8220;Contractual Dilution Reserve&#8221;.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Excluded Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means (i) a Note Receivable that has been sold to National City Bank prior to May 21, 2004 pursuant to that certain Purchase and Sale Agreement, dated as of March 25, 1994, among Cardinal, the Originators, National City Bank and certain other parties named therein, as modified by that certain Modification of Purchase and Sale Agreement dated as of June 29, 1998, (ii) a Brokerage Receivable and (iii) a Kinray Receivable.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Excluded Taxes</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, in the case of each Affected Party, (i) taxes imposed on its overall net income and franchise taxes (and any interest, fees or penalties for late payment thereof) imposed on it by (a) the jurisdiction under the Laws of which such Affected Party is incorporated  or  organized  or  (b) the  jurisdiction  in  which  such  Affected  Party&#8217;s  principal executive office or such Affected Party&#8217;s applicable Funding Office is located; and (ii) any Taxes imposed under FATCA (or any amended or successor version of FATCA if such amended or successor version provides a commercially reasonable mechanism to avoid the tax imposed thereunder by satisfying the information reporting and other requirements of FATCA).</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Existing Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the Preliminary Statements to this</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agreement.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Expected Dilution Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, as of the last day of any calendar month, the average</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dilution-to-Sales Ratio in respect of the twelve months then most recently ended.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Extension Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(a)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Facility Account</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the Collection Account Disclosure Letter.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">FASB</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.2</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">FATCA</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version) and any current or future regulations or official interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the Code.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Federal Funds Rate</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, for any day, the weighted average (rounded upwards, if necessary, to the next 1/100 of 1%) of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average (rounded upwards, if necessary, to the next 1/100 of 1%) of the quotations for such day for such transactions received by the Agent from three Federal funds brokers of recognized standing selected by it.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Fee Letter</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each of (i) the letter agreement, dated as of November 1, 2013 among Seller, the Agent, the Managing Agents and the Purchasers, as it may be amended or modified and in effect from time to time, and (ii) any other fee letter or similar letter agreement relating to the payment of fees to any of the Purchasers entered into among Seller, the Purchasers party thereto and/or any agent or agents acting on behalf of any such Purchasers, as any such fee letter or letter agreement may be amended or modified and in effect from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Finance Charges</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to a Contract, any finance, interest, discount, late payment charges or similar charges owing by an Obligor pursuant to such Contract.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Institutions</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble in this Agreement.  For the  avoidance  of  doubt,  if  any  Person  that  is  a  Financial  Institution  is  also  an  LC  Bank, &#8220;Financial Institution&#8221; shall be deemed to be a reference to such Person in both such capacities.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Institution Termination Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.2</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Fitch</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  Fitch,  Inc.  (d/b/a  Fitch  Ratings)  or  any  successor  thereto  that  is  a nationally recognized statistical rating organization.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Funding Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means this Agreement and any agreement or instrument executed by any Funding Source with or for the benefit a Conduit.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Funding  Office</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means,  with  respect  to  any  Affected  Party,  the  office,  branch, subsidiary or Affiliate of such Affected Party in which it elects to book its interest in the Purchased Interest or its other interests hereunder.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Funding Source</font><font style="font-family:inherit;font-size:12pt;">&#8221; means (a) any Financial Institution and (b) with respect to any Conduit (i) such </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Conduit&#8217;s Related Financial Institution(s), (ii) such Conduit&#8217;s related Managing Agent, (iii) any insurance company, bank or other funding entity providing liquidity, credit enhancement or  back-up  purchase  support  or  facilities  to  such  Conduit,  (iv)  any agent,  administrator  or manager of such Conduit and (v) any bank holding company related to any of the foregoing.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governmental Authority</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the government of the United States of America or any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Griffin</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Griffin Capital, LLC, a Nevada limited liability company.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Griffin RPA</font><font style="font-family:inherit;font-size:12pt;">&#8221; means that certain Second Amended and Restated Receivables Purchase and Sale Agreement, dated as of May 21, 2004, by and between Griffin and Cardinal Health 110, LLC, a Delaware limited liability company, formerly known as each  of  Cardinal  Health  110,  Inc.  and  Whitmire  Distribution  Corporation,  and  as successor by merger to Cardinal Syracuse, Inc., a New York corporation, Ohio Valley- Clarksburg, Inc., a Delaware corporation, Cardinal Health 106, Inc., a Massachusetts corporation, Cardinal Health 103, Inc., a Mississippi corporation, and Cardinal Health 411, LLC, an Ohio limited liability company.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:52px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Incremental Purchase</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a purchase of one or more Purchaser Interests which increases the total outstanding Aggregate Capital or the LC Exposure hereunder.   For the avoidance of doubt, each issuance of a Letter of Credit hereunder shall constitute an Incremental Purchase.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indebtedness</font><font style="font-family:inherit;font-size:12pt;">&#8221; of a Person means such Person&#8217;s (i) obligations for borrowed money, (ii) obligations representing the deferred purchase price of property or services (other than accounts payable arising in the ordinary course of such Person&#8217;s business payable on terms customary in the trade), (iii) obligations, whether or not assumed, secured by liens or payable out of the proceeds or production from property now or hereafter owned or acquired by such Person, (iv) obligations which are evidenced by notes, acceptances, or other instruments, (v) capitalized lease obligations, (vi) net liabilities under interest rate swap, exchange or cap agreements, (vii) Contingent Obligations and (viii) liabilities in respect of unfunded vested benefits under plans covered by Title IV of ERISA.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Independent Manager</font><font style="font-family:inherit;font-size:12pt;">&#8221; shall mean a member of the Board of Managers of Seller who is not at such time, and has not been at any time during the preceding five (5) years, (A) a director, officer, manager, member employee or affiliate of Seller, any Cardinal Entity, or any of their respective Subsidiaries or Affiliates, or (B) the beneficial owner (at the time of such individual&#8217;s appointment  as  an  Independent  Manager  or  at  any  time  thereafter  while  serving  as  an</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Independent Manager) of any of the outstanding membership or other equity interests of Seller, any Cardinal Entity, or any of their respective Subsidiaries or Affiliates, having general voting rights.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Kinray Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time following the merger of Kinray, LLC, a New York limited liability company, and Cardinal Health 110, LLC, a Receivable originated by legacy Kinray, LLC, which receivables are processed on the iSeries/AS400 billing system as of November 14, 2016.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Law</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, collectively, all international, foreign, Federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes, executive orders or administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of Law.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Adjusted Exposure</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, the LC Exposure minus the amount of cash collateral held in the LC Collateral Account at such time.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Bank</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble in this Agreement.  If the context so requires, the LC Bank with respect to any Letter of Credit shall be deemed to mean the LC Bank that issued such Letter of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Collateral Account</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the account or accounts at any time designated as the LC Collateral Account established and maintained by the Agent (for the benefit of the LC Banks and the Financial Institutions), or such other account as may be so designated as such by the Agent (which, for the avoidance of doubt, may be one or more accounts maintained at the respective LC Banks).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Expiry Notice Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.6(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Exposure</font><font style="font-family:inherit;font-size:12pt;">&#8221; means at any time, the sum of the amounts then available to be drawn under all outstanding Letters of Credit.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Facility Limit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the lesser of (i) $200,000,000 and (ii) the Purchase Limit. </font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Fee Expectation</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.9(c)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Limit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to each LC Bank, the amount set forth as such LC Bank&#8217;s LC Limit in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Participation Advance</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(c)</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Reimbursement Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Reimbursement Obligation</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(a)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LC Reimbursement Purchase</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.8(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Legal Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable that is the subject of an action, suit or proceeding before any Governmental Authority or arbitrator or as to which the Obligor thereof has taken any action, or suffered any event to occur, of the type described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 9.1(d)</font><font style="font-family:inherit;font-size:12pt;">&#32;(as if references to Seller Party therein refer to such Obligor).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Letter of Credit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any stand-by letter of credit issued by an LC Bank at the request of the Seller pursuant to this Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Letter of Credit Application</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Letter of Credit and any related Purchase Notice, the applicable LC Bank&#8217;s form of Letter of Credit Application, substantially in the form of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit XII</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto or such other form as such LC Bank specifies from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">LIBO Rate</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the greater of (I) 0.00% and (II):</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(A)      with respect to any Tranche Period and any Purchaser other than WF or PNC, the sum of (i) (a) either (x) the interest rate per annum designated as LIBOR for the Related Financial Institution for a period of time comparable to such Tranche Period, as determined by the related Managing Agent from time to time for purposes of providing quotations of interest rates applicable to dollar deposits in the London interbank market) as of 11:00 a.m. (London, England time) on the second Business Day preceding the first day of such Tranche Period or (y) if a rate cannot be determined under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (x)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, a rate per annum equal to the average (for purposes of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (y)</font><font style="font-family:inherit;font-size:12pt;">, rounded upwards, if necessary, to the nearest one-hundredth of a percentage point) of the rates per annum at which deposits in U.S. dollars in the approximate amount to be funded at the LIBO Rate and having a maturity equal to such Tranche Period are offered to the principal London office of such Related Financial Institution by three London banks, selected by such Related Financial Institution in good faith, at about 11:00 a.m. London time on the second Business Day preceding the first day of such Tranche Period, divided by (b) one minus the maximum aggregate reserve requirement (including all basic, supplemental, marginal or other reserves) which is imposed against such Related Financial Institution in respect of Eurocurrency liabilities, as defined in Regulation D of the Board of Governors of the Federal Reserve System as in effect from time to time (expressed as a decimal), applicable to such Tranche Period, plus (ii) the Applicable Margin;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(B)      with respect to any day during any Tranche Period and solely with respect to WF, the sum of (i) (a) either (x) the interest rate per annum designated as LIBOR for WF for a period of one month that appears on the Bloomberg Screen BBAL 10 Page (or on any successor or substitute page thereof, or any successor to or substitute for such service, providing rate quotations comparable to those currently provided on the Bloomberg Screen BBAL 10 Page, as determined by WF from time to time for purposes of providing quotations of interest rates applicable to dollar deposits in the London interbank market) on such day or (y) if a rate cannot be determined under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (x)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, a rate per annum equal to the average (for purposes of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (y)</font><font style="font-family:inherit;font-size:12pt;">, rounded upwards, if necessary, to the nearest one-hundredth of a percentage point) of the rates per annum at which deposits in U.S. dollars in the approximate amount to be funded at the LIBO Rate and having a maturity equal to one month are offered to the principal London office of WF by three London banks, selected by WF in good faith on such day, divided by (b) one minus the maximum aggregate reserve requirement (including all basic, supplemental, marginal or other reserves) which is imposed against WF in respect of Eurocurrency liabilities, as defined in Regulation D of the Board of Governors of the Federal  Reserve  System  as  in  effect  from  time  to  time  (expressed  as  a  decimal), applicable to such Tranche Period, plus (ii) the Applicable Margin; and</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(C)      with respect to any day during any Tranche Period and solely with respect to PNC, the sum of (i) (a) either (x) the interest rate per annum designated as LIBOR for PNC for a period of one month that appears on the Bloomberg Screen BBAL 10 Page (or on any successor or substitute page thereof, or any successor to or substitute for such service, providing rate quotations comparable to those currently provided on the Bloomberg Screen BBAL 10 Page, as determined by PNC from time to time for purposes of providing quotations of interest rates applicable to dollar deposits in the London interbank market) on such day or (y) if a rate cannot be determined under </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (x)</font><font style="font-family:inherit;font-size:12pt;">&#32;above, a rate per annum equal to the average (for purposes of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (y)</font><font style="font-family:inherit;font-size:12pt;">, rounded upwards, if necessary, to the nearest one-hundredth of a percentage point) of the rates per annum at which deposits in U.S. dollars in the approximate amount to be funded at the LIBO Rate and having a maturity equal to one month are offered to the principal London office of PNC by three London banks, selected by PNC in good faith on such day, divided by (b) one minus the maximum aggregate reserve requirement (including all basic, supplemental, marginal or other reserves) which is imposed </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">against PNC in respect of Eurocurrency liabilities, as defined in Regulation D of the Board of Governors of the Federal  Reserve  System  as  in  effect  from  time  to  time  (expressed  as  a  decimal), applicable to such Tranche Period, plus (ii) the Applicable Margin.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In any of the foregoing cases, the LIBO Rate shall be rounded, if necessary, to the next higher 1/16 of 1%.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Liquidity Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any agreement entered into, directly or indirectly, in connection with or related to, this Agreement pursuant to which any Person agrees to make loans or advances to, or purchase from, a Conduit (directly or indirectly) in order to provide liquidity for such Conduit&#8217;s Commercial Paper or other senior indebtedness.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Lock-Box</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a locked postal box or departmental box located at a bank, in each case, maintained by Griffin in its capacity as Servicer with respect to which a bank who has executed a Collection Account Agreement has been granted exclusive access for the purpose of retrieving and processing payments made on the Receivables.</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Lock-Box Account</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each deposit account that is associated with each Lock-Box. </font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Long Term Non-Trade Show Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable that (i) is not a Trade</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Show  Receivables  and  (ii)  arises  under  a  Contract  that  requires  payment  in  full  of  such Receivable within not less than 91 days and not more than 180 days of the original invoice therefor.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Loss Horizon Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means as of any date, an amount (expressed as a percentage) equal to (i) the aggregate gross sales of the Originators during the four most recently ended calendar months divided by (ii) at any time, the Ratings Level then in effect is (a) Ratings Level 1, the amount equal to the Non-Defaulted Receivables Balance as of the last day of such calendar month, or (b) Ratings Level 2, Ratings Level 3 or Ratings Level 4, the Net Receivables Balance as of the last day of the most recently ended calendar month.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Loss Percentage</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, a percentage equal to the product of (i) Loss Stress</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Factor multiplied by (ii) the Loss Ratio multiplied by (iii) the Loss Horizon Ratio.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Loss Ratio</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date, the greatest three-month average Default Ratio as calculated for each of the 12 most recently ended calendar months.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Loss Reserve</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date, an amount equal to the Loss Percentage multiplied by the Net Receivables Balance as of the close of business of the Servicer on such date.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Loss Stress Factor</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, the &#8220;Loss Stress Factor&#8221; set forth in the table below corresponding to the Ratings Level in effect at such time and set forth in the table below:</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:62.109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:47%;"></td><td style="width:53%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ratings Level</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Loss Stress Factor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Managing Agent</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble to this Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Material Adverse Effect</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a material adverse effect on (i) the financial condition or operations of any Seller Party and its Subsidiaries taken as a whole, (ii) the ability of any Seller  Party  to  perform  its  obligations  under  this  Agreement  or  Performance  Guarantor  to perform its obligations under the Performance Guaranty, (iii) the legality, validity or enforceability  of  this  Agreement  or  any other  Transaction  Document,  (iv)  any  Purchaser&#8217;s interest in the Receivables generally or in any significant portion of the Receivables, the Related Security or the Collections with respect thereto, or (v) the collectibility of the Receivables generally or of any material portion of the Receivables.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Medium Term Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable that arises under a Contract that requires payment in full of such Receivable within 90 days of the original invoice therefor.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Monthly Report</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a report, in substantially the form of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Exhibit IX</font><font style="font-family:inherit;font-size:12pt;">&#32;hereto (appropriately completed), furnished by the Servicer to the Agent and each Managing Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.5</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Moody&#8217;s</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Moody&#8217;s Investors Service, Inc. or any successor thereto that is a nationally recognized statistical rating organization.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Net Receivables Balance</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, the aggregate Outstanding Balance of all</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Receivables that are Eligible Receivables at such time reduced by (i) the aggregate amount by</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">which the Outstanding Balance of all Receivables that are Eligible Receivables of each Obligor and its Affiliates exceeds the Concentration Limit for such Obligor and (ii) the aggregate Contractual Dilution Reserves for all Eligible Receivables of all Obligors.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-Defaulted Receivables Balance</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the aggregate Outstanding Balance of all Receivables as to which no payment, or part thereof, remains unpaid for more than ninety (90) days from the original due date for such payment (determined without regard to any extension of the date due pursuant to Section 8.2(d)).</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-Renewing Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(a)</font><font style="font-family:inherit;font-size:12pt;">. &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Non-U.S. Affected Party</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)(ii)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Note Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable that is evidenced, in whole or in part, by any note, draft or other &#8220;instrument&#8221; or &#8220;document&#8221; within the meaning of Article 9 of the UCC.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Obligations</font><font style="font-family:inherit;font-size:12pt;">&#8221; shall have the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.1</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Obligor</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Person obligated to make payments pursuant to a Contract.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">OFAC</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Originator</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  Cardinal  Health  110,  LLC,  a  Delaware  limited  liability</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">company,  formerly  known  as  each  of  Cardinal  Health  110,  Inc.  and  Whitmire Distribution Corporation, and as successor by merger to each of Cardinal Syracuse, Inc., a New York corporation, Ohio Valley-Clarksburg, Inc., a Delaware corporation, Cardinal Health   103,   Inc.,   a   Mississippi   corporation,   and   Cardinal   Health   106,   Inc.,   a Massachusetts corporation, and Cardinal Health 411, LLC, an Ohio limited liability company.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:58px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Taxes</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Outstanding  Balance</font><font style="font-family:inherit;font-size:12pt;">&#8221;  of  any  Receivable  at  any  time  means  the  then  outstanding principal balance thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">ParMed Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, a Receivable originated by the ParMed division of Cardinal Health  110,  LLC,  which  Receivables  are  processed  on  the  Business  Planning  and  Control System as of November 14, 2016.</font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Participant</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.2</font><font style="font-family:inherit;font-size:12pt;">. &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance Guarantor</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Cardinal.</font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance Guaranty</font><font style="font-family:inherit;font-size:12pt;">&#8221; means that certain Fifth Amended and Restated Performance Guaranty, dated as of November 1, 2013, by Performance Guarantor in favor of Seller, as the same may be reaffirmed, amended, restated or otherwise modified from time to time.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Permitted Commingled Collections</font><font style="font-family:inherit;font-size:12pt;">&#8221; means all cash collections and other cash proceeds in respect of receivables owing to Subsidiaries of Cardinal that are neither Originators nor Approved Sub-Originators not exceeding $3,000,000 in the aggregate per calendar month; </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that, such collections shall cease to be &#8220;Permitted Commingled Collections&#8221; upon the occurrence of any of the following events: (a) an Amortization Event or Potential Amortization Event shall have occurred or (b) the Ratings Level then in effect is either Ratings Level 3 or Ratings Level 4.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Permitted Linked Accounts</font><font style="font-family:inherit;font-size:12pt;">&#8221; means such accounts designated as &#8220;Permitted Link Accounts&#8221; by the Seller or Servicer in writing to the Agent, as the same may be updated from time to time in writing by the Seller and Servicer.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Permitted Sub-Servicer</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.1(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Person</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  an  individual,  partnership,  corporation  (including  a  business  trust), limited liability company, joint stock company, trust, unincorporated association, joint venture or other entity, or a government or any political subdivision or agency thereof.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">PNC</font><font style="font-family:inherit;font-size:12pt;">&#8221; means PNC Bank, National Association, and its successors.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Potential Amortization Event</font><font style="font-family:inherit;font-size:12pt;">&#8221; means an event which, with the passage of time or the giving of notice, or both, would constitute an Amortization Event.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Prime Rate</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a rate per annum equal to the higher of (x) the prime rate of interest announced from time to time by the Agent (which is not necessarily the lowest rate charged to any customer), changing when and as said prime rate changes, and (y) the Federal Funds Rate plus 0.50%.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Proposed Reduction Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.3</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Pro Rata Share</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, (a) for each Financial Institution, a percentage equal to (i) the Commitment of such Financial Institution, divided by (ii) the aggregate amount of all Commitments of all Financial </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Institutions hereunder, adjusted as necessary to give effect to the application  of  the terms of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section  4.6</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;and  (b)  for  each  Conduit  or  Purchaser Group,  the aggregate of the Pro Rata Shares determined pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (a)</font><font style="font-family:inherit;font-size:12pt;">&#32;above for all Financial Institutions in its or such (as applicable) Purchaser Group.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchase Limit</font><font style="font-family:inherit;font-size:12pt;">&#8221; means $700,000,000, as such amount may be modified in accordance with the terms of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchase Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.2</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchase  Price</font><font style="font-family:inherit;font-size:12pt;">&#8221;    means,  with  respect  to  any  Incremental  Purchase  of  a  Purchaser Interest, the amount paid to Seller (or, in the case of a Letter of Credit issuance, the amount available to be drawn under such Letter of Credit) for such Purchaser Interest which shall not exceed the least of (i) the amount requested by Seller in the applicable Purchase Notice, (ii) the unused portion of the Purchase Limit (or, in the case of a Letter of Credit issuance, the lesser of the LC Facility Limit and the applicable LC Limit) on the applicable purchase date, taking into account any other proposed Incremental Purchase requested on the applicable purchase date, and (iii) the excess, if any, of the Net Receivables Balance (less the Aggregate Reserves) on the applicable purchase date (determined as of the date of the most recent report, whether such report is a Monthly Report, Weekly Report or Daily Report) </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">over</font><font style="font-family:inherit;font-size:12pt;">&#32;the sum of the Aggregate Capital </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">plus</font><font style="font-family:inherit;font-size:12pt;">&#32;the LC Adjusted Exposure (determined after giving effect to such Incremental Purchase and any other proposed Incremental Purchase requested on the applicable purchase date).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchaser Group</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each group consisting of a Conduit (if applicable), Financial Institution, LC Bank (if applicable), Agent (if applicable) and Managing Agent, as listed on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement under the heading &#8220;Purchaser Groups&#8221;.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchaser Group Commitment</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Purchaser Group or any Purchaser in such Purchaser Group, the aggregate Commitments of all Related Financial Institutions in such Purchaser Group.</font></div><div style="line-height:120%;padding-top:3px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchasers</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each Conduit, each Financial Institution and each LC Bank. </font></div><div style="line-height:120%;padding-top:3px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:3px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchaser Interest</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, an undivided percentage ownership interest</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(computed  as  set  forth  below)  associated  with  a  designated  amount  of  Capital  and/or  any</font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">designated portion of the LC Adjusted Exposure, selected pursuant to the terms and conditions hereof in (i) each Receivable arising prior to the time of the most recent computation or recomputation of such undivided interest, (ii) all Related Security with respect to each such Receivable, and (iii) all Collections with respect to, and other proceeds of, each such Receivable. Each such undivided percentage interest shall equal:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:13px;text-indent:288px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#32;E </font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:13px;text-indent:264px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">NRB - AR</font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:13px;text-indent:264px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:13px;text-indent:84px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">where:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:1px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:198px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:102px;"><font style="font-family:inherit;font-size:12pt;">E       =</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the amount of such selected Capital and/or such selected portion of the LC Adjusted Exposure, as the case may be.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NRB</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">=</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">the Net Receivables Balance. </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:232%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AR</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">=</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;the Aggregate Reserves.</font></div><div style="line-height:120%;text-align:left;padding-left:102px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Such undivided percentage ownership interest shall be initially computed on its date of purchase.  Thereafter, until the Amortization Date, each Purchaser Interest shall be automatically recomputed (or deemed to be recomputed) on each day prior to the Amortization Date.  The variable percentage represented by any Purchaser Interest as computed (or deemed recomputed) as of the close of the business day immediately preceding the Amortization Date shall remain constant at all times after such Amortization Date.  For the avoidance of doubt, unless otherwise specified or unless the context otherwise requires, (x) each reference to the Purchaser Interest of a particular Purchaser or Purchaser Group shall be deemed to mean the Purchaser Interest calculated with respect to all such Purchaser&#8217;s or Purchaser Group&#8217;s (as applicable) outstanding Capital and Pro Rata Share of the LC Adjusted Exposure and (y) each reference to the Purchaser Interest  generally or  the  Purchaser  Interest  of  all  Purchasers  or  Purchaser  Groups  shall  be </font><font style="font-family:inherit;font-size:12pt;">deemed to mean the Purchaser Interest calculated with respect to the Aggregate Capital and the entire LC Adjusted Exposure.</font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Purchasing Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1(b)</font><font style="font-family:inherit;font-size:12pt;">. &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Rating Agency</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, collectively, S&amp;P, Moody&#8217;s and Fitch.</font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Ratings Level</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, the &#8220;Ratings Level&#8221; set forth in the table below corresponding to the &#8220;Qualification Requirements&#8221; set forth in the table below.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:70.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:49%;"></td><td style="width:51%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Qualification Requirements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:90px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Ratings Level</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The senior unsecured long-term debt ratings of Cardinal are (i) at BBB- or higher (as determined by S&amp;P) </font><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">(ii) at Baa3 or higher (as determined by Moody&#8217;s)</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 1</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cardinal does not qualify for Ratings Level1 </font><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">the senior unsecured long-term debt ratings of Cardinal are (i) at BB+ or higher (as determined by S&amp;P) </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">(ii) at Ba1 or higher (as determined by Moody&#8217;s)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 2</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cardinal does not qualify for Ratings Level1 or Ratings Level 2 </font><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">the senior unsecured long-term debt ratings of Cardinal are (i) at BB or higher (as determined by S&amp;P) </font><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">(ii) at Ba2 or higher (as determined by Moody&#8217;s)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cardinal does not qualify for Ratings Level 1, Ratings Level 2 or Ratings Level 3 for any reason</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ratings Level 4</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means: (i) for purposes of the Receivables Sale Agreement, (a) all rights to payment owed (without giving effect to the transfers under any Sub-Originator Sale Agreement or any Griffin RPA) to the applicable Originator or Approved Sub-Originator for goods sold or services performed by such Originator or Approved Sub-Originator or in which such Originator or Approved Sub-Originator has a security or other interest, whether such rights to payment constitute an account, chattel paper, general intangible or otherwise (as each of the foregoing terms is used in Article 9 of the UCC) and includes, without </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">limitation, the obligation to pay any Finance Charges with respect thereto, excluding, however, any Excluded Receivable and (b) all rights of Griffin under each Sub-Originator Sale Agreement and each Griffin RPA and (ii) for purposes of this Agreement, (a) all rights to payment owed (without giving effect to the transfers under any Sub-Originator Sale Agreement, any Griffin RPA or the Receivables Sale Agreement) to the applicable Originator or Approved Sub-Originator for goods sold or services performed by such Originator or Approved Sub-Originator or in which such Originator or Sub-Originator has a security or other interest, whether such rights to payment constitute an account, chattel paper, general intangible or otherwise (as each of the foregoing terms is used in Article 9 of the UCC) and includes without limitation, the obligation to pay any Finance Charges with respect thereto, excluding however, any Excluded Receivable and (b) all rights of Seller under each Sub- Originator Sale Agreement, each Griffin RPA and the Receivables Sale Agreement.  Rights to payment arising from any one transaction, including, without limitation, rights to payment represented by an individual invoice shall constitute a Receivable separate from a Receivable consisting of the rights to payment arising from any other transaction.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Receivables Sale Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means that certain Amended and Restated Receivables Sale Agreement, dated as of May 21, 2004, between Griffin and Seller, as the same may be amended, restated or otherwise modified from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Records</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Receivable, all Contracts and other documents, books, records and other information (including, without limitation, computer programs, tapes, disks, punch cards, data processing software and related property and rights) relating to such Receivable, any Related Security therefor and the related Obligor.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reduction Notice</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 1.3</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#32;&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Regulatory Change</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, relative to any Funding Source:</font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)&#160;&#160;&#160;&#160;any change in (or the adoption, implementation, change in phase-in or interpretations or commencement of effectiveness of) any:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:150px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">law applicable to such Funding Source;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)      rule, regulation, interpretation, directive, requirement or request (whether or not having the force of law and including any such rule, regulation, interpretation, directive or requirement regarding capital adequacy) applicable to such Funding Source of (A) any Governmental Authority charged with the interpretation or administration of any law referred to in clause (a)(i) or of (B) any central bank or comparable agency or fiscal, monetary or other authority having jurisdiction over such Funding Source; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:102px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)     generally accepted accounting principles consistently applied or regulatory accounting principles applicable to such Funding Source and affecting the application to such Affected Party of any law, regulation, interpretation, directive, requirement or request referred to in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (a)(i)</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(a)(ii)</font><font style="font-family:inherit;font-size:12pt;">&#32;above;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:48px;text-indent:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       any  change  in  the  application  to  such  Funding  Source  of  any existing law, rule, regulation, interpretation, directive, requirement, request or accounting principles referred to in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (a)(i), (a)(ii)</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">(a)(iii)</font><font style="font-family:inherit;font-size:12pt;">&#32;above.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reinvestment</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.2</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Related Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221; means with respect to each Conduit or Purchaser Group, each  Financial  Institution set forth opposite such Conduit&#8217;s name or as a member of such</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Purchaser Group (as the case may be) in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Schedule A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement and/or, in the case of an assignment pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 12.1</font><font style="font-family:inherit;font-size:12pt;">, set forth in the applicable Assignment Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Related Security</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Receivable:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i)        all  of  Seller&#8217;s  interest,  if  any,  in  the  inventory  and  goods  (including returned or repossessed inventory or goods), the sale or financing of which by the applicable Originator gave rise to such Receivable,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii)       all other security interests or liens and property subject thereto from time to time, if any, purporting to secure payment of such Receivable, whether pursuant to the Contract related to such Receivable or otherwise, together with all financing statements and security agreements describing any collateral securing such Receivable,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii)      all guaranties, letters of credit, insurance, &#8220;supporting obligations&#8221; (within the meaning of Section 9-102(a) of the UCC of all applicable jurisdictions) and other agreements or arrangements of whatever character from time to time supporting or securing payment of such Receivable whether pursuant to the Contract related to such Receivable or otherwise,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv)      all service contracts and other contracts and agreements associated with such Receivable,</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(v)      all of the Seller&#8217;s right, title and interest in the Records related to such Receivable; provided, that with respect to any Contract, such Related Security shall only include such right, title and interest as it relates to payment under such Contract,</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vi)      all  of  Seller&#8217;s  right,  title  and  interest  in,  to  and  under  each  of  the Receivables Sale Agreement, the Performance Guaranty, each Griffin RPA, each Sub- Originator Sale Agreement, the Cash Management Agreement, the Demand Loans, each Lock-Box and each Collection Account, and</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:100px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(vii)</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">all proceeds of any of the foregoing.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:50px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Required  Financial  Institutions</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means,  at  any  time,  collectively,  the  Financial</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Institutions with Commitments in excess of 66-2/3% of the aggregate Commitments.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Required Notice Period</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the number of days required notice set forth below applicable to the Aggregate Reduction indicated below; provided that such notice shall be given by at least 12:00 noon (New York time) on such day:</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:146px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Aggregate Reduction</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Required Notice Period</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:168px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8804; $250,000,000</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">one Business Day</font></div><div style="line-height:120%;text-align:center;padding-left:168px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&gt; $250,000,000</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;">two Business Days</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reserve Floor</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, an amount equal to the product of (i) the Reserve Floor Percentage multiplied by (ii) the Net Receivables Balance as of the close of business of the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Servicer on such date.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Reserve Floor Percentage</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, on any date of determination, a percentage equal to the sum of (i) 25% plus (ii) the product of (x) the Expected Dilution Ratio multiplied by (y) the Dilution Horizon Ratio.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sanctioned Country</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, at any time, a country region or territory which is itself the subject or target of comprehensive Sanctions (at the time of this Agreement, Cuba, Iran, North Korea, Sudan, Syria and Crimea).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sanctioned Person</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by OFAC, the U.S. Department of State, or by the United Nations Security Council, the European Union or any European Union member state, (b) any Person operating, organized or ordinarily resident in a Sanctioned Country to the extent dealing with such Person would be prohibited by applicable Sanctions or (c) any Person 50% owned by any such Person or Persons described in the foregoing </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">clause (a)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sanctions</font><font style="font-family:inherit;font-size:12pt;">&#8221; means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State or (b) the United Nations Security Council, the European Union or any European Union member state.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Scheduled Facility Termination Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; means November 1, 2019. &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble to this Agreement.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Seller Parties</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in the preamble to this Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Servicer</font><font style="font-family:inherit;font-size:12pt;">&#8221; means at any time the Person (which may be the Agent) then authorized pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Article VIII</font><font style="font-family:inherit;font-size:12pt;">&#32;to service, administer and collect Receivables.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Servicing Fee</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.6</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Settlement Date</font><font style="font-family:inherit;font-size:12pt;">&#8221; means (A) the 20th  calendar day of each month (or if such day is not a Business Day, the next succeeding Business Day), and (B) the last day of the relevant Tranche Period in respect of each Purchaser Interest of any Financial Institution.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Settlement Period</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means (A) in respect of each Purchaser Interest of the Conduits, the immediately preceding Accrual Period, and (B) in respect of each Purchaser Interest of any Financial Institution, the entire Tranche Period of such Purchaser Interest.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Specified Regulation</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, without regard to the date enacted, adopted or issued, (a) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (b) all requests, rules, guidelines  or  directives  promulgated  by  the  Bank  for  International  Settlements,  the  Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sub-Originator  Sale  Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means  each  of  (i)  each  Receivables  Sale</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Agreement between an Approved Sub-Originator and an Originator, dated as of March 1,</font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2010 and (ii) that certain Receivables Sale Agreement, dated as of November 14, 2016, between Medicap Pharmacies Incorporated, an Iowa corporation, and Cardinal Health 110,  LLC,  as  each  of  the  foregoing  may  be  amended,  supplemented  or  otherwise modified from time to time.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sub-Originator Sale Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means each Receivables Sale Agreement between an Approved Sub-Originator and an Originator, dated as of March 1, 2010, as the same may be amended, supplemented or otherwise modified from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Subsidiary</font><font style="font-family:inherit;font-size:12pt;">&#8221; of a Person means (i) any corporation more than 50% of the outstanding securities having ordinary voting power of which shall at the time be owned or controlled, directly or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of its Subsidiaries, or (ii) any partnership, limited liability company, association, joint venture or similar business organization more than 50% of the ownership interests having ordinary voting power of which shall at the time be so owned or controlled.  Unless otherwise expressly provided, all references herein to a &#8220;Subsidiary&#8221; shall mean a Subsidiary of Seller.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">S&amp;P</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Standard &amp; Poor&#8217;s Financial Services LLC or any successor thereto that is a nationally recognized statistical rating organization.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Taxes</font><font style="font-family:inherit;font-size:12pt;">&#8221; means any and all present or future taxes, duties, levies, imposts, deductions, assessments, fees, charges, or withholdings, and any and all liabilities with respect to the foregoing (including interest, penalties and additions to taxes), but excluding Excluded Taxes.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination Percentage</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 2.2</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terminating Commitment Amount</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Terminating Financial Institution, an amount equal to the Commitment (without giving effect to clause (iii) of the proviso to the penultimate sentence of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(b)</font><font style="font-family:inherit;font-size:12pt;">) of such Terminating Financial Institution, minus, an amount equal to 2% of such Commitment.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terminating  Commitment  Availability</font><font style="font-family:inherit;font-size:12pt;">&#8221;  means,  with  respect  to  any  Terminating Financial Institution, the positive difference (if any) between (a) an amount equal to the Commitment (without giving effect to clause (iii) of the proviso to the penultimate sentence of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.6(b)</font><font style="font-family:inherit;font-size:12pt;">) of such Terminating Financial Institution, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">minus</font><font style="font-family:inherit;font-size:12pt;">, an amount equal to 2% of such Commitment minus (b) the Capital of the Purchaser Interests funded by such Terminating Financial Institution.</font></div><div style="line-height:232%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terminating Financial Institution</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in Section 4.6(b). &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Terminating Tranche</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4.3(b)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Trade Show Receivable</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a Receivable originated at a trade show.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tranche Period</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any Purchaser Interest held by a Financial</font></div><div style="line-height:120%;text-align:left;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Institution:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)       if Yield for such Purchaser Interest is calculated on the basis of the LIBO Rate, a period of one, two, three or six months, or such other period as may be mutually agreeable to the applicable Agent or Managing Agent and Seller, commencing on a Business Day selected by Seller </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">or the applicable Agent or Managing Agent pursuant to this Agreement.  Such Tranche Period shall end on the day in the applicable succeeding calendar month which corresponds numerically to the beginning day of such Tranche Period, provided, however, that if there is no such numerically corresponding day in such succeeding month, such Tranche Period shall end on the last Business Day of such succeeding month; or</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:54px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)       if Yield for such Purchaser Interest is calculated on the basis of the Prime Rate, a period commencing on a Business Day selected by Seller and agreed to by the applicable Agent or Managing Agent, provided no such period shall exceed one month.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If any Tranche Period would end on a day which is not a Business Day, such Tranche Period shall end on the next succeeding Business Day, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, however, that in the case of Tranche Periods corresponding to the LIBO Rate, if such next succeeding Business Day falls in a new month, such Tranche Period shall end on the immediately preceding Business Day.  In the case of any Tranche Period for any Purchaser Interest of which commences before the Amortization Date and would otherwise end on a date occurring after the Amortization Date, such Tranche Period shall end on the Amortization Date.  The duration of each Tranche Period which commences after the Amortization Date shall be of such duration as selected by the applicable  Agent  or  Managing  Agent.  Notwithstanding  anything  to  the  contrary  contained herein, with respect to any Purchaser Interest held by WF or PNC, the Tranche Period shall be the Accrual Period.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Transaction Documents</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, collectively, this Agreement, the Existing Agreement, each Purchase Notice, the Receivables Sale Agreement, each Griffin RPA, each Sub-Originator Sale Agreement, the Performance Guaranty,  each Collection Account  Agreement,  each  Fee Letter, the Subordinated Note (as defined in the Receivables Sale Agreement), the Collection Account Disclosure Letter, the Cash Management Agreement and all other instruments, documents and agreements executed and delivered in connection herewith or in connection with the Existing Agreement (other than the Contracts).</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">UCC</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the Uniform Commercial Code as from time to time in effect in the relevant jurisdiction.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">U.S. Affected Party</font><font style="font-family:inherit;font-size:12pt;">&#8221; has the meaning set forth in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 10.4(d)(i)</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Weekly Report</font><font style="font-family:inherit;font-size:12pt;">&#8221; means a report, in form and substance acceptable to the Agent and each Managing Agent (appropriately completed), furnished by the Servicer to the Agent and each Managing Agent pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8.5</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">WF</font><font style="font-family:inherit;font-size:12pt;">&#8221; means Wells Fargo Bank, N.A., and its successors.</font></div><div style="line-height:120%;padding-top:4px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Write-Down and Conversion Powers</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write- down and conversion powers are described in the EU Bail-In Legislation Schedule.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Yield</font><font style="font-family:inherit;font-size:12pt;">&#8221; means for each respective Tranche Period relating to Purchaser Interests of the Financial Institutions, an amount equal to the product of the applicable Discount Rate for each Purchaser Interest multiplied by the Capital of such Purchaser Interest for each day elapsed during such Tranche Period, annualized on a 360-day basis.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">All accounting terms not specifically defined herein shall be construed in accordance with generally </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">accepted accounting principles.   All terms used in Article 9 of the UCC in the State of Illinois, and not specifically defined herein, are used herein as defined in such Article 9.</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5.1
<SEQUENCE>6
<FILENAME>a18q1_10qx093017xexhibit1051.htm
<DESCRIPTION>EXHIBIT 10.5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1daa2fb7efd34ac49e0a229e35ab08ca"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Exhibit 10.5.1</font></div><div style="line-height:120%;padding-top:1px;text-align:center;padding-left:170px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:center;padding-left:170px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SEVENTH AMENDED AND RESTATED PERFORMANCE GUARANTY</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Seventh Amended and Restated Performance Guaranty (this &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Guaranty</font><font style="font-family:inherit;font-size:12pt;">&#8221;), dated as of November 14, 2016, is executed by Cardinal Health, Inc., an Ohio corporation (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Cardinal</font><font style="font-family:inherit;font-size:12pt;">&#8221; or the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance Guarantor</font><font style="font-family:inherit;font-size:12pt;">&#8221;) in favor of Cardinal Health Funding, LLC, a Nevada limited liability company (together with its successors and assigns, &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Beneficiary</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:277px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">RECITALS</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1.         Cardinal Health 110, LLC (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CH 110</font><font style="font-family:inherit;font-size:12pt;">&#8221;), a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Originator</font><font style="font-family:inherit;font-size:12pt;">&#8221; and, together with any other Persons acting as &#8220;Originators&#8221; under the Transaction Documents, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Originators</font><font style="font-family:inherit;font-size:12pt;">&#8221;) has entered into and may from time to time in the future enter into Sub- Originator Sale Agreements (such term being used herein as defined in the Receivables Purchase Agreement described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">paragraph 3</font><font style="font-family:inherit;font-size:12pt;">&#32;below) with the Approved Sub-Originators (such term being used herein as defined in the Receivables Purchase Agreement described in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">paragraph 3</font><font style="font-family:inherit;font-size:12pt;">&#32;below).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.         Griffin Capital, LLC, a Nevada limited liability company (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Griffin</font><font style="font-family:inherit;font-size:12pt;">&#8221; and, together with the Originators and the Approved Sub-Originators, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Transaction Parties</font><font style="font-family:inherit;font-size:12pt;">&#8221;) has entered into that certain Second Amended and Restated Receivables Purchase and Sale Agreement (as amended, restated, supplemented or otherwise modified from time to time, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CH 110 Griffin</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">RPA</font><font style="font-family:inherit;font-size:12pt;">&#8221;), dated as of May 21, 2004, by and between Griffin and CH 110.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3.         Griffin and Beneficiary have entered into an Amended and Restated Receivables Sale Agreement, dated as of May 21, 2004 (as amended, restated or otherwise modified from time to time, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Receivables Sale Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221;), pursuant to which Griffin, subject to the terms and conditions contained therein, has sold and will continue to sell its right, title and interest in and to all of the accounts receivable purchased by Griffin under each Griffin RPA to Beneficiary. In turn, Beneficiary has entered into a Fourth Amended and Restated Receivables Purchase Agreement, dated as of November 1, 2013, by and among Beneficiary, Griffin, as Servicer, the Conduits  party thereto,  the  Financial  Institutions  party thereto,  the  Managing  Agents  party thereto, the LC Banks party thereto and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Agent (as amended, restated or otherwise modified from time to time, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Receivables Purchase Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; and, together with the Sub-Originator Sale Agreements, each Griffin RPA and the Receivables Sale Agreement, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agreements</font><font style="font-family:inherit;font-size:12pt;">&#8221;), pursuant to which Beneficiary has sold and will continue to sell undivided interests in the accounts receivable it purchases from Griffin under the Receivables Sale Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4.         Each  Approved  Sub-Originator,  Originator  and  Griffin  is  a  Subsidiary  of Performance Guarantor and Performance Guarantor has received and is expected to continue to receive substantial direct and indirect benefits from the sale of the accounts receivable by the Approved Sub-Originators to each of the Originators under the applicable Sub-Originator Sale Agreements, by the Originators to Griffin under the applicable Griffin RPA and by Griffin to Beneficiary under the Receivables Sale Agreement (which benefits are hereby acknowledged).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5.         Concurrently   herewith,   Griffin,   Beneficiary,   the   Conduits,   the   Financial Institutions, the Managing Agents, the LC Bank and the Agent are entering into that certain Second Amendment to the </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Receivables Purchase Agreement (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">RPA Amendment</font><font style="font-family:inherit;font-size:12pt;">&#8221;), dated as of the date hereof, and the Performance Guarantor&#8217;s execution and delivery of this Performance Guaranty is a condition precedent to effectiveness of the RPA Amendment.  As an inducement for  Beneficiary  to  enter  into  the  RPA  Amendment,  Performance  Guarantor  has  agreed  to guaranty the due and punctual performance by each Approved Sub-Originator of its obligations under the applicable Sub-Originator Sale Agreement, each Originator of its obligations under the applicable Griffin RPA and by Griffin of its obligations under the Receivables Sale Agreement and the Receivables Purchase Agreement.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6.         Performance Guarantor wishes to guaranty the due and punctual performance by the Approved Sub-Originators, the Originators and Griffin of their respective Obligations (as hereinafter defined), as provided herein.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:266px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">AGREEMENT</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-top:1px;text-align:left;padding-left:54px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, Performance Guarantor hereby agrees as follows:</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Definitions</font><font style="font-family:inherit;font-size:12pt;">.   Capitalized terms used herein and not defined herein shall have the respective meanings assigned thereto in the Receivables Purchase Agreement.   In addition:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Obligations</font><font style="font-family:inherit;font-size:12pt;">&#8221; means, collectively, (i) all covenants, agreements, terms, conditions and indemnities to be performed and observed by each Originator and each Approved Sub-Originator under and pursuant to the Griffin RPA and Sub-Originator Sale Agreement(s) to which such Originator  or  Approved  Sub-Originator  is  a  party  and  each  other  document  executed  and delivered by each such Originator or Approved Sub-Originator pursuant to such Griffin RPA and Sub-Originator Sale Agreement(s), </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation,</font><font style="font-family:inherit;font-size:12pt;">&#32;the due and punctual payment of all sums which are or may become due and owing by each such Originator or Approved Sub- Originator under such Griffin RPA and Sub-Originator Sale Agreement(s), whether for fees, expenses (including counsel fees), indemnified amounts or otherwise, whether upon any termination or for any other reason, (ii) all covenants, agreements, terms, conditions and indemnities to be performed and observed by Griffin under and pursuant to the Receivables Sale Agreement and each other document executed and delivered by Griffin pursuant to the Receivables Sale Agreement, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the due and punctual payment of all sums  which  are  or  may  become  due  and  owing  by  Griffin  under  the  Receivables  Sale Agreement, whether for fees, expenses (including counsel fees), indemnified amounts or otherwise, whether upon any termination or for any other reason and (iii) all obligations of Griffin (1) as Servicer under the Receivables Purchase Agreement, or (2) which arise pursuant to </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Sections 8.2</font><font style="font-family:inherit;font-size:12pt;">, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">8.3</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">14.4(a)</font><font style="font-family:inherit;font-size:12pt;">&#32;of the Receivables Purchase Agreement as a result of its termination as Servicer.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Guaranty of Performance of Obligations</font><font style="font-family:inherit;font-size:12pt;">.  Performance Guarantor hereby guarantees to Beneficiary, the full and punctual payment and performance by each Transaction Party of its respective Obligations. This Guaranty is an absolute, unconditional and continuing guaranty of the full and punctual performance of all of the Obligations of the Transaction Parties under the Agreements and each other document executed and delivered by each such Transaction Party pursuant to the Agreements and is in no way conditioned upon any requirement that Beneficiary first attempt to collect any amounts owing by any Transaction Party to Beneficiary, the Agent or the Purchasers from any other Person or resort to any collateral security, any balance of any deposit account or credit on the books of Beneficiary, the Agent or any Purchaser in favor of any Transaction Party or any other Person or other means of obtaining payment. Should any Transaction Party default in the payment or performance of any of the Obligations, Beneficiary (or its assigns) may cause the immediate performance by Performance Guarantor of the Obligations and cause any payment Obligations to become forthwith due and payable to Beneficiary (or its assigns), without </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">demand or notice of any nature (other than as expressly provided herein), all of which are hereby expressly waived by Performance Guarantor. Notwithstanding the foregoing, this Guaranty is not a guarantee of the collection of any of the Receivables and Performance Guarantor shall not be responsible for any Obligations to the extent the failure to perform such Obligations by any Transaction Party results from Receivables being uncollectible on account of the insolvency, bankruptcy or lack of creditworthiness of the related  Obligor;  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">,  that  nothing  herein  shall  relieve  any  Transaction  Party  from performing in full its Obligations under any Agreement or Performance Guarantor of its undertaking hereunder with respect to the full performance of such duties.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance  Guarantor&#8217;s  Further  Agreements  to  Pay</font><font style="font-family:inherit;font-size:12pt;">.     Performance Guarantor further agrees, as the principal obligor and not as a guarantor only, to pay to Beneficiary (and its assigns), forthwith upon demand in funds immediately available to Beneficiary,  all  reasonable  costs  and  expenses  (including  court  costs  and  legal  expenses) incurred or expended by Beneficiary in connection with the Obligations, this Guaranty and the enforcement thereof, together with interest on amounts recoverable under this Guaranty from the time when such amounts become due until payment, at a rate of interest (computed for the actual number of days elapsed based on a 360 day year) equal to the Prime Rate plus 2% per annum, such rate of interest changing when and as the Prime Rate changes.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 4.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Waivers  by  Performance  Guarantor</font><font style="font-family:inherit;font-size:12pt;">.    Performance  Guarantor  waives notice of acceptance of this Guaranty, notice of any action taken or omitted by Beneficiary (or its assigns) in reliance on this Guaranty, and any requirement that Beneficiary (or its assigns) be diligent or prompt in making demands under this Guaranty, giving notice of any Termination Event, Amortization Event, other default or omission by any Transaction Party or asserting any other rights of Beneficiary under this Guaranty. Performance Guarantor warrants that it has adequate means to obtain from each Transaction Party, on a continuing basis, information concerning the financial condition of such Transaction Party, and that it is not relying on Beneficiary to provide such information, now or in the future. Performance Guarantor also irrevocably waives all defenses (i) that at any time may be available in respect of the Obligations by virtue of any statute of limitations, valuation, stay, moratorium law or other similar law now or hereafter in effect or (ii) that arise under the law of suretyship, including impairment of collateral. Beneficiary (and its assigns) shall be at liberty, without giving notice to or obtaining the  assent  of  Performance  Guarantor  and  without  relieving  Performance  Guarantor  of  any liability under this Guaranty, to deal with each Transaction Party and with each other party who now is or after the date hereof becomes liable in any manner for any of the Obligations, in such manner as Beneficiary in its sole discretion deems fit, and to this end Performance Guarantor agrees that the validity and enforceability of this Guaranty, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">including</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">without</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">limitation</font><font style="font-family:inherit;font-size:12pt;">, the provisions of </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8</font><font style="font-family:inherit;font-size:12pt;">&#32;hereof, shall not be impaired or affected by any of the following: (a) any extension, modification or renewal of, or indulgence with respect to, or substitutions for, the Obligations or any part thereof or any agreement relating thereto at any time; (b) any failure or omission to enforce any right, power or remedy with respect to the Obligations or any part thereof or any agreement relating thereto, or any collateral securing the Obligations or any part thereof; (c) any waiver of any right, power or remedy or of any Termination Event, Amortization Event, or default with respect to the Obligations or any part thereof or any agreement relating thereto;   (d)   any   release,   surrender,   compromise,   settlement,   waiver,   subordination   or modification, with or without consideration, of any other obligation of any person or entity with respect to the Obligations or any part thereof; (e) the enforceability or validity of the Obligations or any part thereof or the genuineness, enforceability or validity of any agreement relating thereto or with respect to the Obligations or any part thereof; (f) the application of payments received from any source to the payment of any payment Obligations of any Transaction Party or any part thereof or amounts which are not covered by this Guaranty even though Beneficiary (or its assigns) might lawfully have elected to apply such payments to any part or all of the payment Obligations of such Transaction Party or to amounts which are not covered by this Guaranty; (g) the existence of any claim, setoff or other rights which </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Performance Guarantor may have at any time against any Transaction Party in connection herewith or any unrelated transaction; (h) any assignment or transfer of the Obligations or any part thereof; or (i) any failure on the part of any Transaction Party to perform or comply with any term of the Agreements or any other document executed in connection therewith or delivered thereunder, all whether or not Performance Guarantor shall have had notice or knowledge of any act or omission referred to in the foregoing clauses (a) through (i) of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 4</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 5.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Unenforceability     of     Obligations     Against     Transaction     Parties</font><font style="font-family:inherit;font-size:12pt;">. Notwithstanding (a) any change of ownership of any Transaction Party or the insolvency, bankruptcy or any other change in the legal status of any Transaction Party; (b) the change in or the imposition of any law, decree, regulation or other governmental act which does or might impair, delay or in any way affect the validity, enforceability or the payment when due of the Obligations; (c) the failure of any Transaction Party or Performance Guarantor to maintain in full force,  validity  or  effect  or  to  obtain  or  renew  when  required  all  governmental  and  other approvals, licenses or consents required in connection with the Obligations or this Guaranty, or to take any other action required in connection with the performance of all obligations pursuant to the Obligations or this Guaranty; or (d) if any of the moneys included in the Obligations have become irrecoverable from any Transaction Party for any other reason other than final payment in  full  of  the  payment  Obligations  in  accordance  with  their  terms,  this  Guaranty  shall nevertheless be binding on Performance Guarantor. This Guaranty shall be in addition to any other guaranty or other security for the Obligations, and it shall not be rendered unenforceable by the invalidity of any such other guaranty or security. In the event that acceleration of the time for payment of any of the Obligations is stayed upon the insolvency, bankruptcy or reorganization of any Transaction Party or for any other reason with respect to any Transaction Party, all such amounts then due and owing with respect to the Obligations under the terms of the Agreements, or any other agreement evidencing, securing or otherwise executed in connection with the Obligations, shall be immediately due and payable by Performance Guarantor.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 6.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations   and   Warranties</font><font style="font-family:inherit;font-size:12pt;">.       Performance   Guarantor   hereby represents and warrants to Beneficiary that:</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Existence and Standing</font><font style="font-family:inherit;font-size:12pt;">.  Performance Guarantor is a corporation duly organized,  validly  existing  and  in  good  standing  under  the  laws  of  its  jurisdiction  of incorporation,  and  has  all  corporate  power  and  all  governmental  licenses,  authorizations, consents and approvals required to carry on its business in each jurisdiction in which its business is conducted.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Authorization, Execution and Delivery; Binding Effect</font><font style="font-family:inherit;font-size:12pt;">.   Performance Guarantor has the corporate power and authority and legal right to execute and deliver this Guaranty, perform its obligations hereunder and consummate the transactions herein contemplated. The execution and delivery by Performance Guarantor of this Guaranty, the performance of its obligations and consummation of the transactions contemplated hereunder have been duly authorized by proper corporate proceedings, and Performance Guarantor has duly executed and delivered this Guaranty. This Guaranty constitutes the legal, valid and binding obligation of Performance Guarantor enforceable against Performance Guarantor in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency, reorganization or other similar laws relating to or limiting creditors&#8217; rights generally.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Conflict; Government Consent</font><font style="font-family:inherit;font-size:12pt;">.   The execution and delivery by Performance Guarantor of this Guaranty and the performance of its obligations hereunder are within its corporate powers, have been duly authorized by all necessary corporate action, do not contravene or violate (i) its articles of incorporation or code of regulations, (ii) any law, rule or regulation applicable to it, (iii) any restrictions under any agreement, contract or instrument to which it is a party or by which it or any of its property is </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">bound, or (iv) any order, writ, judgment, award, injunction or decree binding on or affecting it or its property and, do not result in the creation or imposition of any Adverse Claim on assets of Performance Guarantor.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d)     </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial  Statements</font><font style="font-family:inherit;font-size:12pt;">.  The  consolidated  financial  statements  of Performance Guarantor and its consolidated Subsidiaries dated as of June 30, 2016 heretofore filed with the Securities and Exchange Commission have been prepared in accordance with generally accepted accounting principles consistently applied and fairly present in all material respects the consolidated financial condition and results of operations of Performance Guarantor and its consolidated Subsidiaries as of June 30, 2016 and for the period ended on such date. Since June 30, 2016, no event has occurred which would or could reasonably be expected to have a Material Adverse Effect.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(e)       </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Taxes</font><font style="font-family:inherit;font-size:12pt;">.   Performance Guarantor has filed  all United States federal tax returns and all other tax returns which are required to be filed and have paid all taxes due pursuant to said returns or pursuant to any assessment received by Performance Guarantor or any of its Subsidiaries, except such taxes, if any, as are being contested in good faith and as to which adequate reserves have been provided in accordance with generally accepted accounting principles and as to which no Adverse Claim exists. No tax liens have been filed and no claims are being asserted with respect to any such taxes which could reasonably be expected to have a Material Adverse Effect. The charges, accruals and reserves on the books of Performance Guarantor in respect of any taxes or other governmental charges are adequate.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(f)        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Litigation and Contingent Obligations</font><font style="font-family:inherit;font-size:12pt;">.  Except as disclosed in the filings made by Performance Guarantor with the Securities and Exchange Commission, there are no actions, suits or proceedings pending or, to the best of Performance Guarantor&#8217;s knowledge threatened, against or affecting Performance Guarantor or any of its properties, in or before any court, arbitrator or other body, that could reasonably be expected to have a material adverse effect on (i) the business, properties, condition (financial or otherwise) or results of operations of Performance Guarantor and its Subsidiaries taken as a whole, (ii) the ability of Performance Guarantor to perform its obligations under this Guaranty, or (iii) the validity or enforceability of any of this Guaranty or the rights or remedies of Beneficiary hereunder. Performance Guarantor is not in default with respect to any order of any court, arbitrator or governmental body and does not have any material contingent obligations not provided for or disclosed in its filings with the Securities and Exchange Commission.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 7.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Covenant</font><font style="font-family:inherit;font-size:12pt;">.  The Performance Guarantor shall at all times comply with Section 6.12 of the Credit Agreement (defined below), as in effect on the date hereof and without giving effect to any subsequent amendment, modification or waiver thereof (or any amendment or modification of any defined term in the Credit Agreement that would directly or indirectly change the covenants set forth in such Section 6.12), unless such amendment, modification  or  waiver  is  consented  to  in  writing  by  the  Agent,  the  Required  Financial Institutions and all LC Banks (in each case, in their capacities as such under the Receivables Purchase Agreement).</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For purposes of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 7</font><font style="font-family:inherit;font-size:12pt;">, &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Credit Agreement</font><font style="font-family:inherit;font-size:12pt;">&#8221; means that certain Amended and Restated Five-Year Credit Agreement, dated as of June 16, 2016, by and among Performance Guarantor and certain Subsidiaries of the Performance Guarantor, as borrowers, each lender party hereto from time to time and JPMorgan Chase Bank, N.A. as Administrative Agent, Swingline Lender and LC Issuer.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 8.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Subrogation; Subordination</font><font style="font-family:inherit;font-size:12pt;">.   Notwithstanding anything to the contrary contained herein, until the Obligations are paid in full Performance Guarantor: (a) will not enforce or otherwise exercise any right of subrogation to any of the rights of Beneficiary, the Agent  or  any  Purchaser  against  </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">any  Transaction  Party,  (b)  hereby  waives  all  rights  of subrogation (whether contractual, under Section 509 of the United States Bankruptcy Code, at law, in equity or otherwise) to the claims of Beneficiary, the Agent and the Purchasers against each Transaction Party and all contractual, statutory, legal or equitable rights of contribution, reimbursement, indemnification and similar rights and &#8220;claims&#8221; (as that term is defined in the United States Bankruptcy Code) which Performance Guarantor might now have or hereafter acquire  against  any  Transaction  Party  that  arise  from  the  existence  or  performance  of Performance Guarantor&#8217;s obligations hereunder, (c) will not claim any setoff, recoupment or counterclaim against any Transaction Party in respect of any liability of Performance Guarantor to such Transaction Party and (d) waives any benefit of and any right to participate in any collateral  security  which  may  be  held  by  Beneficiaries,  the  Agent  or  the  Purchasers.  The payment of any amounts due with respect to any indebtedness of any Transaction Party now or hereafter owed to Performance Guarantor is hereby subordinated to the prior payment in full of all of the Obligations. Performance Guarantor agrees that, after the occurrence of any default in the payment or performance of any of the Obligations, Performance Guarantor will not demand, sue for or otherwise attempt to collect any such indebtedness of any Transaction Party to Performance Guarantor until all of the Obligations shall have been paid and performed in full. If, notwithstanding the foregoing sentence, Performance Guarantor shall collect, enforce or receive any amounts in respect of such indebtedness while any Obligations are still unperformed or outstanding, such amounts shall be collected, enforced and received by Performance Guarantor as trustee for Beneficiary (and its assigns) and be paid over to Beneficiary (or its assigns) on account  of  the  Obligations  without  affecting  in  any  manner  the  liability  of  Performance Guarantor under the other provisions of this Guaranty. The provisions of this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 8</font><font style="font-family:inherit;font-size:12pt;">&#32;shall be supplemental to and not in derogation of any rights and remedies of Beneficiary under any separate subordination agreement which Beneficiary may at any time and from time to time enter into with Performance Guarantor.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 9.        </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Termination   of   Performance   Guaranty</font><font style="font-family:inherit;font-size:12pt;">.       Performance   Guarantor&#8217;s obligations hereunder shall continue in full force and effect until all Obligations are finally paid and satisfied in full and the Receivables Purchase Agreement is terminated, </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">provided</font><font style="font-family:inherit;font-size:12pt;">, that this Guaranty shall continue to be effective or shall be reinstated, as the case may be, if at any time payment or other satisfaction of any of the Obligations is rescinded or must otherwise be restored or returned upon the bankruptcy, insolvency, or reorganization of any Transaction Party or otherwise, as though such payment had not been made or other satisfaction occurred, whether or not Beneficiary (or its assigns) is in possession of this Guaranty. No invalidity, irregularity or unenforceability by reason of the federal bankruptcy code or any insolvency or other similar law, or any law or order of any government or agency thereof purporting to reduce, amend or otherwise affect the Obligations shall impair, affect, be a defense to or claim against the obligations of Performance Guarantor under this Guaranty.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 10.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effect  of  Bankruptcy</font><font style="font-family:inherit;font-size:12pt;">.    This  Performance  Guaranty  shall  survive  the insolvency of each Transaction Party and the commencement of any case or proceeding by or against any Transaction Party under the federal bankruptcy code or other federal, state or other applicable bankruptcy, insolvency or reorganization statutes. No automatic stay under the federal bankruptcy code with respect to any Transaction Party or other federal, state or other applicable bankruptcy, insolvency or reorganization statutes to which any Transaction Party is subject shall postpone the obligations of Performance Guarantor under this Guaranty.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 11.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Setoff</font><font style="font-family:inherit;font-size:12pt;">.  Regardless of the other means of obtaining payment of any of the Obligations, Beneficiary (and its assigns) is hereby authorized at any time and from time to time, without notice to Performance Guarantor (any such notice being expressly waived by Performance Guarantor) and to the fullest extent permitted by law, to set off and apply any deposits and other sums against the obligations of Performance Guarantor under this Guaranty, whether  or  not  Beneficiary  (or  any  such  assign)  shall  </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">have  made  any  demand  under  this Guaranty and although such Obligations may be contingent or unmatured.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 12.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Taxes</font><font style="font-family:inherit;font-size:12pt;">.   All payments to be made by Performance Guarantor hereunder shall be made free and clear of any deduction or withholding. If Performance Guarantor is required by law to make any deduction or withholding on account of tax or otherwise from any such payment, the sum due from it in respect of such payment shall be increased to the extent necessary to ensure that, after the making of such deduction or withholding, Beneficiary receive a net sum equal to the sum which they would have received had no deduction or withholding been made.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 13.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Further Assurances</font><font style="font-family:inherit;font-size:12pt;">.  Performance Guarantor agrees that it will from time to time, at the request of Beneficiary (or its assigns), provide information relating to the business and affairs of Performance Guarantor as Beneficiary may reasonably request. Performance Guarantor also agrees to do all such things and execute all such documents as Beneficiary (or its assigns) may reasonably consider necessary or desirable to give full effect to this Guaranty and to perfect and preserve the rights and powers of Beneficiary hereunder.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 14.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Successors and Assigns</font><font style="font-family:inherit;font-size:12pt;">.   This Performance Guaranty shall be binding upon Performance Guarantor, its successors and permitted assigns, and shall inure to the benefit of and be enforceable by Beneficiary and its successors and assigns (including the Agent for the benefit of the Purchasers). Performance Guarantor may not assign or transfer any of its obligations hereunder without the prior written consent of each of Beneficiary and the Agent. Without limiting the generality of the foregoing sentence, Beneficiary may assign or otherwise transfer the Agreements, any other documents executed in connection therewith or delivered thereunder or any other agreement or note held by them evidencing, securing or otherwise executed in connection with the Obligations, or sell participations in any interest therein, to any other entity or other person, and such other entity or other person shall thereupon become vested, to the extent set forth in the agreement evidencing such assignment, transfer or participation, with all the rights in respect thereof granted to the Beneficiaries herein. Performance Guarantor acknowledges that the Beneficiary has collaterally assigned all its right, title and interest under this Performance Guaranty to the Agent for the benefit of the Purchasers.  The Agent is an intended third-party beneficiary of this Performance Guaranty, and this Performance Guaranty shall be directly enforceable by the Agent.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 15.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendments and Waivers</font><font style="font-family:inherit;font-size:12pt;">.  No amendment or waiver of any provision of this  Guaranty  nor  consent  to  any  departure  by  Performance  Guarantor  therefrom  shall  be effective unless the same shall be in writing and signed by Beneficiary, the Agent and Performance Guarantor. No failure on the part of Beneficiary to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 16.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Notices</font><font style="font-family:inherit;font-size:12pt;">.   All notices and other communications provided for hereunder shall be made in writing and shall be addressed as follows: if to Performance Guarantor, at the address set forth beneath its signature hereto, and if to Beneficiary, at the address set forth beneath its signature hereto, or at such other addresses as each of Performance Guarantor or any Beneficiary may designate in writing to the other. Each such notice or other communication shall be effective (1) if given by telecopy, upon the receipt thereof, (2) if given by mail, three (3) Business Days after the time such communication is deposited in the mail with first class postage prepaid or (3) if given by any other means, when received at the address specified in this </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section 16</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 17.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">GOVERNING LAW</font><font style="font-family:inherit;font-size:12pt;">.  THIS GUARANTY SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF ILLINOIS.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 18.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">CONSENT   TO   JURISDICTION</font><font style="font-family:inherit;font-size:12pt;">.       EACH   OF   PERFORMANCE GUARANTOR AND BENEFICIARY HEREBY IRREVOCABLY SUBMITS TO THE NON- EXCLUSIVE JURISDICTION OF ANY UNITED STATES FEDERAL OR ILLINOIS STATE COURT SITTING IN CHICAGO IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS GUARANTY, THE AGREEMENTS OR ANY OTHER DOCUMENT EXECUTED IN CONNECTION THEREWITH OR DELIVERED THEREUNDER  AND  EACH  OF  PERFORMANCE  GUARANTOR  AND  BENEFICIARY HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT AND IRREVOCABLY WAIVES ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE AS TO THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN SUCH A COURT OR THAT SUCH COURT IS AN INCONVENIENT FORUM.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 19.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Bankruptcy Petition</font><font style="font-family:inherit;font-size:12pt;">.  Performance Guarantor hereby covenants and agrees that, prior to the date that is one year and one day after the payment in full of all outstanding senior indebtedness of any Conduit or any Funding Source that is a special purpose bankruptcy remote entity, it will not institute against, or join any other Person in instituting against, any Conduit  or  any  such  entity  any  bankruptcy,  reorganization,  arrangement,  insolvency  or liquidation proceedings or other similar proceeding under the laws of the United States or any state of the United States.</font></div><div style="line-height:120%;padding-top:1px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 20.      </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Miscellaneous</font><font style="font-family:inherit;font-size:12pt;">.     This  Guaranty  constitutes  the  entire  agreement  of Performance Guarantor with respect to the matters set forth herein. The rights and remedies herein provided are cumulative and not exclusive of any remedies provided by law or any other agreement, and this Guaranty shall be in addition to any other guaranty of or collateral security for any of the Obligations. The provisions of this Guaranty are severable, and in any action or proceeding involving any state corporate law, or any state or federal bankruptcy, insolvency, reorganization or other law affecting the rights of creditors generally, if the obligations of Performance  Guarantor  hereunder  would  otherwise  be  held  or  determined  to  be  avoidable, invalid or unenforceable on account of the amount of Performance Guarantor&#8217;s liability under this Guaranty, then, notwithstanding any other provision of this Guaranty to the contrary, the amount of such liability shall, without any further action by Performance Guarantor or Beneficiary, be automatically limited and reduced to the highest amount that is valid and enforceable as determined in such action or proceeding. Any provisions of this Guaranty which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. Unless otherwise specified, references herein to &#8220;Section&#8221; shall mean a reference to sections of this Guaranty.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The effect of this Guaranty is to amend and restate that certain Sixth Amended and Restated Performance Guaranty, dated as of November 3, 2014 (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Prior Guaranty</font><font style="font-family:inherit;font-size:12pt;">&#8221;), by the Guarantor in favor of Beneficiary, and to the extent that any rights, benefits or provisions in favor of Beneficiary existed in the Prior Guaranty and continue to exist in this Guaranty, as the same may be amended, restated, supplemented or otherwise modified from time to time, without any written waiver of any such rights, benefits or provisions prior to the date hereof, then such rights, benefits or provisions are acknowledged to be and to continue to be effective from and after the date of the Prior Guaranty or any applicable portion thereof. The parties hereto agree and acknowledge that any and all rights, remedies and payment provisions under the Prior Guaranty shall continue and survive the execution and delivery of this Guaranty.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">SEVENTH AMENDED AND RESTATED</font></div><div style="line-height:120%;text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-style:italic;">PERFORMANCE GUARANTY</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:6px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">All references to the Prior Guaranty in the Receivables Purchase Agreement and any other Transaction Document or any other agreement, instrument or document executed or delivered in connection herewith or therewith shall be deemed to refer to this Guaranty, as the same may be amended, restated, supplemented or otherwise modified from time to time. The Receivables Purchase Agreement and the other Transaction Documents and all other agreements, instruments and documents executed or delivered in connection with any of the foregoing shall be deemed to be amended to the extent necessary, if any, to give effect to the provisions of this Guaranty, as the same may be amended, restated, supplemented or otherwise modified from time to time.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:269px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">* * * *</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="sa8b0b3e272214ae4b45e8467e4b4daa0"></a></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">9</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, Performance Guarantor has caused this Guaranty to be executed and delivered as of the date first written above. </font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Sam A. Samad</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sam A. Samad</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate Treasurer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Address:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7000 Cardinal Place</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dublin, OH 43017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Attn: Senior Counsel - Corporate &amp; Securities</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:48.828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Consented to as of the date first written above:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH FUNDING, LLC</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Scott B. Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Scott Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Address:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7000 Cardinal Place</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dublin, OH 43017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.3359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:7%;"></td><td style="width:28%;"></td><td style="width:62%;"></td><td style="width:3%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD. NEW YORK BRANCH, as Agent</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Luna Mills</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Luna Mills</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5.2
<SEQUENCE>7
<FILENAME>a18q1_10qx93017xexhibit1052.htm
<DESCRIPTION>EXHIBIT 10.5.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sa375f62a654848479e83b213f01ec262"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Exhibit 10.5.2</font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">AMENDMENT NO. 1 TO SEVENTH AMENDED AND RESTATED PERFORMANCE GUARANTY</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Amendment (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment</font><font style="font-family:inherit;font-size:12pt;">&#8221;) is entered into as of May 1, 2017, by Cardinal Health, Inc., an Ohio corporation (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance Guarantor</font><font style="font-family:inherit;font-size:12pt;">&#8221;), Cardinal Health Funding, LLC, a Nevada limited liability company (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Beneficiary</font><font style="font-family:inherit;font-size:12pt;">&#8221;) and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Agent</font><font style="font-family:inherit;font-size:12pt;">&#8221;). </font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">PRELIMINARY STATEMENTS</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, as of November 14, 2016, Performance Guarantor executed that certain Seventh Amended and Restated Performance Guaranty (&#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Performance Guaranty</font><font style="font-family:inherit;font-size:12pt;">&#8221;) in favor of Beneficiary;</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, Performance Guarantor now desires to amend Section 7 of the Performance Guaranty in the manner set forth below and has received the consents required by Section 7 and by Section 15 of the Performance Guaranty; </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">WHEREAS, Section 15 of the Performance Guaranty requires any and all amendments thereto to be made in writing and signed by Beneficiary, Agent and Performance Guarantor; </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NOW, THEREFORE, in consideration of the mutual execution hereof and other good and valuable consideration, the parties hereto hereby agree as follows:</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 1.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Amendment of Performance Guaranty</font><font style="font-family:inherit;font-size:12pt;">. The first paragraph of Section 7 of the Performance Guaranty is hereby amended by replacing it in its entirety with the following: </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;Section 7. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Financial Covenant</font><font style="font-family:inherit;font-size:12pt;">. The Performance Guarantor shall at all times comply with Section 6.12 of the Credit Agreement (defined below), as amended by Amendment No. 1 to Amended and Restated Five-Year Credit Agreement, entered into by and among Performance Guarantor, JPMorgan Chase Bank, N.A., individually and as administrative agent and the other financial institutions signatory thereto, and without giving effect to any subsequent amendment, modification or waiver thereof (or any amendment or modification of any defined term in the Credit Agreement that would directly or indirectly change the covenants set forth in such Section 6.12), unless such amendment, modification or waiver is consented to in writing by the Agent, the Required Financial Institutions and all LC Banks (in each case, in their capacities as such under the Receivables Purchase Agreement).&#8221;</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 2.&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Representations and Warranties</font><font style="font-family:inherit;font-size:12pt;">. </font><font style="font-family:inherit;font-size:12pt;">On the date hereof, Performance Guarantor hereby represents and warrants to Beneficiary and Agent as follows:</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(a)&#160;&#160;&#160;&#160;after giving effect to this Amendment, no event or condition has occurred and is continuing which constitutes an Amortization Event or Potential Amortization Event; </font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(b)&#160;&#160;&#160;&#160;after giving effect to this Amendment, the representations and warranties of Performance Guarantor set forth in the Performance Guaranty are true and correct as of the date hereof, as though made on and as of such date (except to the extent such representations and warranties relate solely to an earlier date and then as of such earlier date); and</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(c)&#160;&#160;&#160;&#160;this Amendment constitutes the valid and binding obligation of Performance Guarantor, enforceable against Performance Guarantor in accordance with its terms.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Section 3.</font><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Miscellaneous</font><font style="font-family:inherit;font-size:12pt;">. </font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(a)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Effect of Amendment; Ratification</font><font style="font-family:inherit;font-size:12pt;">. </font><font style="font-family:inherit;font-size:12pt;">Except as specifically amended herein, the Performance Guaranty (as amended hereby) is hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect. After this Amendment becomes effective, all references in the Performance Guaranty (or in any other Transaction Document) to the "Performance Guaranty", "this Agreement", "hereof", "herein", or words of similar effect, in each case referring to the Performance Guaranty, shall be deemed to be references to the Performance Guaranty as amended hereby. This Amendment shall not be deemed to expressly or impliedly waive, amend, or supplement any provision of the Performance Guaranty other than as specifically set forth herein. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(b)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Costs, Fees and Expenses</font><font style="font-family:inherit;font-size:12pt;">. Performance Guarantor agrees to reimburse each of the parties hereto on demand for all reasonable costs, fees and expenses incurred by such parties (including, without limitation, their reasonable fees and expenses of counsel) incurred in connection with the preparation, execution and delivery of this Amendment. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(c)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts; Delivery</font><font style="font-family:inherit;font-size:12pt;">.  This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or other electronic means shall be effective as delivery of a manually executed counterpart of this Amendment. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(d)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Severability</font><font style="font-family:inherit;font-size:12pt;">.  Any provision contained in this Amendment which is held to be inoperative, unenforceable or invalid in any jurisdiction shall, as to that jurisdiction, be inoperative, unenforceable or invalid without affecting the remaining provisions of this Amendment in that jurisdiction or the operation, enforceability or validity of such provision in any other jurisdiction. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(e)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Section Headings</font><font style="font-family:inherit;font-size:12pt;">. The various headings of this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Performance Guaranty or any provision hereof or thereof.</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(f)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">GOVERNING LAW</font><font style="font-family:inherit;font-size:12pt;">.  THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF ILLINOIS. </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-align:justify;text-indent:48px;"><font style="text-align:justify;font-family:inherit;font-size:12pt;padding-right:48px;">(g)</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">WAIVER OF TRIAL BY JURY</font><font style="font-family:inherit;font-size:12pt;">.  EACH PARTY HERETO HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AMENDMENT, ANY DOCUMENT EXECUTED BY PERFORMANCE GUARANTOR PURSUANT TO THIS AMENDMENT OR THE RELATIONSHIP ESTABLISHED HEREUNDER OR THEREUNDER.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">signature pages follow</font><font style="font-family:inherit;font-size:12pt;">]</font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;&#160;&#160;&#160;</font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the parties have executed this Amendment as of the date and year first written above. </font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.78048780487805%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.78048780487805%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CARDINAL HEALTH FUNDING, LLC</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Scott Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Scott Zimmerman</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:384px;text-indent:0px;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:48.78048780487805%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:40%;"></td><td style="width:40%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Luna Mills</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Luna Mills</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director </font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:384px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>8
<FILENAME>a18q1_10qx093017xexhibit121.htm
<DESCRIPTION>EXHIBIT 12.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s19453C9331A8576192C8AF1EB14EEC8A"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 12.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Computation of Ratio of Earnings to Fixed Charges </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:35%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:middle;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;vertical-align:middle;">(in millions, except ratios)</font><font style="font-family:Arial Narrow;font-size:8pt;vertical-align:middle;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30, 2017</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:6px;text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Earnings before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,798</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,967</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,276</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,924</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">178</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Plus fixed charges:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">129</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">137</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">178</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">187</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">74</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Capitalized interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization of debt offering costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Interest portion of rent expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Fixed charges (1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">144</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">156</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">201</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Plus: amortization of capitalized interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Less: capitalized interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings (1)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,944</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,124</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,473</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,135</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">259</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Ratio of earnings to fixed charges (1) (2)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.&#160;&#160;&#160;&#160; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The ratio of earnings to fixed charges is computed by dividing fixed charges into earnings from continuing operations before income taxes plus fixed charges and capitalized interest. Fixed charges include interest expense, amortization of debt offering costs and the portion of rent expense that is deemed to be representative of the interest factor. Interest expense recorded on tax exposures has been recorded in income tax expense and has therefore been excluded from the calculation. </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>a18q1_10qx093017xexhibit311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sFB49E597AD595191BB452D35F653C949"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, George S. Barrett, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-Q of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:720px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:193px;"></td><td style="width:526px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ G</font><font style="font-family:Arial Narrow;font-size:8pt;">EORGE</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;S. B</font><font style="font-family:Arial Narrow;font-size:8pt;">ARRETT</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">George S. Barrett</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chairman and Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>a18q1_10qx093017xexhibit312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s25BF1DE8C7C554FE85774D3255635159"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, Michael C. Kaufmann, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-Q of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:716px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:193px;"></td><td style="width:522px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ M</font><font style="font-family:Arial Narrow;font-size:8pt;">ICHAEL</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;C. K</font><font style="font-family:Arial Narrow;font-size:8pt;">AUFMANN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>a18q1_10qx093017xexhibit321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s986BC588F1C2585FB75A0E8F72028212"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Each of George S. Barrett, Chairman and Chief Executive Officer of Cardinal Health, Inc. (the &#8220;Company&#8221;), and Michael C. Kaufmann, Chief Financial Officer of the Company, certifies, pursuant to 18 U.S.C. Section&#160;1350, that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the Quarterly Report on Form 10-Q for the quarter ended </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;containing the financial statements of the Company (the &#8220;Periodic Report&#8221;), which this statement accompanies, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Dated: </font><font style="font-family:Arial Narrow;font-size:10pt;">November&#160;7, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ G</font><font style="font-family:Arial Narrow;font-size:8pt;">EORGE</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;S. B</font><font style="font-family:Arial Narrow;font-size:8pt;">ARRETT</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">George S. Barrett</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chairman and Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ M</font><font style="font-family:Arial Narrow;font-size:8pt;">ICHAEL</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;C. K</font><font style="font-family:Arial Narrow;font-size:8pt;">AUFMANN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>a18q1_10qx093017xexhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s8B9031EF6DDC54A18BF921F3716DA3A7"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Statement Regarding Forward-Looking Information </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As used in this exhibit, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2017 (the &#8220;2017 Form 10-K&#8221;), our quarterly reports on Form 10-Q and our current reports on Form 8-K (along with any exhibits and amendments to such reports), as well as our news releases or any other written or oral statements made by or on behalf of us, may include, directly or by incorporation by reference, forward-looking statements that reflect our current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance. The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements. These risks and uncertainties include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">competitive pressures in the markets in which we operate, including pricing pressures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the pricing of generic pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">with respect to our distribution services agreements with branded pharmaceutical manufacturers, changes in the amount of service fees we receive or, in cases where part of our compensation under these agreements is based on branded pharmaceutical price appreciation, changes in the frequency or magnitude of such price appreciation; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in the timing or frequency of the introduction of branded pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance authorities, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory consents or approvals associated with those activities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of healthcare fraud and abuse laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">costs or claims resulting from potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from remediation efforts or recalls and related product liability claims and lawsuits, including class action lawsuits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act, Chinese anti-corruption laws and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses being Medicare-certified suppliers or participating in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals  that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs and other applicable standards and regulations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">material reductions in purchases, non-renewal or early termination of contracts, or delinquencies or defaults by key customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unfavorable changes to the terms of key customer or supplier relationships, or changes in customer mix;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">adverse changes in U.S. or foreign tax laws, including proposals relating to new taxes or import tariffs, unfavorable challenges to our tax positions and payments to settle these challenges, or failure to permanently repeal the U.S. medical device tax;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties due to government healthcare reform, including possible repeal or replacement of major parts of the Patient Protection and Affordable Care Act;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reductions or limitations on governmental funding at the state or federal level or efforts by healthcare insurance companies to limit payments for products and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in legislation or regulations governing prescription drug pricing, healthcare services or mandated benefits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in hospital buying groups or hospital buying practices;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the risks of counterfeit products in the supply chain;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increasing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">disruption, damage or lack of access to, or failure of, our or our third-party service providers' information systems, our critical facilities, including our national logistics center, or our distribution networks;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">manufacturing disruptions, whether due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product is manufactured at a single manufacturing facility with limited alternate facilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks to our business and information and controls systems in the event that the Pharmaceutical segment's multi-year systems replacement project or other business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any compromise of our information systems or of those of a third-party service provider, including unauthorized access to or use or disclosure of sensitive information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, product liability claims or lawsuits, patent infringement claims, </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;actions or other legal proceedings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">possible losses relating to product liability lawsuits and claims regarding products for which we cannot obtain product liability insurance or for which such insurance may not be adequate to cover our losses, including the product liability lawsuits we are currently defending relating to alleged personal injuries associated with the use of Cordis inferior vena cava filter products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">possible losses and other effects that may arise from the defense and resolution of the lawsuits and investigations in which we have been named relating to the distribution of prescription opioid pain medication;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain adequate intellectual property protections;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks and uncertainties relating to the acquisition of the Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses from Medtronic plc (the "Patient Recovery Business"), including the following: we may fail to realize the synergies and other benefits we expect from the acquisition; we may fail to retain key personnel of the acquired businesses; future developments may impair the value of our purchased goodwill or intangible assets; we may face difficulties or delays establishing, integrating or combining operations and systems; we may face challenges retaining the customers of the acquired businesses; we may encounter unforeseen internal control, regulatory or compliance issues; and we may face other additional risks relating to regulatory matters, legal proceedings, tax laws or positions, supply interruptions, commodity price volatility and global operations, including the effects of local economic environments and currency volatility; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks relating to the use of a significant amount of cash, including borrowings under our existing credit arrangements, to fund the acquisition of the Patient Recovery Business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks and uncertainties relating to the acquisition of Cordis, including the ability to achieve the expected synergies and positive impact to operating results and the additional risks the Cordis acquisition subjects us to relating to regulatory matters, legal proceedings, tax laws or positions and global operations, including the effects of local economic environments and currency volatility;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increased costs for commodities used in the Medical segment including various components, compounds, raw materials or energy such as oil-based resins, pulp, cotton, latex and other commodities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with our use of and reliance on the global capital and credit markets, including our ability to access credit and our cost of credit, which may adversely affect our ability to efficiently fund our operations or undertake certain expenditures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to introduce and market new products and our ability to keep pace with advances in technology;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, effects, timing or success of restructuring programs or plans;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">significant charges to earnings if goodwill or intangible assets become impaired; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to general political, business, industry, regulatory and market conditions; and</font></div></td></tr></table><div><br></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">other factors described in the &#8220;Risk Factors&#8221; section of the 2017 Form 10-K.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals. We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div><br></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>13
<FILENAME>cah-20170930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:ef10ab634f98494e849eec8fc4d96bf6,x:8348e4b147334ef8a8cc038f0ffed6a2-->
<xbrli:xbrl xmlns:cah="http://www.cardinal.com/20170930" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="cah-20170930.xsd" xlink:type="simple" />
	<xbrli:context id="FD2018Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q2Oct31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4Jun1-Jun30_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2017-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Jul29_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-07-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1CompleteFortis_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-29</xbrli:startDate>
			<xbrli:endDate>2017-07-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1CompleteFortis_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-29</xbrli:startDate>
			<xbrli:endDate>2017-07-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_cah_ContractTerminationAxis_cah_DistributorContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:ContractTerminationAxis">cah:DistributorContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateBondSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_MunicipalBondsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateBondSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_AssetBackedSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_USTreasurySecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_USTreasurySecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_AssetBackedSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_MunicipalBondsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesduefiscal2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesduefiscal2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_cah_A1.7Notesduefiscal2018Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.7Notesduefiscal2018Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesduefiscal2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesduefiscal2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesduefiscal2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesduefiscal2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A1.948Notesdue2019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.948Notesdue2019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A1.7Notesduefiscal2018Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A1.7Notesduefiscal2018Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesduefiscal2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesduefiscal2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-04-01</xbrli:startDate>
			<xbrli:endDate>2017-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Oct31_us-gaap_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-31</xbrli:startDate>
			<xbrli:endDate>2017-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_MajorCustomersAxis_cah_CVSHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Oct31_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-31</xbrli:startDate>
			<xbrli:endDate>2017-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Oct31_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-31</xbrli:startDate>
			<xbrli:endDate>2017-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Oct31_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-31</xbrli:startDate>
			<xbrli:endDate>2017-10-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q1RedOakSourcing_us-gaap_MajorCustomersAxis_cah_CVSHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-07-01</xbrli:startDate>
			<xbrli:endDate>2014-07-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cah:ContingentConsiderationClassifiedasaLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cah:ContingentConsiderationClassifiedasaLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cah:ContingentConsiderationClassifiedasaLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q2Oct31_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:NaviHealthMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q1naviacq_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-08-26</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-07-01</xbrli:startDate>
			<xbrli:endDate>2016-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="organization">
		<xbrli:measure>cah:organization</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="category">
		<xbrli:measure>cah:category</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="country">
		<xbrli:measure>cah:country</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="segment">
		<xbrli:measure>cah:segment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="plaintiff">
		<xbrli:measure>cah:plaintiff</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="lawsuit">
		<xbrli:measure>cah:lawsuit</xbrli:measure>
	</xbrli:unit>
	<cah:Amortizationandotheracquisitionrelatedcosts contextRef="FD2017Q1QTD" decimals="-6" id="Fact-83FF153A7559637EDD73BEBD23A490DF" unitRef="usd">122000000</cah:Amortizationandotheracquisitionrelatedcosts>
	<cah:Amortizationandotheracquisitionrelatedcosts contextRef="FD2018Q1QTD" decimals="-6" id="Fact-35192BD1E11B460FF083BEBCCD83E4EB" unitRef="usd">183000000</cah:Amortizationandotheracquisitionrelatedcosts>
	<cah:BusinessCombinationTransactionandintegrationcosts contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-39E2177A895436FF2D06C88B1D222D4F" unitRef="usd">37000000</cah:BusinessCombinationTransactionandintegrationcosts>
	<cah:ExercisablePeriodOfPlansInYears contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-B4B13E4BCE54577DABC1CD2EA7ACD96B">P10Y</cah:ExercisablePeriodOfPlansInYears>
	<cah:FacilityExitAndOtherCosts contextRef="FD2017Q1QTD" decimals="-6" id="Fact-A3F25C4B04C29FE1139812491B71CD91" unitRef="usd">2000000</cah:FacilityExitAndOtherCosts>
	<cah:FacilityExitAndOtherCosts contextRef="FD2018Q1QTD" decimals="-6" id="Fact-D9E1C69036982BFD0E0D12491B7451E4" unitRef="usd">128000000</cah:FacilityExitAndOtherCosts>
	<cah:FacilityExitAndOtherCosts contextRef="FD2018Q1QTD_cah_ContractTerminationAxis_cah_DistributorContractMember" decimals="-6" id="Fact-E6606774FF98718A059E1249E2230186" unitRef="usd">125000000</cah:FacilityExitAndOtherCosts>
	<cah:IndemnificationReceivable contextRef="FI2017Q4" decimals="-6" id="Fact-4711CC351FCF55BEA81B14DE113777AF" unitRef="usd">142000000</cah:IndemnificationReceivable>
	<cah:IndemnificationReceivable contextRef="FI2018Q1" decimals="-6" id="Fact-55D78717A0B850EB895FEEF52EED5669" unitRef="usd">144000000</cah:IndemnificationReceivable>
	<cah:InitialtermofPharmaceuticalSourcingVenture contextRef="D2015Q1RedOakSourcing_us-gaap_MajorCustomersAxis_cah_CVSHealthMember" id="Fact-1BD8018BB7385CC35F9DBA3ED7E02264">P10Y</cah:InitialtermofPharmaceuticalSourcingVenture>
	<cah:LossContingencyAccrualNetofInsuranceRecoveries contextRef="FI2018Q1" decimals="-6" id="Fact-B347A8AB17F9B5FEE2D96EE2FCBCA8CD" unitRef="usd">129000000</cah:LossContingencyAccrualNetofInsuranceRecoveries>
	<cah:MaximumQuarterlyPayment contextRef="FD2018Q1QTD_us-gaap_MajorCustomersAxis_cah_CVSHealthMember" decimals="-5" id="Fact-780B649C12C4CED62AF7BA3ED7E1A959" unitRef="usd">45600000</cah:MaximumQuarterlyPayment>
	<cah:Netproceedstaxwithholdingsfromsharebasedcompensation contextRef="FD2017Q1QTD" decimals="-6" id="Fact-B6E74B8C5C5B93D920D6BEC352E6020B" unitRef="usd">-9000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
	<cah:Netproceedstaxwithholdingsfromsharebasedcompensation contextRef="FD2018Q1QTD" decimals="-6" id="Fact-4648C095357C92260DAFBEC1D6DF5AA7" unitRef="usd">-18000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
	<cah:Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="2" id="Fact-87C38A46EE6A1A0167196F10A7C044CF" unitRef="number">0.16</cah:Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent>
	<cah:NumberofProductCategoriesManufactured contextRef="I2018Q1Jul29_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="INF" id="Fact-131618A7ACA862BFF1A559D18968D99C" unitRef="category">23</cah:NumberofProductCategoriesManufactured>
	<cah:PaymentofContingentConsideration contextRef="FD2017Q1QTD" decimals="-6" id="Fact-B9A98D9B685DD31749B7BEC352D0ECB4" unitRef="usd">0</cah:PaymentofContingentConsideration>
	<cah:PaymentofContingentConsideration contextRef="FD2018Q1QTD" decimals="-6" id="Fact-EC80B554B7C67B9FBFBDBEC1D6CFF399" unitRef="usd">15000000</cah:PaymentofContingentConsideration>
	<cah:PrincipalCountries contextRef="I2018Q1Jul29_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="INF" id="Fact-B8614BCF23915BFFE1F859D2CBB5583A" unitRef="country">28</cah:PrincipalCountries>
	<cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments contextRef="FD2017Q1QTD" decimals="-6" id="Fact-D6F6C0FAD589C7E753DABEC352D4CE28" unitRef="usd">34000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
	<cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments contextRef="FD2018Q1QTD" decimals="-6" id="Fact-D9CF6A13D7F759FBF066BEC1D6E13CE8" unitRef="usd">64000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
	<cah:ProjectCostsOnInvestmentAndOtherSpending contextRef="FD2017Q1QTD" decimals="-6" id="Fact-5C297246D2475432AB7EA9B05B28013C" unitRef="usd">1000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
	<cah:ProjectCostsOnInvestmentAndOtherSpending contextRef="FD2018Q1QTD" decimals="-6" id="Fact-F1D268A6AD135E12BB60A7E54C3D8A22" unitRef="usd">5000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
	<cah:Purchaseofavailableforsalesecuritiesandotherinvestments contextRef="FD2017Q1QTD" decimals="-6" id="Fact-FDBA5318B72AC7C995B9BEC352DDEFD5" unitRef="usd">52000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
	<cah:Purchaseofavailableforsalesecuritiesandotherinvestments contextRef="FD2018Q1QTD" decimals="-6" id="Fact-02A8B36C06EBA28F651CBEC1D6E09BEE" unitRef="usd">3000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
	<dei:AmendmentFlag contextRef="FD2018Q1QTD" id="Fact-D3E5153318F4D1D2408CBA3ED7E19FC9">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2018Q1QTD" id="Fact-66DCAE5FC927047E1296BA3ED7DB7CFA">--06-30</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2018Q1QTD" id="Fact-6B95CCF3F98FD0073C71BA3ED7E1F730">Q1</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2018Q1QTD" id="Fact-4CACE5BBEE8060183C94BA3ED7DB0BDD">2018</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2018Q1QTD" id="Fact-E1B1450CD0F13A97F17ABA3ED7E1E9DF">2017-09-30</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2018Q1QTD" id="Fact-B9FBCFC4C00F6541F2DABA3ED7E1F8D9">10-Q</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2018Q1QTD" id="Fact-DE104375573E259D77CCBA3ED7E0AFCE">0000721371</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2018Q2Oct31" decimals="INF" id="Fact-5A8C5A3F33670F2B569CBA3ED7E11D15" unitRef="shares">320063302</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityCurrentReportingStatus contextRef="FD2018Q1QTD" id="Fact-36750A56FD9BCCF5D9A2BA3ED7E196BB">Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityFilerCategory contextRef="FD2018Q1QTD" id="Fact-25E7309986563A43D043BA3ED7E1407F">Large Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityRegistrantName contextRef="FD2018Q1QTD" id="Fact-23EBC9F2312CBF3BA90CBA3ED7E0B49F">CARDINAL HEALTH INC</dei:EntityRegistrantName>
	<dei:TradingSymbol contextRef="FD2018Q1QTD" id="Fact-8540C1A5A75B1A812717BA3ED7E0339C">cah</dei:TradingSymbol>
	<us-gaap:AccountsPayableCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-29DE285519E757CEA26264D4988BD63A" unitRef="usd">17906000000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-56E3FED74CD25F71826698B146802B8C" unitRef="usd">19202000000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q4" decimals="-6" id="Fact-73F537700EEC502BBAE33681C4E541E1" unitRef="usd">-125000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2018Q1" decimals="-6" id="Fact-32888071FBEC5BB8ADBC5E70CA10658A" unitRef="usd">-86000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_RangeAxis_us-gaap_MaximumMember" id="Fact-7C92AB2C555E5FC994458ABF7B576896">P18Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-EC1B398B4E785426ACB17DF922706E45">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" id="Fact-5968C457628B5C7ABF4377817349150F">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" id="Fact-5AEB52917BFC5AFBE39D53B5DD354C14">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q1QTD" decimals="-6" id="Fact-9089213C70D2EEC922B8F31E79E00BB2" unitRef="usd">23000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-6" id="Fact-B075F2D8DCE9026B3C51F31E79D89240" unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-4B14CF150DCD8BD115AAF31E79D1F25A" unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-D70B12B3E618DD543839F31E79D90304" unitRef="usd">5000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1QTD" decimals="-6" id="Fact-88BC1FBF0A9FF2486008F31E4201E192" unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-19CE29FE572B8F800BAFF31E41FF43FC" unitRef="usd">5000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-6" id="Fact-0D9C8FCDC14BC8BB3EC5F31E41FC0E99" unitRef="usd">-6000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-6A0F7925285816B2458AF31E1C838ED3" unitRef="usd">18000000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2017Q1QTD" decimals="-6" id="Fact-E97F1890015B6F6B9C66BA5246C33653" unitRef="usd">101000000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2018Q1QTD" decimals="-6" id="Fact-530B92C1D56FB8DE50BCBA51F1692EFB" unitRef="usd">135000000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2017Q1QTD" decimals="-6" id="Fact-A66181AFEC6702D7190CBA75A5504FC3" unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1QTD" decimals="-6" id="Fact-5C37517E8F0D442A2A12BA726650A5CE" unitRef="shares">5000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:Assets contextRef="FI2017Q4" decimals="-6" id="Fact-67AED41A78EE525F886CC5BCCFB377BE" unitRef="usd">40112000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" decimals="-6" id="Fact-2A753488D754F73C46145A04EA2B5A87" unitRef="usd">7576000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-DC56BE077A7D6C60B2815A04EA2FFCFB" unitRef="usd">10688000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-FB01B0843BA8CF42E1325A04EA276292" unitRef="usd">21848000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1" decimals="-6" id="Fact-29F05AB1834C5018804F8F37133E793A" unitRef="usd">41940000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" decimals="-6" id="Fact-C9914CEACF1F57BDA525D750E595A772" unitRef="usd">1665000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-E8A7588DD8215FA18B17E0B5D1FDA256" unitRef="usd">18055000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-21B1CE91CA6F544BA75D6F150F4933F4" unitRef="usd">22220000000</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-FBB216CAEED05A7C97FC4C6C7546B03A" unitRef="usd">28345000000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-EE63458EA83656238C578D445C9CC9F1" unitRef="usd">23725000000</us-gaap:AssetsCurrent>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4" decimals="-6" id="Fact-39782E755F2D5A9F430D6F3E395ABDD5" unitRef="usd">65000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-E971EC99C4E656BA80187B2DED4EFE30" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-4737B3D910045983ACE13D841146FA57" unitRef="usd">65000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-162B2CCE6A375E4881167139B3EEC3D7" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-87048CC5D7455E6E9B3B0152E1773300" unitRef="usd">65000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_AssetBackedSecuritiesMember" decimals="-6" id="Fact-AB141B099A7A068B5D156F3E3955FAC7" unitRef="usd">3000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateBondSecuritiesMember" decimals="-6" id="Fact-10E8EB2A28AD48E9703A6F3E3961B606" unitRef="usd">30000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-6" id="Fact-B69E8AC80398EFC3CD776F3E3953F4F5" unitRef="usd">1000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember" decimals="-6" id="Fact-87558A857C6775D642646F3E394F8452" unitRef="usd">3000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_MunicipalBondsMember" decimals="-6" id="Fact-5AE69A4FA94A5A1FC2716F3E3940217E" unitRef="usd">3000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2017Q4_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_USTreasurySecuritiesMember" decimals="-6" id="Fact-5190832C4EF08D4F4C506F3E395DC266" unitRef="usd">25000000</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-43AA60A6ADF853C5B9ACA783E2CC317D" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-22599B0530ECDE519E176F3E395B250F" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-1295DEABC03B5C76A1A913898592CE2D" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-EEC73AD6CB635785BA984CF6C80E34FA" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_AssetBackedSecuritiesMember" decimals="-6" id="Fact-8236A15AF66B3FC704DA6F3E3957AE11" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateBondSecuritiesMember" decimals="-6" id="Fact-D99C2DA7EEC861C311616F3E394D9DCE" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_EquitySecuritiesMember" decimals="-6" id="Fact-8C4FCC8C555CA854D45B6F3E3958EC6C" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_ForeignGovernmentDebtSecuritiesMember" decimals="-6" id="Fact-8FB15256F0ADF0B917206F3E39633C29" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_MunicipalBondsMember" decimals="-6" id="Fact-952468D7C739C62E2F8E6F3E395178F2" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:AvailableForSaleSecurities contextRef="FI2018Q1_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_USTreasurySecuritiesMember" decimals="-6" id="Fact-F026A8E5BE054F3254BB6F3E3965A590" unitRef="usd">0</us-gaap:AvailableForSaleSecurities>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-40950414E6DB59AFE7B36ED9AEAC5AC5" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-72B10154FA49DB934A476ED9AEDF6EFC" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-32C6A6772A8A2FB9FE8F6ED9AED0650A" unitRef="usd">32000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-B0A6E1BEBEC0CCF2BEEF6ED9AEDFAC58" unitRef="usd">32000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-EB43F739BF91C7B60E4E6ED9A5077BD9" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-192771BCE532587BB3216ED9A55585C7" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-F4BABB46CE794C1077D66ED9A4A462B4" unitRef="usd">23000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-CBF6A8ADC9AED1F0BAF96ED9A5A3D5EF" unitRef="usd">23000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-577A1C553F4747EE4A77BE59CF1D7E02" unitRef="usd">24000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-14F2392FF030D1F8365959D74EFC5DF8" unitRef="usd">106000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-FB4B366F639D389E8396BE5A6E181724" unitRef="usd">153000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-030B731F88A39F2DEBA5BE5A6FDBB86E" unitRef="usd">873000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-47D75BA40F9F3EB9E670BE595DF364FA" unitRef="usd">2630000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-F2B9E9A103DD2AA861CBBE58B9657158" unitRef="usd">1712000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-F057F6EB47D315AF154FBE58BC99EABF" unitRef="usd">732000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-6" id="Fact-3FC556DA421CD298C4CABE58BAFB2D50" unitRef="usd">186000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-030CC7B2F7AE3185B6FBBE59FD0DDE33" unitRef="usd">434000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-DBD781841B6F632EAFBFBE576BCDE1C0" unitRef="usd">2975000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-64F1DE4612D891FB4688BE5A311C3183" unitRef="usd">807000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-FA11D4EDB4A09424B3EDBE5E35602528" unitRef="usd">6078000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2016Q4" decimals="-6" id="Fact-1E8BA7B337E17682C567BEC3EE0780BF" unitRef="usd">2356000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q1" decimals="-6" id="Fact-4850CBCA40C3006A6E17BEC403CE8D8D" unitRef="usd">2001000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q4" decimals="-6" id="Fact-AF93F69F57FF5AB3A89CF7F947370CF6" unitRef="usd">6879000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q1" decimals="-6" id="Fact-A2FCF4AAD90E56B3847C86DFC7DA1291" unitRef="usd">1181000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-594D7990C2AC5A9CA16BB0C4746B17FC" unitRef="usd">739000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-50DF249BD95A565487719734E44EEB41" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-037F1D6EE65E5B36B29902A7692739D1" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-93ECAB5C53F05A5FAE4CE50E592DAA7C" unitRef="usd">739000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-77AA7FB18E0E5CB9A41696978DCCAEC3" unitRef="usd">1162000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-1D681CEE603E56FC982D702366EE5BE1" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-DD0A9E8CE9895516B7889DFC39668AA0" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-BE2DF8D28AD254768F605ACA72EB8712" unitRef="usd">1162000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2017Q1QTD" decimals="-6" id="Fact-B9821FF4F8865355886CBEC3C5689EFB" unitRef="usd">-355000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2018Q1QTD" decimals="-6" id="Fact-FAE82E9FB7650FD20A7FBEC2240ADDA5" unitRef="usd">-5698000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CommonStockDividendsPerShareDeclared contextRef="FD2017Q1QTD" decimals="INF" id="Fact-DA6E4F665DAC37A5C0ABBEBD23A5C826" unitRef="usdPerShare">0.4489</us-gaap:CommonStockDividendsPerShareDeclared>
	<us-gaap:CommonStockDividendsPerShareDeclared contextRef="FD2018Q1QTD" decimals="INF" id="Fact-2D07866DE14AAFB166A0BEBCCD8E8B13" unitRef="usdPerShare">0.4624</us-gaap:CommonStockDividendsPerShareDeclared>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2016Q4" decimals="INF" id="Fact-CB007FC4F24B8B4089D3BA3ED7DADC4F" unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2018Q1" decimals="INF" id="Fact-F6527B6E644504ACB866BA3ED7DBE0F2" unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="FI2016Q4" decimals="-6" id="Fact-44FFB25FA73E82545F68BA3ED7DBEEC3" unitRef="shares">364000000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued contextRef="FI2018Q1" decimals="-6" id="Fact-8ADFAB36EDE13ED32C4DBA3ED7E066F0" unitRef="shares">364000000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockValue contextRef="FI2017Q4" decimals="-6" id="Fact-F3B83C18509F5EA08BB32D8D0A130947" unitRef="usd">2697000000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2018Q1" decimals="-6" id="Fact-68E6410C38CE54B694CADEC0A8116C6D" unitRef="usd">2674000000</us-gaap:CommonStockValue>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2017Q1QTD" decimals="-6" id="Fact-940C299B5A57AEF34E77BEBDEAA92B28" unitRef="usd">309000000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2018Q1QTD" decimals="-6" id="Fact-B0F6053C4DBBBDEDF036BEBDC218BEA9" unitRef="usd">154000000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="FD2017Q1QTD" decimals="-6" id="Fact-6C8F75FD62FBAA07928CBEBDEAA8B1CE" unitRef="usd">1000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="FD2018Q1QTD" decimals="-6" id="Fact-B68543256F779BA6250ABEBDC20AD767" unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2017Q1QTD" decimals="-6" id="Fact-04E367E51ECB60E488CFBEBDEAA7723F" unitRef="usd">310000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2018Q1QTD" decimals="-6" id="Fact-DEF7E5292C12EF8F8CCFBEBDC2163329" unitRef="usd">156000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:CostOfGoodsSold contextRef="FD2017Q1QTD" decimals="-6" id="Fact-FF05E5A493307A358519BEBD2395888F" unitRef="usd">30449000000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold contextRef="FD2018Q1QTD" decimals="-6" id="Fact-3EAA438829FBAEFBDEAFBEBCCD829174" unitRef="usd">30969000000</us-gaap:CostOfGoodsSold>
	<us-gaap:DebtAndCapitalLeaseObligations contextRef="FI2017Q4" decimals="-6" id="Fact-5BCFF827B2A45618A87F7D1B5178E369" unitRef="usd">10395000000</us-gaap:DebtAndCapitalLeaseObligations>
	<us-gaap:DebtAndCapitalLeaseObligations contextRef="FI2018Q1" decimals="-6" id="Fact-C3F0D31AE3B516A9A7F35E6995D3A966" unitRef="usd">10003000000</us-gaap:DebtAndCapitalLeaseObligations>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-6" id="Fact-9574AA2298DF5915B62F7FF310789AE8" unitRef="usd">10713000000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-6" id="Fact-608A76AFC19A5058B1D3E4AAC9DB65A3" unitRef="usd">10333000000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A1.7Notesduefiscal2018Member" decimals="INF" id="Fact-36EF655B9C4F5F94BBF1328F82C808A8" unitRef="number">0.017</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A1.948Notesdue2019Member" decimals="INF" id="Fact-FC4016AB6DB0571AA19AA44B0F0BE4EB" unitRef="number">0.01948</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesduefiscal2022Member" decimals="INF" id="Fact-84E0D024EBE85952BA9DCF2308824D25" unitRef="number">0.02616</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesduefiscal2024Member" decimals="INF" id="Fact-A4B928CCA3B25D03962427C1B4B810CF" unitRef="number">0.03079</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesduefiscal2027Member" decimals="INF" id="Fact-3524456FCB315F6B8CAA920F80BA36BB" unitRef="number">0.0341</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesduefiscal2047Member" decimals="INF" id="Fact-CB184F2FEC8B55AC9320C04C6FA57F9A" unitRef="number">0.04368</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="FI2018Q1_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="-6" id="Fact-0D6F7109B7D056B6A163FA784DCA60C7" unitRef="usd">35000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
	<us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="FI2018Q1_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="-6" id="Fact-CAB1FF89A7D851ED97956EE8BAA7CF62" unitRef="usd">0</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
	<us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-6" id="Fact-911D06507EBD57529163C7DD4B1D8288" unitRef="usd">2877000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent contextRef="FI2018Q1" decimals="-6" id="Fact-DD2B9BC4C73D591B9BDD8951A5C88EBB" unitRef="usd">3758000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2017Q1QTD" decimals="-6" id="Fact-1B3B0F232946A0E11BEEBEC352E0F922" unitRef="usd">173000000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2018Q1QTD" decimals="-6" id="Fact-9D80B458B7F406EA6E5FBEC19361FDBC" unitRef="usd">229000000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-38E56AC030DA1092BEA26EB6895794F0" unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-38A7E3E6F29118A432D46EB68D0BD2A9" unitRef="usd">-21000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-29A3923004B749E1FAEB6EB6919FD12A" unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-6E8EB3DF88AC611999316EB698C526B4" unitRef="usd">-21000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-F0DC69285A6BB4D98FF16EB6304E24C1" unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-220826C54B9F0F70FD706EB6369D90EF" unitRef="usd">-21000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-422FEBD64BF9559CBB046EB63D719EE5" unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-2B15C4E02320AC50E9AC6EB641DA1818" unitRef="usd">-21000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2017Q1QTD" decimals="-6" id="Fact-F7058B7BCB0641EBAB17BEC3C566C8F0" unitRef="usd">1000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2018Q1QTD" decimals="-6" id="Fact-03531E51CF5DCB06E925BEC1F85A150A" unitRef="usd">9000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2017Q4QTD" decimals="3" id="Fact-907C3642D8E7B70440AEBA47883D391B" unitRef="number">0.373</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2018Q1QTD" decimals="3" id="Fact-4A6AD477EF565C74EFF15A51E2D87A68" unitRef="number">0.342</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-D2594790D9B358DFB1C385FD89E4154C" unitRef="usd">35000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-6" id="Fact-8CA737BE714657C085D182690B2884D0" unitRef="usd">18000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-A8FD9051307D5B069F6843053579B925" unitRef="usd">117000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-2866804449CB564092C0EBD732DD520C">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" id="Fact-09A4A9031B8A5D948D696C76FEA40318">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" id="Fact-3D22C2DDAB55547BBCA87BC5DCBB25E7">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2017Q1QTD" decimals="-6" id="Fact-974F38F88C3DCBC85C80BAC5958E61FD" unitRef="usd">8000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2018Q1QTD" decimals="-6" id="Fact-99466AE409A8EAB6B212BAC5356B0396" unitRef="usd">6000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="FD2017Q1QTD" decimals="-6" id="Fact-CFCB80662C9474E8BF7CBEC352D10B1E" unitRef="usd">30000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
	<us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="FD2018Q1QTD" decimals="-6" id="Fact-A445DDC02040B34F00ECBEC1D6CCB17A" unitRef="usd">0</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2018Q1CompleteFortis_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="3" id="Fact-2093332B2EEC777CFF4EC89BC7953B03" unitRef="number">0.082</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="FD2018Q1QTD_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-EF8B6804290D000279755A40CA2C8793" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="FD2018Q1QTD_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-72EDA2737AEE653EC5615A40CA275480" unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2018Q1QTD_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-685EC6AFA8607B3B17DD5F3D1982D702" unitRef="usd">-15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-E53308345F1E50A0AC9ED0DEA95BFC43" unitRef="usd">32000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q1_us-gaap_FairValueByLiabilityClassAxis_cah_ContingentConsiderationClassifiedasaLiabilityMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-D69EFB3F7A9D26C589405A40B146A49D" unitRef="usd">23000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4" decimals="-6" id="Fact-62EE36C0B4845F9C96D3716D308E84A5" unitRef="usd">1466000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" decimals="-6" id="Fact-BB89F74FD1D55078830F1263E0931931" unitRef="usd">195000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-1656218A15B55238A7F306B0FB214557" unitRef="usd">967000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-09AE0E6E666F593D8DAC8BCB9974419C" unitRef="usd">304000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1" decimals="-6" id="Fact-92DDB542DD455931A54F31DA5E16F505" unitRef="usd">1604000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" decimals="-6" id="Fact-2C341865B30359A1A70A2030D2BE7178" unitRef="usd">212000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-F698EA17997B5744BFF5C7B651EE64D0" unitRef="usd">1046000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-321658D96A4F53A59AB015C6259969A0" unitRef="usd">346000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="FI2018Q1" decimals="-6" id="Fact-DED3E98825EA5AD0A4836EF79385F3AD" unitRef="usd">444000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="FI2018Q1" decimals="-6" id="Fact-494028CB6219582CAA34BA87F8B6370E" unitRef="usd">421000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="FI2018Q1" decimals="-6" id="Fact-1FAA43FDBDD5599E831167C64181C26B" unitRef="usd">458000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="FI2018Q1" decimals="-6" id="Fact-DF72777287B1500F84DF25022DC415BB" unitRef="usd">531000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="FI2018Q1" decimals="-6" id="Fact-58B0A50FD7EE5F83BE200349876E82D9" unitRef="usd">563000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4" decimals="-6" id="Fact-8B8F4EE6E57E5BC78FF688FBA834BA47" unitRef="usd">3391000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" decimals="-6" id="Fact-180279C576C85D0A9674E46A010527EB" unitRef="usd">509000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-436D9ABC78D45441829DABEEF7432D93" unitRef="usd">1966000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-5657FF23A81950FA8EEF359ADEDF95EF" unitRef="usd">916000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1" decimals="-6" id="Fact-57E29978D92C5201A5CC7243FBFE9DC5" unitRef="usd">6050000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" decimals="-6" id="Fact-1059EA4466AE5249A70C0F9FBC31A9B3" unitRef="usd">697000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-C40FFF5297BE5F3EAA11AD89099413F2" unitRef="usd">3705000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-D4D93D225D725D289BA938812C4E277E" unitRef="usd">1648000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4" decimals="-6" id="Fact-28E7280E2977547CB2078D3444811757" unitRef="usd">1925000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" decimals="-6" id="Fact-C9E43399316B59A2BAE1811731D0945D" unitRef="usd">314000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-826E9FD9E2D85C519F307D6B047F0754" unitRef="usd">999000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2016Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-882B92D3E1945819A197842C81F22205" unitRef="usd">612000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q1" decimals="-6" id="Fact-4C4C6CB8D3405CEABDE485FC271725F2" unitRef="usd">4446000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" decimals="-6" id="Fact-7DFF82E7872E528A99D96005B766443B" unitRef="usd">485000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-6" id="Fact-014A1D55CD8B5096894A98E4343FC5C1" unitRef="usd">2659000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-6" id="Fact-AAE31FA9E1405A5E80C29219E7C7466E" unitRef="usd">1302000000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="FD2018Q1QTD" id="Fact-52E32CB3B8E55883ABF16FB9EC3DF40D">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
	<us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="FD2018Q1QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" id="Fact-1D301B6C19D05C9688640CB97D208F3B">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
	<us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="FD2018Q1QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" id="Fact-07BAF492A1E55272AAB127EB82C19D4D">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
	<us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="FD2018Q1YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" id="Fact-52C6709DAB0A5B04AAB09E6BCC86BEDC">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
	<us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="FD2017Q1QTD" decimals="-6" id="Fact-C433C7C34A11297E41E0BEBD2394C28A" unitRef="usd">-3000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
	<us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges contextRef="FD2018Q1QTD" decimals="-6" id="Fact-490F4BC80BD5980FCF3BBEBCCD8B3BFC" unitRef="usd">-1000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
	<us-gaap:GainLossRelatedToLitigationSettlement contextRef="FD2017Q1QTD" decimals="-6" id="Fact-008420C498C9B5D3ECEFBEBD23A91BEE" unitRef="usd">-1000000</us-gaap:GainLossRelatedToLitigationSettlement>
	<us-gaap:GainLossRelatedToLitigationSettlement contextRef="FD2018Q1QTD" decimals="-6" id="Fact-69D817CAD97D0B72C354BEBCCD848A84" unitRef="usd">-32000000</us-gaap:GainLossRelatedToLitigationSettlement>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2017Q1QTD" decimals="-6" id="Fact-A84304F28F58A7A457C5552C7ABA0E7C" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2018Q1QTD" decimals="-6" id="Fact-642D2F08E1573B74D243552C02D208BF" unitRef="usd">-1000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:Goodwill contextRef="FI2017Q4" decimals="-6" id="Fact-CD720D688A3B5BC78303B382441C38C8" unitRef="usd">7221000000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-98B399044C24550FA3292E5CC0CE9568" unitRef="usd">4282000000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-D825A46B5D285A3AAF2D770CDED4A7EB" unitRef="usd">2939000000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q1" decimals="-6" id="Fact-33AF729933B8561F8BCBEB4B7B783442" unitRef="usd">10419000000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-6" id="Fact-CC0F316B77A4473AAE6BBE559478775B" unitRef="usd">3103000000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-B8C0E5FAD6675ACB920CB63CAB670BED" unitRef="usd">7468000000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-A1D8C0D4388B5A76AA519CBC991BF1C3" unitRef="usd">2951000000</us-gaap:Goodwill>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q1QTD" decimals="-6" id="Fact-4DA6810202E5595EAD835EE965FE8A80" unitRef="usd">3157000000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-CE9C552D350C5C46A24C72B9B0079386" unitRef="usd">3156000000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-D74FD44B80AA5BDE81D27FB7ED83D3D9" unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="FD2018Q1QTD" decimals="-6" id="Fact-A41089785FC352238B8D5E6A649759A8" unitRef="usd">-41000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
	<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-E4A111F0E3975A08A6FEDC1A8297010C" unitRef="usd">-30000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
	<us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-2359CCF3284058A7BB9D555D6260F9CC" unitRef="usd">-11000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
	<us-gaap:GrossProfit contextRef="FD2017Q1QTD" decimals="-6" id="Fact-C54271DD61229060C9D2BEBD238C934D" unitRef="usd">1590000000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q1QTD" decimals="-6" id="Fact-6510902E5A0954D6AA9590879E9D25CB" unitRef="usd">1672000000</us-gaap:GrossProfit>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2017Q1QTD" decimals="-6" id="Fact-A19A573B059F7B02986EBEBD2391DFE1" unitRef="usd">494000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2018Q1QTD" decimals="-6" id="Fact-F0256F907C8AE5A0DD24BEBCCD89A482" unitRef="usd">178000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="FD2017Q1QTD" decimals="2" id="Fact-25F9CA483D38FC6D49B2BEBD239F2DA2" unitRef="usdPerShare">0.97</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
	<us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="FD2018Q1QTD" decimals="2" id="Fact-5E08F32E5BA370EF6918BEBCCD7E45ED" unitRef="usdPerShare">0.36</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
	<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="FD2017Q1QTD" decimals="2" id="Fact-F2FB8F41DF3C43B0AAF8BEBD23970179" unitRef="usdPerShare">0.96</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
	<us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="FD2018Q1QTD" decimals="2" id="Fact-66FB4AA10C65508852A4BEBCCD91881E" unitRef="usdPerShare">0.36</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2017Q1QTD" decimals="-6" id="Fact-008E377FF651284D0F66BEBD23A71DA2" unitRef="usd">184000000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2018Q1QTD" decimals="-6" id="Fact-658C022DBCC446213666BEBCCD80B26E" unitRef="usd">61000000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="FD2017Q1QTD" decimals="-6" id="Fact-50CFDC8962B946B485D8BEC352D6F76D" unitRef="usd">279000000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="FD2018Q1QTD" decimals="-6" id="Fact-6D04419C8CCCFBC20838BEC1935E637C" unitRef="usd">1296000000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2017Q1QTD" decimals="-6" id="Fact-9842C095A88C75C381A6BEC352C5BD6B" unitRef="usd">298000000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2018Q1QTD" decimals="-6" id="Fact-DAE0EDD54B3423DF707BBEC19362804F" unitRef="usd">381000000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="FD2017Q1QTD" decimals="-6" id="Fact-8C1FBE1236D5487DF9DABEC352CA4D17" unitRef="usd">87000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
	<us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="FD2018Q1QTD" decimals="-6" id="Fact-5AFFD6D23880757D566FBEC19366F314" unitRef="usd">-229000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
	<us-gaap:IncreaseDecreaseInReceivables contextRef="FD2017Q1QTD" decimals="-6" id="Fact-0E857217C88AE493B904BEC352DE7648" unitRef="usd">306000000</us-gaap:IncreaseDecreaseInReceivables>
	<us-gaap:IncreaseDecreaseInReceivables contextRef="FD2018Q1QTD" decimals="-6" id="Fact-ECED35B33DBF0D98D7A5BEC1935C0EA6" unitRef="usd">359000000</us-gaap:IncreaseDecreaseInReceivables>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2016Q4" decimals="-6" id="Fact-B00836A920265DDEA6B25AB749D6B1F4" unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2016Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-6" id="Fact-2A2161EA0D6F50008658A40FDDBFB167" unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2018Q1" decimals="-6" id="Fact-B4E538CBA9C35BC8801D8DF2238E62B1" unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="FI2018Q1_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" decimals="-6" id="Fact-3121DC64930D537788B967B9D59D50AC" unitRef="usd">61000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
	<us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="FI2016Q4" decimals="-6" id="Fact-59C6060D23F058349E66B845A7342A37" unitRef="usd">3452000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
	<us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="FI2018Q1" decimals="-6" id="Fact-5D673EAC072855E3978D9D3C6F75142F" unitRef="usd">6111000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2016Q4" decimals="-6" id="Fact-82DEE6E2BA9A57AB87CEFF70F6BDB817" unitRef="usd">1986000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2018Q1" decimals="-6" id="Fact-5A574A76558C5EAFA4C724CC6AEE75E6" unitRef="usd">4507000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="FI2017Q4" decimals="-6" id="Fact-D5E81158B878500FB12A878258301014" unitRef="usd">9207000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
	<us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="FI2018Q1" decimals="-6" id="Fact-5ADCBBE7102751D4BFD10AF823211621" unitRef="usd">14926000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
	<us-gaap:InterestExpense contextRef="FD2017Q1QTD" decimals="-6" id="Fact-AE4E574B146B77B524C6BEBD23A1E235" unitRef="usd">44000000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2018Q1QTD" decimals="-6" id="Fact-9D045745FC2FA5CBD749BEBCCD85CB67" unitRef="usd">81000000</us-gaap:InterestExpense>
	<us-gaap:InventoryNet contextRef="FI2017Q4" decimals="-6" id="Fact-8B33031CE00955038E10032E91C1F95F" unitRef="usd">11301000000</us-gaap:InventoryNet>
	<us-gaap:InventoryNet contextRef="FI2018Q1" decimals="-6" id="Fact-3CDF09A32EBE55849E01604A7B3E406B" unitRef="usd">12121000000</us-gaap:InventoryNet>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-B311EECC75685D27B1E6EACD4F2A828F" unitRef="usd">116000000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-A5C5C48835DE5756B812B7BCD14E5A22" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-EBB1A0067CD65FA88EF856E76FA75487" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-448F955BF85558C08742EE8D23C6EED8" unitRef="usd">116000000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-6852C95934E45952AE9E8BCFE3D8D65F" unitRef="usd">116000000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-C9BA46FEC87E5D968F5A3F67124997A0" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-FAF63330E4B75F34ACB391F421C6FF97" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-6" id="Fact-36F402068B8350179ABE6989B7ED1213" unitRef="usd">116000000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2017Q4" decimals="-6" id="Fact-D9A5E2125D81521083B09827419EEB99" unitRef="usd">40112000000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2018Q1" decimals="-6" id="Fact-3A59EBFD4E17534FA2615E13280F6878" unitRef="usd">41940000000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-7F21BC9FE1905D4488A806EB8143D84B" unitRef="usd">21221000000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-ACBCC8A4821452348A5C1F30E16D0426" unitRef="usd">22407000000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding contextRef="FI2018Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" decimals="-6" id="Fact-71B5BC4E641BBE06D2AB7CD26FBF857C" unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="FI2018Q1_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" decimals="-9" id="Fact-41638D9EE9765853B8BF09C64E3B87FB" unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="FI2018Q1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" decimals="-9" id="Fact-CE1642DF642C5A5DBBD38CA06ECF6730" unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="FI2017Q4" decimals="-6" id="Fact-8457901D37545CB291016FDAF8D518D8" unitRef="usd">9068000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
	<us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="FI2018Q1" decimals="-6" id="Fact-DD0CE7AEFBE85DC4B583DEC28B555FA8" unitRef="usd">9068000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
	<us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-F22032657534538B90F8D4F6A9501691" unitRef="usd">1327000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
	<us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-19944A50D3555CC3A61FEBBCDD9898A6" unitRef="usd">935000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
	<us-gaap:LossContingencyNewClaimsFiledNumber contextRef="D2018Q1Oct31_us-gaap_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="0" id="Fact-785E37F23112507F8658FFC1439911A4" unitRef="lawsuit">15</us-gaap:LossContingencyNewClaimsFiledNumber>
	<us-gaap:LossContingencyNewClaimsFiledNumber contextRef="D2018Q1Oct31_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="0" id="Fact-4C4CBC1C59AC393A03C35EFB51D9D204" unitRef="lawsuit">98</us-gaap:LossContingencyNewClaimsFiledNumber>
	<us-gaap:LossContingencyNewClaimsFiledNumber contextRef="D2018Q1Oct31_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="0" id="Fact-64AF9EC863EF5643BCBEF2F570B044B7" unitRef="lawsuit">90</us-gaap:LossContingencyNewClaimsFiledNumber>
	<us-gaap:LossContingencyNumberOfPlaintiffs contextRef="D2018Q1Oct31_us-gaap_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="0" id="Fact-23BBCFCA7D555D75A475B5E337CC9DF9" unitRef="organization">25</us-gaap:LossContingencyNumberOfPlaintiffs>
	<us-gaap:LossContingencyNumberOfPlaintiffs contextRef="D2018Q1Oct31_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="0" id="Fact-E7A098DA52225643B95667C533AC85E2" unitRef="plaintiff">1030</us-gaap:LossContingencyNumberOfPlaintiffs>
	<us-gaap:LossContingencyRequestForInformation contextRef="FD2018Q1QTD" id="Fact-277E244697BBED679ADC6EEBC6F23866">40</us-gaap:LossContingencyRequestForInformation>
	<us-gaap:LossOnSaleOfInvestments contextRef="FD2017Q1QTD" decimals="-6" id="Fact-003A0B6BFFB0EA3CED79591BA11DD9A4" unitRef="usd">0</us-gaap:LossOnSaleOfInvestments>
	<us-gaap:LossOnSaleOfInvestments contextRef="FD2018Q1QTD" decimals="-6" id="Fact-8CA8C75302E2E8FED754556A3072CEFB" unitRef="usd">6000000</us-gaap:LossOnSaleOfInvestments>
	<us-gaap:MinorityInterest contextRef="FI2017Q4" decimals="-6" id="Fact-DC2D4EE841385AB78A138D50E5E61E9A" unitRef="usd">20000000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2018Q1" decimals="-6" id="Fact-17D7B4AF214F53E99955AC1BFA807670" unitRef="usd">17000000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterestChangeInRedemptionValue contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-4A406ABB583AC43507D55F362182198D" unitRef="usd">-5000000</us-gaap:MinorityInterestChangeInRedemptionValue>
	<us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-4E02D20657F85FFDA61DFD99883A9A3A" unitRef="usd">103000000</us-gaap:MinorityInterestDecreaseFromRedemptions>
	<us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="2" id="Fact-ECB2BC7C0E5B543CA050C49A05FD61B0" unitRef="number">0.98</us-gaap:MinorityInterestOwnershipPercentageByParent>
	<us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="I2016Q1naviacq_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="2" id="Fact-CF894591A87F5F40ABBFDED67DCA9008" unitRef="number">0.71</us-gaap:MinorityInterestOwnershipPercentageByParent>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2017Q1QTD" decimals="-6" id="Fact-7D48143F03B3EAE4CB20BEC352E26303" unitRef="usd">-350000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2018Q1QTD" decimals="-6" id="Fact-AC56C27BE78E3F3BBD81BEC1D6CB73AE" unitRef="usd">-744000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2017Q1QTD" decimals="-6" id="Fact-C187E23FD997C5CB0193BEC352E46040" unitRef="usd">-110000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2018Q1QTD" decimals="-6" id="Fact-5D2A368F373E0BFAF8C9BEC1D6C220F2" unitRef="usd">-6144000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2017Q1QTD" decimals="-6" id="Fact-246637D3527291ED9776BEC352DB7564" unitRef="usd">104000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2018Q1QTD" decimals="-6" id="Fact-E82B86F8B85B62CD0271BEC19365C17B" unitRef="usd">1181000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q1QTD" decimals="-6" id="Fact-431B893DAD1CF0D9779EBEBD239DCAB4" unitRef="usd">309000000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q1QTD" decimals="-6" id="Fact-76D3EBB3BCB55D21A05A3B529C968026" unitRef="usd">115000000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2017Q1QTD" decimals="-6" id="Fact-2DE7E31E097BF2BE4451BEBD23A61627" unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2018Q1QTD" decimals="-6" id="Fact-A6F229E3B19C50FBB22CFBE07A7FA663" unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-468378C970CA5006BB7A718B22B0D1EF" unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
	<us-gaap:NumberOfOperatingSegments contextRef="FD2018Q1QTD" decimals="INF" id="Fact-E813B3D9F8177048DF23BA3ED7DB6D58" unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
	<us-gaap:NumberOfReportableSegments contextRef="FD2017Q1QTD" decimals="INF" id="Fact-A58FB679FE9017281C98BA3ED7E104A3" unitRef="segment">2</us-gaap:NumberOfReportableSegments>
	<us-gaap:OpenTaxYear contextRef="FD2018Q1QTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-041D36A02E3D90EF9DDA6EC546CB2005">2008</us-gaap:OpenTaxYear>
	<us-gaap:OpenTaxYear contextRef="FD2018Q1QTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-979A54149E76D3B9F7726EC546C6B6A3">2008</us-gaap:OpenTaxYear>
	<us-gaap:OpenTaxYear contextRef="FD2018Q1QTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-E4372C5B0B648C2E5DDA6EC546CA917E">2008</us-gaap:OpenTaxYear>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD" decimals="-6" id="Fact-BF512DE312295F827417BEBD239E56DD" unitRef="usd">535000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" decimals="-6" id="Fact-12D0E09DDC4C51AC441A5A046AE29427" unitRef="usd">-126000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-6" id="Fact-7CABED557EC3EA525C765A046AECD467" unitRef="usd">661000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-DD56A763A1E6D95DE37C5A046AE8C957" unitRef="usd">127000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-C014C2EB29E4A0C1D1B15A046AE5391C" unitRef="usd">534000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD" decimals="-6" id="Fact-18D1C10A261F4C48FB21BEBCCD8CA554" unitRef="usd">262000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" decimals="-6" id="Fact-8A008B4409097AFC36EE5A0442568E14" unitRef="usd">-334000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-6" id="Fact-FFE10F5D54084C5B15705A04425DF0A4" unitRef="usd">596000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-756C506E7225DA7B850A5A04425A24A8" unitRef="usd">129000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-C80FA2AD87F1D7D60CBC5A04425FE67F" unitRef="usd">467000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-E300D8FD95025675B388CDBA57412B9F" unitRef="usd">1988000000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-F6202063AD7057589A68497A1829608E" unitRef="usd">2270000000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAssetsCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-8B799CC2B8585E8DAA049CEFC2E484EF" unitRef="usd">2117000000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-D9BCC89D97025759B231642F3D20A005" unitRef="usd">2041000000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2017Q4" decimals="-6" id="Fact-B2E550D181C05C2689C3D840EF787AE2" unitRef="usd">681000000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2018Q1" decimals="-6" id="Fact-723F0F099859552A888159895A594CA2" unitRef="usd">638000000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-BE7ED56CB5D75E0DA869D833D3A23894" unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-82C1DD20078C5E6DB774311B24C60B9E" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-4F8F625A0BA9807AFE555A3A28249453" unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax contextRef="FD2017Q1QTD" decimals="-6" id="Fact-644288DF74B8CD292F71BEBDEAA668A2" unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax contextRef="FD2018Q1QTD" decimals="-6" id="Fact-A850CD2CFA8BCC431551BEBDC20EA59D" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2017Q1QTD" decimals="-6" id="Fact-EA7F725A66C1C396AF76BEBDEAA3720C" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2018Q1QTD" decimals="-6" id="Fact-131030284F9D06639193BEBDC20C1FDD" unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2017Q1QTD" decimals="-6" id="Fact-84E46AA2197F6E681D72BEBDEAA23A10" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2018Q1QTD" decimals="-6" id="Fact-5417A1C0B74BAB0F636BBEBDC214C7C4" unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-3BC146F7ACB4559699B208E495A11C27" unitRef="usd">40000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-5C0D298287EF5E5D98B614158A5E699A" unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-6F9E483B18AC5584BB763F30D3A78B50" unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2017Q1QTD" decimals="-6" id="Fact-262D023C887D212AD4CCBEBD23AC5069" unitRef="usd">3000000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2018Q1QTD" decimals="-6" id="Fact-709D3A4EF2A3A5072E3BBEBCCD8FA53A" unitRef="usd">-2000000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:PaymentsForProceedsFromHedgeFinancingActivities contextRef="FD2017Q1QTD" decimals="-6" id="Fact-CC9DEB8A21012843FAF6BEC352C24C03" unitRef="usd">-14000000</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
	<us-gaap:PaymentsForProceedsFromHedgeFinancingActivities contextRef="FD2018Q1QTD" decimals="-6" id="Fact-8FC04EC762D0B9A94E17BEC1D6D69062" unitRef="usd">0</us-gaap:PaymentsForProceedsFromHedgeFinancingActivities>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2017Q1QTD" decimals="-6" id="Fact-14D2428C430FA6DAD75DBEC352E8DBB7" unitRef="usd">250000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2018Q1QTD" decimals="-6" id="Fact-B99CA0DC26955AD9BFA4BEC1D6D82E11" unitRef="usd">150000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q1QTD" decimals="-6" id="Fact-53ACBD8D443C57D3BCDD0A569E61F49E" unitRef="usd">9000000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" decimals="-6" id="Fact-04C5B901F1B257168FF48BDB4EBFA827" unitRef="usd">9000000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-6" id="Fact-91A9A31280F75009BA7F76DFA6D16904" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsOfDividendsCommonStock contextRef="FD2017Q1QTD" decimals="-6" id="Fact-1349FA40FEF50A2512C2BEC352D28368" unitRef="usd">149000000</us-gaap:PaymentsOfDividendsCommonStock>
	<us-gaap:PaymentsOfDividendsCommonStock contextRef="FD2018Q1QTD" decimals="-6" id="Fact-4F4985347E56344D2F43BEC1D6CE67A8" unitRef="usd">150000000</us-gaap:PaymentsOfDividendsCommonStock>
	<us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries contextRef="FD2017Q1QTD" decimals="-6" id="Fact-9AB184B60A90EC9D44BFBEC352C3FB14" unitRef="usd">10000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
	<us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries contextRef="FD2018Q1QTD" decimals="-6" id="Fact-4C26B0C2A70B123EDE6DBEC1D6F06F73" unitRef="usd">3000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="D2018Q1CompleteFortis_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-8" id="Fact-12CB7E734388170804D559CE67E83438" unitRef="usd">6100000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2017Q1QTD" decimals="-6" id="Fact-E3D5352B71D42C5EA070BEC352D3657D" unitRef="usd">9000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2018Q1QTD" decimals="-6" id="Fact-4A516F772A0693D0E7A7BEC1D6C307A8" unitRef="usd">6139000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2017Q1QTD" decimals="-6" id="Fact-B4A3797F31F0E0660512BEC352DC6FA2" unitRef="usd">100000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2018Q1QTD" decimals="-6" id="Fact-8D5D118F7A50B0BD5FDDBEC1D6EE7443" unitRef="usd">67000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2016Q4" decimals="INF" id="Fact-E43554FD07A6A1A198B2BA3ED7E05F51" unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2018Q1" decimals="INF" id="Fact-AA21166649F6F156B317BA3ED7E16CBD" unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2016Q4" decimals="INF" id="Fact-F0CDCE104A70915099B1BA3ED7DB9ACB" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2018Q1" decimals="INF" id="Fact-36BD13F489C6FBFC6DA5BA3ED7DB04FB" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockValue contextRef="FI2017Q4" decimals="-6" id="Fact-179B7A9F4E8E55568D3D27429FA2313E" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue contextRef="FI2018Q1" decimals="-6" id="Fact-EEF9F968B9145791BF58B8900CA64F8E" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:ProceedsFromIssuanceOfDebt contextRef="D2017Q4Jun1-Jun30_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-8" id="Fact-C96303BB9CC7400FF22159D4FC8B7D4B" unitRef="usd">4500000000</us-gaap:ProceedsFromIssuanceOfDebt>
	<us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="FD2017Q1QTD" decimals="-6" id="Fact-9C89CC70DD1CBFB4B049BEC352CECFFD" unitRef="usd">17000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
	<us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="FD2018Q1QTD" decimals="-6" id="Fact-1F96B7B71C7C85C7D79FBEC1D6C5DFA6" unitRef="usd">0</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
	<us-gaap:ProceedsFromNotesPayable contextRef="D2017Q4Jun1-Jun30_us-gaap_BusinessAcquisitionAxis_cah_PatientRecoveryBusinessMember" decimals="-8" id="Fact-D3EC8091597E554683A37D60482FC886" unitRef="usd">5200000000</us-gaap:ProceedsFromNotesPayable>
	<us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="FD2017Q1QTD" decimals="-6" id="Fact-A152FCE50412CA5D635DBEC352CB6707" unitRef="usd">25000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
	<us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="FD2018Q1QTD" decimals="-6" id="Fact-BB05AB441D50E3C6A233BEC1D6ED8D69" unitRef="usd">-6000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
	<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="FD2017Q1QTD" decimals="-6" id="Fact-EA9251F1B3C07B540E91592F8D5BB483" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
	<us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="FD2018Q1QTD" decimals="-6" id="Fact-B8AA8DABCDF6C55ECF37592F283810B0" unitRef="usd">1000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
	<us-gaap:ProfitLoss contextRef="FD2017Q1QTD" decimals="-6" id="Fact-577CAB1448A27748DE83BEBD239BF72E" unitRef="usd">310000000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q1QTD" decimals="-6" id="Fact-5374DF77E20CEFC999D1BEBCCD88634E" unitRef="usd">117000000</us-gaap:ProfitLoss>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2017Q4" decimals="-6" id="Fact-F6DC35A22D0C535ABAA0F5EDD3AD5FC7" unitRef="usd">1879000000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2018Q1" decimals="-6" id="Fact-911161EC1BAB5AC6A3A3544E319D704C" unitRef="usd">2651000000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2017Q1QTD" decimals="-6" id="Fact-3F1EF71E1B87575F6FC3BEC352D9BEC9" unitRef="usd">7000000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2018Q1QTD" decimals="-6" id="Fact-382929F662CE4A9FE069BEC193644026" unitRef="usd">25000000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ReceivablesNetCurrent contextRef="FI2017Q4" decimals="-6" id="Fact-BCC7EFDDFF5354E5B41454EBFD2CF324" unitRef="usd">8048000000</us-gaap:ReceivablesNetCurrent>
	<us-gaap:ReceivablesNetCurrent contextRef="FI2018Q1" decimals="-6" id="Fact-33B1B43BDCDE554EAF3209624E1C0C7A" unitRef="usd">8382000000</us-gaap:ReceivablesNetCurrent>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-221FEA1EF8E659E9AEC4644AA3C523C7" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-97F1682BDC8D544CB3BAF4296F689F1B" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-090662C417BBAC4EE32D5A3A2827E82F" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="FI2017Q4" decimals="-6" id="Fact-F3ABB70CE0545F249C990E838FFADE75" unitRef="usd">118000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
	<us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="FI2017Q4_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-039BEF6A9907519C9C2C089B357E54F5" unitRef="usd">118000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
	<us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="FI2018Q1" decimals="-6" id="Fact-495B4B97F93E5E4AAAC2A3AE5C06A3BB" unitRef="usd">12000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
	<us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-F3A61382131C5C279323D8CC4C4C25B7" unitRef="usd">12000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
	<us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="I2018Q2Oct31_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-6" id="Fact-993E8A14ADDDCE0B79E75F386AA1661E" unitRef="usd">103000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
	<us-gaap:RedeemableNoncontrollingInterestEquityFairValue contextRef="I2016Q1naviacq_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-F1F0A411DC256A7D98BA6F103391D0FF" unitRef="usd">119000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
	<us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_cah_NaviHealthMember" decimals="-6" id="Fact-1D23654F1E099B85F54A6F12943DA154" unitRef="usd">109000000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
	<us-gaap:RepaymentsOfDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_cah_A1.7Notesduefiscal2018Member" decimals="-6" id="Fact-579A17FD493D596CA8802DF4897B953D" unitRef="usd">400000000</us-gaap:RepaymentsOfDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2017Q1QTD" decimals="-6" id="Fact-CF667A8E856F70DD973FBEC352CD4F9A" unitRef="usd">1000000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2018Q1QTD" decimals="-6" id="Fact-588D2770A08120758A08BEC1D6D75EFF" unitRef="usd">402000000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RestructuringCharges contextRef="FD2017Q1QTD" decimals="-6" id="Fact-E3ECD894D82A5EC9DF3FBEBD23A8C4DE" unitRef="usd">9000000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q1QTD" decimals="-6" id="Fact-9C5A525B810E1DE05903BEBCCD863D9E" unitRef="usd">132000000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCosts contextRef="FD2018Q1QTD" decimals="-6" id="Fact-9200F748C175511882F1A9FBF4BB9650" unitRef="usd">129000000</us-gaap:RestructuringCosts>
	<us-gaap:RestructuringCosts contextRef="FD2018Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" decimals="-6" id="Fact-F0AD11DC907155419F3CA40C07FBFE57" unitRef="usd">2000000</us-gaap:RestructuringCosts>
	<us-gaap:RestructuringCosts contextRef="FD2018Q1QTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-6" id="Fact-E22720B1CE6D5E71B570974E3BB058B4" unitRef="usd">127000000</us-gaap:RestructuringCosts>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4" decimals="-6" id="Fact-5C057B3AF3F65CD3A530F449D52D24E7" unitRef="usd">41000000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" decimals="-6" id="Fact-527C2E98881D5DC79E1132B31DFF46FB" unitRef="usd">41000000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-6" id="Fact-1D93008B61B351118DBEC1AD384015FC" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1" decimals="-6" id="Fact-39F0FCF580605C5CA7D86448C773143C" unitRef="usd">161000000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" decimals="-6" id="Fact-EF6E33A2A421597880104CFF4B154426" unitRef="usd">34000000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-6" id="Fact-EBB706A91CD85F75BB045C8B00F8C556" unitRef="usd">127000000</us-gaap:RestructuringReserve>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2017Q4" decimals="-6" id="Fact-6F09CA988CDD5C2AB3F9430DE76AB5B3" unitRef="usd">4967000000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2018Q1" decimals="-6" id="Fact-78BA04ED6A225EEC8D200C0198D3DAF4" unitRef="usd">4943000000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:Revenues contextRef="FD2017Q1QTD" decimals="-6" id="Fact-9332AB176C676B1CECB4BEBD23A1C1A0" unitRef="usd">32039000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" decimals="-6" id="Fact-461E55001D27BCAA1E6F160808FCCCB4" unitRef="usd">-2000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-6" id="Fact-1168A266F0506131CEFC160808E6A08F" unitRef="usd">32041000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-D1B3CF8B281012AA4E411608090F4FFD" unitRef="usd">3279000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-9B456DB8CE1898B7761A160809204FC1" unitRef="usd">28762000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD" decimals="-6" id="Fact-F666B4F6B0C05C3DA24AE4D72D97E8AB" unitRef="usd">32641000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" decimals="-6" id="Fact-91F0189B3475F3553F951607D4F5B760" unitRef="usd">-3000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-6" id="Fact-3C1F350CF91709E93C1C1607D4F2864C" unitRef="usd">32644000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" decimals="-6" id="Fact-5A169EA8A9B966066BB41607D4F7C892" unitRef="usd">3724000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" decimals="-6" id="Fact-3067175211562F5EA7D21607D4F902C9" unitRef="usd">28920000000</us-gaap:Revenues>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2017Q1QTD" decimals="-6" id="Fact-13F7345361723CE07D93BEBD2392E608" unitRef="usd">920000000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2018Q1QTD" decimals="-6" id="Fact-14EF648B88DF5B65B4FE0D08F5AF4847" unitRef="usd">1062000000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SeveranceCosts1 contextRef="FD2017Q1QTD" decimals="-6" id="Fact-50EAAD6814633438427212491B599100" unitRef="usd">7000000</us-gaap:SeveranceCosts1>
	<us-gaap:SeveranceCosts1 contextRef="FD2018Q1QTD" decimals="-6" id="Fact-76D374D1C802BDA753D112491B6DA879" unitRef="usd">4000000</us-gaap:SeveranceCosts1>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD" decimals="-6" id="Fact-3BF0A3B46EF6C07741F2BEC352C8D5DC" unitRef="usd">23000000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1QTD" decimals="-6" id="Fact-5EA9B1C8D9EBDF427361BEC1935F229C" unitRef="usd">17000000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-A766F5026F355830A435188B7AB2C4DB">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" id="Fact-B2ADE69C92735AB396B525885C7008C5">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" id="Fact-FB43F4AF6A315C1284D79EA31DDB8DE1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-E499CB422E1251D6B0B4C4FFD5AFB42A" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-EE3A3BB470665A129E0424584E2FA73E" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-8FACFD1062175518BDCC46A9D7910B49" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-7C1998FE217D5D468F98A6C219B6F84B" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-2B25649574A354C7BA743AD3E01B594F" unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-A2F527A345D950778BF88BD2D9B7F42F" unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-B252F6C256D75AD1AA980058F6AE50FD" unitRef="usdPerShare">66.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-2F09960962025040A4CCB8293CD3B2B2" unitRef="usdPerShare">66.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-70DB63704E52589581E68788B2D6A906" unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-5AFFEC4885E7515BBCECBE9E9781D769" unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-D31F01AA52435F50AD81B6A98164463B" unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-A9EE2239ABF1593BA59613DDD1D5FDB8" unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-81A4570363D4558B9F854A6BB3FAD96A" unitRef="usdPerShare">77.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-F5126046995256DBB16BA25D94CF4BAA" unitRef="usdPerShare">76.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-8E3C6216396955CBB64C211AC2EB889E" unitRef="usdPerShare">75.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-A328C05168AE5096B2D756134B1FF8F7" unitRef="usdPerShare">71.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-B69336F8CE295183A0BAC93194895CD4" unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-6" id="Fact-C38B18B18B3958A593DC75084F1A90B1" unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-96D207058C4B5E2B8E9FEB251ED0221C" unitRef="usdPerShare">71.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-A26F9A8C16C15470B222EB3F20F472D6" unitRef="usdPerShare">79.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="FI2018Q1" decimals="-6" id="Fact-400634C9A1195940AAC94EADC072EA8E" unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="FI2018Q1" decimals="2" id="Fact-045FE22F961550329FCD10346CDC7380" unitRef="usdPerShare">59.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="FD2018Q1QTD" decimals="-6" id="Fact-A8CFFCC75CA9531BBBB32D5E5A323367" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q1QTD" decimals="2" id="Fact-BEDBE64DC5AD5F27B5CA39AC8C2447AD" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="FD2018Q1QTD" decimals="-6" id="Fact-938E65C856A455B9B43F5936903DFA74" unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-74CFEF9145A95FA8966BA78CC4953493" unitRef="usd">109000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-5AE408DF31B35A1FB1E3C24FF8B88C36" unitRef="usd">65000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2017Q4" decimals="-6" id="Fact-BBD9676A6B985F979B51646A846EFBBB" unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2018Q1" decimals="-6" id="Fact-6098BD9877CB5130BCB65653391CEE99" unitRef="shares">8000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2017Q4" decimals="2" id="Fact-88387DDA129C56AF87A89A4D21D22F66" unitRef="usdPerShare">63.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2018Q1" decimals="2" id="Fact-8726E886650950A187648AACB56C5DC1" unitRef="usdPerShare">64.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="FD2018Q1QTD" decimals="2" id="Fact-9C49507942A85910B658D1417E58F8D4" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q1QTD" decimals="2" id="Fact-37135B1350025F98909D56469C57CF2C" unitRef="usdPerShare">66.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-5E7FA8050410511595DDFF7C06C5CD81" unitRef="number">1.33</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="2" id="Fact-8EDB3A7BF4545B119D9FA633505F62E7" unitRef="number">2.00</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="2" id="Fact-36926C43017C5C898A9D875A49DBE496" unitRef="number">0.00</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-D74EDF9D8E3352F7B855C94B5C688187" unitRef="usd">106000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-6" id="Fact-FE4AD1AED04C532092C2AE5DFF167D7F" unitRef="usd">65000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-0426100727615AAE82CFA7B6975228C1">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-52F8228127A550B083019DAE1FCA1424">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-26277BA33F165C66A5D58379C253CEF5">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2018Q1QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-446D719CED8B56B7B96B00A18DB050EC">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2018Q1QTD" decimals="-6" id="Fact-3C87B59B663A54218CD984C1D0928830" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4" decimals="-6" id="Fact-ED07A8262F0D5067A1C20BAAD552FC35" unitRef="usd">6808000000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1" decimals="-6" id="Fact-3D5EF30B94BA52B7882EDD236C0E5CEE" unitRef="usd">6678000000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4" decimals="-6" id="Fact-04B7E8A8121C5753ADBDCB1930F389CE" unitRef="usd">6828000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-C031C213BC1B47B6E9065A39C906BF69" unitRef="usd">-148000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-C8B69CD53033836F0B485A39F31B6224" unitRef="usd">23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-D1C1FFE41BB3C1F477A65A39F3175C7C" unitRef="usd">-125000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q1" decimals="-6" id="Fact-1776C83128EC5DB592E33777817A263F" unitRef="usd">6695000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-70531D46B43D5EC685989836C88FFBED" unitRef="usd">-108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-8668B760FE9A5C27B307B36A691876B1" unitRef="usd">22000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" decimals="-6" id="Fact-4EFB7B26EBE1538E968411B183BC09CA" unitRef="usd">-86000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:TreasuryStockAcquiredAverageCostPerShare contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="2" id="Fact-B402A6EED2595231B63D7FAF401A16F2" unitRef="usdPerShare">81.37</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
	<us-gaap:TreasuryStockAcquiredAverageCostPerShare contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="2" id="Fact-138947EBE980510693F4AD454ED571F3" unitRef="usdPerShare">67.92</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
	<us-gaap:TreasuryStockShares contextRef="FI2016Q4" decimals="-6" id="Fact-8E62F4B5EF09917A03BABA3ED7DBA367" unitRef="shares">42000000</us-gaap:TreasuryStockShares>
	<us-gaap:TreasuryStockShares contextRef="FI2018Q1" decimals="-6" id="Fact-2BE245640D182BCC6396BA3ED7E0AF3C" unitRef="shares">44000000</us-gaap:TreasuryStockShares>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-5" id="Fact-31AB60D2529C53D19A99DB9BB0FA6C05" unitRef="shares">3100000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-5" id="Fact-323DE3A759FE59E1A0D355E93337436C" unitRef="shares">2200000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockValue contextRef="FI2017Q4" decimals="-6" id="Fact-173AF9F122E653ACB29BD34ECBBC8000" unitRef="usd">731000000</us-gaap:TreasuryStockValue>
	<us-gaap:TreasuryStockValue contextRef="FI2018Q1" decimals="-6" id="Fact-E2FA82BE258B5F538F0B1631E13DAF6A" unitRef="usd">853000000</us-gaap:TreasuryStockValue>
	<us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-6" id="Fact-9E402E34400E5D5E816023F1E5BED7FD" unitRef="usd">250000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
	<us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="FD2018Q1YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-6" id="Fact-6ECE42A92E7070995F81BA6D7574113D" unitRef="usd">150000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2017Q4" decimals="-6" id="Fact-1D9B4881AF4B58559B8BB0A34D99AAC9" unitRef="usd">417000000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2018Q1" decimals="-6" id="Fact-8377D6296299BD869A23BA4877F46EDF" unitRef="usd">410000000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2017Q4" decimals="-6" id="Fact-8926BCF9622E54C493961C4A43BC1FED" unitRef="usd">99000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2018Q1" decimals="-6" id="Fact-5C9C47065B595A9895CF4A4B8F880B27" unitRef="usd">97000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="FI2017Q4" decimals="-6" id="Fact-E875D7D05B485DAAB56C4D6E7FC4528A" unitRef="usd">268000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
	<us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="FI2018Q1" decimals="-6" id="Fact-48077BC56199742A6A09BA48C0ED7122" unitRef="usd">266000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2017Q1QTD" decimals="-6" id="Fact-DEA143375A2A8E9D43586EF72E41E104" unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2018Q1QTD" decimals="-6" id="Fact-C00A754F6274ECD54DAB6EF72E6C8C11" unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2017Q1QTD" decimals="-6" id="Fact-A6FF5A79EE1E12328996BEBD23995A6C" unitRef="shares">322000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2018Q1QTD" decimals="-6" id="Fact-1EF11D0EC61B7D9258E4BEBCCD8AD39D" unitRef="shares">318000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2017Q1QTD" decimals="-6" id="Fact-B824B9B929542E46C295BEBD23AB087E" unitRef="shares">320000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2018Q1QTD" decimals="-6" id="Fact-263745A5D363AF33632FBEBCCD90D98D" unitRef="shares">316000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<cah:AdditionalStockOptionPlanDataTableTextBlock contextRef="FD2018Q1QTD" id="Fact-CFDF55B199C3BD0A5E7DBA3ED7E18A10">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables provide additional detail related to stock options:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;109&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;106&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cah:AdditionalStockOptionPlanDataTableTextBlock>
	<us-gaap:AvailableForSaleSecuritiesTextBlock contextRef="FD2018Q1QTD" id="Fact-EFE52518AA1CD5028427BA3ED7E05ED8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We held the following investments in marketable securities at fair value at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Treasury bills&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;International bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;30&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;U.S. agency bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Asset-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;International equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total available-for-sale securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="FD2018Q1QTD" id="Fact-4CFD20411E52AC6A784EBA3ED7DA20B4">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our fiscal year ends on June 30. References to fiscal 2018 and 2017 in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, 2018 and June 30, 2017, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. In addition, financial results presented for this fiscal &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2018&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (the "&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Form 10-K"). &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="FD2018Q1QTD" id="Fact-3205552EB27C3BE4E3DCBA3ED7E1E05C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;1. Basis of Presentation and Summary of Significant Accounting Policies &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our fiscal year ends on June 30. References to fiscal 2018 and 2017 in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, 2018 and June 30, 2017, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. In addition, financial results presented for this fiscal &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2018&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (the "&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Form 10-K"). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recent Financial Accounting Standards&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In August 2017, the Financial Accounting Standards Board (the "FASB") issued&amp;#160;accounting guidance which is intended to improve and simplify accounting rules around hedge accounting. The guidance will be effective for us in the first quarter of fiscal 2020 and early adoption is permitted. We are currently evaluating the impact of this standard on our condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In March 2016, the FASB issued amended accounting guidance that changed the accounting for certain aspects of share-based compensation to employees. The guidance requires all income tax effects of share-based awards to be recognized in the statement of earnings as awards vest or are settled. Additionally, the guidance increases the amount employers can withhold in shares to cover employee income taxes without requiring liability classification and allows a policy election for accounting for forfeitures. The primary impact of adoption resulted in the recognition of excess tax benefits in the statement of earnings on a prospective basis, rather than as a component of equity. The impact on the presentation in the condensed consolidated statement of cash flows is also prospective. We adopted this guidance in the first quarter of fiscal 2018. The impact of adoption on the provision for income taxes on our condensed consolidated statement of earnings was immaterial. The inclusion of excess tax benefits and deficiencies as a component of our income tax expense will increase volatility within our provision for income taxes as the amount of excess tax benefits or deficiencies from share-&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;based compensation awards depends on our stock price at the date the awards vest.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In May 2014, the FASB issued amended accounting guidance related to revenue recognition. This guidance is based on the principle that revenue is recognized in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the transfer of goods or services to customers. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The FASB also subsequently issued several amendments to the standard, including clarification on principal versus agent considerations, performance obligations and licensing, and certain scope improvements and practical expedients.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We continue to make progress on our evaluation of the amended revenue recognition guidance, including identification of revenue streams and customer contract reviews. Our revenue is primarily distribution revenue, which we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Although we are continuing to assess the impact of the amended guidance, we generally anticipate that the timing of recognition of distribution revenue will be substantially unchanged under the amended guidance.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
	<us-gaap:BusinessCombinationDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-984D2BC2EE4C0ED6A941BA3ED7E0B1FD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;2. Acquisitions&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Patient Recovery Business&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;On July 29, 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$6.1 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in cash. The Patient Recovery Business manufactures &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;23&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; categories of medical products sold into multiple healthcare channels, and includes numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo. The acquisition further expands the Medical segment's portfolio of self-manufactured products. We closed the Patient Recovery Business acquisition in&amp;#160;&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;28&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; principal countries on&amp;#160;&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;July&amp;#160;29, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and acquired control of, as described in GAAP, and the rights to, the net economic benefit from the entire Patient Recovery Business in the remaining countries at the closing. We are in the process of transitioning legal ownership in the remaining non-principal countries, which we expect to complete by the end of calendar 2018. The results for the entire Patient Recovery Business in all countries are included in the condensed consolidated financial statements beginning&amp;#160;July 29, 2017. We funded the acquisition through &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$4.5 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in new long-term debt, the use of existing cash and borrowings under our existing credit arrangements. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Transaction and integration costs associated with the acquisition of the Patient Recovery business were &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$37 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and are included in amortization and other acquisition-related costs in the condensed consolidated statements of earnings. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Fair Value of Assets Acquired and Liabilities Assumed&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The allocation of the purchase price for the acquisition of the Patient Recovery Business is not yet finalized and is subject to adjustment as we complete the valuation analysis for this acquisition. The purchase price is subject to adjustment based on working capital requirements as set forth in the acquisition agreement. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The valuation of identifiable intangible assets utilizes significant unobservable inputs and thus represents a Level 3 nonrecurring fair value measurement. The estimated fair value of the identifiable intangible assets was determined using income-based approaches, which includes market participant expectations of the cash flows that an asset could generate over its economic life, discounted back to present value using an appropriate rate of return. The weighted- average discount rate used to arrive at the present value of the identifiable intangible assets was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;8.2 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and considers the inherent risk of each intangible asset relative to the internal rate of return and weighted-average cost of capital. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of the assets acquired and liabilities assumed as of the acquisition date for the Patient Recovery Business:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Patient Recovery Business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Identifiable intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,712&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trade names (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other (3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;732&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total identifiable intangible assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2,630&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash and equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;434&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Prepaid expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;106&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Property and equipment, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other accrued liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(153&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Deferred income taxes and other liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(873&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total identifiable net assets acquired/(liabilities) assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2,975&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,103&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total net assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,078&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The range of useful lives for customer relationships is &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;18&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The useful life of trade names is &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The useful life of developed technology is &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-DCA8DFDBC36D5EF09003BA3ED7DB8EAF">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;8. Commitments, Contingent Liabilities and Litigation &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Commitments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Generic Sourcing Venture with CVS Health Corporation ("CVS Health")&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;July 2014&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;10 years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of both companies. Due to the achievement of predetermined milestones, we are required to make quarterly payments of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$45.6 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to CVS Health for the remainder of the initial term.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Legal Proceedings&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We become involved from time to time in disputes, litigation, and regulatory matters.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;We may be named from time to time in &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we may determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges, net in our condensed consolidated statements of earnings.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Opioid Lawsuits &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;As of October 30, 2017, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;98&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; counties and municipalities, one state attorney general and one tribal entity have filed lawsuits against pharmaceutical wholesale distributors (including us) relating to the distribution of prescription opioid pain medications. Many of the lawsuits also include pharmaceutical manufacturers and retail chains. We are also a defendant in a purported class action lawsuit brought on behalf of unions and other health and welfare funds that paid for certain opioid prescriptions on behalf of their members. These lawsuits, which have been filed in various federal, state and other courts, allege violations of controlled substance laws and various other statutes as well as common law claims, including negligence, public nuisance and unjust enrichment, and seek equitable relief and monetary damages. We are vigorously defending ourselves in these lawsuits. Since these lawsuits are in early stages, we are unable to predict their outcome or estimate a range of reasonably possible losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In September 2017, we, along with other distributors, received a request for information related to an investigation being conducted by a group of approximately &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;40&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; U.S. state attorneys general. We also have received civil investigative demands, subpoenas or requests for information from several individual state attorneys general offices. These investigations are focused on the distribution of opioid medication. We are currently evaluating and responding to their requests.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Product Liability Lawsuits&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;As of October 30, 2017, we are named as a defendant in &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;90&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; product liability lawsuits filed in Alameda County Superior Court in California involving claims by approximately &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;1,030&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; similar lawsuits involving claims by approximately &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;25&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#5b9bd5;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;At September 30, 2017, we had a total of $&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;129 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;, net of expected insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits. While we have recorded accruals based on our assessment of these matters, because these lawsuits are in early stages, we are unable to estimate a range of reasonably possible losses in excess of this accrued amount.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-5EEE6BD6626BB9E7BD085E4F2C80DFD7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;"&gt;6. Long-Term Obligations and Other Short-Term Borrowings &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Long-Term Debt&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had total long term obligations, including the current portion, of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$10.0 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$10.4 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;$19.2 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In June 2017, we issued additional debt with the aggregate principal amount of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;$5.2 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; to fund a portion of the acquisition of the Patient Recovery Business, to redeem the &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;$400 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;1.7%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Notes due 2018&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; and for general corporate purposes. In July 2017, we redeemed the &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;$400 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;1.7%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Notes due 2018.&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; The notes issued in June 2017 were &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;1.948%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; Notes due 2019, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;2.616%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; Notes due 2022, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;3.079%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; Notes due 2024, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;3.410%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; Notes due 2027, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;4.368%&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; Notes due 2047, and floating rate Notes due 2022.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Financing Arrangements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition to cash and equivalents and operating cash flow, other sources of liquidity include a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;$2.0 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; revolving credit facility and a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; committed receivables sales facility program. At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;, we had &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt; amounts outstanding under the revolving credit facility or the committed receivables sales facility program.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In November 2016, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&amp;#8220;CHF&amp;#8221;) through November 1, 2019. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers.  Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="FD2018Q1QTD" id="Fact-C4BDD0756971557EEDDDBA3ED7E1E380">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;15. Share-Based Compensation &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We maintain stock incentive plans (collectively, the &amp;#8220;Plans&amp;#8221;) for the benefit of certain of our officers, directors and employees. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;17&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;17&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The total tax benefit related to share-based compensation was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$6 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$8 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. As of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;July&amp;#160;1, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, under ASU 2016-09, excess tax benefits, which are immaterial for the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, are prospectively recognized within the provision for income taxes on our condensed consolidated statements of earnings and prospectively recognized as operating activity on our condensed consolidated statement of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Restricted Share Units&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Restricted share units granted under the Plans generally vest in equal annual installments over &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;three years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:24%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;76.72&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;66.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;79.53&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;71.60&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$117 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;two years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Stock Options&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Employee stock options granted under the Plans generally vest in equal annual installments over &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;three years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and are exercisable for  &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;ten years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;63.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;66.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;64.30&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;59.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$35 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;two years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables provide additional detail related to stock options:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;109&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;106&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Performance Share Units&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Performance share units vest over a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;three&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;zero&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;200 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;77.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;66.43&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;71.57&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;75.39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)    Vested based on achievement of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;133 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; of the target performance goal.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$18 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;two years&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; if the performance goals are achieved.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2018Q1QTD" id="Fact-C5D57A41F7FB801F09F1BA3ED7DB0248">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;13. Earnings Per Share Attributable to Cardinal Health, Inc.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&amp;#8211;basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;316&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;320&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units, and performance share units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&amp;#8211;diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;318&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;322&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The potentially dilutive employee stock options, restricted share units, and performance share units that were antidilutive for the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; were &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;5 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;3 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="FD2018Q1QTD" id="Fact-B6B6E237AB37D3C404FBBA3ED7DBB418">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents those liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Contingent Consideration Obligation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;32&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions from acquisitions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Changes in fair value of contingent consideration (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Payment of contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(15&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The sum of the components may not equal the total due to rounding.&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amount is included in amortization and other acquisition-related costs in the   condensed consolidated statements of earnings.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
	<us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-3936D1CD485C1CE37C02BA3ED7E1BB24">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;9. Fair Value Measurements &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&amp;#160;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&amp;#160;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Available-for-sale securities (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Contingent consideration (4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&amp;#160;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&amp;#160;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;739&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;739&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Available-for-sale securities (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Contingent consideration (4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(32&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(32&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The fair value of interest rate swaps, foreign currency contracts and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in the condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. Observable Level 2 inputs such as quoted prices for similar securities, interest rate spreads, yield curves and credit risk are used to determine the fair value. See &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Note 5&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; for additional information regarding available-for-sale securities.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds primarily invest in the equity securities of companies with large market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Contingent consideration represents the obligations incurred in connection with acquisitions. We do not deem the fair value of the contingent consideration obligations under any single acquisition to be significant. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding future business results, discount rates, discount periods, and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents those liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Contingent Consideration Obligation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;32&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions from acquisitions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Changes in fair value of contingent consideration (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Payment of contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(15&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The sum of the components may not equal the total due to rounding.&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amount is included in amortization and other acquisition-related costs in the   condensed consolidated statements of earnings.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
	<us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-165081D41C2FCD575643BA3ED7E184D0">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;10. Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. Our derivative and hedging programs are consistent with those described in the 2017 Form 10-K. The amount of ineffectiveness associated with these derivative instruments was immaterial for the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value of Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The carrying amounts of cash and equivalents, trade receivables, accounts payable, and other accrued liabilities at &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; approximate fair value due to their short-term maturities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:26%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;10,333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10,713&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;10,003&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-4BA6A6D778BC7B67314DBA3ED7E014B4">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;4. Goodwill and Other Intangible Assets&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:24%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2,939&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;4,282&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;7,221&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,156&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,157&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;30&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;7,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;10,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:11pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The increase in the Medical segment goodwill is primarily due to the Patient Recovery Business acquisition. Goodwill recognized in connection with the Patient Recovery Business acquisition primarily represents the expected benefits from certain synergies of integrating the business, the existing workforce of the&lt;/font&gt;&lt;font style="font-family:inherit;font-size:11pt;"&gt; &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;acquired entity, and the expected growth from new customers.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,705&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,046&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2,659&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names, and patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;212&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;346&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,050&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4,446&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4,507&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,966&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;999&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names, and patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;509&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;195&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;916&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;304&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;612&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,925&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,452&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,986&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The increase in definite-life intangibles is primarily due to the Patient Recovery Business acquisition. Total amortization of intangible assets was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$135 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$101 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2018&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; through&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; 2022&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; is as follows: &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$444 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$563 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$531 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$458 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$421 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-F094017471DECFFB0A8BBA3ED7E04443">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;7. Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Fluctuations in our provision for income taxes as a percentage of pretax earnings (&amp;#8220;effective tax rate&amp;#8221;) are due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the effective tax rate was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;34.2 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;37.3 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. The decrease in the effective tax rate was due to the impact of discrete items.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$410 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$417 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of unrecognized tax benefits, respectively. The &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; balances include &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$266 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$268 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of unrecognized tax benefits, respectively, that if recognized, would have an impact on the effective tax rate. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$97 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$99 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for income taxes in the condensed consolidated statements of earnings. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;zero&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and a net decrease of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$35 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, exclusive of penalties and interest.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$144 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$142 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and is included in other assets in the condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-D5A38947742E7E92ADE1BA3ED7E08D27">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;5. Available-for-Sale Securities&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. We held the following investments in marketable securities at fair value at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Treasury bills&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;International bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;30&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;U.S. agency bonds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Asset-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;International equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total available-for-sale securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In July 2017, we liquidated our marketable securities. There were no unrealized gains or loss at &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and gross unrealized gains and losses were immaterial at &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. During the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and 2016, gross realized gains and losses were immaterial and we did not recognize any other-than-temporary impairments.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
	<us-gaap:MinorityInterestDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-2ACEADA7C38615D385ADBA3ED7E0827A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the acquisition of a &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;71 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; ownership interest in naviHealth during fiscal 2016, we recognized redeemable noncontrolling interest with a fair value of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$119 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at the acquisition date. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The noncontrolling interests are redeemable at the option of the third-party noncontrolling interests holders at any time after the two-year anniversary of the closing.&amp;#160;During the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, certain third-party noncontrolling interest holders notified us of their intent to exercise their put right on the noncontrolling interest representing &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;16 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of naviHealth with a carrying value of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$103 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and a redemption value of $&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;109 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Upon notification of the intent to exercise the put, the carrying value of the &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;16 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of naviHealth became mandatorily redeemable and was reclassified to other accrued liabilities in the condensed consolidated balance sheet.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The reconciliation of the changes in redeemable noncontrolling interests are as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Redeemable Noncontrolling Interest&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings attributable to redeemable noncontrolling interests&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net purchase of redeemable noncontrolling interests&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(103&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustment of redeemable noncontrolling interests to redemption value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2017, we settled the &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$103 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; mandatorily redeemable liability with cash, which resulted in our ownership interest in naviHealth increasing to &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;98 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2018Q1QTD" id="Fact-7D8B90A3BC56D9A741BDBA3ED7DB6E82">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recent Financial Accounting Standards&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In August 2017, the Financial Accounting Standards Board (the "FASB") issued&amp;#160;accounting guidance which is intended to improve and simplify accounting rules around hedge accounting. The guidance will be effective for us in the first quarter of fiscal 2020 and early adoption is permitted. We are currently evaluating the impact of this standard on our condensed consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;In March 2016, the FASB issued amended accounting guidance that changed the accounting for certain aspects of share-based compensation to employees. The guidance requires all income tax effects of share-based awards to be recognized in the statement of earnings as awards vest or are settled. Additionally, the guidance increases the amount employers can withhold in shares to cover employee income taxes without requiring liability classification and allows a policy election for accounting for forfeitures. The primary impact of adoption resulted in the recognition of excess tax benefits in the statement of earnings on a prospective basis, rather than as a component of equity. The impact on the presentation in the condensed consolidated statement of cash flows is also prospective. We adopted this guidance in the first quarter of fiscal 2018. The impact of adoption on the provision for income taxes on our condensed consolidated statement of earnings was immaterial. The inclusion of excess tax benefits and deficiencies as a component of our income tax expense will increase volatility within our provision for income taxes as the amount of excess tax benefits or deficiencies from share-&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;based compensation awards depends on our stock price at the date the awards vest.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In May 2014, the FASB issued amended accounting guidance related to revenue recognition. This guidance is based on the principle that revenue is recognized in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the transfer of goods or services to customers. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The FASB also subsequently issued several amendments to the standard, including clarification on principal versus agent considerations, performance obligations and licensing, and certain scope improvements and practical expedients.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We continue to make progress on our evaluation of the amended revenue recognition guidance, including identification of revenue streams and customer contract reviews. Our revenue is primarily distribution revenue, which we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Although we are continuing to assess the impact of the amended guidance, we generally anticipate that the timing of recognition of distribution revenue will be substantially unchanged under the amended guidance.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock contextRef="FD2018Q1QTD" id="Fact-1CEA8B2EA97F29DF1C86BA3ED7E0008D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September 30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June 30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;22,220&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;21,848&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;18,055&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10,688&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,665&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;7,576&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;41,940&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;40,112&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
	<us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="FD2018Q1QTD" id="Fact-4FC582A2F4B6A4F92363BA3ED7DB5837">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;534&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;129&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;596&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;661&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(334&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(126&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;262&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;535&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
	<us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock contextRef="FD2018Q1QTD" id="Fact-1F93B1663D58FABAB4B8BA3ED7E0C907">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;28,920&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;28,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,724&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,279&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;32,644&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;32,041&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;32,641&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;32,039&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
	<us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="FD2018Q1QTD" id="Fact-311B5F4FD7D88B1EFBB6BA3ED7E0D958">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The reconciliation of the changes in redeemable noncontrolling interests are as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:77%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Redeemable Noncontrolling Interest&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net earnings attributable to redeemable noncontrolling interests&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net purchase of redeemable noncontrolling interests&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(103&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustment of redeemable noncontrolling interests to redemption value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2017, we settled the &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$103 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; mandatorily redeemable liability with cash, which resulted in our ownership interest in naviHealth increasing to &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;98 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
	<us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-80ADAEB21097D2115A8DBA3ED7DBF1DA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;3. Restructuring and Employee Severance &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes restructuring and employee severance costs:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three months ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;128&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;132&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs primarily consist of product distribution and lease contract termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In September 2017, we entered into an agreement to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. The expected costs with this restructuring include &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$125 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, on a pre-tax basis, in contract termination costs. These costs are reflected in facility exit and other costs in the condensed consolidated statements of earnings during the three months ended September 30, 2017. The contract termination costs are expected to be paid before the end of fiscal 2018. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;129&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;34&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;161&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
	<us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="FD2018Q1QTD" id="Fact-A6F732C02E132517237FBA3ED7DBCB5B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Accumulated Other Comprehensive Loss&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Comprehensive&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(125&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;40&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;40&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;22&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(86&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
	<us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="FD2018Q1QTD" id="Fact-49091B37F02F2555A515BA3ED7E1CCB9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:26%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;10,333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10,713&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;10,003&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
	<us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="FD2018Q1QTD" id="Fact-0C71504783B38DFA996FBA3ED7DB0A27">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;17&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;17&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2018Q1QTD" id="Fact-2AA89A9E0571E34E3037BA3ED7DB41BD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&amp;#160;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&amp;#160;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Available-for-sale securities (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Contingent consideration (4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&amp;#160;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&amp;#160;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;739&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;739&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Available-for-sale securities (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;65&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;116&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Contingent consideration (4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(32&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(32&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The fair value of interest rate swaps, foreign currency contracts and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in the condensed consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. Observable Level 2 inputs such as quoted prices for similar securities, interest rate spreads, yield curves and credit risk are used to determine the fair value. See &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Note 5&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; for additional information regarding available-for-sale securities.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds primarily invest in the equity securities of companies with large market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Contingent consideration represents the obligations incurred in connection with acquisitions. We do not deem the fair value of the contingent consideration obligations under any single acquisition to be significant. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding future business results, discount rates, discount periods, and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="FD2018Q1QTD" id="Fact-D859B7251E9182CFE2A1BA3ED7E104E2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,705&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,046&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2,659&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names, and patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;212&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;346&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,050&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4,446&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4,507&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,966&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;999&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names, and patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;509&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;195&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;916&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;304&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;612&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,925&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,452&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,986&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
	<us-gaap:ScheduleOfGoodwillTextBlock contextRef="FD2018Q1QTD" id="Fact-55158A5CC89D8A47C9AFBA3ED7E158EA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:24%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2,939&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;4,282&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;7,221&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,156&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,157&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;30&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;7,468&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;10,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
	<us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="FD2018Q1QTD" id="Fact-31B75592929D9B0ACB95BA3ED7E132A7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,705&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,046&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2,659&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names, and patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;212&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;346&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,050&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4,446&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4,507&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;61&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,966&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;999&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names, and patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;509&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;195&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;916&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;304&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;612&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,925&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,452&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,986&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
	<us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock contextRef="FD2018Q1QTD" id="Fact-3E7380F843FFD8171807BA3ED7E1A279">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;77.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;66.43&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;71.57&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;75.39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)    Vested based on achievement of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;133 percent&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; of the target performance goal.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
	<us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="FD2018Q1QTD" id="Fact-B2BE7B71BADF0BAA1695BE2CA084B73D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of the assets acquired and liabilities assumed as of the acquisition date for the Patient Recovery Business:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Patient Recovery Business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Identifiable intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1,712&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Trade names (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other (3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;732&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total identifiable intangible assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2,630&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash and equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;434&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Prepaid expenses and other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;106&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Property and equipment, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other accrued liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(153&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Deferred income taxes and other liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(873&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total identifiable net assets acquired/(liabilities) assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2,975&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,103&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total net assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;6,078&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The range of useful lives for customer relationships is &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;18&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The useful life of trade names is &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;The useful life of developed technology is &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
	<us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="FD2018Q1QTD" id="Fact-8744739C51957132C32DBA3ED7DB98A1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes restructuring and employee severance costs:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three months ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs (2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;128&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;132&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs primarily consist of product distribution and lease contract termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
	<us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="FD2018Q1QTD" id="Fact-7D91CFDB15CFB19D01C5BA3ED7E07D24">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:44%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;129&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;34&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;161&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="FD2018Q1QTD" id="Fact-F73A460AA8931790009DBA3ED7E1035C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:24%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;76.72&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;66.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;79.53&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;71.60&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="FD2018Q1QTD" id="Fact-49CB4BACF9FCA20EBB69BA3ED7E1A3E7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;63.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;66.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;64.30&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;59.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
	<us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="FD2018Q1QTD" id="Fact-6B967181AB3D0BFCEE91BA3ED7DB8119">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&amp;#8211;basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;316&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;320&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units, and performance share units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&amp;#8211;diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;318&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;322&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
	<us-gaap:SegmentReportingDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-02F0232024E46F50C598BA3ED7E18278">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;14. Segment Information&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operations are principally managed on a products and services basis and are comprised of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;two&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents revenue for each reportable segment and Corporate:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;28,920&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;28,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;3,724&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;3,279&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;32,644&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;32,041&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;32,641&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;32,039&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;amp;A") expenses. Segment SG&amp;amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance. The results attributable to noncontrolling interests are recorded within segment profit. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; other income, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In addition, certain investment spending, certain portions of enterprise-wide incentive compensation, and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. We encourage our segments and corporate functions to identify investment projects that will promote innovation and provide future returns. As approval decisions for such projects are dependent upon executive management, the expenses for such projects are often retained at Corporate. Investment spending within Corporate was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$5 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$1 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table presents segment profit by reportable segment and Corporate:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;534&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;129&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;596&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;661&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(334&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(126&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;262&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;535&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;September 30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;June 30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;22,220&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;21,848&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;18,055&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;10,688&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;1,665&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;7,576&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;41,940&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;40,112&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="FD2018Q1QTD" id="Fact-45C31BA49617F569AAB0BA3ED7E1814E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;12. Shareholders' Equity &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2.2 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$150 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$67.92&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. We funded the repurchases with available cash and short-term borrowings.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2016&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;3.1 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$250 million&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;$81.37&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. We funded the repurchases with available cash &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The common shares repurchased are held in treasury to be used for general corporate purposes.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Accumulated Other Comprehensive Loss&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Accumulated Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Comprehensive&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(125&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;40&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive income/(loss), net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;40&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;39&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;22&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;(86&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Activity related to realized gains and losses on available-for-sale securities, as described in &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Note 5&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, was immaterial during the three months ended &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. There were no unrealized gains and losses on available-for-sale securities at &lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>cah-20170930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20170930" xmlns:cah="http://www.cardinal.com/20170930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-roles-2017-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2017-01-31" schemaLocation="http://xbrl.sec.gov/exch/2017/exch-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20170930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20170930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20170930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20170930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="Acquisitions" roleURI="http://www.cardinal.com/role/Acquisitions">
        <link:definition>2102100 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAcquisitionDetails" roleURI="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails">
        <link:definition>2402403 - Disclosure - Acquisitions (Acquisition) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsBusinessCombinationsTables" roleURI="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables">
        <link:definition>2302302 - Disclosure - Acquisitions Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.cardinal.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2402401 - Disclosure - Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableForSaleSecurities" roleURI="http://www.cardinal.com/role/AvailableForSaleSecurities">
        <link:definition>2105100 - Disclosure - Available-for-Sale Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails">
        <link:definition>2405402 - Disclosure - Available-for-Sale Securities (Schedule of Available-for-Sale Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AvailableForSaleSecuritiesTables" roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables">
        <link:definition>2305301 - Disclosure - Available-for-Sale Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails">
        <link:definition>2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigation" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation">
        <link:definition>2110100 - Disclosure - Commitments, Contingent Liabilities and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigationDetails" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails">
        <link:definition>2410401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003000 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1014000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1002000 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncomeCalc2" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncomeCalc2">
        <link:definition>1002000 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarnings" roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings">
        <link:definition>1001000 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthInc" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc">
        <link:definition>2115100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails">
        <link:definition>2415403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails">
        <link:definition>2415402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncTables" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables">
        <link:definition>2315301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cardinal.com/role/FairValueMeasurements">
        <link:definition>2111100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
        <link:definition>2411402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details">
        <link:definition>2411403 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables">
        <link:definition>2311301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cardinal.com/role/FinancialInstruments">
        <link:definition>2112100 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>2412402 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails">
        <link:definition>2412403 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables">
        <link:definition>2312301 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssets" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets">
        <link:definition>2104100 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2404404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails">
        <link:definition>2404402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails">
        <link:definition>2404403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables">
        <link:definition>2304301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cardinal.com/role/IncomeTaxes">
        <link:definition>2108100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2408401 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowings" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings">
        <link:definition>2107100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails">
        <link:definition>2407402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsTables" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables">
        <link:definition>2307301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterests" roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterests">
        <link:definition>2113100 - Disclosure - Redeemable Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails">
        <link:definition>2413403 - Disclosure - Redeemable Noncontrolling Interests (Changes in Redeemable Noncontrolling Interests) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsNarrativeDetails" roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails">
        <link:definition>2413402 - Disclosure - Redeemable Noncontrolling Interests (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsTables" roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables">
        <link:definition>2313301 - Disclosure - Redeemable Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeverance" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance">
        <link:definition>2103100 - Disclosure - Restructuring and Employee Severance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails">
        <link:definition>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails">
        <link:definition>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceNarrativeDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails">
        <link:definition>2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceTables" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables">
        <link:definition>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cardinal.com/role/SegmentInformation">
        <link:definition>2116100 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails">
        <link:definition>2416405 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2416402 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenueByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails">
        <link:definition>2416403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentProfitByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails">
        <link:definition>2416404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cardinal.com/role/SegmentInformationTables">
        <link:definition>2316301 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.cardinal.com/role/ShareBasedCompensation">
        <link:definition>2117100 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2417402 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails">
        <link:definition>2417405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails">
        <link:definition>2417404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails">
        <link:definition>2417407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails">
        <link:definition>2417406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails">
        <link:definition>2417403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables">
        <link:definition>2317301 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cardinal.com/role/ShareholdersEquity">
        <link:definition>2114100 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2414403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2414402 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cardinal.com/role/ShareholdersEquityTables">
        <link:definition>2314301 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="cah_A1.7Notesduefiscal2018Member" name="A1.7Notesduefiscal2018Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A1.948Notesdue2019Member" name="A1.948Notesdue2019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A2.616Notesduefiscal2022Member" name="A2.616Notesduefiscal2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.079Notesduefiscal2024Member" name="A3.079Notesduefiscal2024Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.41Notesduefiscal2027Member" name="A3.41Notesduefiscal2027Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.368Notesduefiscal2047Member" name="A4.368Notesduefiscal2047Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AdditionalStockOptionPlanDataTableTextBlock" name="AdditionalStockOptionPlanDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Amortizationandotheracquisitionrelatedcosts" name="Amortizationandotheracquisitionrelatedcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_BusinessCombinationTransactionandintegrationcosts" name="BusinessCombinationTransactionandintegrationcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CVSHealthMember" name="CVSHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CommittedReceivablesSalesFacilityProgramMember" name="CommittedReceivablesSalesFacilityProgramMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ContingentConsiderationClassifiedasaLiabilityMember" name="ContingentConsiderationClassifiedasaLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ContractTerminationAxis" name="ContractTerminationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ContractTerminationDomain" name="ContractTerminationDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_DistributorContractMember" name="DistributorContractMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ExercisablePeriodOfPlansInYears" name="ExercisablePeriodOfPlansInYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_FacilityExitAndOtherCosts" name="FacilityExitAndOtherCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_IPRDTrademarksandOtherMember" name="IPRDTrademarksandOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_IndemnificationReceivable" name="IndemnificationReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_InitialtermofPharmaceuticalSourcingVenture" name="InitialtermofPharmaceuticalSourcingVenture" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LossContingencyAccrualNetofInsuranceRecoveries" name="LossContingencyAccrualNetofInsuranceRecoveries" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_MaximumQuarterlyPayment" name="MaximumQuarterlyPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalMember" name="MedicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NaviHealthMember" name="NaviHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Netproceedstaxwithholdingsfromsharebasedcompensation" name="Netproceedstaxwithholdingsfromsharebasedcompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent" name="Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_NumberofProductCategoriesManufactured" name="NumberofProductCategoriesManufactured" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OpioidLawsuitsMember" name="OpioidLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PatientRecoveryBusinessMember" name="PatientRecoveryBusinessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PaymentofContingentConsideration" name="PaymentofContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalMember" name="PharmaceuticalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PrincipalCountries" name="PrincipalCountries" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" name="Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ProductLiabilityLawsuitsMember" name="ProductLiabilityLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ProjectCostsOnInvestmentAndOtherSpending" name="ProjectCostsOnInvestmentAndOtherSpending" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Purchaseofavailableforsalesecuritiesandotherinvestments" name="Purchaseofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ShortTermCreditFacilitiesMember" name="ShortTermCreditFacilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TrademarksAndPatentsMember" name="TrademarksAndPatentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>cah-20170930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/Acquisitions" xlink:href="cah-20170930.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails" xlink:href="cah-20170930.xsd#AcquisitionsAcquisitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables" xlink:href="cah-20170930.xsd#AcquisitionsBusinessCombinationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsNarrativeDetails" xlink:href="cah-20170930.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecurities" xlink:href="cah-20170930.xsd#AvailableForSaleSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:href="cah-20170930.xsd#AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables" xlink:href="cah-20170930.xsd#AvailableForSaleSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20170930.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20170930.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:href="cah-20170930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20170930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:href="cah-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20170930.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20170930.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:href="cah-20170930.xsd#FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20170930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20170930.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20170930.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20170930.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20170930.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20170930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20170930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterests" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterests" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20170930.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20170930.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20170930.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20170930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20170930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20170930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20170930.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20170930.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20170930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Acquisitions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ea5f0c55-82ec-3013-b10d-5cbd46212889" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ea5f0c55-82ec-3013-b10d-5cbd46212889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72cc2501-68a2-887c-26e3-e18106a6e94e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ea5f0c55-82ec-3013-b10d-5cbd46212889" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_72cc2501-68a2-887c-26e3-e18106a6e94e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5a23735a-10c2-64f7-3d5a-453792d1607d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5a23735a-10c2-64f7-3d5a-453792d1607d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_de234906-4555-79c4-6c13-51f5af410421" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_de234906-4555-79c4-6c13-51f5af410421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_31b59b3c-3561-f961-13ba-e3cc74150736" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_31b59b3c-3561-f961-13ba-e3cc74150736" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4e5d7007-764c-d3cb-5dbd-3a33b1b3941c" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4e5d7007-764c-d3cb-5dbd-3a33b1b3941c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_833b6d2d-a622-8759-6212-2a8447c58ff7" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_833b6d2d-a622-8759-6212-2a8447c58ff7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_f54f861c-821c-f61f-8552-032ba9f25ff0" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_e66eb458-8500-fc68-5c5a-c52959376fd5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_f54f861c-821c-f61f-8552-032ba9f25ff0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_93a64cae-271a-5e6b-8c83-5adf9f941142" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_Goodwill_93a64cae-271a-5e6b-8c83-5adf9f941142" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecurities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_13aaa34e-8d7d-009a-bd8a-20360af7ca09" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_13aaa34e-8d7d-009a-bd8a-20360af7ca09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_00b000cf-7f1d-4891-7244-daf9f6335db0" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_00b000cf-7f1d-4891-7244-daf9f6335db0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_7a72b51a-735c-1ad4-bd3f-d9bcf2d6a26d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_AccountsPayableCurrent_7a72b51a-735c-1ad4-bd3f-d9bcf2d6a26d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f68a050d-d5b6-1395-99ff-ed06c9a31fb4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_f68a050d-d5b6-1395-99ff-ed06c9a31fb4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_3bdd6481-d3f9-8073-51b0-5e638af7354d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_3bdd6481-d3f9-8073-51b0-5e638af7354d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c3b9426a-456e-2e20-8220-9338acf9491e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_c3b9426a-456e-2e20-8220-9338acf9491e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_00443492-92dd-7fc1-13b6-792f3e163e73" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_00443492-92dd-7fc1-13b6-792f3e163e73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_00443492-92dd-7fc1-13b6-792f3e163e73" xlink:to="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_4fb6195d-d905-dac7-e5a0-79f324993f79" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_PreferredStockValue_4fb6195d-d905-dac7-e5a0-79f324993f79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_c3f7606a-e7e9-61d5-b60b-b4b059f68b26" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_CommonStockValue_c3f7606a-e7e9-61d5-b60b-b4b059f68b26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_065cb284-7fca-cc9b-5752-2feaf74d0011" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_065cb284-7fca-cc9b-5752-2feaf74d0011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_40678492-c421-af67-b276-f663f9ff2f98" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_TreasuryStockValue_40678492-c421-af67-b276-f663f9ff2f98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_cb565c4d-35c2-d825-4672-f1619e51c133" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_00443492-92dd-7fc1-13b6-792f3e163e73" xlink:to="loc_us-gaap_MinorityInterest_cb565c4d-35c2-d825-4672-f1619e51c133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07da1db4-2708-4446-4250-1fdd5956185e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07da1db4-2708-4446-4250-1fdd5956185e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4261eb63-a0fe-7be1-e8a2-dcf5644ff056" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4261eb63-a0fe-7be1-e8a2-dcf5644ff056" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_1cb4a384-e314-2300-ad55-c1ed289c8f7a" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_OtherAssetsCurrent_1cb4a384-e314-2300-ad55-c1ed289c8f7a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c04dd71c-529e-62f9-136d-a0a478e6fbc1" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_c04dd71c-529e-62f9-136d-a0a478e6fbc1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9b27fab9-d497-627b-4cfb-6b585220b978" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9b27fab9-d497-627b-4cfb-6b585220b978" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_37b0c31d-5d8b-0577-dfd9-aa56a79334e3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_37b0c31d-5d8b-0577-dfd9-aa56a79334e3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_1ce1e5cc-c8be-0496-da5c-d3c5dedae4f5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_1ce1e5cc-c8be-0496-da5c-d3c5dedae4f5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9ce4805d-7e26-0a6e-b5c8-5b3b64e0710f" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9ce4805d-7e26-0a6e-b5c8-5b3b64e0710f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_e3eecf87-b290-4567-8a59-5b0a8e27c85b" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_ShareBasedCompensation_e3eecf87-b290-4567-8a59-5b0a8e27c85b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_3bb02469-191c-4baa-c8ee-e08be21b11bb" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_3bb02469-191c-4baa-c8ee-e08be21b11bb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_bba7070a-94e8-0b85-254d-f01f9c4632c7" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_bba7070a-94e8-0b85-254d-f01f9c4632c7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_bf3f9720-ba63-7ecd-52ae-e754a6f349db" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_bf3f9720-ba63-7ecd-52ae-e754a6f349db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a8b6fe35-4809-bddf-7ef6-3144a6c89165" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a8b6fe35-4809-bddf-7ef6-3144a6c89165" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_962cfc51-230d-a221-126b-1d12af7a5921" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_962cfc51-230d-a221-126b-1d12af7a5921" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9d35c912-5b2d-89f7-eeb3-812a0511db5e" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9d35c912-5b2d-89f7-eeb3-812a0511db5e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fee12b15-6b42-6245-2e2f-ff030b98332c" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fee12b15-6b42-6245-2e2f-ff030b98332c" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_fdeafdae-471e-39c6-6473-16cd03592165" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_fdeafdae-471e-39c6-6473-16cd03592165" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_0ab7c5a9-54c7-9521-9116-16cd03316ae7" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_0ab7c5a9-54c7-9521-9116-16cd03316ae7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_f7ed6106-862d-edb5-3fd1-677e7651af64" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_f7ed6106-862d-edb5-3fd1-677e7651af64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_b49c7a2f-2986-824d-e7cb-bc082ac0e888" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_b49c7a2f-2986-824d-e7cb-bc082ac0e888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PaymentofContingentConsideration" xlink:label="loc_cah_PaymentofContingentConsideration_26df1fbd-360c-98b6-699c-16cd02ac3133" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_cah_PaymentofContingentConsideration_26df1fbd-360c-98b6-699c-16cd02ac3133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_27f3e695-baed-1adc-cc35-793c3b76e4f9" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_27f3e695-baed-1adc-cc35-793c3b76e4f9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_5f7d7f74-45c4-afb3-6117-ea0cc133d19b" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_5f7d7f74-45c4-afb3-6117-ea0cc133d19b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2b72fe5f-3c0e-d5e0-8e5c-ad01818e58e5" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2b72fe5f-3c0e-d5e0-8e5c-ad01818e58e5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5e2384e7-2100-07d0-2d64-67d581ee3a2f" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5e2384e7-2100-07d0-2d64-67d581ee3a2f" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_f0d35f34-d9ab-ff0a-1629-16cd026b0239" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_f0d35f34-d9ab-ff0a-1629-16cd026b0239" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_cf22d061-7c46-e185-574b-89b7ef77509e" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_cf22d061-7c46-e185-574b-89b7ef77509e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6f80ca9e-82d0-f056-a403-c4914c1ce379" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6f80ca9e-82d0-f056-a403-c4914c1ce379" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8a1490c4-32d9-5132-1fe2-2675a45abdae" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8a1490c4-32d9-5132-1fe2-2675a45abdae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_8629a772-7004-5d77-9980-0f501e29c5c8" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_8629a772-7004-5d77-9980-0f501e29c5c8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_499015ce-2160-aed2-85a3-080e8c4c6cdf" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd69e307-3cf6-284a-5315-8fa7ac464283" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_499015ce-2160-aed2-85a3-080e8c4c6cdf" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd69e307-3cf6-284a-5315-8fa7ac464283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd69e307-3cf6-284a-5315-8fa7ac464283" xlink:to="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dd69e307-3cf6-284a-5315-8fa7ac464283" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_351eeed0-a987-88e4-c007-095f3644ffff" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_351eeed0-a987-88e4-c007-095f3644ffff" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_cc7c59d2-21ac-163e-0898-1c1f212ef02b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_cc7c59d2-21ac-163e-0898-1c1f212ef02b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7908f590-67cb-1122-d422-880e24cad7ce" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_499015ce-2160-aed2-85a3-080e8c4c6cdf" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7908f590-67cb-1122-d422-880e24cad7ce" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:to="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_33f76b65-31cf-be04-0849-25af345446d5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:to="loc_us-gaap_Revenues_33f76b65-31cf-be04-0849-25af345446d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_23c68b7c-81fb-cba2-1814-b7ab4991d5d0" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:to="loc_us-gaap_CostOfGoodsSold_23c68b7c-81fb-cba2-1814-b7ab4991d5d0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_29ad42f4-24c5-90ea-4492-fdb757d66249" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_29ad42f4-24c5-90ea-4492-fdb757d66249" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_3307a290-1a1d-a4c6-877c-16cd0350fa23" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_3307a290-1a1d-a4c6-877c-16cd0350fa23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9ce4805d-7e26-0a6e-b5c8-5b3b64e0710f" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_9ce4805d-7e26-0a6e-b5c8-5b3b64e0710f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_71426e29-337e-291e-f9d3-40031a50cd68" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_71426e29-337e-291e-f9d3-40031a50cd68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_250c3b2f-7db5-7088-68cc-1dd831a2c2d7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_250c3b2f-7db5-7088-68cc-1dd831a2c2d7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_7c9599ab-2a77-022c-c720-63fecff6a62c" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_InterestExpense_7c9599ab-2a77-022c-c720-63fecff6a62c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_78b7d85e-8366-fe6d-cb1f-faac5a041b79" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_adacf05e-7e15-bd60-3e53-87432885dc29" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_78b7d85e-8366-fe6d-cb1f-faac5a041b79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_baabbf0a-644b-708a-c310-1211f9af2775" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_baabbf0a-644b-708a-c310-1211f9af2775" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_86e61cf2-b7b2-e230-65f1-5a2b152f3a30" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_86e61cf2-b7b2-e230-65f1-5a2b152f3a30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7b1369dd-f813-fe00-b292-96e275568f1b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7b1369dd-f813-fe00-b292-96e275568f1b" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterests" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_e0e093aa-0075-43de-2f65-66924da64b1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:to="loc_us-gaap_SeveranceCosts1_e0e093aa-0075-43de-2f65-66924da64b1f" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_5f752869-2424-766e-784e-16cd02ef7979" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:to="loc_cah_FacilityExitAndOtherCosts_5f752869-2424-766e-784e-16cd02ef7979" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_80870f71-876e-eaaa-f0a4-8338d8e9798b" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_80870f71-876e-eaaa-f0a4-8338d8e9798b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c1323577-e536-9051-1401-d064e7621fd6" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2a6e77d2-a694-61f8-1c68-085fd849c780" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c1323577-e536-9051-1401-d064e7621fd6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>cah-20170930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/Acquisitions" xlink:href="cah-20170930.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails" xlink:href="cah-20170930.xsd#AcquisitionsAcquisitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables" xlink:href="cah-20170930.xsd#AcquisitionsBusinessCombinationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsNarrativeDetails" xlink:href="cah-20170930.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecurities" xlink:href="cah-20170930.xsd#AvailableForSaleSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:href="cah-20170930.xsd#AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables" xlink:href="cah-20170930.xsd#AvailableForSaleSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20170930.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20170930.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:href="cah-20170930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20170930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:href="cah-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20170930.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20170930.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:href="cah-20170930.xsd#FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20170930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20170930.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20170930.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20170930.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20170930.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20170930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20170930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterests" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterests" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20170930.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20170930.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20170930.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20170930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20170930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20170930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20170930.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20170930.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20170930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Acquisitions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:to="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:to="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_636E9F4D59D8FAA7D7D682A1AC0F7758" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:to="loc_us-gaap_MinimumMember_636E9F4D59D8FAA7D7D682A1AC0F7758" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_B5CC674820A09208FCBC82A1AC2E93ED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:to="loc_us-gaap_MaximumMember_B5CC674820A09208FCBC82A1AC2E93ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8027051EFD74D17C9F59829E87A1615A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8027051EFD74D17C9F59829E87A1615A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="loc_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_D19701FBA6C58A899C74829E87A20D60" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855" xlink:to="loc_cah_PatientRecoveryBusinessMember_D19701FBA6C58A899C74829E87A20D60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_D4C22BA90C56D0A6B751829E87BA6283" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5" xlink:to="loc_cah_PatientRecoveryBusinessMember_D4C22BA90C56D0A6B751829E87BA6283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_NumberofProductCategoriesManufactured" xlink:label="loc_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PrincipalCountries" xlink:label="loc_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_BusinessCombinationTransactionandintegrationcosts" xlink:label="loc_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecurities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2E8FECC5726DED27AF0E6F44CFFC8AA5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2E8FECC5726DED27AF0E6F44CFFC8AA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:to="loc_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_754C9A595E2E11C665005F188C36D8C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:to="loc_cah_FacilityExitAndOtherCosts_754C9A595E2E11C665005F188C36D8C7" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:to="loc_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:to="loc_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseAxis" xlink:label="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:to="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:to="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_051924D286FB7AA9B36D6EE324400182" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_051924D286FB7AA9B36D6EE324400182" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_7098F8CE8A9812D099076EE324417C50" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE" xlink:to="loc_us-gaap_SubsequentEventMember_7098F8CE8A9812D099076EE324417C50" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_InitialtermofPharmaceuticalSourcingVenture" xlink:label="loc_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyRequestForInformation" xlink:label="loc_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_LossContingencyAccrualNetofInsuranceRecoveries" xlink:label="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:to="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:to="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5788C6501FE7479E1C276F096D0CBE43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5788C6501FE7479E1C276F096D0CBE43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_E44C5B465E886AA9BFD16F096D0C9755" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_E44C5B465E886AA9BFD16F096D0C9755" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_D195AE71894F1C2BD8E66F096D0DB314" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_D195AE71894F1C2BD8E66F096D0DB314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_CD8A96A7C0A70C80C6AC6F096D0D5BD8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="loc_us-gaap_AvailableForSaleSecurities_CD8A96A7C0A70C80C6AC6F096D0D5BD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_22D3721183DBB89C7DF36EC1E6784398" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_22D3721183DBB89C7DF36EC1E6784398" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContingentConsiderationClassifiedasaLiabilityMember" xlink:label="loc_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:to="loc_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:to="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:to="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:to="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:to="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:to="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B1C59C8BD61DDBEA3E45BA3EFE9492B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:to="loc_cah_PharmaceuticalMember_B1C59C8BD61DDBEA3E45BA3EFE9492B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_03FB66CC9D94FF0BD05EBA3EFE94FBEE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:to="loc_cah_MedicalMember_03FB66CC9D94FF0BD05EBA3EFE94FBEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:to="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:to="loc_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:to="loc_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="loc_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="loc_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_67DA17E1D339CEF3DA745F1818EBBD92_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_67DA17E1D339CEF3DA745F1818EBBD92_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_67DA17E1D339CEF3DA745F1818EBBD92" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_67DA17E1D339CEF3DA745F1818EBBD92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="loc_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:to="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:to="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_1C42DF6F175A47C64F015F1818EBE3A1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:to="loc_us-gaap_MinimumMember_1C42DF6F175A47C64F015F1818EBE3A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_2819272978EDB2D8ADBD5F1818EBED0A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:to="loc_us-gaap_MaximumMember_2819272978EDB2D8ADBD5F1818EBED0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:to="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:to="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D" xlink:to="loc_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A1.7Notesduefiscal2018Member" xlink:label="loc_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A2.616Notesduefiscal2022Member" xlink:label="loc_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A3.079Notesduefiscal2024Member" xlink:label="loc_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A3.41Notesduefiscal2027Member" xlink:label="loc_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A4.368Notesduefiscal2047Member" xlink:label="loc_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_ECC840F39F44747894E1937424C5A9C9" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_ECC840F39F44747894E1937424C5A9C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:to="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:to="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_E093867FD22F56137A56937424C56831_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:to="loc_us-gaap_RangeMember_E093867FD22F56137A56937424C56831_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_E093867FD22F56137A56937424C56831" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:to="loc_us-gaap_RangeMember_E093867FD22F56137A56937424C56831" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterests" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:to="loc_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:to="loc_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_757C30237C148440F79C93726D6BEB35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D" xlink:to="loc_cah_NaviHealthMember_757C30237C148440F79C93726D6BEB35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent" xlink:label="loc_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_A8C635E520F0C54C9E0F9373CE5D9E55" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_A8C635E520F0C54C9E0F9373CE5D9E55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_F3A69EC6435F4CC34C789373E4B1F157" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_F3A69EC6435F4CC34C789373E4B1F157" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_C2F3D38A1BB1F984EF279373E4AFA2BE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:to="loc_cah_ContractTerminationDomain_C2F3D38A1BB1F984EF279373E4AFA2BE_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_C2F3D38A1BB1F984EF279373E4AFA2BE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:to="loc_cah_ContractTerminationDomain_C2F3D38A1BB1F984EF279373E4AFA2BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_C2FD53955E95A2B4145B9373E4AF15F4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:to="loc_us-gaap_ConsolidationItemsDomain_C2FD53955E95A2B4145B9373E4AF15F4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_C2FD53955E95A2B4145B9373E4AF15F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:to="loc_us-gaap_ConsolidationItemsDomain_C2FD53955E95A2B4145B9373E4AF15F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8FB12F07B3D23A6B7A769373E4AF62E4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:to="loc_us-gaap_SegmentDomain_8FB12F07B3D23A6B7A769373E4AF62E4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8FB12F07B3D23A6B7A769373E4AF62E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:to="loc_us-gaap_SegmentDomain_8FB12F07B3D23A6B7A769373E4AF62E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4EE8CAE4CF13C2E3B5F69373E4B0A327_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4EE8CAE4CF13C2E3B5F69373E4B0A327_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4EE8CAE4CF13C2E3B5F69373E4B0A327" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4EE8CAE4CF13C2E3B5F69373E4B0A327" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_DD615E166683711877A59373E4B0F2A5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_DD615E166683711877A59373E4B0F2A5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_DD615E166683711877A59373E4B0F2A5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_DD615E166683711877A59373E4B0F2A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:to="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:to="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:to="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:to="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:to="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:to="loc_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:to="loc_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:to="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9DC971DD7897305FE15B7A3EE7D4E8F9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9DC971DD7897305FE15B7A3EE7D4E8F9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:to="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:to="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:to="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_DistributorContractMember" xlink:label="loc_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7" xlink:to="loc_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_BEA7CE870AF20AB945BD7A3EE7D42F99" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9DC971DD7897305FE15B7A3EE7D4E8F9" xlink:to="loc_cah_FacilityExitAndOtherCosts_BEA7CE870AF20AB945BD7A3EE7D42F99" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2451D2AD390832AB7FB5BA3EFE287D55" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2451D2AD390832AB7FB5BA3EFE287D55" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:to="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:to="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:to="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_3B433B30055BEEFDF946BA3EFE28EA4C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:to="loc_us-gaap_OperatingSegmentsMember_3B433B30055BEEFDF946BA3EFE28EA4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_82E69E88CFAF34B568EBBA3EFE28A0B9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:to="loc_us-gaap_CorporateNonSegmentMember_82E69E88CFAF34B568EBBA3EFE28A0B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:to="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:to="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_DD97F8D09A906B87DFE7BA3EFE285308" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:to="loc_cah_PharmaceuticalMember_DD97F8D09A906B87DFE7BA3EFE285308" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_A14D780034E108F28B3ABA3EFE286809" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:to="loc_cah_MedicalMember_A14D780034E108F28B3ABA3EFE286809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2451D2AD390832AB7FB5BA3EFE287D55" xlink:to="loc_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:to="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:to="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:to="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:to="loc_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:to="loc_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:to="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:to="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:to="loc_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:to="loc_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:to="loc_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:to="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:to="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:to="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_BD2D8FBF040DA200DD07BA3EFEA7D2C3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:to="loc_us-gaap_OperatingSegmentsMember_BD2D8FBF040DA200DD07BA3EFEA7D2C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_43ADABB899D8C4B06977BA3EFEA7DFF1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:to="loc_us-gaap_CorporateNonSegmentMember_43ADABB899D8C4B06977BA3EFEA7DFF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:to="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:to="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B55D19B82F77FFFCFE35BA3EFEA7B377" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:to="loc_cah_PharmaceuticalMember_B55D19B82F77FFFCFE35BA3EFEA7B377" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_94E363F086A4E3D1F730BA3EFEA832EA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:to="loc_cah_MedicalMember_94E363F086A4E3D1F730BA3EFEA832EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:to="loc_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:to="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_39495D380D9CFE174CF215FFAE868EE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_39495D380D9CFE174CF215FFAE868EE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:to="loc_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:to="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:to="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:to="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:to="loc_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:to="loc_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D03A55030F6F83337F2415FFAE87FEB3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D03A55030F6F83337F2415FFAE87FEB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F72189A1A7E6FF3F4D1015FFAE877D5A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F72189A1A7E6FF3F4D1015FFAE877D5A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:to="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:to="loc_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:to="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_29B6A68F89A290289FDB5E8D0C2E0314" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A" xlink:to="loc_us-gaap_PerformanceSharesMember_29B6A68F89A290289FDB5E8D0C2E0314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B6A03F2596838B56EF25E8D0C327FB8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B6A03F2596838B56EF25E8D0C327FB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_66306FF5C6162B44CCFD5E8D0C322AA5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_66306FF5C6162B44CCFD5E8D0C322AA5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:to="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_524B509B51AB642580E415FFAFD9959B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_524B509B51AB642580E415FFAFD9959B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_468A63879F7B081006C21603FF2BD303" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_468A63879F7B081006C21603FF2BD303" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_877DDAF0749CAFF736D915FFAFD983F6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_877DDAF0749CAFF736D915FFAFD983F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_C93D69C062F86EB7B69615FFAFD95098" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_C93D69C062F86EB7B69615FFAFD95098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7A046466574FA7DAB13615FFAFD964E3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7A046466574FA7DAB13615FFAFD964E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_582AFD21E2722704232915FFAFD9DD9D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_582AFD21E2722704232915FFAFD9DD9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59DF893796AA4EDAB70D15FFAFD963D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59DF893796AA4EDAB70D15FFAFD963D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_00429A96BCEB701AD65D15FFAFD9DF68" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_00429A96BCEB701AD65D15FFAFD9DF68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F43E50A694A727523A3115FFAFD90B2A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F43E50A694A727523A3115FFAFD90B2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_05551067AC81626953D715FFAFDA5981" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_05551067AC81626953D715FFAFDA5981" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142536CC5DB3E48070E9BA3EFE48E2CB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142536CC5DB3E48070E9BA3EFE48E2CB" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:to="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:to="loc_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142536CC5DB3E48070E9BA3EFE48E2CB" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:to="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:to="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1D8959E03E8704BB396A6F14C956789A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1D8959E03E8704BB396A6F14C956789A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:to="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:to="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:to="loc_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>cah-20170930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822" xlink:to="lab_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69_label_en-US" xlink:label="lab_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:to="lab_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C_label_en-US" xlink:label="lab_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:to="lab_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:to="lab_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:to="lab_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:to="lab_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84_label_en-US" xlink:label="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Member</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84_documentation_en-US" xlink:label="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:to="lab_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:type="arc" />
    <link:label id="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7_terseLabel_en-US" xlink:label="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7_label_en-US" xlink:label="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Member</link:label>
    <link:label id="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7_documentation_en-US" xlink:label="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:to="lab_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03_label_en-US" xlink:label="lab_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:to="lab_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:to="lab_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:to="lab_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:type="arc" />
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E_terseLabel_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E_label_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E_documentation_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:to="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:type="arc" />
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F_terseLabel_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPR&amp;D, trademarks and other</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F_label_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPR&amp;D,TrademarksandOther [Member]</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F_documentation_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:to="lab_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPR&amp;D, trademarks and other</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284_label_en-US" xlink:label="lab_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:to="lab_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:to="lab_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:type="arc" />
    <link:label id="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA_terseLabel_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names, and patents</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA_label_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks And Patents Member</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA_documentation_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:to="lab_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technology and other</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:type="arc" />
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3" xlink:to="lab_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, by Legal Entity [Table]</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, by Legal Entity [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:type="arc" />
    <link:label id="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6_verboseLabel_en-US" xlink:label="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">naviHealth</link:label>
    <link:label id="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6_label_en-US" xlink:label="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6_documentation_en-US" xlink:label="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:to="lab_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at June 30, 2017</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment of redeemable noncontrolling interests to redemption value</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at September 30, 2017</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating earnings</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:to="lab_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:to="lab_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:to="lab_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of outstanding options at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of exercisable options at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:to="lab_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized gain/(loss) on derivative instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:to="lab_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62" xlink:to="lab_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:to="lab_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:to="lab_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="lab_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired (using cost method), shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired, average price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:to="lab_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421_terseLabel_en-US" xlink:label="lab_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421_label_en-US" xlink:label="lab_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:to="lab_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463_terseLabel_en-US" xlink:label="lab_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463_label_en-US" xlink:label="lab_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:to="lab_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D_terseLabel_en-US" xlink:label="lab_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D_label_en-US" xlink:label="lab_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:to="lab_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594_label_en-US" xlink:label="lab_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:to="lab_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:type="arc" />
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF_terseLabel_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable period of plans (in years)</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF_label_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable period of plans, in years</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF_documentation_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The instrument's contractual term.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:to="lab_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Target performance goal (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:to="lab_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership interest (as a percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:type="arc" />
    <link:label id="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC_terseLabel_en-US" xlink:label="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease from purchase of interest</link:label>
    <link:label id="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC_label_en-US" xlink:label="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">noncontrolling interest, decrease from redemptions or purchase of interests percent</link:label>
    <link:label id="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC_documentation_en-US" xlink:label="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease in noncontrolling interest percentage (for example, but not limited to redeeming or purchasing the interest of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest by the non-wholly owned subsidiary from the noncontrolling interests).</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent" xlink:label="loc_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:to="lab_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Redemption Value</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Redemption Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6" xlink:to="lab_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="lab_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE_label_en-US" xlink:label="lab_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:to="lab_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4_label_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:to="lab_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10_label_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:to="lab_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB" xlink:to="lab_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:to="lab_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22_label_en-US" xlink:label="lab_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:to="lab_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:to="lab_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution, selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:to="lab_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:type="arc" />
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC_terseLabel_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC_label_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC_documentation_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:to="lab_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairments and (gain)/loss on disposal of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Litigation (recoveries)/charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E" xlink:to="lab_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7_label_en-US" xlink:label="lab_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:to="lab_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6" xlink:to="lab_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:to="lab_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per common share attributable to Cardinal Health, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends declared per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:to="lab_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Inputs, Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:type="arc" />
    <link:label id="lab_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305_label_en-US" xlink:label="lab_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305_documentation_en-US" xlink:label="lab_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_DocumentAndEntityInformationAbstract" xlink:label="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="lab_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B_terseLabel_en-US" xlink:label="lab_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B_label_en-US" xlink:label="lab_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:to="lab_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814_label_en-US" xlink:label="lab_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:to="lab_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:to="lab_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:to="lab_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:to="lab_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006_label_en-US" xlink:label="lab_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:to="lab_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77_label_en-US" xlink:label="lab_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:to="lab_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:to="lab_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:to="lab_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:to="lab_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08_label_en-US" xlink:label="lab_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:to="lab_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:to="lab_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt and Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:to="lab_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="lab_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:to="lab_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:to="lab_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:type="arc" />
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417_terseLabel_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417_label_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417_documentation_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other short-term credit facilities and an unsecured line of credit</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:to="lab_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:type="arc" />
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A_terseLabel_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A_label_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A_documentation_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:to="lab_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="arc" />
    <link:label id="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F_terseLabel_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F_label_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F_documentation_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:to="lab_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:to="lab_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:type="arc" />
    <link:label id="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247_terseLabel_en-US" xlink:label="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.7% Notes due fiscal 2018 [Member]</link:label>
    <link:label id="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247_label_en-US" xlink:label="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.7% Notes due fiscal 2018 [Member]</link:label>
    <link:label id="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247_documentation_en-US" xlink:label="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1.7% Notes due fiscal 2018</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_A1.7Notesduefiscal2018Member" xlink:label="loc_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:to="lab_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:type="arc" />
    <link:label id="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8_terseLabel_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1.948% Notes due 2019 [Member]</link:label>
    <link:label id="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8_label_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.948% Notes due 2019 [Member]</link:label>
    <link:label id="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8_documentation_en-US" xlink:label="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">1.948% Notes due 2019</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:to="lab_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:type="arc" />
    <link:label id="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A_terseLabel_en-US" xlink:label="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.616% Notes due fiscal 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A_label_en-US" xlink:label="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.616% Notes due fiscal 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A_documentation_en-US" xlink:label="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2.616% Notes due fiscal 2022</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_A2.616Notesduefiscal2022Member" xlink:label="loc_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:to="lab_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:type="arc" />
    <link:label id="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64_terseLabel_en-US" xlink:label="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.079% Notes due fiscal 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64_label_en-US" xlink:label="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.079% Notes due fiscal 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64_documentation_en-US" xlink:label="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.079% Notes due fiscal 2024</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_A3.079Notesduefiscal2024Member" xlink:label="loc_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:to="lab_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:type="arc" />
    <link:label id="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874_terseLabel_en-US" xlink:label="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.41% Notes due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874_label_en-US" xlink:label="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.41% Notes due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874_documentation_en-US" xlink:label="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.41% Notes due fiscal 2027</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_A3.41Notesduefiscal2027Member" xlink:label="loc_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:to="lab_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:type="arc" />
    <link:label id="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5_terseLabel_en-US" xlink:label="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.368% Notes due fiscal 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5_label_en-US" xlink:label="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.368% Notes due fiscal 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5_documentation_en-US" xlink:label="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.368% Notes due fiscal 2047</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_A4.368Notesduefiscal2047Member" xlink:label="loc_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:to="lab_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:to="lab_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:to="lab_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="lab_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:to="lab_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:to="lab_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain/(Loss) on Derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:type="arc" />
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Loss [Rollforward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(loss), before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:to="lab_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:to="lab_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:to="lab_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B_label_en-US" xlink:label="lab_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:to="lab_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:to="lab_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:to="lab_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E_label_en-US" xlink:label="lab_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:to="lab_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Redeemable Noncontrolling Interests and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:to="lab_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="lab_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, without par value:</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;500 thousand shares, Issued&#8212;none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:to="lab_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, without par value:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;755 million shares, Issued&#8212;327 million shares and 327 million shares at September 30, 2017 and June 30, 2017, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:to="lab_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury, at cost: 12 million shares and 11 million shares at September 30, 2017 and June 30, 2017, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:to="lab_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cardinal Health, Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:to="lab_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:to="lab_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290_terseLabel_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities</link:label>
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290_label_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:to="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D_terseLabel_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities</link:label>
    <link:label id="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D_label_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Types of Debt and Equity Securities [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="lab_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:type="arc" />
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury bills</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:to="lab_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International bonds</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Government Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. agency bonds</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:to="lab_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:to="lab_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:to="lab_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:type="arc" />
    <link:label id="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F_terseLabel_en-US" xlink:label="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract Termination [Axis]</link:label>
    <link:label id="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F_label_en-US" xlink:label="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Termination [Axis]</link:label>
    <link:label id="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F_documentation_en-US" xlink:label="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Termination [Axis]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:to="lab_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:type="arc" />
    <link:label id="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C_terseLabel_en-US" xlink:label="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract Termination [Domain]</link:label>
    <link:label id="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C_label_en-US" xlink:label="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Termination [Domain]</link:label>
    <link:label id="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C_documentation_en-US" xlink:label="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Contract Termination [Axis]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:to="lab_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee- Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:to="lab_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:type="arc" />
    <link:label id="lab_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:to="lab_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="lab_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:to="lab_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:to="lab_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:to="lab_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF" xlink:to="lab_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6_terseLabel_en-US" xlink:label="lab_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:to="lab_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054_label_en-US" xlink:label="lab_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="lab_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:to="lab_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:to="lab_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:to="lab_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:to="lab_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:to="lab_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Identifiable intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total identifiable intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total identifiable net assets acquired/(liabilities) assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F_label_en-US" xlink:label="lab_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:to="lab_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Unit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:to="lab_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Unit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:to="lab_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:to="lab_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:to="lab_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee-related costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:to="lab_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:type="arc" />
    <link:label id="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67_terseLabel_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67_label_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67_documentation_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:to="lab_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total restructuring and employee severance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621" xlink:to="lab_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:type="arc" />
    <link:label id="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966_terseLabel_en-US" xlink:label="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Obligation</link:label>
    <link:label id="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966_label_en-US" xlink:label="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Classified as a Liability [Member]</link:label>
    <link:label id="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966_documentation_en-US" xlink:label="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Classified as a Liability [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ContingentConsiderationClassifiedasaLiabilityMember" xlink:label="loc_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:to="lab_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions from acquisitions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9" xlink:type="arc" />
    <link:label id="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C_terseLabel_en-US" xlink:label="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medline [Member]</link:label>
    <link:label id="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C_label_en-US" xlink:label="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distributor Contract [Member]</link:label>
    <link:label id="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C_documentation_en-US" xlink:label="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distributor Contract [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_DistributorContractMember" xlink:label="loc_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:to="lab_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments, Contingent Liabilities and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share Attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Profit by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:type="arc" />
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:to="lab_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated range of decrease in unrecognized tax benefits within the next 12 months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA_terseLabel_en-US" xlink:label="lab_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax years open for examination</link:label>
    <link:label id="lab_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA_label_en-US" xlink:label="lab_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:to="lab_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:type="arc" />
    <link:label id="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED_terseLabel_en-US" xlink:label="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED_label_en-US" xlink:label="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED_documentation_en-US" xlink:label="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indemnification receivable from CareFusion related to certain pre-Spin tax exposures and transaction taxes.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:to="lab_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Share-based Compensation Expense by Type of Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Transactions Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:type="arc" />
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13_terseLabel_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Additional Data Related to Stock Option Activity</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13_label_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13_documentation_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A disclosure of additional data related to all stock option activity</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:to="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Restricted Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Performance Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="lab_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:to="lab_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174_label_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:to="lab_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:type="arc" />
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C_terseLabel_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C_label_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C_documentation_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:to="lab_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702_label_en-US" xlink:label="lab_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:to="lab_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:type="arc" />
    <link:label id="lab_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB_terseLabel_en-US" xlink:label="lab_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB_label_en-US" xlink:label="lab_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:to="lab_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:type="arc" />
    <link:label id="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2_terseLabel_en-US" xlink:label="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2_label_en-US" xlink:label="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:label id="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2_documentation_en-US" xlink:label="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:to="lab_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C_label_en-US" xlink:label="lab_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseAxis" xlink:label="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:to="lab_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A_label_en-US" xlink:label="lab_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:to="lab_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="lab_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:type="arc" />
    <link:label id="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E_terseLabel_en-US" xlink:label="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial term of pharmaceutical sourcing venture</link:label>
    <link:label id="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E_label_en-US" xlink:label="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial term of Pharmaceutical Sourcing Venture</link:label>
    <link:label id="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E_documentation_en-US" xlink:label="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Initial term of Pharmaceutical Sourcing Venture</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_InitialtermofPharmaceuticalSourcingVenture" xlink:label="loc_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:to="lab_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:type="arc" />
    <link:label id="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20_terseLabel_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum quarterly payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20_label_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20_documentation_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:to="lab_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of lawsuits filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Request for Information</link:label>
    <link:label id="lab_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F_label_en-US" xlink:label="lab_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Request for Information</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyRequestForInformation" xlink:label="loc_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:to="lab_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:type="arc" />
    <link:label id="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120_terseLabel_en-US" xlink:label="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Net of Insurance Recoveries</link:label>
    <link:label id="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120_label_en-US" xlink:label="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Net of Insurance Recoveries</link:label>
    <link:label id="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120_documentation_en-US" xlink:label="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Net of Insurance Recoveries</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_LossContingencyAccrualNetofInsuranceRecoveries" xlink:label="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:to="lab_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:to="lab_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:to="lab_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:to="lab_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of the Changes in Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairments and loss on sale of other investments</link:label>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7_label_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:to="lab_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:to="lab_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for bad debts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities and operating items, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:type="arc" />
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A_negatedLabel_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A_label_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A_documentation_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow from purchases of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:to="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:type="arc" />
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938_label_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938_documentation_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash inflow from sales of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:to="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from maturities of available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:type="arc" />
    <link:label id="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC_negatedTerseLabel_en-US" xlink:label="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration obligation</link:label>
    <link:label id="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC_label_en-US" xlink:label="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment of Contingent Consideration</link:label>
    <link:label id="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC_documentation_en-US" xlink:label="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow from a settlement payment of contingent consideration assumed in a business combination.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_PaymentofContingentConsideration" xlink:label="loc_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:to="lab_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:to="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction of long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from interest rate swap terminations</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Hedge, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:to="lab_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:type="arc" />
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9_terseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net tax withholdings from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9_label_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9_documentation_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7_terseLabel_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Excess tax benefits from share-based compensation</link:label>
    <link:label id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7_label_en-US" xlink:label="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Excess Tax Benefit from Share-based Compensation, Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:to="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividends on common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rates changes on cash and equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net decrease in cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-Sale Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;basic (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating and Reportable Segment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:to="lab_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="lab_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:to="lab_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill acquired, net of purchase price adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE" xlink:to="lab_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:to="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2_label_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:to="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for acquisitions, net of cash acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:type="arc" />
    <link:label id="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533_terseLabel_en-US" xlink:label="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Product Categories Manufactured</link:label>
    <link:label id="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533_label_en-US" xlink:label="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Product Categories Manufactured</link:label>
    <link:label id="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533_documentation_en-US" xlink:label="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Product Categories Manufactured</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_NumberofProductCategoriesManufactured" xlink:label="loc_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:to="lab_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:type="arc" />
    <link:label id="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2_terseLabel_en-US" xlink:label="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of principal countries</link:label>
    <link:label id="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2_label_en-US" xlink:label="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Countries</link:label>
    <link:label id="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2_documentation_en-US" xlink:label="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal countries.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_PrincipalCountries" xlink:label="loc_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:to="lab_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:type="arc" />
    <link:label id="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D_terseLabel_en-US" xlink:label="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction and integration costs</link:label>
    <link:label id="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D_label_en-US" xlink:label="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Transaction and integration costs</link:label>
    <link:label id="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D_documentation_en-US" xlink:label="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Costs incurred during the initial evaluation of a potential acquisition that primarily relate to costs to analyze, negotiate, and consummate the transaction, as well as due diligence activities. Also includes costs related to activities required to combine the operations of an acquired enterprise into our operations and to stand-up the systems and processes needed to support a global footprint.</link:label>
    <link:loc xlink:href="cah-20170930.xsd#cah_BusinessCombinationTransactionandintegrationcosts" xlink:label="loc_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:to="lab_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Discount Rate</link:label>
    <link:label id="lab_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5_label_en-US" xlink:label="lab_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Discount Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:to="lab_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>cah-20170930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/Acquisitions" xlink:href="cah-20170930.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails" xlink:href="cah-20170930.xsd#AcquisitionsAcquisitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables" xlink:href="cah-20170930.xsd#AcquisitionsBusinessCombinationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AcquisitionsNarrativeDetails" xlink:href="cah-20170930.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecurities" xlink:href="cah-20170930.xsd#AvailableForSaleSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:href="cah-20170930.xsd#AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables" xlink:href="cah-20170930.xsd#AvailableForSaleSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20170930.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20170930.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20170930.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:href="cah-20170930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20170930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:href="cah-20170930.xsd#ConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:href="cah-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20170930.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20170930.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20170930.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:href="cah-20170930.xsd#FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20170930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20170930.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20170930.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20170930.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20170930.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20170930.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20170930.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20170930.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20170930.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterests" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterests" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables" xlink:href="cah-20170930.xsd#RedeemableNoncontrollingInterestsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20170930.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20170930.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20170930.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20170930.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20170930.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20170930.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20170930.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20170930.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20170930.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20170930.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20170930.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20170930.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_4C56A429ABAD583130B0738384F50F78" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_F6B4C14D38028E4D663B738384F5CAD9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AcquisitionsAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6D09B727BD4DB7BFD75A829E87A12C0D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6D09B727BD4DB7BFD75A829E87A12C0D" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_6E219BD3B851B9DCFF7282A1ABC8C307" xlink:to="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_636E9F4D59D8FAA7D7D682A1AC0F7758" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:to="loc_us-gaap_MinimumMember_636E9F4D59D8FAA7D7D682A1AC0F7758" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_B5CC674820A09208FCBC82A1AC2E93ED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_B0101AE264A4FC1EF03F82A1ABC92485" xlink:to="loc_us-gaap_MaximumMember_B5CC674820A09208FCBC82A1AC2E93ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A5EA7187449E1AC17142829E87A18917" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8027051EFD74D17C9F59829E87A1615A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8027051EFD74D17C9F59829E87A1615A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="loc_us-gaap_TradeNamesMember_EB63E1745597E409A68D829E87A1AF94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3BE7E28FE7C4E2036D67829E87A158A4" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_50FA8EB57F35FDF7603F829E87A124A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_B08F8023E160FF128759829E87A25DF7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_D19701FBA6C58A899C74829E87A20D60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72BD7F19F27B7C8F4AAB829E87A20855" xlink:to="loc_cah_PatientRecoveryBusinessMember_D19701FBA6C58A899C74829E87A20D60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CBD693AABFDA811F1429829E87A1BC76" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_6AA8441F94198AD5A4CE829E87A29C4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3D2F0A28B6CD1580422F829E87A20FDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_25385E811069A9FE83F0829E87A2CD3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_961A6FBF69A0956D1B8A829E87A2EBB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7DBB9A1C12260AEA9163829E87A247DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_E09BA467DCB4CED35472829E87A21F7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9B2088F6579D3D034C74829E87A3CD57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_59B9993573C88FB261B5829E87A36962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1262751B54B54649AA79829E87A31D10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_Goodwill_8889D32B76BB43F03264829E87A3037F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_197FFEE82F910EF2B1EC829E87A386E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90BED7BB6F537997C13D829E87A2D2F8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_F1464A7990B265C51FA982A1ABA53269" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_D348CBF19EACABDDC99F8296F9F999E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_D348CBF19EACABDDC99F8296F9F999E7" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5855BA4D869E9C4BADFB8296F9FB387C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_995551F316A11F4BF237829E87B9DE96" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_995551F316A11F4BF237829E87B9DE96" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_283A565E200530C3D590829E87BA00CF" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_DD30261D0F552E33A4D2829E87BA5F48" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_C5614AEABDB4EFF3E246829E87BAA849" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D10BFA2C41E9FDFF9EAB829E87BA30C3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_D4C22BA90C56D0A6B751829E87BA6283" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511441C3604EC6F77534829E87BA75C5" xlink:to="loc_cah_PatientRecoveryBusinessMember_D4C22BA90C56D0A6B751829E87BA6283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D021721095F67B82E483829E87BABE0B" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3F82D996CDF63E82E75E829E87BA4177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_481293AF40AA86A7D0E0829E87BB5EED" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_NumberofProductCategoriesManufactured" xlink:label="loc_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_cah_NumberofProductCategoriesManufactured_7ED719D15225F156E927829E87BB7533" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PrincipalCountries" xlink:label="loc_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_cah_PrincipalCountries_B8265CFC1D66B424C11A829E87BB70D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_4AEAD97C7C29A104AE58829E87BBA1A7" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_BusinessCombinationTransactionandintegrationcosts" xlink:label="loc_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_cah_BusinessCombinationTransactionandintegrationcosts_165A3EFCEC8E58053D93829E87BB821D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8A55BACCDE741FF84366829E87BA05B5" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_8F5B138A7D086DAF2DF7829E87BBE1B5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecurities" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_423E14FED8ED4C4F8FF1BA3EFE4E5705" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_423E14FED8ED4C4F8FF1BA3EFE4E5705" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7B3EF30A289543824E3DBA3EFE4FB96F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_58B7593AADDBDDE47B876F2E29C07914" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_BBBD5617D4C43F85FBCB6F44CA678011" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2E8FECC5726DED27AF0E6F44CFFC8AA5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9827D2D366DB26893E6E6F44CA6E3CDD" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2E8FECC5726DED27AF0E6F44CFFC8AA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C4556273C0F7173825FB6F44CA0D9801" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_E3C7F072D35B672A8EBD6F44CA1EC388" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6166A1DEB9C0EA0845996F44CF4B4F57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_2F0ACD82AD321143E88D6F2E29C0D290" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_AA1D79FE6F12C7E953176F44CACCC3BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_F821B23642DAEF876D226F44CC357D21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateBondSecuritiesMember" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_DA23A6CE778835EB02D06F44CC72EFBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:label="loc_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_MunicipalBondsMember_EC8EEDD598659670FCB76F44CCE0A617" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetBackedSecuritiesMember" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_A09B754CEDB1A202C9E66F44CDC2D3A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_007DE333AE1E8D89DFCA6F2E29C1270D" xlink:to="loc_us-gaap_EquitySecuritiesMember_9A06A4BD895F290F9E586F44CE53FB69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_EA0351987ED800A704636F2E29C05794" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9A67D74BF92D2DAA37646F2E29C1C5EF" xlink:to="loc_us-gaap_AvailableForSaleSecurities_9F3F87E8C1C31AAAFFC26F2E29C10FAF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/AvailableForSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5C61680405867DF3EE5CBA3EFEC7FE24" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5C61680405867DF3EE5CBA3EFEC7FE24" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_B79DF8296725327BB49EBA3EFEC7AC12" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_B5E1F4B615101A0353CDBA3EFEC1048A" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_6C1F2DFB688C12ABC018BA3EFEC1A3D9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_F0B189DBFD61EA4C2FAA5F188C36DB9E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_F0B189DBFD61EA4C2FAA5F188C36DB9E" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_6994899DE949B8E17C0F5F188C36E100" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_346D14EFE1167BA2A9195F188C369BF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_D7F8EBDD0EE5A2661E365F188C36FE18" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_754C9A595E2E11C665005F188C36D8C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_130FAE7195050922ADF05F188C36B34B" xlink:to="loc_cah_FacilityExitAndOtherCosts_754C9A595E2E11C665005F188C36D8C7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_AC518318EB49A56BA637BA3EFE5E50A1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_AC518318EB49A56BA637BA3EFE5E50A1" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7B4BD2AB2847846A40FCBA3EFE5EC22E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_AC518318EB49A56BA637BA3EFE5E50A1" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_D63EE60032822AB7269ABA3EFE5E243E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BC6D33CB88C7D2E039EBBA3EFEFF6B76" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_AF736005993821F78A48BA3EFEFFE292" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1771C8851AF6085B48A06EE32440C0E6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1771C8851AF6085B48A06EE32440C0E6" xlink:to="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_21CE4E190A09BB7A3E9C6EE32440DCD1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:to="loc_cah_OpioidLawsuitsMember_A2440F447B9EEBAA34A66EE324406174" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_D8F028D4B734BB913DEA6EE3244082BF" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorCustomersAxis_57866E92AAA84A8F30866EE324408702" xlink:to="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfMajorCustomerDomain_8CBA2FDE2AC49B5D56516EE3244027BB" xlink:to="loc_cah_CVSHealthMember_770EDF52590F0545F3236EE324403FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseAxis" xlink:label="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseAxis_0827CB7C10035C2FCD8F6EE32440284C" xlink:to="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_D64C48878C9FAD1A05C86EE32440488A" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_8EDC3B0BA438C36EB3586EE32440894C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7FE503E5534ECF6F803E6EE324411A90" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_7098F8CE8A9812D099076EE324417C50" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_808B3A11BC727DEFFA066EE324413EAE" xlink:to="loc_us-gaap_SubsequentEventMember_7098F8CE8A9812D099076EE324417C50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_CDE2FC61376739A9AF226EE32440DE40" xlink:to="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_InitialtermofPharmaceuticalSourcingVenture" xlink:label="loc_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_cah_InitialtermofPharmaceuticalSourcingVenture_95B8208F4A03195096806EE324415E4E" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_cah_MaximumQuarterlyPayment_C0614579657D6C99CE466EE324411D20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_794E0DF06A7EB0C9BB0C6EE324417E00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyRequestForInformation" xlink:label="loc_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingencyRequestForInformation_0E31A042BE652DF82A096EEBC6DBC36F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_5FD89E7FC6B47EA546BD6EE32441E647" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_LossContingencyAccrualNetofInsuranceRecoveries" xlink:label="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_487EB03003F7124FD64B6EE324419737" xlink:to="loc_cah_LossContingencyAccrualNetofInsuranceRecoveries_C8CD884BAC563884A20A6EE6A94AC120" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:to="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:to="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5197C7C30E577B0D632C6F14CA50EE21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:to="loc_us-gaap_ReceivablesNetCurrent_21A1F07E1D5969C034256F14CA50F765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:to="loc_us-gaap_InventoryNet_A2DE4068C1B52C43D1C76F14CA50637B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:to="loc_us-gaap_OtherAssetsCurrent_C2ECFA4C3F8AE5FE3FDD6F14CA51532C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_EEB35110815739E988516F14CA50139E" xlink:to="loc_us-gaap_AssetsCurrent_823FC7C9ED896296A5AA6F14CA516F39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_110896FB93824D6D197C6F14CA516FD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_343C79A50DDAD35EC6136F14CA51C231" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_23B87142A3728B40D6906F14CA51D4AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2B48D63819E8FF28DADA6F14CA503539" xlink:to="loc_us-gaap_Assets_1ED4C84F8AA9A366E9E06F14CA517A4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B4EE177AE48DFC25019E6F14CA508EF5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_54517054DCEC664D94EB6F14CA57C209" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:to="loc_us-gaap_AccountsPayableCurrent_54517054DCEC664D94EB6F14CA57C209" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_43218C1378761F71E65C6F14CA57EDCA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7328D791984405181CF66F14CA57CC94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C1DCAE34CC348FFB53216F14CA568346" xlink:to="loc_us-gaap_LiabilitiesCurrent_4D2EFDE37EE582BCE4BD6F14CA5744B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6B6A61AB122FFD5576216F14CA57B1CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_7C257D9D6DD51EE5B2D26F14CA57EBA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_91F44917F08F2778C33E6F14CA57C016" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_3D8BB85A23C3C77500896F14CA57EDF8" xlink:to="loc_us-gaap_PreferredStockValue_7F291ADEC318675DBA4E6F14CA57A8DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_98367A75E4FA7B92FCFC6F14CA575522" xlink:to="loc_us-gaap_CommonStockValue_369C40ED6CAE87E7BB276F14CA5727EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0B14C6BDD0AFEAC3E8F46F14CA5863DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_TreasuryStockValue_E9E9403C143B25F073866F14CA586844" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2A1E4CD9883ABBD789C16F14CA5850BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_StockholdersEquity_1ACE1879825677152C7A6F14CA586350" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_MinorityInterest_148CE199460BE2140D416F14CA588D76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_BE0C8A2391BA2A3763576F14CA576339" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0BE42138552B83DCB53B6F14CA58D86E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_43D3AE71C7C3E275328D6F14CA51F1B8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_C22ACB626424997613346F14CA58B53E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_22FF3941311626DBA197BA3EFE4BC61C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22FF3941311626DBA197BA3EFE4BC61C" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7574DF12F05414BEC602BA3EFE4BF0AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22FF3941311626DBA197BA3EFE4BC61C" xlink:to="loc_us-gaap_PreferredStockSharesIssued_253C77EE734676710AEDBA3EFE4BFDB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22FF3941311626DBA197BA3EFE4BC61C" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_46151B21C7CE40221988BA3EFE4B87EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22FF3941311626DBA197BA3EFE4BC61C" xlink:to="loc_us-gaap_CommonStockSharesIssued_0920A6C5B439A72633BFBA3EFE4CFB29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_22FF3941311626DBA197BA3EFE4BC61C" xlink:to="loc_us-gaap_TreasuryStockShares_A2B35ADC47833F708525BA3EFE4C805A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_BA3B85AC030AAD928608829E87F72C0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:to="loc_us-gaap_ProfitLoss_BA3B85AC030AAD928608829E87F72C0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_41B12CCD5A801882C5A1829E87F70DD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6FF35853F357060B8BB1829E87F8DF40" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6FF35853F357060B8BB1829E87F8DF40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_7603253602739C0E0CAA829E87F848A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B1B90BE188B9B82E3413829E87F8DF0B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B1B90BE188B9B82E3413829E87F8DF0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_ShareBasedCompensation_DA92AF909A5FA197484B829E87F8C1D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_80BF7024ED45C1FDA6A9829E87F86370" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_F6CBEAA231A0B433F46D829E87F72233" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_3A884646FFDFF14CAF64829E87F857B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_DB7BA3B8687EDAF6989B829E87F8E304" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_EF4D2BE7DA4C1DA4ED2D829E87F80C9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_458F71FA62968119F270829E87F828C9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6205114E83ED238391C3829E87F8D219" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5C5A9F64F0C2C8F3BAE6829E87F78AF8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88C66D939489AD626C54829E87F85327" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6649064D56FC8A14876A829E87F8F179" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A0E2908E9B41FFF359DE829E87F99492" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_223D5BF8D59DB5315831829E87F9ED1A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_AA9B47ED171BF1C6851C829E87F90938" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3A56930F64C2C4619DF8829E87F9B1BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_A45CCA6C95985CD6A824829E87F9F957" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_DC444A40104606FE045B829E87F8B9A2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B4A0F127E4D0122554B5829E87F9A8D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PaymentofContingentConsideration" xlink:label="loc_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_cah_PaymentofContingentConsideration_81B113FD29E2486186F1829E87F991EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_0574654B949C229B3A3E829E87F9512E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_B0CFE207E393D976DE5B829E87F9A4D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_CB993AF1D94D5B5052C0829E87F915A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromHedgeFinancingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities_5783AC6E29C65D434B6B829E87F9EA24" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_9D82012465FC11A13F76829E87F9DBE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_A41932E203357F71F23C829E87F917E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_04FAE35FAF9BBC9DE388829E87FA4DA1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_A05C49336188E1400640829E87FA6778" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_DBDAFB96F4E4AA880C26829E87F919C0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1FBD59425EAD9D6E7F01829E87FA4439" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D924E836B531D5DEB20A829E87FA5F0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D0B22279F6528F869037829E87FA37F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8648D70E6B49D5B759BB829E87FA751E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_84B884074B438370C96A829E87F74276" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2ED4451A9107A397C1EE829E87FA8BD8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:to="loc_us-gaap_ProfitLoss_D18A2261C33A9CE891096F14CA6CA05E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0B14BEB8ABD1A06FC3696F14CA71CC3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_8CD6533ECAFE2E1ACFBC6F14CA71F21E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_CCCC30F92A73387731856F14CA710D15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15B18557DB39637AF69C6F14CA72EADB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_D8C15085AF62483B9C626F14CA72CFFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99D4AB33669F0238EA526F14CA7264A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_AADAF05FC6DD00ABB07F6F14CA6CFE66" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_AA0DBC042A375328E9D36F14CA72EDE0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:to="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_46CC2D9AAB6754FE62576F2E2A1F48B4" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_50507ABE374833CE836F6F2E2A1F1A10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CDB238D87854D17B9D116F2E2A1FFFDE" xlink:to="loc_us-gaap_StatementLineItems_ACB0A55FF49F57E3311F6F2E2A1F28BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_Revenues_A7C223018D98B616281C6F2E2A1F32CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_CostOfGoodsSold_F0AAE74AA07A66E9C4EE6F2E2A1FDD57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_GrossProfit_1555C031EC47B8DB98C26F2E2A1F3B22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_AC17E74115A50EBE008B6F2E2A1F92B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:to="loc_us-gaap_RestructuringCharges_957FAA5E77760DC3F1E56F2E2A1FC3F4" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_48D89456E32DE3A62AD36F2E2A1F30EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_B139F45793047A44F9406F2E2A1FD9C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4AF7F1FF8E97A16980BE6F2E2A1F065D" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_909615528838BAD242136F2E2A1FDA90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_OperatingIncomeLoss_3ADB05DEC4BD0A2B4A586F2E2A209D6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_BF06E0FF645B2461D8086F2E2A2023BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_InterestExpense_52E5909FA966C6D68F526F2E2A20E2A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_B6373592FF3807E8EE556F2E2A2083C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DAB3803CB0E4F97B05966F2E2A208819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3497E07A03387F3832B86F2E2A2084B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_ProfitLoss_E0BAC21E62DC2D62A01E6F2E2A2025E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0153C722675EE5A3012D6F2E2A20366D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_NetIncomeLoss_8D0C00A7542EC40DBF9E6F2E2A201990" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_29EB734E5AD2FEEE4E986F2E2A20C607" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_A61C5306295D332CFC296F2E2A205E26" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_1FE70EDC6EA4071327F36F2E2A200183" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_D68C4D86ED05BEC3AAC26F2E2A202618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_95C177A4A383B22BA0476F2E2A20BAE4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_56EFB616E3684066EAAF6F2E2A202D01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5C46321280553D8420CD6F2E2A1F1953" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_C36979E9F8CA096F9C276F2E2A20DFB4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="cah-20170930.xsd#cah_DocumentAndEntityInformationAbstract" xlink:label="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_DocumentType_2D3B8305342982AB4B2EBA3EFEBF007B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_AmendmentFlag_0884CEA252920F7936E2BA3EFEBF6814" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_DocumentPeriodEndDate_80B3DFF4615FB3740D4FBA3EFEC027B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_DocumentFiscalYearFocus_8BCEA1C91F4D943BFFAABA3EFEC02928" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_DocumentFiscalPeriodFocus_93A82F944D227729F5D5BA3EFEC0443E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_TradingSymbol_371214FAD5A87F91E8D4BA3EFEC04006" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_EntityRegistrantName_DE799FD41647635C41C2BA3EFEC0CC77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_EntityCentralIndexKey_ECBBD8416A6321F5478CBA3EFEC00589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_CurrentFiscalYearEndDate_B3BCE47E52CFA09F570ABA3EFEC09394" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_EntityCurrentReportingStatus_012CC411361D11B952A5BA3EFEC09CFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_EntityFilerCategory_AAA2030F3EB5A007D74CBA3EFEC08E08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_DocumentAndEntityInformationAbstract_E362EF6C54DEAE3ECCEEBA3EFEBF9305" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_F560EF0019D5F823BD0EBA3EFEC003D4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_38BD006470E38ADE53B15A08E166E6CF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_38BD006470E38ADE53B15A08E166E6CF" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_9BBDE3124EF96217E69F5A08E166AD4C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_DB22555B5D8F545D57EB12787C8D98C6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_E6E79456D147F152A19612787C8EE03E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_33D3AECF2D6B99F075566EE08CBADCD0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33D3AECF2D6B99F075566EE08CBADCD0" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_5951C05BF806204B73BE6EE08CBA9E16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33D3AECF2D6B99F075566EE08CBADCD0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_CC7D953FD5F5839C16126EE08CBABAA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33D3AECF2D6B99F075566EE08CBADCD0" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_A3E903A4D3F3A84A52246EF9FB526B54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_33D3AECF2D6B99F075566EE08CBADCD0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4A5F431A17A8E492BDE06EE08CBA353E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_637DAA8E504686B0487B5A08E206CF16" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_637DAA8E504686B0487B5A08E206CF16" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_6A51FCD09C31A22A36C75A08E206D3C3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1BF94C2D90A1F0C693DABA3EFE681E1B" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_78E4CC1372713FEB2824BA3EFE68A234" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_07B906335E306D1415A46F096D0A1329" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07B906335E306D1415A46F096D0A1329" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7B3CA8CE8FB33618F36A6F096D0A7C6B" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5788C6501FE7479E1C276F096D0CBE43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3802C94DA45D02003CDF6F096D0B6466" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5788C6501FE7479E1C276F096D0CBE43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A72614FB51E5BBD56BC86F096D0C3DA2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_66C516315E5FB1C0B1736F096D0C804D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_E44C5B465E886AA9BFD16F096D0C9755" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_E44C5B465E886AA9BFD16F096D0C9755" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_D195AE71894F1C2BD8E66F096D0DB314" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_E200BBC43D804A2456306F096D0CFA9B" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_D195AE71894F1C2BD8E66F096D0DB314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_CCED507095A542E46F936F096D0AE162" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_DC6BB3B42C44AE4FB1A56F096D0D8BD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecurities_CD8A96A7C0A70C80C6AC6F096D0D5BD8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="loc_us-gaap_AvailableForSaleSecurities_CD8A96A7C0A70C80C6AC6F096D0D5BD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_36292D1BA408AEC498E56F096D0D4962" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_E17F2AF5454E41F5DDC96F096D0D6B82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_DFC1098D8FCAE1AE40DA6F096D0DF1A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_B6FF743D092B7B7283596F096D0D0E9B" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1ADFBC714137D4616BFE6F096D0D3FB2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_FD3F76BAF36BD4EB16E56F096D0D6ABE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_CDE772630889FBB7FECE6EC1E678CEAE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_CDE772630889FBB7FECE6EC1E678CEAE" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_44167B92013D7AB16F466EC1E678F0A0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_22D3721183DBB89C7DF36EC1E6784398" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_99B40DB13EDC1217313A6EC1E67887D5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_22D3721183DBB89C7DF36EC1E6784398" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_4ABF119A2301CD3C8CB76EC1E678F25F" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContingentConsiderationClassifiedasaLiabilityMember" xlink:label="loc_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_858D2CACFCDDEFF579276EC1E6784347" xlink:to="loc_cah_ContingentConsiderationClassifiedasaLiabilityMember_10AA5F9D9AD8BD0AAD206EC1E6788966" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_50BFC0A526810CC9ED8C6EC1E6780B8F" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_A4DF3D95CEE3ECB9F0AE6EC1E68A1BCD" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7D3DD4E1FE601736DC9B6EC1E68AC2DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_EC25BABD85BB0A80B5C16EC1E68B1C03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_19EE06850B594C62E6906EC1E68B86BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4D2740626280B9C786196EC1E68B5D83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_31360442E01D0300CBD16EC1E68A695F" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_793768B9E7AFB16CDFE36EC1E68B77C8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_957588D7A4DF7CAEB4ADBA3EFE7AD346" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_957588D7A4DF7CAEB4ADBA3EFE7AD346" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_042A0C83432E0E5B6BCBBA3EFE7A7F3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_957588D7A4DF7CAEB4ADBA3EFE7AD346" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_002B5CC60E29CE0042F4BA3EFE7A6A5B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_45979585B1C03831824EBA3EFE52DC95" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_2A5D1B52C9D9A3660DF8BA3EFE52657C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D5A437F097B981CAB3616E649DB6DFC6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D5A437F097B981CAB3616E649DB6DFC6" xlink:to="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_EB0C863142D3CC17871E6E649DB6849F" xlink:to="loc_us-gaap_HedgingDesignationDomain_27108C96B5A2DD02298B6E649DB6F034" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_17831E377B25DCA9F8E66E649DB60931" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3B6CAAD6476D73FA3DDE6E649DB6BEC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_50D2D113A1889F873CF76E649DB6E26C" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_88152D60685EA408B2FA6E649DB6BC70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2C665A4FDA01D95F84B96E649DB69054" xlink:to="loc_us-gaap_DerivativeLineItems_6E35C29BA35F40844D496E649DB6FE73" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_F48BEECD1B388B8EEA22BA3EFEE4D64F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_F48BEECD1B388B8EEA22BA3EFEE4D64F" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E0FE7B61BF60D429E68ABA3EFEE4881F" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6F2F0107D9816C1AF262BA3EFEE5ED27" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_223F5F15230A1DF36D6FBA3EFEE5EC42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_295643F98E8A05280256BA3EFEE4622B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:to="loc_us-gaap_DebtInstrumentFairValue_9D85BDF95C10D1534899BA3EFEE59B84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_A3AFFCCC881B965C899ABA3EFEE5101C" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_ADF3ED8E59C4D5E66A95BA3EFEE5C440" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_DE7E95B89B31E29A324C4F3541534C40" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_DE7E95B89B31E29A324C4F3541534C40" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_60C1154CEFA918C9175E4F354153046C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0A19AA6E033F5E6891C0BA3EFE67124F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0A19AA6E033F5E6891C0BA3EFE67124F" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48762F0473D434B14F61BA3EFE677585" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_EB21380FA9166A6FB2D5794F64849F91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3615A0C87E35F82E82A8794F67DBBE59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20F1B3D3F8177FE039E3794F64855746" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4A9ED3F894AE0CF5D07C794F6485BC05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DCD5A9E59472265259F3794F6485E95E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DFAC62151BB0B4FCEF4C794F64804BFE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4A863061E077B0C0C62B794F6485A964" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DF80DBBB4AAD7C9DB745BA3EFE93F416" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DF80DBBB4AAD7C9DB745BA3EFE93F416" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0685B45763362B80C63BBA3EFE94FC48" xlink:to="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B1C59C8BD61DDBEA3E45BA3EFE9492B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:to="loc_cah_PharmaceuticalMember_B1C59C8BD61DDBEA3E45BA3EFE9492B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_03FB66CC9D94FF0BD05EBA3EFE94FBEE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5E9D1C68C429EDEE8C52BA3EFE94C21D" xlink:to="loc_cah_MedicalMember_03FB66CC9D94FF0BD05EBA3EFE94FBEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_DCA1E50982000819FD1DBA3EFE946302" xlink:to="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_C6411F6F86DF6A305835BA3EFE943932" xlink:to="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_Goodwill_B2B4B99C34DB8BF1158DBA3EFE94D022" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_48D6F339221B2DF6DBB6BA3EFE948711" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_06BDD785BED5A89777DEBA3EFE944F22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_52C90043566620BB5825BA3EFE9490F8" xlink:to="loc_us-gaap_Goodwill_D38FFC037CD323DBBEFCBA3EFE9436BE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9BB5D36A7ADD6BE4F2ECBA3EFE3BD192" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:to="loc_cah_IPRDTrademarksandOtherMember_D820C42EEF64400F8F86BA3EFE3BC02F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_EACBBB3F054AE7DFB6CABA3EFE3BD15C" xlink:to="loc_us-gaap_TrademarksMember_F8038B4FF861346F10C4BA3EFE3B2284" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2DE27E734C9133F55308BA3EFE3B808F" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_241BF3EF281BC6DF4766BA3EFE3C5EA6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_80EF525A0BC547B33C2ABA3EFE3C0F22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_B65FD53CE14855E2B146BA3EFE3C32B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="loc_us-gaap_CustomerRelationshipsMember_B4280526C496455DBB2FBA3EFE3CE6A9" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="loc_cah_TrademarksAndPatentsMember_73804905BDECCE477D61BA3EFE3C8AEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_476902DCF27C01C1FAB3BA3EFE3C2383" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_E4D4827B4F24A3CE7968BA3EFE3CD4A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_429C4904658660A75BC5BA3EFE3CE90F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_F239B5D68C1075E424E3BA3EFE3CCF98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64C66004BF33B54FFCF1BA3EFE3C0362" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2C1B291A70486F3FFF57BA3EFE3C4E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_8986198AD4E662E6652EBA3EFE3C30FF" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_1C7F558682E1636F805BBA3EFE3D410F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_E1BD55B10A40F7C7FB01BA3EFE3D7DC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BADD81F4320FD9E9A784BA3EFE3B31F7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_30FCFC4BEA355A21CB29BA3EFE3D6E67" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C0710467AEE12ECD072FBA3EFE6474BF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C0710467AEE12ECD072FBA3EFE6474BF" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_49074B81BD491A212C85BA3EFE64C882" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C0710467AEE12ECD072FBA3EFE6474BF" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4815652A55A38A8C5CFFBA3EFE642079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C0710467AEE12ECD072FBA3EFE6474BF" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_4B63A3B3DAA367D30CB7BA3EFE64A706" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_BF2C9270424573B5C3144B0A3D4046BB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_BF2C9270424573B5C3144B0A3D4046BB" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_DEE760A55ED54CC35BA34B0A3D406139" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_90E5C6470F3C1A441F2E5F1818EBEBB6" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_67DA17E1D339CEF3DA745F1818EBBD92" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5D862C7D3CCF69D8389A5F1818EB0602" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_67DA17E1D339CEF3DA745F1818EBBD92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_1F6ECD504161C3B80C5D5F1818EB4092" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_8FCEA88ED80F7CDCDE825F1818EBED51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_45A7ED867EC318CD32615F1818EB1465" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_79EECDFEA254FC7AE7625F1818EB1E15" xlink:to="loc_us-gaap_ForeignCountryMember_AF59203EBCFE15EF96C45F1818EBE467" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_D2A282AB86B6E860A7D65F1818EB99B3" xlink:to="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_1C42DF6F175A47C64F015F1818EBE3A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:to="loc_us-gaap_MinimumMember_1C42DF6F175A47C64F015F1818EBE3A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_2819272978EDB2D8ADBD5F1818EBED0A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_AFCD390A39C3E0376CB75F1818EBABBE" xlink:to="loc_us-gaap_MaximumMember_2819272978EDB2D8ADBD5F1818EBED0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_4EFD3ECCB4CD808A88735F1818EBADE5" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_B9D74F22EB5E7DCE0E005F1818EB6775" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_BE2847EB4A2F003A8FE85F1818EB8150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_A6062255E0C7E31B07195F1818EB39F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3D51B6B13E55AD09D5255F1818EB68DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_8208968C9DF128AACAF95F1818EB5FF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_us-gaap_OpenTaxYear_B0D49F757CED27B055675F1818EBA6BA" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_93917914C3F0132A0E515F1818EBC820" xlink:to="loc_cah_IndemnificationReceivable_6D0A318B22B3BCB1CEC65F1818EB60ED" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0C1BCF1EE2B6A8A1789C7384EE1C9A80" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0C1BCF1EE2B6A8A1789C7384EE1C9A80" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7B568D4A853798299E1C7384EE1CA149" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_7377BBB4CFFCB2FD8E41937424C21271" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:to="loc_us-gaap_AccountsPayableCurrent_8D9D3B1C9E59C3467F45937424C34B76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F5E5B7C307C492D2B993937424BD1974" xlink:to="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_CD5C4448857B9FF23470937424C3F10A" xlink:to="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_F62684299467CEBE712B937424C353B3" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3F251CA2B2AC3A9DE8F7937424C38801" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_A580362D9EE4FB9AD2F6937424C35417" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_24624D7BE091853BBFB6937424C451BF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6D254931049D01375D51937424C4D44D" xlink:to="loc_cah_PatientRecoveryBusinessMember_55F9EA78A957E1096AF5937424C49F4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1376207B8B34AD99E6A5937424C4F513" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_D506D98D46908DC9C16C937424C4682E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_79D310E9E7F451C62F69937424C4E5A5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A1.7Notesduefiscal2018Member" xlink:label="loc_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A1.7Notesduefiscal2018Member_59C3CA3F06BA83C664D9937424C47247" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A1.948Notesdue2019Member" xlink:label="loc_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A1.948Notesdue2019Member_6164F061519035A6B871937424C4E4B8" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A2.616Notesduefiscal2022Member" xlink:label="loc_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A2.616Notesduefiscal2022Member_6CF69F052611F652E802937424C4814A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A3.079Notesduefiscal2024Member" xlink:label="loc_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A3.079Notesduefiscal2024Member_A4A958119B267A87F9C3937424C54E64" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A3.41Notesduefiscal2027Member" xlink:label="loc_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A3.41Notesduefiscal2027Member_33881348B3282B5C5B3B937424C58874" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_A4.368Notesduefiscal2047Member" xlink:label="loc_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_A4.368Notesduefiscal2047Member_4FB7EFE424B33D2A22CB937424C5A9F5" xlink:type="arc" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_95CDE251C938E6B15535937424C4EA9F" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_9BCB8DCAA2F456AB1F7F937424C3BB5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_8C5744906B0D4D889C74937424C5C87F" xlink:to="loc_us-gaap_VariableRateDomain_377E437053F3E9D6C450937424C54FDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_F2D2718E0E8DEEC794FA937424C5659D" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4B0A680A1A4DF972A9AA937424C5582B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_E093867FD22F56137A56937424C56831" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_02370A6F7C5F02808E46937424C5BE6A" xlink:to="loc_us-gaap_RangeMember_E093867FD22F56137A56937424C56831" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F1DC5E96D8113F67C3A3937424C385DA" xlink:to="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_78CC58A5885E78D3436E937424C55579" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_RepaymentsOfDebt_70E82ED067264ADA9B55937424CB34F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0C5294C869036048C9B6937424CB6633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_19C6E04ABA348A4FEFF6937424CB8DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_08E24B3990E3ADDC2BC6937424C50646" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_654111735AF8CFEE4C1E937424CBC50E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaap_TemporaryEquityAbstract_DBB16E7BEE405BA5E0ECBA3EFE6576C1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_DBB16E7BEE405BA5E0ECBA3EFE6576C1" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_47AB0CECB9671EA8E634BA3EFE668FB9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_D7839EE93D89570CABF39371556C1DF3" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_A6939CA474E26412464C93715571BC87" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_BEA9FCCB6973A63B885393715572FF7C" xlink:to="loc_cah_NaviHealthMember_98B46FD5EF741C68119F9371557257C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_6053DDF6F38B7DF840EB937155709CD6" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10125C067ABB5DF6794E937155727216" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_65E2D71DFF5D23C6A25F93715576956C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_CA3F6D7DBA429EB7A8B49371557647DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_91DF0450067AA4A9A6B093715572DAB1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6F037694FD8325484F9F9371557906C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_FC47CA3C4A2ACA4063129371557259B3" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_FEFDCD5EFFB41638BE6593782BD8F221" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaap_TemporaryEquityAbstract_B0619B1F39DA412D3F1C93726D6B902D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_B0619B1F39DA412D3F1C93726D6B902D" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0975B95A32531E0BDE9C93729E99D0A0" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_D515390BCC54B0B5DFF69372A05312E6" xlink:to="loc_us-gaap_SubsequentEventMember_17B09683796C27383B8F9372CB7CF7E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2FB3FF67CDB2C1137AEF93726D6BCF3B" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_757C30237C148440F79C93726D6BEB35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_FCF7745B2828862AB7E393726D6B751D" xlink:to="loc_cah_NaviHealthMember_757C30237C148440F79C93726D6BEB35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_F1DF5F1113051DF8697693726D6BC265" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_C7F4A65EF5314DE3823793726D6C256A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_88622A35EE3E071AE0F293726D6CDA7D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent" xlink:label="loc_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent_2A109D4D639B898B892093726D6C08DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_A8C635E520F0C54C9E0F9373CE5D9E55" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_A8C635E520F0C54C9E0F9373CE5D9E55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_D754D3CDE80456EB517C93726D6CA97E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestLineItems_660BCE1DD6525E04EF8493726D6C242C" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_D286567A79AC811F91EE93726D6C6A38" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaap_TemporaryEquityAbstract_61216E5A24A307A564C4BA3EFE5DDFCB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_61216E5A24A307A564C4BA3EFE5DDFCB" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_46739149383E36024FFABA3EFE5DBF7E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_47CE13BBB6FF650AB0FDBA3EFEAC7DEE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_47CE13BBB6FF650AB0FDBA3EFEAC7DEE" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_C65DE0BD4C95C781F04CBA3EFEACD94C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_F6A1C81D51785C204D799373E4AE84F0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F6A1C81D51785C204D799373E4AE84F0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_C2F3D38A1BB1F984EF279373E4AFA2BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ContractTerminationAxis_C306C22C5A7E8361EF489373E4AEC037" xlink:to="loc_cah_ContractTerminationDomain_C2F3D38A1BB1F984EF279373E4AFA2BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_C2FD53955E95A2B4145B9373E4AF15F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsAxis_0CFB567FD61E9BA811649373E4AF65EE" xlink:to="loc_us-gaap_ConsolidationItemsDomain_C2FD53955E95A2B4145B9373E4AF15F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8FB12F07B3D23A6B7A769373E4AF62E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8879B5B521A1F72D55A99373E4AF3F8A" xlink:to="loc_us-gaap_SegmentDomain_8FB12F07B3D23A6B7A769373E4AF62E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4EE8CAE4CF13C2E3B5F69373E4B0A327" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_480DC356D364963CC1D99373E4AFDD40" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4EE8CAE4CF13C2E3B5F69373E4B0A327" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_DD615E166683711877A59373E4B0F2A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1FDD70C342EF28E57F149373E4B08C56" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_DD615E166683711877A59373E4B0F2A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_78B173F22FCB06AD92B49373E4B09E6B" xlink:to="loc_us-gaap_RestructuringPlanDomain_94405392663A60CC85C89373E4B02DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_C2D94B6D02117394F41C9373E4B0B5A0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7600500CE93CB81E55259373E4B0B5C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_48873354B7D760DB9EAB9373E4B0D650" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_96053662D77E56CBB2789373E4B12E74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_F3A69EC6435F4CC34C789373E4B1F157" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41F1FD07E46830755BAF9373E4AE2481" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_F3A69EC6435F4CC34C789373E4B1F157" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F6A1C81D51785C204D799373E4AE84F0" xlink:to="loc_us-gaap_SeveranceCosts1_508DC1A9EE8461881C8C9373E4B1A561" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F6A1C81D51785C204D799373E4AE84F0" xlink:to="loc_cah_FacilityExitAndOtherCosts_6A442DD963C047371FF59373E4B1CD67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F6A1C81D51785C204D799373E4AE84F0" xlink:to="loc_us-gaap_RestructuringCharges_EA5F866E85A0F42F0A179373E4B15621" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_54B688C6E7630649390F937412139C68" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_54B688C6E7630649390F937412139C68" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:to="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ContractTerminationAxis_299A053729940C93FF7693741214C31F" xlink:to="loc_cah_ContractTerminationDomain_4D84DE8794DC6617813493741214572C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_76C1F8CFE80F63D1B9DA937412147F09" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:to="loc_us-gaap_EmployeeSeveranceMember_105ED89C3196A790922393741214B574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_EF469AC85F8E520A7BCF93741214303F" xlink:to="loc_us-gaap_FacilityClosingMember_81C733886878921FDB4F93741215BCB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E009067B8178790D0FF893741214EAFC" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7E344E46C7D9C6AB489793741215FE98" xlink:to="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_RestructuringReserve_A1C085FD18A6C938597E9374121541DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_RestructuringCosts_C838EA9BE19568A961B9937412151949" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_PaymentsForRestructuring_DD7E8CF4E724F738BF7993741215531D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5A77ADC0CB90B3F4B9B0937412155BD6" xlink:to="loc_us-gaap_RestructuringReserve_B375178FE61DCC59BD5E9374121544CF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0C24B5E3BA204426CDC07A3EE7D006E9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationAxis" xlink:label="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:to="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ContractTerminationDomain" xlink:label="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ContractTerminationAxis_D139AF8F268B0CD5B18A7A3EE7D33F0A" xlink:to="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_DistributorContractMember" xlink:label="loc_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_ContractTerminationDomain_A6696E84C9D96BC92E177A3EE7D375B7" xlink:to="loc_cah_DistributorContractMember_4EC015169B669A77733B7A3EEB5CA01C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9DC971DD7897305FE15B7A3EE7D4E8F9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BD9E588B86A6A8C1D3C97A3EE7D2394D" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_9DC971DD7897305FE15B7A3EE7D4E8F9" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_BEA7CE870AF20AB945BD7A3EE7D42F99" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9DC971DD7897305FE15B7A3EE7D4E8F9" xlink:to="loc_cah_FacilityExitAndOtherCosts_BEA7CE870AF20AB945BD7A3EE7D42F99" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_6CE6FF9A6B229E753827BA3EFE7CDE96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_DA979960998E1C2F4709BA3EFE7C3A74" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_FE1344C665239A8D4AD9BA3EFE7CBBF0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_1D09F896AA653D65D211BA3EFEBCB27D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1D09F896AA653D65D211BA3EFEBCB27D" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_BB8BA3BA548D3C086F97BA3EFEBC6649" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_4E2D0543CAD8563C9E6BBA3EFE271A1E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4E2D0543CAD8563C9E6BBA3EFE271A1E" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:to="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsAxis_D7A8E24905256695DE8ABA3EFE28C42A" xlink:to="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_3B433B30055BEEFDF946BA3EFE28EA4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:to="loc_us-gaap_OperatingSegmentsMember_3B433B30055BEEFDF946BA3EFE28EA4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_82E69E88CFAF34B568EBBA3EFE28A0B9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_84BFDAC5DF23406FF60DBA3EFE287289" xlink:to="loc_us-gaap_CorporateNonSegmentMember_82E69E88CFAF34B568EBBA3EFE28A0B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0E645A75B88EE661929EBA3EFE28237B" xlink:to="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_DD97F8D09A906B87DFE7BA3EFE285308" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:to="loc_cah_PharmaceuticalMember_DD97F8D09A906B87DFE7BA3EFE285308" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_A14D780034E108F28B3ABA3EFE286809" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7829DA411ED3DFE7E717BA3EFE282135" xlink:to="loc_cah_MedicalMember_A14D780034E108F28B3ABA3EFE286809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2451D2AD390832AB7FB5BA3EFE287D55" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3BC34F0A9FC91C7D7330BA3EFE272BC2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2451D2AD390832AB7FB5BA3EFE287D55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2451D2AD390832AB7FB5BA3EFE287D55" xlink:to="loc_us-gaap_Assets_778EA63AF7116C903D39BA3EFE28BCE6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_8F253376E3A22472FFBD6EE08CAB0DFD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8F253376E3A22472FFBD6EE08CAB0DFD" xlink:to="loc_us-gaap_NumberOfOperatingSegments_EA528DFD7D3C55FF76D06EE08CAC7581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8F253376E3A22472FFBD6EE08CAB0DFD" xlink:to="loc_us-gaap_NumberOfReportableSegments_07028D9155E37B04D5056EE08CAC36DA" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8F253376E3A22472FFBD6EE08CAB0DFD" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_3011093E75388693DF876EF38BAA554E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_AE74AE054F4D17FD6079BA3EFEC5A822" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:to="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsAxis_E33CD8DC135757D5C585BA3EFEC56F69" xlink:to="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:to="loc_us-gaap_OperatingSegmentsMember_45FD8D89A41860E4BFDBBA3EFEC519C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_716EEF3F2F0CBFB8C4F0BA3EFEC5AA9C" xlink:to="loc_us-gaap_CorporateNonSegmentMember_CE456FF07F3C6EA2A92BBA3EFEC50F07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5C6E1C0D14B48A7A2C28BA3EFEC5A891" xlink:to="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:to="loc_cah_PharmaceuticalMember_5C9C92EE0003566BB7A2BA3EFEC57C84" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3C5EE7E5186710F4BDA2BA3EFEC55371" xlink:to="loc_cah_MedicalMember_DCA7738999423204176DBA3EFEC6E5F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_1526DA9D747E0496CB95BA3EFEC5ABD9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_363487D258DE2A00245ABA3EFEC6F45A" xlink:to="loc_us-gaap_Revenues_2AA9241AB6FFEF0E3DD3BA3EFEC6FC03" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_F837EA17B74B78059675BA3EFEA726BB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_F837EA17B74B78059675BA3EFEA726BB" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:to="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsAxis_346EF212B204CD25FF4CBA3EFEA7D468" xlink:to="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_BD2D8FBF040DA200DD07BA3EFEA7D2C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:to="loc_us-gaap_OperatingSegmentsMember_BD2D8FBF040DA200DD07BA3EFEA7D2C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_43ADABB899D8C4B06977BA3EFEA7DFF1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_9DB6C1ADC59324C3138FBA3EFEA7B940" xlink:to="loc_us-gaap_CorporateNonSegmentMember_43ADABB899D8C4B06977BA3EFEA7DFF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3B7E7600C203F7205AF3BA3EFEA73D3C" xlink:to="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_B55D19B82F77FFFCFE35BA3EFEA7B377" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:to="loc_cah_PharmaceuticalMember_B55D19B82F77FFFCFE35BA3EFEA7B377" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_94E363F086A4E3D1F730BA3EFEA832EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_048C36F79827C1C56CC7BA3EFEA7BFDA" xlink:to="loc_cah_MedicalMember_94E363F086A4E3D1F730BA3EFEA832EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_C4E9B5BB5A792A7E079EBA3EFEA729D4" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_3EDCB6E764D262CBCA4BBA3EFEA88496" xlink:to="loc_us-gaap_OperatingIncomeLoss_80CBD41E34993E8B5419BA3EFEA81C39" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_ECBE35B5DFCD78E502211606F0E76D70" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ECBE35B5DFCD78E502211606F0E76D70" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_0E4E27BBC6C8F4F2C20E1606F0E78116" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ECBE35B5DFCD78E502211606F0E76D70" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_F21FF6FB0C58CE3AC4E51606F0E7D084" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ECBE35B5DFCD78E502211606F0E76D70" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_FD5C8C829F747A2857BA1606F0E7153A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6778712AEF0C3D875051BA3EFE691475" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6778712AEF0C3D875051BA3EFE691475" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_333AEB19F74A2B74815EBA3EFE697C17" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4EE77E12F5CF9E19ACBC15FFAE868F65" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4EE77E12F5CF9E19ACBC15FFAE868F65" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:to="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_D40E64AD9B544024F1D615FFAE86F88C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_39495D380D9CFE174CF215FFAE868EE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_39495D380D9CFE174CF215FFAE868EE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_F53E1B2BAACD024FD75D15FFAE86EB60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0D4926B568CFBA1CC9B315FFAE86E94D" xlink:to="loc_us-gaap_PerformanceSharesMember_7AB191367AC7F32A0AA215FFAE87AA36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:to="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_344EA28C4FCD2A6488B715FFAE874421" xlink:to="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:to="loc_us-gaap_MinimumMember_A26E01275DF76723EAAA15FFAE87152D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_668C45DEB2ED83635CDB15FFAE87B463" xlink:to="loc_us-gaap_MaximumMember_8BFE294FB8DA2766244015FFAE873594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3002270DF085F6361C9C15FFAE86F390" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_B99871D30AF624E4670615FFAE875B78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_77EA3150AC6B218770B415FFAE87DA9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D03A55030F6F83337F2415FFAE87FEB3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D03A55030F6F83337F2415FFAE87FEB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F72189A1A7E6FF3F4D1015FFAE877D5A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F72189A1A7E6FF3F4D1015FFAE877D5A" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_5C97765F880CAFFD637615FFAE8C23EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_FCBF5E48B6CDDE2FEE5615FFAE87B3A2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_91C327CA16582FEE677F15FFAE8C2568" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4450AF200BEFFC2D447D15FFAFA2EC5D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4450AF200BEFFC2D447D15FFAFA2EC5D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:to="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_CF7C34D8E322CBD1237C15FFAFA24F52" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_D4E8E59B69AE8ADCAE7415FFAFA251AA" xlink:to="loc_us-gaap_EmployeeStockOptionMember_DD9B936F43879CCED95415FFAFA21F97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D43A7864D3232D5EA7D715FFAFA2FF54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_A88A8ECE8C85CEDF479316003F4204E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_97C3F154A47D74D40E871600190B7666" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0F00DEA4FF58087BE9CC15FFAFA2B04A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_C5E3093AB11284781D5B15FFAFA2A9E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_686DECBB56F0E5F52BF115FFAFA20559" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_D3224225185C3637213915FFAFA2AC57" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_A5AABC0D1AC41288EB3615FFAFA26028" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_A359542513DDC445B31DBA3EFEBA2001" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_08B262F157BDDFF14783BA3EFEBAED91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_624B16DAEDBF2004D596BA3EFEBA4A87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_140AEFA87B6A78E29E63BA3EFEBA560A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_115AEF775A68CC2BFB20BA3EFEBA4AC0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_D5D62A90BEF9CF8782ACBA3EFEBAF91E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_F484AD71DD57D9EC99DBBA3EFEBA27FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B50A382502F12D7EA9E6BA3EFEBA960E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DBFAF230FD08A4CE65E1BA3EFEBA7A47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_892C802951AFB26054F5BA3EFEBA9EB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_54B6ABE82424BA0B7E38BA3EFEBA80F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_E81EE9E0330E4BFFC94EBA3EFEBA0F39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E41A0A48D16AF00E7E10BA3EFEBA9C75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_43022B20E6C9E68508EBBA3EFEBAAF33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_96D7C806CCBA81A47D52BA3EFEBBB4E1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_358DF4D70460674FC40C5E8D0C2D9B6F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_358DF4D70460674FC40C5E8D0C2D9B6F" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:to="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_C15DB4E2515D5ABD81515E8D0C2EF02D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_29B6A68F89A290289FDB5E8D0C2E0314" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BD9BB43A4580DA5A8B605E8D0C2EC92A" xlink:to="loc_us-gaap_PerformanceSharesMember_29B6A68F89A290289FDB5E8D0C2E0314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_B231827B2FDD3B2372BC5E8D0C2E9BB5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6E5E2936CC04CEC2CF4A5E8D0C2E0580" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12C688FAB6B8418116A25E8D0C301994" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DF6EAA6CD5FE9B6316495E8D0C30204E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_144E9C2BC49D071C3CE05E8D0C31A068" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4449E662ADB06D0EB93B5E8D0C3141B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F02E8D592DE60AEF2E2D5E8D0C2E400A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4063AD31E0F33B86D8085E8D0C312873" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_B6BFD21B10F52F838EEF5E8D0C3143E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_408C312FC1EFB8E01D2C5E8D0C31E1A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_89E778272C2615C4EE285E8D0C31E134" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_78CB0674F436FEE487285E8D0C31A00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_57B5E8C0E3016B3060AC5E8D0C31DFA3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_EB8DEF31FACE0AE2F12D5E8D0C3161D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B6A03F2596838B56EF25E8D0C327FB8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B6A03F2596838B56EF25E8D0C327FB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_66306FF5C6162B44CCFD5E8D0C322AA5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_01AA5643A2E971EF2CC55E8D0C2E225E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_66306FF5C6162B44CCFD5E8D0C322AA5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2A48ED2ABF418864E6AA15FFAFD872E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2A48ED2ABF418864E6AA15FFAFD872E7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:to="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_F6C262FDC0607CB1F63D15FFAFD834BB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_524B509B51AB642580E415FFAFD9959B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1C4E8F72D116DFB8CBDC15FFAFD9CC7A" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_524B509B51AB642580E415FFAFD9959B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6D7873756D5447D012F815FFAFD8AE6F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_468A63879F7B081006C21603FF2BD303" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_468A63879F7B081006C21603FF2BD303" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_877DDAF0749CAFF736D915FFAFD983F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_877DDAF0749CAFF736D915FFAFD983F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_C93D69C062F86EB7B69615FFAFD95098" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_C93D69C062F86EB7B69615FFAFD95098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7A046466574FA7DAB13615FFAFD964E3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7A046466574FA7DAB13615FFAFD964E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_582AFD21E2722704232915FFAFD9DD9D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_582AFD21E2722704232915FFAFD9DD9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_76E62B70D20CD486715915FFAFD96ADE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_EAB1887E6CDFC2FF021515FFAFD9CB2B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_76E62B70D20CD486715915FFAFD96ADE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C306402ADD57F264B75F15FFAFD929D0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59DF893796AA4EDAB70D15FFAFD963D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59DF893796AA4EDAB70D15FFAFD963D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_00429A96BCEB701AD65D15FFAFD9DF68" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_00429A96BCEB701AD65D15FFAFD9DF68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F43E50A694A727523A3115FFAFD90B2A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_F43E50A694A727523A3115FFAFD90B2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_05551067AC81626953D715FFAFDA5981" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_05551067AC81626953D715FFAFDA5981" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_912755F523B7BDB8E33815FFAFDA7712" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_E21FA08BA324B12BA61A15FFAFD94450" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_912755F523B7BDB8E33815FFAFDA7712" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_755806C300F7061D3C3EBA3EFE4705F0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_755806C300F7061D3C3EBA3EFE4705F0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:to="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2CCC1F5FB38748314F0FBA3EFE4760B5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2D434117828FBF571DA7BA3EFE486BF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3D3E059C5E537398F476BA3EFE481CD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_49D35BC2D39818D042D2BA3EFE48C08D" xlink:to="loc_us-gaap_PerformanceSharesMember_EBE33ABC5814E63BC6A8BA3EFE48AA24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142536CC5DB3E48070E9BA3EFE48E2CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19B88FFC91B8FDB50265BA3EFE4735B6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142536CC5DB3E48070E9BA3EFE48E2CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142536CC5DB3E48070E9BA3EFE48E2CB" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_922173DA1A5AB926E3FDBA3EFE483854" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30DDAF6B1A85D398ADCABA3EFE17F391" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30DDAF6B1A85D398ADCABA3EFE17F391" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_A099F5DD7FDE45860F84BA3EFE1FD748" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30DDAF6B1A85D398ADCABA3EFE17F391" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8A5CE23B7C5B3F048D8DBA3EFE206465" xlink:type="arc" />
    <link:loc xlink:href="cah-20170930.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30DDAF6B1A85D398ADCABA3EFE17F391" xlink:to="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_6C03C47DE5C43D3145B7BA3EFE209E13" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30DDAF6B1A85D398ADCABA3EFE17F391" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6856A789E61FD818675FBA3EFE208DE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30DDAF6B1A85D398ADCABA3EFE17F391" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_0F90772868890D13511ABA3EFE2083A6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1AE8494A69B527244B78BA3EFEC8E5AD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1AE8494A69B527244B78BA3EFEC8E5AD" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_56DAE161A2AFC544592FBA3EFEC8482F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_E4F641FFFFB7C791CC1E6F14C9556CD6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_E4F641FFFFB7C791CC1E6F14C9556CD6" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39C34E8DCF454BDC79CB6F14C9569A40" xlink:to="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_E7197CDBBBE0C2CFC8106F14C9569002" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_22D26A7243FA711989966F14C956FF65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8271603D7D49B8625BBD6F14C956C78B" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_55E3AC733DA6D411BDBD6F14C9564EB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_82665FD08A67A80F2CFA6F14C955BD56" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_FBE8DCD4864CB58E623E6F14C956278B" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ACB0332AFAB826B2CE826F14C956E647" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1991C51B41C86F3D66C86F14C9561B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7D5B0A35BDBDBC45B4526F14C956F434" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1D8959E03E8704BB396A6F14C956789A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1D8959E03E8704BB396A6F14C956789A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9E2402D1585039C5E0346F14C9561E47" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_CD0072A2A211EE6E5B056F14C956D89E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_111BD2562DCEDDF4DEEA6F2E293CBC62" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5D4FD4ECE2046EF145A76F2E293C477E" xlink:to="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_D69472A0D99F35E091A36F2E293C5A92" xlink:to="loc_us-gaap_TreasuryStockMember_979112E6D17E1C8E105A6F2E2941BB37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_CB59BB8655CF372708456F2E293CE54A" xlink:to="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_A44091B09B0A5AC533F86F2E2942CBF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_729F595CBE7EF8A627DD6F4B31D4CD14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_C5B480396FE526E72DA16F2E2942CF4D" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_82DA12185047C8A992E06F2E29424618" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_9F786B272BBE9EA6E77BBA3EFE2D3972" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9F786B272BBE9EA6E77BBA3EFE2D3972" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_555FB4B41A96C4A9D1A7BA3EFE2DFE35" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>19
<FILENAME>a18q110qprintready.pdf
<DESCRIPTION>FY18 Q1 10-Q (PRINT READY)
<TEXT>
<PDF>
begin 644 a18q110qprintready.pdf
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M;46;JR'7/R&W(C4P#[U)X*PGX=T=&,>+9$ *(J5Y;4B\QIE(]4A7(P$?Y:^
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M_@WTE_1W>AOT"WH']!^"?DGOEG]!7PEZF-Y#31GT%_]7VO3/^]GTS_]#F]Z
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M\8!GOS^E<4"%+KM1=4#9,/^H\7J]+@_KDO7J=)GYV./]ALRA=Y@<%M6AXE"
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M/SO-;E_ Y@_X^?B %I'Y/2HK%(85B,4!RYJ$O7.9V(VVLG%T>KRL+Z\[X/1
MRHZJL-^E>MRJ&[LR"+WA.(."W1Y%]4+70<VGJ9XP%.Y$;S=&LKG<./,QJ,,/
M]\$'\3L=0#=<==YN09^+/01+J,HM%,:+,0*;B929^.M #S9M"G](.8(:[#)L
M+F 3=EKU><U.MRO@A8U R>L&5%3&.6,3$YD9FTYC0&#3:7;!XW Z@4VL&6CV
M>2LC.BO#]I^D!YO8V&%(+NP+,C8]2C LL!E450PAL D^?.&0*\Q_QH2#R&T
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M8BY1BC04<U4S9Q4Y%D\<G6_.#QX\:LBHHPEC!L\Z"6'PX,%SYA[?WMXPK'E
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M[!O)4N7W*O%_@B&;9+-LD:U20;;)=MDA.V67K,BJ[)8]LE<JRC[9+PV0ZN4
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MY5 ]WFTZ9+ HA[H.R4,FC[I4MM$.I-U(W4B/(1U$,H(S_G5_77(([T/\Z_M
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M=?%.O^IF/'[51[Q^-4B\ 7N(>,-R$N,)R\F,)V!/X9T!>RKO#-.-F%.1Y $
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M<NOZNMLJ5U:HVX.--<DW3"IY:\MMM]:<N&W4W-'U'SWOGO3BW>F/;I5(7]_
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M_>XSX]W/00I*@5H5IBW)0N_KJ;7,8N9>9A?#1G1;M+\HI=J61Z/N(/Z \I
M953=RRT/<JG+W78IR0<+/YZ^VC$D!\*;@4=]Y=G76O#+K:9Q S.>" EA[:;>
M]$C.M =X48@Z8WQ JD$15WH-3O$DU:!,>SI=/P?:HJ76H&0O'#+4:&>S3A4&
ME=^Z^%@L2U:RY&@+ON4(%U-@"K<<1A!I@W8ARR(!$*'JQ#-4B8!.*@8_X*1.
MP8?;0Q:@)7-]LS?GNE&KA_7'A3LK&C^Y8W_-L6^_?VG#B?B)!R:/V;#^]NI&
M=I1:7S!PST;C^^K)1OSSYN_FX,%X)7X2U[YPY=/=KQS;O>N9IT'VAH).C>&>
M $]9HLL*:B68Y06; D)T')SH$#N_6FC!PE%4;FLGE&EJ:*QG^8"$3^<1D]$K
MA(N',O*SQD^>[<SL5^O8GP_<^Z=XKK&K!?\-O[@+//0-P+MQP#L_R@#]NJ)7
MS!5M*-P-V5("X>7=NKG2EO-<UG*7/66U0\+O2Q>D[Z0VB94^=DA2E]4'':=H
M?)_JJ'(0QY#N@=7@W$\SYY@OF4L,RWSL99C,U=[R@@Z&EN1KEP%X=!A&\Y7)
M6\I7;&( IPD'@;^WX?QL9Y<:''-G G.%E!J<S@5J4 @':DB>/[.&)"DI-4Q7
M>Y<:)D?+JD%1#QQ2Q;0:G,'"(4C"-0CG^[J!FT?),KQ0<E5X8;>9EC-A/CL'
MJ_AJ' 26$EN1*;SC[LSF3N<X-G;\ZUL?>..VL;/F_WG_4W]>/'S.J)%SYH\8
M,;?[_353-VV>6G,?$\[>.ON)#S]]<D9S3N[I36?^_>\WFT_A43-7K9@R;<VJ
M*[\T[-MS=\.^QQ+(9EQ"A][1TZ>0>6!U-A/0H:@R4!13%="A8.IR)P>V!6"=
MJ49'F>5!NTC51G=XA^18BJ1V4B#+_<:I^M#42FLG[>F9G&D+L+P_QD7=T4Q;
M>@UB V U4EQ)-3BBP<L,>[0&\3[P.\F>5.IW4J_1GTX*),E9DJE ;$PV%0A+
MXE4% F /%'/UQ:;B%/6DBN,"-&6&_8D DXX8NRG]\2&+;\W;-;+YDS\\7/?J
MC#FO+=[00FZZ=WS5UDV3;U^/1VE_J<'DF<RQTS&^\#66MAA?&O\T/C0.[WR!
MZ?W0\Z?W-#W]#/5))H)E8V9FN;^>Q4]AF2F89V6()>GMM:9S+/M?>%;LA&<U
MBJC,'"&-O2F:<M-@TD2W^_<S8]]]]\H3%.42"^.;OZ.BVW5)865FBHYYF:+]
MKJOX*3HK*_)9815&ZD+A__IIQ__OIR'$Z\#^W\+!27G6/HV.(&!_(@QHGU-[
M,(#1./0GB'Y>0SRJU7MCEF&V$NP!^(U8CMO* \SE$?X*?<5&F#=T\@7[181[
M@]X_C5H7D;T+HW(A$?^4FC;8HD;^T-90,!X/!>!):VVE65/PK(DG.CWLE;!W
M'),4WT 6DM7[\<XCQAGCE2.PR@GX$9@/;W*D\'D&HA0(5F[5W0(_BZ4920$-
MD7A<+K;_*OPDRC>A[8^F-<,TY(('L^#*UTR(/IB)^^,/[D?7K'6:WANP!-E*
M&Q(QXAF6W<KQ'H[CT5?\5TR$?4/GOF"^B) W,',7CX:('+TI'[ZZ5C,O#&84
MXJ+_N5()%\'_&"9SD2R,;V"2R&ICTA%<ADN/&%-AM8/ ?@^S<NNH64^;9U\7
M6!?<R6]W;@ORHC:.&V.?8I\:6,PM@C!75!L! 1P_JLQTX3"H]#:]2_*4U"0Y
M^:[4E#EH;?@%<>TJ+_9N4\\VFCE5!CGP< =VE$?&W=D1H8)N@Z9?+C51]H\F
MS+X&8C].(?;C%L0&D(BS>A;WZD#8G< A1=@@8'@UZ9X^:TC>O>,K5[NW^][?
M^]CYP3,G=&.V[<>UO>Z_?<#\X9/[W+ESTX.^CS_ZX\'J/0LFS]UD;#/K'V.-
MD?P,[A.DHV'X#GU J3Y+7Z[?JV^S/Z3O&'1 ?V;@2_J)@0J?Y<L:E#4FB[U'
M=+HT]Z#!Y2KK0)K;/0\Y(,ASJ&C08*?++=SDRYL9H\I4D),RLQ=STTQ%T!Q\
MCNR;V6_ 3.:I?O*@P=;V0H""H>MSSG;Y*#2YKL^J/J1/"\G4DWM<OU;X3?KD
M2(^"'GJ/ZA[LH1Y?]KC4@^E1/GS\AD3P-#3^8ZMF$H_B"C,/#1I?!DX4/))&
MW_6;&3>*L;"5MZ"^B8*M;C</NZ%_?E]_E)6Y:.]H4BP2[1G+C!5$2V.!Z-"H
M%.O/7@_PL3CT#DXM2F_!LX^@:#Y]U@/(WS?T.+Y9AL]OX <\CL(E*>_@M,(4
M.@AG=(_100H*7N=[' T3;WJ\/:WZZ^8UFL2S8B9J6K/ 5;FH]_(7%S()F^HJ
MZDDR,])9XO2XV,(>F<6%*F8S(ID4OV06]F!=7DTP[3 =W2X1A#G69UW)HELF
M;WJU<L!=^>$M"P/I_JZ/WKG3^.?NEXSW3CV#R\Z_CG.';>G^1^/2<T;<>."#
MKW'5W\[@DI>>;3YPRXW&S%D#^MP[I6YXWZ53]MYRZZRUY_;CLFT3)CP8GW2/
MEAR]%RM;#^/(H^\8LXSX9>.IP_LV+/[#S'-X*T[&^?C;;TX;S7\P/O[SZ9&X
M9N.V^3]MN'?+=.,RV-LV R%V,L0: MC;#_1)V2B+J=8:U"?4X^HY34!P^I&=
MJ26 /LEBAJ4W+P4XS'*2C95LG&@S;_<@B%B06/*8#9,(M@E"%<*TQ$%L+%ME
M)2EL(L&$X\=*8@M^2]<$7:#W4D+P=XBP&O,R/H-L\(C C,+(H?T EL("XV;V
M@MH0,-UFG<G5'GTD+$>NF?PJ:=#.G!%*&\XTP)-6*M"2'08MSL"%.(.A926&
M9KX(?N]I_.VQ>PUY[6&\;7F?L+\+=_+G@?A%8P 9AQ]X8?Y]]]#ZT3*@B0@T
MT<R<]GF]SVA1DEQ9+N?8[.R#6:>R2%86"B>-A26E)(_5D"@E\XO].S,6(YMF
M(Q&;;JNVK;+ML9VV\;86TDWWY20E5V,K;61F[^@)31EM1CDT6UU*RS25E?'+
MK6:^(5Z:"$<J:?+53/19VJ$S,:_/XR,\&PW&U%A:>B2=\-&86_2O -OM7X%3
M'1DK<$S.6,'X!-<*) :X\ J<;D]9@3*5K!58IM"L-"'R7>AC=:$SK8>)R4QD
M!@*/TWJ81BP/#)NSXSPC;1E^;<.>J;>-J%T\Z]ANXQ/,3LWMU[]OS9I_XMS)
M^0,&#9B[U/@;=W+T\[-J'NT>.W[WNC?',[>HWLFCA]=F_[+'%5HX;M3<(O K
M(]J^81>:5OR</B 8*DL>3 :K0YPWA6]3QSO7.Q\D.YT[0KO"3Y,G0P?"6A;)
M5KLZH^%BTELM=1:%GW9*N:*C3?N#:ZF-P6T:?&$+?D6/!I>RDG;0L1<=M*J]
M=7@5WH-/8Z$,5V&B@=_"&'QC0+?[%I\3<8$X0JP3&?$$45 2!<U@ZFD1C294
M+$27,/4I[@"G\%%/5(X%.-\DY%;@X!>"DY!7<DW"'<DLTUQ@/\^"TE,LEDGM
MA4"HUGMI2-.+^6Q/D?'OEY]HW;8-D]W/_MQCUXA_+CI4^_&ANUXBI/N__[47
M3__A>SS\Z<\_[(9[+#6NO&%\9'QT FS_"I#$:I!$&PJB)_0ND3 N$0-!*GFJ
M?:P-B>[%UF*^$UDDTM-J>-$D\J!F?CT)!>W87MTA>/1)1PS-71)3^D)6\= L
M>,-SA^Q9F3W&+\? E;@(O<6FP JF^?,0WJ&X)V$_ P>7I$Y"'B&0($67+ET
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M!Y$2A"21+GUBY<0YE0D\?U&[V%$%A'6;>7/:JG3,F,><,.9P]@,'?OX7C2;
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MZ$>YFKW:?LG.(+MN'P'SV6/_$EX*!>;+.OLJ^SD[+]$QI(3.Y+E A/:"6!G
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MO:S7FYU<:_PA8UX<V3U#O&3QU5ZUPXUV2**J^NR,O0$)DK]-=A4,69.5 2Z
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M/,"/$!4U%'F0GZWYW<ORX)?VLBE[FN8PCY.W$CDK$64)W4$F&'F*F*]=@.G
M C&C#/SX+ 7R4B"F588'.FP\T%YWK0#7JWUUOEL^!O@L/I]OB6^C;Y_ON.^B
M[ZI/ZRMMK8K,)(J9TB"!X,U D&J"HB Q%@FIY%)4,U^KP\X@(<Q.J,Q$"GI3
MU*9%C<S,[I67XD]SB:)+FV31#,@OR^V4DY(:$V,7G=HDYC2R[1S;L6/GU$!A
MHCW&WZI6'M?<.?@O^<;XSEWR,O-]ONCX5GUA$5G16J&_TBAT<9C2C5** -*
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MH@K=)*QF2/]+5<#0KT0R6AN<SGCA87B61C$:U'R2K1'Z8*YVJ50*$9HD +N
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M 2.PIT9MJO9"+Y&<,FP!@(6H+7:[S<:D5^BR*RP6G9!4P;@J8F,9O7=>U(S
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MT0QY3;7#"Q)XJ*I&JHJF:#ZJ'P[QZ\FQY3!98RX>.S3^#T<5_QXZV"#8)E?
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MZ6\\0_X,O1O,^;=/^GGW:)P]G @ /XFE.\60:MKAQ!IV][UFMOG^V!I,ZT4
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M'[7NM1/K7KM/$/]=7(G)%UJ]FQGII[EJ<G3&CGV$J[SQ7#44C23W".*Q,1Q
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M-^;GZ+T)L(@+W3S/)2YT3=</GS MSH7N#$&Z(<Z%+D:'N*?P&>I!-S<,NKK
M*LC-<IJ?Y-/P5'.:RVW18T<1%V1(CX5*_.0>:GSY@.8?%[&#WW)/,U?RK^KG
M[XK#(8PE$@R0,XAO</L8S# HG)I6C,(^?S$ROL$A ]2A'\@0IMED#"DI.:&0
M>;?N@E=?6-O7^,B.'0\.['F >QJ[U+^2-;3HZ YXZ^OL^+M!T)20*RP1MZ,D
M'+P)*[[CWHCN;X;L G(_0OY,- R=I?Y.OAM<#"6"!["9P9;#@ROW.YUDR>W8
M <E4;,'$5TVV[E<B!2&^!,H6@O QZ5]K@+(I!["%ECT&/6.$0M1;.(/(KI_N
MZD8KS632TB/05W&ETPX03RL"^;++52P04UFB#I$MG9R"N*\G#7[)7\W_#FJ:
MUZ&5)GA;#C))#!-$6#D>A^6K]#LEN"7N.QZ*I16^<P FZU8FS@L/W1%V4UHW
MZ["KM1*)#$XB;6&R%R=Q\7Y[?@VUL=-1CZZ7X>]/(N0/6U@&FU)8XEW?J'NJ
MI\->S'<_W95,H[N4M\*]@=ZG(R++9+AOYHG')1EUA]-841 6(M8)\S2&X_F%
M6GA.D7-+&$8PAA'X,NXP_C@<Q#*\)R%;8)@(H@KT'MD_DB0<-&'):L(&XMR9
M+&+E>W.(K2+U^'B&A.PLR8D4%>FQEM:0J)W$"#X+ \GA$,[(%+CF<YOQ>T\]
MIJK,X^KYL4DN_JAZW?D=[)1G5MX=W2F@^ ^C]:'^->C]!'I/5[OI?3:])YK:
M)'H_(E;_F^G]*$3D!:G_?#I^-X?#)$3I0@8[&6A*@R0ME)%3EJ&]Y)=((%N,
M&(:5X(%!8F46\@H,0U:N!7FA"3>;]IJ82"NI<BO4F0QQU,DE6;K*)W;PE]09
M1OU44F$1?OZT'9_:H[Z9FI@44H]N)W%EN*R6E7<VG?L(Z1Y[?J XYZ+HO5;'
MT>1X!=& V&]H'Q+.+PF'N+(<_CV>(=YARS CE1ED5F1%XSHC-IH1!Q4BTBM'
M>;?51G[C'6H0/P18_VMEJ\]_R;Q]_A2[GK?LV3/0K?VAZ H&_SO ((^VXAK
MJ! P$&$\-(ME#,-CF:L(4L/GUK 5Z"/JF5JAKIW7'S0$I4D2@R-4):*6P263
MX/LA;6$_A#.WL?NV#CQ$FH*WP!>)3U8/K7,^_>(LJ/,.ZG=Z2;B(-<KR0A**
M698X5I:-A'(EV2E)LL0;69GCJ(<4'MI!YEF6XX"01=%L-$HY^3ED7,XA^]K4
MY+:?!)DM(9[58B%E:?CE-3SI,N(P12+'Y LD/(L=/="#'U-KF5^<WX/7JEW\
MT3T#WPP\N^<M9C16HSYV*,:%M->H!DKO2^B]0:,\N"^F-;I.ZV7D1HO"$_U6
MOYN1W@#J*K,]ZL1.KVPN=CH=)A$S#CG9F^.=Y/W4^YV79RJPJ<)L-M@K1)A'
M8H?#ZT%>W$JWZ/.I1D5B9Q,'A&1U(3M2,A#1_%:2U6,W63D-$L,5!1'#@11T
MW;;?;-F&J[>I/YS?]A?U#/L#?D6M.O$Y>^WY_?@UJ.1U:K]Z4BW&K^-",D8"
MQMM!?@5059C$I)(87Q!431>928ID2ID&6+MZ1%;QFW&9!<F*XO=[L=G>+9ME
M.=';C:T<YHB3EP289N;UZRH2\;F0IWEY+BJ:U$^5P6P4R2\(90"BH"+9%*+_
M%J39QA!?#"Z%=]V(A1]PUO?G<>!'+*C9./W])W;\%H?VJ+@9C\5WJ77JIVKO
M(-JS_>?XF1]QD?K./]49>[8C;1Z!W[T@]L?)J%<A\7*Q/_Y7\>D@/_6E0N82
M>)0^MSND[_XED_6[D!"WPTL]=="\N9I7H4G:K",%9ATI::ZX/;UV=3%;2'(R
M7AWJOKCU!*?;(5ZP_X?WTMF,ML?RP-MH:.?F D]HK8-?LP5D=&%2Z0CV/7H)
M1<<7/QU?_+K'+WU\H>?,%K-=0 ,.E(4ZPZ%[T[$_Z' 6>[PV>W&6UZ(4/Q;
M@F*R%O,6G\ @%XFQFN)V"X%2"Y8M::6@2KG=R=XZ6V8=:V/9[&0I0OR/D+6'
MX5J43(THJ*<(PJ%45/471;*)%D0\2>"HVF4;LC?E4PN"]!"%!;MLSJ@U.S-S
MW>97'GWQYMZW?K[A^67J/[-P<D?IE0V9PU;=L&C%=C;=?6++KP>W#?R)W_;)
MWSY:O_R91:M^J%YU?<<&M:1OQ^T[[UG_#/$O"_7-Y]*!>_M [H RRBWC!2?/
M"RS#<LPRR(!A[+#P'"@7+"L@^75\G#_-LPSZ R;.V7E6B&!$/'1D#"NFO_X$
M^ANVN]R:59@L[95QLOR=#.,)963BM:._*"\'+NU%P,PPH-"!A8PH!N( @(@J
M ]T+"9$(TOG8EHH7J$<?/_O#(^KS?5SZ^1?8*>=^KRZFL<IF,Q^!E$E \V&^
M"I]5#!)9F$>V,L4JE[ED@4P8K<YB,V%@C]E:K#CJ%'-"6'$6)[!F-@D)=<A'
MU%XR=IS(SJ$JI.[<AJS$DQ%$0"YG$D=ZA3A0'\7"S*;P9<;]#[4_?/,O%D_[
MV9.9]UWYMSNOP>S'?-;#/<<&SOVQOCYHS[W]NN[?[O)TC)UL6O#KN_Z _W&0
M[B8 I7,3@+X6A)U6!4C+Y#5;BB6+0["687,9J^\AL 1=HVPIQJQHEPT1B6XA
MV-&5MHABQW9"3TY"3]HF;72/=A(5+=F."_U0T/V#'RKW-VS,ZFV_:DYO+]D6
M6+JK[]SON<3#-=H^ 1EW9P*_$,^S(K(@)[KUT HW7H:P@V R$AJNB\,FXD%(
M*36$_8'B',-[AD$#:PA#@QL,R%3*D?DYAQVEB)2PP@TR2M:ZQ:!H@-P_S/@.
M, :ECB'NA%P*B70X$(F0*#?9_? _E>;9_=D:'T3XH$T)P1\.R<0U)P[980Z"
M3Y'HG'CMP!K\F:&U:VD;_E@-RO?=]+F'.<O\:T >,+$3L0NSZCFU7#U(/*KK
M47I@3/H _?]PAX_P)V"<3S61^\)38HZT!1#;.KK$J36SC.6<@#71X7C(RK R
M-#J[1MPK,J)B H09CN7A/Y'E"(N&4HK)[Z% 0G$%%"(<Z0'%B3K5B<34/+NF
MX\4X$K2\J&_MD!%P9_,Q\^C9LX_C*7<\CH^Q@?-?<';\BQ^G M:M0.50&1C[
MIX>31 OF@;9YUD"<^"AF>S%K=!I$4%&O=$6<0-?/B9(0441,]XP]M#6!JL^2
M49[LC)$%!B#L4($N%&&D3V+H$6EB&O[T->N7 TDK>7/RPDM&]M[VZ-T#*O^B
M.FG19^7%L]<_S1C._9Z,BRYHQS&4$LHH)12#W'B9_RW*0,N.P&3S6#@)9$2J
M0;$7UZ1B'U.&L2-4%L1BF4.VE)FM,B'I3-E4[%8,QN($)Y$>"N@&9A].9ZX,
M*75F.20/2Z]+X.L2W$2&]!-Q K]GHIZ*=)%"A3VA\.QLG.^BRS^:O-=",]"S
MM(4T+<8NS6O4J0=>?F?'\95[MF1NN&[!^[??M[*I[?@C3SS4U,5^M.''+:_G
MC*^Z]]:7=]F[)N4Z1WW^T/J_7^U^?/&ZP^NKY^Z+[K=Q$Z'>L^G\B(QOJT#^
M$']XMQPT$O]@/)&0^B\5G[927C2[2T&AQ!;*_1)PO86POB&:Q5)G,/@=5R*Z
M"G&8L1WTS?*O\#,1322]J_1K_IB@ 8C"DTV],M&PZ=3?5"8-H: YFL),[YM'
M]W_VP9XG%N*_W-/V[:T-R^X!''=A&TY2WS]W7OUM#][UYFFU_,5W3D*_35!G
MLQ; /QG-"Z?D>0YZ&*749G.46D1OJ21CS)8F68T*2-0,]TXW$Z"2"'J,2/F
MH@1"[CJCUC=4T$>RZ785.=J8IVT>X^AB1R:H8VCH?">OC\HX.WU4VC65>77J
M/3CMPY[R](6E6XYCV\[JO0]>H=Z\RW3]Q(SQP0[<<@Z7!1]-_]M+_U@X?LW\
M^PX0GB#:"/"$#14>0<+@5V&[U5YL)8UIA#E7F=5HC,C # <9VJ:$%>QDLX*(
M]_Y)):0-=25WZ*Q$1FMO1UEY9^\K.YY\'F]AU@RTWKYYZ_W,;0.=;_[ESX3*
M3="2%53>[0A/!P$AB (O@HIHE R2;, DKI$182,G""+,+0PRSV B!QD0+# =
MEN5E1LYIA.D'&?V)-W\+IXO!_2#=J3BT2#)(%RQCD356F'$D!P1)/EF$R2?J
M#94C)2473Q77&)37#*]=E)887I/H:"^1H+>IN%Q]:_MW/VQ7C^%9OU!5]<<=
M>"9S>N  ,W-@Y(";J1G8K,D9;C[4SX>:CB#CX&?[S0J1;)^%A\&%6<0@S$L=
M;J/+$B"C%!/!YHC%8'%&8'+AVN<ZYF)=U+>8FVS9'PO+0#:*"[M< ;^NI[3"
MG".OA,PYLC6GYY-*:)3A;*TK/#0& ^T-W:J#:>V]][[>^^_KO?:=AWO[WIG&
M&)C$@=]_L%-D=YU?8-C]/I,Z\/F+GZX0U#OP"F'U:2J)8.YY NJ0@@X?00:H
M XS^2:0."7!A4R0R 8'$$<389?(+0K#4YC+2TUP6T!XDHIAZB1Z12#R8@0PO
M-M7!3+#.8G$8C)9B!Q.9A3$)FK0.G\0<]M<% HEUN,*[S?N9E_62:CMA,-_F
M/0;WWWLY;T[:K+25:6P$JM]*?*OU$X^-1=EY.72[C+(U;0?JA3^;'E;(QC'"
M',/F$]^5P.("=2OGR&>T,Z],<5_%K)E+NA]<M??A(S?,.?CPWCO6=2^9>4,E
M?H_$FOGY_O>>/(<GJW]5SPZJ_^?[[W'2($Q$G.IS_]Q^<C^1WQPTU<FAE2+T
MX/OZ[@A'=D<XXX6SFHLT?_0@.G+1;HJN]_^$[]X'T"_U60T][>!'PL6SBE=B
ML!] 6R[8!8KW(4S[EN:-^H.?K><%28)2T[V6?Q=I,GAQI$DF+E(X&C[X);\$
M-(-$='>XE.OQ^3P]@H!,EAZKU=9CP@'$)I8A1I#&.V<X%SCKG=U.0>(EM\2(
M%HO?V:U(VR1&8HYS_HK$X])G 9P;" =6!HX%/@OP$@I@,1!(3M+/'T1:\\GA
M@YP(.7)#[D%JEFBG54@.3792[ZMC8R*^<"B6*%D &<X>4YM/;GKIZS?W+5@<
MF#!E<>]CO6N/;%5;^*._4L=5J5\<?T']++0C_9&M?0=O'KB1-T.+4*^PI$5P
MMM[21^-B7@H&%!>/<3:T-(DSZT?;PY5W*0<E9KB<81LOC[7-D*?:%LCS;:OY
MM9Z-_";/+GZWYXC'RI19_5B"/X/?;Y.1J(BS1%84^1X9!("GQ\:Z_77.+N<F
M<9-KHW^W>,1% EN+KFZG4^PV',:Y!Q,8QM]M/LP8GPM8$W(2)B6P,/I!4RCG
M^_5C\A%M<(&_2+0AM;5N[ JY[?E!AX<)!9%MC%W;#F)"*8+('%2OE-Y[ B?-
MV%2I-JC?J']9-?"K(^='/3Y55;>\XV&O^=4/ZAG<,5KUXY?PU>_A:X]_^DX>
MSC_[E^@I%_X4C/5C+[M6^&_6!FA<T(NY:.3@E\PKM/Q(;6UU\$OA&: X/TI'
MU>'\=%"2_($R&3EZG$YWCX)-97Z&Y]W\DN#RX&I^(P_TQKMX1G3@0(4L^X+=
M_&$F\4"FN<+A.X*WD:@ >?V*2E2B@1*=K+2!6%.3:.AG,OVU8.(U0S.RT>G*
MAD.ZC5PV9M_ R?_\J&GW%G6X>EUJ^]S"Z8',A()QS-_PA/)%4ZZ[?<L'_-&!
M!T\=7_7A;-X\8/[3Z6[?+YT5SW.&'_\ZLO/FA<O22=U6(R0L@KHY0;-H#(].
M-O=@NUVQNLJ,1BO,M!A>< L+_/7^;O]:_T88+7G!)3 B=E4X((._&Z8WB6%S
MR&ZI,"*K8B5Q.<EI-7(X)@^T65I)$)M:)4M(1');]#PMJ:1NRA:BBX7$^88C
MKGI=V/BK%[J:=NQ1QZC7;MV*]V_%PVNKKIVV9M_+I&)7G;CO[O?G,D\,+"1W
M3-N/?TU;5AE91@Y<HRR$^.OI&EQU>)( 52A3ZI5N9;4  R/<,2+7 [6D<L.)
M6#?("U.%8@P:&:/1"Z+!4>$^+B$G%IU.KT<G82((B,/#?BH#2G3V)Q4;$@%#
M4T_*^UGL*VKS9_<\^.LKMK:OON_];6HS8?H)-S_\Q^?4VW'/N\^7$X9'.L>_
M0WQ6,U.B)P=TG]4A$N<B%<7)5L/@-UR&&(2\U^IG:DQX<>SDJ]>.N"'IL$JM
MY\;0U=6KPG;&(I81[V&@["QG&!* \#!>'U;,8H7F )&5$(<-'.D_DZ)%=534
M 2U8#M28>)JF:[JZ0R=F^P-JTU:F?:M:CQ_AC_[X#][\X]2+=RJ PM;"O4./
MPA4)IWG+. Y9RRR(+N5*+JG;L=;Q"$AH<DW<MSJZ)4)4-C]GK4 6Q1*T &(6
M;+#H<;<(8I2TBF*\H[,-[88AHBK4 VEEX[6L"6:6R=N.MBUY:ILZ?"N>V+/F
MVCM^]@'ICI(9[ZR]X_W2G9WWW;PL\Y*=E:@TYI]GW$0:$UFB/L6-I;$?G6A:
M.,-*?'8[Y#*1ER01.2L8AN&7<YP;D$>2H\)H-"R7))<"E$^D8[[V5Y1#&C6?
MALJDZ^4.ZC%(8P.[+3U$S(E"WS&_;WCP_)\?C*QG2M1(P6QF.&GF@0$\7WV*
M8;',CLRZYLA ST?HXOT4Z'D!^%HBMG(X-;S:XW:_Y7(Z7:#.6Q1E(<O#I)D?
MG969N3!_M#,_?W0P%%J8DNI,24G-S&>5K-&\Q3"R(#7H<7(I]G1_8@\N*!CI
M2DA!\H@>:>Q(IHR.JNS\U-K4I:GL=$L96V:I9^LM76RW19R:-3]K?GYM5FW^
MTBS!Z>$MK"($9-E=X3J,WPT; ZF>K-&9^4)":,1AG/)LJ"*%/ XEH$#%V)4)
M&"5L2SB6P"H)P823"9\E< D)XPHEZSBZ#T6'EM:V$CI+/D-.'L!O48[-4T3\
M9Q.E>T!??: KSC;M= +1P2U1[YHD2-[0!3_D;Q/4V<*)#$P]<W *,>,4W1Y'
M*CN*^M2%!VRJ@\Q.B?,[L8#ZXR3.'MFRI?.F%L]NO,N5G#9C1LZ$.<5+FW]X
MXZV;VN8^6=-T_5NO_]#:$9Y=E#]CQB3GFB5SQT^=MQ0DU>W,HC=_OF+T;HPC
MZYZK3ASV1]6+'SRT9& V\_1=CZMM^*M/,X-+GG[\!F;WZ#MVOE'%,'=";X8'
MOV2?A5$^ _T^O&T.L\!5P2QQ=3(;F)W, <8PEBMR3.6F.^9Q"QRK_6O3#<G&
M,JN^?T="3TD(D\@47$\ZMGK@L2?9PX@>CZ/'SPJ)8LH"<8&R1%RB+!>7*RN3
MUR5O2]Z7;)*$1"'%G>A)X<1D!2;$HM+]7B).3!2[44HP)9RR,F5=RK:4?2G'
M4CY+D5(\W5XO[DYI(<N>F41*YA-JSR%>LR-ZX"I=?<JC3*O_QK2#H@C=S(@%
MLLK&!7FZ^9P%NS+M=#C40]L&PX\J&V_K?F3S73.;6B.=3:6W%3TZ#C<_<V)+
M><\_7E6?PEMRZS]^K&/Y@[N3;IN[H*_FF0G#\:GOMQ[O2/[UZI<&D.9UGTI%
M"56&$T66818:1*?! ',_UB 80 JRB#&PC+B<HP+2R"Q'DB(%)192+$IDVTN6
MK- F@'N\H(RN?Q&?Z%H(4WH$%!/.QJEWK6-6;ELWL&(K?_1<%[?VQZG<ZG/+
M-?G"C:'R_$I=GI?K\IR<:+(9X^4Y'2?X%U$0/1R>+2AV^T).<'*<X/-Z%WK<
M3@\PNL^;P-D%A3,Y$\H8!GF\063J,1H1L]&'X;&=,WI];B/G\:0PR14P4 >#
MP>^#G(2"V! D$C84E;#0C3"G]="%:A*TC8;I+*)G?HHNY2I:T[RQP$3Y>9Y+
MN(B,AW=M;2J=6G!U5TUB4C#MBIECB^=,Z&S][]??6M@V7I2V$LZH?7W3K5>Q
MP!G7;#]8DY3Y*>&,%ZOQP&RHN04XX#B-5SHE;&>A2F:SM<>(>3)TLQ4T^*C5
M*528*NQ80G;%SHAVHFLYE+.D-E3?RHFI653>IEZD6IUF_K8M7H^B6Y9Q>M/E
M=G OWJ6^8#\5[O7]5,;-"/3^@MW/J-T@U5PS$+IXKQ%J3<=ZJ+6">L)3IENQ
M56$5Q#**8F4P7H@4)T**P+"L3@;D&IEEZ&YS#XG7AQ$C<P+9W< *7"%DHYWJ
M@S\OV2\FRQ3:9$9?KHU*16V_5'G-HODBSI=P/J9-54 #E1NVX;5X_E9U0FGC
MPBO*PE<7S\WGCYZ_G;WSW/V?K$S=-7+!DX@EWC>X(S0^FQ=TRPU'D ,G'TKN
MD=::L.DPPSUK1/;#\,37PZY&Q-CYL; ',UGNC(2Q0I%UJC#=2G0U("'0,?'S
M^^6$;NMA_$)XF)%UR!4H>26)GAPTYAJW&?<93Y(P"R2N<-AXS/B]D3<:0\'H
M:*%9H?7#_YH$.A\I&3BCI=IA2S=R.9'H2BW((">W>!N5.^G468J'&;/A"VQ4
M?_AJPX<D'A:^I??(,^K)#8</;^#E??NLZKM??*&>L+[XHHRSSI[%PQX?0,87
MCCS]&\GPYKY]OQ$OMSM,-++M5".;'+9)%H$I P9'(&MDF:V FCX."AE30>H2
M-(+>8\0&XX4*6;^NC\%81WE.\QH'Q+R*Z&)-#YQOTG6Q?PR\@!^!+TX#FOHO
MRCG7A--D;KZEUK+4LI8#=87S<Z!P]2B*I8?C)) U$J/@"NB*]?N=<H5$-G0=
MQ+^[2G8K2B;9XE7>4*I-/\FN+8$4VO+9_]KZX1,]+TW9>NOR74>W,M=7WO?[
MY_!>M>JC?3<Q;^EREU])ZSXS+-.:&Z#J9B)/I0H#7P'3R]?W<TP%B-W7P^:?
M:H,S_0K\/_ M%;8T"'Q^3"<-W;45/[0-/[3U'!=M!:*5DF^K]7P_M5A8$+:;
M+>3S5OIYTW*+Q6"#AK\L#MJ<1D)6;* 3&^5"'.Q:9Q \XKHCUB51;!H?/)<>
MAX_6,]2C#CTI8$8>-#M<X"'RV@*M8B::L>@6Z^W==IC8PA5(L^Z@&(9?QE(A
M(N,L8X61A;F*V4N/>D7R82(9Z;](';9%E6&&V%3BF#;,F*DJ_*)Z7AVK]L)=
M:M_:&U8\_CLRC;KFG;4_5P=Y\[E'N^\M[T[391C_$-$D&<TN9 0W"Q"7#S#[
MW-A-73,P5,[9:,^ZH&^37*0F)JB)5H_ERFJ1U,-%=F6Z1:+=RQZ8<0UUK9LV
M*]7JM4K$5/K\H3H,Z?-KMN+D+2_0&A1NI>C?_CB=[,YX>^UN=7!G]_WE7>1
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M4J!/[">U@-1&4Z@C#M!2 5HJ0$L%:*D +16@I1)HJ01:*H&62B9]!"G0.:1
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MNYL["> J0E#0F)2)-,(# J!4"'T(#-0$V2OKVFIJ"+$1&KP<>GK&:D((!##
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M*;)J'4ZV"6@18H8]NMTL9&& =K>-/]VP</8-8)=LCVZ[4V796MKW.<#9+NX
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M0\3"K.E0("24#WOT.T,JQZ SB#Y^O)78!Q/6"LM1W5[9Y_$Z4KJJLSVF@$.
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M6I21)LB8(Z.O+^H-N\(P9,VAJ5P.JD$U$(6?JOH5.$FN;,Z7\V5]OFPT$ P
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M:CZ+=VP@XE)<\L&KQ27C//O+J412CT5T7?'JL9*N1_1D))Y*=>BI&-S?H*;
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MIH"+M0BN<+V<U;,X<WAR9-.+%F6JR7@C&4]%XQ$80E<=%I--A,:&TVF:6C5
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M?+^R_^+]YSYWUK.G/OO._7?OO^S9FY[]^#-7/W/],Y<0/7,#CWHV^,SV9TY
MJ?[,TF<:SV2>GGAZ_.G!I_N?[GFZ\73GT\6G]:<C3_N>IGV_V_?K?;_<]\*^
MYWC4ON_O^^:^;^S#&ON^M^^+^[Z\;WS?R+[A?9E]^K[4OKCY&\*"]HB_'O_V
MN?1NI L,M[SAK]R_:O@+_W'X-]3^C?X7P? ,)\/^N=+3]+\=#'<:[EKXGOTO
MNQGI\W0!76BXE*ZF%^E#]!&ZA#Y#-],72*6=U*(/TL?H#_0*74:?H(NPT7WT
M>_HL?8E>I?^@/]+U="O=2]^GVV@+;:4K:!O=1]/T _HA/4CWTP/$?S_M1'J$
M'J*'Z78ZB7Y'5])CQ'_-[63Z%?V:+J93Z10ZC<Z@T^FM="V=26^C[?1VVD%G
MTUET#KV#?DGOI'?3N^@]]%XZE^ZBZ^@\>A].Z?OI9?H-[9$^+ETM29)!,DHF
M>HW^(7U"^J1TC?0I^B?]2S)+%LE*!Z1/2Y^1/BM]3KI6NDZR27;)(3FEZZ7/
MTY_I+](7I"]*-T@W2C=)-TM?DFZ1;I5NDVZ7OBS=(<U(NZ19^BO]1+I8VBGM
MENZ4OB+=)7U5<DFRM$>Z6W)+BJ1*'GJ6]DM>R2?=(WU-\DL!Z1+IZ](WI&]*
MWY+V2M^6@I)&7Z8[I) 4EKXC?5>*2%$I)L6E[TG?I[_1W^DY^H64D))22M*E
M'TCW2C^4[I/NEQZ0?B0]**6EC)25<M)#TL/2(]*CTH^EQ^AN*2\5I*)4HN?I
M!>DG]#@]0T_13^EG]'-Z@IZ6?B_]07I%VB?]A_2J]$?IS])?I+]*?Y/^+I6E
MUZ1_2/^4_B5U2 > ;&20# :#T6 RF T6@]5@,]BEBL%A<!I<!MG@-B@&U> Q
M> T^J6KP&P)23>HT! V:(60(&R*&J"%FB!L2AJ3A$D/*H$MUJ<N0EAJ&C"%K
MR!GRAH*A:"@9RC1#NPP72]UT)WV%OB.]0+.TF[Y+'Z"]]&'ZD_0274._I6_S
MWU&1EM#ETK!TMG2%="70ZQSZJO0>(LE""_^I"+#;_D\S'!K0R'_ P&JS.YPN
MV:VH_#-C(*B%PI%H+)Y(IO@?Y'+Y0K%4QJNQUEGO:G0OZNGMZU\\, B7?>GP
M"#REB67+)X]8,;7RR#>M6GW4T6O6'G/L<>O6'__F#6\Y8>.FS;1EZ[;I$T\Z
M^9133SO]C+>>N?UM;]]QUMGGO..=[WKW>\Y][_O..__]'_C@!1=^Z,,77;SS
MDDLO^\CE5USYT8]=]?&K/_'):SY%G_[,9S]W[777?_X+7[SAQIMN_M(MQEMO
MN_W+=\SLFMU]YU?N^NJ>N^_YVM>_\<UO[:7O?/=[W__!O3^\[_X'?O3@0P_3
M(X_^^+&?//X$/?73G^U[^N<X_\.CQZP=7KIDJ#DXL+B_K[=G47>CJ]Y9JU8Z
MRJ5B(9_+9M+\[ROQ6#3"_[\(O\_K414W_W^P[3:KQ6PR&B2J3&26;4K-Y#?-
MF/*9R<DJES.;4;'YD(I-,RE4+7M]GYG4)M$M]?J>P^AYXAMZ#K=[#B_TE-14
MDYK52FHBDYIY<#R3VB,=?]0Z?%\VGEF?FOF=^#Y2?%\AOF5\ZSH&I"9")X^G
M9J1-J8F99>><O'-BTSBFV^5TC&7&IAW5"NUR./'IQ->,EMF^2]*62.+#H$T,
M[#*03093,Y',^,1,.#/.',P8<Q.;M\VL/FK=Q'A4U]=7*S/2V-;,EAG*C,XH
M':(+C8EE9BQC,U:Q3.H4W@U=DMI5V;OSTCTJ;=G4X=J6V;9YP[H9X^;UO(:G
M ^N.SVCO?B%TL(C)O6/K/GQH:]2X<R)T2HJ+.W=^.#5SW5'K#FW5F:Y?CSEF
M#+EEFW8NP\*70H13:^!,SQ@N7+]N1KH0"Z9X'[RG]NZF,Q-<L^G4U(P],YHY
M>>>IFZ"8R,X9.OI=^FPD,GQW:S]%)E([UZ[+Z#-+HYGUF\=CN_RT\^AW[0X/
MI\*O;ZE6=JF>MEAWN96Y#Y=\Z,?T0IOX$MWY:^KH!;E*S%'F")C#3&IK"IRL
MRV!/_4RF^VGGUOZH^&%MO811,]N@CU-F[&.;=JH#J%=Y_(PY![=BYY\)^L_\
M[K>OK]D\5V/)J7\F_F0K63 TM,]_SW1TS)3+;"#6,6@4/"X1Y9YJY9P]AIG,
M=C6%#.*CU9#MYO4#G1"^KK-Z+]DS3%M0F#G_J'7M<HJV1&=IN+-C_8QA$[?L
MG6\)',,MY\^W+ S?E($=WRG@*S!CRR_\3U&#OHF3!V:DX/^B>;K=/K4F,W74
M\>M2$SLWS<EV:NWK2NWV_H6VN2^IW0"!SYARD-01&9C>T<>OXPK\SYQ;EIDX
M9=,DCAIXG/&-K3-&#>O;7X:H44P%^]VP,#,7UKEX+E/.(NQ_VQZK#08L:J34
MLAEUTV2;KG?PK\+_6X/VM%[A42([.&QN3S,#':\O#[ZN_#KV7#N-8-B4-TRM
M/7[G3L?KVI8!K';N7)9)+=NY:>?F/:WSMV12:F;GW<9UQG4[MT]LFE?_GM8]
MET1GEEVZ'ILX61J :1MH=%=&NNBH7</216N.7W>W"M?ZHK7K9G%QCFT:7;\K
MB[9U=Z> SZ+6P+5<R844%VA*PJF8Q=7*_:-W#Q.=+UI-HD*4M^Z12-39YNLD
MVKK'T*Y3Y^L,J#.UZX9%'0=&BK&UZPZU 7&PUE=A4W?36N-O=QO+R:4C >,+
MM,GX,EUK?)&>13*1BAH57TN1MN.[A61N[34^MWMBHC&\!WE'3>2SQ5+C;FZ8
MC<0:WS ^9[B-"I1$Q;.SP:AH>69V='3NH[>__;&[7&T\.^(P/D-_0#(8GS$^
M2\7VJ-W%6N.5$1D5DO%]I$@2)>DZX\]I!LE P\:?[<[F&]=^R_@CM-]OO _N
M) ^[;U;V-##AO<:ODI>2QKN,7YEK^<INMZ=!(SN,_-^/V@OZ"-)^I%>03'2F
M\28Z#^ERI#N03*2 )I$ZD59QC?%6XZW@\P:,5T [D<Y$NAS)!!'>@OK3F!IO
M-I[*?_L0;ZFK*(#\$N/'1/Y%Y!'DGT=] OGU*'-^[5SYT\BY_5-S]=>@'$3^
MR;G\$ZB/(K\:9<X_/E<^QWBV&'?67'Z=<<=L(JF.)-">0JHC&?%U%;ZN@NBN
MXG<MJ&3\H/%TL=(NY WD9[1SB.N]LWI&Z.B]N[5PXSJ(]+T0_7LAN?="<N\E
M$YK.G>]S;KM/U7@N^IR+/N>BS[F02MVX ^OM8%\,5$5*(1DA]QV0.]?/@.Y%
M>D347P!Z!=)U7#*^ W(L@:N+C:?.%I,PLI-V+QYN+/V:\42(>MAXXNYPO''Y
MP9+=P8:(W#V7*]QW6K1.[[:[N'9Z=R3>SM'KM!&W<2N]!\E ?M LTB*D<223
M<>MLMC-YC_%-=(:-AMW)\PSG&<\SG6<VU<<E[[>,#5IM(YBDUUBE)CJ4DAN;
M4M\F^W;[^7:C:D_9Z_9A^VJ[^4SC><;+C<:DL=.XU+C*N-%HWM/:.VL=Z$8V
MO-PRT'V%\SKGC'.O\Q&G><:RU_*(9;_E%8LY9:E;ABVK+9LLVRWG6ZZP7&>Q
M7V&YPFK8Y-SN/-]I5)TI9]TY[%SM-">MTG4C%QJW"/]V"V2\!>=T"Z2X!?)_
MQ;@1]2GC"4@;H8V-$,4)J"=00DE%>@3?^Y&;45+03T$_!;4*:A74$BBWK$;:
MA+1]KM6RT#(_AON_PBU(_-\B<:/6#=GN!WV%OY!6H"2C)*,DH]<CAG^"0Q4T
MA;0:R2CJ]B.Q$__/A;;Z7/LF)(MH?T7TF6\;YK&&?PYO+NPM23,EZ;J2=$5)
M&FXN'6D,IT&\7N_&S,;<QN+&&TQG9L[,G5D\\P;3JLRJW*KBJAM,2S-+<TN+
M2V\P=68Z<YW%SAM,R4PRERPF;S!=OO*.E=]:^?!*T\:59ZX\;Z6Q#ZK;/=M1
M;X@\G>/\*[/A2*-/&1DTW('M; 2]%NE9)",E03N1EB*=B60RW &:--R.VMM1
M>SNM0MJ(9,:(VQE>0)-S;5Q_K6CC+VXWO*[=B(W?-CO0O6ID!2!W(]*U2$;,
M?1O:;Q.]VU]WB/H9T/VB?M5<_^M$?1)T?HP1 '>\@+GC<?R.!_@?3QN1MB.9
MZ6'C<;@<CN.909-(VY'N0#(9CT<\SGB<X7;$VPRW&2O#<E<@2<$@[AFOQZ:.
MJ 87;$"6;A;TDX)>+.A20;/#[A7R7U;(WUPA?VB%7,"'H4@C:+A*4'W8.2+?
M.2*O&I%+(S)FTT@GV1 0U,)4^HV@;Q*T,NS7Y;_K\A]U^3]T^;.Z_#9='M)Y
M7 QG5S;X!74RE:X6=(6@^6%G4OY!4CXN*?<EY1%9^IR$U6E4T(2@4:;2JW<J
MXPK9OR:]2N.829IMEI*XDD4FM6:;(\@.S#:7(_O7;/-SR%Z;;7XL^76\LL65
M)OUE-OM"<B0@_4DZPL3E/\[E_R$=0;<B?P7Y2<AOI*:40_[%V>;[N?\7,/Y3
M*'^>TC;N?SVM%N.NE8X0]9^=&_>9V<H6K/KIV<J[L.JGJ")6_<1LY074?FRV
M<C&RC\Y63D=V^6R.&3QUMEE.CGBDDRAKX+Y;*6=@3E;.K3B)F4]'OKP]>&*V
MPJ/&>8$]TMALI@M9@;G\NI2AU6*YY&Q&;#).&3%%C#*"Z2CE1.Z6%,&\3&F1
MVV8S[\<LECMS+R3_VOP:;YS^+"FSGTL^_W7L[U@4?R$=,7MK\M&[65RSR8<K
M>Z3<7<F',E]+?C^[1SIV-KFWLL>&AF]5]ABDKR1W0<@SZ&N0[DK>43DI>7M&
MM-Z002M4?6VSFOQTYOCD-3F49Y/OKWR=V: SL.-CT;R^LB2YLGEK<EENCX3F
MX286&W8D!S)O3RY&=?\>Z8C=MR:[LGN8E3KFN/6N9!DKYC."E6/Z[C'TD%4Z
M>[AB/<NZQ7JL]2CKH+7;6K6FK'%KS.JW>6VJS<U__47\>1N3S6 CFW]/:_]P
M!_]LX;>HG%E,3$WB6S4P-;1_U3!(-@/.SHS/.&686C,JS7BG:&KMZ$Q?Q]0>
M:^OHF?Z.J1G;ZC>OVR5)'UF/THSA(GB2:]?!0+GJPBB_/^\F2>J\\+(HY^=>
M>-GZ]=+4S-ZM-+4E-?.7-=B' WZT.3,:HN Y2T-+O4L\BY>-_QNR:8YV' RA
MCD-#*#YS]=2:=3.WQ-?/-/BC%5\_-;.<7ZYW&]YF.'-B_&[#=L[6K[M;>K?A
M;1-'<[WT[O'U"]TH;=B.;M3DC+OMIC1WH[2T6W1;*;K!3-,3X[O2Z7:G[TA'
M<">8SW=$IY/:<V6Q!.9:S1FZ&1*4%7-E#0GN!GMH3Z8<.IF+)$5,IKA(3!;C
M3KMR.72IY+C+KKX<.NS*]8GF6P\V9W)M=M933JR3D]:+=23I8)]BNP^L8*Z/
MP88^'?]/ANG1P^@L[=[\]+:M_/O!ILS$--*FF4O..3DT<_Z65&K7MJ?G?EC(
M;]JR]63.-T_//)V9'I_9EAE/[=J\]=\T;^7FS9GQ7;1U8NVZ75N'I\=G-P]O
MGLAL'E^_^\;SQJ9>M];%"VN-G?=O)CN/)QOCM6Z<^C?-4]Q\(Z\UQ6M-\5HW
M#M\HUIHZ>E2:6KUNEXU&U^,!*O+=!J<#YV%35%\_&E2W+Q&'8U /O2]ZCXG_
M8[A./-Y=F=$9&8F;JB/5$6["Z>0F-_]"--<4>M^@'KU'NGFN246U)S-*'12:
M.&5\X7\[=NPXB]/99W> GG5V2-2=A4.KKYF:6<;OV>9,<V)F>-/X>HG5<?9<
M&%LWK'ZK^7#3<&;SO.;ES6N;=S3-9Y^]'M7>;Z4?3ALVIL],GY>^/'UM^HZT
MA1LVK+MKN'EM^@]IX]FP)NDLA(EQL>;9R/$_+IYU]@X.A 5V(+67ZSB[8VS=
M2)JVPMN5X)E7R8>40>I&6H-DIN^"/H;T/-(?D4ST0="/(7T!:3?7&*O&ZD3H
ME'%><7T'@T[(V-A=[VGT[T&^^<1VON;X=C[QIG;>'&F$D,\N[7:,*'"\);H'
M]'ZDGR']&NDU)+.Q86R(R<]N6^WZ';2C0P+[A,)93'9TG"5UX$-B<9^UHZ.#
M.+&!0P/HVB&]WNY)VG$V0110"#)T$K4[>-C9G,\';N!_(?P(TDI*(L7$"XU:
MSR&]@/2K RM:_S2?1ID#I[;V&WWH?/M<(LK1U70M9>D5J8N^0WN!Y#?"U5E-
M5]%R>ICN(#>]2WH TLS P[@9>)$$[B\C33+3-?13VD!OIQ=I/U[-4_2,Y,4\
M$[0=K\7%K9=!I^BBUMWHY: Q^C+=(YTNK:%.?$\:*I!$CBYO[26-BJT'6T^A
M]%EZ4<JV=M$DOEXB#[SS\^A*/*-/I?M;_^3_BC1MH9ND<Z67X5MMHDM,BTP[
M6Z?1('V%'I>F\'4DO<O\E/TK\ ZNI"](FK2W]6SKE_1-W*73F.D#=!$XGJ6]
MAIIQS'P=I2A/0_0FVHS6]]!/)9_491QN%5JCK6M0>Q.]:N@P_,!H!1\== 1M
MI,OH>DCC"7H!KH!3ZH&'<ROBH]+OS4^!MRDZF]Y-YX/S&S'V-KI;ZI*Z#!K\
M0P-V6*)CT'8YW2#^5>$1:4I:S__B8KS!7#^PM.5O!5J_;+6H3.O X;7T[?^+
MLO< D*+(&L?K57=/#CTS.SGGV3BS.[.1A>TEYUW)("L+(B @["(BH!YK7,$
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M]P[<9I(6/'J$W*O8*_R5-(&=$#Z06X]2_C&Y#'W.?^'S7:0>\9M"'N5+$.L
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MHJK_[-6Y;26AU<T6O;I 79<N'WSUM-D[&79CH8-.HG;TA@U2@ H=WIE5*P0
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M%*$*]@HM52BC'K?7[7-S"DO,&-7&'$Z[DRJ"O&D&\2M<,Z# @#6;#FL1",P
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M2=01V7_MK$>-2F7#3:.NW6([M]#]^-*F>\?Q AOA'=[SJ6!$6QT!*O57^Y+
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M-.&SAS&ZM#4,+CB 6E>(\?Q^U+H V2&Y12)"@ 1 "DVDL^FU=%7@P<#6P(&
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MHM%,8!&W9$K"&X^>^XB7#\^ONOC#JG-WH)_K^;SG*\S(1I(X/"^-6&4&\VH
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M#XDT=,8(B!*A<Q(A:1*A<U*;SQO-18 ^VN$,*J)$MD3V1=C(TW2&\IYYU[
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MLOFE5!^ZF?IDC%.CD'!D=]1*BKNF#!@Y8X 9 ,#8&XU7;J)N=M[2-IJ[I?!
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M7!'W0LUGI=B@EU)BZ.R==$2!#T*IFOT<P[UC]6+FE[!:%=N@;=0V86/'\>J
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M/""^(?+BXW8/2^T!N&+RAEJV0XT<AK(K=MW.G+(C.]R)A-^E?4%D05-RP2K
MJMGM(+9LAQ2B&2SGDS*+8P!2N3$G_D18UM[FP;(VF )(E;XQ8BBA>GLA;V?!
MQD,\3 "\?8@H!\2:/$;L>@+^-4N\9C4*-1M>8.+ @QDPZD$#-.)@T-P*FON:
M6[*Y)9M;$MDR[%+-H_AK?MU9L^DDE!SE/B*E#PT-N7C?N8EX:$(+O)YD+&7&
M#_T&;=VZ>].=A:CGG[[RT#M_.OS B[.[T:.<XK^L>\WM]+R?WG##93>[]_P.
MH5^_@X2?/-ZW,=%K_!V6AU93%',+]UDJ1XM-[$X6"+\J&,!V"D2O#N:08N>1
M:,\BD40>JW;(*E0!0>TJ07TS!)E_VLSM-60QD8SX*,J1=4RAX$&5AXI1,]/*
M=/WXC#)C,J5I$*>/*2_"OV,D%S/8FO#,0<ZA\*E&.,LG\)7$+"*(B'C 0$3D
M:G(;KQH6@HUD'&__ALC7=GLAWV)!K\$*__SQXV:T>M"8?X]^O^?^%+.066A=
MZK^3N=/*/<"B4F%7;(*?$";%2>EKRM><!PJ2PF,ZM:5]2XX.B?9#$?$+;>A0
M1)AB1",:CTQ&GHO0$6<BZ4.Y0:S\EMNSJI,7!5G! #Z%+GIR+U9XI^CW#J+V
MW!12#%LFBU2'4_F"PX$2 *Q/CHQ42-O79[;UNMDF.DAK>$.QRH0= 8AOL8_:
MI^TG[+S=GW^:X1FA&1AG N6JF=:<?_VX>7/XY!BQMO7WSX[UUV>Q9EMJ1G2K
MR;3;FTIZ4DEO)D2EW8D0^IM83BPDS3$[0SA,O-H%D]$TJ_#!-& @,&'-S]/E
M00^'DO/7S+Z6S9SO/WAPXU/;K][85XGXNI9'HZFB$7J763G[\'A;/I'(++R4
MWK2T?\_W;UQ8Z(U48Q]WN3JN?.7\I5 3ZKS&8N;_8)E\'K6,&F*^;'Q:]0Y^
M.75_-T,5E,WT3>TWK:&I=K[(7W2/SM9[5F_>UG-C:G0S5"*^W7>'MK?ZF?FW
M+]J[XJ[57_1]4;M_]11[E#OD.Z3]N/+C%=.;3VQ^8_.IS<& [NE2JN[NZ&;N
M$7%Y=SU(>9GNV/(@Y5^@0LDN&Z0_2BZ76Q+'DTA-@GU(Q7PH228-L]:A-2RJ
MI3Z9W)]\+LDDI]#7GMJ8&X]!6,YO#1L<JT[&]L>>@TD!S7-(BT^)X6,-;6(Y
M6@ZS/"PW\-#R/*#.<I+@BT3#M4U$NT3<<4(85I6_G]0"[#"L_N5RR8\&_>-^
MVO\L_0N*Q\BUBNK'NV1>\%^(+LSG':N^SY0QOXO@=8U:Q92-J%)&V\I[RY-E
MIJP!?RU; 27*U5J1&5^+UL*SV3"VXLX_'5+<I/-;8HM9:R;L8$1:FXQF$ EF
M]_H"E;T9M#HSFIG.G,BP&3L<F6EY97#G/PP5"$;F1GUS>;.Q>1]^Y]QF.#5D
ML58VV_=^:3%:3*PXBSMT+W)X1[TO8V(_=>;/AI-$]UE!,/"2>_1.T<\:KOOK
MJ-Y19@89>I!!D*!"@UG\27^X0EI\509^'L1DZ!R!9V2NWK3Y:70SUNOD)_:
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M;KO2O_/8,6B.B<<$W(AXU)QCD!0[:84N6C!.R1"A^/X1J>8#*P/NOP6S5'E
M295"SKK-""JD8."3>$,C=31]]CH'/DT!2M=V0Z\/1!'<9C,.N-JIPXY:4G<
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M P#J>2ODO7# N]R+1KRC7@2\"2\ZXGW!B[SZL4O_=J8G#"EST<L($33"W4,
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M/2FQR!5T6Y94:':="4MT?6+J^ G7KWG@@35K'K@?'Z$;NM",+G\N=>''V)E
M"Q:?!"(H&D,_YV5J+7-(C5C$'6.I88Z!1+,E,@+W#A'AWH,07J_20,TFO6RC
M3C\&<R>=W4)FGPNDA?LN#N7'J57IOS\FK9LOT$Z-^CMJW,*_&!)22J2<!ES7
M<[[WY6^M##=]^Q'X1];PMWKNK;_5,SKQ_.,;-W8M7T'G2=R7_H+_B;T7-('/
M^::$I3\Z8%ENV9M^V/A-B^@.\5X5XBT[<BAA3=0@8%:;'>:$F9DA9H-U8+I+
MDW+8O;: )A&WC<$G>0=(>.-QD/5* 9 &O":I)^:HIZ#TF42B.9^J5]!) 6VD
M7F_--S9Y.-;2G/]/YY,S!)+21$"SU!_W%86!-7YQJ'A!<*.CYC)A>KZQ&O]5
M=DC+IG/>L,$BDH>\#9+&6B 6962I6N@W>VN!SQLT1FIA3IRMA6DY6?DL@5H0
M-@1J*Y)/M8\M>SL/45Y/95I11I-NJ+*YP,YH"CN+*OQ<P2I)5K\ C3N?,@P-
M/?OH/V4#5]]YUYE#"]>&/?XPPZE4UKP_]<"7UUV[=N'LU1[6T;@,??"W-<-G
M[UTW/1L*O/Z-YTJ?+6\/1<,>M<8LTRJ5F:[[W[XH;;SI_CT[1E_^["^ (7K,
M;]FWV?6 IO5N!T2?X4^F>5EC/5E29 F0)4H6ZJ0?Y[651=]HCD%F5J]]999Q
M20.*&$B##&N/V>-(%5#%$!FDC)Q54A?/Q+,WZK8;Q*P[X$:;+)OL:)E]N6:Y
M"0]H!DS++/A&_^XXBL27^)?$\1:Q/QZ+'0_X]8& /Q"+8W\T$/%WQ-N/.AJ.
M9M-',QU'XQ\E8"+AS$2.1J<_Y%#3.#A'&9L5M_%R(L_%LO8,?"$#,W1'LUC=
M!;"Y2RS)@#21@=(X?6]]NR/<8,_"[(;\: 1&-HQ&872#O1NJNF'W<;4'CGH.
M>Y[W8,\8<O!Z)M'1,7.FFL@(QUOB^?WY WF<)P?.R&N[7J%0V-C-R_1= W(H
M[^U;N:+2,PX)SK7%+17S[-"6\:$M%X8N#-&]U' Y)*3"IB=MR5?.R)>Y+SXD
M^(V4?U1RF]U9GK,N2W3S.GNA;YJW'(M:YS,*T:A6;Z>O.P5[7=W-4*/2+P!V
M6+L FB2D9!&14I>W(P5\_A[W]&8:I7H=M&&R,LC,UX$:EJQ 13X(7SE#*_"M
M ,DS!(>V; Z#+7!RPA8F&2UA7L;M\E#0:H_)Q2"#7LNDDAYM)HT\K%/HLLI(
M.P8W=&NN0#_PN77);"7]!Y:>A/->?JGTW-A8Z?F77H;S3CQ6^L%SS\+TTT_#
MS+//E7Y0_"F\];Z#P]?_V%>G<XV5?CF3BW:4[DL$)"(L\D;'MU_;M'F1+\:N
M/UMZ]MQ8Z;GSY^&<L7-P_MF6ITMO//-TZ8='CY)K/0,;GO[I;4,SM]I+[V;T
M<NR$#Y;^V5GG=)J,ZCXDFZXP64JWQ>9F9F]4 WS9=]$&X[QWNW:[:7=\=W)G
MANU.#@;F1P9S:P.KHVMSVPPCB9'Z.^*R?G%B#'?P\OIE]9OJ=]?C^L94ZQA>
MP.L=+J<SU>9(>]> 1G6CHS'1R#2.X7F\FO)GK$N5LJ?BJ4**20D[*<,F#M9G
M'5G704"1B&&4KV'"QU59>S:>+629[(>$ 8\P+S"O,!\QC,"&"LJ&R^5(/MH^
M[ZJIC"@L%ZA[$G64$%87\X35\H)_PU#\@M#3-4'[E4Q%6.DZRDK745:ZCK+2
M=5_(/E<$.1.V$:9T_A?V,.G*(0[53$-$DG2[0"663Q M_U>>.*_W>[ZV<<YH
ML"YPYL%7MWF_=/'[I;]!\R]C+;,L<K51]O_ #:^4?G_]ML[&\+W]/WWC4=T_
M0WSN%:B26\6:6BH5UB&OZ#0944V@'3[!=]T=AT.Q:\Q;S5LMVZ([8WO,MT?O
MBAV*/15].B;OB/;&!BVX,=9IGF;%27/6VA#!K-GNL_O5&7768_99PS&QX[7V
MFC$H.>5J>:V]G1;<SM?:O4(A_%J[3SB4>*T]*^S)O];>0 I\P:5YK5UQCTO\
M6KO\'K?>$HLZS):$U1&QF+*1N YY#GK]![T^7Y9T?IF#V6SN8$.#7,&)1%JM
M[A# : RWGH!&$]GP46!NKSU84]-VL+T=6B% T8/K8C!VS&+):S4B<4L^$G9T
M$GDD'%)1MD.]9UH2AT >DCXOQ&O%^" R'C1E <K".\4A<*?F/%(0Y:P3_O*D
M<]%.ZI5SH7CQ@OHB[<$(_^4) PHB3-4/CK)=7U'0E02WN/*L54GX7PY.J.;H
M4BEHCJY\^9Q*Y7*O.&5:=H+AJDFAP9#.::)L1<,53&5L+XTP)>2%T&E0(D-E
M/QV%H;OL3WX9LE,FA7YN=$GGKY@1:"_=U>:>N6Q Y6)60PV40%/.J_7UEK8T
M!W6E-QVE'VJ\?D_I1SF_5A/(L3/?Z)E6_-:\*/9XN/ <U%F8]4;Q-93W0GVD
MJQ29'V(\'F@,M<'_*FY$^TIUG4&CQZ,/38/_,C-@$'(^_Q=C0!DAIUXCKP((
MEO/I(6%*<@P63^/;D:623>^#BGQXL2(@QOO&A\J>!M"M0YG2+UQK:4X].$AY
MN)%9CK:PC8)%J)>/8,L\_\JLG-^MA5K [^8@9Z'R)_^VY'T)DMRAXI<9-AF0
M89Z9=B*"G:+X\5#U/D-]5,BG,2]3Q5'GE#+BHH5"-,KSI1_&"GPDRA?81CY:
MV5?9TK>UE/[,S&"[@0Z:^)S$,,VV,IO3=HN>DF,(6 5B "O'(ATGQV*U1(YE
M*JD<*U52!=*H)0JDU7$*A.5R.G,H5R"]0H'*W$YWF( 0#J-B[6R<Q2Q&2*W1
MB,7"-*-,*I7)5$JY A]#8ZB;]P-XC-E*\^8>TP*=3JTY)N8D$EYZ1(J 5"UU
M2#&@9>D8:N1-LF/*K2KY,>I8<$2!%;O4JFGZ\KQDWG)QR$RZV2*%R"O[>U;7
M%ZFWJ)G*S_%\V3&MC)X7'ZHZJE53I1/M2%7Y*R?1=.I2V&EP"HM;Y\PX=4X+
MNNI?!GX$;R\M/( :BX_]9.#'I9O@4_<5OX^3R%#\SZ6E>X>*XTA'LR<!=.GW
M ' 72._5#J;!'GZX/IE,='9X/)T='5Z14Z%H$->(7/::6J<KDHC61#@G0@UL
M#1?VAFK"'M(E)A,)M[=#[_5VU*BLWD2X*^EJ#'A"WH15GX0=N7:WQSVM\VT$
MW0JELK;=W9@'S>IFU#R&?L*'FW)'FQJ1Q?K[FIK:2%C_A.UHN%9L.=I-6,W:
M%&X^JLK;\RC?RUF/6LY#%^" "$5X"5"Y.ERNKN[P&/JODQ%+5_>+:)@,?^AX
M)0>L("'EBT2&^ICV+\4+%<11VI^,EVG^.0TR5Y<(=<>KYPKAY]K&R[L.P:.C
MHIT*^FC%CZ?LUE$&*JSX>-Q)TVOF17GJ[D?5'^IPD:+Q>7Z?VUGN0007#-):
ME72^S@E?M%;4 ,NJ*6D^=SG%/.E8&0SAUJ5BCT<>3)B&2I>4D<8SUVYOZ(W[
M-GS.I>;ZS:7K=G6U+"\MB!2F-\)'^FI<(\Q"E4OAK4G9UA?_I_0P7,6BXN\7
M;"H%5TXSR$J%Q6ZS)]VYJ?2LM]YQ ZS[P^W!VKC(ZX6>I>LPWI]T:"V<M_3N
M<-:OE1;GT<P,O9=^S-[ [@!&X ()B/F-@R:8B,?<;A-2MHJQPNU1*A%0FUPJ
MJ-9Z7"8%8!V8BY*26H&!R!* *I5;B?3D+*7*H87DNU<%I,@ L25@P(& 5**4
M1/-VTKU8^21,.O)J+51IEVF1UE)/Y60APP4U@6[^> MM/P%^0]-XF;53635W
MEDT&U*;0*%+F!3NGLHQC047B6#!BM>OT(DF=W6:OM=?8&4[L"T="$<19]8XH
M"$JB46C76:(P(@I$*[ 6H3!-S'@+1]JT'#$^!!M,5!M3E[/4B?P-/HT:.).F
M<K@X5\[++$@F9/ @+<K<>%O3'6N67GSIM\/_/N^6YMO?@'NA_M^77?>3H>R,
MYO[IO>C=XMQLZ^"U:_=LFZ=5,N\^&GEJ\^^_5GKFIX_-Z#P<?_PMV 9]\+[/
M3QOKVA>5#O_N..8^/S''ERO<_M&I&]?VT3:J!^O9G?@%"@( 4N \?QU'.BJ)
M5J(W*2SZ.YF]_H=2SR#I;N5NU>[D7O%9 [O3<7UL>Q)?CZXW;Z_#7S$\97C*
MA&\W'%(>U.#5R7V:LR:\NFZ]8SB&!QW#:-B,,V@:6J3"?HL",)S.[R-;5FUL
M"JF;$@E7*.2J;9*,P>V\QM6$1?8NSIJ)=NDLZ<K(0%OOX[[RU(!&\#VD W3%
M^E,Q[0A_9%R::@><:BO4368 I Y-DU;!ABS:U_GHW=_XS<_O6#$_=S5_<,.!
M[XW=N.#V9V?<O_C&)Y[;,&TX9'ZS_N8EZ_;?,[BL-XX>?N2&WY\[.]Z;>&+7
MM3]Z[(D?#):>>63]\0<?>*6K+SIOXYH';[KC\/P<&7=,X!YF%O,JD>G?X#UQ
M$(=Q)LXZI Z90^E0B1TBAYAF6#HB.B+FE&180? \]I.3 9Y] HM%8W@V+^%D
M6"J1<!PK##\,(\?+94=D2'9>&&)TRRE..'>>7:X\0KZ-\V*:=I'LKT$L0T;B
M(PBA\Q "OBD#^&R&)GCX9S5-J+Q4$-EI^M +0Q79*"]HC$+&W'QUI% +Z6 N
M5D(YR\Y3#9ER-N-4.0&TP03_7%+"/P_ BR4Y_)][9L-'Y\ _E51S2DMG$WG
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M%"X4J-7E[PS(C56]6"U^37FE%=GA#]CJ= 9.K/>)?#:#W0'\XJ #UNEJ'3#
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M:181,3X."[&KA/Q$T" 2AEOC]#"Y_L]->&-I'9Q&9:^%ETXPPZ(^( (/\7P
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ME_=4G6./BPW62?QNTZDZ^QYWT)O-F7"]*IMK[D_#]!CNY!7-WB@P#/BA/Q'
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M$BM.U8GWN'S!.H??A4[5B?:XK<$ZN]^M443")HS,5E\@9(J23M//IZ(_,AL
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M7,[#KJ$I'HE85%&-980DN$TRC>.VSQ5$]OB;@X([%Z1(7()S#(7IN@RERR_
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M9A30(Q>NGVU*'Y## 3D\(/](CI;+1^1(?L)TXK%R'.3F+>'Q:B">=C)E9=D
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MR.^'SV)H90$%38$C4WQ8RG*ISFEPFM#-Q5O9WE%2MX')HJWL+* "';Q"*I%
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M6NTZX6)<EECO5<D@9BW$<&$1C2K>G=^<H2<@Q)BQEH;J)5PJXY%O:696NO5
MZ!+YQNHW83UDZSF_V.$I\.5[PBY0[,"70G?(!8N<D72<J9MN@F0+L1S_(_'/
MQA&5/7E"$M5$#5ZZ"Q$I,W'>DJ1IH)9X^6@*4_$ HQ'T3.(+Z&'=;FM("34%
M#SZH<ANS"^2)LX6]5P]\X/2OQZZO%U5/"X_M.^'%^1/8_.&3"]3>YL39X?':
MQ_K;--Z66_KUN'3\..P_)#X0?MRGN:)^]I_^_!& G3]S^UBM2";862 FL(>Z
ML[X$[\1\!$$+^*TSK)8XPW+[1M(\-V@T?(7)!7)@W,=<@\F1%!Q@A@(1"'=
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M8] _J28U++FF-V**@&4N6%\&F\H6EJTJ8\I06^>-*>^)'1FZ4+)-F&[S2_@
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M2MJK73*9O(VIWJ50*$D?@5HDC$<!=JACXAT+):LD2'(([L=LC(6?[Y?+%6F
M8Y:$B?*Y%+R%!*(IB)..BHAI>!FU#0J(=.GN73@NJL+=8^;C_A<4T?Y/F;2T
M&\17\U:9=JUJ02G!#93+5K"(8 M29K&LF"*$;(<4I!&"]$\)LC"P11R2RLA
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M>M@7/AA&(!RAX#X4V6$B!F0!1;"*H0A:P5L;:!5R._0%M@60&.@/G Y\%N!
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M**0#_5%4ND5U)?E?.,ZRB5AHG-6YK<T#A]!/*+PBO)*79"R=E+H\$P< *WU
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M! #_4]9&PW>CL945=KG(D+PGM$&MD;.LC25Y>?U<@1ZUE7'JP]>.TX-("2L
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M=&D[C&_Q[YB_E"M_S;^L_[4-KY"=D#TEQY?CS;*=5JR0*XSS95@NARJMUN&
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M_O[:7^V^Y,-Z?672?OGN:W9VK[^&59+-M>/+\ / "AX6&VNL:\'5X%:P"QX
M!U1RO=UKKT'8*JB0%9MD$,@$EJ25,&1III9.9Y+)]$A0$"HA0'M4K%!99/-4
M!BMW>U)!*]<HK$+"8+!Z80)FR8"#>K 'L(HP>XB?1TLJ6AV)@0%F22<V&/+Q
M4"HZ8N0/9%F&1T]/?LU)#5.DU#RV")0JU1%$8Z)!(9TRFM!/7\^MUZ^>T6_M
MFCOS&F7HEP/KZO"=YY[:M2+W\>8??;(7WG7H6=B9^R+73-^ZG;RUR.\"M>"<
M6#)7N5R)TLI6)7I*]6L56JJ\4KE;B;/*+N5Z)7;4PD29Q<8Y*BH%FL*942A
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ME7)5@\\*/Z/RW$OD#!74+'F$BH"8E%B? E1IIJE#DZ9F[WA%QD*5H& D% P
MNF34;+2F?28;\ON (6,,2<9<=9I[*^S*_6//@[DO+4@8^?R6U_= YW.N7^0>
MR?T^=_UO8/"9ZP9+]:'B '[PX.]R?\N]WGDR]]%-A$]R+\$?PN)W8//A.OW4
M0I44ECE2];UY5_]_YC1993MVCS+FSVA'/Y<=(V.E#%2#%\69=:FZJFSMM-2T
MJB6I)57K4^NK-ODW!2X+7>_?%7I:JR^JIH50RZII(=1$17'4XYU67EU=;$W9
MU*)&R*C5>CT?)=H8!NTVE!G"96)Z6_!@$ 6#93:KM8N:.4;39J2'Z^%!ZM(6
M>3SEY8D >*,,BF5]98-EN*RLMD:*/HV-C1Z6X-,C=5./E/N3#T+%!"F@W"",
MY <$]+-H\K@?:33D$U=TR&*0\'Z(4<,&AJDP#Q?$=^>V__IGG=V9L+>X++1@
M7?LUG'ON//>LUU_9LO/=_\K-6=19=#+CO^JGCSW H]SVD5_D?CHM&:[R$+$(
M[X!NEM<" RT#N5WM/UNS[OAY811LV@AO&WE>^?!UUPT2*D<!D!TG5*X#K= I
MWIUMOUNXV[!?>-CPL>'3EB\,BC^T?&H8SN)7LZ^V_"&+-YJW&[:;\?26]=GU
M+1L-W/_#VIL 1EU=^^/?>[^S9_9]R7QGG\ED)IG)3)+)G@&2D 4( @$"!,*^
M0]A1T:2M(F %U-:J[1.Z:+750BU6K.T3;5_K4A_T]6EK;0NM:!>EVFHM*IGY
MG7N^,TE VN=[_S_*AS/W>[_W>^\]=SGWW'//;9W2U;JD=<D42;2UH95&?)&Z
MBBD97Z:N><I47WN=HL+C2OL"(FMHQB7W!309E\+G%[UIU;BJ@ZX0=!2=1Q :
MFUK*;%I=HR[0UI8&03T45LAI=9I6U]0$@Z$G^66<EYL$7 N.F(Z9J,E$"1$$
MMT:K;6QL\F]V$[>[@>,\'J^_(GY?N^CG'%ETF5=9QB2\%;>P59* OP4K#V#3
M^/%C_86BL9&XKF2>:XH6'6@M?#FW#+XK_7=.L"PF8ZPD#Y&_.&==0R?-[S?U
M_N>SUWW^Y1\#_WI*<\:659[1)Z-UW39'UR0/;?=TM;CIMS+"#0\]_!7Z"W+M
MT.0 !2FE=S%R<=?)K@(7<\NOG371)CF2V9BK*K(61AOHFU)F8Y?F_O$$=,M?
M?K?47?T0(;"P_V4VXW)7RS,N];L!0\:E>=<?S+@\/K_;)7!VZK&RB<9JY:B>
M'J4\E5=45D:CXR<(%L12Z70H% [$8U3P*-0:]U&!# DCPF&!YP2]0 6?0R8W
MROU/L35;,%Z92E:,L+-GCE@T55X.@X/=[O"'],Q5Y4B0O!,DQX/$&TP&:5#<
MV[[ZY(.WG,'S)H[Q[:IS$)N"D'EL5(15+A&79A;SF&4C$XC^Q204H%_Z[C.K
M;P^4MDT=?7=SG;5ORF?OO?HTM);^ZJ75=__VY:TM?FDHI.SYS,NW?KKKWW-W
M_*N92-HKE\),-*4@7\PB7RAX*LGHPZ*GDK&9B').F(GVRS6<A6LB9=GZ&EV-
MJ5W7;EJE6V7:I=MEND5WB^F+[I(RQ?,-M"MSLN[9.OZ>A@?KZ#UU]]13GH\H
ME?6<6FUX6':2/IS5U=?5 7/-[KJ,VQ6-1)@%:L#C-GL\[OJZ:,3C=LFM\5 J
MZ$\% P%[RM8$ Q1-I6K9'.6SEH* &5<F$O71G=FZG6ZOSD_\!SVA59%#3:3I
MOGK[#\B_<2[R%2[+U=.ZK-+M]?1E$Q$"7S%E5=ZD.\O.CK4TBRK3<=6]TSYZ
M7G]^@-V'-B#^9HL]3G2RAM<_B5X3Q>OGKC ZY^QL,FQBAN?P?\&FF!EH3=36
M6<7K/FJ)#_5\HJZ560K*B?:RH3C#KJF3>(6*'_SPN<?C/E\BUK3G^N98Q24/
M#=^^GI3]LNU&\M!=,W*C*V_\_,SV):E8>4/$W+LL9ZX>F";7U 07#(_T!VK3
M\_;LF9_*M89DG>DG1R]2Q=?J9AA#(>/W1N^^\.Q 8SI4Y;=\C5^Z<)H&]P1S
MUZ&U98+[V1-<)53T""PO^2S @8I?4JJH\%9U5O)GJLY5T:&JHU4T4H4VF.QW
MV./R^_Q*=B3";_*X=-!Q/2Z?+Q!A1U$"*H]+RVPP2<SO\^ET6NJP!Z0223P>
M8R?AB3D<\;NSI>1L*3E:RDXU\^R6CZ%2OA3-,:M,9K^*J0RH\KZD_CWLBT6G
MWFRL+&QCC1:=>:<35YIF;HG%")JS?LPV4[1AO=)<$T9)^GZ(__JCN>/,3I-.
MO:%#%9E#ENZVM<,/%I3[TJ?O2N2N>_EX2-)Y,[]DS&[SRT,Q@__ Q(";@5KW
MZ)46]]";@NSF6:AM)_3#;V:G_4E%7O&_);SMYY\5GO6_(O [-)]1W:SA-PN;
M_=M*^$YAL;#$SY<)B4B=P%O0P-7,3%O]<D5(T14(./7N,AUENUKL\MJ?9TV<
M5!;@G%2G5W TU<M,,+Q,R- QNV0U4:ME+K_%?%\89R:8E<2SDO5%69J-8:+!
M89H=6IG@^I'@ := <<;Q%2L5JI",ZZ+YOVJ#WIN_<;[V@S_?>2[WE]%G;NQP
M3^XGN^=77?^3,T<K*J73<K\\/&/T#ZV/WO"%\Z+QZ^I.01KZ2*K]VNUWW:[X
M^)D$(DK.4&-6;D[68?2XK.A57N/S*_"0TX3".S@80#DK56N@[%E6=KM<X3<:
M[K-A<<4A' =ML:AB8Q&M4J^PXI6LE$8DW>M7YFYJOV'T>VB\.RWWP\'MGBOM
M=AE/G="#9D(.W5R8.YXMN4WS:0/59$L*LO64$F-UQCO52Y46OR^@+P')W&0V
M X-HBKA37%CH(APM2:E42J4,Q%&9F^,<II39;+&T^GI]QWR\S^<X2>[(&D>8
MR;A4Y@^?#1%O*!FBL&[T<F70*[:(9K@71"<;: 0^=@*F8 K.A(G6HM6W?K1)
MW"B+Q09,Q1Z0-F!%L$G(4&LTXHI=2JD<N\I?)4MN[$CM]PLW/[0S]\!K+UG\
M7WY^1JI]/>EP?'8G>7]OC70:JY-1PZ]6Y_H^]UCS^X?)-[5D%55^?<5BNR0T
M>BSGWY_XE$1QY5D*X*^1X^1VZ2)N%?E,]J-]NOV+Z+6ZZQ?M5?+]H;6AG4I>
MV>L,1\/\[#E]?;/FS9\_5Z-6:R4>%^?S+_.X5J$;U"I?H)8Y0_4;=+I@B=)<
M4J*<U=<77#!@7K!@0*O3JY0&V=P%?7,6+IH]:T!9Q5USC=1HS,27QKNDTBIN
M7FJ^)J6>-[^GUNFN[NF9-#6K-U1/C<./J5,G3:JRLV"[W5_*@DM9<&FIWY^J
MHNJ2$FY^?_^J51S;=%:5P(<,1I5'LGA@T<(%_7/[YLR>=8VZC?,0CZ>MK2(>
METHEM9G,TJ7+_!4Z"6F5;)8<DIR5Y"728<EI"94D)OB[*X@=S FK>.UI8;0K
M;MRSQ1@J82:2!:M3%"-1?9-@;^*<)<Y58X2]>!X-6\@M+*AX'$;L A'F"Y%G
MM*DVP^X&'-MHJA;U; )E.ZGC ZBH\6':N0FZ?+F,G:"WH803YOFBP&.ST"W#
M':6AI'OG3W)?_]S!;[2 T)V.1F&@3@?+,W-FS1RNK8HGYK79PAW#M//&]E)[
MS]Q$1;)V^)H9\VMC_II:OZ^\K+JYJ6K2CLTW;,U]77WP2]K:FA)=^XVL#9(C
MI+3R5[G;0K:3I&)3)+[KF[=,$MRI4,7469ON.[0L+2,[BETX=ZLLO>2.?]LX
MIRT92KF%]L\\O#,>''SQ1ZLM(2>1$Y^K@>26BKV<<#%8%SX"*_(8*<W>)5/&
M/+$ O\J^6[U/_9P@6:=>I5]OY.?JY]GGN?BLOL/>K^9;U%7ZZ1H^HH,EN$*K
M]?5EO81=?9%D5U\HH")LSE@O1X[A15"$;RSK*:.2,G-9L(PO*U/PQ>,[2I\7
M5L^VU(B5Z*W$:C7 P!%+$3U'O-PP=X@[QDDXSC S1$)LN$GX@M6MS-&U)Y0(
M4>;I&F3VDA)WD\= -AL.&<X:>)TA8>@U\'I#TD -"6:!= %W96#&9$:( UN;
MQ!/+6[=@>T)/4P/L[P :C6S!O?C"_9B.PFV(W)A/&$-ZP@X.'I.7!+Q\IK@I
MP7QX%#;!Y*L"^@9KYY8]#_[TWN$#W\A=>CKWN_O\Z6>&;K[S>[^X^][!O=L.
M?=G!GR4')KNBS]]R_;&HX[E]#_XW5,+LW=\>N>F[D[.'EVSZ[$,')IP8*>?>
MSS:L,:^Q[#/OLT@ZS9V6^>;Y%@F#W>;=%HG#[+!$S5&+Y$S\7)P.L3,VJCB*
M,^RW^4E^@+E_Y0>R3LM$J48\91)E7I?]W$D2SI:X)$7YQL)^5[.)V>MQ!7U,
MP@F%@I2YY=9I85CPFSBS.6LB9YF5PQG3.1/O-25-0R;>A&)./%I>;O%[9\(H
M<5]LS"&S*.C@0'W96=OB^5KF0JDHYW#,'0\1_6]?=O3$0 3Z\9,I$J%W-^W!
M@RB/?:IC]%9BF;YL]'$4>+J&.R0;KIMTV5F4KIMYU:5?S6OTTRL/J[P+,Q_6
M.ZX-LB20[6-K@C7E:V*?TGW*M*]\7TS16=X9FU\^/R9AL+M\=TSB*(?%5WDT
M)CDS^=QD.C3YZ&3JG8P<8+^9R1PL&J+,JYTR)JX;?@"+$6 )S/]9QIC81&;4
ML+&?G7EN]/FM(F/&&!$3&9/$N:'!%P".-#8VT*ID$OBC@!5ZU%I>GHV2LU%R
M-'HF>B[*>Z/)Z%"4CR)C)K=FLS%_[<P:4G/?I#'&C'X"QHPM"-#=TN5LNNJR
MP/3)F6?W5)Q\=L+2H+RR_%^QDZT)^D?&UP2C2_X7["WTJUZ8FVNYE[.WU;)3
MGZI$MFYW<F=Z;UHZ-4EJ:ZZ-[8\]R4GT3!;SRSVN$I3.++Z DTEJ_NJ:=+JF
MYC]XB9GG);5\3;4DG9);8$GGNA_*H^9(!9M=*RJ"43:Q1J/!H)50A=5"2]0*
MJ82GM6P/03G"[#R<+A?,)WZ#1T_T]V7&?9=#'1?M740CH<)TB%.A0YP$QV8^
MN;:IX.:>8\<N8B&8F;APY*IGN%IXG- FS&=4SF8S:6_N*_6Y.V9>P\YUW3 5
M:KISN'WCG+7-R8KZ&^?=VQPIG=Q@\U:F!C^_\,O?/!H*+20?9$AN??%LUW@=
MY_82U^#FX5T#4S:$Z[SN*?OS7+O^3_]X *6B_#O2J7A[ZG79GE*\74E<6XEK
MKLOTB:(R$01BR%RKHI=9J#$=XB$"4R'\*77[N;-AX@TGPTS9>9G(N&5,<UA8
M A25AJ)L_$]5A9>U5?Y'N457Z :GB"?=;NSXI]K "8VP<^]53FI^[$SM9:<$
M"WJ,K[#G5,I][+Q<\7XYC!_&WY>=&X,:1KT&UO!?LH'G@Z3+=]+_K)^_)_B@
MG][COR< !??[Y5*SW.^32TT& ^HJE'*S4BD/^$T&I5PJ)U9=2JM.:34:F)+#
M*9#C2TN]15V%UVM5.AP!T\ZL?Z?<JX/%UT&E;I7A$+3E^P*4Z2JDJ*L(,%V%
MW*OLRR8,Q%#05<BST-CD99'_7W45!1'/](FT$,[_6>, ,O\GT##P[!89F1QJ
MVLM%8>&OS;8,5A^M?J>:+PMTJ=KM?$>P*]Q5V9&\)K@PO+#RFN1@<'UX?>5@
M\O'@XTFM*674IPS>%*SH2+3+&NNRJED%[U3JJF%V(+XNM[N\2YJ%GU*I@2,*
MHX$:328OYX.FJZ>4^,JMT:C;IX[%8#8O+U<L 3&IR>-,."F[EN>H\QVGA/D?
M]SH'G1)GE[>:5,],$%@E*;P*VJLXI*#LHM)6!:_H2J]8+EY0O67K] M;IS.?
MU .,0HD;1R*<N44I_;VFHFZ7#48%1R0P9!<NWV#_%88@7$EGO.QBRF"ZDA;N
MV1#OJ_2!Z!P1Q:5P@#?@%?-6JV3&Z./;>FGN6[F7ODTDS])DXSS:M;-;^LN+
MW\K]-O<U?OJ._[CSV+;MQ^XX]<4'M]Q\(D0;%I+2EX[^?MZ<6@L;YEL7+_[5
MET_G?KN@D?YN^K-W'GBJ_=+S?&W/B4/_=J;Q*N<GB_JA*/=X=K,W1G;S^_@#
MDC.Q<S'I4.QHC$9B.'W#[X(^2(6.,D0UA3AFE3 IBO5G6-]*_3Z?7J]CRB"9
ME*V!0?C]UYJ@F-GB+V$&7%1U7WEAW"]J@E)C"]QQ-1!N54U4!(4,5U<#?5P+
M)#WB+WWQ%Y?6X/S9>6.'=1,9&#%WC-#N&SLFA7)]][YUQ2RY>TDPLID?6U!<
M.G(KNW(S_R&450MU5L6=RHZ$HC71]BBO=CO=Y6[^DIL\[_ZM^R]N/I%^H92J
MV7:$GV38H65[QF7R^349EQ%DF R[XB/B"G/W.QRN9#*;I,FDRV6$-54X'*(F
MHR+,188B1R-\Q!?S>F(>_TC\6/Q4G(_'U1J_'2K5X3AK)TD[.\'FY=(XY!?6
M_N-*[*8)Y_9AW-_"VO+XI@.>;R03CI!.U%:+=O@U$W8C\'!XBC]0.G<6[9PS
MI]37.V?TY/P9PJ4CNSX?<L^;2;O[%MB$15/OHB?)W=LF^=FI47_[YDL/[YCL
MYD,AZLMN)QNV+-[\P!M;VGSP,-RSZOLW;6YD;;">X^2O0'TVD[KLRT=21]+T
ML/:PCGI2GC35:Z$U'4L=2].CVJ,Z.IP:3M,A[9".PO(Y3;U:KX[J4KHTY;2<
MCGI;R9G6<ZU4WYIM/=K*>UN'6FE#*S9@%AR"YOJNO][CJGZ7J9=@3C6"D/^N
M/^%QI=\--'A<Q!> R=C[;D#)5%"!4+@T[->YAEWTK.MM%SWM(BY7@Z(ZG?;!
MFDVKU=#R:-1F#U"BJ&_P)[*5Y&PE\5:>J3Q7R>LKCU;2;.50)?56)BMI)3;U
M5J/)KYRI&(0I_+Z6\:8^?@H=/1R-ZP)(P;SFP@01M-CL![84E'?B'^;/FYT9
M_A\UH2QD+*C =/DK%P>EWNG-DS91Q;*,+M!*%"N"M2O(N\MK_4-$D_$K,\NI
MK+O'9F17$1)>EMW/#WRF2Q8*J7INN/35U1F]]R _<-T,%01,O_[25V\J-X5W
M\ -[ID$ +>M:<NFK:QL2C,^YZY#/D\DUV=>R6:6F>G_KD>21*OZP^K"&>I*>
M*JI7ZS7T6/)8%3VJ/JJAP\GA*CJD'M+01#)11;UJKX;JDKHJRJDY#?6VD3-M
MY]@UZ=FVHVV\MVVHC=:U(;M9<,#C\KSKSWA<J7>9RR3.YV=R[+M^IE)ZETFP
MPKL!4:9M;FGA6E+-S4U-=8&@,^C7.88=]*SC;0<]S>S1ZF2IJBJ/1Q#4ZA)V
MER6,WH')G")3YZ_(QLG9./'&V8J3U[,59Y9Y=?#&DW$:1Z:WZ0U^.;NBC,KN
MFS*NZ9[(=/T_Y7I!Q3>N_OYG_(^E_^_LMZ%JL/X3MH"E_O*1AQ_XO[8"DNO[
M^E>;8&W)=@V7%33ESV97O^4GK_K?XB\(_//"\_Y7!7Z[[";^)AF_G2>]?J8N
MYWN$)4Q9'A4:!"JN/C3LPA*V ->;J=FLU04L+C?;>P^1KD# HE"RA8;%E$J8
M2:OY;19%@\IR+TQ46>;HV,EQH9#+K_5JR%'-<<TY#<\<75)-8J)A"O!!/*M8
M7YSOF?*<[>.*OA$FJ-'9>8_+].?%.T?&=&BB&IU^5U2@OSWZ](T=<P^L:U.5
MZ?B:&SOFU(AJ=/JG,06ZI,2[<#6),_*C2P4E.L]D8]G/H>YL(!4W<S_)[BZK
M)&]YR*L>J$ 7_[SK><^KKF(%;G9M]FSG^2[7$M<2#Q]U-;AHE2OEB\5PA5W/
MML[]#;BBMC&O5WZMA\U/8M7:G:PZ_:3+ZS5"=09#BG0*YB8*H]TQYMK<+>X]
ML+JTV>%-#=$4Q[6"OKKH)NNRFBN<>]._QUT8KSNRA5RY^3!1^RC6W+]PJT4>
MFK K(4[O8]L2Y<S95F';N^!L:T(=C\_WQ2H>/7@5'UP3=G=8O7\V>\TGK?)$
ML,'%?[QV+Z]<J-:QZN2*-:JY+S"^E7-9^[LP\>JN@4]2=0_^T_KYEW7!UE:-
M^=])1J7KR6Q:*>WDN%.PK.'\63MG]5@35LK,0;W6I#5KE5J[ DR,GJY_?V"K
M@>TNA_._D_]%NIXKA_Y^/'OCPO"<^)SDPM3"6JDK;(Z;DZZ4JU9Z792L2Z^K
MO<[+KZI8E5B5Y->%5I6OCO/R9-R[)L!#G2E\_E+L\I2Y@@GH4 515191QLI\
MO.#FW %"+'(%Z_#53<'E=95-PA*.>)CFE5U90ZA?IV5*A:8Q)PW,B\[[XU4J
M7KQZ(79YK?XK@PN#S\@<.1CT,*T$*<'CFVD\RDF?ROWI*J86Q*8EMQ$5X<B!
MW"VYWWX_]]M'Z<%GWOK-?_WTS=_0S^96?-S(XEH2)D.YG;F?YE[)+3Q.ZOGY
MN:=R_YG[?>X+I)E4DA09R.?S?X%Q-"V=1F9S-=*Y!=[8LDK"P1(G"8(&$P]K
M&4,,->-W;>!YCC;<L9R1/\__6GJ0*^7*N#>S,^>I=O([Y-<I)6OD&U0[";\X
MLI*LY/DV7T]DEH^O]C5&*$<5]JVG].2P_JC^N)[7Z\TF=X@Y>),'0HH24\)L
MEG)X.HKSEH1/YO]Z@IV>##,#>FG^3]E*-*>7)J1+I/PA*3DC)4/2P]+C4CXK
MG2D=9'[%O.CAP&MDKWG9:R7YBUD7LZ0OP1.Y)=Z2F27\VR7D6,GI$EHR):I_
M?TOA $>ZX+3@ C/1B*$[>F#KP(4$VMQ?$%79!46VT5<P&J0UU4;TMY)):ZE<
MRX?\8WY>Z5W;B.&I=]__KY?/;1]Y\*5[LNZ(;_&&6^_:MJ>=+%HQ\O"6-;N^
M1 \27^[W)_\]]QQ9GO\QF?>-&91J?<OFN"62T*$_SGG@T;]>?.3?GR=J&+>3
ML%P>X3_'6=D=D<257?PM[BGN1]9G0Q](_F&5U9C:331HBIB]%?P?W7\*?>CF
M?^E^D_^CE=\;.A!YD/ VD]5,I2:I66GE.2YJ<\2B'F]([PA%HWI87X2D4IG*
MH)=QI56GF=EVF-D!E[/KOF5]67J$ODUY+SU'X8_79HO%?"4^/'GJP\OM?.ST
M^*].%,XKO([G3]G!A:P&S_NI2%)U3D71<EEI,%=SJC/PJW"V]_(SJ -H1SB:
M$M<>HRE4U*%;*T/:P3R%CUU+4Q(5]-T!5520=?OQ6AI4HJ*_%(**U*+C>:8_
MQ0%..N8J?.)T>O-'/WLRU]2?L%1TD >N^\+2G#6NW'_=GGW5J?9=V^^ZV1<F
MYZL?OV%/:,IF\L:&L"<<'IKY)1M9VS-OQJ6<?LVL1<LH#!0>=F,/\,;&?2&K
M;^2ZN2$'KP3II)SC"67%UBO5U;"^E84XFTRMD7&4V=.;"6$F2.AF0XX5*0\:
M3N;_C">D@7@OBY=ZP3!A.&S@#>PBTN(U/6/;\NR(8[%.C,:H8(L$#%%!$_'+
MHX*Z.Q K7O9';.(>?<$9T-@&/6\-Q</3]SQC373D:I?563/3^<]]N*=Y]*9U
M40](7O6[R!M+,W82QKWL/.5?AU*RO>Q<=K*W;+^#9LOV:6\Q\:59A[NZ1*VV
M6*Q6OR]D-*C"0HAP,I]942KK([1;KDZ4E*A4<DL"1$:;SR=P;K?K9/ZM$^RY
MBYV@48*,C/>""^STIPM/+@O3A!'AF" 1!)D\+%>)510ZF?]#\3[7MXKWN5[*
MHOGZS! YQ7; WPG1XAVNQ<.BXGV[HAWDV$XXNSBL*590$HP6]\"+%5JB$FR"
M@0K$+7"B8F:T7[1E-16,[,P%^5<4U@RUM<::ZHC-HA=WQG_ E[55.*L6A"5=
MGQY^:].>V<K0K+VKOOB;1\F<1:7\Y\*NLDVYQD.3^-QO9EV7BNQ92 +\'K+N
MV,-25R9G><>SG!Z&,7<:C+&S^>,PYG:BSL4&8_86_@@WC_PLVRU12)2J&:I>
M20??6=DQA]]OWY_=/XE_O/-4/]UOV!\<Z7]")]G4=OV4Z]OXZ6U=75V]?*QM
MJF*JEE>VZ?H=;=Y^R2NZESMIO*)PDJXBDIP[C[78 /R8%YD=*V>N(LHC$L(Q
M@HM(@(N::=.G=^LT&M;%0WAJ(*A4F)5*16=W-[*A.SBCUSQC1J_!4-71$:Z2
MSF+-O:&UJK?J4!5?517C- I=P"3M[NVL;I/&N$GZ29GFY@P3!9Q.;R83\WKC
M,=GT&3,XE5(YCU,QOPW9&B6P7*G0Z (&D]PM:;.SWS-ZNSNK.]KD#0UN=W)V
M9';PB(0DV)9Y4G)8DI?PN'-^H;!A;H-1W6ACSE.:)NR7B]99QOJZ N*^>*$%
M/%:24$U+3&><[\>%U>C8_OGX@>UQ"@\$B<NN]V*7_2VD]_A<(G 5Y4(,'1R.
M-O47_(T,B"<]MXCF?_["_CJ;53ZVO\XN5:T9D]$L*?3U=?G.^MC&.MM61P^)
MY/<#J<FQ],.YOW5T-@_,3377.@6GV5/A**OL2,Q:7A';,+-F ?G1PNK>#;':
M'36-S95EC@J/P2TX:YNKY_:W=G;D_O9P.C:Y<4Y(><T-9X1EN1,A:?OU3_9*
MG <F1=7&VG \L?2&79UW?6J:,AQ631NYJW/7O6VUH7"M41V==, IF?.=&]NE
M(3)MF7#F4',)[IG;\^?I'_ACJ&/72I52%:V3=<KH5!610+MZ3!(D&HV;#0SV
M5J%7H(*@,%KL5JL]G!#WQ&5!]K!,(;?7&$L$MY>UNU9W+[/CXW0:G_6GO99A
M"_58$K".L^C8@'N"A!/,G<4?LQ8<75@Z.IV/]/J([XZ2$A>;\IP>W;".9ID7
MI%.Z=Q@UI*-Z'5,4B>(!<QZ_!;?"8X6M\(&!\^*.$H2(YV"*!YJ,HBNW47$C
MO YWPLF6RW;!Y9+"!4 9<4X*C5UC,:?<:#74+VFZZ=MO$N/Q!S=]?9GS:W?.
MV9#+7[MQ8/JC#70'\>CUKNM6?K&C_MFU7^Y=[!S>NO GZH9/=4]:EF?U6PGK
M#2>,UA6D+UNFM)-7['^R?V#GN^SWV)^S\TJ[PQZU\[V27NG,Q&!B)"&-A+M]
MMI/\X EF&<8!D5UL-QB-I>P&7*FTK"PB([82M8W=5"WK4P>M!C8$6QU:YO]$
MAYX\K,-6FK"V6@>M_)#UL/6LE3]D/6(];CUME5BM%1QGE[#(Q0../G8W'4O#
MQVZJ9$^ >$MT63'31T9\AWU'?:=\$LZG]PW[>%_!9<5HP1?(F'.4CWN=+@[?
MJA*4#DBO(#W)Z[*V0$54*.OV^_ N7'54,'0'K%'!",].^.V]0ND3O)8+%#0E
M_8D+L B%968QM4?#0@0F@7[1R1[3H) )QM:%:15]!%LGW'I3N/E:9B&+R6=I
M[63RC2F53C;7ML^NRVVG\:Y<?W_*6CF5/ GAQ$F>G]X$R;)YP8D3</,.<BQ7
MTY<EH="D+>2-]1$//F6S,?)7>@UGX::0.[+=RDIRLW1OR2N5?ZK\H%+:57E/
MY7.5O++241F%?RP.2[FEP=+K['7-;!]L'VF_9%1IC [+6LMU%HE>'^>X2DVE
MCO>P#78%<WICHH\\UMS<U)VIP!9A(S8KMHC*2%E9*I56E;I<+2W-,EN%SU_A
MQQ;A#\:Q1<2Q1<3%%L$<EB;BK?'!.#\4/QP_&^</Q8_$C\=/QR7Q^!2KM1);
M1"6VB,I@IM@B,L46D1EO$1DR@A=UG<I(N(P^,YSA,_^'%@&\+^WVVWH%E]@B
MID2%EFY_)BJDN_W^J!#I#L2AC6"+J.P54E=O$9R^D-ZWFX0+_>C(X_RXD>\6
ML7F8QF_ GG! W_2_:C2_C@B3T^Z>8&NVM+Q9*'_^QON_^NG_N1E)^4!L3T>@
MMF--S#O]IMV7-GWR5H6C!O\+D"Y:R+)L5A$F'P3)^MKK:X>R'_"2>MI%^X,+
M:R5>I]<5"4=K)"#BNI0UO"P3J0LV\ )Q4FN#I='2)&WAN*:&!B8?H).?AB!/
MS#Q/ZNH47C\;MON.RH[+*%-L#HGWQ7B9/PB'KHEO"-5(';JT/AU-)*)1IT/&
M$:+5ZE0U.-\3OJDA5%<CU\5)/DZ6Q$G<HS0KY:)'%U/Q[EL@+J!@",2[6;RG
M>Z:)C)@.FY@S$0ES)D)-8RYPH'TP6A0,QJWH"K) L?NW)+BB$#  "Y2T8Z((
M0%(P[Q<;F=T3%9P1OSDJ.+H#IJB@Z_8KHX(V@@T)9_RB3V.?KS"]6R8TA0G\
MMV#KN=QR;MQPCO]%[F\WKK)'_&JGK6EJKE9L <_/CGAMBN;UY9'TPE1MMC)J
M]95;*P6_M\+3M;RWM^?Q4_$8_?ORC'T"[^V!G2=H^]"Z[D1U>:!*K>M=6!-7
M=G_KUFZVME'GW^%_AIYBWLQJ=+$93BIDU=IJ06!7E6<C(/?[USI*U!J5R<PD
M?HU*F] 0G<:CH9J(,<%V/<(A<XBYRG+Z4%1_(ZM1.H!*6FR,61;FJ*B4<2MK
M.66A"<L1-F'+Y":Y4I3WC:P9H0L&HY]%.V(D7N,Y=#=VI;.QPD# 5.0P !1[
MJ9;U4I3P6]D"(%9DE$E<(\FB NGVAR=%!:X[6%PPF:[LH^)E!+++[YUB@MA]
M?!J$?-89P],;_;G3D6W=(U%?0(B8*Z(5 P4I7^QW^N:5=$_NQE>_W;<N6.D.
M?^$'SW^I35Z<JU^#.BXCSV=OM.JU^FJ4MG6PL$QPO-QBLT0L&<M42Y]95FXA
M+DO(#,L!BSG,\3)SB27*\0ZNGJNW\,GR+J[+TELN*;-:+$&NS,Q!DB:S66^P
MROK,=C74H3G)$3,>B37Q$78XB5D3PQQ/"6%S/,>.#FO9]?9L3:53JV5].BUS
M_*#M-KI*16<_ZNK2;EN9Q4PD)JO)&,S*%2?S?\&.IV#C-?)2(>#]]@K2JSBH
M.*O@=8HCBM,*7G&2G,B:.:_5IC<X97VV(#N';TMF_3ZV[BU( Z(" 8A?9S5,
MC\,Q:>"4C_I.DEE9M9=Y@$TR1XGET3$3"-:3FYQV-A4PTX<!UC(P (_O%Z7P
MV'@/+RP BG*^3M"ZA-*"G"^ZQ(G%;KD!+_^!?\;4#G9H,K0X52A@H=T=$,6)
MV-A*&W=G.'8FG5QEG \0P\?Z.CU,!%(#C<C4V)QKGU67^WX@]UUS0W/N*V*7
MGOPVO5]L14LRI6STII%12G.CK^#/8B^>*/-5$6]V\\ST8'HDS1,NY' Z8] *
MO%Z?2B&7QV%MI=%2K8S5LA;G7FW0CI.WW8KNQ+2LUO7V83M-V%OM@W9^R'[8
M?M;.'[(?L1^WG[9+[/8J5]B%&B 7)N!BJ_)SQ57Y>\55>7'R#I&1T.'0T="I
MD(0+Z4/#(3YTF0>R"9-W[.IWB(S-X)JHH.CVTZ@@9S.X(5 5%>+0>Z-"K#M@
MCPIF#/6'HH*OVZ^-"J;N@"LJ>"=.Y"*?B*]FPD@[@2D0<O71F(EPVDP'>;*E
MWJQKF"S.O4CTI^ ?#"<?/3.O)A0.E]8,YISSZ@*,6Z^]A@3CT[PZ/S[[N&^<
M<=X%N']DE\X,#89&0CP)&06/1RY7J$Q&F=W!.9!G#JQR1S" / L@SP*HJ=,'
MA@,T$6@-# ;XH<#AP-D ?RAP)' \<#H@"00(U5 Y\R5"@^HBMX!X%[D%Q(4"
MM]1D1'U8?51]2BWAU'KUL)I73YPL/\ZLPO;CA2*3]'96\7Y@E;$[$(@*'I$I
M:F2=(RH(W0'&P E,*;#$</6:GQ!,_YS;CH(/=@W^K7$YB)]=4%I-%&G&!!YV
MVOZ#7#?_/:SQV6CUU0$<Z,;?'<@!-<@^6X$#3NZQK$_*J8B%<Y(P%R/57"/I
MX+I(MK2/6TAFEFK9?'Z2!+,6G-\C?KE" <-HB /QV>%PHI,T&"6=3I@/08PE
M/%M\4JKD'$P/XG0Z%2"T8.\9$UUH05RY5-#Y@8AR'/V=3=3Y&<84?TSM-\%Q
MM+CQ8/+94!=E&#]*6-A%3/'VL@IU7>>\F8ZZ%3GM8&;67&BL%?SG+O;,<H[>
MM"IC9$86#3OI'DOO[.)=Q?SGH&86X4T(\W+=DE]*#X(,4,VUDL'L@IM5!TH/
M>/G>28.3AB;=+),X--4UY:T!7N%SF<S:2'2'1URD<\TSI/+X#)^\;D9)26J&
MJP2>\JTU&FV@O!H6H!P7I-J@%CTN:;$JM-\CG9P=A 4<CIA AR/2R?P'C^.R
MT2XTGLS_ S6DC>PI"VQD>GY%?A1#80KZN^B'4\$4_F<5)*'8K!A6'%-(CBK(
MD&)$00<50PJJ5\QDQI )].J4P.5*@BD '(*$?5K0HBI2PL)[!9(4B) H#EBX
M45!4+J)%:9%)3+7(?).@=Y*FHI?V,9W A7K16^_88,8&K+TX3#U!@EQ@3%D;
M2D]P2S"Q4\C$'0>0/T0E@6G<+U+!BE[/MNN^2;3QA8L_]<3W]RZ?86L:S)E6
M-/:LO/7D\8-KIWG+?)'#=?/[EBSIFS'YB^:YD>G+'^GJD;JWC+XX)W?^^1_G
M?C<_]_J*C"T4JK^6N.83[^DGB6_PXDB'8?3#G6=__<Q/%AJJZY[Y3W+B&G;C
M-C2./V [62B.87E:T#FHLAN87N%6R4A" J*%$_<70L&@P:"7T00S["J/>6(X
MG,5P.(L%!1S.!!S.!'$X$X8%FA!:A4&!'Q(."V<%_I!P1#@NG&8J8:NMQ(;#
MF8UM/YPK;C^\6]Q^* YG*C*B.JPZJCJEDK K!8=5O.K;E$ZY9OYQZ6W]_V)@
M*]J/%:8B6.:-ST+E42'4[0=!/\B&-A/3(QBZ_9?O212'M:*)V<<'M73ZXV$2
M9XB_\^G1P^/K.<^<KPPX01S 'Y6AW&]V[+]LC!O]:)[7/T!&EV1<XI@7_503
M\$( WKS"9 'N+T\ ;UQ9@1F+,5&.&8N%C":5:"\F"R<BK<P]!Z][-"9#34F,
M< Z[6D,T,E&Y:W=B-[ 3O;W73NWV6-P;QT=QYMQ1[(2>XIJ+$5D+8\9,#SGC
M(8<\QPLW3'E8OYFHDM]27*RC;:1H<B;6-IJ<L:XU-J<(,'O(N_U>5O$!<69A
ML\Q>?T0(2P59\4 \J_&K3>PMM*9FW"PM<)E9&GW0U-A$GBP(8(F959X[O]J_
MS*FORY!C4.6F]M:-Y(,?C56O*(7QNI9EYWHJ&B=_O;_.BP^V3*[TB/.X]".H
M]U:2SGK9\'ATTO%)DG@L9K-90X2JF(+7[_-I-&J9SWN27_*HRQ\XR2_.AB-E
MI678(<IX5J%E09=+UMB4;%*PL";L)$W!!*O=1E:[B2H<N7"C))M8DAA)G$U(
MCB1.):">O?A;DD@83;".PJD%WS<%9;AG J_+6$)F[" R@JMQM@P_#,OPHH_-
M I,FB&F,'T@P;C5==NYL=*(X_9UD5*AA#2D0:(P*M=U^(Y.4_6/++9"@FR;!
MHBL0\ H^??'>%+&S6/Y91QD/%"V/KM9YK-*//DS/KBOV'/_2#=DR#<@'Y!NU
MU7K__-V#1GP$G-;5AE /,BXIR)<$=<$5Y/5U42$<)O[J!:,?S?5%UY WQV+,
MW)OU%D8YY/ 4F G3@^U#[4?;C[=+6EC7:FGA6K-96)E$H6V%IG"JZG2:7?=3
M4J*291.MK2TM#1Z!,=WA]2'30V%G&)D>1J:'@PZ'I+ZALD'!U%\-"E%Y4C'&
M] ID>H7(](HE%2,59RLD1RI.55!/A1=_2RHJ] :I 9E><+X<E!29+AEGNH0<
ME1R74$ZBEQR6\)(K1\3_F?UC!TC_62/P"8*'[7$4[6Z+X951(<T:AR-0'Q6J
MN_WZJ%#2[9=&!55W0,(6X1/&SO3_E\9@PX&W\A.VAXZ0_-8G_B]-@N9^L^?3
M3"/+Y$>V/^K@@L24K6KGR-]++FKH&YKSPIL^_@7?2\*K/GZO<,#WM,"#L!B4
M*T)^/Z=WEH9T.KW*[F!RHPH:D<,!<J,H*^I@T,W;B3VKL5;;[>;QT9:)/.K\
MQ:RW(+%[U<?4YT!05\OD\F#0:7$BZYU!\\G\'W%F-!<W2\U,?F(/S;B:-YBK
M/6:B9_\GS6^;WS%+S(6-T^+@C,T S2+PLDR40 N>=<4-^M&F])CL_QVF30'1
M^+M,_Z4O;LT7K"8*@V[!WJ@P);)#Q1..B:=IW\JH;][7'EWR@U_E%LZJV[W:
M54%>S%3OV+A[H[>3_US8&MSU1.UUL[<=9 OA/>W;1K^CV=8]>ZN,R:D5,/:F
M<!\^P=63WFS'WYT72^D;I>>KWZSE7ZA]J?J56GYO];[:IZOY>KLCE,E$/<E4
M2-!HM=!6F0JDO#PJDRO,"I1%%4&3JZ!._'O6@:-H&0L_9#IB.F;B>TV;F9>7
M&O0"#\$UC">N@NCJ8EHM-YH_N(ZYSK&+?1)V>WU],IA$SB2#@:+,$BAR!H@_
MB^)_-C S,!+@ Z+%A*6:8^NZ +.8N((ML8*G^&+P92OGHOU$?;HXB9:**@M8
MM&CW,@:1O0%1H9&("N5L0:/Q!Z-"5%RT%?KA! Y^?$YE78YDO%?:6XC11*;Z
M_')^)7FQN<YBA-DU/2/AM69&']Q*[O[)D[E.4<HYN[Q2J*E9<4/N[[8HORD<
M=M8NS3D79]SB+$O>6%IGRQVBEW;<-B[WV$([1N_0KKOF%"GLA?!KD.\^[E?9
MY-_I10E]0W*^]$V!?T%XJ?05@=];ND]XNI1O#1 ?1T(>CT%N=X9@::0R&F3N
M(@?=HJ/.#PJ,XX_QY] G)\?Y?':U75;PS%GL4B7,$($Q#H@+N#S)EA"@3WV7
M&;D >36&78A=9MLRQIOOV-A6%+) W)HJ07FG.!"*#/@?:YHL_J<52R[]TQID
MDCRLA:/\,3*;[N$WCUGI*3FK58FWP+#FC/87'BNQ]OAGZ-^'(0*M]"KRYZ4G
M<!^WBH2R#7\,_2%V/LYO#%T7_H/ KRU=*:P*\-U5??$%57Q-O+ZJ(\X['<RC
MDE%1$0J61$+N@GH#))L/L3831>^%;#WV72]^W\O<\*(4ZO$N\5)O3]I9CL8B
MY6AO4,Y6;G$.I4ZNFH5S%$56CO1RAYC;3SL,JH1J*78^&M04MPJ >!^_R@AT
M6*X93.G?G\BUU/C"#TM](18K7F(AGH$>UT[9M6."*:H_"IJJ[L!EZD$2L%S6
M@\8.2:1K"ZL^MLPC;&%G9![I*,V^9DY.S;6WEY<F%Y(GVY/6-YSO?O.'[U_[
ML^M_<('<M6SXR*=_^R7RY/G5,6^QR^RN(^&P$%OS]--_R_WQ^WORW/7$2K<_
M].UG<V?)\C-$S^YVS1<LRI@]63Q;GM \8/F'F=>I=9J$FI]CGF.A$K/$$G/U
MN!ZS2/>7$J?7:C"[^%CT)'$]/L+\YEM] ;:;8^6\,M'X1V6U.?FX1:<19YR_
M9G6H(S1;>+</VHM!#Y,/]A1]4"IC;2K$F""+L%@R%$R.R,@AV1$9/2W+R^@Q
MV5,R"JL4UB_=^7>R.A;[*?=I-^7<;[NI&Y<018^XZ!X7#_K8ZF.Q<<<(()>D
M<!L^Q?PEC"V^+5*4-?1,*/7+F P";#$S+[-*E]/L<CEM@E5_H7 )O+TX#)(M
M6X&!'],9ROT1PDZO9TQHIF$;7Y;S(RV-1GUS"U-1196VW*_/IR(U+[]Q_T]6
M1P(K5QS<4**%.<U?O3#GG)<),I'T)X3DEH5</:1RYOT#^Z>5K&B?OYT6[8"D
M=33,[("8OSKN'@B-/\93RM-@T>VC6+K'N(J(P9"-N1X?C)!(R8+.6&Q+?PWS
M'6C(=?!KI0<AYO[L[6%;6*BV50MMMJF"3%6BTCI*7-IH24P[5'' J%B@7:/=
MK>5U%8F*XQ4\QTLLUK+$H2@Y'3T;I4>BQZ)/17E/='-T.'HH*HE&8V71J ]:
MCLX?"! NY*->/3^3I^?898(QN<3B*H]QIKA<[G2I-&JUE5"JAV601X5Z,!7V
M2Q7KQAJ]E7%9CPH8/9L2T<1(I_?H3^OY)?I#>JK7QZSX6O'F@ #(V,4>[6'W
M5!46HJ-9W(88\I!63Z]GQ'/8(SGN(6PQ>LK#>P;C#SS!RSG[N.P;$P^/L;9D
M2+/-A/&^CU)L?>'F8.S\[/8:W'_8VM14.'QS@>"M&(5+.,?6KFK/"<'5[;>>
M$)QL%["?%W5$Q>N&B<_B,V#7-^BE-;6 8]XP"DJ\FG3Q3A,RG=R;6[5Z7<V^
M@SGS@[=,G3MKJ'I!+KLP]84O1+V.F(J4>B4'&G/WW9K)_37WCTM_K ^6D6ZR
MAQA>W)_K_4R'-A127;.'G]TX(ZD/;(/V@Y:+S',I702M2L;=UEOP)^JTH^=)
MY[@_4>9E'-K@'!CKO=QOL_Y^V5K9&M?U,HG.JV.>AY7::J7]D/\U\]_,DGVV
M W;J9IZ6%[DE#H->;U+(E?*02N4P>5T>XI%Y'-S8S5>2D$.N#9E*%$HEWH?E
M7<*106X(!FZ>X_2)I&'0,&+@#0:K7*Y2E>!RN,3(^%K"Q@5K_B-H,\P619RI
MIOC8\#V*+$P4/8)N:1)]ZXL&.J)Y3BNZ&4X43LJD10L==O ;[QX3;]P SHC=
MV#:N>4,OE;PEK-ZS>.4^$XGFSMRW\YM;_+?^Y$<7<_>U#-3I+98PW;7VX-/W
M3ZKZR2-?-K] 0B_^%Y&[#2:H[Q7Y\_0EU#G/11UT$PS$<NE!^#T-?[/;KANE
M]=#+_QOY<? Y=H.SE9+#WJ/>X]Y3WG->J==:UAF#_N-^@I\WYKPVG\\OSW60
M0])#D-9TM,Y6Y]^1W@GC>SE73:9F^_ZNN*BB;ZC.)]ZLXE^H>BGQ2A6_-[&O
MZND$;S2%R@7![[=7R^2A5*I<$ZL(J=4:%5<N<]EQ $=-VF;7(==I%Z]S>5P)
M5ZM+PG9V+]O7K<!]W1J3&24ELP:7&U[&FR-F,FPFQ\QY,SUD/L*.TQB2C'G*
M_'M9-XO@51Y3GF,.P*4R675US%A4"AKPQB"\)"G_:U&A-V0X:J!'#:<,[S _
M)2,%V]BQ>T'&!"W#Q(D!N_) [$KA"X^TZ\<F\.^P.4$4PL*3A/)NM*4M"F&B
M"";.U!,%L<*V</B*?>&B[RN0RB3U*RJ$+>3N'W\_USF[+O?3^ T+IBRN\?FK
M*IV9=&H^?2237K$G][Z]#*8"$,N>1D&-K6YR.W_\[679=*@\&M[[^.\_WT?#
MEYX413:*:YT#P-UJKH6LR?9XL^3/^C<;WS-<-$G>,)VO?[.)?Z'II?I7FOB]
M]?N;GJYGWEZU[M+2EI9FK2[4W%P9K,F$F+EN(!!DNX*)1*7,*$5] V.,,?]6
M-H*,,8X8CQEYHQ$622TM-;!&*BVM0>;4!%V!PE+GS^(Z=,A%=*Y>UPA;[51S
MG-LM@ C$'@C!LN)JIXQ)SZCE8N(!,C1;1@Z7'2T[7G:J3,*5Z<N&R_BRB7I9
M_>77B>FOE*8_MN*9Z"EI;$^J.BHD]OJC4:&R.P#Y"ISDM5E#H"PJ!$51;6]Q
M4_$$VS&T/L'KN(\M@+9<OFMH*1AFB.K%?[IO.&9W3@;(#>:&7O)&3[-KV>]_
M_-37<M:I&4_N,[:*_EQ:E-A?[(_;::"Q;G#7QL/3R4?/+*ESAL.FS.IG;AK:
M=$^(&%J6O?;:^K*)NURET0VC=^HV]O3L9+HI=JC^79C?:\CQ[)Y,MKQ&F1G4
M#-3"$.UC]E.2XYE3F3,9OD)&9F8&,T,L*)LA+D6:(Z[21.)T\FR2'DD>2SZ5
MY#W)S<GAY*&D))E,)9+)LFAY>74Z5%83T7/D'-O>24F(2UN5XAQQB5QTXZ>J
MKJE11LO*PE9+49I'\XXH8[,EJ%#BG09*"VY]H3A_6$F.*XE..:0\HCRME"A/
MTA]DS>%4*>K$2A7B#4+ED4@8%@#8?L)LQ$&%&;OO R^N](1GA@?#0V')2/AP
MF!X/$RZL#Y\*GPE+PH.U#VRRQ_3O7SZKZT<GC O%B;W8D*XVL4^<UL<T'9:H
MH$/M/]M]]HM&/MV!TJC@*YCZ%*;Y*==F]3:[5&Z76DN)3&Z3.4H)#-KZIMBG
M/L4FG*TPW;#&30RU8[<T7'9PJ. +M-BT0!H(%V\X\UG(]/4W3YF]J;RNR9QK
ML;2D=*VS-N\VM4S)-?2G#Q^B8<%6J241!WE ,BEW;%?GP#T/Y+Z_I3X4"F9Z
M2=OQ;9_)E?:GA5"H;16_M6EY3!\8RKW=!/,0VH&AI_'E!9_4_U;T-#ZIU10'
MR6#2!,F BCN&:(W81)[(SIXJK!;>E[VODDBE4A55&AV6J*7>TF61/N FG>6=
M#2,M?+VEV]+IYKF62+FWA5?6$Z^>Z/5>[BQ'$PQ@_&@8-TI\V'22/E*X8$00
MZJT5X8#]NB;29 W*K++4=;6DMD(7#C=;K2W->+=H?8)K_<W CUI;];\9.'/F
M%'.Z6I4\KN^9,_\'7"Q_D8OFW^'*\^]\VZ.O@S_]KFPE]$^[O4FPAL+AX-$
M&0J,! X'^$# 8VNU]]J7V'F[W6U-P">;&J GG*0?90."QRP('K<@!.L;S/6"
MI[ZAKKQ>:'![HHI0,&BS666US':IL;9B*#62HJE4A:X0GDQ"7'>Y)RKW"&2)
ML%G<YJ)Y@<P43@MO,Q^U7B$M\(*C<),PWN)4;*)X$5&=^,-6?XNB\G(7;N*]
M%.C34+P/GFUE<86MXC%[1703+3HAVB+:K&P9N+K1(L].K5G,-A/S"B)Z(Y*3
MPI17D(<R)!SYSS)A4EKH%JT5/>4OW'C_5Y\AW[3T>\\^;UY$RM,UGMRMM=^:
M43=[G2]5KNUNGI1[?-*R*XP5<W\,=X2GY%+DW62P-AR6ULZXM.FF_:U5 V;#
M%X[21V_13]QE3!-#UC2S9K!F/S]2([E\2^[6JVW)185D-W,ZZ@Q)DU55$W8D
MN00A*K8AB6KSF+RP(8G+30%'*T&IU0+J/^&V)'O%ALG@YN39_\WFY-4M8XH[
MS./N38M6%Y=Y-Y6B!< GW&N$(06$7)H)JZ9N''AV?,>QM.O8 H&IR9\4S2M>
MO&=7;OGF^.6[CJ/S_)X!RJ%N?,S2XD#!,Q2_0S:)LW+79%/[343-W'TP1Q]R
M/(,I\P6L%@M' @8]E<D5%ACRLFPZL1/J5Y=,<,@I;B\4SN7$QCR47^&/B3D7
M3/,[<M5%;YS4-KBVA_=+Z97^.'W;EHIGM>@/)2V<G;LMJ[7;;&82,LD5*K-)
M9F,:=SUGMSN9ID@VIBGZ;5%3=*&H*7J]L(FB(8<U1S64T^@UPQI>,U%H8=.*
MF'WQI-'8(2VVVQ]A.YB*R+ARJ!\=*EVN5\6R9=+TA[DOFA.=N=JV&I\U,YU\
M;7.7LY(9NZR)^D(AHF]83=Y85FLGX=KM4+I)Y'GY*;H05D[Q$Y2 T,?.]5C=
MU01$1G9GU6-*735/N$13(M;$H3LGR&M5T@2-8I)\F#Q_^^T<)^'T^=_)%TD7
MP"S0P+5QG=R?L[=V<B?;_J/U^39)E_6Q%@KL\EN9O&.IN+O22BI=C2V)1+:E
MIJ:CO7UJI\)L489"+I_/I82:4ZME,JZ26JBI8^K45'MG9]WDVT=2))G*LB&Q
M^?;C=>_4T9$Z4E>G5WK913*$FDW?8F="J<TC)-C1C\J*"JLM6O:MI"UKHS;Q
M& Z,:2G1C9KXB]W+AC>O;QGW<6H4]RJ8,6^B540TGF'6-.Q&973%S50\$G2!
MQ"9B0L;NG!Z[=\K K/:NE/$+#FXG>&VS^7&M6%--V8J>Y,E%SZ>73IO;6!F/
MI2QA3\7HYVL_/7UV;W.\+%5G"3E+^V9)/[/KQP]N_=23]UR[:WWOYL6Y>^G<
MT6](IUW:3+[S\V]NFE95UNSR3+_MDE(R>W3[K[[2,RT1JW$)*X[1)X;: B24
M6W'_EVY]Z*G;KCV>./Z9U^_?2LBEMX>8# BK]//,8I>49.<=X8Z0#TS\'O=!
M]T&!;W!WN]>Y^0_H!SR]U_20B:J,*I/.K1)4GAYAOVZ?4='H;A1ZW+R=G=93
M!'4AYBJR-03=R.?S D>8?]K37N8X>$5V-1>5C;!;"30E7N^@>8@MZUPN?3#!
MA;(A>C0$(\%@:"@TPM[6<X>9OS%I28)3D7.J=U1T1,5NM.&9\YXA& (E*M41
MZ3$IE0[J]+U,T\/I-^L/Z8_I)7I@Z2CC[D#!G8(XJ>$%T/7,JRUS<;4%AHF!
M,:&_&*NIE<UN!?>3E@!?T,FE19=6&5. TN(ED+49]+'>0M/\[_YHEDVJ'#0&
M?3^8O][B^F]+X]3FRM;:WAGFMEGS(D'WHJ5[^,_=D3O3VW!K\[6Y/V]8U_%[
MXLU]+G=\66V\O&O=ZQ]VM:T_4,Y6X"[NQ_QKDOV< &+2B6SM@Y('HR<E)Z//
M29Z+RM(E-0*=[YPOK'&N$:[E=COW.?<)=W-W.QYR/1A[PO5$[%G7LS$]K,Q.
M\I&L4KP@TF TXB^=WJS3Z4$NPE^B02],V_C+83<['';C(X:3_,P3^EV,H#]^
M3+]+)W]$P8*4NQ@!0<I=*OX1RH+(+D9 $-G%61^QL2#[+D;0'V<#]ET.CC.7
MPFK3HU*I(1<>J4ZGAN][X#NE\-<CG:2E-W-E?#/GA[]F+L1'.#7?QYGAKX=E
MJ53='GJA] 5/&<N@*B%- IOW>?;YV4^CSDPVFX^9GS*_;9:8'?$Y"PJ>M*9?
M>.^]@0OZ-]YX@TM<N'2)4:\3=LT<DUQ0?/GGE/[\A0O<^?,7_@7!/* 5A::K
M_,O.:H%43C(V.3NE99-'\)26/,*N+LI$,G@AHU4^?MH['.:=AQH.KUY]N.'0
MWGWSOUYV1]WA5:L.U]U1?;2K_9YS7_CY?W_^\R\O>YC_Z&#];3=]_MY/WYXY
MM+JY_%#F]AWW_]N-M]4?K*BO=K]TUYW__?*="X\OYM":BC,/<H1?KN8XI6(6
MC.C!/-.(9?*O M8C-B VY4]P/'F'/247$3]D2#E$!8M#E2P.U0*:.3-@D./A
M:1!2<P/6YRX"-N07 3;EVP#[\VL %R"]"/$QB!GE=! GRAD0@Q G >F< ,Q
MG 3DBF$#AC?ETX"+X"L)>+>-2V/,-*3@!C0@!B&\!MZ]&; >TJR!=P\!-B$N
MRG^+R\!;KP+J(,T,S$MM@ :DW?E[ 06(F8%T%@&F,&9;?@M@!V(GXK3\2<!9
M2/<A/1?I^4@O0'H18#U^JY[306W4X[?J.0/2;OAB/7R+81!#VB#_]9 ^PVF0
M_WIN%H;W(3T?<1$\;< T&R#_;8!ZR&T#Y)_1;JB-!DB381!CMD$I&B!-AM.@
M[ V09T;W(3T?<1&DW(0UV83Y!+D>WFW"?#9!FFV  F(0P]N "TV0)L-I\/4F
M2)/1LS'.'(PS'[$?PKNX+LAM%_<8MX7K@SQ_"U"?_P6@ =[MX[KA:1\\G<;U
MP]/K 0V "Y!>@/0BI!<A?8([ 37V&.26X5Q(X3%N'J3P&+2'-=PS- Y??(;6
M(/8@SLP- \X&^H?X](?X](?X](?X](?L*2F'KZ@ #0S)/[AI@!=S/P3\,*\E
MY91C-'7D3Y(8](C[ #_,OTABT". AKYP+Z 6,(Y/XQ"R"E +^ [K%^0=$LL_
M#!AG2"6(BKP'4)E[#E"+:,EO X2V 1@ ^CU,[3W\UGOXK??P6^_AM_X.:78#
MQO,VP HHQ=])97XN8#+O DQAR,7<<< /\QSY.Y0":/@ZO$75B#H6AP(O (V(
M-D0'HC._&+ 4T8,QPQA>!O3[F).+6+J+4/\><A'+>!'+>!'+>!'+>!'+>!'+
M>!'+>!'+>!'+^"&F\"'$?Q50P4(@Y<F 6L \I+D-,(Y8D3\!6(F81$PQA'?A
M*;S[ * .0ZR(=D0!,818GC]!83&1?X%R++>48_ED/D3R'D#()R#DDTI8S0-"
MS5,)JWE *"\@U#R506OQ !H80LP.P _S@U0&,3NHG%3E7Z4*UD\!89P!U$.X
M@HTS@.[\EP %AI 'B .E8UB1WP98B9A 3"*F$*%- E[,+P+\,#^'*N!; 4 )
M>Q>XR5#'8E(]H@7RJ0!NG@"$=@M8BK0;:0_&"2 =Q/ (8AF&1X%6LC$!4)<#
M?D#^/8"&/+,Y=T-9E)!_0-8" :$% D(+!(06" @M$#"%(= " :$%4B5K@8 2
M]A9K@8 Z%H>U0$ CHB5?!6A#VH$([1"P%-&#\<,8#NV0JH"S_PY8#E@">;@!
ML!(QB9AB"%]A:(=:*H$4&!U"+$,L!U0C?]7(7RV678NETT+I&++2:;%T6BR=
M%DNGQ=)IL71:+)T62Z?%TFFQ=%HLG19+I\5R:;%<6BR7%LNEQ7)IL5Q:+)<%
MVL!OJ!6^^UW 2L0D8E5^'6"*T9 ^0T/^.* %:1O2=J0=^5L G?G_ '1CB ?*
M986R,[H,L1S0"5_Y"V!E_N> 2<04"X'T&0HL!-YEZ$,,87@9TN5 NR /#$U0
MPR[( Z,=^3\ .I%VYU\!]./3"&(44& ]&K 2,8F88LAZ,: 544#T(/H0RP #
M\.[/ 2L1DX@IAO N0P^B#S&$6(98#E@!K?IU0 /B@_EAP(>@IU=PWP9,PVAV
M+ZU&K ><1NMI%L+KZ5060KL1>S!\&N)T2*$>9I/G .=BS/[\ZX +\G<#+L:0
MU4BO0WH]IK !<6/^4=I ZR%^ VU&NA7B-- VQ*GYOP%V(_9@') ] *?G?P<X
M ^/,A'0:8!9C[\[/?Q]P ,-78/P-0#="^L. +/U&3+\1TF<T2[,1TEP . /#
M66J-D-J=@/.1'L#P#1AS$^(0A("TD'< &A!9'39A'39A'3;!%WV S5 _333+
MI0';\JL VR&%)B@7B].-]'P,[\>0A9"K)O@B"UF<7P&X%$-68,A*I%<AKL:4
MU[+O0MY8R':D=R#N@IPWT=WP5C-^O9E.XQR <Y%>C/0@T"WPU '8!CEI12ZW
M8MY:(6\,>Z /MD+]O 8X._\68#^&+X#T6R&'=P.N1MP XWD6ROL9P%9(+0MI
M/@ X#>)GH58?!9R/.( AC#M3\%M3\%M3(.8O *?#6U,@/GLZ%_(V!=O2%/C6
MHX"#2*^&KT_!MC0%VA(+WP EG4)WPM,V2('A L3%T'+:(/Z+@*PEM./3=@AG
MN!I#Q/ A2&<J<.U>P&9$UDZF0BD8W0TYF0HYO UP.M(S8+Z;"OED<>;G-P(.
M0)I=T"HX0 .B&^:L+EBK,GP(:KN+UL-LT@7IKP)LA9;<A?7?A6VCBTY%NANQ
M!Y'57A?D^3> ,_*; ><#?[O@6X\"LE)T82FZZ$Y,?S>$=V,INK$4W=B/NB&=
MUP%GP+S?C7GN!FZRD 7PE6YL#]UT'>)Z#-^ <8:0W@GA/1P;R7N@7 P?A)1[
MH+6_0'OP6SWPK6' -J19"^\!SC*<#J--#_*]!UM.#[1P%F<QABS%D.6(*S!\
M)=*KH39ZZ!J,LQ9Q'>(&C+,)<2N&;$=Z!WY]%]*L!J;!^,;0@.C&$ 'Q0>@U
MTR#GPX"LG\+HE;L6L!GFW&G0_E\';(,>/0W'NFF0_S6 <S%\/H8O8.]"*1B]
MB*5&!W*_ UR<5P$NP9!!Q*6(RS"=Y4BOP+=6(KT*<36&K$%Z+>(Z3&<3U/,T
MNAE#MB!N1=R%N!O>FHYCVG0<8:9C^YF.[6<Z]-D7 :?!Z#$=>,WBS,<XK(9G
M8!^? :6[&[ ;ZF0&E'$:("OC#,C/,. &".E%#O9"R.MT%MT *<^&N6"8SH;4
M;J9]2/=!'AX$;(89N0_:,PO)0II]D)]O ;8CLC[>AWV\#_*V"G &])<^R)L+
MD'VW#]*\D\Z%=.8 LGXW%_O%7$AG&' JTM,Y%> ,R/E<B'\[X #&9"/)/,C)
MHX"L9\V#%+8 LM8X#]^=AW4R#][M )R),0<P9 D^92GTTQ6<$7 -TNNA;?=#
M/=P-. 2E6(#Q%V"/6P!<9O0*Q)4P*B[ $7@!<(WA$.(V?+H;<"&.8 MQ1%J(
MZ2R$=-X#7 *2R4+\^D)(YS> JV&\6@AM@#U=CS$WY+\'N!'CL)078LH+(>77
MZ2*<@Q;A'+0(4KX7D.5P$:1Y-^!*I-GXL AS,@!CO@.0C16+N4Z@%]-^1#9V
M+<:GBV$<@*<X BRF&S%D$SYEL]X2+,42_,H2C+\$TU\">7X54(RS#9X.0IJO
M BY!9#$'(3^O :Z&T@U"^B\!;H3R#L);OP#<!C6P''KH"W0YU-CO != :LM1
M?EB.(_]RG&N6X\B_'$>JY9#.:X ;,60(9+_E. NLA!3^!LC&KM60D_\ 7(PT
MX]UJK//5D)]7 %EY5V-JJY&/JZ&\+,X0Y&1U(87=$',MUM):+,M:3&$MI/ [
MP/5(;T!D-; 6:W@=UNTZ'&/7X=?7X9R[#F.NP[I=AW6[#FM@'7YK/?!T%:"!
M(::P'K^['MOJ>OSZ>FQ[Z[%OKJ=K,60=X@8,85]?CRUD X[;&W#<W@ C(0L1
M$-E\M %;Y@;DZ0;XRC#@8J27(*Z N7@#MJ(-R.4-6,\;L"UMQ):\$7.R$5O+
M1GCZ'N!0_CE ]O5-F/XF2/]10,;'3<C'39 :"UD'?-F$[7P3UOPFE 8W00KW
M FY#FG%S,Y9Z!\[U.^#I"KH3OGX7X!*0A'="'EX%7 F2]D[,PTZHU>. + ^[
M(.;=@(SONS"WN[!$NY!KNS#^+HR_"_O7S5AC-V.-W0RUY*"W0$@-H '1#2G<
M G7(D,TFM\!L\B@@S"8<QTWF!3S?R_ZL0^11\RC@+QZMR+3<O@+-<]7<705:
M,B&.E'-RSQ=H&=#G"[2<^T\N5Z 57!GY:8%6<GO)>P5:P_^-7L=TG?BG1K:A
M0!-.)_MR@::<7':\0/.<4_9X@99,B"/E-+*?%6@9T+\MT')NM>S- JW@S/)9
M!5K)!>6K"K2*?DU^H$"7<*6JR@*MYBI5W05:0W^NVEV@M5Q TP,Y(1*>63YH
M-B$M!5JON0YI&88?0%J.X7<AK4#Z :25A3H7:;'.15JL<Y$6ZURD)1/BB'4N
MTF*=B[18YR(MUKE(*[E.FBK0*FFGYKL%NH2K,Q;CJ[E%IMH"K9$^:KJC0&NY
M#D<;TJH)Y2UA97&(951/"-<RVG$OTGI6%H=87A/01L<)I,T3XELPG1\C;9T0
M[L!W7T;:A7'$,KHGQ/%,H(,8_SVDRQGMI$A7(*UGM&)"_A43OJ6>$*XNEN4A
MSLNEN"3\5PO4'&X-MQ+^G<YMYC;!W^W<M=P0ADR!7UN!9K@4PM=BC$IV%S2W
M ?[S<K,@;#6\OYW;AK]6PK\K(?9.P!40<PX\WXBA7FX&_+L+8VV&L*60$HN_
MFML!*2V%=R9!K.40L@G>9&EXN0K,W;]*82[&W%;(F9>K@6\FN2IX-OZ>^-;X
M._\Z12\\94^6PM_M6&Z6FXV8P_40MIE;]7^H,Y;J)DQ1?*\/?JV%7ZR6O-QL
MH);B+_'+K 82F((7TUY3J(_E\&L'/&7Y6HNQ*Z]2:U?/P<=S.F>,:L.8NS"/
MJ^%W+Y1Q%?Q:CD\KQG*X"3BU$MX2R[T5:XJE&H>0N1A_>R'7T["^5F"^ML/O
M*JZ>2T.;8_4FUN\J?),]VX9UNAV^S]Y9.<:!8EWMA/ -4.ZEW#+\OA=RO17>
M&<+R;L?\B%SYI'5Q91VO+;3?;?^OO2^!CJ+8_J[JF4QV H1]LPT[)*%GR\(B
M)"&$L).%35DZ,YV9-CW30W=/%O9$";L* @I/,0CZ!!51%@599/$A_$5%1$%D
M4YX@* @(""A\5=4UR020Q_?.]\[Y_N>\Y&1N=U5U_6[=K>[M*12A^-"O1*2K
M!&FC9HR?6#B+>,&X940C 8ZQ?HK)D[I>_4&<!%:CD7L/&:]SC2U-HM+VTMEY
MI <\BT L%<LID5K=PTJO]HQ.@BP'<:SS__ 2*Z2RTI]7B!9T&>%^GD0#?40!
MD1&V)6RAP3+39\(R#G"#K:R8ZO3NV1S$)WUHO$;[L Q&4OZQ1^(5Z#9=@Z$]
ME(QT3CR$X\!3/%WG_PU'NHZEZI4&I(MG*Z9(!<1W='DX_T+?A<2B/??5B"XI
M)_G$W& I9()2,LI'UL=3Z\4<.]#,NN_R)$:75:_$0VPX$'-T_0>LLC8_\4$K
MN5O.#N)Y90\IZ<15K(7CDM@\M\ .E+VR5N83V Q9\<D*KXFR-Y%-DR0V1W2Y
M-97-$51!*1:<B7FB1U#904()FR-[>&^.X/)+O)*F.@2O4U#8!/:N <,$1463
ML?9$SLR3/M1%>NX:R(HJR[.:PCL%#Z\4L7+A7W+&BEY60WWY7E$3G&RNQFMH
M)M[K["(KK(QZ%-8A^[V:(@IJ8C5K01.@)[R24(8F5T15]L:SPT2'AIX=P"M.
MP:NQYE2K)<^-&%((+WR!)+"8B4+>(;"%HJ)J+._S";R"T!$O>#BFF%]]58CY
M ;+7B5CU"B6JC_<)2CQ;B!!*W*+#S8H:6\*KK%-019<7"95ELS76C5I4?X$J
MC/<C'J0RMD!PR!Z!E;T"G@\ON$16)*?*>F3$@.IW. 15+?1+A#76H0AD;2J:
M#3."EN82O;S$.A6^1/2Z5+9$4 36@^3+^HE [I)">\20J @.(N&"LKMEPFLU
MZ],91AQYT:1>?*7(?I<;J8 52C7!JXK% EJD@*6-KGR*C%E%(BJ6I6+$"UOH
M5XB:T(** MK,PZOHK3/+#BXL%!T"PDGG521D&4^,A(C O<@:*<=(9$ZD::_3
M[\!VX%?QDT,$Q2=H?A[; SM$XKV:B!0LZO)%=E;&RI*35;4RI%.'FU=X]"R:
M31,=*EO@UQ7#.WD?GE&361=>@%#J$"0)KU027&*!*(E:&38QGX0&E8B:FW7)
MLI-%^O+*GC+$]7#1*2 -^E7=0 IDN8@8*&+ Q4\0O8*JFX,B()/4T(U,ULLZ
M98=?7R(>S$NJ3(8Y1=4G\65ZH[-84#01KS71K6F^KEVZE)24)/+4S!W(RA.1
MW71Y4!\V&&I\BHIF\4C$V@MEM$)5+M1*D&5C?\1J*>8E/W$ I$6D ;1P9(SW
M<ZJ  XH:MF.?3Q+1Y(1EW()$@8VJ3/;CB1TR6@16&9D$PR E>(C?\*R$).%%
MPWF7(@A8&HGL_=FC XF>\,1H_OLRAD6(^A46\8_,!OD$:BC YH*M$G.&!OE]
M>!H[VZ$0:;QCS5 D+Y]?PW)B1R(,#U(#BDCD*>U>KM!$'EG!7<@7'C 96KF$
MP3';;AZ9F%R@\8@?9]#Z"Q794[,@Q)Q31D");":R1A]R2"1FG^ 0D>'P$C(V
M!.(1-6RV2 Y8I'2>> (2X-LA^\KNPWAB='1V80TWV$U0&%))0(EGD9TC-T36
M6BRB<!TT=XV.R+,H>@AHP=0G[D6)#]@(<A0-.=Y]U858R:#=V5ZD.@]I[1I]
MO['1#[!RVG6/\0MHPS)SQ.I1C2&3W1?OQS@;*(/1:&=\$NV8/Y%=-= 7R+&=
M>NYL6&IXU[#5L!W];3)L-KP5E/TI015)358<R.P+49N#9A4BR5+T',%'>OGJ
M[%2O2 *9>> ^4-D$5TEZGCJ [/).FCMY2>6$<PZ>YA?Q05EB">'5@3[US)DE
M&8%*\AB!9(<NF@_A;(8%V62,NSJ3\:-5X4QD/+K2\U\]DRD@&8Y,.-.S.*&:
MOT N4T)XD-#<*LWQ5)J;^-&S#IJK%9*ZDPVJAQQ$,C4YKTIY"TA$KWA<1$YZ
M/NBL53>I!%N@&:6'5HZUJX 'UU'MJ81$,H<C*/O6L[4'UU@\^;Q7?\$2UF7D
MI9QZJ]L4DNVYB+[T/%A &:9&,\) 1BS2O%>747%0+>:HSH"Q+(I1BX0^ _5D
M(:D8:NI874-%]U3%#U>1ZNM))[:B6[)<S;%NB6)UU:3>(V/=RIPTD\6:\1.9
M!BHVM1IS")D+SZB1ZK.F%AQ"WEAXB13TZE>L9;_ZFP2]+I7($RJQ,XG:F9MH
MCJ>X.F\:69U*ZZ=@C^%)1/!5\ZC7 ZYJ#0BT%I#(_+I.)?)F141SB22WUZMD
M_?V!C_0Z"8)(9(]GD]&OD\SFH&\*/.@97=;#T3@G02BKKK1J(D@!>;:H5K7L
M(14L#R94UX'!T4$AE8M,;$+OD6N]<7 2B_+7TF)@9NQY*JT=]=F<1'X^HI.R
M6B.=M!K7R A=KXGD;96&QG=%]7\7) /\FTAD'5QW.6@=G$CC39=_^[E A*D=
M^?1Z%L_I09S_][W(?]^+!+\7L:._#M7O(CK^?_1^Y-_C[+_O2?[%>Q(0#2+(
M7S:Q_7OE$]A1](Q(#<I2X@GG$LE=="GA&8N)KY;\)>_W\Z4:7#W_$*B6:^\5
M#[.>^'MBB8..U7>]A_>P&LEDW#5#-KHKK,Z? ^.[DK$/.SL>^^_%]=I/_>M=
M0*#?<Y@!%Q3W:VH#GN@G<'\*U*X;A%K5@9[W!?<CVS"V,IJ-_8U9QA[H,[76
M3-BC!A%+PGNB;J%NN!8N-P"R)Z:AD0K]9H''_SP9_]QY%(V]SP\S#S+0 (W
M (P@!)A * @#X4B.D?C_/8S_=].@+J@'ZH-8T  T!(U 8] $-,7_.PW0 K0$
MK< C2!N/@CC0&K0!;4$[E/5V0'&D$^B,K"8!R:8+X& (JDBLP(:B31)(!BFH
M1ND*NH'NH =X#/0$O1#'Z4BCO9%_]P%9H"^RA7Z@/\J(!Z)U#D;YV5"0@R26
M!_)1SCP<C$!1<11X'#P!1H,Q8"P81_9,!]%5(<EZ152/%2%)>8AT?,C+]+K)
MCV16@F)(&<ID)H))8#*8 J:":: <5("GP--@.J@$,\!,, O,!G/ 7# // .>
M!<^!^6 !>!XL!(O 8F@"+X(E8"EX";P,EL%04 66@U?!"K 2O 9>!W^'86 5
M6 W>!&^#-> =L!:\"]X#Z\!ZL %L!.^##\ FL!E\"+; <+ -; <?@1U@)]@%
M=H./P3_ 'O )V OV@?\!GX+]X#/P.?@"'  'P5?@$/@:? ,.@R/@6W 4? >.
M@>/@!#B)[.%[\ ,X#?X)?@1GP%E4@YX#Y\'/X!=P 5P$OX)+X#*X GX#5\$U
M<!W\#FZ F^ 6^ /\"6Z#.Q# "!@)HV TK -C8%U8#]:'L; !; @;P<:P"6P*
MF\'FL 5L"5O!1R +'X5QL#5L ]O"=K ][  [PDZP,XR'"3 1=H$<-$,+M$(;
MM,,DF Q38"KL"KO![K '? SVA+U@&DR'&; WS(1]8!;L"[-A/]@?#H #X2 X
M& Z!0V$.S(5Y,!\.@\/A"#@2CH*/PR?@:#@&CH7C( \+H ,ZH0 +H0NZH0B?
MA$50@A[HA3+TP?%0@2K4H!\6PQ)8"LO@!#@13H*3X10X%4Z#Y; "/@6?AM-A
M)9P!9\)9<#:< ^?">? 9^"Q\#LZ'"^#S<"%<!!?#%^"+< E<"O\&7X(OPV7P
M%5@%E\-7X0JX$KX&7X=_AV_ 57 U?!.^!=^&:^ [R /?A>_!=7 ]W  WPO?A
M!W 3W P_A%O@5K@-;H<?P1UP)]P%=\./X3_@'O@)W OWP?^!G\+]\#/X.?P"
M'H!?PH/P*W@(?@V_@8?A$?@M/ J_@\?@<7@"GH2GX/?P!W@:_A/^",_ L_ G
M> Z>AS_#7^ %>!'^"B_!R_ *_ U>A=?@=?@[O %OPEOP#_@GO WO,.0?JC(&
MQLB$,"8FE ECPID()I*)8J+QB7*F+E./J<_$,@V8AOB\-WB%:<(T99HQS9D6
M3$M\4IIAF4>9.*8UTX9IR[0#+S#MF0Y,1Z83TYF)9Q*81*8+PS%FQL)8&1MC
M9Y*89":%266Z,MWPB5WF,7P2EDECTID,IC>3R?1ALIB^^%PFTQ^?"&0&,8.9
M(<Q0)H?)9?+P"39F.#."&<F,8A['I["8,?AD%,,S!8R#<3("4\BX&#<C,D_B
M\SF,A_$R,N-CQC,*HS(:XV>*F1*FE"EC)C 3F4G,9&8*,Y69QI0S%<Q3S-/,
M=*:2F<',9&8QLYDYS%QF'O,,\RSS'#.?6< \SRP$?P-;0_U>D4,_E/:NZY6]
M^.6^Z'4I@N97O.$NJ<SG-IM3D_4AZ79,+69+4ACIL7/)QDR_(I->L]FLCTKK
M0T<GF](*%*%8,/&$A*;)+MDK%(7R.C7U=O"*[#4Y":%S<*&9=)1 1V7JHP2=
M#. =?DTP23H9H#=*A!@'.&7-**$/TR"]VZN30?HH;Q".G:/4;,K1!RDZR=''
M*CK)U1M50O0GDBR46DUY^B"-D)!\!<DMQ(\_]1')%"/9;!JESS,A:)[D=$HS
M0K)XCX</R7,+&F\8XA9#>,GGYD.<@J3QH8)/%24TNRJZ/+Q!X_T&GUN,)B^)
M58>L",X"*5PH=4B\!U]Y53_^2D!63#Y!1=.%\XHBETA"H19*KOR^"$(5_!66
MWNF42[SZ58&LN</I,*<WJOJJ0!4B9$5S8WWP4I3HQ6]K]2]%(H7Q?K&8EP2O
M0PAQRWY5B$::EF07?@'KE;4(/-BE\)+FJ[XLT(@1V76[0]1":89.S;3=;*,T
MA5+:;Z'M%GIOI?=6>F^GS]O-E-+Y[59*Z7B[G=(D2I,II7CV5$K3*$VG-(#3
MF]),2OOH-(GB)U'\)(J?1/&3*'X2Q4^B^$D4/XGB)U'\)(J?1/&3$+ZO0)(=
M1:%(-YB&Z'=2H4X5C=YKJIMW"B'D,]191&AXH2A)R&KDT@C]"G^]%:HI(N_R
M^W2JT'NG5Z=2H<DA*@Y)"!>]Q05^])"&KVB;ZA$E\BT@,HSBZAN#ZO>:"@4/
M,@TC_@A1?0C<Z)#\!2%N@4<03I'WR%YGI,>O4F,1Z@1=(VMFLOLQXI.17MXG
MJYHB^]R"R2-ZB3_BKY6<>BSB:$PR4_&F4;&G4;&E4;%E](F0?8)7YS\TS<,[
M<##@=1J9@5?C]Q1*0FFDH^9:=U$NC=+TT$SZG*!34Z8>X 0]P.DA+(G2Y,BL
MH%E==\]JH>'!8J:4!A:+-;)OT'/NFFMCWP)>,;K1ARE;$R6G8!()"<VF7(F4
MJVR=*U'G*IL&5%&GD?V"9G_R;JZLE'MK<E01_B+#*_%>I^B@C31FZ:[&F6UV
M2I,,F5Z704"1;S!E1::L#-99D8,$9*<0]N3(W"!6U*"%YN&%:GBA^?I"_?I"
M\^GL?CI[OCZ[7Y\]GR[43Q<Z/&CVDJ#KD4'79377(2C.NM2(-!S!2:!&L3)P
M&9J6J5->(#1RL"KQR*'(M5QS'<YCXY4$D3<-1\$.\5:BD^'Z#E"BCQKN% 5%
M4$4UO"1P91JI#RPC)'J\'\V#5X5"K6[IG#73*(D*'XZ_@_+PR$7"T2H%',G=
M49H;Z4J_5B/Q-VST.DI%4W@#'0X9;32\PR%XM;I^_1N@ZH803?;*:G2 '7(7
MD89W(G(9E:EO1.0F+%/36\.S97H5-=@C8I7H-_E!@R,&>P27/JB>B(;70@@A
M",9TM%>%]"8;'L4QCL*[(<(Q8HB0_KS/QZ/-WU/@Y)F!?F:0GQDAAE),9HAH
MR''+(;EDC\SC_:$4WY#A%@U#5#$J.P@WAG8&[B/XFD4*P8L4 HL4 XMLX*_]
M*&DT%F#F77@/-T[ 3.-;#6_F1OQ@2!%A7=)9]_J94A$Y!^';H+AE$]G840B@
M'#L0Q^@R1,9"BPJ65\Q=X%%RL,3]P1*7JR5./,W&F2FU4&JEU$:IG=(D2I,I
M3:$TE=(T2M,IS: TDU(]\[/I6SBB%-=,<<T4UTQQS127ADR;F>*:*:Z9XIHI
MKIGBFBFNN3>E%-],\6EHM='0:J.AU6:A^!:*;Z'X%HIOH?@6BF^A^!:*;Z'X
M%HIOH?@6BF^A^%:*;Z7X5HIOI?A6BF^E^#3HVJP4WTKQK13?2O%I_+71^&NS
M4GPKQ;=2?!O%MU%\&\6W47P;Q:?QVV:C^#:*;Z/X-HIOH_@VBF^C^#:*;Z/X
M-HIOI[AVBFNGN':*:Z>X=">PV2FNG>+:*:Z=XMHIKIWBVBF>G>*ETO6FZGL_
M9P[D!$GZ275\VKL>@'?NX'/%  QD?K0PP+ 0@/20D 'HGAY1"OS<03^@YYW;
M>0,'Y7 < )6 GH2'Y-PY^FOH0;2!WMQ0X"H:\J;P3I5]*Z]'PU"FJJ)A#FH:
MQ$!HKL-%F<+T'B8D!'#C3!&=3= (*Y(9:*S*X89P\4$M+5YM-:T%Z$Y^!Y/O
ME&7R-@V_W7T,_W)L[?F,=<^\_]GM]1E_>__1UM'?7<S^O%U51;T&7(5A E?!
M%%09<$5<-Z7M-S=_Y]]9]MMS9]IM^'K4(2ZZFEF(><HU1W+A)D.^T13+Y.>:
M&W,-\4U$;)UAJ)1 ,=4;SV9['8GFSEQ'W&&(C0MT$+GA0U,>'SYGE"LHQ:(#
M"3(CC6O5.)I+YI)0H45^1C6.1@E/DAFYH#W5GCJ*>^(A05',TD$[_RO07')V
MATU@LRQ<^2O!BX0AP% ^#W#ELYCR<K![P^6<AEMF5H[KV*C?XUWZSR^:,?^*
M/6^$_=R!I#$% W.&VL;OG%C8<M8GQSKM?C+B6O*1%[7YUQ:L6;NA>/&E5?T<
MF5F)19$+!O7O//?"B'YSO@H]W2S^]XK5(X[L3[^2\)'_^+PW]SS3<JDT(&Q1
MJ^-'+[I.*3NS=RX;U_W4]]L:K7"4B@TFOIW &) 9K2C?S97OX&RF,*3\D)!0
M"(T=N'9<F\ ]!RN;T-,:LD/U)1;C UEH@?BX!C(!0W[+6 CO&!D.<%9\]X@Q
MGNO$=:AJ5]6F,HX^Z%"D6L]UT50UP<$GHG:N$7ZH+9XBBHL(@!K"N#JX/0:W
M&PV,Z2.N%;ZO9T3J61G+U3/'(+$2;9CR<M/,"9:[3,E0 2$8\G'_3]I,.W$Z
MNLW.X\W>7<XL?[TB(>JIAN7)$15UXM>.:LQO.!QR>^;12_/GKQO6K-?KYQ=L
M2TE=ZT_2NKXX^'3RYB6S]BU*;[EVTYZJ><-/WCSD-*;;!\$#UE<;?S)P=?L]
MET]5#F!2!CY5^H\_<D^>/VF:<6SEXF5CHE[\_K5MVRNF[QIWZL3;'0[O>:V_
M\]L]S1_?^E9JV*&4N.76.5UF+SV_)?31GKW3PD,W""W:;.E[L/>T\\L_W\NL
M;_!YWIY&*Z8]<:/LL='*Y)F-E\5GO+HO][/)/:YUZOK!X(7@-4_$4Z-OC,G]
MK<FZX3&^7;>NOKVHJD[CX[L;31NW-Z:SM])XZ?QOI>T/A'Q\P?;XF$W9ELM6
MY'V[T5\"];ZL[4T7G9B7TR?C^E%/WVCSRKN]KWQ.D">,2C,WY&+Q35ALU'"4
MZ F*E\W@?8*Y 5<?-X?&1O;V*P6\MQ@7;P%]1"!]N/D233"WY)KCALC8!GH#
MFX%/QN'S4+A<-S_"M=3UUXAVD\ 7<"7JME;DJ;8:M\6WUH#;_D=B106,N]M=
M*V ,0.T1#+:H5?O>6_GI?O:=B,FSWIKA_W7]H$LG=L1L=_%;5SA;?/OAC7W6
M-Y_F9HV8,O=HT;&D93';#_Q<>KGD]2ER]^W/OQ.]V?V;M'#?UIR$-_OVN+KQ
MT.BQS9E7;G8I:K7R^HJEKS?[A#DU=4#.#W7&_=RKQ91-T<=[[EE_8L;6L1.>
M-"<:EI3'OI'%?F96HX<G["^U61?57U)_TW%WE]4__K!S]MQ.N^8\.J-PZU,C
MALO^[=U7MYLQ>E_=AMU?>?I<WHX([^[;'_<[MBFTW@MQDXX^UOY J]*?7S'O
MO?1C7-.CN]=E92QM-K:JU7.GQUR],.G2Y#<+X+-7!T8>_R)NV!N+]J^96;SF
MPN;H*Z<''JFZY:Y:TZ#;NAD[/J01XRA7?OC?C!CUJR-&&&="A(& 2]/C1E<N
MA4NJLE59*KF_BANZK02;2D8:B2*Q)(H\*(1 $^*0A!!DF2N;<HT#]FV(C4(A
M!!E:2H(YP6Z].Y"@.-VOZ,:Y$3M[MS#/*EO2>?'VBK?@URT&[%\[>X3W1%C'
M%6,^V?=\[!EC3O3%K/9=0,K:TWN?'[3TJ[B"AM=[)C\ZV&>>=FE.RHQU9\^^
M &Y_GK]X4)LO5[4?-&'-^WS:E4Z?G=E[9,RQ#SM/?VS#RQN.G!I^9]OZCZ=<
M_3QJV:\OW.Y\L%M.\^8I[:_W[,=5&+>COP[4C]/F+Q^56GKB\VRA,*7E /_.
MN_UX[$-Z1C)GUSTT,0-5C2IK98?X"R31P0Y14%6GE-7V6#;-K[EE1=3*B&NB
MS-R<5..:^-8><,WR]0_) 0T"D;&-:GQ3\:L:.TC0\.EC<S<N51]@R0L<0<5G
M.WF-Q1:BTL.%M4Q$\?%L!T='E((GHHR&Z+=M]>R!A6;(3H%LTS@ 6#C.]C#.
MOVW+A2U3+CYU_F3RX%N&NBG;PKZ<._GEFPNF-HW:670A/6?N\8,M^L:V/;?#
M,>'&4.'"P=7=KOZZ\*7.MRX7?M7FV^M77_$V34W:\L6*XK!6<>W;2"GSVW__
M=/::YK.7_]FV(KXN=W;\FQW.EO0;>NGG_;__FO>5_-$/GHAGCQQVSG.\ES"H
M_;7I=6Y[?NBXY/OI69,2*J>>'?[LVZZ=5LO\6/:/5:T;+/7L?+I_L=MX:'S\
MZ$=OSHQN]^<C"?,[GX'Y R][[!TJ3API>F+CUT=6E_\Y=O]3FQTO?Q'WQZIN
MZ>)[SW3=L&7]LI@QN\_%5\SI\&=NV.)C&R![X,9K3<Y\=&&H+_G4QI"^.7WE
ME'.[SDH3>S]-G;\"5B&)O'1?1^Z-VUAC#P[K+7)<95]8^7LF#&ULP!E!P#$9
MV*C%@[3'F?5P@![A4!)1%5?)_E4X\#EX*W'_EKK[-^(:5+L_4WUEN"<0U#.%
MZ\REH]B%F@ DFP2*#7$<N[(5U\+<C&NBVTX]8C+6C$" 0!45 :MC;&1L$'9U
MZ-E;MWOT<"9-<G_^>.D;)S9]G,R53\/]K8UE7,ERQTK^/^Z.%75]FT^WK'ND
MHVUCRKZ)AD\W;[]/"%O3M?$'_2;FWW3F_]QKY2_9:<\M>6G6EG<26^XK;7VC
M1=.8J>?=6RQ'9J8<_Z[GP5GK>[Y;L?C2RE&;?TEL=_#X).@%$6"E:4&]ON&]
M;K1H4N9JW>;DAX=.#5G3_&J=8R<3R_=/6R'E#)[OSY^].>[RE^?2_#.[./(G
MM\H;M6CDOB.V\H_&CKDV80-7@?:%"L-%&L+&S>C:=?%V;0HW/WKDW,U#NM^3
MBOSOC" X,":9S<&E!L>9+2G5@7%?[675XV+T#"LL6Y)$KRRJ <,+C:V7*16Q
M68I<++##4(;%NZI3JH@&#>YWW-K\&-==7ZJ]M^@2-5YBLWM7\YO #L3O:/!A
M;S8W<"!^&"^)3MV<BBVD0L3/-PCI(WLU-0!GN#_< RN;0]??L-@[@F=&KQV]
M<0/W[)%>5Y[]NFQSG7V_IGY?.J+!NC%97<8:ZVQ<_\J!#W=_&Z<N2EVVI+SC
MF 1Q:'3;.O;EY;#'H9A%_]P^9G7<-6-!MB'JNTD?+Q(6UALX_<>R.]VFO-3,
M4%3F>6E)29L%^7_LVA_B[G?T]./I*:_MC[APYH<]66/>J#]G22!4346A:B*1
M>,M84J+4B@2AT[A>>JQ)116BO<I:9:X,_-.,C-P,:P+6:\(]4:>ZBX2>_S<Q
M[S[YBX'S!V58(N=ZR RK9_4HIM)ZSVIXD?^+U9 NAZ!PC^CQJPG7:-K](]S=
MX=-8%U5Q->\.FNL[ D!2OE]5UF?+J^\WJ[OMU:()UR?O2?GDRG++X/ZQ[U^Q
MS^C^Q.TV'W;U[IK"-0!7OBEILK'NIIOOK^WQ]Y3VN4<&.KB/S]K2MF;]\N+
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MAD HA*'?"8<(<$(D1$$TQ$ L=(+.$(=1?1=(@$1(@JZ0#"F0"MV@.Z1!.O2
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M$5L.Q!X&8O^_KVE :D62\;D!^-P G-< ['L KF@ U@[ 9XOQ6HE4@[2WO4;
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M1.9'TDC&!K\XLQ_Q^]#?WXR"VM2QK_# U*@S4Z.%JU6<C=DVAKC+&%!+3&$
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M@@QF4QU)/B:=S?0G_G6TRY$PRQ/6>O(B&$FU8C$\03;5H(NE7@7A5/4(19U
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MA'M_6*&NS33<WY-H?R^6QUX,?1]"&:'?ALZ&&$?6=?VM3]H7L!KVZ>V&)'W
M86G%7S^:QJZU-/N.ZL,!.5 =J \T!BX'>!"0 B@0Z]SR[NY(.0$3BL60:=]V
MJ7T+S<CI,*,<6$03"4L&P1*2BYE.4U:+L#&/2">[T:1HYTXH212%T8,J$S,$
MO:^XAG1N<F@D[EW<N3O?VEI3>-E3-*1Y=]/#.<7]Q][9NGIX@?OK/KAS7UL[
MB*7W7(($9B>S ^MB*^3J\:[;T$S7 M=]+J[ -<0U"=VCWZCG&)?=%7(Q(IYV
MNHGZ6_6WF9@B_3#])"QD]4Y]FIX1.:R8@)G2"3A3U\889SI/&&8R!@B,K\ B
MK, "?'63@# -!A.0"X)T$46#J0/JD]U*-6HJ&JR\6C^*M>N2.0\4ULQ:D1E>
M5M)O7.'@K+$35XQ8@ 3(/.#-&S1\I/)M_[Z)[GY#J/]BMS(7;J=UZR)8*_?;
MA969UUF&W<BUBKO%E[#=LE%'(NX Z02!8<7/"%H1P_."&303)-=)<HAI%H@&
MN5OWDNZ4[HSN@DX@.T@+WD%85;-D=*2D7BUKN@90E=@,'%WO' 54K</_2%Y
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M[[R]EG91C-:-:=U>8+J6MC)*B]?.$$V>4EK?+]#B]3 D*D_=1)ZZDU3JZ!Y
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MF^%!4X\)F6@F)@(P7%>$_ZDR8RF6&6'ZG='T.V/H=S)D7SBQ(A$Q2/:U^%#
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M7$W5)\4-Q,$KH -G]Q^?/ID]0-RX6[>"JWD7'F4@RX(V=!)VX[<ZPII]FCF
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MVUCU&AOOUT.>;HZ< '\D<$9"JQR/>!X+K$U]-B#<!_<)]TCWV'C#8>@5GHH
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M"(0[E\F4)&BS6E,J%<01MKR2,.:4'Q<GDIU%RD&%5Q14?0B@ AI@)BR"92!
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M\K/@<7 SL^$-,[JI(D$_BB*!+ HPWE _$XCPHR@@-JG+%B6L";4@ ,V,9R.
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M(^VYT1BADDECD[ LVG@L"QP@1> 4M%BF:CU1%,A%3ADCY8AHFR&@(Y:MGUJ
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M)-B> OLFW3&@=]];=S&>[VXBT*@L_HQ:7#*X]XT;PT3\S$=$'$454B6:*.U
M>R55P@A=+TM>69;2%Z>E24F-JBKY&S5-8@Y(,H]0^&9/^LW!.H=#3#%\?NK\
MZ2I-J5OK 8\G4\+_/5 -R7\4J-:E<Z":98+.HUUTF"JJ+/\Y/=YK=.D4PD:
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M;"Y1RUM^&^SO:+LR>]XDL_9WY&CPB!SN3QWIE^UH3&;RF)B2RY'IE;5J<'B
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MONWG[JXNJ[%MW'SN?5/+IGI^$*[LC=W?E;C'LW3YC/C==T<VM)UE=]V=V/'
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M/GS+@ 4%:F\:L 83<90!VZ (UQLPN7.\VH =4(A?-6 G;!%7&+ +2C2' >?
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MCJ-EH&OI:-#CZ1B4GP#Z+IU(*Y%>1VM 3Z)C"W^EDT5Z/=+OT"ET/$I.I1-
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M]>H*%MZ#@+"J>O5ZNQ<+@S^C6EU>._P1#\;#$63AK0@^'%Z/Q0M;I[-CKVC
M'[K#-GHQ@]W.PT+QF$_7@TV;#LJ#!;%A#&A#P!W"X6(5$:/SBWED+>OXV%$A
M:H=--:I&E "ZG!=@@51A.U!O-P9"-HZVH)M-DPIU'$QPJR$.F+6D).!V0Z@V
MF]MI<4'M<&5,JDGPU 4]AXTC,]%]%EAT*K"A*_+)G#*?JJT8/;A=H=X+9T'O
M<7!$'L#"LIW\'4AUN4TNCTN'%4.+.)B<*BL4YL/N=,"',D,(-K:F.BN?=@*
M#B?KRVEW0^V8WN^#CA@4C +HS88Q, 3>#A1[O2YHR@?9 OL6' H84F4H6]R(
M-JO;H[JL%OS EV$H0,4PO%:3-Z *8\*+T0&;X:B/L)EPGGH<_)G.SA?_'K\(
M]P_8*A]O==7N<NBM#KO;X8(F>#E@P(Y[#&XG?*19X2'S:>01'T>0$W85V+1Q
M9X?+T<O=8A9ZG6_LJV$,I]./>Z_?Y<'ZK Z;QZ_"$?5B/!Q!5M5IM?H=#I??
M:_7SGL%F5S7@#]VQ'#]F4,7*H'C,U^NW-':]"FCK(328!9L-)6ZW&\8$Q0Y$
MC,XO&!(^_>QZN]&.X]"!!GS508G!;N:\@ F\<[L93H5=-8;"=H[V$@_ X71Z
MG)Z#"LXP!Z E$@UYO1"MW>YU6]TZL]_N-)F<)L&3M7@D%XT?,]&]WZQZ2-..
M-3F+58)/A[T8X21PO=_CLAN $I?(PU_"LMW\D<?A]IK=7K>>-['=H7>H;@<K
ME,'F=NGA0T$(O/.Y$PX3]AYM3C?KRZUZH'9,'PRX86T<?'BK7IP8=HR!(?!V
MH=CG=P,Q 0=;8[O5:6'9.6W"D4&TVSQ>A\=FQ8_=+*#@\]IA<&UF?\@AO@KQ
M8O3\AR(2 6#3B/X^%ZYD)I5_V],#&R-_AU.#O-6=S+G=I7I=;J<;.9<SX'2J
MP!Y:V=EL&1D<=KU/?!Q!S@Y%6N'7VKFSR^WJY6WIBR=K5Q"^&L9PN8)&HS.(
MA3F=V(B^H!,.= #C&:$#)T8#'^Y@P![D%6&S.S7@#]U96)B!K8)>#P5@OEZ_
MI5'U3L!2[U)Y3/%)T>OUJFXN9KUB=*%[\(A95#U,EAF;#PWXJH,2Z)WS B9N
M+^\:U#M,X9C*48WZ1&^?VW=0P17C@%GCB;#?[_!@ K_7[M59@@[<D%SF(AZ=
M(KI5CLQ$-S;M.*S!:Y%/YI3Y=*G%&,!ICOJ@SZT: VZ.3D:;"\OV\D7:!7?$
MZ_=B%T-_+KW+Z74YH% [#"L0Z\0R]:P3U89..$R$<71[65]>IP]JQ_3AD%=U
M,BB0]>/$4#$&AL#;C>)@T M-A5BVZ.JRLNQ<0M$^1(?=%W#Y.,U^)T,AX <:
M,5,PXF*%L1J,C,UX,D@PET"'WPULFIW\.:@W-C&D(\A;SNGPN VPFCXW; 1R
M;F?0Z73@C@U4BOUJ= #V=H.?]Q,./H<X\^$&J]S9[7'WPB9OCQ[GJPN;V-@A
M8#/D\3,V7:H_)+")\8QJ$9LAM]L3"MI#;/T8FUKPA^XP[B',X'3RL+!);!]Z
ML.DP..'!&MSP\6 ;590 &CCH4.Q&Q.C\8AXA% ?N(@ZSV^%& [?9;7:R];1R
M7ARLV/$.J]/L<CC-D;B#HR/F9WBX#Q*;?G>< V9-)".! $ !0P/-Z:PAI]O"
M9Y]@KHC-XL',3!PX"PR0AL-0Y),Y93[=CF(,>IQ<'_)[',:@AR/R,'H\+V/3
M[0M8?0$?C@_HSVUP.WUN5J@*J7L]!B?LM8%UXN!.0 RO7/5X65]>!B*D;(^4
MP'X C9C.&7"P?PE40 4.G!]N5RCD"[E<)9 M7 ZX 3R"F\VLW8_H4'''\0.;
M,-I6 85@P %G0+6&HMW8!*R S519&-@TH7_(JS>9+"[^2MH#&QPO3J<KPEO.
MC>/4X/"Z EZ_VX^<UQV&B<(=V^DPP:"['":7"UT-(=Y/%N0<0)4=GK63.V.C
M]KH*L'Q[G"]QCS [L+$C)J,[XN>MX/ X@Q$W+DDE&,^$5?,Q 3[\D; CPBOB
MW:$%?^C.PL(,?&(9#+AA8#Y#SS<!%U3HLAN]+$A8"I0$ A .%WL1,3J_F$?H
MU65P65P6/@?]+J_%:W'SIR([YX4A@U1==C?JW99$RL7151IR>K'"H"]X,"'D
M37' K.FR1$D)! IE!AQ!O2WB]EJM7JO@J0ML?A='9J(;FPX#I.DR%/ED3IG/
MXOGM=87];JZ/A/PN4]C/T<UH\V+9 ?X0ZPV6V((E00-6#"T:O.Z EQ4*K+D#
M?@/.-P@!.G%Q)Z?#)HRC+\#Z"KA#4#NFC\>"+@^# MD2-UX>H (J<'G\R$4B
M06@J!MG"+CO@L&!(+YM91PC1[<0=)^ATX,=E$U (E\ M<3ELD:27%<9J,#$V
M,U5QPF4>YVDT8#";K5[^E-<#&]R-8:L2O"R?)Q0PN0*>< #; KF +^[S>7#'
MQLT9KK7'9?9XT-44%1]'D(-5AY-ILKJY<R 4Z'458!9Z?"]QC[!@?8&$V>Q+
MA")>G'E^3R3I@R,:PWAFM\_EPS$!/D*)N"O!>\;G<?ETX _=L9P$9O#Y>%C<
M,%@'/=\$/":?R^,P!3P8 R85)7#T/"$N#B!B='XQCRXT-'EPP0QX F@0L,*^
M\*<B!^>%\8)4/0Z?S>_QV<HR'HZ>B@@?FP&HXV!"-)#A@%DKJ\IB,6\))HB%
M76&#FO &<'FW"YY</A%#'H[,Q(']9H(T/:8BG\PI\QGP%&,\Y./Z1#3D,<=#
M')$'L-C!Y>] @7!4#<?"V*+07P!.4SC "G5[?+YP"')U0 C0B8<[P=?P\#$9
M*F%]E?BB4#NF3Y>&/;Y P(_I?#& WN,'*J "CR_D"_@3B7#"'RAEV3H]KH"3
M91<0BHXB>MW1F#_B=N$'=R*&0CSJ<;@\;C51%F"%L1K,)F S5U,*;%K1/Q$R
MPK_V\U?)'MA@"WN]OA3?*0/,N2?DBX;"@7"(EU.*U0%[7GBX/D0K@\-C2O#9
M84?.$P8W\*R]W#D4#O6Z";!\>PXX<8_ &"4E::LUD ['@UAMR!=/!W"Y2V(\
MJQ=" "S2H5 X7>I)\XIX=^C '[JSL# #6P63"0K ?*:>>Y=/P-(,H4&07A@E
M:S0:]86YF/6*T87N2T*L5Y^)72)L/C0(V4-VE%A]3LX+F.#FZ',&4!^P9W(^
MCKYLW%OB+2F)E\0/)B1*<AQ*2DJJ:S+)I#^""9)13\SH3/E+<'E7>_ (:^#C
MR$QT8]-C@C1]II"OI%@E^ SYBK$T'.#Z="+LLY:&.088;258=I0_Q(9B"6<L
M&3/Q)O:%3*% -,0*]0)L42#6YX00>.=S)R#5!W?%&XZROJ*!.-2.Z2O*8KX@
M@P+9I!^O(% !%?B"X4!)*)6* 3%E)1[NZBEQL>Q*A*(3GKC'[XTG0W&O!S\^
MIX!"*@$T^KS.=&6(%<9JL#(V\_5EA,V$_J41D\VFEF!CF7M@8[/AC R4\U8/
M!6(1LR\22$1BH1ARD5 95F<SV_P^FX_-EBT V/O,I6QD5>1\,7"C6E0_=X[$
M(KW<+=X>@0-!^&H8(Q*IL-E"%;%2+!N;N;0BA,M=&N/9_! "8%$1B<0JRGP5
ML'5FWAUZ\(?NL(T5F"$4XF%QP\!\YIXO5 $!2TM$F'N_'R6)1"(0X^(((D;G
M%_/(F]X<4 ..2"""!A$UHJ+$%G!S7L $-T><:PX8"367#W ,U);Z(UAA,IH\
MF% :R=<B8-:Z^EPZ'8I'@H%TPI<TN2I"$5S>G8*G+K#% AR9B>ZSP&>&- /F
M(I_,*?,9"11C62S$]16EL8"M+,81>9\O@F4G;#8^.E.N9#IIQHJA17,DE(BP
M0OV!4"@1@US=$ )T$N!.0&H@X WX8PG65R)4"K5C^FQE,E 2B80Q72B-$R-0
M E1 !8&26"@2+J](EH<CE2Q;;\ 7\;#L(D+1I8A!?VDZ7.KW)?U\)V(HE*>
MQH#?55$=9H6Q&FQF_@.1_3)DL=C1ORQFAG]=PE])>V"#NS&<HTJ^4V(-,4L@
M%DK%$I%$C)>3P>KL%CMNS@$V6_90"%TM9;R?',@%H$@O/.L@=XXE8CVC!O@;
M9^A "+ KI 9"\7B5W1:I2I1!9=C,9541W/0J,)X]""'$ X&J6"Q1E0E4>;T6
M"^\./?A#=XO%6X49(A$>%@K ?):>>U>(8>FU0&@09#"($CAZH007LUXQNM!]
M/,9Z#5E"SI 3FP\-8HX84 KKZ>%\R(N8* V%/&$GC(0SWQ#B&*HO"\:"\7@Z
MGCZ84!9OJ$> !6WL5UM1$4[&2D(5J4#:[*D*QW%Y=_7@$=8@Q)&9Z/X^'+!
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M:]+N_C4<D0>PL.PZMSO@KJKO&^[3KX\#6H$6'545=57E4&AINJ*BKL91D8Y
M"- )Y)J$,2Q)PUTIK:EC?=55-$#MF'YH2WTZPZ! ME\Y7AF@ BI(9VHJLE7-
M ^JAJ99L(IV*IQ/9*,LNEV)%-R8:$N6E#?VK&E*)^M)$.IQD*#3W34<3Z61X
MP/ J5ABKP>T -B=.&4PNER^63@^H57V^8"6NHZX>V/A\V-J9(>RW9S/UM:YT
M;:9?;7VV'KG:;$LVF\$5K#SM2V<0?9D,NKH&\,>1('+I>G 3= ?+N7-M?6TO
M=XN_(V4.!.&K^=.9?+[5Y\VUUC=5YW+IFHJFUAR\Z1:,YRO/I7. 16MM;7UK
M2[HUD7"Y<A7IK!G\H;O+E6C%#-DL#PO%8SY7S[TKX\JF,PE7;2:;SF;*RU&"
MPS13S\6UB!B=7[5YP ,-79E0IJ0V4XL&M<':($I\F3CGA>=6WS>3B6=+:C+9
MT.B)&8Z9\<WE^?)\OJFNZ6#"@/S$"0CY?'[RE-$#!U8U8(*!_=+]U5AK53X<
MSH<%3^FLB/49CLQ$]S>XM*LV79;!FO+%*L%G;:886^JS7-\ZH#[C:ZGGB'PZ
MG6<GPH<+<VW_@;%^@_J[:FMST**K-MNOEA5:GLEF^]:[LIDXA "=9%*NLG1%
M.IK)E&;*ZONROOIFFZ%V3#]J>/],KK:V!M-E!U75UF:J@0JH().KS^9KA@[M
M/[2F=G@^G:DHS:3SR4PFF<E7L*('I)O35>7-+35-Y6G\9&(""D,&9I+I3%FL
M]9 :5ABKP><"-F?.'4$>3Z TDQG:@"M9N):_1/7 !O>/JJK<J :$?*ZIP9-I
MR UJ:,HW(=>0'Y[/YW %P^TDDT,,Y'+HZAG*9T<8N4P3N E[PU7<N:&IH6?4
M#']'RAT(F12C.9/KV[<]X*]K;QJ2KZO+U&>'C*X+E)0,QWB!JKI,'6#1WM#0
MU#X\ VOE\=1E,WDK^$-WCR?=CAGR>1X6BL=\GIY[5\Z3S^32GH9</I//556A
M9-"@0;DF+FY Q.C\:NC;@/I,SI.+Y*(-N08T: @WA%$2R)5R'KLCG6L:F,N5
MYE&?CTR:F>.8FSZDJK&J;]_!_08?3!C:=^8,A+Y]^\Z:.ZFMK;:YL3K7-BC3
MXBQMK^T;C_>-"YXR>1&;<AR9B>YO<!E/0Z8RAS7U+58)/AMRQ3B\*<_U[4.;
M<H'A31R1SV0:L>Q!@4 TT#"XM730L!9/0T,=M.AIR ]J8(5F<_G\P"9//E<*
M(51G4I!K);2:R.7*<U7]![*^!N:'0NV8?N+8EEQ=0T,]ILL/JVEHR/4!*J""
M7%U3OK%^5'O+J/J&L8V9ZEQY=:9O&K*K[BL4/12QMFKH\/HAV<S@JDPN6<E0
M&-F:2V=RE<GV0QM88:R&@ ?8G'_$(>3SA<IRN9%-KE HUH<_Y?7 )A3"&9D?
MQUN],=_2Y,LUY5N;6AI;D&MJ'-/8F _Y0C6Y4"Z/&,KGT=4W$L8@'T,NUY++
M5<1\L1KNW-32U#-JCK='_D#(L2L4SN6;FR>$@HT36H;W;6S,]:\=/J$15\<Q
M&"]4TYAK')#+36AJ:IDP)C>AHL+G:ZS--=K '[K[?!43,$-C(P_;TM*"^7P]
M7P'ROL9<OL('H>4:\S4U*&EM;<VW<#'K%:,+W0]H0GTN[\O'\W%L/C1HBC7%
M4!+*EW$^7X'8,C2?+VM(],\WQF?.SW/,'SZBIKFFN7GXP.$'$T8VSY^'T-S<
MO/"(F>WM]4.:ZO+MK;EAKK+Q]<W)9'.RB,=&$5OR')F)[K,@YX,T\UA3<[%*
M\-F4+\8Q+8U</V%D2SXTIH4C\KE<,Y;=&L+-OFG8J+*VT6T^: 5:]#4UMC8U
M0*$U^<;&UA9?8[X,0JC+E>>SZ)3/I?+YJGSUH%;65VOC2*@=TT^?/"S?MZFI
M/Z9K'%W?U)3O"U1 !?F^+8W-_<>-'S:^?]/DYEQ=OJHNUXSS,%,W0"AZ)&)]
MS<@Q_8?79H?7Y/)I 85QHX#&?'5ZPJS^K#!60\C7]8]Q=/V['6[Q[VZ0%,2C
MHYY_S$,6;7X94,G_<Z;>8#29+5:;7>5?KWJ\/G\@&"H)1Z*Q>")9FDJ7E5=D
M*JNRN>J:VGQ=G_J&QK[]^C<U#Q@XJ&7PD*&M;<.&CQ@YJGWTF$/&CAL_8>*D
MR8=.F3IM^HR9A\V:/6<N'3YO_H*%BQ8?L63ID4<M.WKYBF-6KEJ]YMCCUAY_
MPHGK3CIY_2FGGG;Z&6=NV'A6Q]GGG'O>^9LNN/"BBR^Y]+++K[CRJLU7_^::
M:Z^[_H8;?WO3S;?\[M;;E-M_?\>=G5NV;KOK[GONW7[?COL?^,.##^U\^)$_
M/OK8XT\\^=33S_SIV>>>?X'^_.)++^]ZY=77_O+Z[CUO['V3--K-6.D#M)YT
MU$PG22=+%TH%.20_(3\EOZ&<I'0HYRC7*<]I+)JQFIF:V9H+(F=$OHQYQ/>R
M=*PF5A?K'VN.#8RUQDZ.W1B[.79[7!MWQ;WQ1#P=S\5GQ2^)WY*0$SK</)P)
MOI='X6A5)D8DYB86).6DFHRG*"6G+"DUY4[Y4R6ITE05KI_-J2-3ZU.GIS:F
MSDE=E+HN=7MJ:VI'ZH'4HZEG4L^G_I+Z&X[-EO20])STO/3"]-(?Y4*!_Y,>
MNA;<_R#[Y<?!_6O@_G1P?YYR@T;2V#3C-;,TFR+K(U_$7+ E,<%]/M;O /<W
M_ /W,^*;#G#O /<!W!F*W,])S!?<Q_X)]^,.<+\I=6WJU@/</PWN7P/W_0]P
MOR"]Y$>I4"C\E:C@+NRAXXGVXXKTT[5X'\$@W%^Y/[._8G_YS]_]];"W/R\"
M<]\9^RYY:\:^T_=]_]8M^X[==R]*-NU3]W7L6_?6ZC>7O+EVWXY]Y[UYRYN7
M[KUT[_5[SR;:>Q/W>M.W=\7>V<C5[&W96[>W=,^P/6U[FO?TV].PIVY/S9Z*
M/8D]H3WN/=+N3W9_N/O]W>_N?IM[[7Y\]T.[']R-.78_MONWN^_<W;9[R.[!
MNTMW)W;'=T>T#XHMM*-KDQW3]6 5\NGRK;_<3O(7\C>*YE=[C.3OZ%\$>2\_
M\KZNW![ZMX-\EWS/@?36?]I,H1OH=#I#OH NI;_1F70>G4U7T^_H1E*I TL[
MC2ZBS^AS.I<NHXV21'OH4_H-W4I?TA?T%5U/M].3]#C]G@ZG>;2)YM/3M(">
MH*?H.7J&_D3/TGNTD/Y,S],+= <MHD_H GJ97J27:#']G3ZDLV@)'4%+Z2@Z
MDI;1M70TK:#E= RMI-6TBM;0L?0^'0=,K*43:!V=2/?2=70RG83=>@I]0!_1
M?=*ETF62+"F21M+2C_23=+ETA72E=!7]3/LEG:27#%20-DM72[^1KI&NE:Z3
MC))),DL6Z7KI!OJ&OI5NE'XKW23=+-TB_4ZZ5;I-NEWZO72'=*?4*6V1MDK;
MZ#O:)75(9TMW27=+]TCW2MLEJV23[I-V2'9)E1R2D_;16Y)+<DOW2P]('LDK
MG2/]07I0>DC:*3TL/2+Y)#_=29U20 I*?Y0>E4)2B126(M)CTN/T/?U ;]-?
MI:@4D^)20GI">E)Z2GI:>D;ZD_2L])R4E$JEE)26GI=>D/XLO2B])+U,.Z0R
MJ5RJD#+T#KTK[:)7Z$WZ"[U.NVDOO4IO2)]*GTF?2WND+Z0OI:^D;Z1OI>^D
M[Z4?I$KI1^DGZ6=IOU0%^T:R),NR(FMDK:R3];)!-LHF*2N;98MLE6VR759E
MA^R47;);RLD>V2M52S6R#Y8E( =A'4ODL!R1HW),/D>.RPFI5LK+2:E.+I53
M<EHND\OE"CDC5](6VBIW2'WH;KJ'_BB]2]OH+GJ43J6':0-]+;U'5]#'] C]
MEBZ4!M'YTF!IC70!+-A%TK&T73J1J&70H($#FOOWZ]O8M[%/7;ZVICJ7K:K,
M5)27I5.ER40\%HV$2T+!@-_G];A=3OZ/NOG_G^ _VJ'5*+)$56W)87-BG>DY
MG9IT<L2(+.>3<U$PMU?!G,X8BH;]LDUG;(YH%OMERQ:T7/BKEBW%EBT'6DIJ
MK)F:LU6QMF2L\]G69&R[-'W\5*3/;4U.BW5^+-)C1%J3%ADK,O$X>L3:_(M;
M8YW2G%A;Y[ UBSO:YK1BO"UFT]#DT 6F;!5M,9F1-"/5.2RY?(LT;* D$O*P
MMOY;9#)8P57GJ&1K6^?(9"NST*FDVN;.[QPW?FI;:R@>GY:MZI2&SDL>WDG)
M(9WV2M&$AHII.G5#._5BFM@1O!PZ.[:E:F?'.=M5.GQ.I65^<O[<F5,[E;G3
M> Y'9>?P9&OG\./?\6>KMDLW39K::1RZ7:))4^^C487U6T:N;VV=QK,YAT[=
MT+MY2.EH\Q\1XVQ'QX98Y[7CI_:NC3.=-@V#9JO:)TR-@^MDVSDQ7L:$J6(%
M&%3R5X-)+N-E%A>\(-G&)7.6Q#J-R2')Q1U+YD!9P8Y.FK VOC4XJN6^PCX:
MU1;KF#0U&>\<%$I.F]M:LL5-'1/6;AO9$AOYRYILU1;5493T%IN]*V&Q]DXL
M.% G4J(YI\!UMZ@EYB@Y$A#IC,V+@9.IR4XYU9?)@K[4,:]O2/R2?IH$B1X!
M^<WI4/NS(K0IG*T=7\-NS$E^_-$O2^9VE>A2ZM?$28;+ <BAOCO=65G9F<DP
M4O1#H5IP-E#DZ[-5:SK;D\O56&<[1$;CIJ+3M/[5$'D\SEH^>WL+'8Y,Y_KQ
M4XOY&!T>VDHMU973.N4Y7+.SN\8SF6O6=]<<Z#XG"3C?)0Y'3Z<A?>#'KGI=
M;8O[=TK>?U&]H%B/[=,6VZ+1ICK&34W/[3@[E)[3<<XTJ&88MF)'Q[!D;%C'
MG(ZYVPOK#T_&U&3'EO;VCN5M<[J7M+VP\^Q09\LYTQ9+$&IG75$:G:ZA4Y60
M/*V8DD/*M/^ZK'UBLGW\]*E]BXKLRL7:.N9T[R)391*"[O1A"T&=G=2WL[RR
M TIZ(=FI5G9JAT[=&6J>%E,=G>246%]R2GTA^3 .%E<GN=5.J5FL4>HD5Z<$
ME(SL5'Q]49D5[NAGTF+AIB]NB4F?/2K1H])G?Y1@0C_[6H+A_&RA1 NESV9)
M-$N*#;;*UU,-GA8\X_#,P;,<ST[Y^I:4?N>:%];L6Z.<K3E;>[_F?JTFI EI
MVS7M6DV3IDE[F^8VK492MAMH:Y1DO%KV18UV):I4*X,43;]KE#N5AY3GE3>5
M3Y6"HC>2437&C#5&3;]-QFN-G<:=QA>,^XR?\7\*KH_JJ_6#]&/UL_5'Z_7]
MKM'?J7](_[S^3?VG^H(>/<VJ.6:N,;>8QYGGF/7]-IFO-7>:=YI?,.\S?V;6
MCXU>$Y7YMS/RV,@U$=D>B49DHSUBC\J&F#\6D(\.?!:0!P5: C(%5&3]G_GE
M0?X6OTQ^U2\;R4\!V7"T9Y-''N1I\<CD43WRT>Y-;GF0N\4M0]QN-'*3!\,-
M-LO;(*YM$-<V4O!,,Q!%Y:TMH6GSH]2H-K8TCFM<WKB^45?3.*?QVL;.QA<:
MM=NEU-;GM-$=4HJ>*WRY5>M]>[OTUZW:*+]:\HU:[[SC*Z/SCO=4>F\X+A2]
MX;A^H9Z$1'";C+A@&6C8,"C7Z3"TW"_'D#)*KVQ=G8ANEU[>NCH5':Q*S].4
MLA.T?<@K/4%+9!.-0NHQ6B)%J *I1[8M^3+IW2[MW+;DU:AWL%%:2JLE,T6E
M)7B/P7M^5X-YVY8\&<:[=NMJ#T:OWKHZ'AULDLKI!]&LC);HEZ.C5PK?O>2W
M?N_W/]R7VJWML]7[W9+[4O6<^&;)=DENL::\7RXYQ>7=M[HL^D:QS;W>UWGH
MQU=OEZ_<&GT$S;(MUDKOPTM^*/7>O;HR^KL?4-%BC=[$'/YVR4:W][(EVS4W
MMEAN]FY<O3=Z^NKRZ*GHU+&MKW<E*DI:C!=[ER^YU.L]>LEV^99M<[S+4#MD
M6\Z[B&>X-SJ'YY_Q@YAMVI+[G)<AX3UTR0[Y2JSCI:UK:J*#0](+-+WL.2&U
M/V$_L$">[GH_A3>O^''L%LX_2@L5!>ZD5UJV=4T)2_R( WT7TW3%"A?5*QV.
MUA.H :F:K6LB$&!VZYHS\:K:NN;FZ /PO*:+Z=-;9ST4'6R5DC3+?*WT )I'
MT3%*.:0B2 6V9;U?+]PNSVHQSO&^NO#%A/>QZ=LU"[9=['UT^G;E-]N.]_YQ
MUGVZ'R7S5N]=:[;C%;UZ^GWZKSF_>2&+,1'=,&MO]+19TZ)'KFF(+EUS?'3!
MPN_+O<,(49[,?\YF$[1Z"NEI$QPFICE!0RU-^DUOZ3?MU6]Z6;_I-OVF]?I-
M4_6EAH0A9H@82@Q!@]_@-;@-3H-JL!DLXJ\\\)^/D V :,5#@&8_/"/P/(E'
M(W6ZE':Y?>(0:65[Y\YYU'YXK/.;B<GMDFG\]$YM<HC4Z6RG]DE#.OM6ML."
M3.ALK&SO-(Z;,76+))V'4V&C< JV2P'.GQ%B?^ ^;(F*,\X-\;MPQKDX[<E;
M^8_!WY.4VL>MW1K]2E_9/G'MUDUX^\.=E[9/G-IY:WA:9YX3A?"T]LXS)\9F
M3KU/3LBQMM;[X)GB-6WJ?<JS<@+. \J59^&3M&^7QHAVV&,);I?@%]H95] 2
M;D=+C"M$._G*8KO)HAVMZFKG_( FBW:3G1_\HMT4.<[M5O,+[5P[:(IH-\6U
MHU>[+3^L:FO=LFI5]U@_B#8_B+&HO;-4M)DU"VW6S.(V6SZ<A19;9GW(8W1F
M>ZJGB^K[L+%GB2%F2>6BR?$]3186FRC9[B9*%DVDY9#!EQ.G;AT6']9V=BLX
M4][CW%R1V[IZRK"VQ4FXGO^ZV:K)_U:S)3]T-:/*_TV0*O_]L&"(U'8$,-D^
M;NH6 PV9-G1F\;U--IN L#FA^+0A7G7Y0 $WT[.#/*$=]'OE<S+#43'!\S4G
MA]"@0?Y*M5FJUEDZ=2C2X^'637'_2:$=&I)N$:TM*+9V564'9P=S%6[Q7&5C
M%[JKRG]24SRT0[JEJTI%L0.;H]>:J%-N6[Q=SK0M[FPY&PXA'%X=%U1V%210
M0%R0+19LEZN2K2M755:NI%DK9ZT4X4!B55=J-=Z]'[1>M6K5RMX1F)H_H3.
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M^UI;3;=0_>"CJS\.M6T5;H(Y,*NL-K0H5*,LG%1<CFO\+U??%E_&]65%?IB
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M6D1-)D#Y!47L4IE6B=_7!&F&.TG.E0VY7*Z21?GY,JE2HA*^O[N6-3#*CN)
M@JW!MB!WC<X.(*&WE41>H#B#)%B']C2CR,?R69%/]LD9,*[AJ<.Y![R/^3[I
M?KAQ42USU+S7=]NMH(1^G?=ZX7LU9_CHAI#/V</"$40Y<XP$C:J21>87%Q"8
M(F(_59%(%I$H*A5#J"R9AHN&. ZB' _9A@T;H88L^/9N$J*EUFE_C<X>K;>.
M:FUK'3UD^N#3'1X[!]]JCKP(>^(NYB$Z^>8]-(3>A;Z?04GHX.=P-\AP=VAI
MZ+?04MX[9^@=F 911"-]]Z"=W&.X1)4"(^('9*ZA:1(B4YSP8]L;M%GB'GB6
M6/0+N""+\_GBC&EI1M'H+7S693O(1;@84V]KR4AY?+ZOST!]'D3]Z\-GV7WZ
MV/'\EP; <EI,GT);E6#8\2?F(.IB\*K(M@KZ:;W9F9]'<LR5X4YFR77P04ZH
MB#Z%4!'("/SSF[&/_"]Y$G(NTW!U\97%_S;4@G\97E,(.5(7<:@9Q?_NZNZK
M9^@6U&9&BHTHU!96A5B,UXDRGLZTP/,4-6"[R)XG>VA_(J#YZ5#D#ILOHUTO
MI=<_W_:J7SQ[R8-]GHM(<;]X@#A($BDS>BZ@=VBW);#I=)8V(P%1M]>209E[
MJ<T6NU04HV<K^NQRI58YI; JI4'9H#!E'UV+\/=11"LA]/(M>HMIY;B"!8-N
M'1=L?IXK2L<E=,V+N$R#QJ\G,7?G75,6/O+F]KN"MZ\^<";0LW_^H*E&S[ZY
M(PNZPC<01^5YUX>N_AIJ;KLT;TSHK8550X+4MOJ6FP;/"7UW"B7Y/KJ*B>+?
MD6T\9,1F*<7*"&6B(ARFH%/ %7-)DCW\"BLHVUE&-"&2P,1,4;("D9F(7$*2
M)9V@1WC<<*GE4I5T0&)ETGZ)ZA)(4A-]#-F#9+*'_T38PR).(WA^PD3GJ#(E
MV8$2@D:^I9U A U[+*05X=RY[?!^-^BY:75;RY;A;[,10)[]XE(_]FLQ3ARI
MQKYSN<>15=LGN@#V@@7EN&YG[%)!M-MX%C?7H5O+;1ML6VT7;()A*[=5V6IM
M#3:$Z,!/]DLBN<0@Y40@LP'T)'0^35!F:-&SR^5:^93,Y":Z=G>5WJ!OT)F^
M!V<H'FTJHF 3+K<$.=["KIK\(M#2UHPSAO8 <15W/>9U1E!O"XO,_\SY@C?.
M)/S/X\^^5UJX:5T1_*U[6[IK7)^C3V7W+BVXD_V[ZV>?']OQX'TWO_G2N-"E
MY]9.N[ACZ)31HR?RE3(.->Q5'&E7\K/1^X6X78[=<:PZ:67*)@>KCJY.6AA]
MT';$]J.*I-"O9"DL65N::S-LAVVG;$(YCI?:;&X!N8#%L"9ZKWHIHMQ#'.C2
MO^QP+XT5"1<<T+\8Z<+23"0;R6ERHW6#=:OU'>MG_$!4)Y%GIYUUSBY/J$UH
M3& )32 8;I+DS?4:WG*OX)U]V <'?( _,,5PP>PD F5D"=F/JZPTN^4T-U!7
MZH*C6EI1MX.<1+1R$)43Q#O3H;<UXRU87\=A;$Y=L(V[]CI3]XL24)9AT<E%
MOO9G&85%[=Z=HU9S68S[IWU$OU%S)PQU>K*B)T\;W*NFVQ?=KI_[E\?WU06'
MC9ZSY.VU'\"2Y 63[IE5.5WXA=;-+"W_L-=K$^<?VK)P5U:/=5->?7CS(5S)
M/5"C7D&OK1$;^<X8$FM%6@?H%VQ^*S)/?*2*RB]X0\%J$S)M5K#8)"M10!94
MT28)*O)SJR:HZB7-ZM$T*S^G$_5PFF&ES,,K$\$J2+9]<)APAW2=D:*AO]*L
M@LW*-%5T4*NF ]C53=H!C>9J9>BHM";ZQ':[JG4P<%Q"80X ^;B \KAC1_Z&
M7JG8:2X@!5<0/D;SE<3M/N=PV7@CSF+D[=$Y^:0'JNF4X)0@>B](+D).GB\C
M%XL%H'(H(XL^\-$SCW1]I->W4T:'_@[9Y]CZ*]-;0T=I(GP8*D)-G(.:^+&X
M"2W=7B/Y8Z2,-#]Z4#0R5O<EW>'1=0<J$]C%I0DVQ]Y,^UX8BU8UU?"4^R#)
ME^LS?$SW)?EJ?0T^P;</WB8NXL9E&IOIU(5,'6F'XG Y[=AKXG0JLV.2 -#P
M9&PW8@"!Y).[<@F8+-^TE1>"]2UU'*7GYSA-D&C"Q.P *<EN(R6(?8)MK8C8
M VW(H)JY:.QAXQ($5"R9F]$(*I0SN'^1(^N6<G6:\R\867S#_:/[Y8S/?&<W
M#78/U16E#$E9OG/5D5L?_P@V^A-F3'_GU9G5O0I<M"5TZ3NW^]MW-H>^?N1_
M48=67CW-WL.U&DW2R7+#DR852H.E&R1AH1-D-17]C)#:!*G;556(P\=M#AMR
MT%0D]*+LSX$ HJG9A.0D0=+LU59(M(*UB3YMN/RS[W"?<I]S,X(/5'>#>P\Z
MS@P]A/:GI:T>Y9!O&B33<^" (["Y.#Q>D'L 'VAXV=#4%.1_.L$7\#M.PM[[
M6B[J,6Q.ZLB*5;M;=DU='X2NWRY]MFW7=;V']!PXHJ#K^+["#=X)0YY[KE_S
M)V="+R]H^03^2NW;KOQMP;RR65MNG5?Z&L[.:[B&6E%#=%*^PV*UZH0;8@MZ
M$YTQJ*5 37>':I&QO9(/#S3#4H/V8C5A9>;D/D.<>J@NR%$D#BO/=!)H8$LX
M0D[NN*Y=:F$,%+W6G?E3^P^9.O2FHI'N4YXU!^X2G@'UDWZSUCW]U8[+MZ^!
MP_# 5K1#-3@G33@G?M*%]"0/;;.1^";XQ'!MR-F:<RZ'Y>9 3HZ<M=1CXU-C
M=)%%F]Z-Q+!NLPV]%LT_T\_F) 62:-+L0]I5C29J.1Q#TK_NCIG-2\HHPK3Q
MABU]MN$K]_WB8ZCL/JZC>7P8+:WU+6W<\H6#)GPI\CG"^:D/FA %(F3\#Q8-
M*8R[DY*R3L]A5L"8\>*L)]Z87CVBM'KQ)T^^O^JC807];AY6&*B<-;+/N!FC
MBTMO91GYR\;.VS_M[\_5/%]0],ST70]M^;9IW6E(&W9]_9C2<75MK.+&?7>-
MFKR11][XJGXQHK-KC,1LJ:]TG311FBTMDE;*3\A[Y8_DKV2+G*IV4M\XKK?;
MO#:NQ8;%@>H[>[5[*X]/H<)V2>(:;$V"7#"@' 14ZK.-UE-6JEMSK5565H9W
MU,KG.@-=:GVPU:3;;<$V#MS,)7M-@Z'=$12%Y8*<&J6D$WP!811D<KK^, ?5
M-P?5=]0-JW;_],;-3P=#Q[Y=MIF.1?7-&U!:D#V^+XSUCA_RW+,EWW_2#!-N
M_>7C4%5;ZQNL8CZJ[];Z>2->X[)8B'<>(=V,U58825[!+XWG5QX49(Z"A;FR
MQN82*9,"D41!9@-4.(9J*_)[VH_(R+P4Q'&HNQP>H/9F!SB><W8$(!$C(+!A
M/!;:[8><'\<A.A720S^%1$2HE P.O4/]YJ_;28UASQ1Z"^/93.$V=KL@(6W9
M8R2:8-PFB4RP\XZH'PAS,^V:8)=$347\_&;G[FQ39]G#7##4C%UJRS-C1'Q%
M9;>@UR7A$&FQB=C;^]6!VR'WQ]P?QE\#[^%>=@!X(*/)"VRYB'+ G@ZD(H]'
M4P]#+R=*TLHPL&9S*P7($0)"F<"$]RM%R!$#8IG(Q/>EN6'TQ0@G;1)^31.,
MV:[ 5AFQ?RN2+)(3;/.W!G'=!*-;5G2.,B*7@0)PJL"67_F ]6Y[A_9_ 7;^
M![:'O@^UAGY"*0Z!^<BP\LPY'&;PRTT*G%J@QF9ND_:;K,IKH'/A;ABG%N=V
MA"J4*F$VU:R?YC\?"(YJN]!IWMR<-^%M""N]LIN5LER@H5!H,+!0&\IB%-G$
ME@M741;UQ@@1F<5*0?0(.# *L))('@Z=YU8RX/:BC#'V?B6%'!J@98@*WH<.
M6809+)%&**14_EUW<K [_Y<XBE 63H@:18VV ZQX$\2"!U_[0Z/.H2S^AQ#!
MAIS'3^+)O89+$DJM$ZTL-BZ>P&<Q<^,UQ+PV(RJ B/A][6DGQ,;%Q,LU99X:
M#_4TT>=WV..^B4> /]30*P&X@RH#!EMRXP$MZ!C#DH1_5U.+R/GK!#-HV<H[
MB,K/<5Y8T]I:@\V!M@LE8>4/0BKJEAE=-%UOA^%#K4/UH_V.N&8^O;B@8O2-
M"V*^R/[O"YL_F[+KMMZ_H2;"+2O__OSR8,Z LMM6]?CHQ*&_W;2EZ8ZJ5\U5
MDQ<:(U6*1TA_G(>OC0&[;#M3:$J7/L-?]K+486F^+NGIM_C2/#Y?6J_I5A@Q
MG:!QDKN0-$B3LI_V> 9.]VO(A$JF"P[?Z,PTG]Z%!S32OTGC@9488N*66M\N
MGUCH&^J[ 9\@T/.!XFNB@5VYT_599+H95X\K<Y2!BC<E4+,Z;GT<C3O:>[JR
M8;3/YQL=B>JVH8@X]M(OM"!C-U%8<UMS>T2WK15I1(G>$@B6!(+H(U;8>V2+
M"%H@8C@0L77)EX3DI#3JU%UI^7D"TD+3661$+"-W\#[D39$H%Z>)%.4LT"B/
M2\C/2X/?LT?Q]=?&AQI#YT/G0BL^.PT+6CZ&OCM7K;\X<*BM:LFRIH</U)3.
M3?5\>:?5;4OO?_WL1WYYZ:/0YWM>@QY?'828*Z?&&;US^DV<$)@>F.#^XN=C
M\ RD0!9\]?.;H6>^#UT^>K&PI/[4VV_!B$<'#ZYIRQ\2Y?/W'@'T_LW@7+4_
MM#!T/+3CA?MHTCT+NQ:"L*SN]OH-A%YM06V=C0A<1@S>9 SH)I:((\7)XESQ
M+O%!\6GQ%?%#X1/Q:]&J\&.^-:"47X1SHBI[5%46&)M(503:Z*84[5T EJDV
MT5N-5%&@R&$I4Q0B,@DT@:E4_I5?!)7.,-:KYU2JODF7(J9E,!0&D>CLG!A_
M2S FVN0IX3R2+Y($"92T< #>AD\C?'5%&&SS*/L*O>2@J>/):-R3W:D(>-B$
M4&ICB&X&U]]_&C8D=!$&A]X0]UX:2GO3T6W;>)QV$(YX,X[8B3PVG>PV)LZ(
M!U=Z?%Q<?/SXL!'5NKB[I+M=DP+ID)->F;X^_5"ZD)Y.,F/C)J$;HID)\9,R
MG431;.@0BZ$4)L(L$.,ACJ%Y(WK* IO-MZ!,!F2SRPRUEC20 _BS:&Z=VS-0
MD=O9.7K?%AQM.S</FDC%Q-+MF)H//%B'3_02_# R?)GG%2"8[T[.\W'P$H8P
M=D!/DL>7>0_(ALC3]-3D09?AZ>>'SEM87S]QSCV'WGKIS;OF]N\Q=/[^%__W
MP9E#)T\-?2GNC4IZK>&>U[HG/#WSX=/3V>S,FP/YPZ*O9&3.&50VB7/A]5=/
M"\UF7FZ#D3.13F0S*1M!A[/A'M:']F:]/<RB1JN9E*DV%90"SPRQRG>;6.L3
M[3\ZFB#;B'(MM##X$;^*&]T&TDC.$1&E\:7A\"_$E;U =0 HFTWJ\?).QXM]
MS+" ;%B\"_:C$$OCEK]A4EIDM.>#+5=P#4]I,:U<'9JYUF83<9LK.\A#TT)J
M2F2Q>GUA%$[-M5G(7OGMNM")M[]L:X+X3?M^\[9$U=\8?.6.!Z=5/DOU[E=#
M4(+_.>"9#R_\*^Z^6Y:'WGWS]3<?X_BD%/7E;=07!]KS,T:CK/66ADLS]"_T
M,[JD6C0K564-5(MJI4J\KD=4R*E/<A E+GX2UY<^, (FP4RX'5; 8[ )/H;C
M\!/\!E:>9B[$#V^$V; <UL%&V 'OX(=6%;S0!>V^'L_W6>NH3DJ-LEHYJ0BK
ME2W*(>47Y:HB$B51H0I7,E<YJ2)A13M,))WO^>#:EM!)V^J#;9RZF-KF"R>3
M$>2;2/]:'&@*<I<IG,"$M0LE1]%-2*D9:,3Z [=B&>G94'H9!K]8,GW=A$G/
MO5;9?^7*NU<5#5\\^;I ]]K5XEZ[?^W%5W>%/CXSRVT[ZXY^#-37&C?&>\PH
M+!'VH1PMY#_&@Z*B\FNF1:0E*Y,D(NIBDI@K&F*5*/&G_,DYT7QG@[A5/"R>
MXM>R4IE@RE13)UF(,AE7W@E@Z= 'KD,1ST(1?P)?P0_P*V@J"(P2BRSAO4][
M])0$TENYM)QNH >HT&@^L%R^@[&)WF?$JG\68:D5Y5?Y *\?7S1:/V<*,7O1
MJ-_,)W4\<1M&G'SQUIF2-&7JY(NV_II<S06+ N7!*?,VY#*[LVO;W<7TEJYM
M:X;0[5GBWO.A[>=#]>=YC!:EM!REI)+7C)O_+"7$*A$!J(1?$]>+^G,=3,9Q
MBV%;%-:S=:AENTU1<#VS@2J8>B2]C@/F&*B2-M)S5.1C7[Y3+6]7&*VS><I>
MQ$<:K#O+=<8<8WY[_)"G]W/^SQ$.N,Q&=&U[K1\=VK5M[QP^N WGVQKQ-QZ[
M>D;,1$N21+XWKAL>-4&FFL5OZ1W%KT.I1%'!"LI'CG?CCSL^B_]GO CQ0)-(
M0DQ"8N)$H!X FI@T"5;SOKIC]!^_<O[DO.1D&F)$;F7RW MM+&:AJ"8F\.!R
M<B;5GX$780\<A"/0#*T@BQ %',<. !% =;ZH-]%[#<WWXGYS Q)#SW7/SF3P
M07(8.X20Y[=DEP"/ '&X *9+0J[46A<T(V?!B !XF(.XBB'?#/60NJ"YBH+<
M*7%KE)$>P0X^.;W#&A45!B"9?D_]<Z>%?EKUOW<\\CZD[G@/A.S3_3ZK/W#W
M@\M&#*T<E![Z!W.T/5 ^]>&7H#M(L/NCYI^2+CT0^N#POM>\\5V_0DD,)^A@
MS35UT*B0B<6B2*C0HJIIXRV*!U_B%(]G@H=?L5TBTJ3,<H!S:&F!J0HZZ4S-
MPIVT16!ZC66UY4T+R[$$+)7X=+_ED.6D1;98FJ#-\*OEK(KQ/,T+; \[P XS
M1<>7E.?6G#NMJL7'?-G7#$WVHE/AP!FO:^!>G*M,B1ET#M9GM_P_/3F_H5M#
M/^[.9\D\B\#N">747;S\Z\WPV4T7+U^DJ]OJQ+UM']'"2T.Y5^J+IKD[CIR1
M1XV;7J @TPR^%YE%U@KE*08ELU:$9--!SX0%<!\:W\WP!;2!QH"*H/-0-%_N
M B$ZX<X)O1$BF1P2(&6DDKQ(]I-#Y"11>,#]D>U"9''PJ&#0=#AF:4YQ<9#;
MTL U,PIU05YZT??RQ<L<>?#>]D2^?PY[ZR%/&B43&.HR'>\A'@^WBU3[,6 !
MRT5]8::HNET6FZ9XHC*)GNO9XMGO80'/>L])#W-X<I @>)K@1R-:S442\.(!
MY3!/:FQ =W!.83D*H"MX9&>4Q^>)BJ!?;O CLU'?H<7<9"'IST9HW(R=CD!>
M$T7E,QK&M0%H![1%M.V_?PD<VK]IA_ O<<B 8$8"6JLK*T,/_;!G2VJWA.RX
MZX8-RFO%40Q$31S(-1&&&1_?#D\+KPAL!>K+B\(>X4/AN/"C(,]2UTIOJ$Q"
M[?1),=ITZ3ZV2MO)CFL_\LOXR>:E#T745,VBB1;*+W4_7E4\_!+P_.*W5!@O
M:AY1U*C%$IED_"YLC6]D(A?F-I%??ITHW!=,1 /XB>EF?P6EB^E_9\$=^!+7
MAX5?25X15#2(LDS48K%4G"#N%3\0OQ1_$'_EUXV=*=XAKA3_PB]_UD17&':T
MD.VN00Q;2NOO+>6/OXL4^XK-) 6OZ@F4</3& \(Y!&UH)\4W \<*9Y3BW0=E
M12]12L+WI@V)Z! DJZC ,AMX^>)LV@U&MGT/#X9^#'WQXRA<"X_0FK:WK]Q'
M]_X6"N ,C$1P^ZF9 6\PRGZW$C(%-@G1@I@6\1!<$L_#1^@=?@2-&\5\%!!W
MI<_#3K277X'&4W4H'D&0KSD'Z7=#=EX;:GZ[[^M8 ;SKR?+(R[]^1J=U%?=>
M[LL]VV#4D+]C_ZSPMG&U*TV3LN04M0\ME@K54G&8>B.=*'Y@_<%JF\!FT1E:
M/5E!5UK7D&?)9OJRM$G^!_V'=%P\JOY+/:\Z)2K+@AH+?NI1LR&39EIZ2[VM
MPZ7),('>*,VA<Z5%]$YI.32H*ZR/PTLT>K/4).V2/Y8^L!Z#$])I= >J (KD
MER;2"=8GZ=/2":H8<H-\6&;I5BB7&_DSB5ID:F6BH%@)N4=6/#(_PT:;:+&B
M9;4B+I+NH8#LAPMK8CCZ0&4KXY< ED1N6RT$#:V@Z%;8AJ[-JC%[7[%8GBE^
M+!IYG\@_B9=$V2M.%&>A"6<4))G(@M4B"GJE90F:X V6 Y9S%JD6;?%)"T-+
M3%<:46JY6<;4(!P0#@L2$72!"@*WPC:TPL+_:86Y_ZX+\KOZL&*&=1/O(THI
MM*<Q(F&.B)+B*S-F!28A)@A[H+ZN+AA,3K5 JCO9;1IL^NO/V?M/7H:;NL"3
M,.WR=RW"AY>+<-;;!'9I**^R!'(=SCUP5 ,]C,W[Z5:9!FBN7$EY,<!JVB ?
MH@=DU(6^T@?2A[* HJ!4%@4NXHEA$:-AGAB> 9[5:1=W1-)A,:NERD1EEO*U
M(J3ADT7*2D50B*4/KFXNXMWB)^)/HIR'+PZ:\N9UC;*6R2\%K=?("^75\@9Y
MORP&Y"WFAF-!1OJVRG#_7N"Z *:X#7[M592WK)FFMK/4?[PF]0AJJ LZ>5UF
M7H=)B'C SJFC:\(N+KX6?JA#00-WB>#.%Z0SH7V;SUP^ T,VGV''KV2@'<YF
M1SE#>?3J:;$+XBH'22"SC*()&GBUWO'#XYG&)"V:,959T%9:!4ECBGNA58U=
M*#+?@G,*&,IZ92NZ$6&)Z3WN-6SZ@OVFF6,;S-3 /231K&HQN4-[EAP]'V=;
M[EY%+I*?1YPZ-6%..'J.)"'#Q#F/&F.@_Z?'P?]AZ-CV8TO6G5]?/WG'?6.'
M+YC2= \-O/4A&B9+:%?H^U H-/+PXZ]#]+-O-T+I2]NJ)ZT)O<E'Q?G"TZ@S
M=N(GVXPIX[09VOLB<^!+/R'CPXC09I^DYSH,!W4X(-H_B5&N#$H&[4.OHQ/I
M+/HXW41WT7_0$_0L/4^M^702/8X*1/P( $#W+ AO+6=\KN]',U\%M=  !^ P
MAXC<YL6H\"= W,ZA3!O?#H:#?T##@#.''"I,S64I&XK"E)SS)RBY>!E^7+EF
MXISU\_IN6=]UY.[[QO5/NW>;N'?T"W>L.;\PRO+?O/LF5*9%<2FLO=I/3,>Y
M]9(>9+LQ:'@B]+;U3AQN8YH6K?F<")TU*SK+(<XAK@IGA4MXS/<;4)7S(=<0
MWW2?Z((TUBW3YQ&BNG=/BU]H95%-\):1D[:0J=U]F<05)7FZ=4OV>&(6G'/
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MOD!?8 *RO(KVX@B2R8A6(VX1D>7M,L'E=^2_1.2'"J80=B.91IXB7Q)!B"0
M:LT"5ID'YN[LJ @*[[7E>AU)"7:B<;R_ R^?O=)>"52":K@=K7T6##96KX!E
M6J.%]11[6H;3 >( RWBQW'*3I<ZBYF279]=F[W+LCMT=MSOC/?@"U%^RP95
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MF@ )7-S61">Q:(D)4;&NS&Y<F#U7IT%E&J0])7SC2-BX.A8J8R'V*<=+.5I
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M3M-).M^.2KZ&Z40BEEU ,KKS4_JR"PBV,O?YRB/Q6S/-;WT([L!O=1D:.)*
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M>?@V2(+# 8>>""=TK>D*.Q?5^E_RG?*=\_WDXV;XEOH04=I\+Y!D#I+,@)X
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M]=P\=A#@7X2SR<"%45>@ PC./@C>-QD;4->PQ6PPF(QF@X21M4>/WF8=32@
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M"Z-.2&WS=3 $[0'U$^Z%'=]0SDW:JQCAP)/*)]/WH!SXA-)9*81?P;U*5Z6
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MGF*N*LL<,,A5R+VP=GS;I)3\!7.S<J@_,O<^>I[?3&@=.(  F4Q>.X3IQ-D
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M:5O&]I^U>1P.3IRB_*(\ -%9Z((3C<;+D6V0/S9^:3/84WLOH?E=9, P<AE
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M.XX@E!:VX60.A7UXBP]#ZJ-Q"4<.KUO:';,L4\G3W!!FQ6I@<'XE3Y-;V+U
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M;N+F1Y%1?#6IYL6A9(1P'G^NP',"K@#.7.3G *4BA!-$F"'5"%.M!^%%1(-
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M(I8B6^C>D$AHA'FRFKI.-,KP#8]@(:"[5JS6P3A9U-D"H"SK- *#]:CS3AS
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M_*I9XV_',PK4UW=<U[$F/&-$N'9E ?;>>WWW55.".37%XP&OROJ/DA\ KUQ
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MLQ]^@ M$*RL-0T?>=0TW\3<:D6.JNDO8#^TJ1"^&NQ19-MCL]H/:FDP'3S8
MM3, "UI54.@J*"@<Z".QV6L,Y!1@V23FVQT.:[-3SF].,QH-J# [2W+:[,1A
M,)K<#F&TC&5<B.0484C!Z *N("L[IX ?$I@)/39(-32@&6(R'?"1H805[73K
ML $<H$JBA&Z)X;/6?V?H1/)2O(O6#1\;G+M[_.@+\JZ[;: G5QA93\)R$.^L
MDX?R'13;)V4M.$.G4OF51G6?SE9,%YH9+M:U356ZMFD/59KO,<JF/9QHCTC(
M8J+G:9<9KS;>:MQI?"NF;-+B!9^FP:&Z)MW5N*9KHHS>5#]'9F#_VFM?O"GZ
MSFU;@KL^N' 56?RB.O6:-0^^1A:K->J/-YX]%J@Z"'#"G_A<-(I;QG1,!\B7
M3.*&Y^0&J+$!.1)T3/JZ9J0U-NVA%C&B-2*9,/??=4QTS=)J:-2DT2S+BT=G
MX,#EU^ZZ265U@\4+JO; 'OQ'5C%*,63@A2X$'MF+FE^ &CT7+@_C2KP&;\8\
MQ@9;):48[GJ;L55:*5TC[9=X21+J#1)"DI>+S#1W LTH DXB(IME5\2I[4;6
M@?16XAADPL0BY=5YF>8IE"!@TJ4BE_%%I7BA_>3Z^G.^7H&]#[ZF?O'A=2\D
M?6I>??WY>,<3>0<N#^+@\;^J7ZB;=SWNW?8+[3M?_Q&A&6KN0&FH)EP, ANM
M<I5VWA75"P(FOGHK7?R=]8K$$]$=$1T.E!HQ8>#H])ZDY^'Z_HN6B5G2A&+!
M:FE=$TR!\=2I1W8>.7?[\.^V/;U/_>*C>_?*^/"B#3/'7W(QWJ;.AMY>\-=_
M?OV>^I5ZR3<? L/PGU?F]^+)5QZ@6J4=,/)O,![4AVX(UTXS8][A=!),UW.F
M6I*H]:IF*6*030*_9[4#.QQ8D3DB.X$QI=JE2\@Z<AO920X2H8+N(KHCU$J!
MZIONM0I6V2!9>26HFR5HIN=Q]IN><2@K.U79I''<J(XQ:%F95AQPCBIE'K.I
MOHFV&Q_"_WKCZ+0+SVFZ0?W\C5'GCJN[#U\=VKIW3CL]]X*W/'(<EU8'K1L7
M;/J;FH_S'SPG')>OF6WD9-V.["G-VI%P@4S"H4!VFIQH.>A19S&_C87HF7#.
M,&H/(Q8R]XT.ERM&_0H+=;>-J%"FGAMWA,\=\-PXM"#@X@N-0YK-4GJSSPYL
M88KLRJ)N&^E"L1_D.ZX0))U BOB_>&T,:L@1+4GPV5A1?IK(0G>;:.=9?L]E
MH\C%'9]1T]D$_XU_7IR\A/IO').BOEW(_#?.2 E[)BPL6S C:]30$>EEING.
MLN'C+AN1D>C-<<R5:ND]ZO&SSAF:T6<K_VPZWM.2-C*\YK:=ZER8&Y1G[F4^
M!10T-AR@)W<T&8>ZOQ9X6&7V"*+(<4B1Z=8A4[FRMC*6#RX'G$T[0PIVTI;@
M*QXYJ1Z/_OL%[K%\M>(FS97 ;Q?R.9^>W$4I247_4::+2T9USS3;L$)5(,.I
MZ6/84FE9:R$6BZG>89Q'M8BDWBM)DL$2"5+?7CB"4*JH&"))^LF;OC+-3]ZI
M],/;QW!3LX(,25F,X]"B/6@J.;+IL&W5M%4I__;_ZZH5YWX^[:V;'MZ+TSZX
MY47N(]^V:U8]D7Y@7_&?'CUV "?CI3M1S L:X[ZKD7X:A_EZ=%-?C_K]'Q-M
M>K_Z+S:]_5/4\W7KR?.8)1+(F2+5(GE0!FH/G^VUF'UFGZ_*[0&^AOJ]KC*8
M7 :#R;L'NL8M[R&*;X];]J ]9I.8&G$X CZ/F;B!CIF06S"<;OP8HU=GL'[$
MA$O<_#YMX<(?+QCY]YF+F.SI741L,W#&Y=>^ (O8S?<%7_S@@HNI)*J^1R71
MC5REMF:02>HJ?=7@$)UVMT/+'##::\+GFD :,1L="!F<'*8K1I4!0<N0#7AN
M?6_+Z+0[G'LXSNK:0YW;4J<]HB<BBJDN$%8-9JO-P%LTQ=:IAH]]['CJ8 D-
M&KF.2B'P8QZ+=/<<<=-'C]Y.;O_1&9^]=..+6Z.'9ZE?5_[KQ2/G8O>;L!:>
M?PE="U=O^)_=L!96T.LGH'%CS_Z_^(S%+_W_R&<LTR,Q>_&%NKWDAD2/W"F<
M<JKWH_?BWH\^1N_H>?W4^U%JHI>QJ6H+^9SIIVX(U^ DM\?G]59YD,OC083G
M#VJ:J0$9SM%,1",O6'Q(]GI,1M'G\9)*Z,"'$9D)T$3"$P%D'P$)0Y31RDR%
MR.Q8A\;EGG(,JWS0%$I<#JFD6\YD =I_ SRL3L1#A)OEK>N=^-(Y-Z4V?;,X
M:73!V9>4)55_LV-35[[:C:\O/93],%<9O7:-.1CNNGX5_H7Q^W1?\0FI$DG
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M!-Y5=;1&FA;Z+X@T1)K@XXZ%P<YN?R>\Z?8W=O9V1+I;FWJ&QZN8 &!6YP(
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M%%,/LK@G*R$]3LJ-107CY\9Y*F<2LSU9 5M/: [:J.02VLKFE^,>4?(?&>/
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M A_P@P H ^6@ E2"<6 \F  F@DE@,I@"JD UF J> M- #9@.9H"98!:8#>:
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MZN_V7.[IM&U+9QY8U*?%QJW[:N<./W'SL$W5)V4P^-RXLM%'@]:UWW?Y9,U
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M6A6W)COA4[TO>GC2P0J3<=%#2Q_:>LS>==V//^R:-:?3[MD/3R]^;^J(X>[
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MZ-OT*]2\0[\&Q0B%-^D]>A[Y/:!OTF_I!=#?T8N@>^FEPAOT/KT,NH]> ?V
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M BK A2O1R,PFM!@U+D:5@U$UM-G Z%#5KU?1H3>(.M%L4D?16:RJ!;FM3@1
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MU\VG=<GL#\JJP7@R!F S$C,1?^9RV/U./KLY^#K:>RXRF>"$[$&G$Q:7,1]
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M_$()20HDE"CO>4%?-!G <24>\_DD;\ 3"'L\B4! 211[T,IL#OA< 2.V/Q?
M999*5&_$;''#8!OT?@3PF.$E7=C= A#>ZT4-#GH^Q6,-0$ L>I\$YAXL=4Z
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M)QEFBQL&_)+DZ D!"V#IDZ(!V"T0#*(FD4B$X@%)@8!17R#D /, _!XG 4O
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M=\A=&9N];V9!SSLUIS;G'*3N5K7 $B7' "*=\>/BD&1&LE-,#6"R8 !M/&Z
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M0OVO)SN=Y9V&$3.>4AI;XTY7)[D%MH28<KZ>?!K[A:>3O,Y.H5&57N@D3Z<
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MY P-#36%EH<,%'0&AP:;@LN#!@N%! H*YCF^93YQCG>95R2?TS?4U^1;[C-
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M\+9CY<KNE%OW?50NG%_9@3_,L5-L6;Q+G-"RN+/I(AP4<1 V<L7$KHI$LAD
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MI[>\^=CN$1N(]NB!=<,71/Y$?_@G 'N9T"<9[3;T(^)Y?%9D+L*XR_*[,;W
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M1G_\.?I)5+W81+[?>&C#TFVC-O6I>0ND4P-^\$4VT\R-WVWD(8YE,;W!(4%
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M;ARZ0<,]'8\2X,'+X?I<Z(AQ%V_E;$2W>FPDP];%5FX;XJ'9R$K)XJ*W [2
MPOX>?<3/UR3DQ#(CN;,A9"BOJI97U3T%4IE$)*D)SS82)*:^P+G4><G)''!>
M=9)QSEGPZH"3=3:1!\ZZ)5URQ]65QHZ8PLYN!LK85EIA3AV"KM(ZIMLTU%D2
M Z$0'J ?<3K<>X=U9'FG(46>9PX]FW5N_<:#^*0Z(O>><.=IRUG;C;?_?/'0
M@5[0TX&@>9^:FO>%L7*]C$4VFQW(KF<_8ND=LLU;S'$,P\H6F;,0\\:HE0+O
MHC=WA1&2.9?,$+F=$LH2T"$+C!^H8+:I@Q9&QH2E=]66F!:*6V"L,:=BK0/J
MUDX1?XT^0M+;O^R%Z81'<;@ K%:/37F@TM(\.NU16NK0V] >G1_GXIHI4M44
MM5*Q-/9,!QF9ZHF+)< P%CSPQJ&%9..7D7?PGM/1QVX.!06]D[P<.7ES'_DZ
M^GTTG6I!+^!7=>8,]F0CZ99&TH@"II;-Q722K>.X)L(:3HB=(T$EGP6EY )H
M'$V;PM">YMO%S=D0-W^&X[7;0LFM@&D:D-#KQJ&KI"X1E/&O1^EU0'3GSL-U
M> ECM%SAKEJONAF.R")G=]G9/)PCIMM':I7Z-'&:-%.=X)FDR_/Q K5!7VE;
MJ7'/:F?L%YR-GK,ZMYWLT+;;'R?'I"/:(<]1790QI\G.D'. VLLVP#G -<!=
MKJ_45NF*)+*2["J71I/1SFK7*K+2ML:YRO.^I P@4YV3]7?))^)'RA]L[[O?
M\;RORQH)B$FJ9L]3"UR\)A6(%62<N(4<$+?;MFA;[ <<!YSO6:_8/G);)=HT
MX&)"G-5!?"(C6NWV%9SHHO=AE>5*B]5EL5B)V^%8P1%XDV"WUQN7NINS,D@2
MC9YF0+?8'5XD6NF=3RU>C(C#S4GTCI$P'MTL RRC+%,M"RQ;+1<MO[9\;/G)
M(OLLA99J"Y-BP19+$_[8<$E^#N=RF[F=W&^YGSEN'^@DC.(L(R-%HK @YE\>
M-R'0V^A?2%Z-=J,KZ#O$;HGKZ-D$R6(ZR]:A!3WU 2A*@$$.Q\T7WJ+,!!<7
M%-MCQ7UTN@I1=UH:\ZQQ_;W%^N-^-?X*AV/I\]FSZ^OKS:07F@TZXJ3%'9CZ
MV:Y.7L!I)GMA!MQX99%7*&[ 1U^_\>CB#D,[#X[VW+=0$YVN0]R%FP->.+'C
M)K,!7/#K/^*BS8_?[,D\^<#3S\V_.1HZ-!2\P ^@84[<T3@@6A.L))/DJ"$Y
M9 EI_7%OYWWJ(E5::]O)[5'WV';:'R./V86SY'GUG.-U@64(4:Q8E515=CB=
MA-Y06E8U!W':-1431;E?Q2Y5Q19%J51E.).)TQD?5$&S,N#U+3(,JJ(ZP: 4
MV>*D[MXBJW0LU?[J:'6SRMK4<7"XJK*JVD26 $ZEWJ-7&U)]Z19./>N2U/;C
M4A]N"_ZQL3!K,$+MXIK^;X0Q?C!I/XZ5-<0JU>ACM?7R:FNKXPW'QH*.!HUZ
MV!R&H3?V_W9,<7JN'MS^R(T#T?>&=+2D[P'W\O$_'ZO_U0LO,6-_+F>&?/G$
MYBLW5X*+V L8RF%6DB2BEXUA$"T87N)E-H%X)-WN];)&,AZ27.V\QW>2N4">
M<S8F"^GV/&_(V=]Y'YXDU=H7X;G2//MZ9H5]G6N]=Q^SD]OGVNYW[ 9-UP!.
ML117%<))PGR6<<RW2)YZ3< 50%OJ@$\V"ER*4 CD<AD0RXL"'Q J@-LPP"WK
M#(^M7M(@_FK4E=6@+:@1PO6?Z0SL;-#(Y@AH=[@Y/NL>R\G6TYGWDJ[!(N T
MA(4H1$I:<R/FM/O>UT]C_"%.>S'ZV<'U5S<]^N[6F>\]_-:V$VN.DEJ\[<;5
MZ&/1W_X4G?:[[;C#V?>BAW'5FY^U'#.S0)1S[P#]5)".?FV,R-:Z:?VT$>(>
M[81VW'5!$RVJKNB@7S&MLJK5 )*01S?1L@):I5IT!=3)49_"E_%U_#)^"]_(
M W@NY"O@E+W*8YYO(HN-5"F_'?\Y9)J_=!$,GT@UZ& ;LO"V<^FQ*?D8U9X=
MCA'MF'[=PM>EOX"NB\PD/Y]&:T_-A!!EU$"C__70TM&;OSX2?;?V(2QMV3*^
MJ+(N^CON0M]?S=D1_=?XR%/DI[[')PZNS@2I/-(RBG.![CA1%F:-63P(H='-
M[%'/JT14O$IC#E.9.-6RT#+/N3+K2=>)M%,9CV5)'.MF<Q,R4DK\??TC\'WN
MR8%%[OF!M>YU"2O\JQ-7I.QS[TO8D7A<.>D^ZV_*^#3+2_]@2,X(?-[]:1;$
M<!:+ E4L*U4L#YRDN3(R61_B@H)OOI4)SA<DI@D/-#H1B6-01EJF2T@F>KUF
MQQ7V&GN=G0)X+L5>:#?@]*#]HIT/V"OL6^R,G2J=/;E>D\?)I$;>(C?*C/SG
M;*IO,66+T.!O*EQ9<[Q^U*SW,&?X8Z5PL9HB2JH[4Z1.]3#+3,W=0NN9624>
MYL?N]_6M&UZW_H/HI\_AQ*,?X=1'_C1NV>^WS?ITX[N[>_4:-+C[I'F5PQM&
M+^J#Q^'0CWC7JU0WOXBN44;A_F>_PNAH],P[UZ+!X9T6=:;Z.03T\PT:H5$Z
M^J,Q3E">L?S.PCCTA/1TKPK\6W.X-. .;<%,]GG\"=6Z[O&@M'132[T:T'+;
M.0&#MB;HZ5Z'ILHLLH'2!NHKP%9IWN>2P%V,97YLAO<VILY3V$':2&S&;53]
M5B*(*F>L/I<J**7M%%NV5U3@@?;;$FBTBL*<IT#YK8KKT>,%AA[=24-//L[#
MC!/@)XDI\9 ;^*?'MJ85OO%&KXQ^':K/5';JD35BW(6Z]9\VK;BW>Z<!8Z/S
MN0OEO:N77OPBM;3GTN71OV+[_OOZY$?F,KG^(8L&]*I*HZAG?LO7[%30[D[H
MNE$Z@;M/G>&:%IB8O]C5X'V@4!PCCK%7!89G#LOA\NS] Q7%#XAUQ1O$=:Y5
MF7MM>[/.95I$UUF.J#E964WX12/!IKKH7;VRU!RV8*D?^S\*SO<P%1CC)E)B
M*,+\ BEQ7IE_B)_XF[!JI'2H+Y0WRP?DB_(E^8K,#Y%GF2\/RIRIGG(3Z?I,
M>KVS";N,-#R/SG89, P'P5WPMT:%:Z0#HM':%7S2G :<':8U&G2&,W+==)[7
MPF7-S6$:@N(5*S@_'EKHA+D>+\_(RLRB8C:+.\%MV'").;,%J!_&@*96J+.=
MOQ]G)V^^=^W!COE/K2H<><\7EU=?JL>/X+XK*N]?V[GS[W9,NR,:??O+_\$?
M.SI-&-2]_];I@[J55/5-[[E_4N.'M9?K K9@WT6]%DP875@X<^BDC:.:OO\[
M7/[;H-D'S4SP3J,/I9WQQ 0F7#5+JB'X"S$8S$G+V"WL0;:1O<1R=2QF62E%
MJI&629<DEH@'F4:&+&,N,02<PS##WSYIR?<$P='@ O#.5%Q*QNO#^#H0MA#E
M;.'ZUI0%K5G3Z/SI+?)&JRYHF@(OOAJ=F\0\DQA=\!GG/';LYV:X^L,M7YF\
M6D>O&/?H',[BNLG]Y%I^JCB/7RCNXHYQ9[A&_CE14:W62EEQR;*"":GT(!=8
MIJHH&*!EMC#?(7ED+T 3Y-$L\E+0A*LR>U'&LDRQB%\J\-SEJ?!,\,SV/.C9
MZ3GJ.>>YY)&O>+#' \9HR%Y)AF&2/5[*[TIO R:?T]1,O0E,@.-= H6(K_YH
M)7AP]+8Q/13&K?,-)5W]]-R<[>S2N00//K3/N7/>(Q,&%J\[N"UWR]L/O?9-
M*H"^^^M*ZK<OFX"SF:R;C_W4@I9^_>N[GP>Y7(%1_9=9A;/94$;*$\E9AI%L
M"IVV'VJD<$A.01A7QDNZ)"F>:Y!$D=!,?A/V&ZFRC$11E@AF$,M9)$DQN$JN
MQJ3R!SF><KSS>!ZR)&C7*._V%L1JG&FNOCG>Q=NS]'%''F1:T2W&SWZ];WV6
M97 A?O)H9#KT9N??'KXXC;D$%!VC=Q#B*6+UX='&-15)@BK"\+FY1)0@^ER9
MSDQ?5V=77[FSW-=$;VU.G*ROM[.WCULCKG:N]KWK_%!_U\=KS@1=\S&C\#BQ
MPCG:7>'C=C'[^%WR/F6[OMUW46QT-KD;??+#UH>U ][]"8W\&>M9VUE-'*)?
MU8E&[TFL!G16=^D^U_V*Y%(4R>EP5-H5E]VNB+K/=S\ONGA>-&5I+F7B%9T1
MD<,NT1D1GPL +RVM]/N '+MTI]WA2"Q7)BIS%$;9,U"?IM^O7])9K&.GCO4F
M,M/P&(!7:@# F/"E)_\@3YX&Z'(>?XS\9MU$!#!8,XC;'FHM*(_3C1CEL-^.
M=6^G&V*L>!"^!<^F?",<&PNWX,2Q(3$')<8U,$X<<"11QEOPS*/9 K&E]4C&
M(X]$]C^9P[&= ]$:@+MY?UM;@VN803>/[7^E:/S1?DQWP+T+&A[;TN]F/X1;
MW@!.:Z&, _UL3)8Q%G$"[FN9BEG)YL8B"U*S*!998< "-:L*@(;G64RW(I4L
M%D4#GB$#ON59@ABBJI4* \)G))D2"W-Y$B@MK5NE-Y@'_(<U"\\BJ0F'#8<\
M6V'VD&>0.L]0QBF70-07B .(3]BP#4%O(6)#5]&W=)K'=0%WPSHRIT/KPX-I
ME2F=+3>+N.-33K<4^1:!0Z:0@2E<%B^OILF'R]92RA@NBZ6M+^.JCL)I$F[5
M=JE5LEW(G=$GG]Y7D7'G$BR^'7D>]S_U:W]6!R/:2/Y,WHN>.7GOI,/XGH@E
M<@=^ZH[)_>Z)#@)K> 6DZ33Q\=?&1M$RQ$)*^+>L1!1 .Q@LL1QO87@@%DQE
M;&9>XOE*B^RR\(Q%MK3A9FSA.580A;CPE)ACQ_#7BD40)6D+Q#\ 98:\#"*@
M#'2<$#45XG-/<U^#1G#EWR$Q5OM!H^$6Q%,X\L5I];9LCH.F7<&KUX?UUD1T
M;,8_IIO67\KEK+YLO4RE20^MQ79MHL,,?G]\=-.3SW0+E4[%ODN1E\>2$F9Y
M=/B:Q]8<PJ=NSHQ\2/%$#OB\CB C#3UH^ 499VGSM5<5AI6A_YAU8<QB!<DB
MVX3ELT(U6*@-SHP4I5I#(JLX\ $*O22;#<F.;R4L20Y<EV+67CZ [ !2K]G-
M:CCH'4TOFY7P9:61/\/C>W/935Q+8E=?7(*[E@#VA\B%A:[%02''1C[,3!W4
M(?+/)*:'-7+_KJQ<,B-I&YO5K:-R;,_-T1\!PH,?LT1GD:UF-)YOE+$<-RHV
M< P[!S"DELUS<[(%Y,@6>!L,/ *?3F*3!5HK6&01.DB#+!+-9&/K[$ \+UY<
M8$YXAPM"_S[/T19OG3@HI.%BP8)+\0#];/2[LWITEC!P_4]OK(?KV]SR#7[#
MK!\O,0)>NB?5;27D%KR(K$>+F*W<DD]I]46$3KJW+R#'80Y\#A[U^IS7XQ7D
MN.51Z'..V><%1IF T*A8"2C+S1&R>8TA<S!HJ2.;@*M@>('C!$;,9C4D: (!
M*H(8:,(<$24&/&];G\.TTK/XUG2 J9".6*\UZ&Y97NEMG0Z6@.<K"7X5;?*>
MQ=H9+QX0G;6>[[*>CDE'\@SY!OK,HRE&(@&5'X4):!-A>!@?EG&Q+ .^BZ,U
M*(6&Q8#KY!CP6YB]0!H03QH,*64SOH()*!@@1%]"I-EANN[80@KPVN;$[.W%
M+VFF)[Z\"Z?.QZG;WR#/,,&;5\D(D-;U%L2<:J%+-Q(-*T9_)PSS5Y:$N=\]
M  *_IGUO%KMT*A2"[J#"/'>SS]Y:VH?OV6- UV@^/FA83H!"_;0,A@ZP&EGV
M#/Z:U7YHINKL:S;+/>@([3AXIH8]AIW19CK[V/(-T\#>B=)0(?K1R.=$'K@!
M,]>Y621>,4\9")Z9E@2NTK'-%PB,0#;069L\1[)E8C&SB0PVK.J<]'2=<2T.
MN*^ZB;L)IQAW.&IT(9@J=YS#6'A-MH92 X7I*F-#G;)M2/.]'1AC>SL;]0:E
M;D K6DOH"7*965?<;.@04<<4N+'[[=R)A3QNY+_C2:%9F5E^MA/H?Z=VR?;K
M--^NQ3C2M4A;PIT"%K,6L_16-2:=VVUNQ>HH/]Q*/V\MP[H3E\#_\9KJ+#K-
MZW8)%+7I:9E.7K"2>*J>+!^V94##GE$'MB\.!QWCJ\^7[!R'"W<VN@IU^PZU
MJ&3YJHG=Q@SLN^*>%97E1S?7[AXJ")HVJ+#7T)<U7+Y__O#ZZ(]+[BX94X2_
M\5FM'<;<,73LJ*/0^6XP%LM-+Y>"_FS,%@1=F&5;:MMLXPXRF!<]8@Y.MW1E
MBBP3G0W.]:[M3GD7<Y(]ZGQ"/^M\3N=MC#O1YK"G!)(9@6@,;TMT:X2,B%4Z
M@0UG)];P@H;D;'>-2I.M"1.'2'7FUH#?2MQ2ZA:;"#+2I%EH*=J,CJ)S9O[T
M<_0/)#E0$2IOY:MTD)33P5^84JXW<R@Q)!Q[;K=NU!XREYB:J;GX]+(Y=Q,O
M.J)P.$MP"NVR3KS =[NQ8TR_.7<L/+KJ\KC3 ]+&X!D5Q@.3I@WMMZ8 ,'+D
M^M"RCS[\3?2%?5^\CL]DKEX_%?O7;-VVZ<@"L(NQ(,TQH-E^=,A0# GK"K:G
M.%TA;U/+E=-P$0Q=+F&UVD*Y4G>)L!I\9&EJ^>ZLTQ.R+;8VX;1SCAJ+@!:#
M[6<:@80YK&4A,/PQ%X%WGK2-*;0:UAKK%FNCE=M,2[5(+\/AF7A)^%P@!=#,
M3,PQPGE<CA)!48$ZQHN$PVUU!;'U+G0U9SB,]=9"2%J:9,.Q"J-8=1+9LJ/;
ME67KSJY\XX%5)_##X_L.61J>5-YO!5[N_,U+'[_U!AZT\_G'E"FSID;__.2R
ME:M CT9!S_\*>D0GU+X_[4V&RVOY\33TS]G4\LUINS.$:=>[V[10E5 A3Y1K
M/;7)#?)<S]SD%4D[DN2.0K8U)Z$S[B%TD3M[.NO]A=YR?^^W065, B943!)-
M'PUSND/(HOO81#?R)O@LG&(#K#="L0&:LZD*U39)L-JHMA&+8M,"MA+;)ML!
M&SO$5F4J]0$;-\0V#@Y7;:P4L.$0Q.R&L_:)A4 _P-*?2;&9E3#-UV+S?[^L
M6*TJ%4\GT?0]%6@&WR9-W<SN A]O5V!-R$-+-BPXONKR^$/#)FR_L3:Z O<H
M&#SQGAEU@P>NJ-C[S,<?_QKWV7N1W/%S.7XA;\7PGLM._K1LPRJSO@J-!.DN
M!KWRH53TO 'XR(G\1 P4@F!T4"W##W)5O*HU))#UEO6!?9:3EN< G(F@<BI=
M*V6A96F+#^)&"!M-^!XCY$CT[P)0S*7,405O#6=Q:'XG"#6F:4EC"K4*[:#6
MJ%W1OM/X1NUSC6A:H69HC-9$ICWKGDAW^R02U;0T+1HVTVWQ:G1S26JL5MDL
M_PNWTSD0*M9OKX@#7Q>,5\3A8%Q0SVY-7SYCU;A'JC?^;OZNBY;($F9VQ:!M
MT47X+W4CQ^['4QW[YHR?_.:FYW#O'5^]<_>PE(2=^Q;A11F;-AVD:]] 7+3&
MT8.>-";4LI/MA - RB&'V^.Q ZS@D,ON!/CNM"O;+!:[QS,"<1!>.,5IM2C6
M1@G3+.LNIP."L(<NTM-R($CU1B/0 @#-?T!?H;\#64 #T2:@8>8D>/DS>GQ!
M"(4'9LJAM)2&X3)SM5$;1L5%7G.!30PR%;35SK;FR=)*BND"+% >6I[/VP S
MI3&#'UWI7>GS9W5K*)GN'U34H:/===1[=#^S=\.N_45]DQ[U=ITP>\--6MO9
M(3J2.0,:DH(*4/-YU!'\#2A'&E6.GO![G2U%6:2CO8=]L/TNUVC[,->4W"=R
M185:EIR=D^OF/)+N]8Z0/"Y)\LA9N6XVHT.-4] ]?#9>#+T\:N1FU"@R5Y-H
MDPJS/5JVU%4:*M5*\Z1UTB[IF/2V)-TA]9&(%G/ITXT$*3C11L8$ H7!B84V
M' "K(ZT65WZV4-*EPGA$I:86-FO;M>98AF-VO/#"5*3HM9C]V6,Y+Z[- &-+
M]_+R CB>X2C#[2R05EH*L==.<R%)W+];(6;>?<^#I;FIMH:''CR[_I6))\/)
MJT]E#ZT]=?3Q%XI'%_5:-W'AB#ZK1]38O7W*AW2_7+GY+Y_^"A?O>O57-UJ^
MJ5VV;9F7#)^_JL\LS*Q9M?O^"$5#W1!B%IC9W->,"EW,84FF!RB3Q'N(J#$@
M5R(IR@A5<ZFJ1D#*<1#NI?'1"?'1:[)..9L!3$YGL:2=BK93&8/40I6H33C/
M2,]!=Z-8B#S0%B2_ %54G*";Q&].'D. /).@QNLQ0(37Z^/5 +$9AGBB*.[/
M[/^1L[6VZJ*)3]H%28%.&\9E)S 0',>/W-QO\@.^:3MF><LZ#]XT*GT(1,4W
M)U>LFMM]9V0C6;X^HZLQ]O25:#?JN8J@IR^92%% !XS[S.4/K07I 'F)@, ^
M)2(((UCLHF^CUX@-TS)ICA=8&:B(C2U@0^Q =@9[/[N9?9A]G(VP<@X;9F>R
M2^&- ^QQ]B+[+W#GT.XYEF'[BZP^]:@WC_)P"()Y,<98%BY%@]NF5?):5Q\+
M;>4HU#G1ZF,ZYR^G;4^+;C^W_1S;_.:;-YQLYHV/:95KY^A(?,GLBP.]?C:V
MP=D9R>;"XAEDD65\AE%40LY 1()S%[S!G;&P@ITY8_;I#'1*L9SAA4:[[8SL
MS,;R&8W;QNX]4R5/D^\_(V^4#\AGWI;YB_*9JS*QR6?\<H$<.B/WAX_/W"^O
MEQ\^(Q^66^0SEF3XX,P+,B/W/^.4==EY6C;[&]MF@\Y\#+X>!Z4Q-$KK7$TP
MU&I _]EK<S$?G90TC08$L"T]LMM7G%W8+?G9'2^F%_28WIW*XJ<5>^T53[*%
M-TZ],W \:'X(-/\PK0;!C#%;0CR?@'2>]? X1WI 7B<SC8 A?[DJ9$2L*H1A
M&<*.X&07Q\G$8HF;ALQ(E %1^^!8WB)FBX( ]D'?%@46H(X6YM[@:&*QQ>A*
M]EKP7LN85O/X%7H1\39 8 5H"-C%+/0)$JK@< "=0A<1A_HK2)_Z7%P]:)X&
MC.1:.+:&C_(Y<X8#G+AI);>EO\S$ G=;M0A-,=!J$3,+%H[5BV!G&B,PH1L[
M'L&-KT0W?'[XJ;,]N LWY^"?H@V16A)\,;H?)$?W37K>U*5IQI *[A1'@'F-
M:-OH@T%4]5O[]%2L3S[H4V\T'!U!SZ%K2/2C*G0&,5( E4&;Y]!;B NADRR-
M1M?C^"6F^VV\U+S"#C=VM-4M=87(-QRB1@[ZFQ&>ES@O:15AN*2"/"./\:0F
M)DG)V5G Q24F(\?F<(QP>EQ.IT=*EN3D$8%4>N-&DI,3O^:,&CZA1E' J#&?
M$P@D)SN=#@=TPN-,#<!X.2_@!A3 #4:G; B>X]I<&9TP?1_P_G=(*02T3P(P
M7! G$(:>Y#KU0&QFOK4_UV/NS$P":?%_9L2E&PK\TDA9V^;E8\M^0R@_O[6
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MRP8[%;:O17!NWC)0<>3UPJG[HU8V,_+LQ/=F;R5+X<(P>@A0MY?NN8_W&BU
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MQ1 ]/GS:G4)7S],B(WNH0#<3UK[F[YO-LI?F]A[)I)%LC.%3[F,OB><93=4
M*Z<3*%)^7D=_9F[!UH?O<EGQRGV1]^Y9.JASM/:$YDVMFL+F1+X^M)\9>6/P
MN>G0KR!H0#7TRXZV&OI]S%K@UH"Z99N35OD(*J[4L$8Y4(:DAC2G)+.RJHZ(
M%1M(<H*<*X?DT?)"F<=JK/) .BOL HD G)0,F[H+S$ME,>.0G<UOTAW78L/7
MKJ@ A^,CB*E#RPN;BX3BQ*Y]C0%O%AD$O?C=HCOO*XB^X".'G-&L["'WY^.1
M_@UD>>_^ZJ[9D84E-=(!Z%4]C!;+_0'EH\5&7\[N=(YB.!?#<!X/>BD_/ZB^
MI-A37@HZ/8R3LX.WFZ*JA;9";&X;&YR2<BEQ<N8R[^3<0VB*EH]1?DI^83Z3
M3S=?+ !($[YVO?EZY#J=D*&E?=<<^JV]4.@29&LKRP=^ZKR3E,1V[;H#"R:1
MMQ(!@(L90\RWZ+Q#20SF;.I6U3T8M"<694R^.S_1U^N.],2,.T<-;BA2._5)
M\.</O[LP(RDKN0>9B'NO/'^N=+Q1F+,_8_BC[YV8E-/S2%7T?_IWZ)2S/Z>Z
MU\"/'NM^=Z<,>D_D?=&A.-&L9D@]CQB\T0#42Y@_X(,F6&/0$18Z5$JWNFZ&
MBX41V/=@=*CPT(]+P#<T1(<2NC:R "TP^KM8GA_E<+D<#I>NHY<P5E-?2K-;
M7U*=.NMR\!SHW9342\F3LY?Y)G<XA*?8$*;S;@7H*F)M@ X)0IVL4]0=A5J$
MEIE0IA^3HOV_B<\4%V]NQ)"'2\R8"P)M%5FF^1XM0A=,3$B$I&[5H6#0 1*L
M!0DF]"I-]V>6U?0NZY+NZ]3;EP@B+,A(S$HB$X\0$.&9LO%& 17A@?>>G):2
M,V7XZ+<>S@,19E?W'OS!X3N&=$H'"?8C'9G-S%SD03.,<AY[,)'4!)6PQ&)U
M$;^5S2"YUBZDN[4/&6"M)*.MM62J=3Y937:18^198E..,^)E&W/9]0_;<:2:
M!8I*$Y%HYO6@3C?OH'FD4I10<-U+MVZ P&YN7QL..[N8B#>V/XR;@H\LRB3Z
MC=R8/Z.VJKA3?L_.M8L+1XV>WK-H+.GXYH+4+@6).;W?G>WK=$=7U-(2V_]
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M<99GJ6M)XJ+ :O_:E$?]NU,.L8<\QWVGDIT2RYDEEQA@)9<4P*JF&^HD>V+
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M]STS:-#6']_H/C4Q?F?3 OA 3L6*LN=N>4U25GG/$;5C9Y/(6HO;=C,?LVN
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MUKO]/0K[#'KX'@]S<]/ ;0TGWU;>WUVVJ=^6A2>@'6X]VW6^\N.C4WI/[+P
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MQR/B'OZFNG2%(.;6F>KB%6)Y!O>4_;(=]Q0][LT, IBC65YX]J GFS*OZB1
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M?*_CDN-[!R<F.F"QXU74!WCA2R $_RT;,J8D\G S#T,44;8_,6Y23>VHL$N
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MWP=]/D+_>)%0'VT!$?IS $QT8.+[W'<1[+OL*"#S'1J@6'/*B6V L(8CAAL
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MYS-:]"=,QY*.I9W.:,GR\1ZOE_,S/L[K?<G'.GP^UF4/^CR\G^%XKQ=@RH/
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M[[O)NS'KN <5?'V/_U;+%FWDX.2'(/O(A3607Z0O6G/A$9#(YTQ)Y'-^!)^
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ME*'4W';YQ9OP1@Y7WH27YJ9*DAJ23^F._!B+1(^[6HORZ8N?QAYP9DD%6AV
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MX=ZU([(>#L[R]QT(*]BQ+7<Q.Z]DW;? N<_[*-YN,_",^&G%7!](!H_$O%+
MCQ^-G,0!B&2YW*@%Y3\!>P$G; (,E%_$(PN<P.\=^$>"<BS#8H&R(N"'7^Y9
ME81DO,R*8DNJ:>!A"@]Y/M538Z,,;3;5IPV)2^7'UY?(!U^W?AVO ?4:_D<T
MZ"*S!A36/S1: ZH++-! $)*J(!ZC"!3ZR+'=]?NO]+?TEX,-::]^!&^^;\M;
M7VZ%!S>_]S>NU^)5G/ZAWJ+?*>W>;_OE7>B&]2TI3#^+_NJ?EF]CBEM^)\+>
M?X&>7XEVR<,ZR46J+2Z-#<,4O="@: "A&?Q#V)Q9Y86%LE3!BT 1!<0QB&G"
M% T5P+(#,<.72,7M&_DB?@#/[.1/\G_B?^!9/L'?VGE<*U$\?D/K@(;&035'
M]N*7-:6K>[2,QX3U5S3G"Z(S$BW#U!WQLV\UX\C<8%'L]EH>VK >I5+C0,'&
M@4+VI^%@M<EBA=T.L6U <_2MBH6)J'U4I.*U4UF_.]<]W\UL<Q]SHQ+W3C=R
MDP+R5[%E:A)<NSU-DZ"CAQ3+<[Q?#0_IH0$-(^P+IC<<7K2S#>R<>.CHMN-L
M%MRB=Q_59^2,<>B=7_JC_J./;>\+# [,Y])5(+X212DW]$+"5XSUB(L8+& $
MEL%*KRSQ'!Z*(LDDR R+(Q:/A66+J7BY"-@4, YKTY@&#;6F79MI_6V=+V)J
M[/@'2Q=V]]_@IB\;OH1KO][1!HQ9IS_]3;JA3VP#3\;NOIIN#-.,K,.U%(0?
M$$'5BJF(XT4%V"PF(>&'MP%6Q>NBL@8A%?,[^0.8BB[R7 H_#K._#B/I,!AB
MF!J*[*\.Z5?IBOSPN5_.PGKLE92.H[R:P"B1(6I]8M$ K, #IL5N*[%/%)&*
MH UBX]OPXZL5" %;A2):L,GIK-'XKCR)L]S-'^+Q/]]%ZP]69+5 FY6-* .5
MD<K;"JL8.X*:W+]JDL!*XFQ(]<3MZ82SX02RSX \E#<]^N<#>NF7^@:X9R2Q
MH6?N(E;SYP]NOS*B@U/!T -X4N6F!RJGGJH;V?X).PM06\0-RF,]!FEE\@29
ML3)X<*IJDIJU@B&L&I!XLOV.)A$Y:D2R9:PBWQ-K+YB\R# N4?[V*T.(='0*
M=+2I&F9<;T^U.P ,<XK06.>V[]B)U)LV+U;:U='=/YB_U='7S^T)P:Q0=W59
MB E+Q5*)M%A:+RT/-%H;O">E@UX9X@6Q.KW>P#RG)$G"/"L#H8R5LYHE&M2T
M9*E&EKTU'L.'%B$NW(3.27[:O6@DVB>M,,U4+WMD1FB1PK1TE%-(P/T<3)-^
M:QI\_NCZ?\W:, 1:G_P80GV[_N/+/]D?59]XJ/XRVO%\QOL_ZF<ZG_U,/Z)_
MHB_612A\%CE^FB3SXQ5H^YI?@4?G!"G@[EC/ A_,<V<&$9_0*E"%(' L-L4Y
M;-#8)>\\A1$#-21JND95TSC<,(?MR2+6]-[0%8@8/BV#95U*8&G1R*6"#*P$
M19B( \1' B 9&Z!N:8 *6F;M@&!'S3\*X+ O/H)(?UK_^Y_TR\RAIO6']6]>
MKSL*&525TSH?+U8MO 5.T'?J[^N[= "KD?1YFSY*?^?#*_ Q;.<VF5G%#I $
M=L1R>TB]E&IUH?*PRD&GRP7L#D<YP+^!JUV;YD2 Y&8L77O!"J=3$WC@$%T5
M=N1PV9E4T!/<"D:!Y7["VYZ11:*C^VN*+8LL!RPG+:R%QW=;9%Z@]MLE*G+,
M0RW"MTE)N.O,M;@]EN8DOE&8 7L49MH) "+>:LZ,.( C:JE]OFOU3/WL>1A^
MJ$K_<M'IC^"G>HMMY&?GZX:5O9N.-L:>T&^'AW^76PAS'_ER^"_]F5SX]X*5
M97<LLL6QF>CI;E^ZY_JV?<.<P2ON!UE88@U?+J^W+PNN3V<WB]NT+4%FM[!?
M/20PS#R/!ZL<M39%2*V5!'\U %.2YB>AI.H&RT'+CQ;&9H$6BS Q8VX&RJCN
MZH!='>,<2,*?]G20XG#9VF52&*ZRM3*?6O[8BKI$<I))C462$H()NY+H3CGI
M/-,C?KQK%"+W8E4JWZ@[1C0/YHQCSM*'QLT<.7O[^M?U?[ZYZZ4]YX[?UT_1
MISU\?,:85<=JN ^6C&.'ZZU+_P__65_USW?>0I/>1YU_V0=[G5R^4S__T<+=
M)-Z[6]O73(3MC64%&?GRV/@>\KW)R^35MF7)W'9^B_PT_XSM=[;#Z3P(U#H<
M2FHMIWAK%>'I# @RJL,(GD,727"'J[I*W:F^JS)AM0USJ:"F,DG5)>(X<::X
M6%PO[A1/BD(*OFP3&1&+BU9O/AD^MBIK*K%=V>[[B1J;VX#H,N)]\/LL3R35
M )%S9K0C=J'1>U[=<;0):G]:LK7UX @W''9[M/I9QQ#^_BDC)L]"G?L?6OU[
M")Z%V7!YW9S7>+ZI5VFC_GENY^7UTX:.'$<P<[#]S.*Q9X(CL8=R@]'@!'$!
MFB.N1MN1L->]-_6(^T@J*P=#H3+#.2>%Y"#K,>'VJ@C&7GHMHX2=Q<Z=3H9@
MPGF$7#[;'^5[^%G:UI\"JC62DV>MWN"'?C_OK':Y4JIM? H?YDNP"#W'8P$Z
MDU^/)2K1QVKB?.^2 <[G); 7AKU-S6VC8)>A:)-I\J(TBF-6#,W81E[(,<#W
M>#:.P8NF+B[1W]W6-*NT=?#ME4-O'Y:S8LR_-STW5W]L4/C>46.GPD&*OO^)
MAZJ?"@WUEA7TOOVF,@MT-3Q473\C;]"-?4>-PGNC .^-A7AON/"P[X[U7V]Y
MV($\206.J6B""T^8BP?NVJ[.#4[D=/+!6JO"U?(,Q_F2076I/$L^)?\HL[+L
MJR[1QFDSM<7:>FVGQFL$<) P>(._&^%>K?G&N SW <7R2%1)O*I(XL]KCXX.
M3G__S3;PY:Y7H??$D[M6-=54+3]6RZPH>NT0NT/_&9N'773NTCLP!!?7Z6<_
M7?8$['5^Z>-Q?"^Z\P=0[]<AS!%).%$![!4[XV"SN>STKNS4%&Z!=8%W>?K^
M;'86"S5;9C=J;(>Z%Q0$B<5=9EK<)&; L+B[=>TZ/2?;E9.3G9*:6I:6[DK#
M3#P0* L68"N\(#W%XV2#6J8_- Z&NQ=W/]?]8G<VI3OLWKW Y4Y+#01%4,#+
MXWB^T[@NO-OI89YW01?NG7%Q7<4J<8EX3OP!<^)  1!9XK9Y*\@$<[IF=V-=
M>25Y2,N#>:GI*7E!;ES:S+3%:>O3V+1V!_I5:K[A,3,/B<G^HYZS#L@AO^HL
MN\ZF%VB)1)(J@)=L=B4YA,]WQ,MYJ@B;2QT\9132J4<AJ7I%_6L$-S3B1-^5
M6$KVS!C;Y<;49&=:N&K$D)X]DV9N+\^X]9:1&T=V'5Y^Y/"W$V9WZQY*]5D*
MY(R\D3=G.OIU&L9FZ;U@WP?MTRUY;\_+2AH]6G\>JC43K;H*_X4&K]2_A.,?
MR\Z9?CY/K947O737#?!ULLH_M7V#+N"]G@%FQ/H\[86-EJ<]398C0=:>5@NA
MQ3/+OX2<205K/9(H<K46(2-#LC/)U;.<2S!EX]W-5-N(8ND3JR7)7^V+JRBT
MCO(E6B ZH:88CK&H>=R7;^"LY)B@C +E;:E,8?OA)RS,^G;K+<-35^4_MF19
M_>YI)W;H7Q2L37^N;%+53-F%IJ*7UA;?Y:Q_<--]1\>4KJW_/;Q5?6UFV9TE
M*(ZP0&.Y1E*[_WK$A3=_'7$!\S\O%@"W8\KW@S.Q!_H+4]U/.A@?-KG]1!GC
M7$Z'H\SMPC::2[79IG."B^,$/$5FR*/#[2,@M(QDTWSU809B==3I G[14B])
M"/(NMX.YZ/P!\P15X&Q.KD0^)R/9CS54G\S/!(O!>L#8\,M)P!# V_#LFFN,
M42VN)&!F&#7#Y:X%MTE0)";$RKC:$*%^V\*;82]((L50W&>;P7A?WCAL0$ET
MY,2)?8,9O?,>GE;5<^*V83?</GPDH2D4F7UP]J8N^O==.AW53T!Y^7B=P.2V
MG6[[%XWSMH/*6!3/1)EQKH>MJ3+CL%.J9_$DB'90KUIYFUUELK7IVB/:LUJ3
MQFD\3W A.'J^:0Z-',X47[K.GW0U.@\YIH,K[DFJ*N\T)J!UZ9V5-!=M.%:W
MFZEK7;9[J;J5&;X+[;CR*5-GK",[@T:B_Q0[$(2:Y%>8+)3*94D%TFO<&?E3
M>(%]5\)&*5<F"MAV%8A_=+K!M62"2ZO(>!PR; ]A9TC$#["(HD)C>EALQK+K
MA4;AKU@%$J" [4!&89*8<<QBY@!SCODS\W<LUID2?,&DX$^QQL/ 8@9BBY[A
MUH%&<!2\!;X%G T;ONNQGG@2G,-VL-!AX8URN2;#HA8DC6TGOZ\.!+K6[PHK
MR8([(;$AB27C/?'I,%CWR>\VUNN3EI8_SF:U'&*&X'D:V;*/F=^RPJ3Z%33B
M:5ML@L1RG$CF0,'V?)G(X=GAVL-Z);F>/4=)6U" J!!M'_(D7U;B1 5!;-[S
M)< @YIUT6$(8E- Q&C[D-B!V&&/<8Z&9='TU3![YI;UF'D9$#$N?GO!XC]>5
MPJVW;VS>/$*?0;C? -A\Y5.LZV:!:Z,439S%>?1Z*,V@^D&?PBREU\/IWRG&
M)[WN3Z][8!MZ!+TNI=<4#8'RDPJ:#]A-GTRQ& T<X]_'5J5FAKMVS2SN.MY7
M=</,KL)LM%"9E?F8PJ[)VYK2(.Y-V9_''68/I_PN[ZV45_/^F/=5GH#%$K18
MK< 6" 958+66J4&7J@8;O5"UJA9;>JVD=*JU*S 0JF6ZU#)>(0A $]_L0EG5
MO#4(>-:C3E?1:K5>/:$RJMJM>K%KO0NY# 6BW<HE17WSB29-H0C;(TVT(@-%
M%Y*T$=-X-)5K9(3/&DXAC0(-!#L&4UZE<#>.O&O9_!WZ[H$/!N^NJ[CKH?D[
MVIX<L"A4]<N<O1-NNZ=Q3*OKP6WT#;;!+J_]XF7]:WWBV.&M[R!IY5]>A@&X
MO:(4Y;;^J.^X,&LU'/+=W)4M9^ #+\U<HQ_Z;MX*O%*ME"[)S(^AWK]!^AEF
M%:;3-/!BK*?=X70"/'_30TFN4"@)L^4R)\!J")!DN8P773PO\C)PLZ(:J$K&
M&FNRR\E+(J]6)3?#^EAGI 0#24PHE.%TN9G;\%)/!(_@;=D$W@4_ I'4FQ/Q
M?F<[\9=YQ!-#)5V[7$EU=&^$^DE!\5=4:\!B#G/FN";*==07N$3,,@D[R(I#
M)44,#.*;H?FV%SE_%O#?T/@]CXV?YYBS\5[;G#MW]_*-V++"55A=NN@FL=?0
M@V^LJ.T]!3W>>D_Y;?/7GEH.S[=J<VW=L#V7@48,)+,S%L\6W@Q8)YT?&S#5
M\9@#J7@JK(2%6667U2J3V#VL0KE<4)6$6DW#)"@J,MZ_%EEAUEJ?L*)Q5FAE
M(;*RVUW'7$C"C0UU:?;_-]\B-* !*# 4W:K&B!_V;TP)-8VM&+GU^-8!M14K
MMS#;UQQL'+ F#^IXUS[:=?VR6VF6:MLWW%C\_-E@9ZP0IJ5GL)D@*SN[#&1B
MQI/IQWJCQX<53!^![33R&F$:;]$\WH"8C;E*%>.J8LC29HM*5J;?Y[.I?'9F
M%@-XGS\ .(^FVCQLKF6@992%*2&!6357.1L)"\(K2F2L-_^ZR-($>BE>YFY=
MTXPH\VO6LX?YSA-?6E9-6;A[Z%QA54/%O%!-W0+[^+N>R:ZJ6Z1VOV'PYGZ!
MT1M?/G2F9O1;#U0/V(EJ6T>/S9EW]%T4;+U]6#B_]^(#J^'W5SZE\Z*?H?/2
M#9R-]:<XIIAUF.EG1.2&N[G"X6Z=<G/+LG)<65DY>%],-])TG"Y7*"LW)0Q%
MR6^5.MNKW I?%>I<%<+3="1-L2C V8S&QV[LE,,[L7+B\F-B<7%2UQ38#4C8
M'GDWC,*Y.9W";&[6P*Q164Q)%LQJUY_C4W<I,7.7[-2U4W1MP>7KWQC12ATG
MJWT?]*9');\VO<SX]KG;*!:.'[*HI[ANX(-WW3[OFCEFLUIO'Q U9['ETZP\
M8Y\\EK%PP/433GP=F/,S)_ <JP!KC;'"I^7C,K(1F U,:U85;Q[55H]EGE9O
M%=5ZA(U6M]A5/(@M=Z"I"(A<H_5#*[+2:?DM)RG!S4AC(E>%9)$H[HS^ =@X
MZ,6Y*TON?FRIOG#/@-BYR\.F,76;](GA=>.FOWH+4Z=/TNO?&#K4Q$+(9+-!
M#S27^D?/,[745T,D> K5=UQ@0JROZ1@U9;:5/+I:3QRCO)T^.5HBPKAO=#V
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MG:2!V;%;U$#0:@T&RWQ^E\_G)XJ*D44<J%=5GT6L9Y1@O4_V@WJKA0_ZK6J
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MTY\8H&B1\#HDQ778IJF@V*P7P+-FVQ2">!J2;.V^QT'Z9&K=^L!:3%G8*O4
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M$$)) FP@U+3=3=E-#$(@E-!)"$W:9'>2';.-W=D4$"01 @J(**!8, AB1U1
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M[(O0-:@8#4#7HH%H$-AT,%BQ%')I&!J.1H#U1Z)1:#1<,XR%JX+Q: )<?U1
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M "('B+_L%77_ **:OA'_ ()Y?\EZN/\ L!W'_HR&ON[XA_\ (@>(O^P5=?\
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M96YG=&@@,3@T,CX^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $,
M!0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8
M(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_
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M_P#P>7/_ ,71_P +8^*?_12O&?\ X/+G_P"+H _66BOR:_X6Q\4_^BE>,_\
MP>7/_P 71_PMCXI_]%*\9_\ @\N?_BZ /UEHK\FO^%L?%/\ Z*5XS_\ !Y<_
M_%T?\+8^*?\ T4KQG_X/+G_XN@#]9:*^</V ?$?B'Q+\,M=N_$>O:IK-S%K+
M1QS7]W)<.B>3$=H9R2!DDX]S7T?0!Q?QX_Y(?X\_[%O4/_2:2OS%^#]K:WWQ
M:\'65[;0W5K<:]8Q3P3('CE1IT#*RG@@@D$'@@U^G7QX_P"2'^//^Q;U#_TF
MDK\R_@C_ ,EG\#_]C%I__I3'0!^FO_"I_A9_T33P9_X(K;_XBC_A4_PL_P"B
M:>#/_!%;?_$5V=% '&?\*G^%G_1-/!G_ ((K;_XBC_A4_P +/^B:>#/_  16
MW_Q%=G10!QG_  J?X6?]$T\&?^"*V_\ B*^,O^"@/AGPYX9\=^'+;PWX?TG1
M8)M,=Y8]/LX[=7;S6&XA  3CC)K] *^%/^"DW_)1/"W_ &"7_P#1S4 >D?\
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M9<__ "/7W_10!\ ?\,5?%/\ Z#_@S_P,N?\ Y'H_X8J^*?\ T'_!G_@9<_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%&D^*M?D'AZ.9M&\4Z;KNHW]GINOZ=;MJ]O:W'^@_P#\$>/VMOCY^VG^P/\
M![XS?M2?!_QC\%?V@HQK7@KXI>&_%_P_\6_#A?$.N>$[W[)8_$7PSH7B_1M%
MNG\.?$#P_-HWB82Z3#>:!I^NWVN>'-,U"Y70Y1& ?I]7\+W_  ?!_P#)"/V
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M>\$QWES%X9NHOVH_%-WIZE19WVNV#_ ;2=.O)EQN>YTK3]2U2"W)8+%%K%T
M"9B1_3__ ,$!?!'AKP#_ ,$</^"?ND^%K&PL++6/@'HGC?4AI]O' EWXE^(&
MJ:MXU\47UUY:J9[^ZU[7;][RXDW223!@6*JH'X]?\'DO[&OBGXZ_L(_"']I_
MP-X<F\0:Q^Q_\2M9NO''V&WN;G4M*^#?Q@T_1]"\5:_'#:PS23V&B>-?"WPV
MGU@NJ0Z7HMQJFNW%Q;V.F7K-^8?_  0>_P"#G;]E_P#8Q_8;T/\ 9%_;<TOX
MN0:M\!6\21?![QMX"\,6OCRV\:^ ]:UK4O$VG^!M0M6U71KOP_XC\+ZEJU]H
MVA37[2>&[OPVNEPW.M:1-IS0W !\ _\ !X_X4\.^'/\ @KEH>K:)9V%KJ/CO
M]D;X->*_%TMG;QPSZAXBM?&/Q9\%6]YJCHBM=7Z^%?!WAFR2XE+R#3;/3[??
MY=O&B?U[_P#!QG_RKH_M%_\ 8@_L8_\ K2O[.5?YRW_!8/\ ;L^('_!2;]MG
MQE^V#XL\">(?AOX&^)?A_2+#]G[PCXB5)9[#X&^!=2UWP-H-Q;ZI!:6UGK,N
MH^+_  ]XXU#Q'>:=+J&G67C:Y\4Z#8ZE=VVC1LO^C3_P<9_\JZ/[1?\ V(/[
M&/\ ZTK^SE0!^='_  9&_P#)FG[9?_9S?AS_ -57H%?SP?MPZ)8>)O\ @[$B
M\-ZK;PWFF>(/^"HG[(6B:C:7$:RV]U8:MXZ^!]A>6\\3@I)#/;W$D4L;@JZ,
MRL""17]#_P#P9&_\F:?ME_\ 9S?AS_U5>@5_/U^U]_RMS>&_^TKW[%W_ *LC
MX$4 ?Z5'_!0C0]/\3_L$?MN^'-6MXKO2]>_9$_:2T?4+690\4]GJ/P;\9VEQ
M$ZD$%6BE8=,CJ.0#7\&?_!D5/*O[7/[:ML'(AF_9Q\&3R1]FEM_B;9QPN?=$
MNIU'M(:_OD_;F_Y,F_;#_P"S6?V@_P#U4OBZOX%O^#(O_D\#]M'_ +-L\)_^
MK0TN@#_2/K\#?^#H#_E!=^W3_P!>?[.W_K6GP&K]\J_ W_@Z _Y07?MT_P#7
MG^SM_P"M:? :@#^!+_@B'_P04N?^"S'@S]HWQ5:?M40?L[7/P"U[X>:##IES
M\$Y/BM!XOD\?:7XNU%+B748OBS\.9/#B:6WA80-&FFZ^UX+\RAK4VGE7/QA^
MU]^P#X@_X)/?M]Z/^S[^W?X$UCXL?"OP]K>@>,[BX^$_BMO 8^._P/U2]N8K
M;Q!X \6:OH.N2^&[^Y:RO]*UK2K_ $J2]T?Q%H^L>'EU.*$V'BI_Z]?^#'7_
M ))/_P %$/\ LH?[.O\ ZC?Q;K]7O^#H'_@EZ?V_/V#-4^+?PT\.?VK^TK^Q
M_;Z[\4? 4>GVIEUGQK\-#:PS_%SX:PK;6=W?:A<W>A:;!XR\+:9;QM<WGBOP
ME8:+9M OB*^=P#]+O^"2/@__ ()^^'_V&O@]XD_X)I^$?#GA;]F7XC:5)XPT
MB32WO;WQ5JGB62:32_%"?%#6];OM6\3ZK\1O#VLZ==^%O$J>(]6U"]T:\T9M
M#LY(M*T^P@C^>_\ @L/_ ,%L?V0/^"3_ (1\,Z!\;/#>L?&SXP_$[3+W6? ?
M[/WA.+1GOM3T+3KE[0^+/&^M:^L^C^#?!K:O"^EV6ISV&MZUJFHP7JZ!X;U>
M/1]:FTW^1O\ X,Z_^"F$WPE^/OC3_@G'\3_$+Q_#S]H9K_X@_ ?^TKIS:>'O
MC=X<TCSO%'A6Q\S,5K;_ !+\$:4U_'&9(H/^$D\$6-I9P2:GXHF,OQ[_ ,'3
MOG:%_P %WK[6/CE:W_B7X/OX#_9<UK3/#U@;JUOKGX*V.E65KXV\/Z;<-=P8
MNM3\7:9\3WMKFRN+*.*[U+ DBNHI[A@#[!^,G_!PW_P6J_X*F_"WXX_#_P#8
MG_8GT'X;_ :X^%WQ"L?B_P"-/"'@W7_BUJ/ACX?KX8U&3Q_!XA^-OQ 3P]\(
M= ,O@Z>]A%J?!.F^)I5FEET&5M0>S%OTO_!D'N_X:9_;H()V?\**^&&Y>Q8_
M$#5=I/N ' _WC7]!O_!23_@L)_P2X^ O_!)7XP:)^S%^T-^SEKMQ\6_V8_'O
MP@_9E^"?P,\0>$=5UBTU/Q]X&U3P'H2W7PU\(7::CX!T'P+-JQO/%0\3:?X>
M71Y-&O-#G!\0O!ID_P#/%_P9#ZQ8P?M7?MN:!)<1+J>I_L]> M8M+5F FFL=
M#^)'V+49XTSEHK:X\0Z7',P!"/=0 D;QD ^*?^#P[_E+_)_V:Y\$_P#TY>/J
M_P! /_@M-XHU/P?_ ,$??^"@FLZ//<6U])^R)\4M!6>U+K/':^+/"LWA34&1
MXR'C_P")?K5T'E4@Q(6D!&W-?P%?\'C&GW-G_P %>+"XGC9(M6_9.^"VH6;,
M,":VC\2?$[2VD3U47>FW4)(_CB8=J_N"NOVNOV.?^"Y?[!?[<_[-7[$_QJL_
MB7XLU/\ 95E\(>(VG\'^./#$7@3QK\=?A]X^B^%5IK$7C'0?#1U"ZM?$W@R_
M.O6NCS7D.FMISVEU>0W$\:T ?YSO_!$?_@M-_P .:O%7[0OC"S_9@TG]HO6O
MCKX?^'?AJVN]0^*DOPNN?!&E^"-1\6ZIJ=M:W$'PX^($FL0>*KOQ!H\MW#C2
M4LY/#%G(QOVN%^Q^O?\ !:__ (+]#_@LC\+O@GX U?\ 9 T;X ZW\%?'VO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ\TO3M<TK7='_L^[TO7;*UU+3OLLMO$$^CJ* /XHK3_@R5_8YA^*<7B"[_;
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M/#5E)#I\=O%<RWERDMU-]IT4 ?F?_P %._\ @I+^R7_P3>^%7@?Q)^V9X?\
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MM3\5^%?&N@6K7&N^#-+M-1.H>&-3$VDSW\%L+2\EM[^U^NZ* /R:_P""5?\
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M9M0TG5)DM9+7^KNB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **_F9U'_@M?\ '_XO?\%ZO#'_  2H_9&\
M#_!#Q9\!/AO8W[_M7?%WQ?H'C7Q!XW\/:IX*\/ZKXG^)=GX#U;P_\3_"GA;2
M(-$O;GP=\*(9=;\(>+KBR^)>IZJ;VUNM,LEM5_I)\4>*/#?@CPWKWC'QCK^C
M^%?"?A;2-0U_Q+XE\0ZC::/H6@:'I-K+?:IJ^L:K?RP66G:;I]G#-=7EY=S1
M6]O!$\LLBHI( -VBOX;/VY?^#T7X5?#3XB:W\/OV&OV;Q\>M#\.:EJNDWGQJ
M^*_BJ^\#^"_$EQ82);V^H> O!F@Z=?\ B;6?#5W*+B6WUKQ'K'@Z_N8(HFA\
M/B"Z2[3X[^!__![M\=K+Q1IT7[2?[%/PD\2>"Y]05-6OO@?XT\8^"O%&EZ5)
M*X>ZT[2O'MWX_P!*U[4+6%HV6QN=8\-VU_+&ZG4=-297MP#_ $5Z*^0OV'?V
MYOV<_P#@H?\ L^^&/VDOV8_&8\6> ?$$UQI6IV%_;KIGBWP/XLTZ.WDUGP3X
MYT SW$N@^)](6ZM9IK4S7%G?Z?>:?K6C7VIZ)J>G:E=?7M !1110 4444 %%
M%% !1110 4444 %%%?BU_P %Z?\ @HU\;O\ @EO^P@?VH/V?_"WPK\8>/Q\9
M_AW\.O[(^,6B>+O$'@_^Q/%MGXGN-2NO[/\ !7CCX?:U_:L#Z+:BQG_X2#[)
M&LEP)[&Y+QM$ ?M+17\ '_!+3_@[&_;>_:__ ."@7[+W[,'[1GPJ_8Y\'?"/
MXY_$*7X=:_XA^&O@;XS>'O&]EK?B#PWKUMX @T'5O%_[0/C7P];S:G\0_P#A
M%-*NXK_PQJ;7NGWUW8V0M+^YM;^U_OVO;VUTVSN]0OIX[6RL+6XO;RYF8)#;
M6MK$\]Q/*YX6.&&-Y'8\*JDGI0!9HK_,R\?_ /!ZE_P48A\>>-H?AI\"?V'K
MGX<Q>+O$D7@"X\5?#']H"?Q//X)CUF]7PK-XCFL?VF='L9M>ET(6#ZQ+9Z1I
M=K)J#7#V^G6,)2VB_OZ_X)S?M&^-_P!KW]A/]E+]I[XE:5X5T3Q]\=/@GX)^
M)'BW2/ ]CJ^F^$-.USQ)ID=[?6GARPU_7/$VM6FDQ2N5M(-3U_5[R./ FOIV
M^<@'VG1110 4444 %%%% !117D/[07C_ %GX4? 3XW?%+P[;:9>^(/AK\(?B
M5X_T*SUJ&ZN=&N]9\'>#-:\1:9;:M;V-[IU[/ID][IT$5_#9ZA874MJ\J6][
M:S,D\8!Z]17\C?\ P;M?\%\/VP?^"N'[0WQZ^$O[2'PW_9K\$^'/A;\&+#XB
M^'[WX(^#_BAX;UN\UNZ\<:)X:DM=9N?'GQC^)-A<:4MAJ4\J066FZ?=B[2&1
MKYH5>"3^N2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***_B)_X+H?
M\'*7[='_  3)_P""@/B[]E/X#?"G]D[Q;\/- ^'/PR\7V>L_%WP+\8->\9RZ
MEXST ZIJD%SJ/@WX[> =#>QM[@;+"*+P[#<10_+<7-T_[R@#^W:BO\QK1_\
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M\-:?\(=_PEG_  CEW]E_MK_A%O\ AF;Q3_87VS_6?V;_ ,)%K/V?[OV^?[U
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M!\2:E8:EX9TFRUF_GUZ'Q[\3/AI:VMC-:WT,=I)I]YJD\DZR+-;6\865_P"
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MRJ00OP2_8-4$="!\??V9 "/8@<5\#_\ !D59PQ_LC_MK:@J 3W7[1O@RSE?
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MBPN1$^E:KX=^)?PCB6Z78P>$:W\4=&=,F,K<+ 0^,QR>??\ !F;\</"7C?\
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MUK5==\"^.8=&TO2=+L89[[4M2U2XO+6UT^QLX)KJ\N;B&"VBEEE16 /Y5?\
M@R0_Y/6_;$_[-;T?_P!6SX3KYO\ ^#RS_E+5X,_[,U^#O_JQ?C97Z2?\&?W[
M&7[8/[,_[7G[5?B7]I#]E']I3]G[PYXB_9OTK0_#_B#XW? OXH?"G1-=UN/X
MG>&;^31]&U7QYX6T&PU/58["WGO7T^RGGNUM(9KEH1#&[KX#_P '8_[#/[;/
M[1O_  4]\)^/_P!GK]CS]J;X[^!+;]D[X5>'+CQK\&?V??BU\4/"5OXAT[QY
M\7KS4-!F\2>"/".N:-%K-C::GIMU>:6]ZM]:VVH64\\"17<#2 '^BY\/E5/
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ML(3L1$_=VZ_*JKT4 ;.CQO%I&E12H\<D>FV,<D<BE'C=+:)71T8!E=6!5E8
MJ000"*T: /X=O^#WWPSJEW^S3^PKXRA$_P#8F@_'/XI>&=0*D?9AJGBWP#HV
MJZ.)1U,YM/!6N?9R#@1BZSG(Q^17_!+K_@U8T3_@IE^Q!\'/VRM%_P""@Q^%
M)^*+^.K'5_AI)^RK%X\G\%:WX#^(7BGP%?:9/XJB_:6\(_VL+Y?#D'B"SGD\
M-:-+_9NLV2O9@CS9?[M/^"Q__!.+1_\ @J3^PC\3OV8CJ6F>'?B&MUI7Q&^"
M/B_5H5DT_P ,?%SP:MX_AZ74IEL[ZZL]#\1Z;J&M^"?$EYI]O)J%IX>\3ZG=
M6<<US!%#)_G5?LN_ML_\%R_^#?B_^)G[+VG_  !US1_#7B;QFU^OP^^./P9\
M:_$+X;#QS=VEIH\OC'X.>,/!>N>'=/UI_$MI%HL%Q+X9\6Z]X8UF?3M.\[2V
MU2*[$@!^Q'PT_P"#.CX8Z%\:K+2O#/\ P6-^'NO?%'X0^,?"FN>(OAUI?[,'
MAN?QKX>U73SHOC/2=/\ $/AVU_;%O-=\/7.I:1<Z5JUF-2TI)9=+U*QU.&">
MTN8'E^A_^#W_ /Y-R_8/_P"RV?%K_P!03P[7YW?\$1?^"2/[=G_!0_\ X*1Z
M?_P5&_X*(>!?&WA/X;^%_BG_ ,- ZIK/Q>\*WOA#Q!\>/C!HNHK=^!/#O@SP
M1J,>DZCIOP]\%:WI^CZK<ZI+I,/A*#0O"^D>!/#UMJ4-[>/H/[!_\'A_[,/[
M2O[3?P$_8MT;]FW]GGXY?M":OX5^+_Q/U/Q/I7P/^$OC[XL:EX<TW4/!F@VM
MAJ&O6/@+P_K]UH]C>W4,UM:7>H16\%S/%)##(\B,H /UB_X-O]%LM!_X(F?L
M$65A;Q6T%Q\/?'VM2)$BHKWOB+XV?$[7]1N&"@ RW.H:G<W$SGYGEE=V.YC7
M\K'_  ? >'-2M?VAOV"_%TJR#2-;^#'Q@\.6+$GR3J7A;QQX6U/5508P)%M?
M&&C&4Y)*M""!@$_UY_\ !!_X;?$7X0?\$C?V(?AM\6O /C7X7?$7PG\,=:L/
M%7@'XB^%M=\$^-?#5_+\1?&M]%9>(/"OB6PTS7=&NY+*ZM;R.VU&PMIGM;FW
MN%0Q31NWC?\ P<"_\$H]1_X*M_L3/X$^&\^EZ?\ M&_!/Q'-\4?@/=:Q<0V&
MF>(-6.ESZ7XI^&NJZI.5BTK3_'NC-#%::E/)%9V'BK1O"]]J<T>DVM\: /JG
M_@C5XNT;QM_P2:_X)OZSH5Y;WUE9?L6?LY^$9YK61)8X]9\ ?"[PWX#\1V;,
MA(%QI_B#PWJ=A=QGYX;JVFBD =&%<"O_  7"_P"":T'[9VO_ + .M?'NX\-_
MM/Z)\3=,^#UKX+U?X>_$&31O$OQ&UB72;33O"_AWQQHWAO5O!L^IW&IZS::,
MMKJ6MZ7.-72YT\Q">W=:_P XS]FG_@H#_P %Z/\ @D-X:\5?L3> /!WQH^&>
MEZAX@\26OASX5?%+]G6\\:WO@[Q?J=Q=OKVN?!>YUSPS>O-#K-U#=:Y!'H%[
MXD^'VMW4ESXNTS2KRXU:^U?4/V2_X-I_^"+7[6?CW]M"#_@J1^W;X$^('P^T
M;P1XA\:_$/X=Z5\8M%U'P[\3/C5\=O&S:S;W_P 2-:\+^(+2S\0Z?X8\.W.N
M:WXKM]>U?3]-D\3>,9O#^H>'S?Z38ZE<, ?CU_P<$_"-O$G_  <*_M&?#CQU
MXAD^''ASXO?&#]FJPD^(.IZ6FJ67ASP;\0?A/\&=%N?'$6GSZIH5OK6F^%X;
MK49YK,ZYI,-Q-H=WIDVJZ=)'-<V_[AZG_P &/&EZ+I>H:YK/_!5:PTG1=)T^
M[U;5=7U+]C*WL=+TS2["WDO+[4M0O[K]KR*UL["SM(I;JZO+B6.WM[>.2::1
M(T9A]@_\'4W_  0_^-'[:5WX'_;N_8_\&7?Q&^,7PX\"K\./C7\(- C,WC#Q
M_P##[1=1U#6_"/C+P'IIEC37_%7@Z76=?TK7?#5K'-X@\3>'[K0E\/Q7=[X:
M32M4_G"\4?\ !:K_ (+U_%3]EG6?^"9NJ?#/QYK=[JW@-/A#XHU_3?V:OB?-
M^UIK/P_N8SX>O/"&M7D#30EM<T5)O!^JZXGP[MO&.I:?)=I)X@.MW%QJ4@!_
M5Y_P0T_X-Z? ?_!-O]IV_P#VR/AI_P %$?!W[7WAOQ!\&?%WPH30?!'P6T3P
MKHLUMXRUWP9XAAU^'QWH/[0_Q7L;B.S?P?$D>G1Z*%OA>"9=2MQ;>7<?RS?\
M%FT63_@ZE\5(P!5_VL?^"?*,#R"K?";]EL$$'@@@D<U_59_P:[_\$8_B=_P3
MA^$'Q-_:)_:AT!?"O[2_[2.GZ!H-K\.;HV%UK'P?^$_AN_OM3MM$UR_L)[J"
M/Q7X]UFXL=?\3:/;W4\.C6/A_P ):?=&'6X-9M+;\ ?^"LO["'[</Q'_ .#E
M+Q%\=OAY^QI^U9X\^"$_[3O[#&OP_&3P9^SO\7?%'PJFT+PC\,OV;[#Q7K47
MQ#T/P??>$9-)\,7VA:W9>(=235S9Z+=Z/JMMJ4UM-I]VD(!_I _$P9^''Q !
MZ'P3XK!_\$5_7^8=_P &9G_*67Q__P!F6?%__P!6C\":_P!/CXA6US>^ ?'%
MG9V\]W>7?A#Q+;6MK;123W-S<SZ+>Q06]O!$KRS3S2ND<44:M))(RHBLS '_
M #K/^#3+]AK]M?\ 9Q_X*<>-_'W[0W['O[4OP'\"W?[(WQ3\-6OC7XS?L^_%
MGX7>$KGQ'J/Q'^"]]I^@6_B/QOX1T/1YM:OK+2M3O+/2H[QKZYM=.O[B&!X;
M.X>, SO^#W,'_AL7]C$XX_X9H\4#/;(^*6LY'X9&?J*_OO\ V'"&_8I_8^92
M"K?LM_L_$$'((/PF\)$$'N".0:_CT_X/,?V$OVAOC2O[)_[5WP8^%OB[XH^#
M?A=X8^(?PN^+@\"Z'JOBC7/!4.L:UH7B;P3XAU30M&M+W4$\+7LQ\5Z?J'B!
M(#8:/J$6EVVIS0'5[ R=A_P:E_MW?\%+?VA?B-K_ .SU^U7#\6M=_9=^!O[(
MVC>'?@5XJ\0_!.+PIX,T?5_ 'C3P%X3T+PUJ_P 5+/P7H\OB[QI<^ =6:TT>
MV\1^)-5U>^T#P;JFIB*XOX=<U2\ /[?Z_P PS_@]+\!>(M$_X*7_  ,^(5Y:
M2CPMX[_8\\&Z/H.I-)NAFUKP/\5OBX/$FF1H3NBDTZT\2^&[Z50!&PUJ)U)=
MI0O^GG7\^O\ P<0?\$>]0_X*P?LI>'U^$SZ/8?M4?L[ZGKWB_P""DVL3VFFZ
M=XUTOQ!8V<'CCX3:KK5S'LTB+Q>FC:#J.@ZI<SP:?8>*O#VD)J=Q9Z/?ZK>0
M 'ZX?L6_%/PC\;OV0OV8?BYX"O[/4O"'Q#^ OPH\4Z'<V"O';K:ZGX)T69[/
MR94CFM9]-N#-IUW93QQ7%E=VD]I<11SPR(O^:'_P=M^,-*^-7_!9Y?AY\-3'
MXK\6^!/@/\"O@KJVCZ!&UWJ$OQ&UG6/&'C:Q\-;(UQ=:W+IOQ,\,6RV\+2,D
MES;V,A2YAFAB\ ^ ?_!1'_@OO_P2/\(Z_P#L3^$=#^-WPLTAM4US2?!_PX^*
M_P"SNOCJ^\"^(KZ\NY=5U+X*ZAXJ\):O'=66I7<-[J=E9Z1=^*OAWJ,\EYXC
MTC1I[C4;S5+O]8_^" __  0H_:[_ &F/VQO#W_!33_@I-X6^(?AGP?X/\?)\
M;/#.C?&Z'5M/^+?[07QHBO\ ^W?#'C'7] UZ&+Q!I?@7PSXA6T\627VOP:8_
MBC4--T32M&T^^\,2ZG/& ?T6?\'*OA^X\)?\&]W[1GA6[9WN_#/A_P#9"\/W
M3R.))&N-&_:-^ VG3,\@+"1VDMF+.&8,Q+ D'-?GW_P9*?\ )BW[7/\ V=E;
M_P#JG_ %?KU_P<E?"/XK_'3_ ((V?M8_"_X)?#'XA?&+XE^(]2_9^D\/?#OX
M5^"_$GQ"\=:\FB_M*?"+7=8?1O"7A+3=7U_5$TG0],U'6=3:QT^<6&E:?>ZC
M=&*TM)YH_P [O^#0']FW]HK]F?\ 8T_:B\+_ +1_P#^-/[/WB;Q!^TY!K^@^
M'?C;\+/'/PIUW6]"'PK\$:<=:TC2/'>A:#J&I:2-0M+JQ.I65O-9B\MKBU,W
MGPR(H!_7#1110 4444 %%%% !1110 4444 %8'BOPQH?C;POXD\&>)]/@U;P
MUXNT#6/#'B'2KI0]MJ>AZ_IUSI6K:?<(P*O!>V%W<6TJD$-'(P((-;]% '^?
M+_P;B:?K_P#P2U_X+=?MV_\ !*GXL7DMG_PLW0;ZV^&NJ:M>Q6\OCK4/@K=:
MI\0_A3J]C:BWM+6]N/''P#\<^,?&<S64<,EF^ES6)M28IUM/]!JOACXF?\$U
MOV*/B_\ M=_"[]O'Q]\%(]3_ &L_@SI^D:5\//C!I7Q"^*OA+4-)T_0I=>DT
MRUU3PQX/\<Z#X&\6QPQ>)M<L)_\ A,?#&OM?:/?MHE^UUH\%K8P?<] !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MY?\ _!9GP7^U3XV_X)M?M+P?L3>-_B#X!_:=\*>'_#7Q)^&&K_"W6-7T3QSJ
M<_PU\;^&_&WBCPAX?GT2XM[Z^O\ QIX*T3Q)X7M=$S/:Z[<ZK#I-Y:7=M>2V
M\G\+7_!*K_@[)_:4_9F\8_$C0_\ @I;KWQH_:[^&FMZ%HMIX&E\/:3\*=-^(
MWPP\6:!?ZBNJ[X[K3? ,GBO3?%5EJ$5OJ_\ PDOBZ2]T.\\.Z;)I=L_]H:L&
M_P!.6OS#_:+_ ."+W_!++]K#Q;KGC[X[_L1_!3Q9X[\47$MYXF\;:-I6K?#K
MQ=XDOYHXH9=3\0>)?AEK'@[6M:U5XH8D.JZG>W6H[8U N1B@#_.&_P""VO\
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M\>2[UWQ#HVH>$O'7A.36[N2;4-1T3P_H%SK-S?:U)J&I7P!_5+1110 4444
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MENI!J'Q*U.!S#;6=JK?W!4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"">T=O\ L[^-8(E^B11HH]EH _#3_@ST_;&_:[_::_:._;'T/]I']JC]H_\
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MZWXQ\9ZKJ^M7-AH>BV,-I:"]U&2#3M-M(K: 0VT"(O\ &+^V'_P4)_X*6_\
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MMT!V*@'^G?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&Z2'Q=IWP[T.74CJ^O64UPM[H3^+O$OB/3_#VHVEAK.EZ?%K^GV&KVP!]/\
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M)9F)VI''&BDDG"HHR< 4 ?YCW_!7&&__ &EO^#LOX6?"KPC87&K7/AO]H?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK]9:_)KX<?\ )0_ ?_8Y^%__ $^6-?K+0 4444 %%%% !1110 4444 %%%%
M!1110 5X%^U=_P FN?M)_P#9 OC%_P"J[\1U[[7@7[5W_)KG[2?_ &0+XQ?^
MJ[\1T ?Q*4444 %%%% !1110 4444 %%%% !1110 4444 ?3G[%O_)VG[.G_
M &5[P1_Z>[6O[3*_BS_8M_Y.T_9T_P"RO>"/_3W:U_:90 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M -/EC7ZRU^37PX_Y*'X#_P"QS\+_ /I\L:_66@ HHHH **** "BBB@ HHHH
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M?VF5_%G^Q;_R=I^SI_V5[P1_Z>[6O[3* "BBB@ HHHH **** "BBB@ HHHH
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M.G&UM)-(U"\\5>"M7N/B=)J<*'R)KFZ\27_B.;5I)6$YOFN7G:.X5]GXJ_\
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M06D$]U=316UM;0R7%Q<3R)%!!!"C23332R%4BBBC5GDD=E1$4LQ !-?R]?\
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M[.G_ &5[P1_Z>[6O[3*_BS_8M_Y.T_9T_P"RO>"/_3W:U_:90 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5S/C7_ )$WQ;_V+.O?^FJ[KIJYGQK_ ,B;
MXM_[%G7O_35=T ?D;1110!^5?_!:/]F[XT_M9_\ !/?XM_ []G[P9_PG_P 4
M?$_B+X67VA^%_P#A(O"GA7[=:^'/B3X9U_6I?[;\:Z[X;\.VWV/2-/O+O9>:
MO;R7'D^1:)/<R10OI?\ !&O]G7XQ_LI?\$[?@7\"OC[X/_X0+XJ>#=0^+$_B
M3PM_PD'A;Q3_ &=%XE^,/CSQ3HC?VYX+UOQ%X<O/MN@ZSIM_ML-7NFMOM/V6
M[%O>0W%O%^H5% '\QW_!+']BC_@HS\"_^"FG[3?QG_:5\,^-]*_9P\9>&OCQ
M8_#34-<^-_@;QWH,U_XH^-?@KQ'X&33O V@?$GQ/K>@M-X,TW6);.:]\-:9'
MI%HDNE74EA<W45E-\Q_\%3O^"<G[?7P+_P""@W_#RO\ X)R:+XB\::QXLN+/
MQ%XDT7P;9Z)KOBKP9XUB\*_\(CXKM)_ FHP8\9^!/'F@62W5Y%;VNMZ@NMZO
MK4%Q;66-#O#_ &&T4 ?Q8_L5?\$S_P#@HG^WQ^W5X-_;B_X*B:%KWA'PE\,]
M0\->(=.\.^.M.TGPIXC\7W'@G4IM:\"?#OPU\-]#6UE\&^ =$UZ5]:\1RZ[8
MZ9-JXDO+9;?7M2\1ZUK%C_3/_P %'OV+="_;[_9'^)G[.>IZE;>']>UN&P\2
M?#OQ5=0/<6_A?XC>%YSJ'AG5+J*(-,VF7;FZT#7OLZM='P_K6JK:#[482/N>
MB@#_ #V?"_P'_P"#A/\ 9\^#_CG_ ()T^ /A)\7S\%O&4_BG0I%\->'/!?B#
MP<FA>)[R\'BZS\(_&ZY4Z?X0\+>/'U&YO]3L;GQ/H=RRZCJ,XM-&O=1\0)<?
MU?\ _!&__@G5<_\ !.;]E*'P%XSN=(U/XV_$K7W\?_&+4]$N)+S2K36'M(M.
MT#P=I5](J?;=-\(:+$ML]Y'&EO?:[?:]J%H/L=Y;@?K/10!^5/\ P6<^*WQF
M^&_[ _Q;T#]GOX<_%'XE?&#XT6R?!GPSI_PF\$^,_&OB#P[I7C2UO(/&WBZY
MB\$Z9J6I:';:7X,MM<L],UR8VD5MXGU/0(HKC[3-%&_L7_!.[]C[2?V/_P!A
MGX-?LT7=K"-9L/ DMW\49[=C)_:?Q$\>1SZW\091/*&>>WMM8U:[T;2GD7]W
MHVF:;;B-8X%C7[THH _@ZM?@M_P4R_84^!?[97_!*+X=_L._$SXY^$OVH?B-
MJTWPY_:0\*6.MZCX0MO"&N6/ASPQJ.I7]YI7AN]\&VMSXB\&>&=%BOD\5^,_
M!)\"ZK/J4VI6^HVJ6]?UR?\ !-K]EO4OV+_V'_V>/V;]>FM+CQ7X \&W%UXW
MET^[-_IZ^//&WB#6?'WC>UTZ_:.(WVF:=XI\3ZKINEWABA%QIMG:2K#"K+$G
MW#10!V?PX_Y*'X#_ .QS\+_^GRQK]9:_)KX<?\E#\!_]CGX7_P#3Y8U^LM !
M1110 4444 %%%% !1110 4444 %%%% !7@7[5W_)KG[2?_9 OC%_ZKOQ'7OM
M>!?M7?\ )KG[2?\ V0+XQ?\ JN_$= '\2E>1_'3X*>"/VA?A?XH^%'Q M9YO
M#_B:U5!>6+01ZKHFIVSB?3->T:XN8+J&WU72KM4N+9YK>>WE DM;NWN+.XN+
M>7URB@#^=:\_X(K?&&#4+GPQH?[1GAZ/X7:AJ;ZA=V]YIGBB'4#)#(B6%W<^
M#[.[;P[JNIPVBHKW<NNV++)$BPA(F'E?M?\ LV_L[^ _V8/A9I'PL\ 1W,UC
M9SSZIK6MZAY1U;Q-XBODA34-<U-H56)9ITM[:UMK:%1#8Z?:6=E$62 ._O5%
M 'YS_LC_ + /_#+'QB^)WQ9_X6S_ ,)W_P +'TO5M-_L#_A _P#A&/[&_M3Q
M39^)?._M7_A,_$/]H^1]E^Q>7_9MCYOF?:?,CV>0WZ,444 ?G#^Q)_P3\_X8
MY\8_$'Q9_P +;_X6-_PG>BV.D?V?_P (%_PB']E?8]4EU+[1]J_X33Q/]N\S
MS/(\K[-9[-OF>:V?+#OVY?V [S]M'7_A_JK_ !D/PYT_P#H^N:?:Z3_P@#>,
M!>WFOWMC<WVH_:_^$X\+K:%X-+TZV-N+2X9OLPD:YP5BC_1RB@#^??\ X<4?
M]72_^80__&]7Z7?L/_L=?\,:>!_&/@W_ (6+_P +'_X2WQ7%XG_M+_A$?^$/
M_L_RM(L]*^P_8_\ A)_%'VO=]D\_[3]JML>9Y7V<[/,;[:HH ^+_ -NWX,?&
M7]H7X(2_"'X/:MX4T%_%GB+1_P#A.=5\4ZKJ^F*O@_2YCJ4NGZ8NCZ3JDUW=
MWVKV^EFX@N/LMK-IUM>6DLI%V-OTG\/?ASX;^&_PV\)?"W0K11X7\(^%-,\(
MV=M,"YN=/T[3H]/DDNR[,TT]^%DN+V61F>>XN)I)&9W9CWM% 'X,Z]_P2W_:
M7T9?''P0^$WQ\\):#^R7\2?&%IXL\0>&]9M]0F\66?V2ZL+BVM6M%\-WTNK7
M&F1Z5H]O#+!XXT2TU\:7:3ZU;6\D**_[4_"[X=Z#\)/ASX)^&7A=91H'@;PU
MI7AK3'N"&N;B#2[2.W:]NV&%>\OIEDO+MU 5KF>5E55( [VB@#Z<_8M_Y.T_
M9T_[*]X(_P#3W:U_:97\6?[%O_)VG[.G_97O!'_I[M:_M,H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *YGQK_R)OBW_ +%G7O\ TU7==-7,^-?^1-\6
M_P#8LZ]_Z:KN@#\C:*** "BBB@ HHHH **** "BBB@ HHHH **** .S^''_)
M0_ ?_8Y^%_\ T^6-?K+7Y-?#C_DH?@/_ +'/PO\ ^GRQK]9: "BBB@ HHHH
M**** "BBB@ HHHH **** "O OVKO^37/VD_^R!?&+_U7?B.O?:\"_:N_Y-<_
M:3_[(%\8O_5=^(Z /XE**** "BBB@ HHHH **** "BBB@ HHHH **** /IS]
MBW_D[3]G3_LKW@C_ -/=K7]IE?Q9_L6_\G:?LZ?]E>\$?^GNUK^TR@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KF?&O_(F^+?\ L6=>_P#35=UTU<SX
MU_Y$WQ;_ -BSKW_IJNZ /R-HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M[/X<?\E#\!_]CGX7_P#3Y8U^LM?DU\./^2A^ _\ L<_"_P#Z?+&OUEH ****
M "BBB@ HHHH **** "BBB@ HHHH *\"_:N_Y-<_:3_[(%\8O_5=^(Z]]KP+]
MJ[_DUS]I/_L@7QB_]5WXCH _B4HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^G/V+?^3M/V=/^RO>"/\ T]VM?VF5_%G^Q;_R=I^SI_V5[P1_Z>[6O[3*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDL_8 _\ $R/V=?\ YXU?@#_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\
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M/@C_ /-Q1_P\;_X)Z?\ 1^'[&?\ XE!\$?\ YN*^9O\ B"I_X)9?]%\_;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEOV&?_"DT;_Z8Q7L_P#P>(2)%_P2B\%RR,J1Q_MF_ ^21V.%1$\(?%MG9B>
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MRQV6DVOB?Q+J?AG4=7OM4AU;27TW0[C3]3\.^(+&_GTV8 ^1?V)/^"T7A?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7\6:!XIT'Q!I?]HZ1=Z?JVG_ -H:3J%W:?;=+O[+4;7S?/LKNVN8XID^O_\
MB%Q_X(4?]&,_^;,_MA__ $05:/\ P78_8L_:8_;*LO\ @G!#^S;\-?\ A8\G
MP$_X*(?!7XZ?%A?^$Q\ >$/^$4^%?A*+5E\0^*<^//%7A===_L]KF ?V)X:.
ML>([O?FQTBY"N5_>V@#QC]GC]GOX0?LI?!;X?_L\_ /PC_P@7P>^%NC2:!X$
M\(?V_P")_%/]A:1-J-[JTEI_;_C36O$7BC4]VH:C>7'GZSK>H7(\[REF$,<4
M:?S:?\'A_P ,? WBW_@DY#\0]?\ #]I?^-/A/^T+\+;WP!XB8RQ:CX?;QE)J
MOA7Q1:P30R1^?IVN:/<I'J&FW0FLI[NPTC46@^W:3I]Q;_U95^$__!QC^QK^
MTE^WA_P3.\7_ +/O[*7PX_X6I\7M4^+7PE\3V'A'_A+_  'X'\_0_#&NW%YK
ME]_;_P 2/%'@_P ,1?8;:1)/LTVM1WESG99V]Q("@ /V!^ _PZ\$_"+X)_"3
MX7?#?PYIOA'P#\/OAOX,\(^#_#&D0"WTW0_#V@^'M/T[2].M8QEBEO:P1JTL
MC///)OGN))9Y))&]7K%\-VEQI_AW0+"[C\F[LM%TJTNHMZ2>5<6UC!#-'YD3
M/&^R1&7?&[HV,HS*03M4 ?S7?LZ?\K2?_!0G_M&]\!/_ %*/A97,_P#!P7X@
M\?\ QV^/G_!*?_@E;HOC?Q!\./@]_P % _CUX_?]I;7O#&J7&CZQXK^#_P $
M+/P)K&M?"B*\MFM9FT_QQ8^+M7>]6+48E35='\-K>:?K%A<7.G3_ %U\%_V0
M?VB?"?\ P7N_;'_;3\0?#S^S_P!F?XJ_L3?"/X1> OB5_P );X&NO[>^(?AC
M7O -[KGA[_A#;+Q-<^/]+^PVVB:G+_:VL^%=.T.Y^S;+/4KB2:W26[_P6N_X
M)^_'3]L/X;?L]_'/]CGQ!H/AK]M_]A/XSV7Q]_9QD\57O]G>&/&$BG3/^$V^
M&&N7^P+:VGC6VT#0'B%W=6&D:E=:+!H.NZAIFC:S?:MIX!X[^WY_P0B_X)UZ
MU^P]\5M-_9Y_9G^$?[,?QN^"WPN\1?$3X"?'WX-^&;/X>?%?P?\ $CX8>&[[
MQ'X/U;7OB5X<DTGQCXLMKO4=*AM-?N/%NOZM=RQ74NLQ74.NV>GZG:_6G_!#
MK]K7Q_\ MP?\$K/V/_VCOBO>7>J_$WQ3X'\1>$?'OB"^2V2[\6>*?A%\0O&'
MPAU7QG="RMK.Q^V>,IO W_"4:@ME:P6T&H:M=6T448A*+^-WQP_;I_X+D?\
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M;:W4$-S;R;=\-Q#%-&RR1HPL444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7N;2TO%C2[MK>Z2&X
MM[N%+F&.=8KNTF2XM;F-958)<6T\:3V\R@20S(DD;*ZAA8HHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D*96YD<W1R96%M"F5N
M9&]B:@HY-2 P(&]B:@H\/"]4>7!E("]83V)J96-T"B]3=6)T>7!E("]);6%G
M90HO5VED=&@@-S0*+TAE:6=H=" X-@HO0V]L;W)3<&%C92 O1&5V:6-E4D="
M"B]":71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],96YG
M=&@@,C(V-#X^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $, !0,$
M! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:
M'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$(
M %8 2@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)
M"@O_Q "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1
MH0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-4
M55976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G
MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U
M]O?X^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 "
M 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2
M\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D
M969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2U
MMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ ,
M P$  A$#$0 _ /LNBL;QW--;>"->N+>62&:+3;AXY(V*LC")B"".00>]?F)X
M=\<_&_Q'?G3_  ]XP^(FL7@0R&WL=2O)Y @(!;:C$X&1S[B@#]5**_,\1?M4
M'_HL?_?>HT[[/^U3Z_&'_OYJ'^- 'Z745^:8M?VJCW^+_P#W^U#_ !I?LG[5
M7][XO?\ ?^__ ,: /TKHK\U19?M5_P![XN_^!%__ (UQNJ_$?XP:5J,^FZGX
M_P#'%G>6[F.:";6KI7C8=58%\@^U 'Z=>-?'/A'P7':/XHU^RTO[9,D%NLTG
MS2,S!1A1S@$\MT Y) KHAR,BOC+]A7PGIWCZ]UCXC^-[B^\2:]IMW':V<NIW
M#7 BP@;?\^26&>,GCMSS7V;0!A?$/_D0/$7_ &"KK_T4U?"/_!/+_DO5Q_V
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MV\,8P$11@#_Z_>O%/V\_^3<]3_Z_K3_T:*]YKP;]O/\ Y-SU/_K^M/\ T:*
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!3L/#EGXB\<ZUH6D76NWNFZ-K&H6FD07CZA<V.DZE=PV[V]C=21?W+?\%
MO^"ZG_!+KX'?LF?'?Q%H7[8_[-GQ^\:7OPQ\:>'? _PD^"7Q@\!_%_Q1XZ\7
M^(O#^H:+H&@RV'P_UGQ*-(T6[U*]@&N^(-9%KI&D:0MY>3S2O'#:W !_/]_P
M9U?\%0_C#\3M?^*__!.3XX>.-=\?Z'X)^&__  N+]G#5/$L][K&M>$/#WA_7
MM)\-?$/X;-XBO;RXNI_"\1\4>%-=\#:)/%Y?AU+7Q;9V=V-,N-)TO3O[UZ_R
MWO\ @S5^&7BWQ5_P5,\;?$;2].OV\'_"O]E[XB-XLUJ$A--M-0\;^)/!7A_P
MOHM\Y8>9<ZPT6M:E86JJS2+X<O;K 6R<C_4AH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /SB_X+"_\HH?^"DG_ &8]^T__ .J<\7U_%W_P9;_#SP;\7!_P56^%
M?Q%T#3_%7@'XD?"'X ^!O&OAG58$N=-U_P *^*I?C_HFO:1?02*R26VH:9?7
M-K*I!^60E<, 1_:)_P %A?\ E%#_ ,%)/^S'OVG_ /U3GB^OX[_^#'#_ )*!
M_P %'O\ L3OV8/\ T]_'2@#\7/AOK?Q-_P"#;K_@NS-IGB277+SX:?"_XBW'
MA#Q7=&"8R?%G]CCXMRVES9^(HUBTQ4U?5K'PI/H?B\6>DP"UA^*G@-M 6Y T
MVZ ]D_X(M^*O#GCO_@Z<\&^-_!VLV'B/PCXR_:J_X* ^*O"WB'2IUNM+U[PY
MXA^$?[46KZ'K.FW2?)<V&J:9>6M]9SI\LUO/'(O#"OZ./^#PO_@FS_PO;]E[
MP;^W_P##7P_]J^)W[*H7PO\ %O\ LZT\S4/$/[/GBG51Y>J77V>UFN[T_"OQ
MM?Q:O$'EAL]+\+>+_'6KW<GE:?&%_DK_ .#8+_E.A^PK_P!?W[0W_K)WQWH
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M=K?B#PWX?L?$/[.?BC6H+#0+^^ETA?[1\0:K<2RV<DQNV6154 _E9_X. ?\
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MS@TG]JSX>0WUX\0CM;:#3/AW\9I ;A_LT5I900?"C4 D)C=1)J]Y,KQK))$
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M*ZP:EXZ\=ZS+?>*?%5W!YLWV--5U.>RTJ.:2VTBST^S(MU^RZ* /YQ_VE/\
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M\-U:74,5S:W5M*D]O<V\Z++!/!-$S1S0S1,LD4L;,DB,KHQ4@G_,$_X.YO\
M@G1^RS^Q!\=_V3OB+^RU\*O#'P3T+]HGP1\5[/QG\/? 6G0Z%X#A\2?"#5/A
M[';^(] \-6@33O#]UK.D_$>ULM7LM'AL]+GDT2UU!+*/4+O4KF\_O<_X(Z>-
M=;^(?_!*G_@GIXM\2:E=:QKNH?LB_ VTU35;Z:2XOM1N]$\!Z/H,E[?7,S/-
M=7MS_9@FO+J9VEN;EY9Y&9Y&) /TEK\,?VO?^#@7]C/]BO\ ;O\ !'_!/;XK
M?#C]I;6?C)X\U7X/:3I7BSP-X0^%6H_"JQF^-FK6.C^%[C5]>\2?&?PKXJMK
M33+B_BF\22VW@J\>RM4FDTZ/5758G_<ZO\H3_@[D2XD_X+/>-TM%F>[?X&?
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M]]I_VW[7:)<V[3PQB:,L ?U+_P#!T!_R@9_;+_ZX?LN_^M9_ &ORQ_X,C?\
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M+N6#SZ3XDT[Q+\$(M=TF5@2"^EZH+K3SM)4?9L+\H%4/^#)Q5'_!._\ :A?
MW-^VCKBD]RJ_ [X+%1] 78CZFOT\_P"#EWX-?%GXZ?\ !'G]H;X7? GX4_$3
MXQ?$35_%GP$FT+X=?"7P-XE^(7C35+/1/C;X#U35)=)\(^#M+U?7+VVTC2;*
MZU'4'L]/EBL-.M+B[N#%;022)\4_\&A/[.7[0G[-/[!_[1G@_P#:.^!'QE^
M'BW7/VN-:\2:+X7^-GPO\;_"KQ%K'AV7X-_"'2XM?TO1/'>AZ#J>H:+)J>F:
MEIT>JVEK-8O?:??6BSFXM)XXP#\8O^#X#_DX;]@L]_\ A3/QA_\ 4W\*_P")
MK^Q7_@GII'PH\2_\$8_V"O"/QQ@\%7WPG\9_\$X_V5_"/CS2/B)/I4'@W7?#
M'B']FSP/IVM:)KW]M2PZ=-I^I:;-=6]S#<2 / TA!&W<O\NW_!XA^QY^UO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "L;Q'?SZ5X>UW5+41FYTW1M4O[<2
MJ7B,]G93W$0D561FC,D:[U#*67(#*3D;-<SXU_Y$WQ;_ -BSKW_IJNZ /AK_
M (:A^)/_ #[^&/\ P5WG_P M*/\ AJ'XD_\ /OX8_P#!7>?_ "TKYRHH ^C?
M^&H?B3_S[^&/_!7>?_+2C_AJ'XD_\^_AC_P5WG_RTKYRHH ^C?\ AJ'XD_\
M/OX8_P#!7>?_ "TH_P"&H?B3_P ^_AC_ ,%=Y_\ +2OG*B@#Z-_X:A^)/_/O
MX8_\%=Y_\M*/^&H?B3_S[^&/_!7>?_+2OG*B@#Z-_P"&H?B3_P ^_AC_ ,%=
MY_\ +2C_ (:A^)/_ #[^&/\ P5WG_P M*^<J* /HW_AJ'XD_\^_AC_P5WG_R
MTH_X:A^)/_/OX8_\%=Y_\M*^<J* /HW_ (:A^)/_ #[^&/\ P5WG_P M*/\
MAJ'XD_\ /OX8_P#!7>?_ "TKYRHH ^KO"/[1OQ USQ9X8T6]@\.BSUCQ#HNE
MW9@TZZCF%MJ&I6UI.87;475)1%,YC=D=5?!*,!@_=5?DU\./^2A^ _\ L<_"
M_P#Z?+&OUEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *YGQK_R)OBW_ +%G7O\ TU7==-7,^-?^1-\6_P#8LZ]_Z:KN@#\C
M:*** "BBB@ HHHH **** "BBB@ HHHH **** .S^''_)0_ ?_8Y^%_\ T^6-
M?K+7Y-?#C_DH?@/_ +'/PO\ ^GRQK]9: "BBB@ HHHH **** "BBB@ HHHH
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MO@%_X2WQ$_\ GIU^1%% 'Z[_ /#Z/]J/_H0O@%_X2WQ$_P#GIT?\/H_VH_\
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M33+"YAL;O7M7U2_(T_0M%74+B'3;.21+W5-7OS/!H^DWZ:?JDMC^4UK_ ,%
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M/']MU+4[F2."TA\R.++-/<306L4\\8!ZI17Y#_![_@K]\)OB5\1_#G@?Q/\
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,^-?\
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M2M-T[2-*;3/ W@7PK%;:99Z/HME8Z?XGMD@LDU"^>\O?[KJ_(#_@FM_P1N^
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M7Q5+9R1SQZ--H_A7QQXBFBO75BL4D;^(M%M)(\F2.ZOX8'42[E'[IT %%%%
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MKI110!\._LS_ +&?_#.OQE_:$^+G_"R/^$P_X7OXCOM?_P"$?_X0_P#X1_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRBOY _\ A]G_ ,%LO^D1'C3_ ,1Q_:T_^,T?\/L_^"V7_2(CQI_XCC^UI_\
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M?^GNUK^TRO\ +'^&'[?G_!6OX3_$3P7\2_#O_!*+XUWNN^!?$>E>)](M-:^
M?[2USI%Q?Z1=1W=M#J,%CX5TV\FLWEC59X[:_LYF0D1W$388?I[_ ,1+O_!?
M3_I#>?\ Q&#]L_\ ^7E ']_=%?P"?\1+O_!?3_I#>?\ Q&#]L_\ ^7E'_$2[
M_P %]/\ I#>?_$8/VS__ )>4 ?W]T5_ )_Q$N_\ !?3_ *0WG_Q&#]L__P"7
ME'_$2[_P7T_Z0WG_ ,1@_;/_ /EY0!_?W17\ G_$2[_P7T_Z0WG_ ,1@_;/_
M /EY1_Q$N_\ !?3_ *0WG_Q&#]L__P"7E ']_=%?S1?\$3/^"L__  4I_P""
M@?Q]^*_PU_;6_81/[*G@+P7\()/'/A3QC_PJ'X]_#O\ X2+Q>OC3POH"^&?[
M3^+.HWFC7V[1M8U35/L&FHNIG^S_ +0'^R0W"G^EV@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR>(?#UYC[7H6MR:#HFGOJFD7) ,^FWK3V<K ,\)(!'\W_P#P2RNM4_X)/_\
M!3;]H_\ X(T>.+J]M?V:_CY_PDG[8W_!-O7]8N9#IEGH6J2W-W\6?@)I^H7\
MR+/J?A<:=J6I6.C6"32PV_@?Q'XMU=XKGQYIZS@'[_\ [3G[;'[,G[',WP;M
M/VB?B4_@;5/V@_BCH_P7^#.@Z;X*^(?Q#\2_$#XE:\N=,\.Z+X8^&7A/QEX@
M5)':""YUR^TVS\.Z==W^EV6I:M:7>K:9#=_4[,J*SNP55!9F8A555&2S$X
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MV<\4%R\/ZGU_-;_P;]_LVZ)\1=/^.'_!7_QU\(/!GPM^)W[>/B768O@'\/\
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MIIUKKG@?6=1\4^ /![J;W2D\1V$#Z7HC:7J6L^.?[R]"_P"0'HW_ &"M._\
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M_P"-- NS<V%AHUP/6_\ @KY\$?\ @I%^VOXE\7_LH?"7Q3I'[,'_  3KT[X
MZGX[_::_:'TF[L]3^,WQRU:YM/&<E_\ LW?#G19I3+X>\.KI&@Z--XZ\27%I
M;V&HV'BQ-/;5=5MK#6/!>M@'[6?L_?M _!_]J?X/^"_C[\ _&EM\0_A%\1+;
M5+WP7XTLM+U[1K/7[/1M>U7PSJ%W::?XFTK1=:CMH]:T74K6">ZTVWBOHK=+
MZQ:YT^YM;J?YX_:R_P""FW[ _P"PQK7A[PS^UA^U)\+_ (,^*?%4$%YH?A/7
M]1U#5?%MUIMS>)I\.M3^%O"^G:[K^G: ]V[1?\)!J>G6>BJ(+R5[]8K&\D@^
M-?\ @W'_ .4)_P"P+_V3;QI_ZN3XDU\#?\$T[3]G0?\ !4?_ (+72?MU:=\)
MK7]M&Z_:<NYOAROQT&B27UW^P2-"@M/@G=_"I_B%NL)O!D_A^UM!X\;PB3'#
M.OAJS\4+%';Z/"@!_3)\(/C+\*/V@/AWX:^+?P1^(GA#XJ_#+QC9#4/#/CCP
M+KMAXB\.:Q;!VBE-KJ6G33P_:+6=)+:^LY3'>6%W%-9WL$%U#+$GI5?S-?\
M! *W\+6?[1__  63MOV6K33(O^";Y_:[\$7'[*-WX5-U_P *SG^)3^"=7M_V
MGX/A%^\;1)?A[9^*;;P7#HDGA>-/#"V7V*'0)9],C@CM?Z9: "BBB@ HHHH
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M1>*_"=__ &CX8\1Z-J>-+UV]:T^V?8KX6VH6]U:0 'T'_P $Y/\ @G!\+?\
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MRU@A2.**"RTRPMK>-(T5%6, *!Q7:444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$
M P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0
M 0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E
M\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W
M>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'
MR,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^
M_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ9XNU/1] TV35=8O[#2=-CO-0A:^U.]M+"U$MU<PQ. >B45\\? W]KO]D_\
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MTW5=*O;;4=-U"TF4/#=65]9R36MW;2H0T4\$LD4BD,C$<UH4 %%%% !1110
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M[[PIXGBL=/?4(K>_L-1TS2M;TC5=,M/U2H _-3_@J)_P5._9]_X)+?!+P/\
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M\%I=^*O VLZ/?7VB>./#FGWES;VNJR6,MEK^BO<V4^N^'=+L]1TZYN_YRO\
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M_0[/1SKNM-906UF^M:]/;3:SK$EK;V]M)J5]=/!!%&RQJW]JJ_\ &.E_LO\
M[2&I_#P;O'^G? 3XP7_@9=\T6[QC9_#WQ%<>&1YEL&N(\ZU'9#? K3)]Z(%P
MHH _G0_;\_X.U/V"_P!C7XO>,_@5\,_A_P#$K]J_Q_\ #S4]9\->-=7\!ZAH
M?@SX7Z)XST*^FTW4_"</CCQ$E_?Z_=Z9?VUQ:ZIJWAGPGK/AZ":(Q6.K:G.E
MQ%;\U^PU_P '>G["/[5?Q<\'?!;XP_"SXF?LF^(O'VH:;H/AKQGXRU[POXV^
M$@\3ZI>6]A8:'XA\9Z7_ ,(_K'AE-0N[F*&QU[5?"$7AR,K*^N:KH<8A:?\
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M!_\ !2C_ (.G/V&O^"??QH\3_LY^'? WQ%_:@^,7@&]N-(^(UI\.=0\/>'/
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MT:;Q/\-=1:#[Q?2_'VB>'-1ADB*SPRVJ2P,)40U_G5?\'#_[(/P[_P""/_\
MP4Q_9L_:3_8%.D_"GPYXVT[2?CMX#\(^%;^[FT'X<_&#X3^-;=/$>GZ)%;:C
MYMIX)UV&X\*Z@WA>*]BM(DU7Q%HUO';:'-9V4'^GS\&OB3H_QG^#_P *OC!X
M?:"30/BO\-O WQ)T1[>9;FVDT?QUX8TOQ/IK07"_+<0-9:I"8I@,2H5<##4
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M=Q%#\P_\'K__ "C<_9J_[/?\)?\ JAOC]7\MG_!/;4?^"R7_  3"_9&\#?\
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MU7A?]I#Q%8S:IHGP%\"?ML_%_4]*MCBYU:U^'?Q9^,WBR32K8Y&+C4_[*%C
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M)/PFMO%5SHFM?%^76;?PY/X^\-:!%KD^D1:GILFIQ:8UU)81ZA8O=+$MW 9
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M1:(E\-'_ .$@UK^SA/\ 9/[4OO*^TR?YG7P&_87_ ."I/_!QW_P4*T+]H_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)_!VJ2Z7<B6*=;S0/ =SXR\6YM#]K6W\/3O"8V7S8_VWKXJ_;<_X)W_L>_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %9NLZBNCZ1JNK-$9UTO3;[46@5Q&TRV5K+<F(2%7"&01; Y1@I.
MXJV,'2KF?&O_ ")OBW_L6=>_]-5W0!\S?\-:Z=_T)%[_ .#R#_Y64?\ #6NG
M?]"1>_\ @\@_^5E?$U% 'VS_ ,-:Z=_T)%[_ .#R#_Y64?\ #6NG?]"1>_\
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MKX<?\E#\!_\ 8Y^%_P#T^6-?K+0 4444 %%%% !1110 4444 %%%% !1110
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M]!\G6G^)/P^U?P[XSN-$M=4T>TL_%7@J.6YCT.YTIKK5M2T:'28XO@W_ ()
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MK>/='^&%MXBM+=-8?PU9?%W7_P#A.;CPQ'>(VYM4TB;P-J;26#&YNO#LTES
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M)-% '[;?\/M/BC_T1'P#_P"%#XB_^-T?\/M/BC_T1'P#_P"%#XB_^-U^)-%
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M&YO+._OEMKAD]L_;#_;K^&O[($'AO2]<T76?'7C_ ,7QS76@>!O#T]O:7/\
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M -/=K7]IE?Q9_L6_\G:?LZ?]E>\$?^GNUK^TR@ HHHH **** "BBB@ HHHH
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M^&_[(,/B35=&US6/'GQ!\81Q6WB#QUXA@M[.Y.FPRBZ_LG1]-MY;E=,L+F^
MU#4#-?:C?ZA=I;M=7TD-G9P6[?!_[&7_  B?[:7Q"_:^_P"%D?;_ /A._#KZ
M!_PKS_A#_LO]E;]%\)Z/]K_X2W_A*;G[=C_A%_M'D?\ ",V>?MWD^</LWFW
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M_P"D1'C3_P 1Q_:T_P#C-'_#[/\ X+9?](B/&G_B./[6G_QF@#^ORBOY _\
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M#^_NBOX!/^(EW_@OI_TAO/\ XC!^V?\ _+RC_B)=_P""^G_2&\_^(P?MG_\
MR\H _O[KP+]J[_DUS]I/_L@7QB_]5WXCK^('_B)=_P""^G_2&\_^(P?MG_\
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M?Z1=1W=M#J,%CX5TV\FLWEC59X[:_LYF0D1W$388?I[_ ,1+O_!?3_I#>?\
MQ&#]L_\ ^7E ']_=%?P"?\1+O_!?3_I#>?\ Q&#]L_\ ^7E'_$2[_P %]/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[7H6MR:#HFGOJFD7) ,^FWK3V<K ,\)(!'\W_P#P2RNM4_X)/_\ !3;]H_\
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M;O<7_P .?B-IR1I/I^KPVY2]O/!GBJ&VL8/$%E:2ETO-,T35VL]6CTA]%U(
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MPC^%'Q?_ &C?C-HWCKXA3_$?4?$7[2_Q \._$3QAINIS^&_#_ADZ+HFK^&_
MW@*UL_#45KX=M[Z'3I]-O+A-4OM3N?MQCN4MX/R _P"#LCX5:*/^";^G_M>^
M'-4U[P/^T-^R%\7/ .L_!GXG^#=0?0O%FAV/Q=\3Z+\+O'_AD:W:!=1C\/>(
M=)UJPU/4+*TN;?[3JGAK1?.>2S%Y:W7]1-?BI_P<'?LD?M"?MP_\$MOC=^SE
M^R[\/_\ A9_QE\7^+?@QJ?AWP=_PE?@CP5_:-CX3^+'A+Q+X@G_X2'XA^)/"
M7A6T^P:)IE]>^5?:Y;377D?9K*.YNY8;>0 _1/\ 8V_9P^%_[(W[+7P+_9R^
M#>C+H?P\^%7PY\.^'=$@*Q?;=2N#9I?ZYXDUJ:&.)+SQ#XJUZ\U/Q)XAO_+0
MWVM:I?715/-"K]+/]QO]UOY&LKP_:SV.@Z)974?E7-GI&FVMQ%N1_+GM[*&*
M:/?&SQOLD1EW1NR-C*LRD$ZS E6 ZE2!]2* /YQ/^#4'_E"3^S?_ -C]^T1_
MZO+QS6]_P<G^/O&6I_L6_"#]BCX8ZCJFF_$C_@I'^UG\#?V0-/OM'@^TWNE^
M"_%/B1/$?C[5YX$(FET86&@:=H'B!(BJMH_B.\%W+#8FZE7W'_@WP_9(_:$_
M8>_X);_!/]G/]J+X?_\ "L/C+X1\7_&;5/$/@[_A*_!'C7^S['Q9\5O%?B7P
M_/\ \)#\//$OBWPK=_;]%U*RO?*L=<N9K7SOLU[';7<<T$=/]O3]D7]I/]H;
M_@JW_P $=?C)X0\$RZS^RQ^R7KW[4OQ"^.OBY_%_@K3++PIXT\5_#+2M+^$T
MDG@[5?$ECXT\57U[XDT&WTRQO/"WAK7K?0$U2[NM4N-+LI;JX(!^POPW^'WA
M/X3?#SP+\+? >D6GA_P1\-_!_AKP)X/T*P@BMK+1_#'A+1K/0="TRU@A2.**
M"RTRPMK>-(T5%6, *!Q7:444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7\ROP:OG^#G_!U%^V'X;\;*;2+]K_ /X)X_"3Q[\'-6U5O)34)/@]>^ O
M!?B/P7X7DG2,7DTZ^%?&?B_5+"R>XD@C\/W5]<B-"NW^FJOQ]_X*R_\ !,OQ
M?^W1H_P2^-/[-7QF;]F?]N_]D/Q5J_CG]F+XZ#3TO](@FU^QAL?%GPX\?VJ6
M6H75UX&\9VMK:P7LL=AJZZ;+'-]J\/\ B+0]3U_P[K !^N$VM:/;:K8:#<:M
MID&N:K::AJ&F:--?VL6JZC8:2]E%JE[8:<\JWEY::;)J6G1ZA<V\,D-F]_9)
M</&UU )/YH?^"8LZ?%'_ (. ?^"^'QM\(L+WX=^'H?V0/@5/KNGJSZ)J/Q%\
M#_"G3O"WC'1X[^(/97VN^%=;^'.MV&N6L,[7>CM>6D5]# U]!YGPS^US^Q-_
MP<)?\%%O$?[/.F_%_P#9W_8G_9G^._[-/B^WU3X=?\%&?A'^T9\3]#\3>#;#
M4KJT7QK>?#CX?^#_ !OJNK0OXML='L$\0Z3XP\$7=AJELR:=I\7AL7$MYI/Z
M7_\ !!;X&?'G]@K1?C9_P3[_ &@?V6?%/AOQQX5\8^,/CWJG[=VB>)H_'7PB
M_;4NO'WB.PLHO&.H>(];NK?QMH/Q<MM--EI.K>!-7T_4I--T;PRVLZGJ=I=Z
MO9OKP O_  =6_P#*#W]J[_L:/V<?_6C_ (65_0CH7_(#T;_L%:=_Z20U^/'_
M  <!?LG_ !__ &W/^"5W[0?[-_[,/@'_ (6;\:/'&O?!2]\+^#/^$I\%>"_[
M4MO"/QK\ ^+O$,O_  D7Q"\1^$_"EE_9_A[1-3U#9J.NVDEW]F^R6*7-]-;V
MTO[&:3!+;:5IEM.NR:WT^S@F3<K;)8K>..1=R%D;:ZD;E9E.,J2,&@#X_P#^
M"D/_ "CO_;U_[,O_ &I/_5'>.J_E!_X)=?\ !MG^RS^U3_P3W_9)_:*\8?MC
M_P#!23P-XG^+_P '?#WC/6_"'PK_ &A?AUX9^'?A^_U%[I9=.\(:!JGP*\1:
MAI6C0^4IMK.[UO4YHRS[KJ3(Q_7E^VQ\//&'Q<_8S_:W^%'P\TC_ (2'Q_\
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M$U3Q-\+/B7X;T2U^VZUX@^'_ (RT32++SK>V^UZIJOAS4K"PM?M%W+;VEO\
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M=1:EK^N_LC0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !6 $H# 2(  A$! Q$!_\0 'P
M 04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0
M  %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8
M&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X
M>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)
MRM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$!
M 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$
M!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I
M*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+HKDOC3=W=A\
M'?&E]87,UK=VV@7TL$\,A22)UMW*LK#E6! ((Y!%?F/_ ,+8^*?_ $4KQG_X
M/+G_ .+H _66BOR:_P"%L?%/_HI7C/\ \'ES_P#%T?\ "V/BG_T4KQG_ .#R
MY_\ BZ /UEHK\FO^%L?%/_HI7C/_ ,'ES_\ %T?\+8^*?_12O&?_ (/+G_XN
M@#]9:*_)K_A;'Q3_ .BE>,__  >7/_Q='_"V/BG_ -%*\9_^#RY_^+H _66B
MOG#]@'Q'XA\2_#+7;OQ'KVJ:S<Q:RT<<U_=R7#HGDQ':&<D@9)./<U]'T <7
M\>/^2'^//^Q;U#_TFDK\Q?@_:VM]\6O!UE>VT-U:W&O6,4\$R!XY4:= RLIX
M(()!!X(-?IU\>/\ DA_CS_L6]0_])I*_,OX(_P#)9_ __8Q:?_Z4QT ?IK_P
MJ?X6?]$T\&?^"*V_^(H_X5/\+/\ HFG@S_P16W_Q%=G10!QG_"I_A9_T33P9
M_P""*V_^(H_X5/\ "S_HFG@S_P $5M_\179T4 <9_P *G^%G_1-/!G_@BMO_
M (BOC+_@H#X9\.>&?'?ARV\-^'])T6";3'>6/3[..W5V\UAN(0 $XXR:_0"O
MA3_@I-_R43PM_P!@E_\ T<U 'I'_  3>_P"23^(?^PZW_HB*OJ.OES_@F]_R
M2?Q#_P!AUO\ T1%7U'0!Q?QX_P"2'^//^Q;U#_TFDK\R_@C_ ,EG\#_]C%I_
M_I3'7Z:?'C_DA_CS_L6]0_\ 2:2OS+^"/_)9_ __ &,6G_\ I3'0!^M%%%%
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M96YG=&@@,C(V-#X^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $,
M!0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8
M(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_
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M64*PV\,8P$11@#_Z_>O%/V\_^3<]3_Z_K3_T:*]YKP;]O/\ Y-SU/_K^M/\
MT:* .+_X)L_\D[\4?]A9/_1*U]6U\I?\$V?^2=^*/^PLG_HE:^K: ,+XA_\
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M)]*^$O\ ABKXI_\ 0?\ !G_@9<__ "/7W_10!\ ?\,5?%/\ Z#_@S_P,N?\
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M96YG=&@@,3@T,CX^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $,
M!0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8
M(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_
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M_P#P>7/_ ,71_P +8^*?_12O&?\ X/+G_P"+H _66BOR:_X6Q\4_^BE>,_\
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M8)M,=Y8]/LX[=7;S6&XA  3CC)K] *^%/^"DW_)1/"W_ &"7_P#1S4 >D?\
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M9<__ "/7W_10!\ ?\,5?%/\ Z#_@S_P,N?\ Y'H_X8J^*?\ T'_!G_@9<_\
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MNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$
M P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0
M 0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E
M\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W
M>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'
MR,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^
M_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ9XNU/1] TV35=8O[#2=-CO-0A:^U.]M+"U$MU<PQ. >B45\\? W]KO]D_\
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MTW5=*O;;4=-U"TF4/#=65]9R36MW;2H0T4\$LD4BD,C$<UH4 %%%% !1110
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MXCTGXCZ1X TS33\:?$GAOP+I::OX&UY[S2-&\2^(+:_NUOM.@T_Y%_X.$O\
M@X9_;1_X).?MI_#?]G+]G3X8_LO^-/!'C#]F3P5\:-3U7XU>"_BOXC\50>*?
M$GQ1^,O@F^L+&^\#?&OX<:1%H$6E?#O1;BTM;C0[K48]0NM4EFU6>VGM+2Q
M/[(:*X'X4>*M0\=?"WX;>-]7ALK;5?&/@#P=XJU.WTZ.>'3X-0\0^'=.U>]A
ML(KFXO+F*RBN;R5+6.XN[J=(%19;B>0-*W?4 %%%% !1110 4444 %%%>0_M
M!>/]9^%'P$^-WQ2\.VVF7OB#X:_"'XE>/]"L]:ANKG1KO6?!W@S6O$6F6VK6
M]C>Z=>SZ9/>Z=!%?PV>H6%U+:O*EO>VLS)/& >O45_(W_P &[7_!?#]L'_@K
MA^T-\>OA+^TA\-_V:_!/ASX6_!BP^(OA^]^"/@_XH>&];O-;NO'&B>&I+76;
MGQY\8_B387&E+8:E/*D%EINGW8NTAD:^:%7@D\._X+U?\''?[;__  2W_;O/
M[+_[/_PL_94\8> ?^%,?#SXB_P!K_&+P/\7/$'C#^V_%M[XHMM2M?[0\%?'+
MX?:+_94":):&Q@_X1_[7&\EP9[ZY#QK$ ?VJT5^6?_!9#]M[XK_\$\_^"9_Q
M_P#VR_@MX?\ A[XG^)_PJC^#3^'M!^*&D^)-:\!7A^(GQP^&/PTUO^V=+\*>
M+/!7B&X%KH7C75;O2_L/BG3C!JUOI\]V;ZSBN;"[^+O^#=C_ (*U?M&_\%<?
M@!\?_BK^TAX*^"?@GQ#\*OC#I/P^\/6?P1\.>._#>C7FC7_@K2_$<USK-OX\
M^)'Q)OKC4UOKV6*.:QU'3K06BQHUD\P:=P#^AVBOXH?VAO\ @Y!_;A^$W_!<
MW3?^"97ASX5_LIWOP'O/VS_V=_V=)?%NM^!_B[<_%Q?!/Q;\0_##2?$FJ1Z]
M8?'/3?!H\4V5MXUU5]$OF\!-I-M/;Z>U_H>I1Q7,=W_:]0 4444 %%%% !11
M10 4444 %%?AQ_P7V_X*"_MA?\$Q_P!CCPY^U=^R=X#^!OQ"M- ^+/AOP;\9
MM,^-GAKQYXAM-$\&>-;34-.\.^)] /@7XF?#:XLYX?'$6A>&[\7\^LQSGQ18
M206MN+2XDE_2?]BS]JOX>?MO_LK? W]JOX6W"2>$/C5X T?Q;#I_VFWNKOPU
MKDD;6/BWP9JLEK+-"NM^"_%5GK/A76HTD98]3TBZ569-K$ ^H**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *_/'_@K%^UW'^PI_P $ZOVL_P!I^"[BM/$GP]^%&K6/P]>9
M9I(W^*GCNYL_A]\+DDBM_P!_);KX^\4^'I[WRBABL(;J=Y8(HI)X_P!#J_D<
M_P"#S3XKZWX(_P""7/PW^'FCR11VGQI_:O\ A[X;\4>9O,D_AKPAX)^(WQ"2
MW@5650Y\6>&O"=R\D@D18K5T$>^5)(P#Y<_X,GOV<Y=*^ '[9'[8/B"VU&?7
M?BY\6_#/P8\/ZKJJ.\EUH?PM\/GQIXHU/3KRX3[3>QZ]XE^*%G9ZO>&>>&?4
MO""0Y6[LKO/W'_P6_P#^"B7_  1*_9)_:R\!_#?_ (*0_P#!/[Q%^U5\<]9_
M9\\)>-?#'Q$TG]GS]G[XKVVD?"K4OB)\5=#T+P:_B+XK?%GP)XBLY].\6>'/
M&^M-HUGH]QHULGB&.]MM1FO=1U"VM/I3_@UL\ GP+_P1'_9'N)HHXK[QYJ/Q
MS\?7PC_C&K_'CXCZ;I$LC%5+22>'-%T5FX.S(B#,L88_R&?\'J/_ "E1^!G_
M &8/\*O_ %H']J*@#_0O_:"_;#^#'[&W[#7B#]LOQ3X2\<3? WX6?"?P5XZ/
M@OP!HOAJZ\=6_@W6QX:TKP_HVB:'K/BOPYX7^WZ=#KVF0SV<_BZSL+>"VN%M
MM0N3%"L_Y'^'?^#I3_@FIX@_8M\?_ML7.F_'SP5X5\)?%>\^"/A7X2^//"?P
M\L?C-\6_B-9>#_#OC:XLOA[X>\)?%/QKX?D\/V&B^)]-DUOQ/XE\4>'=.T20
M/%?!9KK1HM6[S_@LQ_RKK?M$_P#9H'P5_P#3M\*:_C[_ .#3O_@EM^SY^W]\
M7_VB?B]^U=X'C^+/PI_9>L/ %IX'^%7B>6XG^'/B/XF_%T^*C?:[XET..:.'
M7X_"_ASX<VL<FA7P;1]2N==T:ZU>UU%=&LH(@#]WOV9/^#SW]C+XO_&?1/AO
M\<_V<OBC^S7X%\4^(K7P_H_QDO?'/AKXC>&?#\=^8(;/7/B7I-CHGA35/"6A
MI=R20ZI?Z _CA-(MQ#J-VOV#[=/I_P#9/;7-O>6]O>6D\-U:74,5S:W5M*D]
MO<V\Z++!/!-$S1S0S1,LD4L;,DB,KHQ4@G_,$_X.YO\ @G1^RS^Q!\=_V3OB
M+^RU\*O#'P3T+]HGP1\5[/QG\/? 6G0Z%X#A\2?"#5/A[';^(] \-6@33O#]
MUK.D_$>ULM7LM'AL]+GDT2UU!+*/4+O4KF\_O<_X(Z>-=;^(?_!*G_@GIXM\
M2:E=:QKNH?LB_ VTU35;Z:2XOM1N]$\!Z/H,E[?7,S/-=7MS_9@FO+J9VEN;
MEY9Y&9Y&) /TEK\,?VO?^#@7]C/]BO\ ;O\ !'_!/;XK?#C]I;6?C)X\U7X/
M:3I7BSP-X0^%6H_"JQF^-FK6.C^%[C5]>\2?&?PKXJMK33+B_BF\22VW@J\>
MRM4FDTZ/5758G_<ZO\H3_@[D2XD_X+/>-TM%F>[?X&? )+9+97:X>X;P[=B%
M8%B!D:9I"HB6,%RY4(-V* /ZC/VU_P#@\*_8D_9F^-GB#X-?!'X,?$+]K*'P
M3KDWA[QE\3O"WC#P]X!^'#:G873VFLP> =4U+2O$VI^.X]*GBFMCJO\ 97A_
MPYJMQ%YFA:YJFERPZI)^@'@[_@Y _P"":?B;_@GWK'_!0C5/'?B3PGX3\.^*
M%^&FM_!#5=,TV?X\?\+CN-+DUK2_A?H?A2SU>32]?U'7M'AEU[1_$UKKD7@Y
M?#MO?ZOKFNZ$FBZ_!I/QQ^T[_P &\'_!.CX&?\$9_P!H'X?^'?V<O VL?M"?
M"']D+XD?$NP_:,U.S?\ X7+K?QT^&_PWU7X@KX@G\=+)_:UCH&N>,]#-E/X+
MLY8O"-OX8O)-!CTC[(I+?QP_\&RO_!.WX1?\%%/^"B5QX3_:'\,W7C7X&_ O
MX2:]\=/%?@J2ZDM?#7CGQ+I/BCPCX-\#>$?%PMWCN[O0KC4/&5_XCN],MIK=
M=8MO#%SI&H32:/?ZE8WH!_5-^SQ_P>A?L5_%/XT:/\._C'^SA\7?V>_ASXD\
M0VNA:5\9M1\7^%_'ND:!#?/%!:Z[\1O#.E:9HFI>&-$AN'9=5N?#E]XZDTRW
M"WKPS6PN7M/ZU?C'XK\ :+\"_BIXX\<Z6GC?X6Z3\)O''BOQAHNF0:;K<?B_
MP!8>#]4U?Q!I>GVM[?66D:NFO^'8KNTM(+O4K33=06[CCGOH+69YT_S</^#O
M+_@GS^RG^Q7\7_V,O'/[+7P8\%? O3OCIX'^,NC^-?!_PXTF#PWX,O-5^$>K
M?#232=?L_#-@(]*TO5KRP^)<MCJUQIUM:KJ4>FZ?-<QR74<L\O\ 91^Q]XQU
MGQ]_P;P_"/Q3XAU"[U;6KW_@EA-9:CJ>H3/<7U_/H7[.NIZ!]KO+F0M+<W,Z
M:8DD]S,SS7$C--,[RN[L ?)W_!#']OS_ ((U_M>_'/XS>$_^":?["7B']D_X
ME>%/A/:>(OB%XKU?X$? GX2P>*/ T_B_1M-@\/1ZI\)OBGX]U/59HM?GT_4A
M8:KI]E81);O<1WAN%6"7^1O_ (/#_P#E+\?^S6O@G_Z=?B!7UK_P9(?\GK?M
MB?\ 9K>C_P#JV?"=?)7_  >'_P#*7X_]FM?!/_TZ_$"@#^T+_@Z _P"4#/[9
M?_7#]EW_ -:S^ -?EC_P9&_\F:?ME_\ 9S?AS_U5>@5^IW_!T!_R@9_;+_ZX
M?LN_^M9_ &ORQ_X,C?\ DS3]LO\ [.;\.?\ JJ] H ^BOC?_ ,%)O^"%'A#_
M (+!V'[,'Q(_X)U^)O%?[?<_[5_P.^'-K^TI%^SI^SMJ^F0_''QCKOP^M?AM
M\0O^%F:O\8;'XEQVOA/4]<\*W4GB&/P8WB#1DT5I-'T>^DL;&*X_JQ\9^,_"
M/PY\)>)/'OC[Q-H?@SP3X.T34O$GBOQ9XFU.ST7P]X<T#1[66^U36=9U;4)8
M++3M.L+2&6XNKNYFCAABC9W8 5_EA?MK?\K<.A?]I2_V)?\ U-?@#7]"/_!Z
M%^V;XP^$O[+'[.G['G@?6-9T./\ :D\9>+_&/Q1N=+D@@M]9^&OP7C\,-:>"
M=4F+_;?L/B'QSXT\.^()(;1$CN1X%-I?3_8[F2SO0#HOVDO^#T?]B3X8?$#5
M_!_[/_[.?QD_:1\/:)JB:;-\2;GQ'H'P@\)Z]%%/Y=_JG@^SU?2?%OBK4M/C
MCW-I\GB#P_X3FU*5"##:6CPWTOZS_P#!*K_@O_\ L0?\%7-6U#X<?#2;Q;\'
M/V@M(TVXUFX^!OQ;CT>UU[Q#HMC'')J6N?#OQ#HFHZCH/C;3=+$F=2LXI=*\
M5:?!'+J5]X7MM(5=1?\ %3_@WS_X-UOV&_'?[ OPT_:J_;8^"NE_'SXL?M/>
M&K_QEX>T/Q;XA\2)X2^&_P *=;N[RT\&0>']'\-:OH=J_BKQ/X>@L?%NH>)=
M1-_K>@RZK::7X?NM%DL=0FU#^;7_ (+0?L1ZM_P09_X*I?"[QS^QYK_B3POX
M%FA\(_M-?LTZAJVLWFK:AX,O]&\4ZCIOB3X8:MJW]H1:WXFT'1=8T22PNDUR
M=KKQ#\/O%5AH?B'4-=NI=:O[P _TZ_\ @H+^W9\(_P#@FY^RSX[_ &N?CEX=
M^(WBKX;_  ^U3P7I.M:)\*-(\,ZYXWNKGQUXOT;P5I#Z7IOB_P 7^!=!F@MM
M5URTN-1:[\2V4D.GQW,MM'>7*16DWY$>(?\ @Z6_X)NZ'^P]H_[;4VD_'+3[
M7QO\2O&_PG^%G[/_ (D\.> =/^.WQ$\3?#ZQ\,7_ (JUNRT?PY\2/&'A'0_A
M[HL/B[11J?C+7O%UG'!/.NFVVF7NM7>E:5J7FO\ P<9?&/P_^T1_P;D^,/C[
MX4*'PS\;?#7[&'Q9T 1NSK'I'Q#^*'PD\6Z?#N=4D+06VK1PN)$2171ED1'#
M*/Y_?^#3'_@DW^S/^VSH_P ??VI_VN? 6C?'7PE\&O&&D?!_X/\ PC\=17&L
M?#O3O%&JZ"GC'QYXMU_PQ<3G1_$,RZ;K7A>PT'2M2M;G2+:YN]<U:^L+O4UT
M2[TP _9_]B/_ (/"?V-OVG_CMX3^"'QG^ WQ$_993XA^)K;PGX)^)6M>-_#W
MQ%\ 1ZOJU['8^'H?'MY8Z)X1U7P5#K%U-;V3:E;Z9XET72;RXB?6-4LM)2YU
M>V_K@U_7]$\*Z%K7BCQ+JVGZ#X<\.:3J.O:_KNK7<-AI6C:+I%G-J&J:KJ5]
M<O';V>GZ?8V\]W>74\B0V]O#)+(ZHC$?Y6?_  =<_P#!/#]G?]A#]MCX0:W^
MS#X!T+X3?#?]H;X-W'BW5?AEX4M)-/\ "7AWQ[X-\4WWAW7]0\+:6)WLM!T?
M7M&NO"]P_A_2K:STRQU>VU:]M(475#!!_7A_P57^+WQ/^)?_  :V>(_C1X'E
MN;[Q9\6OV&OV.O&'BRZB$JWLO@SXI77P)N_BU=>6\B/LD\$>(O%#:HLTC&/3
M'U!V6:1!%( ?)/[2O_!Z)^PY\+O'.O\ A#]GS]GOXR?M,:1H6HQ6$'Q%EUS1
M/@]X(\31JT8O]1\,)K^E>)O&LUA &E2RDU[P;X>FU&>$E8;>QE@OY/O'_@E_
M_P '-'[#7_!2OXM:9^SS#X<\?_LX?'CQ*MR? G@_XJ7'AW4/#/Q%N;2T:]N=
M#\&>.="OS;7'BE+>&ZGM_#NNZ/H%[JL,##0FU6Z6:T@_CZ_X-U?VS_\ @B'^
MSYX)^)_PP_X*>? #X8ZY\7_&?Q2_MCP#\?OC-^S_ */\?? 6E?#K5?"GAGPW
M;?#YX;CP]XWUCP#<Z=XCM?%.N:EKUKX4BTC4]+\4[-:UZU@T6.&OZ)O!G_!N
MU_P2M_;,_:^TK_@H3^PG^V1IG@?X0^'O%/PT^(/A'X6?L5W'PLU3PUX ^,7P
M\UJ+7)-=T[Q#J$_CG2_!5I?ZKH^AWZ?#@_#K2T\/:K9ZM+"_V/48-+TL _HJ
M_P""GG[-4/[8'_!/?]L+]G'[%9WVK?$SX"^/[#P?'?VHO+:W^(FBZ--XG^&N
MHM!]XOI?C[1/#FHPR1%9X9;5)8&$J(:_E)_X,H?VP;SQ1\'OVI_V'/$FH7%Q
M-\*O$^B_'_X90W5T)O)\)_$-8_"GQ"T;3[=@)+33=#\6Z%X;UUD1GAEU/Q_J
M,VV*5W,_]T6.,'GC!SCGUR, <]^,>U?Y@_\ P;WZYIW[,?\ P<O_ !A^ 6AQ
MQV.A>,/%G[=W[-.GVL$;PV\.D_#O7_%7Q+TNS2.-/+AAC_X4791PQR>7$K)%
M$A\TPQN ?Z?-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?Q;?\'M>G7,O["O[(^K)(XL[
M+]K.?3IXA_JWN=4^#WQ!N;21N/OQQ:/>JG/W99.#V_M)K^;/_@Z_^ $GQO\
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MX3UW2+37[+2M<T74[O1[B\CU&WT_6-+O9K9+;4+268 _I;_X+,?\JZW[1/\
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MKJ^JZA<V]AINFV%O/>7UY/#:VL,L\J(W\5?_  9[_L;_ +7O[,O[3G[7^O\
M[2/[*O[2/[/NA>)O@1X-T?PWK7QO^!OQ.^%&D^(-6M?B!'>W.EZ)J7CSPOH%
MGJNHV]F#=SV5A-<7,-L#/)$L0WT 8_\ P?,?\A3_ ()C?]>'[8__ *4?LN5_
M0[^P+_RK??!S_M&'XI_]4QXIK\8_^#R7]DO]JG]J#4?^"=K_ +-/[,_[0/[0
MZ>";+]JY/&;_  ,^#/Q&^+2^$7\1S_LX'P\OB=O /AOQ - ;71H>MG1EU4VA
MU0:/JAL1.-/N_)_=K]B3X4_%'PI_P0&^%'P;\4_#;Q]X:^+VG?\ !.KQ)X(U
M#X5:_P"#O$.C?$BP\:3_  E\2:;!X0O/ VHZ=;>)[7Q1-J,\%A%H$^EIJLE[
M-%:I:&>1(R ?R'_\&2'_ ">M^V)_V:WH_P#ZMGPG7R5_P>'_ /*7X_\ 9K7P
M3_\ 3K\0*_4G_@S^_8R_;!_9G_:\_:K\2_M(?LH_M*?L_>'/$7[-^E:'X?\
M$'QN^!?Q0^%.B:[K<?Q.\,W\FCZ-JOCSPMH-AJ>JQV%O/>OI]E//=K:0S7+0
MB&-W7YA_X.K?V$OVW_VB/^"IQ^(7[/\ ^QM^U7\<_ /_  S?\(="_P"$X^#O
M[//Q<^)O@_\ MO3-2\<2:EH__"3>"O"&MZ+_ &KIZ7=H]]I_VW[7:)<V[3PQ
MB:,L ?U+_P#!T!_R@9_;+_ZX?LN_^M9_ &ORQ_X,C?\ DS3]LO\ [.;\.?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN9\:_\B;XM_[%
MG7O_ $U7= '345^,]% '[,45^,]% '[,45^,]% '[,45^,]% '[,45^,]% '
M[,45^,]% '[,45^,]% '[,45^37PX_Y*'X#_ .QS\+_^GRQK]9: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_\ (F^+
M?^Q9U[_TU7==-7,^-?\ D3?%O_8LZ]_Z:KN@#\C:*** "BBB@ HHHH ****
M"BBB@ HHHH **** .S^''_)0_ ?_ &.?A?\ ]/EC7ZRU^37PX_Y*'X#_ .QS
M\+_^GRQK]9: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N9\:_\ (F^+?^Q9U[_TU7==-7,^-?\ D3?%O_8LZ]_Z:KN@#\C:
M*** "BBB@ HHHH **** "BBB@ HHHH **** .S^''_)0_ ?_ &.?A?\ ]/EC
M7ZRU^37PX_Y*'X#_ .QS\+_^GRQK]9: "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N9\:_\ (F^+?^Q9U[_TU7==-7,^-?\
MD3?%O_8LZ]_Z:KN@#\C:*** "BBB@ HHHH **** "BBB@ HHHH **** .S^'
M'_)0_ ?_ &.?A?\ ]/EC7ZRU^37PX_Y*'X#_ .QS\+_^GRQK]9: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *YGQK_P B;XM_[%G7O_35=UTU<SXU
M_P"1-\6_]BSKW_IJNZ /R-HHHH *^<_VJ/%/[+FA_!OQ-X?_ &P/&?PD\(?!
M3XCVMSX!UZ+XS>+O#O@_PKXG;6+&[N&\.VU[XBU+2XKO69;.QN]1L+;3)SK$
M!TZ34[ 126!N(?HRO@C_ (*6?L.:'_P4*_9+\<_L[:CKL/A/Q%=WVC^,?ASX
MPN+0W]KX8^('A>6:71[V_M$'G3:5J=C>:MX:UK[*1>Q:-KE_/99NXH%(!_'+
M^U#_ ,$Y_B%^Q#^T+^V'\9/^"<GQU\<^"/#G[&7PV_9S^.LT<_BN63Q;JO@;
MXX7WB^[OK71=?T>SLM%\5^%_!;^#K74;GPYXRL-0M?$_A2>[&IWFL7MB+/6_
MZ9/%<'[(O_!2[_@FC^RO\1?^"B7BCPI\-_"GC;PMX.^,=]>:K\6K;X*Z):?$
M_3/">L^'-;UC3=5U+5]%LKBPC37/$=Q9Z5??VA86MGJEO*T4SP6MT/YV?A+_
M ,$^O^"O'QB^,W[1G[ GCKXR> O"^C0_"[]DSP?^TM\2[KQ#9^);^Y_9_P#"
M-Y\0+GX(:!X9O],T^Q\4>*D^QP>*+>\TC48] U'6;30=)T3QEKUCI5RZZC_2
M/^WC_P $D? ?[47_  3V^''[%WPUUV'P/J_[/&F^"9O@)XI\0M?7UA;ZSX'\
M-W'A-K/QDUIYU_<Z=XOT&_U6WUB\MX[J:PUFZLM?BL;\Z8NG7(!^8W_!?3_@
MG9^QA\"?^"=^F?%/X$? [X;_  8\=_"/XB?#73/#GBCX>>'M,\.^(?%>C^(;
MN3PY?Z3XOUVRMUU7QG.8KBW\1PZOK][?ZW!J&C"YAU-8KK4(;S]S?V0OVIO!
MFI?LA_L-^)?CU\6O 'A/XL_'OX"_ 2]T_3?&WC3PWX;\2_$GQWXT\&>&80?#
M&C:OJEMJ/B#5/%6OWPELK#28+RYGN]0CMHXVF.ROYY[G_@E[_P %H_VX9/@C
M^S7_ ,%!OBSX%\._LE?!#7-(U+4O$'AK7_!VN^+_ (@6^@Z7+I5A=P)X:M(]
M=\0^*DT6YO/#6GZ[X[_L"#28]1U'Q%=:?K^K+LU+]6/^"L'_  2EU+]L7X2_
M '4?V8O$FD?!_P"/W['US;3_   N;BXO=)\-+X>T^#P\;3P?]NTZ&[E\/WFD
M7_@[PGJ?@_7Q87\6CW>E3V4UO'::O<WUF ?D)_P4;^"5G_P0K^/_ , /VZ?V
M0/''C.YA^-?Q"\4^%?VA_AM\0[_0O%,?Q'M);VU\<Z_)8:@=#TZYT:/Q)#/K
M$5\;%8DT36X_#]_I#6EN;NPN/WO_ &KOV,O^"<_[6W[1GP(\5_M27/A'Q+\;
MO#FD6>F?##X2^*OBQ%HDGC#1H9M;\9+H]Y\'9M<MV\8VS2R:GJVK0QZ--+J-
MAI!M-7DN]#TZ:S'XX^ O^"5G_!4O]N?]I+X'?$O_ (*T_$_P-+\'OV<M234M
M"^'_ (5N_!E[J/CJYT_4=+O)[1-+^'6E:;X<TRR\=7>AZ7<^+O$VLWLOB%]&
MM5T33M#TPW$;Z1]R_P#!77_@EW\<_P!I[XI_ W]M#]BGQ_I'PZ_:\_9^AL-)
MTM]<U#^QM/\ %?AW2->O?$'A[[)JSZ?J>G6NM>'=2UOQ&DMCK]C/X?\ %.A:
MY>:)K,D5K!%#= 'Y@?\ !5_X!?"#]AK_ (*C_P#!*KXL?LD?#SPK\$O$/Q$^
M)NDZ)XJ\(_"G0M)\'^'-5MM%^)GP^\+3M!X7T>TM-#L+GQIX5^(WB/PAKTMG
M:6ZZOI\:"Y7[2DES+_997\PG[*?_  3)_P""@G[1_P"V_P##S]N?_@K-XK\#
MRWG[/]OIA^#7P:\(W/A?6=-F\0Z)<ZAJ&@:M=V/A1;GPEX<TGP_XBN8?&Z7-
MMJ.K>*?$7BBUTA-1ETS2=$M[27^GN@ HHHH [/X<?\E#\!_]CGX7_P#3Y8U^
MLM?DU\./^2A^ _\ L<_"_P#Z?+&OUEH **** "BBB@ HHHH **** "BBB@ H
MHHH *X3XH^.(OAE\,OB+\29].DU>#X?>!/%WCB;28KE;.75(O"?A_4->DTZ*
M[>&X2UDO4L#;)<O;SK THE:&4*4;NZ\"_:N_Y-<_:3_[(%\8O_5=^(Z /RG_
M .'WOA;_ *-XU_\ \.-IW_S(4?\ #[WPM_T;QK__ (<;3O\ YD*_GLHH _H3
M_P"'WOA;_HWC7_\ PXVG?_,A1_P^]\+?]&\:_P#^'&T[_P"9"OY[** /Z$_^
M'WOA;_HWC7__  XVG?\ S(4?\/O?"W_1O&O_ /AQM._^9"OY[** /Z$_^'WO
MA;_HWC7_ /PXVG?_ #(4?\/O?"W_ $;QK_\ X<;3O_F0K^>RB@#^A/\ X?>^
M%O\ HWC7_P#PXVG?_,A1_P /O?"W_1O&O_\ AQM._P#F0K^>RB@#^A/_ (?>
M^%O^C>-?_P##C:=_\R%'_#[WPM_T;QK_ /X<;3O_ )D*_GLHH _H3_X?>^%O
M^C>-?_\ #C:=_P#,A1_P^]\+?]&\:_\ ^'&T[_YD*_GLHH _I<^#G_!7?P[\
M7?BK\/OA?;_ W6M#G\?>+-%\*PZQ-X[L;^'3)-9O8K-;V2RC\+VKW20&42-
MMS T@&T2*3FOV,K^+/\ 8M_Y.T_9T_[*]X(_]/=K7]IE !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7,^-?^1-\6_P#8LZ]_Z:KNNFKF?&O_ ")OBW_L
M6=>_]-5W0!^1M%%% !1110!RFG>!/!&D>+O$GC_2O!_A?3/'?C+3]!TCQ=XT
MT_0-*L_%?BG2O"HU!?#&F>(O$-O:QZMK6G^'!JVJC0K/4KNYM])&IZA]@CM_
MMMSYG5T44 %%%% !1110 4444 %%%% '9_#C_DH?@/\ ['/PO_Z?+&OUEK\F
MOAQ_R4/P'_V.?A?_ -/EC7ZRT %%%% !1110 4444 %%%% !1110 4444 %>
M!?M7?\FN?M)_]D"^,7_JN_$=>^UX%^U=_P FN?M)_P#9 OC%_P"J[\1T ?Q*
M4444 %%%>2_''XU^!?V>_AGXC^*WQ%OKBS\-^'8K</#8P?:]4U74;ZXCL],T
M?2;3?&+C4-1O)8X81)+#;0)YMY>W%M8VUS<Q 'K5%?B'\'/^"P?AGQ!\6M:T
M3XK^"O$/@CX:^,?$F@:?\-O$EQ!8M'X/L;K1+ S?\)Q,@MS=0:I?W<&M+JNG
M2746DZ/J=GYMO/90/JL_Z=?M)?M*_#?]ESX:W'Q*^(MU=RV4EW%I7A_0]'2W
MN-;\3ZW<P3W-MI>DPSSV]N2;>VGNKJ\GGBM;*TADGED)\N.4 ^@J*_)/X)_\
M%=?A#\3_ (B>'OA[XQ^'?C'X32>,KVSL?"7B+7+VRU;1-0FU6XCM-$.I26]K
MI]SI<.KW3FV@OHH-2TJ&8*;G48H#)/#]X?M(?M'_  X_9=^&UY\2OB1=W7V%
M;N+2M#T/2DAGUWQ/KUS%-/;:/H]O<3VT+3M!;7%U<W%Q/#:V5G;SW-Q*JHJN
M >^45^5_[./_  55^&'QU^*&A?"GQ%\._%?PGUSQF=O@34=>U&RU71?$4LZ/
M+IEG-=1V>ESZ;>:VD<D>D%+;4--O;Q4L(]3^U7%I'<>U_M>_MZ?"W]D2;P]H
M&O:1KGCGQ_XIMVOM)\$^&9+.&Z@TH32VL6JZS?7;LNG6E[?126.G1PVE]>W]
MQ%<&WM&AM;B:, ^Y:*_/7]DO_@HK\+OVIO%>H?#?_A&/$?PR^)UAI]SJ:>$O
M$TD-[#JMMI_E#5DTC5[>"S\V^TPRK+<:;J&GZ9?R6:RWEM;SPVE\;3]"J "B
MBB@#Z<_8M_Y.T_9T_P"RO>"/_3W:U_:97\6?[%O_ "=I^SI_V5[P1_Z>[6O[
M3* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_P#(F^+?^Q9U[_TU
M7==-7,^-?^1-\6_]BSKW_IJNZ /R-HHHH **** "BBB@ HHHH **** "BBB@
M HHHH [/X<?\E#\!_P#8Y^%__3Y8U^LM?DU\./\ DH?@/_L<_"__ *?+&OUE
MH **** "BBB@ HHHH **** "BBB@ HHHH *\"_:N_P"37/VD_P#L@7QB_P#5
M=^(Z]]KP+]J[_DUS]I/_ +(%\8O_ %7?B.@#^)2BBB@ K\JO^"POP_\ %?C?
M]DN+5/#%M=W]O\._B-H'CCQ396<5Q<3?\(S#HGB;P]>:D8+:.5Y(-'N_$-CJ
M-_+(%MK'2X;_ %*YDCALF=?U5KY8_:N_:L^'W[)O@_P[XK^)/AKQ?XBT+Q?X
MB/A"$>%=.T748K6]FTV\U$C68]9UO2 MG<6%E?%5M(]1FF^SRQM; $%@#\M?
MV3_BE^R!^UWXV^,GAWXS:'X6TRX\?^/OA%XL^'/PP\:7LVE[M9\'_!_2OAU>
M6_A_4=/N;'3]3$=[::I:Z=HHOA=ZCI=Q9S7.B+(/)M_TQ_:4_8P^'/[3TWPF
M7QKKWBK3-&^$6I37^D^%M'FTF7PYX@BN9="\^Q\3VNK:7J%Y?6[66@Q:;&UM
MJ%G*EG?ZDK/))<B2/\.?VO?@1\#[[3?VR_CIX"ETWPO??#GXK? <_#&/P9=6
M6F>%==TCXC^ ? >IZK;:;I5A$MD9Y;C6M1\96U[I'V2Y62UO99'EMV=$_7OQ
MW^US+^SE^PU\*_C/\1X3K'Q0\3?"OX=6^D^';QQ:7?B7XCZ]X.TZ^N6U!,I)
M;6=E*;S7/$1C42V]K;W%I;@WL]I%( ?$_P#P6,NO"GC/5OV;_@3X-L-.U+XU
M7_BHMHMEIT-NNH:'X;\0K;>'=(TJ>6!3<:?9^(=>6RGLK5%$7E^'9KIHXUA@
M:3$_X*D>*_#-Y^U=^QW\+_B3K5M;_#GPI:Z+X\^(4NKK+)HUQX>USQO'INOS
MWUI&DJWT]QHG@'5+2&V$$TS&_-M"A^W,DGI__!.K]FO5?$GB:^_;E_:4UJPU
MSXK_ !(FG\0> --U.\M6ET'2=5M1;1>++RV:3R[*_O\ 2633?">DQ#RO#OA5
M;9EV7-[#:Z1Y%_P59\)>'M/_ &POV0_B/XVCMC\/-?7PIX5\77&HA3HO]@^#
M/B>FM^(EOY'!@%N^A>-IFNA(=KVD;M@HCD 'O7@W]I7]@/\ ;K^//PTTC6?"
M/C;0_B3\,=0>X^#&H^)GD\&:;K=YI^HZ?K-E;:7+X,\5SM-=V-SH%MJ6CZ)X
MDBM(!$T\-G%-<W=Y8C[8U+]C?X>:S^U7IO[6FL:[XFUCQGH^D1:1I'A?4_[$
MN/"&CBUT.71+.]TJW32(=5AO;;[3?:E'+=ZI?!-2O[BX@6 ):K;?GA_P5=MO
M#%G\1/V*]6\#1:-%\5_^%BP+X7;2S%!/<Z!;ZUX0FT%IGT\;CIEOXA^Q+HLH
M5Q$;C4_[-(#72GW[_@I/^V3K7P/\/:'\$/A!*;KX\?%^.+3],>QF1M1\'>']
M6NVT:#5[6$'</$/B#43+H_A;S#%';S0ZAJQD\S3K6"Z /F;Q!?Z#\5_^"S7@
M"Y^%:07\7PQ\+7%M\3];T>. 6B:QX?\ #/C&TURXO+I-JW;P'Q%X9\$WMPIE
MDCU)1IQ.;5BG[R5^>G[ /[(OAG]E;X?RW6NZOI'B'XV_$*.VOOB!KT%_!>FS
M)9KJU\(:+.TKS36&F2S/)J-\/WNNZP9K^7%K#IMM9_H70 4444 ?3G[%O_)V
MG[.G_97O!'_I[M:_M,K^+/\ 8M_Y.T_9T_[*]X(_]/=K7]IE !1110 4444
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M_:KZX8Q-(SRR?L-10!^+_P"SM_P2&_X4'\:OA[\8/^&A/^$L_P"$$UJ35_\
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M,?\ A4/Q[^'?_"1>+U\:>%] 7PS_ &G\6=1O-&OMVC:QJFJ?8--1=3/]G_:
M_P!DAN%/]+M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"7PC::U9LT)A;7;3QM;:9%XVMO%[L6NI?&D7B%?%4]\\E]/J\MU+)*_Y7?\
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MSPXWV2\UW2H?L*:PVI7'VKS+6SGB@N7A_4^OYK?^#?O]FW1/B+I_QP_X*_\
MCKX0>#/A;\3OV\?$NLQ? /X?^&?!6@^#M-^!G[&7A/6!H?PO\&Z'I.@HFFVV
MI_$1?#MGXY\:Z[816Z^,O(\+ZW)&K2R^9_2E0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<YXO\8^$OA]X8UWQMX\\4>'O!7@WPQIMSK'B3Q9XLUG3
MO#OAOP_I-FGF7>IZUKFKW-IIFEV%L@WSW=[<P6\2\O(M='7\KW_!2KPY>_\
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M3?\ !=S_ ()7?'3X1_M"_'7X2_M-:GXW^%O[*FA>#?$_Q^\2:5^SU^U!'/\
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?S&>/93\'_\
M@ZZ^#'BGQR8=+\-?M1?\$M?%/PG^$>MZK(D-AK?Q#\"?%6_\;^)_!VA3RE5?
MQ#IWAOPLNKW-BI$C6/B.U,1DEO5B/].=?EA_P5:_X)LC_@HC\)/AX?A[\5-3
M_9Z_:L_9N^(=E\9OV5/VAM#MWN+_ .'/Q&TY(TGT_5X;<I>WG@SQ5#;6,'B"
MRM)2Z7FF:)J[6>K1Z0^BZD ?I[=:SI%C?Z;I5[JNFV>J:U]K&CZ;=7UK;W^K
M'3XDGOQIMG+*EQ?_ &*"2.:[^RQR_9HG22;8C*3_ #2?LXR6_P 8O^#IC]O+
MXD^"KF&\\+?LP_\ !.CX3_LW_$F_MED$?_"T/B5X[^'OQ2T72!,J&WNQ9^']
M!URUU%O.#VNK:')IWEM-8W8@^'/VP?V._P#@XD_;_P#!7P@^!?[0/[-O[#/A
MSXJ? ?QE8^*_A5_P44^&O[2'Q1^'>L> /$9GLK#5/'_@[P3X#\86/B>'Q;J6
MD:;;'4_[4^'$GAMY&^TZ+X/T>[6VAT[[V_X(?_L]_M,?\$[/C%^T7^Q;^T_^
MSSXQ\>?$7XU>*_B%^U?J_P#P4V\*:Y=^,_A5^TPPUKPQHXT'XDW?B.:U\1?#
M'XHZ(WC&(:'\/Y(;^/7@?''B?3HY;6WU?Q'J@!]G?\'!'_*&7_@H+_V0V7_U
M+O"U?H[^S+_R;=^SY_V1#X4?^H'H%?(O_!8;X ?%S]J;_@F9^V)^SY\!_"7_
M  G?Q?\ BI\*9/#7@/PC_;WAGPQ_;NM-XCT&_%E_;_C+6?#WAC2\VEE<R_:=
M9UK3K3]UY9G\QXT?[6^!?AO6O!WP2^#OA#Q)9?V=XB\*_"SX?>&]>T_[1:7G
MV#6M#\):1IFJ67VNPGNK&Z^RWUK/!]HLKFXM)]GFV\\T+)(P!:^,O_)'_BM_
MV3;QS_ZB^J5_"5_P0\_X-[?V:?VZO^"9'[.W[47Q"_:S_P""@_PP\7?$B]^,
MD.J^"/@5\>/ /@KX7Z.O@OXY_$CP'8/X<\-ZW\%O%^IZ?)J6G>&;35-::Y\0
M7PO-=O=3O81:P7$5G;_WC_$S2-1\0_#?X@:!I%O]KU;7/!'BO2-+M/.@M_M6
MHZEH-_965OY]U+!;0>?<SQ1>=<30P1[M\TL<:LX_*G_@@5^RK\>OV*?^"4O[
M,_[-?[37@/\ X5I\:OA]??&^;Q?X+_X2CP9XR_LB/Q?^T!\4?&_AUO\ A(_A
M_P"(O%?A._\ [1\,>(]&U/&EZ[>M:?;/L5\+;4+>ZM( #Z#_ ."<G_!.#X6_
M\$SOA3XV^$?PH^+_ .T;\9M&\=?$*?XCZCXB_:7^('AWXB>,--U.?PWX?\,G
M1=$U?PWX&\!6MGX:BM?#MO?0Z=/IMY<)JE]J=S]N,=REO!^0'_!V1\*M%'_!
M-_3_ -KWPYJFO>!_VAOV0OBYX!UGX,_$_P &Z@^A>+-#L?B[XGT7X7>/_#(U
MNT"ZC'X>\0Z3K5AJ>H65I<V_VG5/#6B^<\EF+RUNOZB:_%3_ (.#OV2/VA/V
MX?\ @EM\;OV<OV7?A_\ \+/^,OB_Q;\&-3\.^#O^$K\$>"O[1L?"?Q8\)>)?
M$$__  D/Q#\2>$O"MI]@T33+Z]\J^URVFNO(^S64=S=RPV\@!^B?[&W[.'PO
M_9&_9:^!?[.7P;T9=#^'GPJ^'/AWP[HD!6+[;J5P;-+_ %SQ)K4T,<27GB'Q
M5KUYJ?B3Q#?^6AOM:U2^NBJ>:%7Z6?[C?[K?R-97A^UGL=!T2RNH_*N;/2--
MM;B+<C^7/;V4,4T>^-GC?9(C+NC=D;&59E()UF!*L!U*D#ZD4 ?SB?\ !J#_
M ,H2?V;_ /L?OVB/_5Y>.:WO^#D_Q]XRU/\ 8M^$'[%'PQU'5--^)'_!2/\
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M3+)>7"M&L7X._P#!U;^S5X6\<? _]C_]H+0_$/BCX;?&S0_VI/"/[*=K\2?
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MVL-]J*VJQ"_NHM2U_7?V1H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M #\ _OXHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV<-UXEL=5NHOM.GZ=-;_ $5^UK_P:U?LZ?LB_P#!/3Q3\?\ ]DWXC?&KPO\
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M&ZUN=/&VA?'SQ1^RO\$]:NUNGDGU%M$2+P;K>HQ7$A@,6EWBS2+:HS#\=O\
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M'Q"\>^,]1%A!KM_8:-I=S9Z^ ?>O_!NS_P JUOQY_P"P9^W5_P"H7JE?(?\
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M#OAZUDM8/$NJZ%X2TF_C\4W4&GQ:AXN;0X]0LM9 /7?^#''_ ))U_P %&_\
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M9\4/B9XJ-GHFL^*_"7@?Q&+J+PMXXM+6YNKCPSILVG:];W#Z=)=16MKJ$_\
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M_!L]^V!KO[:&@_M__P#!8[XNV/Q0\;^"_%&F>/\ 0?AA>?$"]^-'C'Q[\0M
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MKM]:1?K5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<UB'3?\ A+_B3XI\3Z]<7V@W>L6NEVL9T.XTO3=*^\OV!?V!_P#@N[_P2/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KY8_;HN-9M/V)/VQ;KPY$LWB&V_98_:#N-"A=VC2768?A)XND
MTN)G1'=%DOE@1G1'90251B #]3UR_CCPGIWCWP5XP\#:P"VD>,_"WB#PGJ@
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MEO/( ?2'_![?_P F3?L>_P#9TVK?^JE\7UW?_!13_E31^&__ &8]_P $P/\
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MH&1S\L:!G?Y%:O?O^#)<:'_PP/\ M7FW\G_A)3^U].-6V^7]H_L,?!CX7_\
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M>*GM .1]ZZ6%0>Q.0">#^ O_  90->'_ ()M_M*HX_XEZ_MO^+FM3S_Q^/\
M ;X B^&.G$":=T.>>< #/ZX_\'$GQ>T[X)?\$8OV[->N2%E\6?"K3_@[I-I&
M(Q)<WOQF\8^&?A>8X$9D4K9:;XHO]3N%4[H['3[J1$=HPA^:?^#4?X!W'P0_
MX(V?!?7=3T*70==_:"^(7Q7^/.K0W,8CNM1M-:\1KX \':W* S$P:S\/OASX
M1U+37)!DTJYL9=J^9B@#^D*BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBJ]Y=V]A:75]=RB&TLK>>[NIF#,L5O;1
M---*516=A'&C.0BLQ PJDX% %BBO)O\ A>?PH_Z'*R_\ M6_^5]'_"\_A1_T
M.5E_X!:M_P#*^@#UFBO)O^%Y_"C_ *'*R_\  +5O_E?1_P +S^%'_0Y67_@%
MJW_ROH ]9HKR;_A>?PH_Z'*R_P# +5O_ )7T?\+S^%'_ $.5E_X!:M_\KZ /
M6:*\F_X7G\*/^ARLO_ +5O\ Y7T?\+S^%'_0Y67_ (!:M_\ *^@#UFBO)O\
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M%?D1_P /H_V7/^A"^/O_ (2WP[_^>G1_P^C_ &7/^A"^/O\ X2WP[_\ GIT
M?KO17Y$?\/H_V7/^A"^/O_A+?#O_ .>G1_P^C_9<_P"A"^/O_A+?#O\ ^>G0
M!^N]%?D1_P /H_V7/^A"^/O_ (2WP[_^>G1_P^C_ &7/^A"^/O\ X2WP[_\
MGIT ?KO17YA_##_@K#^SK\6/B)X+^&GAWP9\:K+7?'7B/2O#&D7>M>'? UMI
M%O?ZO=1VEM-J,]C\1M2O(;-)9%:>2VL+R94!,=O*V%/Z>4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<SXU_P"1-\6_]BSKW_IJNZZ:N9\:_P#(F^+?
M^Q9U[_TU7= 'Y&T444 %%%% !1110 4444 %%%% !1110 4444 =G\./^2A^
M _\ L<_"_P#Z?+&OUEK\FOAQ_P E#\!_]CGX7_\ 3Y8U^LM !1110 4444 %
M%%% !1110 4444 %%%% !7@7[5W_ ":Y^TG_ -D"^,7_ *KOQ'7OM>!?M7?\
MFN?M)_\ 9 OC%_ZKOQ'0!_$I1110 4444 %%%% !1110 4444 %%%% !1110
M!].?L6_\G:?LZ?\ 97O!'_I[M:_M,K^+/]BW_D[3]G3_ +*]X(_]/=K7]IE
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1K<V>N?%#Q3>CQW\:_%MD7>UUKQ]J-C:VLFF:/++'%-_PC/A33[:VT#0E>*
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MX#_['/PO_P"GRQK]9: "BBB@ HHHH **** "BBB@ HHHH **** "O OVKO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N9\:_\B;XM_P"Q9U[_ --5W735S/C7_D3?%O\
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M !1110!\8>/_ /@H_P#\$\/A1XR\0_#GXI?MZ?L8?#7XA>$=0?2?%?@3Q_\
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M2R_Z26?L ?\ B9'[.O\ \\:C_A[%_P $LO\ I)9^P!_XF1^SK_\ /&K\ ?\
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MU._X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_HOG[?_P#X=/\
M9U_^A5H _+'_ (:0_9F_Z.A_9>_\21^"'_S>4?\ #2'[,W_1T/[+W_B2/P0_
M^;ROU._X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_HOG[?_P#X
M=/\ 9U_^A5H _+'_ (:0_9F_Z.A_9>_\21^"'_S>4?\ #2'[,W_1T/[+W_B2
M/P0_^;ROU._X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_HOG[?
M_P#X=/\ 9U_^A5H _+'_ (:0_9F_Z.A_9>_\21^"'_S>4?\ #2'[,W_1T/[+
MW_B2/P0_^;ROU._X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!++_H
MOG[?_P#X=/\ 9U_^A5H _+'_ (:0_9F_Z.A_9>_\21^"'_S>4?\ #2'[,W_1
MT/[+W_B2/P0_^;ROU._X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4_P#!
M++_HOG[?_P#X=/\ 9U_^A5H _+'_ (:0_9F_Z.A_9>_\21^"'_S>4?\ #2'[
M,W_1T/[+W_B2/P0_^;ROU._X@J?^"67_ $7S]O\ _P##I_LZ_P#T*M'_ !!4
M_P#!++_HOG[?_P#X=/\ 9U_^A5H _+'_ (:0_9F_Z.A_9>_\21^"'_S>4?\
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M?L ?^)D?LZ__ #QJ/^'L7_!++_I)9^P!_P")D?LZ_P#SQJ_ '_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JT?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6@#]_O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%RR,J1Q_MF_ ^21V.%1$\(?%MG9B> JJ"2>P&:_9?_A[_P#\$I/^DDO[#/\
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M\EOIK>>[N[F#1O#UEK?B+7[BWM_^/2WDT+XJ:9;*/[+^&C-; 'ZR_P#!:/\
MX*>^/_\ @GK\,/@AX%_9C\#>#?C)^W)^UM\8O#/PA_9F^#GC2UUC5] UB:76
M-(B\9>+/$^B>&O%?@OQ'<>'=&MM5TGP[#<V'B32H[3Q/XM\/WVH7#Z-8:O'7
MZX?#9/B'#\// \?Q>OO!VI?%2/PEX?'Q(U#X>Z/K'AWP%=>.!I5J?%,_@W0_
M$7B'Q9KVD^%WUK[:=#L=:\3:[J=OIOV9+[5;RY$DS?S"_P#!,#PIJ'_!5W_@
MI[^T+_P6B^(MO<ZC^S=\ M0\2?LE_P#!-#0=4B+Z3>Z)X8GO]'^)?[0&F6-S
M')&MSKUSJ&NV^B:O;.LK7?C3Q)H=^@O/ .D26_[A_P#!1C]DWXH?MM_LUZE^
MSC\,OVC/&7[+D?CKQAX4C^)/Q.^'@N?^$XG^$MC<7-QXY\$^&9;6]TTVNH>-
M[,6V@27MQ?Q6-E8W5Y<WUIK5K%+H&J@'P+\$_P#@M5X0_:@_X+.>*_\ @FY^
MSN?A]X]^"GP@_9T^(7C3XL?&2P;5=5U?4OCMX2\8^"]&E\%?#_6]/U^+PK<>
M#O"6E>([C3_%>HRZ)K5UJWC#[1I^DZEI5GX<N9->^F/^"JO_  4!^/\ _P $
M^?AC\,/'G[/O[ GQA_X* Z_X]\>7WA'7? ?P<U#QII^L>!='M/#]YK,?B[5G
M\$_!;XUWLFFW-[;0Z,BWFC:/:BZNHRNIR2[;63\+_P!C3]B3]G?_ ()\_P#!
MRI\._P!FK]F3P6G@[X=^&O\ @CI>ZI>S7,_]H>)?&?BW4?CY<V^N^.O&VMM'
M%-KWBW74T^QCOM0>*""WLK'3M'TJTT[1-+TS3;/^Q^@#^,[Q+_P=!?\ !0KP
M9X>UWQ=XP_X-R_VR_"GA/POI&H^(/$OB?Q+XY^-VA>'O#N@Z1:2W^K:WKNM:
MI^P?:Z;I&D:78P3WNHZEJ%S;V=E:0RW-S-%#&[K_ $(?\$H?V^]=_P""F?[%
M_@7]K[6_@'JG[.,?C_Q%XUTO0_ &I^-+GX@B\T+PGK]QH%IXKTWQ9<^ OAQ_
M:FEZ[<6=XULUOX:2VA>UFABO[[8TH_*K_@N_\4O&O[5WQ^_8P_X(;_!#Q#K.
MB:Y^VAXIL_BC^V!XD\+W%Q!JG@?]C7X=ZE?:MXBT^ZO;))FTD?$.Y\*>)%M9
M+](M.U6X\'V7A'4C/8>-&MKC^D#X:_#CP/\ !_X>>!_A1\-/#6E>#?AY\-_"
MF@>"/!'A31+6.RTCP[X6\,:9;:/H>CZ?:Q*J16MAIUI;V\8 W,$WNS.S,0#M
MJ*** "BBB@ HHHH **** "BBB@ HHHH **** /@7_@H]_P %'?V>/^"8?[.V
MI_M"?M!:CJ=S!<ZG'X4^&_PY\+0PWOCOXL?$"]M+F[TSP9X0L)Y8;<7$MO:7
M%[JNKZA-;Z5H>EV\][>SF0VEI=_@W;_\%:_^#C#Q?H]O\=/ 7_!"?0X?V>+S
M29_$NG^$?%7Q=MK3X^7_ (=E1-0TR5/#=[XO\-^.8-6ETI7W:,OP$O-3N[R>
M!+.QWJEK=:/QGT32?V]_^#I[X4_ GXDPKXF^#W_!,G]C@_M%:/X#OXX;_P ,
MW'QQ\8ZSX(NM.\2:Q8W"RVYU&S'Q2^%.O:;$Z),+WX<:/=*'M3=))_6;0!^5
MG_!*[_@K3\!/^"J'PR\8:[X T/Q+\)/C=\'M;7PI^T%^S;\1E%O\1OA%XF>Z
MU*QMQ>JUK8-K'AW4[S1M6M=,UM=.TVZBU#2]3T77M&T+7=.O-,B_3#Q?XO\
M"OP_\*^(O'/CGQ'HGA#P;X1T;4?$7BCQ3XDU*TT;0/#V@Z1:R7NIZOK&JW\L
M%EI^G6%I#+<75W<S1PPQ1L[N *_E1_:Z\,:=^PA_P<R?\$[_ (_?"N.W\+^'
M?^"G7PY^*OP$_:+\+Z>IL=+\9>,/ NG:;%HGC:ZM[9[>UD\07.L:Y\'7N;FX
MBNGN'\*7LP5=0UZ]O)/U?_X*=_\ !+B]_P""H/B/]GSP'\3/VD/B=\,_V/\
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MUG5[ZYGF>2XO=3UG6M1U'6=7U&ZEEN]2U6_O+^[EEN+B61OL*O'/V=O"NO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'AX>'AX>'O_  !$( %8 2@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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MQ\4_^BE>,_\ P>7/_P 71_PMCXI_]%*\9_\ @\N?_BZ /UEHK\FO^%L?%/\
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MQ;U#_P!)I*_,OX(_\EG\#_\ 8Q:?_P"E,= 'ZT4444 %%%% !7PI_P %)O\
MDHGA;_L$O_Z.:ONNOA3_ (*3?\E$\+?]@E__ $<U 'I'_!-[_DD_B'_L.M_Z
M(BKZCKY<_P"";W_))_$/_8=;_P!$15]1T <7\>/^2'^//^Q;U#_TFDK\R_@C
M_P EG\#_ /8Q:?\ ^E,=?II\>/\ DA_CS_L6]0_])I*_+GX=ZS:^'?B!X<\0
M7L<TEKIFJVMY,D(!=DBE5V"@D G"G&2!GN* /UZHKYF_X;6^%G_0 \9_^ =M
M_P#)%'_#:WPL_P"@!XS_ / .V_\ DB@#Z9HKYF_X;6^%G_0 \9_^ =M_\D4?
M\-K?"S_H >,__ .V_P#DB@#Z9KX4_P""DW_)1/"W_8)?_P!'-7J7_#:WPL_Z
M 'C/_P  [;_Y(KYL_:W^+?ASXN>*M&U7PW9:K:06-BUO*NH11HQ8R%LC8[C&
M#W(H ^B?^";W_))_$/\ V'6_]$15]1U\N?\ !-[_ ))/XA_[#K?^B(J^HZ .
M?^)>B7?B;X<^)?#EA)#'=ZKI-U90/,Q$:O+"R*6(!(7+#. 3CL:^(/\ ABKX
MI_\ 0?\ !G_@9<__ "/7W_10!\ ?\,5?%/\ Z#_@S_P,N?\ Y'H_X8J^*?\
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M#MO_ )(H ^F:*^9O^&UOA9_T /&?_@';?_)%'_#:WPL_Z 'C/_P#MO\ Y(H
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@"A0*: P$B  (1 0,1 ?_$ !\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#G@CQ=KFL0Z+8WFJ:;:7FJ26:V-K<ZC8P3SI+=VZ2 'U+1110 4444 %%%%
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M;5K6ZD1(;A_\R/\ 9?\ ^"Q7_!6;5_"'QR_9>^'O[1?[9/[2'QI_; TGP/\
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MM4U75"/Y_?\ @M3^WA_P4X_X*2?\%7[S_@EQ^Q9K/Q>^%?@#PWX\N_A?\/O
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M=-MI[>+4O$%KXE\,Z;K7@SPIID]XUM;?VUXMU;7-#\,Z0;@PQOJFJVHD"*Q
M_P S+P)I/_!:S_@YE_:+^,7B[P1\1]4M_!/@26SU>_T77?B=XG^&?[,7P4T_
M5]2OY_ W@+PYHFAV^JKJ/BF>WL[R2#4H/#.N^+]7@T6;6_%FL($LIF /]9ZB
MO\RC_@F?_P %)_\ @HM_P1'_ ."E.@_\$]O^"C'C'QYXC^!OBOQOX7^'_C3P
MO\1?&MY\0]'^'5KX^GL=*\ _'/X,>-];OKN:U^'HEFL+_7=*TZ^MM N_#<GB
M(W_ARP\=Z0T5E_6!_P '0/QJ^,GP _X))?$[XD? ?XM?$SX)_$2P^+'P1TZP
M\>_"/QYXI^&_C2RT[5O&]K::I86GBGP;JNC:Y;66IVK-;:A:PWR07ENQAN8Y
M(R5H _H7HK_+F_8B_:4_X+J?\%C/V6]#_P"">?[)?QA^*AM/A1?^+/'O[5O[
M7?Q?_:#\>1^*?%<7C_Q-J$_PS^&GB#XPZA)XE^).E^$-/TC2+RUT[P/X4FUC
M4/%DBZT=:LK;P?H3QS_!.C_&7_@J+_P;N?\ !0K2O!OQ(\>>,;#Q!X0U7P[X
MT\?_  QM/B5K?B_X*_M"_"OQ7J$USJ=]';7\PTK6;7Q3#;Z]:Z9XIU#0K'Q7
MX6\66EY=-%I^LZ;=P$ _U9_VY/VA-7_9-_8V_:B_:<T#P[IWB[7?@%\"/B?\
M6]'\+ZQ=W-AI.OZGX$\(ZKXAL=)U.\LDDO+:PO;FPC@NY;5?M"P._DLDFUU_
ME/\ ^#5[_@H9^U?_ ,%(/VI_^"DGQK_:M^)M_P"-]>@\$_LXV?A#PM8I)I'P
M[^&>@WWB3XV7$GAOX=>#HIYK#P[I3-!:"]N2]YKVNO9VEYXFUK6]1A%Z?8?^
M#K;0OVWOC)^P_P# OXC_ +%FJ?&J'X#V/@KXV_$/]KG_ (5=\3;[P)X3U/X
MZS\.O!>K6B?%O0[+Q9X>M?B%X3DT<^)&_P"$;O+#Q-%)!)JJ)I;I=RK/_"+_
M ,$S/@W_ ,%:OB]J_P 8(/\ @E5K'[3NDZSH6F^"I?C4W[-?QVU3X(7<^F:A
M=>)D\"CQ=<:9\0_ #>([:.[L_%1T:&:75!IDKZDZ1VAOF:X /]K&BL[1UN4T
MG2TO3*;Q=.LENS,Q>8W*VT0G,KL6+R^:'\QBS%GR223FM&@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_BL_X/;O\ DR+]C_\
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MK'JXTZ"UK?\ !M'\4OV3?@K_ ,%8](\3_M[:AX#\*V'_  KCXF:)\/\ Q?\
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M"&LZLK)#&QUK7](TJVUS6G>.VMT>75=0O)'6")6<B-,?Y"7[.7_!0=_V*O\
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M;3];\!O!X7@OM(\/6>N26.M'Q=JVCW#^'=6TG3-=MXOT'_X(Q_\ !1?XJ?\
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M7AZ.\DU:TT]]7UW5K?3M.TKS;@ M_P#!D5_R:'^VG_V<AX/_ /58Z?7X'?\
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MGN+1K)O$?@;Q!<V.IVD$\L!2+4M%UO2M;\+Z[%#;1ZYH>H"TLS;_ ,OVB?\
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M=$3PVW@'XL_#..SANH_&>J-JJZI%K#SO!8&TDL5BN%N@#^IJBOC_ /X)]_M
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M#CX9R>-?BEK7AZ74+=EFLX/%%YX,TSPW'?0AKK3;[5;+4[$PW]E:W,/]>?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#FUB/2M4DTJ/5&M7U!--OVM%F6SN#& ?6W[3OPZUOXH?\&<WA?P[X?DFCO\
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MKX@_&[Q$_C'XQ?!WXC>,OV?/'_C2Z,AU;QC=>"],\+>*/#'B/Q SC%QXCO/
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M2\UI%W[!IFIVVQYXFB/^E\ % 50 H       P  .  . !P!0 M%%% !1110
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M:S>W*VUG:12ZMKU[]ATVQT_2K 6NF6%G:0?45 !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB4HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^G/V+?^3M/V=/^RO>"/\
MT]VM?VF5_%G^Q;_R=I^SI_V5[P1_Z>[6O[3* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N9\:_\B;XM_P"Q9U[_ --5W735S/C7_D3?%O\ V+.O?^FJ
M[H _(VBBB@ HHHH **** "BBB@ HHHH **** "BBB@#L_AQ_R4/P'_V.?A?_
M -/EC7ZRU^37PX_Y*'X#_P"QS\+_ /I\L:_66@ HHHH **** "BBB@ HHHH
M**** "BBB@ KP+]J[_DUS]I/_L@7QB_]5WXCKWVO OVKO^37/VD_^R!?&+_U
M7?B.@#^)2BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z<_8M_Y.T_9T_[
M*]X(_P#3W:U_:97\6?[%O_)VG[.G_97O!'_I[M:_M,H **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M OVKO^37/VD_^R!?&+_U7?B.@#^)2BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#Z<_8M_Y.T_9T_[*]X(_P#3W:U_:97\6?[%O_)VG[.G_97O!'_I[M:_
MM,H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGQK_R)OBW_ +%G7O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#^A7]^ ?<G_!M%JOQ&U;_@F;^U3I&C7=_?RZ+\:?B;IWPQMI[NZN5T[Q%?\
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M'B$>)+F-L>H\^.<Y'&<CJ#7Z:T ?3G[%O_)VG[.G_97O!'_I[M:_M,K^+/\
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MFFVWA'3GU5K*]CNYK;Q'J,.GIH-Q<6UT]_:_TC_&?X)_"C]H?X<^(_A)\:_
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MX=ZS;^'=/UR]DF:>[N[_ $BYTO5=+AN]0E>234;S3+33[N]FDDNIYVNY'N&
M/RP_8^U:?]J#_@JGXI^/?A'3[ZU\$:#?^.O&DMU/:SKC0)?"%[\-_"RWD@CC
MBL-3UU]2L=4-A<,9C%!JD*"X^R3S+^L?Q$_;U\*_#O\ :O\ "?[*-Y\/_$&I
M>(/%FJ>"M-M?%EMJVG0Z-:_\)F(#!-<6,L)O6^P>:WFQQL?.V+LD3>=GT/\
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ML_$7BW4;[Q7K.GRN@"%M+OM9FTP;=RA+-5#OC>WU1110!].?L6_\G:?LZ?\
M97O!'_I[M:_M,K^+/]BW_D[3]G3_ +*]X(_]/=K7]IE !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M /I\L:_66OR:^''_ "4/P'_V.?A?_P!/EC7ZRT %%%% !1110 4444 %%%%
M!1110 4444 %>!?M7?\ )KG[2?\ V0+XQ?\ JN_$=>^UX%^U=_R:Y^TG_P!D
M"^,7_JN_$= '\2E%%% !1110 4444 %%%% !1110 4444 %%%% 'TY^Q;_R=
MI^SI_P!E>\$?^GNUK^TROXL_V+?^3M/V=/\ LKW@C_T]VM?VF4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M //&K\ ?^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K1_P 05/\ P2R_Z+Y^W_\
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M)0?!'_YN*/\ AXW_ ,$]/^C\/V,__$H/@C_\W%?,W_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'TS_P\;_X)Z?\ 1^'[
M&?\ XE!\$?\ YN*/^'C?_!/3_H_#]C/_ ,2@^"/_ ,W%?,W_ !!4_P#!++_H
MOG[?_P#X=/\ 9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JT ?3/\ P\;_
M .">G_1^'[&?_B4'P1_^;BC_ (>-_P#!/3_H_#]C/_Q*#X(__-Q7S-_Q!4_\
M$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\ \.G^SK_]"K0!],_\
M/&_^">G_ $?A^QG_ .)0?!'_ .;BC_AXW_P3T_Z/P_8S_P#$H/@C_P#-Q7S-
M_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\
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M[FAM;.SM89;FZN98X((WE=5/XW?\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M 'Y)?\-:?LJ_]',_L^_^'F^'/_S24?\
M#6G[*O\ T<S^S[_X>;X<_P#S25^MO_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6C
M_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y)?\ #6G[*O\ T<S^S[_X>;X<_P#S
M24?\-:?LJ_\ 1S/[/O\ X>;X<_\ S25^MO\ Q!4_\$LO^B^?M_\ _AT_V=?_
M *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JT ?DE_PUI^RK_P!',_L^_P#A
MYOAS_P#-)1_PUI^RK_T<S^S[_P"'F^'/_P TE?K;_P 05/\ P2R_Z+Y^W_\
M^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M 'Y)?\-:?LJ_]',_L
M^_\ AYOAS_\ -)1_PUI^RK_T<S^S[_X>;X<__-)7ZV_\05/_  2R_P"B^?M_
M_P#AT_V=?_H5:/\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M 'Y)?\-:?LJ_]',_
ML^_^'F^'/_S24?\ #6G[*O\ T<S^S[_X>;X<_P#S25^MO_$%3_P2R_Z+Y^W_
M /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y)?\ #6G[*O\
MT<S^S[_X>;X<_P#S24?\-:?LJ_\ 1S/[/O\ X>;X<_\ S25^MO\ Q!4_\$LO
M^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\ 1?/V_P#_ ,.G^SK_ /0JT ?DE_PU
MI^RK_P!',_L^_P#AYOAS_P#-)1_PUI^RK_T<S^S[_P"'F^'/_P TE?K;_P 0
M5/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\ #I_LZ_\ T*M
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M+ZZBL?!7COX=ZPNLQ7?AG3X[*X?7VL8X)KQ9["X>2&6W_)O_ (;F_P"#Q?\
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M22: /JBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML9+BROM<^&7C.\@LM19?#WB&?3+*>RN+S3=5TRVO$O=)UG3+SPQXG\2VT_\
M/E^WK\;/^"Q'_!0+]G[1/V,?VN_^" WQ?\1?'3P7J]IXU^'G[2GP+_:,\0?#
MSX?^ _C?X?T74?#>A_&/PM+H7AWQ?\.#>::OB+4;JPT'Q+\9-9T;R;V]:V$#
M6_VNQ /T'_X*W2Z?\<O^#@K_ (((?L^>&)AJGB_X*:M\;?VD?'.GV/FW$WAO
MP=(WACQ/H>IZS]F5SIUKJ-Q^S[K]M;/>/'%/.;: _P#'[ )_ZP:_A,_X)6^$
M/VF_^"8?_!32T\<?\%IOAG\=?B9^T]^W-X#^#?[/'[,W[8^A:M>?M!_#7PO?
M7<FCZ!=? 7QE>>#]&NKKPIX[U.?2_!EEJGB=Y]4L%M?#^KZTTC>'=3\4^.]4
M_NSH _FN_P""*'_*2O\ X.'O^SW?AC_ZCOQ.K^E&OQ"_X)>?L@_M$_LZ_MP?
M\%EOC!\8_AY_PAWPZ_:N_:F\"?$?X!>(O^$M\#>(/^$]\&:-HOCJTU+6?[(\
M+>)M;UWPM]FN-9TV/^SO&FF>'-5F^T[[>QE2&=HOV]H _E"_X.L_ _A?XG?#
M7_@EI\-O'&E_VWX*^(7_  4_^"G@?QAHOVW4=-_M?POXLT#Q3H/B#2_[1TB[
MT_5M/_M#2=0N[3[;I=_9:C:^;Y]E=VUS'%,GU_\ \0N/_!"C_HQG_P V9_;#
M_P#H@JT?^"['[%G[3'[95E_P3@A_9M^&O_"QY/@)_P %$/@K\=/BPO\ PF/@
M#PA_PBGPK\)1:LOB'Q3GQYXJ\+KKO]GM<P#^Q/#1UCQ'=[\V.D7(5RO[VT >
M,?L\?L]_"#]E+X+?#_\ 9Y^ ?A'_ (0+X/?"W1I- \">$/[?\3^*?["TB;4;
MW5I+3^W_ !IK7B+Q1J>[4-1O+CS]9UO4+D>=Y2S"&.*-/YM/^#P_X8^!O%O_
M  2<A^(>O^'[2_\ &GPG_:%^%M[X \1,98M1\/MXRDU7PKXHM8)H9(_/T[7-
M'N4CU#3;H364]W8:1J+0?;M)T^XM_P"K*OPG_P"#C']C7]I+]O#_ ()G>+_V
M??V4OAQ_PM3XO:I\6OA+XGL/"/\ PE_@/P/Y^A^&-=N+S7+[^W_B1XH\'^&(
MOL-M(DGV:;6H[RYSLL[>XD!0 '[ _ ?X=>"?A%\$_A)\+OAOX<TWPCX!^'WP
MW\&>$?!_AC2(!;Z;H?A[0?#VGZ=I>G6L8RQ2WM8(U:61GGGDWSW$DL\DDC>K
MUB^&[2XT_P .Z!87<?DW=EHNE6EU%O23RKBVL8(9H_,B9XWV2(R[XW=&QE&9
M2"=J@#^:[]G3_E:3_P""A/\ VC>^ G_J4?"RN9_X."_$'C_X[?'S_@E/_P $
MK=%\;^(/AQ\'O^"@?QZ\?O\ M+:]X8U2XT?6/%?P?^"%GX$UC6OA1%>6S6LS
M:?XXL?%VKO>K%J,2IJNC^&UO-/UBPN+G3I_KKX+_ +(/[1/A/_@O=^V/^VGX
M@^'G]G_LS_%7]B;X1_"+P%\2O^$M\#77]O?$/PQKW@&]USP]_P (;9>)KGQ_
MI?V&VT34Y?[6UGPKIVAW/V;99ZE<236Z2W?^"UW_  3]^.G[8?PV_9[^.?['
M/B#0?#7[;_["?QGLOC[^SC)XJO?[.\,>,)%.F?\ ";?##7+_ &!;6T\:VV@:
M \0N[JPTC4KK18-!UW4-,T;6;[5M/ /'?V_/^"$7_!.O6OV'OBMIO[//[,_P
MC_9C^-WP6^%WB+XB? 3X^_!OPS9_#SXK^#_B1\,/#=]XC\'ZMKWQ*\.2:3XQ
M\66UWJ.E0VFOW'BW7]6NY8KJ768KJ'7;/3]3M?K3_@AU^UKX_P#VX/\ @E9^
MQ_\ M'?%>\N]5^)OBGP/XB\(^/?$%\ELEWXL\4_"+XA>,/A#JOC.Z%E;6=C]
ML\93>!O^$HU!;*U@MH-0U:ZMHHHQ"47\;OCA^W3_ ,%R/^"@OP2\2?L*_#'_
M ()#_$?]C3XM_&GPOJOPH^.7[4OQH^(-S;_ GX8^$?$EC+HGCCQ#\--7B\)Z
M7/XDN-;\/W&J0Z9<:#KGBO5O"\E[%#I.G>,K];;5HOZ1_P!B#]E7PC^Q!^R1
M\ /V3O ^H7.L>'O@;\.-%\%IKM[%%!=^(]9B$NH^*?$]S;P(D-M/XF\4:AK.
MO2VL2^7;/J)@5G$8=@#ZHHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** *]U:6E]%Y%[:V]Y );>X$-U#'<1">TN(KNTF\N573S;6Z@AN;>3;O
MAN(8IHV62-&%BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** *]S:6EXL:7=M;W20W%O=PI<PQSK%=
MVDR7%K<QK*K!+BVGC2>WF4"2&9$DC974,+%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !6 $H# 2(
M A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1
M @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152
MT? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D
M969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0
M'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%
M! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D
M-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$
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M?]% 'B?[(_PE\1_"/PKK.E>)+W2;N>^OEN(FT^61U"B,+@[T0YR.P->V444
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M D,K @@@D$$$'%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /SB_X+"_\ **'_
M (*2?]F/?M/_ /JG/%]?Y*__  2"_;_US_@FG^WY\#?VGK:>];P'I^LGP+\<
M-$L@\C^(_@CXWGM--\>68MHK>YFO;W0H8[#QQX?LH41[GQ3X2T*)I4A,N?\
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M%U/^"QG[+>A_\$\_V2_C#\5#:?"B_P#%GCW]JW]KOXO_ +0?CR/Q3XKB\?\
MB;4)_AG\-/$'QAU"3Q+\2=+\(:?I&D7EKIW@?PI-K&H>+)%UHZU96W@_0GCG
M^"='^,O_  5%_P"#=S_@H5I7@WXD>//&-AX@\(:KX=\:>/\ X8VGQ*UOQ?\
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M.UU+B32/#'AG3[^ZO-&\)6#6EA'8:9X:\&Z3XA\<:Y%;'7==AUR[;6O$4G]
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M]_$L]CJNBZS93Z=JFFWL#?+-:7UC<SVMQ$WRR0RNAX-?EA^PY_P0^_X)I_\
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M#@P3VGACX/?$[1/$XM+@-8_VUX<M)(YX3;P7D/\ K=JRNJNC*Z.H9'4AE96
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M8E38K6/B*TE$4(D$2?RP_P#!4W_@TK_8\_90_8%_:3_:8_98^+/[67B_XO\
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MM.\0O\.O&.K( 5;[)I7@3XC^)M4U3[R1Z=8W%TR$VR,O&_\ !HA\7-+^(?\
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M+1='O8K;7KBV_DC^$O[;'_!7:_\ C=^U9X+^%Q^.7BS]K']K_P"&O@/X _M
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M(\!/<3:WH%YHGB1+2?PMITEG;:Q!"KWL(BOKC[Z'_!EW\+&\<WWPP7_@L?X
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M]OJFEF\74M*NHY(Y+74;2UN(Y$DB5@ ?QI?MW?\ !KS^P?\ MX_%GXR>/O\
M@F#^U_\ ![X6_&31=0MO$?Q>_9ZTOQ)X=^*_PA\,>(/'$GB"\T=I(/ .M7OC
M?X#6_BS4M)UFYL]*NM*\6Z"L.F:A!X3\+:/I]B+2+^1W]M+_ ()I?\%*/^"'
MGQ;^$OQ*^);2?"[7;_7;^]^"O[0WP'^(K:GH-]XE\-1VUQJMCH^O6"Z'XKT'
M5+>QOX'N-'\7>&]!.NZ3=7<=O:ZMIT6JI!^@_A7X0?\ !;'_ (-G?VL_B=XC
M^#OP>UCXC?#WQ99:CX6E\>1_"SQ;\4_V;/CQX T'4FU#PMXD\16W@76+76/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI8__ !^C_A(_#W_0=T;_ ,&EC_\ 'Z_("B@#]?\ _A(_#W_0=T;_ ,&EC_\
M'Z/^$C\/?]!W1O\ P:6/_P ?K\@** /V"CU[0II(X8=:TF665TCBBCU&S>22
M1V"I'&BS%G=V(5$4%F8@ $D"M:OR:^''_)0_ ?\ V.?A?_T^6-?K+0 4444
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MHH **** "BBB@ HHHH [/X<?\E#\!_\ 8Y^%_P#T^6-?K+7Y-?#C_DH?@/\
M['/PO_Z?+&OUEH **** "BBB@ HHHH **** "BBB@ HHHH *\"_:N_Y-<_:3
M_P"R!?&+_P!5WXCKWVO OVKO^37/VD_^R!?&+_U7?B.@#^)2BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#Z<_8M_Y.T_9T_[*]X(_]/=K7]IE?Q9_L6_\
MG:?LZ?\ 97O!'_I[M:_M,H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MYGQK_P B;XM_[%G7O_35=UTU<SXU_P"1-\6_]BSKW_IJNZ /R-HHHH ****
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M]/=K7]IE?Q9_L6_\G:?LZ?\ 97O!'_I[M:_M,H **** "BBB@ HHHH ****
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M_P!E>\$?^GNUK^TR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBSP5I\U_?2ZA;6FIZA:ZC=75X9GD_5/_ (+-?\%3;?\ 8(^%VD_"_P"$,?\
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MPT^.[N5_8.B@#^%3]K7_ ()X_P#!<OXG?\%&OBA^VW\,?@"]OXATKXJZU>?
M?Q/=_%W]EC6[;PUX \,27OAGX8SZ5X5^(?Q1U:PT^:'PG#9:R+74= @FL/$]
M_>Z['8Z=KK&:']:/^"97AO\ X+S/^TL]O_P4HCO=0_9EO/AOXUL=2L=6U?\
M9$UC3[SQ==KID'A^VNM/^#E]=^+KF&>V?5HI(Y('T5HW9=2'S0 _TAT4 ?!7
MC?\ X)L?L&7O@SQ=9^'/V$OV/4\07?AC7[;0GM/V;/@C872:S/I5W%I;6U\_
M@ZV6RN%O7@,-VUQ MM(%F,T00NOYP_\ ! /_ ()Q_$3]B[X'?$74_P!JK]G3
MP+\._P!I._\ C+XHE\(^-KA_A)XZ^(D7P@U;P#\-+*/1K#XC^ =9\77NE^&+
MOQ5H_B667PF_B*T0WR7&ISZ0JWT%U<_T)T4 %%%% '9_#C_DH?@/_L<_"_\
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MVJQ6L2WM]HFA:-XE#F>>XB@&M:;I;3"6Z6U'].'CC_D2_%__ &*_B#_TTW=
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MK7]IE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY^TG_P!D"^,7_JN_$=>^UX%^U=_R:Y^TG_V0+XQ?^J[\1T ?Q*4444 %%%%
M!1110 4444 %%%% !1110 4444 ?3G[%O_)VG[.G_97O!'_I[M:_M,K^+/\
M8M_Y.T_9T_[*]X(_]/=K7]IE !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7,^-?^1-\6_P#8LZ]_Z:KNNFKF?&O_ ")OBW_L6=>_]-5W0!^1M%%% !11
M10 4444 %%%% !1110 4444 %%%% '9_#C_DH?@/_L<_"_\ Z?+&OUEK\FOA
MQ_R4/P'_ -CGX7_]/EC7ZRT %%%% !1110 4444 %%%% !1110 4444 %>!?
MM7?\FN?M)_\ 9 OC%_ZKOQ'7OM>!?M7?\FN?M)_]D"^,7_JN_$= '\2E%%%
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MFC_A]G_P6R_Z1$>-/_$<?VM/_C- ']E_PX_Y*'X#_P"QS\+_ /I\L:_66O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]4TB>VGCT72-3USP3XA:);B.26W\2Z[J>GFU\1>&/#^K:8 ?IUX-_P""[/\
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M/#WP"^#OA7PA\6/"]_X+^)6@>$?AOX0\)Z?XY\*ZGI^I:5>:%XGA\.Z1IO\
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M !'+KND:;?\ V6SU.UM+_P ::!=FYL+#1K@>M_\ !7SX(_\ !2+]M?Q+XO\
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MWO".KZ_X9U3R1+&?M>BZSJ-C)N_=7+X; !VW[ '["7PY_P""=GP"'[//PO\
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MZN-2\/>(_AAJ&HP-X@&DVQ@U=+:,65EIL&LP7NJ^*P#HO^"3L7CW]B']O_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHKX>\5?\%./^";/@7Q/XD\$>-_\
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MVIHU[\2_A3XE_M![AVBN[WQ!<VJ3%;RWBH XO_@S'_Y2Q?$C_LR;XO?^K8^
M5?ZD-?Y;W_!F/_REB^)'_9DWQ>_]6Q\ J_?;_@ZE_P""VWQ<_8?TSP%^Q!^R
M+XTNOA[\=_B[X.;XA_%OXK:'A?%?PU^%&H:EJ>@>&] \#ZBR/'H/C+Q]J>B^
M();WQ';D:[X4\-Z/#/HGV'5/$^EZ[I(!_9717^3-XM_X)"?\%\?V;/V:;O\
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M7^-KC^Q4G@U<Z;I?]M;+)VNF6TM_M!,@!_N$Z=_R#['_ *\[7_T0E7*_E_\
M^#:#X/\ _!6'X1^!OVL[;_@J;J_[3>K:UKOB3X-W/P3;]I'XXZK\;+F#0[/1
M_B%'XQ7P?=ZG\0/'H\.VCW=QX:.L6EO-IGVZ1=-DEAN!:Q/%_4!0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7^5G^P=_RMW>)/\ M)I^
MWU_Z=_VD*_U3*_RL_P!@[_E;N\2?]I-/V^O_ $[_ +2% '=?#3XE:#_P28_X
M.M/CE?\ BCQ!:^&_A5=?'SX^0^+7U.2WTZQ_X0+]IKX<ZU\6_ F@R7,GE0V\
M%AXE\;?#R/3YSCSWTNS#AO/<'U+_ (--/!?B3]I'_@HW^WK^VCXV>VNM3\+_
M  !^*.NZXZ6[M_Q<_P#::^( UG[?:SR2N;>+^QO"OQ&MC&XDGF2_3]ZJQ3"7
MS7_@\S^!-Q\/O^"F7PR^-5II]O;Z%^T'^S5X1N+G4(ALFU#QS\+?$?B3P5X@
M2Z41J'>R\'-\-4BG,DCO#,D!6-;9-_[9?\&;WP#_ .$*_P""<'[7O[0>H:+%
M8ZM\=OC-K'A/2]6:./[7K?@;X+?#BV@TJ03*#(;"R\:_$#XB6,$,C#9>6]_(
M$"R*[@'X;?\ !F/_ ,I8OB1_V9-\7O\ U;'P"KY9_P"#A7XT76B_\'"'[0GQ
M$\;:"GQ&\._!3XJ?LU/:_#W5[M=.TO7O!OP\^%GP@\17G@9KQM/U1=.TOQ3<
MC6A=WC:9J8CD\07M\UC>!S;/]3?\&8__ "EB^)'_ &9-\7O_ %;'P"I__!T9
M\(O'?[%7_!;CP;^VEH&B7$^A?&2+X&?M&^ -2OF==!O_ (C_   3P?X,\5^%
M(KJ#;<1W&FW'@'P7XAUF%2TMM:^.]-GADVW,<4(!]P>,/^#VO4_&WA#Q3X)U
MG_@F7X<GT3Q=X;UOPMJUM+^U?>SP3:7K^EW6DWT$EM)^SAY4T4EI=RQO!(/+
MD0F-OE8U\<?\&7OCO7-!_P""G_Q@\#6U_)'X<\??L>>/Y]7TK"&WO-8\(_$_
MX0ZAH&HL=OF+=:99W_B*U@*NL?D:Q>B1'<Q-'_7?\2?^#E?_ ()D:'^PAXD_
M:R\ ?M&?#'Q%\4F^%]WK7@G]E^_UZ/\ X79=?%N\TM[;0?AYXD^&]K-!XMT_
M3;;Q?);Z?XC\7):P^&;;P_#>^([379--^S74O)?\$"O^"WGQZ_X+$'XX?\+#
M_9-\)_!SPK\#-(\(0ZI\6_!_Q$\1:QX>\5^/?%]SJ#VG@S1?!FO^#TDLGL]#
MT?4M>UB\'Q#UBYT:&;P_:W.F3)X@MK^  _B\_9BTVV^.W_!V#/%\4%B\0Q2_
M\%2_VB=>DM]<ACO(1<_"GXA?%'Q'X%L'@D5HC'H=YX+\-V6F1%6CMUTZS4 K
M$*_U0?C!X6T'QS\)?BCX*\56MK?>&/%_P[\;>%_$=E?1I-97>A:_X:U/2M7M
MKR*17CEM9]/N[B*>-U9'B9U92"17^5Y_P5/L/%__  2'_P"#CWQ%^TK;>%;_
M /X16+]IKP?^VQX/M+4JJ_$#X>?%+7U\6?%32=&GNYHX86U'Q'=?%7X?MYDT
M,5C?6DK1^5:+;L?Z_P#_ (*"?\'+_P#P3A\,_P#!/CXE?$#]F+]HGPW\6OV@
M/B]\+-=\(_!3X1:+I&KS^//#?CWQQX>N](T[6/BCX5OH-,E\&:-X!N;YM:\0
MQZ[>V+:P=*.C^&GUB]U*Q$P!_*'_ ,&<?_*775O^S2OC/_ZE/PLKT/\ X/4?
M^4J/P,_[,'^%7_K0/[45<%_P9V6UQ9_\%?M=L[RWFM;NU_90^-EM=6MS%)!<
M6UQ!XM^%T4]O<02JDL,T,JM'+%(JR1R*R.H8$#O?^#U'_E*C\#/^S!_A5_ZT
M#^U%0!_1U_P<I^)-0T+_ (-W-"TNR>5;;QDW[&?AO5A&"4DT^UN/#/B^-)S_
M  Q#5?"FF.">/.2$=2*\J_X,H/#^E6W_  3;_:5\50V\*ZYK/[;_ (N\/ZC=
MJBBXGTKPS\!O@#J.C6\L@&]H;6\\6:]+ C,5C>\N60*9'+?H;_P6/_93\6_M
MA?\ ! SQU\,_A[IUSK'Q"\*_L]_ [XT>#M&LK*34=0UN^^#EEX.\=:WH6EV4
M+I/<ZQKO@W2O$VC:/! )9IM5OK.*."X9Q"_\K?\ P:F?\%GOV6OV#_#WQX_9
M%_:_\<P?![P3\4?B!I_QE^%_Q7UBQU:_\&V_C6;PQI/@SQCX1\8W6C:?J-QX
M9_M/1O"WA+4O#NOW\">'VDT[7+#6-2TNZDT6/4P#_0<^+'[&/[)/QZ^)7A'X
MQ?'#]FSX)_&+XG> -&&@>"/&?Q0^''A;Q[K'A+25U*YUA+7P])XHTW5(=):/
M5+RZOH[FRAANX[F9Y$G4XQY?^WO^WG^R]_P3%_9EU7X^_M&:J_AWX>:')IW@
MOP;X'\):197_ (H\>>)KNPNCH'PZ^'WA=KC3-.N=0N--TR\F$=W>:5X?T30]
M-OM2U?4=-TFPGN(_X?\ _@LK_P '+O[0WC/]N3X4_#S_ ((W_M#^(G^'?A#0
M=,\$ZCJ_A?P)X?\ %V@?'WXQ^,?%:I'I&A^#?B7X%UE]9TO2;>/0?#6@:K8V
M%M<Z[JFKZZNER/9+IE_=^C?\'D.C_M&VG[-7_!)>?XO:\OB&]L/#_P 6-+^.
MVJ:#80Z)X4U3]HB;P-\#II]6BT2Q8V%C#>M:?$MO"EI"THTW2QK-M%*ZRR/(
M 4/%7_!V1_P4%_:N\8CX&?\ !*7_ ()VZ+INI7-\;+P_'=>'?&/[0GQ!@T6\
MGDM;76AX-^'MGX)\$> 6-_<0WE_>>(#XR\+Z3&MU]OOIX3)J,/XR?\$7;CXU
M7?\ P<C_  ,NOVCH;BU_:)N?VM/VEKCX]V]S;:#9W-O\9IO"'QME^*MO<6GA
M95\,6LT?C9M>BFMO#B+H,#AXM(5=/6W _L3_ ."'_P#P4E_X)&?LL?\ !&[X
M&:_<?'W]G;X%^(/AK\.E'[2/@F_\0^&=%^->N_&FP?4V\5:I>^ (YS\1OB)K
M?C>^LKO4O TNE:5KKZMH$EAI>AF.UTB2PT[^/+_@C_\ '/1_CK_P<K?!S]HJ
MVM+G1-'^/'[9W[2GQ2TO3=5\E;[3HOC+H_QI\0:-I=Z()[BW%_#+XHL[&58+
MB>(W8*Q32J5=@#]P_P#@^:_X^?\ @F!_UP_;1_\ 1G[*-?U0?\$*/^4/G_!.
M_P#[-D\ _P#HBXK^5_\ X/FO^/G_ ()@?]</VT?_ $9^RC7]4'_!"C_E#Y_P
M3O\ ^S9/ /\ Z(N* /UCKX__ &JO#_[$'[0O@/5OV8OVNM1^ ?C7P?\ $G5-
M'\,R_"OXH>,O"=AJ&L^*;S4[>T\,6WAVQO=:T_Q#9>-UUR>TC\+7GAN2T\46
MVLRVHT2XBOGBS]@5_E4?\'0O[//Q4_8E_P""R\W[6W@^.]TC0_CU=_#/]I+X
M.^,A90OINF_$_P"%]IX5T+Q=HR29:*ZU?P]XQ\(Z/XRO+6>*-AIOC31=XF65
MI6 /W!_;&_X,IO@AXMN-7\3?L-_M/^+/A!?7$EU=V?PM^.^D#XD^"$D>$_9M
M*TGX@>'?[#\;>'-,CN%7-UKNB?$G4_)D??/,\:[OY!_%7@;]OG_@WV_X*)>#
MY/$,L7PY^/WPCG\/>.M*NO"GB.?5_AU\9?A3K6IW$%S:"_@BT^;Q-\+_ (A1
MZ#K7AG6M-UC2],U.WN+"^BN=,TCQ!H]O)9_WP_LO?\'=O_!+3XC? [PAXG_:
M4\:>.?V>?CBGA^RB^(/PR;X3?$SX@:2?%EK;PPZO/X'\6?#_ ,,^)M(U#PQJ
M5Z)[S0G\17'A[5X;%TM]6L+:ZB)F_B=_X+?_ /!1D_\ !;#_ (**^"O$/[-_
MPS\7Q^#M(\,>"_V:?V>_">JV.G+\0_B1?WOC37]4CU_4M*L);N/2=4\8^+_&
M\FEZ)X>?6M1CT_0].T6YNY;#5=0UFTMP#^KS_@[P^/C?$O\ X(^_L8^,_ M]
M=VG@7]H_]H#X.?$:2*,@KJGA35_V?_B7X_\ #6G7T@7$D*W6J:/JHC7:)+S2
MK:;I  ?P'_X)*_\ !SC)_P $J?V.O#_[)WA_]A?0/BY-IOCCQUX\U_XE/\?+
MCX>7GBK6/&>JK<Q2W_ARW^"_C 1SZ-H=GHWAR*[D\07CW5EH]J^RU0):Q?TP
M_P#!PK_P3Q\1G_@WG^"_PH\(65_XC\1?\$X?"7[,_BF\ATUQ<W.H>#?@U\)Y
M?@;\1M4E#%Q<:=H/A;Q-J/CW5ID=6@TWPO=7:.\<+PR_#W_!JI_P6;_8Y^"O
M[&.O?L3_ +5_QQ^'/[._BSX3?$/QEXT^&GB3XK>)K+P7X*\;?#_X@7MOXBU*
MPMO%OB">T\/6GBOP_P",[OQ"9]#NM0L[G4M'U32[O28+Z6UU@VH!_)W_ ,%8
M/^"J.J_\%,OVUO"W[:WASX,6W[,WC/PQX ^'/A6'1M%\?#XD3S^*/AKXB\1:
MYHGCS_A(;GP/X'V7ZVVJ:)ID6G7&B7BVT?AJUE-_<17"VEI_37_P>P?$/7_$
M/AC_ ();:8MY-#X;\4^%_P!HCXAWNG0X2PO=?FT_]GVWL+QT(+M-I5AK.J06
MFYL0PZQ<@ F5B/M[7_\ @[!\0^./^"G=E^Q?^QA^S#X%_:W^#'C?XL_#[X+?
M"GXEV7C[QA\-_$'BWQ'K<VE:/XU\8PWW_"'^/=,NOAUH6N7.LW>G:VGA2QAG
M\(Z#<>*9+R;2KN&YC[__ (/)?V-?%/QU_81^$/[3_@?PY+X@UC]C_P")6LW7
MCD6%O<W.HZ3\&_C!IVCZ%XJU^.&UAFDN+#1/&WA;X;3ZNTB)#IFBW&J:[<SV
M]CIEZS '["_\$!?!'AKP#_P1P_X)^Z3X6L;"PLM8^ >B>-]2&GV\<"7?B7X@
M:IJWC7Q1?77EJIGO[K7M=OWO+B3=)),&!8JJ@?P@?\'C_A3P[X<_X*Y:'JVB
M6=A:ZCX[_9&^#7BOQ=+9V\<,^H>(K7QC\6?!5O>:HZ(K75^OA7P=X9LDN)2\
M@TVST^WW^7;QHGW]_P $'O\ @YV_9?\ V,?V&]#_ &1?VW-+^+D&K? 5O$D7
MP>\;> O#%KX\MO&O@/6M:U+Q-I_@;4+5M5T:[\/^(_"^I:M?:-H4U^TGAN[\
M-KI<-SK6D3:<T-Q_,?\ \%@_V[/B!_P4F_;9\9?M@^+/ GB'X;^!OB7X?TBP
M_9^\(^(E26>P^!O@74M=\#:#<6^J06EM9ZS+J/B_P]XXU#Q'>:=+J&G67C:Y
M\4Z#8ZE=VVC1LH!_H0_\'-G_ "K\>)_^OK]D7_U-_ ]?,_\ P9.Z-8P?\$[/
MVG_$,=O$NI:I^VEKVC7=T$4336.@_ WX)WVGV\DH&]XK:X\1ZG)"C$K&]W.R
M@&5R?IC_ (.;/^5?CQ/_ -?7[(O_ *F_@>OG[_@RC_Y1G?M'?]GT^.?_ %0/
M[.E '\T/_!WGI\4?_!9/Q0;6)1<:K^SY\"+B?;M4SW7]FZWIL;NQ(!;[/96T
M(9B $C0$@+7^D_\ MN>#-!@_X)V_M<_#V33K67PQ!^Q=\>_!S:4\,;6;Z'#\
M#_%>B_8&MRIB-N;!?L_E;=GE_+C;Q7^;G_P=W?\ *9G4/^S>_@)_+Q)7^EQ^
MW-_R9-^V'_V:S^T'_P"JE\74 ?P-?\&14LJ_M=_MJ0!V$,G[.'@Z62,'Y'EA
M^)M@D3L.[1K/,JGL)7'<U^*G[7'[8]Q\%_\ @X+_ &DOVQ?B%\-]-^-4GP!_
MX*,?%CQ'8?#75-:;PI8>(K7X#_%?7?"GPSTNZUQ]%\5-I<V@V?@SPI=&\_L+
M4E:\T@%;*-)0L/[3_P#!D7_R>!^VC_V;9X3_ /5H:77Q+_P53T_Q7_P2+_X.
M2=1_:FG\(7A\"WO[2W@S]M+PO':12^5X^\ _$S68=>^,EEHT\TMI -5N?$UW
M\4_"KHUR(;/5(X;B93930K( ?9/[6_\ P>'WW[6G[+G[0_[,/B'_ ()UZ+X:
MTC]H#X+_ !(^$-UXG@_:BNM:N?"K^/O">J^&[3Q59Z1<_L]6,&IWOAF]U"WU
MZRL9;ZR2ZN]/AA-Y:[_M$?L7_!CQXPU&V^*W_!0?P!]KF.DZS\/?@%XP-BTD
MC0)J/AKQ)\3-%%W%"6\J.:2V\5F&XD5!),D5LKLRV\87^@/]N'_@Y;_X)Y_
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MMXI$/4.BD8(!K_/@T[_E<%D_[2=:I_Z=+NO]"G_@KE_RBJ_X*4?]F'?M:_\
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M26[N1<7]IX&T_5]8\)^)?#.FSEYS9Z7>>*=?TS1FDBM])L[32;6WTI/[$Z*
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M^N#4;C[?-]OE/B(VTNV+[/:6NUM_[B_%;X<Z)\8/A=\2?A)XFNM5L?#?Q2\
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M?QD\<7E_I]EX%^('PXU:+7XM6^'FBV]M=7.MW>G)IUUJD,NE37,]I=V7LO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&9'=XY+?0M/"HA,A?_3)TK3+/1=+TW1]/B$%AI-A9Z98P+C$-G86\=K;1#
MQ'#$B#  P. * /Y.OV8?^"DG_!"KX@?\%>#^S)\&?^"=GB;P'^WHO[1?Q_\
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MJW5II>EV=U?74$$G]'%Y_P 'M/['<'Q9E\.VO['_ .T%>_!F/4GLU^**^*_
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M_!N[_8%^/_[-'[-7Q*\):[-K?CO1?V<_AGX0^&_Q5\?_  SO=!O[6[\*Z_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO2ZS8ZWH-EXO^%/@C]FGQ'X+^)/Q=\0>$]0A_L;4OB+;:+H[#7].M=<M[3Q
MB^'-/T'P)<ZK:Z;XC^PRBPTR\M@#](_^#(OP?J5[^U[^VGX^B$W]D>&OV;O"
M'@^^*N1;C4O''Q.T[6M*$J=&F-K\/=9^SN>4C%R!Q(:^*?VUO^5N'0O^TI?[
M$O\ ZFOP!K^U/_@W&_X)/>)O^"6W[%>H6OQFL;&R_:=_:-\0:9\2?C-IMI<:
M;J/_  @NGZ7I;Z=X ^%+:SIJR6^J7'@ZPOM9U379K6^U'38O%WBKQ):Z1?WV
MEVUG?7/\K'[7?["'[</B7_@Z%T;]H#PY^QI^U9K_ ,!XO^"D7[('CF7XV:)^
MSO\ %W5?A''X)\,^+O@C<^)/&,GQ(L/!\_@U/"WA^VTG5;C6_$+:R-)TJ#3-
M0EO[NWCL[EHP#]L_^#UC_E%W^S[_ -G\?#3_ -9Y_:@KZB_X-(_^4+WPD_[+
M)\?O_5@WM>??\'=O[//Q^_:4_P""<?P-\#_LY_ WXP_'[QKI'[;/P^\5ZKX/
M^"GPS\:?%3Q3IGA:R^!/[1FD7GB74/#_ (%T37M6LM M-6US1=+N=8N;2+3H
M-1UC2[*6Y2YU"TBF^C?^#7[X*_&3X ?\$DOAA\-_CQ\)?B9\$_B)I_Q8^-VH
MW_@+XN> _%/PW\:66GZMXYN[O2K^[\+>,M*T;7+:RU.T9;K3[J:Q2"\MV6:V
MDDC(:@#^-_\ X-N_^5B_5/\ K^_;3_\ 37XTK]#?^#Y#_D>_^";W_8I?M2?^
MGCX"UXS_ ,$!/V&/VVO@U_P7IU+XP_%_]CO]J?X5?"22\_:X9/BE\2?V?/BU
MX&^'+KXET[Q<GAUD\;^)_".E^&677WN;9-%(U,C57N(%L3.98PWW7_P>/?LC
M?M7?M/>,_P!@*Z_9J_9B_:%_:&M?!OAC]I"W\7W/P-^"WQ(^+4'A2?7-5^"L
MFB0>))O /AKQ!'H<VL1Z5JDFE1ZHUJ^H)IM^UHLRV=P8P#ZV_:=^'6M_%#_@
MSF\+^'?#\DT=_I'_  3Q_9)^(L_DLZE]$^$FO_!OXI^)HY A!:%_#7@[5A(K
M?)M^9@54U\*?\&/OQ:\+OX1_;Z^!4TEG:^-+;Q'\%?BSIT3O"M_KOA>^TSQK
MX/UF2VC#F>:T\*:MIVA+>NT:Q6\WC.P".[W3JG]3_P#P31^"%S/_ ,$B?V./
MV=_C[\.M<T.;4/V)/AC\)OB]\*_B'X=U/PYX@T^'5/A;8^%_&7@SQ?X7U^SL
MM6T;44MKF_TK5M)U6QMKVTE,L%S;QRHRC_.S_:K_ ."9O_!5W_@W\_;6U'X_
M?L;VGQ@UKX7:9J&OK\(OVDOA;X.D^(F@ZI\-=<N$ED^'?QY\+VNBZ]HNGZC!
M:QZ?9>(M&\<Z!%X5\0ZQI=GXH\'S275C93:, ?VE?\'7?Q)\*^!O^"*'[1GA
MK7]1TBUUKXN^./@#\/O ^GZD\?VG6O$=A\:_!'Q+O[71X'(>?4;'P=\/?%.M
M$Q@FWL],NKDG$>#^<W_!DKX&UG2OV*_VO?B'>6E_;Z-XS_:8T3PUHMQ<1RQV
M-]+X%^&6A7FJ3Z>7"I/Y4OC6VM;NXAW1F:!;9G\VVD1/YE?%]Q_P75_X..?C
M/\+O!OCGPI\0?&'@SPU=;M U-_AI>?!_]EKX16FJRVNG:[XZU_6K;1+70K[6
M&MQ)(US>ZAXM\?ZA8PWVC>$;&XM$DTI?]-S_ ()P?L,?#K_@G%^QO\&?V1_A
MM<R:O8?#C0II_%7BRX2:.[\=?$7Q)>3:]X^\9W$$\]S)91:[XEOKZ;2M*$\L
M6AZ''I>AV[M;:;$2 ?YU/_!L^BO_ ,'"^J,R@F.S_;%="0"58V?B.,L,]#LD
M=<C!PQ'0D'^RW_@Z9 /_  0P_;1SVO\ ]FHCV/\ PUA\#A_(D?C7\OG_  ;T
M_L,?MM?!7_@NGJGQ=^,G['?[4_PE^%$EG^U6L?Q.^)G[/GQ:\!_#QV\16^N+
MX?5/&GBGPCI7AMFUTS1#1@NI$ZF98Q9"<NN?ZQ?^#D;X2?%;XY_\$:?VN/A?
M\$OAE\0OC%\3/$EY^SXWAWX=_"SP7XD^(/CK7UT7]IOX.:_K#:+X1\):;J^O
MZJNDZ%I>IZUJ9L=/G%AI.G7VHW1BL[2XFC /QO\ ^#)22.']B3]L::61(HHO
MVHM*DEED94CCC3X2>$V>21V(5$1069F(55!)( )KU7_@J/\ \&]W_!.'_@J!
M^T;X[\6?LN_M9_"[X _MV^)-(U'XE?$WX<^#_$W@KXG>'_'EK9ZGH^CZW\1_
M&WP<T7Q1I_C;P7J%[JVK:3IVO>//#]S;Z+?:YJT6H:WX9UKQ)J=S?7=K_@T2
M_97^/?P"_8O_ &O/ '[4W[.OQC^!]]XY_:"MKFS\'_'GX3^./A=J/BOPG=_"
MGPYHNHWEAHGC[0=!O-8T*:9;S2[F\M+>>R,Z7%H\HE21!_.-^T3_ ,$X?^"J
M7_!O-_P4$U/]J+]AKX=^./BA\#[?6?$EK\)_B=X2\":Y\5?"&L?"WQCYM_=?
M!KX]^#_#]UJ/B32YM%M;6TTO4M3U>;1[/7]2T'2/&?A'Q#9:TL5OH@!^>W_!
M1+_@A=_P4<_X)%:=X?\ CK\4[/PMJ?PRL/'.E:/X9_:#^ 7Q OK^Q\,^-'FN
M=0\)/>0WUAX.^(W@S6+LZ7)=Z1K+^'HM*MM4MXK&#Q!_:DMA%<_Z)/\ P;8_
MM[_$_P#X*#?\$P_!7Q!^-WB)_&/QB^#OQ&\9?L^>/_&ET9#JWC&Z\%Z9X6\4
M>&/$?B!G&+CQ'>>!/'7A6WU[4D>3^V=6L[S69C%=:A<6\/\ $K^U%_P4B_X+
MD?\ !P%X;\)?L8:9^RIIA\(3>.])UK6_#?[/_P %_B1X-\/:IXJ\,V]_#:7?
MQ7^(_P 4O'/C'0_"F@>'[YM1U'R=3\1>$M'M=3BM4U%[^_LK #^_K_@BA_P3
MHNO^"7O_  3[^%?[,WB74]'USXJ7.HZ]\4?C;K/AYFFT*[^*GCIK)]7L-&O)
M;6SN-3TOPIH>E^'?!6GZQ<VUO/K%KX:BU1K6R2\2RM@#^(C_ (/7=>L;O_@I
M#^S9X;AM0NH:)^Q/X5U2]O\ Y?W\&O\ QR^.D%E8G#%LV)T*[N<%%7&IC:S$
ML$_TH_ACIT^C_#7X>Z1<N\ESI7@?PGIUQ)(<R//8Z#I]K*\A[NTD3,Q[L37^
M;Q_P6]T6']O'_@Z-^ O[+FC:8?%NG^%O$O['7P \8:;Y:369\*F_MOC;\4'E
M67$4^G>'O!OQ(\27FM(N_8-,U.VV//$T1_TO@ H"J %       &  !P !P .
M * %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH _GE_P"#G?\ 8:U;]M?_ ()6_%*Y
M\$:$^N_%;]F'6;#]I;P)86JWCZEJ>E^!]-U;3_BAH=A!86UW=:E=7OPPUOQ3
MJFF:+';2'5_$>AZ#:H8IS#/%'_P:Z_M7V7[3_P#P2#^ FB7.I6]YXV_9COO$
M7[-/C.UB\Q)+*V\"W46J?#?,4Q9S$_PE\1^!K?[3&S6T]_9:C'"8VMY;:W_H
M8N+>WO+>>TNX(;JUNH9;>YMKB))K>XMYT:*:">&16CEAEC9HY8I%9)$9E92I
M(KXB_8N_X)N?L7?\$\8OBA:?L<?!IO@OIOQDUS2?$GQ!T2Q^(_Q9\8>'=4UO
M0UU:/3+[2?#GQ$\=^+M"\'M;P:W?6CP^#-.\/VUU8IIMA=PSV>BZ-!8 'W'1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8O
MB7Q%HO@_PYK_ (M\2:A;Z3X=\+Z)JOB+7]5NW$=KIFBZ)8SZGJFH7,AX2WLK
M&UGN9G/"QQLQZ5M5YO\ &+X1^ /CY\*?B-\$?BMHMSXD^&7Q9\&>(OA[\0/#
MMIK_ (D\+3Z_X.\6:7<Z+XBT4>(?!^KZ!XGTF+5=*O+JQN+K1-9TV_6WGE2&
M[BWDT ?P8?\ !M7\(_$O_!0S_@L!^W9_P6%\=Z5<W/@#PGXZ^+!^%5YXBL;=
M[ZV^)/QVU6_A\/:1I,\<K06TWPJ_9_FO/"^J1112R6UKXT\,K%=L'F:7_07K
MY=_9!_8N_9D_8*^#EK\ ?V2_A98?"'X3VGB'7/%B^&;3Q#XP\6W%UXD\22PR
MZQK.J>)_'WB'Q7XNUF]N5MK.TBEU;7KW[#IMCI^E6 M=,L+.T@^HJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KG/&/BO1/ ?A'Q3XX\2W,EGX<\&>'-<\5^(+N*WGO);7
M1/#NF76KZK<Q6EJDMS=206%G/*EO;Q23SLHBA1Y&53T=>!?M7?\ )KG[2?\
MV0+XQ?\ JN_$= 'S'_P]9_8I_P"BC:__ .&\\;__ "DH_P"'K/[%/_11M?\
M_#>>-_\ Y25_)A10!_6?_P /6?V*?^BC:_\ ^&\\;_\ RDH_X>L_L4_]%&U_
M_P -YXW_ /E)7\F%% ']9_\ P]9_8I_Z*-K_ /X;SQO_ /*2C_AZS^Q3_P!%
M&U__ ,-YXW_^4E?R844 ?UG_ /#UG]BG_HHVO_\ AO/&_P#\I*/^'K/[%/\
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M[MK^+/\ 8M_Y.T_9T_[*]X(_]/=K7]IE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6)XFO;C3?#?B#4;1Q'=V&B:M>VLC(LBI<6MA<3PN4<,CA9(U8H
MZE6 PP()%;=<SXU_Y$WQ;_V+.O?^FJ[H ^ /^&C?BO\ ]!RR_P#!)I/_ ,B4
M?\-&_%?_ *#EE_X)-)_^1*\,HH ]S_X:-^*__0<LO_!)I/\ \B4?\-&_%?\
MZ#EE_P""32?_ )$KPRB@#W/_ (:-^*__ $'++_P2:3_\B4?\-&_%?_H.67_@
MDTG_ .1*\,HH ]S_ .&C?BO_ -!RR_\ !)I/_P B4?\ #1OQ7_Z#EE_X)-)_
M^1*\,HH ]S_X:-^*_P#T'++_ ,$FD_\ R)1_PT;\5_\ H.67_@DTG_Y$KPRB
M@#W/_AHWXK_]!RR_\$FD_P#R)1_PT;\5_P#H.67_ ()-)_\ D2O#** /<_\
MAHWXK_\ 0<LO_!)I/_R)1_PT;\5_^@Y9?^"32?\ Y$KPRB@#Z8\&?'OXF:QX
MP\*:1?ZQ:2V.J^)="TV]B71],B:2TOM4M;6YC62.V62-GAE=0Z,KH3N4A@#7
MZ 5^37PX_P"2A^ _^QS\+_\ I\L:_66@ HHHH **** "BBB@ HHHH **** "
MBBB@ KP+]J[_ )-<_:3_ .R!?&+_ -5WXCKWVO OVKO^37/VD_\ L@7QB_\
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MCH^AZ3:WFK:M?S0V>GV=Q<2+&?6Z_C]_X.MO'VN1V_[#'P>U#7;[0/A5XO\
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MRWT["RL1XPC\,B\U!HK*W,ES=6D=Q^V5?P^_\'"7_!-;]B7]BW]E[]G3QO\
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M'ED\+0RF"?1Y4\+ZG+I7@A(T6:1)!XD\5C5O'\<@23[3::8;.Z98DAA']"-
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?&O\
MR)OBW_L6=>_]-5W735S/C7_D3?%O_8LZ]_Z:KN@#\C:*** "OD[]L_\ 8M^!
M/[>/P2U?X%?'WP_=:GX<NKV'7/#NOZ-<QZ=XN\!^+K*UO+33/%_A#5I+>[BL
MM8LK>_O;5XKRSO\ 2M4TZ\O=+UC3K_3KNXMG^L:* /X;OV7_ /@WR^"_C?\
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M'L7_  2R_P"DEG[ '_B9'[.O_P \:OP!_P"(*G_@EE_T7S]O_P#\.G^SK_\
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M_P#-Q7S-_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\
M#I_LZ_\ T*M 'TS_ ,/&_P#@GI_T?A^QG_XE!\$?_FXH_P"'C?\ P3T_Z/P_
M8S_\2@^"/_S<5\S?\05/_!++_HOG[?\ _P"'3_9U_P#H5:/^(*G_ ()9?]%\
M_;__ /#I_LZ__0JT ?3/_#QO_@GI_P!'X?L9_P#B4'P1_P#FXH_X>-_\$]/^
MC\/V,_\ Q*#X(_\ S<5\S?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6C_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K0!],_P##QO\ X)Z?]'X?L9_^)0?!'_YN*/\
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M /PZ?[.O_P!"K0!^_P!_P]B_X)9?])+/V /_ !,C]G7_ .>-1_P]B_X)9?\
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M^"67_22S]@#_ ,3(_9U_^>-7X _\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M '[_ '_#V+_@EE_TDL_8 _\ $R/V=?\
MYXU'_#V+_@EE_P!)+/V /_$R/V=?_GC5^ /_ !!4_P#!++_HOG[?_P#X=/\
M9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JT ?O]_P]B_X)9?])+/V /\
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M7P)\&OAMJ,&L#4?#ME"+B\U6_LOL4MU&=/,[PW,'[C4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?6(-,\2^'+[4=(OI=+U:RO-,U!+:[E:SO[2YM)Q'<021K_*#ID-O_P $+?\
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M>)M=U.WTW[,E]JMY<B29OYA?^"8'A34/^"KO_!3W]H7_ (+1?$6WN=1_9N^
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M?E5_P7?^*7C7]J[X_?L8?\$-_@AXAUG1-<_;0\4V?Q1_; \2>%[BX@U3P/\
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MGHUEJ/A5XGD!_L2U^!EL"]U>W)8 _5O_ (+ _P#!3[XS?L:^+/V1/V4OV*O
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MA96MYJEEX3\67.B:#<7MYIUM=W&C^(?#WACQ%_9NL0:/<:)J?\]/[8O[0_\
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MJ]]J_@_PEX<OY)+37[ZXMTF2UOQ;WT-Q;1?NO0 4444 %%%% !1110 4444
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M^?97=M<QQ3)]?_\ $+C_ ,$*/^C&?_-F?VP__H@JT?\ @NQ^Q9^TQ^V59?\
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M(KNTF\N573S;6Z@AN;>3;OAN(8IHV62-&%BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *]S:6EX
ML:7=M;W20W%O=PI<PQSK%=VDR7%K<QK*K!+BVGC2>WF4"2&9$DC974,+%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0IE;F1S
M=')E86T*96YD;V)J"C$Q," P(&]B:@H\/"]4>7!E("]83V)J96-T"B]3=6)T
M>7!E("]);6%G90HO5VED=&@@-S0*+TAE:6=H=" X-@HO0V]L;W)3<&%C92 O
M1&5V:6-E4D=""B]":71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C
M;V1E"B],96YG=&@@,3@T,CX^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $
M /_; $, !0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3
M%!H5$1$8(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'O_  !$( %8 2@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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MB7?B;X<^)?#EA)#'=ZKI-U90/,Q$:O+"R*6(!(7+#. 3CL:^(/\ ABKXI_\
M0?\ !G_@9<__ "/7W_10!\ ?\,5?%/\ Z#_@S_P,N?\ Y'H_X8J^*?\ T'_!
MG_@9<_\ R/7W_10!\ ?\,5?%/_H/^#/_  ,N?_D>C_ABKXI_]!_P9_X&7/\
M\CU]_P!% 'P!_P ,5?%/_H/^#/\ P,N?_D>C_ABKXI_]!_P9_P"!ES_\CU]_
MT4 >,_LE?"GQ#\)/!&JZ'XCO-+N[F\U(W<;:?+(Z!#$B8)=$.<J>WI7LU%%
M!1110 4444 %%%% !1110 4444 ?_]D*96YD<W1R96%M"F5N9&]B:@HQ,3$@
M,"!O8FH*/#PO5'EP92 O6$]B:F5C= HO4W5B='EP92 O26UA9V4*+U=I9'1H
M(#8V-@HO2&5I9VAT(#8T-0HO0V]L;W)3<&%C92 O1&5V:6-E4D=""B]":71S
M4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],96YG=&@@-3(Y
M.#4^/@IS=')E86T*_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" *% IH#
M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9QR7-Q<1PHSC@/@E^TA^SQ^TOH&K>*_V<?CU\%_V@/"V@ZP?#VN^)?@E\4?
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M/<SK!-=-# K,&FE6VMKBX:.,,X@@FE*^7$[++0 4444 %%%% !1110 4444
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MH98K#]E'PP/ OB[Q]=_%_P",EAI\MAI&I^)M2T#XU_ &ZAM[*]\9^-M"\3>
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MWM!!%8)X$\=Z%\0==\+ZQILW@_\ L?0(M-N=6M1I']H1:1J%F ?Z"'CWX@>
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M2XM0\:^.)K'P]HEKXQ\(ZIKGA&+0[?5M6\$&[\0:CKOAB^OX@#^S7X^_M'?
M7]ECX=ZC\6OVCOB]\/\ X*?#?2[BWLKKQA\1O$VF>&=(?4;S?]BTFPEU&>*7
M5=:OS'(+#1=+BO-5OFC=;2SF*,!\ ?"+_@NS_P $B?CIX]L?AC\-OV\/@IJ/
MC;5M9M_#VC:3XCN/$_P]M]=UN]G@M;#2] UOXB>'/"N@:]>:C=W,%IIL6D:I
M>G4KJ1;:Q^T3@QC\]/\ @N-_P0X_:._X*Z?M$_LO^)(?VH/"'@#]E+X//H.E
M>.O@U>V/BBQ\4BTUSQ>]W\7/B9X0UFVA\0>$]5^(%_X%32O#OA#3_$>@:5IV
ME/HC27.N26VKWUL?Y6?^#CG_ ()I?\$??V#_ (5_"";]@[XP:4W[2:_%.S\&
M_%+X$VGQ\L_C!K/_  K?4_!7B[5IOB/XGT&ZOM;\0>"]1T;Q7X8T#0X!]MT3
M2M37QE<JFAS-9VLUB ?W#_\ !P=S_P $8O\ @H'C_HB<?_J;>$J_-?\ X,WO
M^41NO_\ 9WGQF_\ 4,^$E6OVCOB3XK^+O_!HS<?$3QSK%]XA\7^(?^"=7P9/
MB+Q!JEQ+=ZKKNJZ5/X!T2ZUG5;R=FFO=4U1]-^W:C>S,TUW>SSW,K,\K,:O_
M  9O?\HC=?\ ^SO/C-_ZAGPDH _JZK_,M_X*07_[4W_!P3_P7>^(7_!./P)\
M8K+X>_ K]G3Q]\2OAUX-TK7Y=5D\!^"D^ UK>Z!\8OBIJ/A"POX!XX^(NN^,
M[;Q)I&A7,9L;O_A';K0]!2_TG1[35]5F_P!-*O\ -@_X+Y_\$Q?V^OV!/^"D
M'C7_ (*K_L%:7\2S\/OB1XNOOC//\2?@EI5WK?BKX#_%77[!X?BA9^/- T^T
MU2=O!?C?4;C6O$C:_J>DWW@O4K+Q/K'A3Q2D!@ACUD ^>O\ @I[_ ,&S/[1/
M_!(C]G?_ (;P^"?[9DWQ>M_@WXI\'3^,=0\(?#OQ'\ ?B5\,5\2ZWI_A71/'
MG@W7-#^*/C^YU"*P\7:SI&FWTUKJ/AG5-(M=5BU2(W5M:W[6_P#;3_P;U?M^
M^./^"BW_  3*^%'Q?^+6KVWB#XT?#S7_ !'\"/BYXABFB>]\3>+/AW!H\^F^
M+=<@AA@BM/$7BWP3K_A/Q'X@CAB2UGUG4[Z]LX[>UNH;6#^1+]CO_@\V_:A\
M'2:1X._;P_9_^&_[27@-Y-.L];\=?#6T@^&7Q22R@"_:]8OO#-TVI_"[QCJ?
MGQ0WEOI-CI?PSL6N!(O]I6JF%H/[F/"__!1K]F;Q]_P3F\=?\%'O@5KUKXM^
M!'@_X$_%'XTK%#IYTG5K.?X6>%M=UOQ'X'\0Z# &N='\7:5JF@W'AW4])'G,
M+\(]A/>V-Q97ER :7[6__!4[_@GM^PGKVF>$_P!J_P#:L^&'PA\8ZO:VFH67
M@G4+K6/$WCG^R[^9H++6+SP5X'TCQ-XITS1;N6.58-:U/2+32I1#.Z792"9D
M^@OV<OVIOV=/VN_A[#\5?V9/C/\ #[XW?#^6[DTZ3Q)\/O$-EKEMIVJ1(DLV
MD:W:PNNHZ!K,,4D<LVCZW9Z?J<,4D<DMHB2(S?YUW_! O_@E5X(_X+K?%[]M
M/]N__@H]XE\;_$W2D^(UMI1T70?&FM>%[_QE\6O&UI=>*O$=]JVKV+-K>D^$
M/A[X8E\*Z/X(\-:+K%K906FI6VDB.VT7PO9Z?>^S?L/>"=?_ ."$7_!S+:_L
M*^ O'6NZK^RM^U8?#G@O3]+\3ZPT]SJWA;XJ^%K[7?@S=ZU'%;Z?I=WXY\ ?
M%RUE\ Z?KJV37.H>'[S7D@-O/XGNK>( _P! ?X[?M _!#]F'X:ZW\8OVAOBK
MX&^#7PO\.O:0ZOXW^(/B'3_#F@VUWJ$ZVNFZ=%=7\T1O=6U.Z=;72](L$NM3
MU.Z9;>QM+B9@A^3OV=/^"M/_  3:_:PT/XC>)/@/^V3\$_%NC_"'PWK'C3XG
MW.L>(Y?AW-X$\#^'EE?7?'?B6P^)EEX/U#3/ >CQ0O-J7C:XM5\*V4&RXN-7
MCADCD?\ B?\ ^#GSXA?%;]OK_@LQ^R3_ ,$JO _BZ;3/!?ANZ^"7@I-&@>YG
MTS3/C+^TIK5C=:[\0O$NEK?V=CJLGA/X6ZSX*FTF.X6.[TC26\4?8+^"/Q1?
MQGZ:_P""OW_!MK^S7^P7_P $[/B+^U/^P7XM^,_@OXU_ +X=7>F_&'4-=^(=
MUK%M\<_@SX\T\?#3XUVNNZ;,EEI?A^\NO"7BK5M8NM/\-0V&@W^B6VK: ="N
M+R\T^^LP#^VSX/?M*_LY_M#>$-<^(7P!^/WP4^.7@'PQJEYH?B3QQ\'OBIX%
M^)GA#P]K>G:78ZWJ&CZYXE\%Z]K>BZ3JEAHNIZ;J]YI]_>V]W:Z7J-C?SPI:
M7=O+)Y#:_P#!13]@34OA;\1/C=H7[:W[*OBOX1?"0Z3'\3OB-X+^/GPO\;>$
MO ESKYN%\/:?XGUGPEXGUFTTG5?$4EI=0^'=(NGCU/7KBWFM](M+V>-HQ_+=
M_P &?7_*(3]M[_LZ+XQ_^LQ? ^OYS/\ @VJ_X)E>#?\ @J?\9?C9\*/VB?&?
MCT?LC_ [2?!_QB\<_!_P9XGOO"UM\3/B[KK>)/!'PSEUS4M/07=I8^'_  X_
MQ$N'O]-N+378O/73=+OK*SUC6GD /]*#]D7_ (*<?L$?MX:AXFT;]DK]I_X;
M_&7Q!X.MY;[Q)X8T:?6-"\6:;I4-W]@DUP^%/&&D^'?$5UX=%X8[<>(K'3+G
M0WDGM@FH,+JW,OE47_!:G_@E-/\ '7_AFR+]NOX!O\8/^$@3PDNA#Q-<CP])
MXJDU$Z.GAF+XCG3A\-)O$+:N/[*_L6+Q>^I#4BM@;873I$W^;M_P4$_8$U/_
M ()__P#!<VV_8<_8@^*WQ$^$'A_X\>(/@Q\*/AEXGLO$^LR>+O"W@K]K_1=
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M\/R>'_&GC&RU)94OW\;Q_#KP5X\\0V&LP3+>VOB.*+Q 'W6C _G/_P $8/\
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MW[Z5IWA[P_\ $J\TNW^&7B#7-0U15TVQTG1?&%_?WE_<6=G;6\MS?6<<]O\
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M\!Z_X@B\;>(O#]E#X4\26ME)X=T2?0M)T_PKJVGZ>EI8^'KFWLO[*J_SHO\
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M/B%=ZJD4D4TOAQ?AWXK\5+XIMX)$GN/#;ZK! ZRR(: /](3]E3_@J%_P3_\
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M06$>J:E8Z'!>7Z64$-HMU-*+>*.$(@ /;Z*** "BBB@ HHHH **** "BBB@
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MMC;* ?HG_P &?7_*(3]M[_LZ+XQ_^LQ? ^OB_P#X,;P/^$\_X*0G'(\(_LN
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M+Y]:T#QQ\/\ 4_%OAKP_J,VH>#_$UMHGBCPW=ZWX7L"-7T>V^V:8]MYD4O\
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MM#M?%/AY_$.A^%M:U?2-)U:ZLM4BBU+0M$O;R*U>%K>T=U=0#\9/^#*1E/\
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M4-4NIYKR[WS3.[ 'U-1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG:3X@TE]4T/5=,UG3EO]/MVO=*U&PU&V$MG>6\TG\ZO_  9Y?L=?M<_LR?M
M_MG:U^TE^RQ^T=^SYH_BGX.?#72_#&K?'#X(?$WX3Z9XCU.P\;:Q=WVG:#?^
M//#&@6NKWUG:RQW-W::?+<7%O;R)--&D;JQ /$OV'?\ E<[_ &AO^RH?M=?^
MJ0\2URW_  ='_P#*P/\ \$YO^R)?L>?^MG?'ROK/]CK]D#]K3PQ_P=I_'7]H
M_P 2_LN_M%>'OV>-7^(W[45]I/QZUSX)_$K2?@QJEEX@^#WB#3-!O-.^*-_X
M9M_ ][:ZWJ4T.GZ1<6VNRQ:E?2Q6ED\UQ(D9YO\ X./?V.?VNOCE_P %QOV"
MOBU\%/V5_P!H_P",'PJ\'?"#]E73/%WQ,^%OP/\ B;\0/A]X6U+P[^UI\;?$
MGB#3_$?C/PGX8U?PYH=]H7AW5M+U[6+34]2M9],T74M/U2]C@L;RWGD /I#_
M (/;_P#DR;]CW_LZ;5O_ %4OB^N[_P""BG_*FC\-_P#LQ[_@F!_ZM']E"NP_
MX/ ?V:_VC/VF/V0?V5?#/[-_P!^-?[0/B3P[^TCJ>N^(/#_P1^%?CKXK:WH6
MB2?##Q3I\>L:QI7@30=>O],TI[^XM[)-0O;>"T:[GAMEF,TJ(W9_MY?LZ_M!
M>,/^#3?P!^SEX2^!7QC\4_M"V7['7_!.CPQ>? ?PY\,?&VM_&:T\2^"/B/\
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M\7)K4DF\R2:LGPC^&RZB[F0F0NUX)F;>2^XG<2V37QO^R'^QQ_P4B_X.)_\
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M\&.!/_"?_P#!1\9.#X/_ &7R1G@D:U\=0"1TR 3@]LGU-?VP_LZ>%_$VA_\
M!/;X%>"M:\.Z[I'C+2/V-/ACX7U;PEJFD:AI_B;2_$VG_!'0])O_  [J.@W=
MO#JMEKMEJL,NF7>D7-I%J%MJ$4EG-;I<HT8_D=_X,ZOV/_VK/V:O&/\ P4!?
M]IC]F3]HO]G:Q\<^#_V>+#PG>?&KX._$_P"#@\42Z1JGQG.N1>%;_P :^'O#
M<FJ7FC0ZMILNH-HD\UUI7]HZ?-,UNUS:NX!\=_\ !7__ (->/VW_  3^U!\5
M/VQO^";UU-\7?!WQ"^)'B+XQ0_#KPWXOM_ 7Q\^$'B[Q;K=UXDU^V\(WFIZG
MH6G>+_#MAK>H7]WX8OM \16/C:PTZ:VT23P[JMQIC:_JOS3_ ,$X?^"_O_!4
M?_@FS^U/\._V8_\ @I+>?&CQM\%=6\0^%/!_COP1^U7H&OZ7\;?A-X:US7O[
M#_X69X4\:^--,L_B!K=AHBFYO)=*\6ZGXD\-:_H^CW%AH%QHMV4U:+Z3\2?%
M?_@LW_P;Q_\ !0WXY?$3QWX$_:+_ ."AO[*/Q,M-<T3PMXQ^)?CSXN_$OPYX
MH^'=KK"^)O!&H_\ "V+RU^).H?"[XG^!X;Z30_$VG^(]+DMM;63Q!/#IFKZ;
M)H7B*Q\Y\6>%/V^?^#HK_@HO^S'\2_&W[$>L?LN_LG?!>P\,Z'XY\8>(-,\1
M:CX7L_A:?%5[XW\5I<_$3Q?X?^'S_$_Q-XU%O-X9\+>&?!NA>3H;:A!J6H6E
MII<^N:\P!_<O_P %C%MW_P""3W_!2(7+ 1?\,2?M+,AX(-PGPD\5/: <C[UT
ML*@]B<@$\'\!?^#*!KP_\$V_VE4<?\2]?VW_ !<UJ>?^/Q_@-\ 1?#'3B!-.
MZ'//. !G]<?^#B3XO:=\$O\ @C%^W9KUR0LOBSX5:?\ !W2;2,1B2YO?C-XQ
M\,_"\QP(S(I6RTWQ1?ZG<*IW1V.GW4B([1A#\T_\&H_P#N/@A_P1L^"^NZGH
M4N@Z[^T%\0OBO\>=6AN8Q'=:C::UXC7P!X.UN4!F)@UGX??#GPCJ6FN2#)I5
MS8R[5\S% '](5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Q3?&+X?
MR?\ !*?_ (.FO@G^TJ\4.E_LX?\ !67P[XC^$^L:RY^P:7X>^,7BR+PEI.O:
M!(\-LMJ]YK?QD\.?"'QK+/J$H-ROQ'UN19MVDRL/[6:** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^/?_ (.H]=\=?M3^)?\
M@G/_ ,$?_@?=7#?%3]L+]H"V^(WBLVK0SVOAWX>>!;:_\+Z=KGBG3A=VMU=>
M&;*Z\2>,/B%>*DD,?V;X0:A*DWVJW@6OZNO@G\)/!WP"^#GPJ^!OP]L(]+\"
M?![X=^#?AEX/T^*-(EM?#G@?P]I_AO1XV5/E,QL=-A:=R6:6=I)79W=F/IU%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %-=TB1Y)'6..-6>21V"(B("SN[,0JJJ@LS,0% )) %.KF?&O
M_(F^+?\ L6=>_P#35=T 7?\ A(_#W_0=T;_P:6/_ ,?H_P"$C\/?]!W1O_!I
M8_\ Q^OR HH _7__ (2/P]_T'=&_\&EC_P#'Z/\ A(_#W_0=T;_P:6/_ ,?K
M\@** /U__P"$C\/?]!W1O_!I8_\ Q^C_ (2/P]_T'=&_\&EC_P#'Z_("B@#]
M?_\ A(_#W_0=T;_P:6/_ ,?H_P"$C\/?]!W1O_!I8_\ Q^OR HH _7__ (2/
MP]_T'=&_\&EC_P#'Z/\ A(_#W_0=T;_P:6/_ ,?K\@** /U__P"$C\/?]!W1
MO_!I8_\ Q^C_ (2/P]_T'=&_\&EC_P#'Z_("B@#]?_\ A(_#W_0=T;_P:6/_
M ,?H_P"$C\/?]!W1O_!I8_\ Q^OR HH _8*/7M"FDCAAUK299972.**/4;-Y
M))'8*D<:+,6=W8A41069B  20*UJ_)KX<?\ )0_ ?_8Y^%__ $^6-?K+0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/C7_
M )$WQ;_V+.O?^FJ[KIJYGQK_ ,B;XM_[%G7O_35=T ?D;1110 4444 %%%%
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M?@/_ +'/PO\ ^GRQK]9:_)KX<?\ )0_ ?_8Y^%__ $^6-?K+0 4444 %%%%
M!1110 4444 %%%% !1110 5X%^U=_P FN?M)_P#9 OC%_P"J[\1U[[7@7[5W
M_)KG[2?_ &0+XQ?^J[\1T ?Q*4444 %%%% !1110 4444 %%%% !1110 444
M4 ?3G[%O_)VG[.G_ &5[P1_Z>[6O[3*_BS_8M_Y.T_9T_P"RO>"/_3W:U_:9
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5S/C7_ )$WQ;_V+.O?^FJ[
MKIJYGQK_ ,B;XM_[%G7O_35=T ?D;1110 4444 %%%% !1110 4444 %%%%
M!1110!V?PX_Y*'X#_P"QS\+_ /I\L:_66OR:^''_ "4/P'_V.?A?_P!/EC7Z
MRT %%%% !1110 4444 %%%% !1110 4444 %>!?M7?\ )KG[2?\ V0+XQ?\
MJN_$=>^UX%^U=_R:Y^TG_P!D"^,7_JN_$= '\2E%%% !1110 4444 %%%% !
M1110 4444 %%%% 'TY^Q;_R=I^SI_P!E>\$?^GNUK^TROXL_V+?^3M/V=/\
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M/]BW_D[3]G3_ +*]X(_]/=K7]IE !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7,^-?\ D3?%O_8LZ]_Z:KNNFKF?&O\ R)OBW_L6=>_]-5W0!^1M%%%
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M3]G3_LKW@C_T]VM?VF5_%G^Q;_R=I^SI_P!E>\$?^GNUK^TR@ HHHH ****
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M^''_ "4/P'_V.?A?_P!/EC7ZRU^37PX_Y*'X#_['/PO_ .GRQK]9: "BBB@
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M7Q,^(,-M9V-G"]S=W5Q,_B8)%!;P1R332.0J1HS,0 37Y9_L'_LS?#']HO\
M;!\<?%/P+X4U'PW^S5\%O$MAK/@S2;V_UR]FUO7[*6)/!5K<ZEK3SZA.;F32
MKKQWX@L);YI]+>;2]$FA&G:C$% /Z=:*** /IS]BW_D[3]G3_LKW@C_T]VM?
MVF5_%G^Q;_R=I^SI_P!E>\$?^GNUK^TR@ HHHH **** "BBB@ HHHH ****
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M_AQ_R4/P'_V.?A?_ -/EC7ZRU^37PX_Y*'X#_P"QS\+_ /I\L:_66@ HHHH
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M,BI#+;Q>B?$;_@BK_P )_P#$+QWX\_X:5_LG_A-O&?BCQ=_97_"F_M_]F?\
M"2:W?:S_ &?]N_X6K9?;?L7VW[-]K^QVGVCR_.^S0;_*0 ^7OVTOB5\*-?\
M^"CO[-?B[P3X_P#A_K?P\\,3?L_0:AXH\,^*O#NI^#O#]IX?^*&H7>HQ7VN:
M9?SZ-I<&BZ68;J]6XNH$TZP,<]P(;<J]?5/_  62\7^%O'O[-'P7\5>!?%/A
MWQGX3U#XOW<=GXB\*:UIOB'0KZ>S\+>*;*=;/5](N;O3[EK2[M;ZSN5AG<PW
M4$T$NR6&1!^5?Q^_8G_X4;^U3\+_ -F;_A9G_"4?\+(N/AQ!_P )M_PAG]B?
MV-_PL#QA=>%-W_"-_P#"5ZO_ &C_ &1]F^W[?[>L?M^_[+FRV_:6_77]JO\
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M_P!-5W0!^1M%%% !1110 4444 %%%% !1110 4444 %%%% '9_#C_DH?@/\
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M_P#3Y8U^LM !1110 4444 %%%% !1110 4444 %%%% !7@7[5W_)KG[2?_9
MOC%_ZKOQ'7OM>!?M7?\ )KG[2?\ V0+XQ?\ JN_$= '\2E%%% !1110 4444
M %%%% !1110 4444 %%%% 'TY^Q;_P G:?LZ?]E>\$?^GNUK^TROXL_V+?\
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M.O\ \\:C_A[%_P $LO\ I)9^P!_XF1^SK_\ /&K\ ?\ B"I_X)9?]%\_;_\
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MS_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H_P"(*G_@EE_T7S]O_P#\.G^SK_\
M0JT ?4W_  \,_P""??\ T?I^Q-_XEE\ /_GAT?\ #PS_ ()]_P#1^G[$W_B6
M7P _^>'7RS_Q!4_\$LO^B^?M_P#_ (=/]G7_ .A5H_X@J?\ @EE_T7S]O_\
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MXF1^SK_\\:OP!_X@J?\ @EE_T7S]O_\ \.G^SK_]"K1_Q!4_\$LO^B^?M_\
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MLZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#\L?^&D/V9O^CH?V7O\
MQ)'X(?\ S>4?\-(?LS?]'0_LO?\ B2/P0_\ F\K]3O\ B"I_X)9?]%\_;_\
M_#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#\L?^&D/V9O^CH?V
M7O\ Q)'X(?\ S>4?\-(?LS?]'0_LO?\ B2/P0_\ F\K]3O\ B"I_X)9?]%\_
M;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#\L?^&D/V9O^
MCH?V7O\ Q)'X(?\ S>4?\-(?LS?]'0_LO?\ B2/P0_\ F\K]3O\ B"I_X)9?
M]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#\L?^&D/
MV9O^CH?V7O\ Q)'X(?\ S>4?\-(?LS?]'0_LO?\ B2/P0_\ F\K]3O\ B"I_
MX)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@#\L?
M^&D/V9O^CH?V7O\ Q)'X(?\ S>4?\-(?LS?]'0_LO?\ B2/P0_\ F\K]3O\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@
M#\L?^&D/V9O^CH?V7O\ Q)'X(?\ S>4?\-(?LS?]'0_LO?\ B2/P0_\ F\K]
M3O\ B"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEOV&?_"DT;_Z8Q7L_P#P>(2)%_P2B\%RR,J1Q_MF_ ^21V.%1$\(?%MG9B>
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MRQV6DVOB?Q+J?AG4=7OM4AU;27TW0[C3]3\.^(+&_GTV8 ^1?V)/^"T7A?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7\6:!XIT'Q!I?]HZ1=Z?JVG_ -H:3J%W:?;=+O[+4;7S?/LKNVN8XID^O_\
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MPAU7QG="RMK.Q^V>,IO W_"4:@ME:P6T&H:M=6T448A*+^-WQP_;I_X+D?\
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M;:W4$-S;R;=\-Q#%-&RR1HPL444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7N;2TO%C2[MK>Z2&X
MM[N%+F&.=8KNTF2XM;F-958)<6T\:3V\R@20S(DD;*ZAA8HHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D*96YD<W1R96%M"F5N
M9&]B:@HQ,3(@,"!O8FH*/#PO5'EP92 O6$]B:F5C= HO4W5B='EP92 O26UA
M9V4*+U=I9'1H(#8V-@HO2&5I9VAT(#8T-0HO0V]L;W)3<&%C92 O1&5V:6-E
M4D=""B]":71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],
M96YG=&@@,SDX,#D^/@IS=')E86T*_]C_X  02D9)1@ ! 0   0 !  #_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1" *% IH# 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%
M!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q
M%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(
M24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*C
MI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ
M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M')&* /9J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O\ +?\ ^#SG_E+#\-O^
MS)?A%_ZMKX_5_J05_EO_ /!YS_REA^&W_9DOPB_]6U\?J *'@7_@S@_X*?\
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MC97OQ&^&OB+5/!/B37K&R@GN(;.R\62Z-!XMM;*-U2QAUU;)8HA;^6OZG5^
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MU^(/Q3M8O%7Q,\>'1/!OB#P]INC> 5BU3P]H>FV5EX@\9W@O-;\'6NF?%_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5_EO\ _!YS_P I8?AM_P!F2_"+_P!6U\?J_P!2"O\ +?\ ^#SG
M_E+#\-O^S)?A%_ZMKX_4 >@?'K_@S[^/G@G]C5?VI?V>_P!JC1?VB?&,7PET
M'XP3? 6Z^!]]\,_$6K:+?^&++Q7K.@^"_$]O\5OB+:^)/%6F:?<W"Z/I-YH7
MA]?$UQ:"TM;BROKRULW^1_\ @V5TS_@E?\0/VS_#'PB_;U^#=[XP^-OBKQ;I
M>H_LJ>-?&'B^\N/@5-XXTVV673_AQXW^&5M:V&G:AXFUJ_AGO_!VK^,=4\3>
M$/$&L?8/"<WAG2]<_L:Z\0_ZDG[+W_)L_P"SM_V0OX2?^H!X?K_+O_X.;O\
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M;_";XT?"7QG?QZ-9>._LZW$>CZ)'=WOC;POK^K3HUMH.K3:9=W]Q::/%JE[
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M-<6UI+>VVD6VOVUN^C:]I%[>_P!F7_!5+]E[Q?\ M5_\&R7@;PK\/M(N-?\
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MQT6\TN*[OS>_T244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!_%W_ ,'HO[7\_P -/V./@+^QQX?O9(-8_:=^)EWXZ\;Q1Q,\<WPQ^!?]
MDZG!I=S+O58&U7XE>)?!&KV1"R-*/!M\G[M1EOWV_P"")?[,R?LC_P#!*S]B
M7X-W&BG0/$D?P2\-_$/QYILK"2\M_B%\8!/\5/&MKJ$P>02W>FZ_XOO-'.V1
MX8(-.@M+5OLMO H_AU_X.T]3UWX_?\%H_P!F_P#9OEUF:T\/Z9\%?@+\.-'@
MB6.6+2-<^,7Q7\97.NZZD13<U]=V>K^&X9D=WCDM]"T\*B$R%_\ 3)TK3+/1
M=+TW1]/B$%AI-A9Z98P+C$-G86\=K;1#  Q'#$B#  P. * /Y.OV8?\ @I)_
MP0J^('_!7@_LR?!G_@G9XF\!_MZ+^T7\?_ __#2%Q^SK^SOH&FGXM>"8?B8_
MQ3\:GXEZ#\8=5^)30>,H_#_C)(M;;P<=:UO^WD76]-T]=0U#[+^J'_!5G_@M
MC^RM_P $?I_@3;_M+> /V@?'#_M!Q?$N;P8?@9X5^'/B5=,7X5OX!3Q"/$Y\
M??%;X9&R:\/Q%T0Z,-*76A<"UU7[<=.,%H+[^";_ ()I_P#*V:__ &D'_;U_
M](_VDJ_5/_@^9_Y"7_!,7_KQ_;)_]*/V6J /V._;;_X.K?V#/V2OAO\  OQ!
MX2\$?$_XZ?%;X]?!3X9?'O3/@MI-UX4\)ZM\+?!'Q;\&:/X\\%6'QM\6)JGB
M_P /^$O&6I:!KEC<OX5\*#Q]>VL174+J2#1[_0]2U?U#_@DA_P ')'[)/_!5
M3XFR?L^P> ?&G[./[14^A:AXC\,_#WQQK6C^*_#?Q"T_1+,W_B*T\!>.])MM
M(.IZ_H%A'<ZO?>'];\,>'=0NM!M;S6-'34[?3-;72O@?_@W>_P""&/["WBO_
M ()P?"C]IK]K']G_ , _M)_&G]J30+[Q;<ZC\8--'CG2O /PUL]5U;PO\-_"
M?@/2=74Z=X<E7PCI.GZWJ.O6-HOB,:AJHTJ#6_[%T#0;6R_E8F^#.B?\$V?^
M#F_X:_!3X$W=_I7@CX5?\%&?@)X=\%VVH7,VH7>E_#'XQ^+O -Q=^#I[Z>5K
MS48+#P#\2;_P:NH7D\NH7UG"MY?337DTTC@'^N71110!_DT_\$+?C[\(?V7O
M^"XOQ4^/?QX\<:/\.?A1\,]#_;7\1^,/%FMR2"VL+"VL/%:QV]K:V\<]_JVL
M:E=/!IVB:'I=M>:OK>JW5II>EV=U?74$$G]'%Y_P>T_L=P?%F7P[:_L?_M!7
MOP9CU)[-?BBOBOP';^-)[)+DP#5X?A/-BQ%K+"/MD5M<?$RWU#R2L<MI%<[H
M$_CH_86_8NT7_@H/_P %F_"/[)?BN\U/3O _Q-_::^,=]\0[S1W>#4U^'GP\
MF\?_ !,\;V-A?I'*-*U#7/#?@_4?#^EZJ\<B:?JFJV5SY4SHD,G]U/\ P6T_
MX-_?^">=Q_P3/^/OC_\ 9F_9I^'WP!^,O[+?PF\3_&GP1XN^%NA-IFL>*M'^
M%6A7OBCQ=X/\>&*:2[\=Q^)/".FZU#:ZGKDU]X@L?$*:1J<&H30P7>G:@ ?T
MI_LR?M-?!']L7X&_#_\ :-_9U\=Z9\1OA'\3-(_M?PQXETT30/N@N)K'5=&U
MG3+N.'4=!\2>']5MKS1?$7A[5K:UU71=8LKO3[^VBG@9:_FA^-__  4F_P""
M%'A#_@L'8?LP?$C_ ()U^)O%?[?<_P"U?\#OAS:_M*1?LZ?L[:OID/QQ\8Z[
M\/K7X;?$+_A9FK_&&Q^)<=KX3U/7/"MU)XAC\&-X@T9-%:31]'OI+&QBN/SJ
M_P"#(W]I?Q7J%E^VK^R)K6K27O@_PZGP\^/OP^TJ>2ZD;1-4URYU3P+\2S:>
M9/);0V.JK8_#BX^RV\%OY=_;7UV[7$E_(8OR(_;6_P"5N'0O^TI?[$O_ *FO
MP!H _I?_ .#UC_E%W^S[_P!G\?#3_P!9Y_:@KZB_X-(_^4+WPD_[+)\?O_5@
MWM?+O_!ZQ_RB[_9]_P"S^/AI_P"L\_M05]1?\&D?_*%[X2?]ED^/W_JP;V@#
M^2O_ (-N_P#E8OU3_K^_;3_]-?C2O[!?^"\'[<?_  23_8\\0?LSV?\ P4W_
M &*M=_:WU7Q_H_Q6N?@[>:/\$_@K\75\"Z?X;O? $7CBVGE^+GQ+\ 2Z"WB&
MYUOPM+''H,6J1ZD-&9M2DM&L;%;C^/K_ (-N_P#E8OU3_K^_;3_]-?C2OT-_
MX/D/^1[_ .";W_8I?M2?^GCX"T ?W#?L1_$'X+?%C]D#]FGXF_LX^ ;GX6?
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN8\;>+M&^'_@SQ=X\
M\1/<1>'_  3X8U_Q=KLEI UU=1Z-X;TJ[UG4WMK5"K7-PEE93M# K!II L:D
M%@: .GHK\Q_^'N/['7_0;\??^$+?_P#R31_P]Q_8Z_Z#?C[_ ,(6_P#_ ))H
M _3BBOS'_P"'N/['7_0;\??^$+?_ /R31_P]Q_8Z_P"@WX^_\(6__P#DF@#]
M.**_,?\ X>X_L=?]!OQ]_P"$+?\ _P DT?\ #W']CK_H-^/O_"%O_P#Y)H _
M3BBOS'_X>X_L=?\ 0;\??^$+?_\ R31_P]Q_8Z_Z#?C[_P (6_\ _DF@#].*
M*_,?_A[C^QU_T&_'W_A"W_\ \DT?\/<?V.O^@WX^_P#"%O\ _P"2: /TXHK\
MQ_\ A[C^QU_T&_'W_A"W_P#\DT?\/<?V.O\ H-^/O_"%O_\ Y)H _3BBOS'_
M .'N/['7_0;\??\ A"W_ /\ )-'_  ]Q_8Z_Z#?C[_PA;_\ ^2: /TXHK\^/
MA]_P4X_98^)OCCPI\/?"VK>-)O$GC/7=.\.:)%>^#KRSM)-3U6Y2UM%N;M[A
MDMX3+(HDF92$7+$'%?H/0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S
M_BVXGM/"OB:ZM99(+FV\/ZS<6\\3%)89X=.N9(I8W7#))'(JNC @JR@CD5T%
M<SXU_P"1-\6_]BSKW_IJNZ /S-_X6M\2O^AX\3?^#:[_ /CE'_"UOB5_T/'B
M;_P;7?\ \<KS^B@#T#_A:WQ*_P"AX\3?^#:[_P#CE'_"UOB5_P!#QXF_\&UW
M_P#'*\_HH ] _P"%K?$K_H>/$W_@VN__ (Y1_P +6^)7_0\>)O\ P;7?_P <
MKS^B@#T#_A:WQ*_Z'CQ-_P"#:[_^.4?\+6^)7_0\>)O_  ;7?_QRO/Z* /0/
M^%K?$K_H>/$W_@VN_P#XY1_PM;XE?]#QXF_\&UW_ /'*\_HH ] _X6M\2O\
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M_P!BW_D[3]G3_LKW@C_T]VM?VF4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<SXU_Y$WQ;_ -BSKW_IJNZZ:N9\:_\ (F^+?^Q9U[_TU7= 'Y&T444
M%%%% !1110 4444 %%%% !1110 4444 =G\./^2A^ _^QS\+_P#I\L:_66OR
M:^''_)0_ ?\ V.?A?_T^6-?K+0 4444 %%%% !1110 4444 %%%% !1110 5
MX%^U=_R:Y^TG_P!D"^,7_JN_$=>^UX%^U=_R:Y^TG_V0+XQ?^J[\1T ?Q*44
M44 %%%% !1110 4444 %%%% !1110 4444 ?3G[%O_)VG[.G_97O!'_I[M:_
MM,K^+/\ 8M_Y.T_9T_[*]X(_]/=K7]IE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7,^-?^1-\6_P#8LZ]_Z:KNNFKF?&O_ ")OBW_L6=>_]-5W0!^1
MM%%% !1110 4444 %%%% !1110 4444 %%%% '9_#C_DH?@/_L<_"_\ Z?+&
MOUEK\FOAQ_R4/P'_ -CGX7_]/EC7ZRT %%%% !1110 4444 %%%% !1110 4
M444 %>!?M7?\FN?M)_\ 9 OC%_ZKOQ'7OM>!?M7?\FN?M)_]D"^,7_JN_$=
M'\2E%%% !1110 4444 %%%% !1110 4444 %%%% 'TY^Q;_R=I^SI_V5[P1_
MZ>[6O[3*_BS_ &+?^3M/V=/^RO>"/_3W:U_:90 4444 %%%% !1110 4444
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ME>\$?^GNUK^TROXL_P!BW_D[3]G3_LKW@C_T]VM?VF4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<SXU_Y$WQ;_ -BSKW_IJNZZ:N9\:_\ (F^+?^Q9
MU[_TU7= 'Y&T444 %%%% !1110 4444 %%%% !1110 4444 =G\./^2A^ _^
MQS\+_P#I\L:_66OR:^''_)0_ ?\ V.?A?_T^6-?K+0 4444 %%%% !1110 4
M444 %%%% !1110 5X%^U=_R:Y^TG_P!D"^,7_JN_$=>^UX%^U=_R:Y^TG_V0
M+XQ?^J[\1T ?Q*4444 %%%% !1110 4444 %%%% !1110 4444 ?3G[%O_)V
MG[.G_97O!'_I[M:_M,K^+/\ 8M_Y.T_9T_[*]X(_]/=K7]IE !1110 4444
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M?:I8S6-AK%S?:YI&G7^N)<QZY=2:%HVAZ7+:1[=/U&_OYRP(M #]RZ*_'O\
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M+X*O8[^Q\-S7/A#4_$6KR^+[2"ST'Q2;R2P TYUN@#\[_P#@AK^W;^PE\=_
M?PS^ 'Q!T7P7HG[8'AGXA_M!^-_A_I_Q)\&Z'J=[]G^*/QH\6_&-M*^#OQ,U
M+3I?/U.RL=;TLZAH\$OACQ'J=]X;NM3L="O+'2X[V/\ =_XZ?"?]F[X?ZYXE
M_;P\7?!7PQXC^-7[/WPK\=^)M)^(MGI"M\1E\-^&? _BB34/#.DZG"K37/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N9\:_\ (F^+?^Q9U[_TU7==-7,^
M-?\ D3?%O_8LZ]_Z:KN@#\C:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M]9: "BBB@ HHHH **** "BBB@ HHHH **** "O OVKO^37/VD_\ L@7QB_\
M5=^(Z]]KP+]J[_DUS]I/_L@7QB_]5WXCH _B4HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ^G/V+?^3M/V=/^RO>"/_3W:U_:97\6?[%O_)VG[.G_ &5[
MP1_Z>[6O[3* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_\ (F^+
M?^Q9U[_TU7==-7,^-?\ D3?%O_8LZ]_Z:KN@#\C:*** "BBB@ HHHH ****
M"BBB@ HHHH **** .S^''_)0_ ?_ &.?A?\ ]/EC7ZRU^37PX_Y*'X#_ .QS
M\+_^GRQK]9: "BBB@ HHHH **** "BBB@ HHHH **** "O OVKO^37/VD_\
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M^W_!FKP>%M5\V>YGA^U:)#'9-Y.U5WJ^?D#_ (B7?^"^G_2&\_\ B,'[9_\
M\O* /[^Z*_@$_P"(EW_@OI_TAO/_ (C!^V?_ /+RC_B)=_X+Z?\ 2&\_^(P?
MMG__ "\H _O[HK^ 3_B)=_X+Z?\ 2&\_^(P?MG__ "\H_P"(EW_@OI_TAO/_
M (C!^V?_ /+R@#^_NN9\:_\ (F^+?^Q9U[_TU7=?P5?\1+O_  7T_P"D-Y_\
M1@_;/_\ EY5'5/\ @Y-_X+W:MIFHZ5<_\$<9DM]3L;O3YW@_9B_;-69(;VWD
MMI6A:369$654D8QL\<B!P"R.,J0#^G&BOY _^'V?_!;+_I$1XT_\1Q_:T_\
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MXB7?^"^G_2&\_P#B,'[9_P#\O*/^(EW_ (+Z?](;S_XC!^V?_P#+R@#^_NO
MOVKO^37/VD_^R!?&+_U7?B.OX@?^(EW_ (+Z?](;S_XC!^V?_P#+RN0^(/\
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M/[1G_P Q% '[%45^.O\ PUW_ ,%4?^D5GQ^_\,3^T9_\Q%'_  UW_P %4?\
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M/_\ EY0!_?W17\ G_$2[_P %]/\ I#>?_$8/VS__ )>4?\1+O_!?3_I#>?\
MQ&#]L_\ ^7E ']_=%?P"?\1+O_!?3_I#>?\ Q&#]L_\ ^7E'_$2[_P %]/\
MI#>?_$8/VS__ )>4 ?W]T5_-%_P1,_X*S_\ !2G_ (*!_'WXK_#7]M;]A$_L
MJ> O!?P@D\<^%/&/_"H?CW\._P#A(O%Z^-/"^@+X9_M/XLZC>:-?;M&UC5-4
M^P::BZF?[/\ M ?[)#<*?Z7: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFWAFGDV[(8I)&5#^"?\ Q%'?\$*/^CYO_-9OVP__ *'VOVU^,O\ R1_XK?\
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MH?$KQW\/?BEHND"94-O=BS\/Z#KEKJ+><'M=6T.33O+::QNQ!\.?M@_L=_\
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MIXTO7;UK3[9]BOA;:A;W5I  ?0?_  3D_P""<'PM_P""9WPI\;?"/X4?%_\
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M"RB\8ZAXCUNZM_&V@_%RVTTV6DZMX$U?3]2DTW1O#+:SJ>IVEWJ]F^O "_\
M!U;_ ,H/?VKO^QH_9Q_]:/\ A97]".A?\@/1O^P5IW_I)#7X\?\ !P%^R?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M._#_ .,WPY\9:[!>0R"*6TFTGPYXDU*_BN8I2(Y('MUE20A&0-Q0!]!4444
M%%%% !1110 4444 %%%% !1110 445Q?Q$^)/P[^$'@KQ!\2?BSX^\%_"_X=
M>$[1-0\5>/OB)XIT/P3X*\,V$MU!91WOB#Q5XEO],T+1K22]NK6T2YU&_MH7
MNKF"W5S+-&C ':45\/>%O^"G/_!-CQSXG\.>"?!/_!0G]A[QAXS\8:]I'A;P
MCX1\+?M8_ 7Q!XG\4^)_$&H6^DZ#X<\.:#I/CZ[U76]>UO5;NTTS2-(TRTNM
M0U+4+JWLK*WFN9HXV^X: "BOC;XC?\%%_P#@GQ\'O&WB#X:_%O\ ;M_8V^%O
MQ&\)W45CXI\ ?$;]I[X)>"/&WAJ]GM+?4(+/Q!X5\3>.-,UW1KJ:PO+2]BM]
M1L+:62TNK>Y1&AGB=O?_ (2_&?X/?'WP58?$KX%?%?X:_&KX<ZI=:A8Z9X_^
M$OCKPO\ $?P5J-[I%W)8:K9V'BKP=JFLZ%=W6F7T,UEJ%O;W\DUE=Q26URD4
MR,@ /2J*** "BBB@ HHHH ***0D*"S$!0"220  !DDD\  <DG@"@!:*^4_@]
M^W=^P]^T-XP7X>? #]LK]E/XY>/WTR^UM? WP>_:'^$7Q,\8-HVF& :EJZ^&
M?!7B_6]:.F:>;FV%]?BR-I:&X@%Q+&98]WU90 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7PI
M_P %)?V\?AE_P3:_8Z^+G[67Q/":C;>!M)CT[P/X/6X>WOOB+\3_ !"SZ?X$
M\!Z?)%#<30MK>LLDFK:A';SKH7ANRUSQ%<Q&RTBY(^ZZ_@7_ .#X#XX^);71
M?V#/V;+*YMX_!^N:I\7_ (X^)K,K(UU=^)?"MIX7\!>!KD.)1%%;Z?I?C'XA
MQ,I@>2>34U*RQ+;NDP!_.=IOA_\ X*]_\')_[4_C#5M+D\1_%N?1[\:YJ-IJ
MGB:Z\&?LQ?LW:!JHN;?1=*TBSU6_NM!\*036MI+8V%EH]GKWQ#\7FTOM6OT\
M17L>L:FO=_MF_P#!LY_P55_8(^$6K?M(>)?#OPQ^*/@7X=P_\)/XSUW]G7XA
M:YXF\2?#72-)C;49_&6JZ)XC\(^ ?$9TC0GMUGU#5_"EIKKZ$B'5[\6>DVEU
MJ=M_?A_P;1?LN^$/V:/^"0'[+=[H>F6,7BW]H/P_>?M%_$;7H+2""^\0ZU\2
MKV:\\,?;YXU\ZY7P]\.[;P?X9M!-(X2/2I)8UB:YE6OWBU'3K#5]/O\ 2=4L
M[;4-,U2SNM.U'3[R%+BTOK"]@DMKRSNH)0T<]M<V\LD,\,BLDL3LC@JQ% '\
M/_\ P:>_\%J_C)^TQK?B?_@G=^UCXXUCXE>-O!W@*Z\?_L[_ !4\6ZC/JOC/
M6_"?A:>PL/%WPP\7:[>RRZAXFU'0+#4+#Q)X0UG49;K6'T&Q\46&K7]Q#I6C
M*O\ <97Y#_L8?\$*/^"8/[ WQ-TWXV?LY?LY)H?QET5M6_L/XG>*O'_Q$\;^
M)= BUW2M4T+5K?P];^(_$][X=\/Q7^AZUJFCWAT70K"6[TV\DM+N6>(*J_SZ
M_P#!Y/\ M9?M4?LOS_\ !.<?LT?M+_M ?L[CQQ%^UP?&@^!GQE^(OPD'B\^&
MW_9E'AT^*!X!\1^'QKYT :]KHT4ZM]K_ +*_MK5OL/D?VC>>< ?W!45_C]_%
M7XO_ /!:/_@L+X \#?%7X;>"_P!KGXS?!C]B7X._"CX6W6O^ =3^('BW/Q"^
M'_PXT!?B#\4?$>O1:BVN_$OXX>/-?AU'Q]XCU*S'B'QQH^A:WX>LKS%JMKJ&
MI_VO?\%-_P#@IO\ $;_@AA_P2/\ V/OA<_BV^^+?[?'Q&^#7@SX6>%_%'Q-O
M]3\87L/BOP;X#\-R?&KXU>+W\0ZK?:MKT'A37=<L=.\.Z5JVHZ@;S7O$'AVW
MU%;_ $32]9CH _JFHK_(M^!W_!/G_@O]_P %=O!/B/\ ;5\+:Y\</BUH2ZGJ
M^K^$?'?Q2_:%A\!7/C[Q'I4DUCJ6G_!71O%/BW0[*W@TR3[1I-IJ&EV?A3X?
MV<T%WX>TO6X[O3[W3;7]2_\ @@/_ ,%UOVO?V7OVR/#?_!-7_@H]XN^)/BSP
M'XV^(A^"VA:G\=;W6=4^+?[._P :K_5FT;P[X;UKQ'XE>Z\4:EX$\0>)IK/P
MC=:-XBOKRV\&RZCI&LZ!>:7X:L=3L;P _P!(>BOYP?\ @YG_ ."I?Q=_X)F_
ML4>$&_9TU.V\-?'W]I#Q_=?#CP9X\FATS4+SX<>&= T8^(?'7C+1-&U>QU'3
MM3U];>31?#&E/?6DEIH]QXG_ +=Q)>Z;8V\_\D_P+_X(!?\ !=+]OCX!_#W]
MN@?M?>&+N^^*_@^U^+/PMTOXM_M1_'.Z^+VM:'XMA;5]-U&+4M.\'>*/"_A.
M[\3Z;-;:AIEI<>-;/9%>V]MK@T!XYX[< _U%J*_@L_X-?/V_?^"FFG_M-^./
MV!/VQ?"O[2?Q<^#>ES_$KP;I'Q7^(/A;XB?$9/V=_C7\(+_6(?$_PV\4?&@6
M&OZ/9>$=3ET3Q+X7CLO%7BN;3M!\9:3X;T#PO=VD.L'3KGWK_@[-_P""Q/[0
MW[&\WP>_8B_91^(.J_"/QS\7OAYJ7Q7^,7Q.\(W\=CX^TWX;ZGK6O^!O"?@_
MPGJR6KZAX0F\2ZOX>\6:GJOBG0K[3/$]K%H.E6FCZA907VHO< ']K-%?Y@WQ
M(_X-M?\ @O;\-/A)XB_:SN/VF?#WBOXE^&O!EUXUUOP)X,_:@^.>I_M!MHFC
M:6=?N-(T_7[[PAI7AG6_%&G@7Y&A:?\ $2XMKBZA":'J>JWMY%;M_1!_P:N?
M\%$OV[/VLO@_\2_@M^VSX1^,_BVV^&.B^&?%_P "OVIOB+X%\<6]O\3O!>L7
M5SI>N>"/$'Q,U;0K?PSXR\2^$[D:#JOAW5GUZ^\6>)= UO5GU%;Z/PM+JDP!
M_6S7XN?\'$?_ "A9_;__ .R2:)_ZLSP)7[1U^+G_  <1_P#*%G]O_P#[))HG
M_JS/ E '^/S\*_&7C#X+^/\ X4?'CPU9RPZC\//B?X?\9>#=3N(YDTZY\8?"
M_6O#'C)+-;F/:7ETZ>Y\/7%]'"XF@@U*SD.WSXR?]W7P'X\T#XA?#KP9\3M$
MNX'\+^./!7AWQYI%_P"?&ULV@>)=#L_$%A=_:01$T#:=>Q3>>"(S&?,!"FO\
M;+P9\"+CQY_P0W^-7QRTS3[>ZO\ X!?\%'OAA::S?.,7.F>!OBU\!]:\-ZI)
M!((W)CNO&^B_#BUG@+Q))OBF+,ULB-_>=^QG^WP^B_\ !J,G[3%KJ$6G>,/@
M1^Q)\5_@1I4VI7"NME\0OA<?$?[/WPK\]TF5W_M.[@\ ZC:6PECN)(]4MK52
MDS*: /\ . _;M^,.L_M5_MA_MA?M202ZAK_AGXE_M(?$?Q99>(9(7^R67A_Q
MIXR\4WOPVT=Y2D:VZIX.TF&PT>TD G;3]#EX?[).X_TXO^#3'_E"I\"_^RI?
MM!_^K8\15_G3>"_@4MA_P16_:&_:9NOWC>*_^"EO[*WP*T(F$ 6:_#_]FG]J
M[Q_XKV3\L_\ :)^)G@SS(1M$7]E1.=YF&S_1+_X-1=2M-&_X(A?!S5]0D:*P
MTKXB?M':E>RI%+.\=I8_%#Q-=7,B00))-,R0Q.RQ0QO+(0$C1G(4@']+U%?Y
M6_Q8^-__  6/_P"#B7_@HA\7_@C\ _%?Q-^$/@'P.WBG7= ^"OB'QMXS^"/P
ML^!WPGTV^T[0-&O_ (MVNDVB:CJGCWQ4;C2)+_\ MC1/$?B6^UO6-4MO#NGV
M7A/3;B#2_E;]H?X<?\%E_P#@W3_:#^"UQXC^/OB3P;=^)K.\\8?#J\^&_P 8
M?%/Q ^ 7Q.T[PE>6FG>*O"'B?P/X@30['7K32%US2X=;\/\ BWP5:"VAU_2M
M5T&Y2^6TU*R /]?&BOQS_:J_:O\ $/QB_P""$'QP_;3^%.N>)OA;XN^)'_!-
MGQ7^T#X,UWP=KNK>%_%WP[\4>)_@/<>-+.;P[XDT:^MM:T37?"FL79BL-7TS
M4HKZTO+".ZM;P2JDU?YM?[/7_!4+_@KS^TG\$_B?_P $^/A!\9/VQ?VG?C'^
MU1\0/ E^FM:C\8OBG\5_B7H_PU^'WA_QG+XI^'O@:_\ $_B#6=2\#>&_&VHZ
MWI&N_$K7]-U;0+&3P_X*M]*URXET74=3" '^Q!17\6?_  ;@_#K]I?\ X)A_
ML,_\%)_VE/\ @HH?VB/ASX:^"VL-]@^"/Q9U7Q1)IWAGPU\$?A?=_$;Q3XH^
M&OA35[V[T::]^)LWQ T/PM8Z]X:66P\27GA/3=.M;RZ:U<)_+C;_ !*_X+!_
M\')/[;'B[1_AKXP\72PVJ7?C.T\"V_Q&\1^!/V:?V:OA[I^I2'PQ'>O8G^SH
MM3^VRV>E6>O#0M8^(WCC6T?4?L]S9Z7=-H@!_KM5%.ADAFC7&YXI$7/ RR%1
MD^F3S7^5=^VY^U+_ ,%S?^"0OP!U+_@FO^U+\:?C%HDWC+Q!X-^+?[-?[47P
MJ_:!^(47B32_#/A&ZU33?'_P\\'_ !CT>?P_XY\2^ =3?7=(&L> O$U_I5]X
M#U'3="DM=&7P]XDT]3_:K_P;.?&;XP?'G_@CW\$?B;\<OBM\2?C/\2-6\;?'
MJTU7X@_%?QUXH^(OC?4[71_BSXLTW2+;4/%GB_5-8UZ\M]*TZVM[#38;F_DC
ML;*WAM;58H(DC4 _'_\ X(#_ /!N[^WK_P $ROV_;3]IK]HGQ!^SSJGPZC^#
M?Q(\ 26WPR^(7BSQ+XF76_%C^'I-+F_LS6_ASX5LSIR_V3<K=SKJ9GB9X-EK
M*K2-'_<#7^:9_P &K/[=W[</[0W_  53LOAY\?\ ]LK]JSXY> '_ &=_C#K;
M>!OC#^T/\7?B9X/;6=,F\(C3=7;PSXU\7ZWHIU/3Q<W(L;\V1N[07$XMY8Q+
M)N^WO^#Q']L+]K?]F/XZ?L4:1^S;^U+^T9^SWI/BOX3_ !6U+Q1IGP/^-WQ,
M^$^G>)-1T[QAX9M=/O\ 7[+P%XGT"VUB]L+:XGM[.ZU&*YGM8)IHH)$CD=6
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M1110 4444 %%%% !1110 4444 %%%% !1110 5_G:?\ !\)X1N[7XS_\$_\
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M'C'523MM],:-FN8@#^'K_@B%\/?&'PD_X+M_L;?"GXA:1_PCWC[X9?M4:_\
M#WQQH!O],U4Z'XP\%V'C3PWXET@ZIHE[J6C:E_9NM:;>V7V_2-1O],O/(^T6
M%[=6LD4\G]'7_!\W_P ?'_!+_P#ZX_MI?^A_LGU^!G_!$;Q#\3?VKO\ @X!_
M9\^.EMX'O-1\0>-_VG_B7^T=\3;#P/HVL:AX?\#:3XJE\9>*?%FM73LVHW&A
M^#-$UCQ/;:7!JFN7S1Q27NDZ?<7]QJ-_;+<_OG_P?-_\?'_!+_\ ZX_MI?\
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M/!OAG6K'Q/=^*],T^SN]2\):9'%XITWQ VJ0IX?;1!INJWW\CG[2/Q$\4_\
M!QA_P7:\.VWPC\*^*$^%_P 4O'7P_P#ACX1M9[&'3]>\$_LP?#%89/&_C_Q1
M+;O>VVDW/]BCQMX^E2[N9C:ZGKVG>%;:2YOC86\X!_8Y_P ')/\ P3B_:#_X
M*>_\$Z_V<_B+^S[X3'CKX\? 6[L/BO<_#:V2WM_%/C3P?\1/ &FV_P 0=&\&
M+/+#;W/BC3]3L/#>N6_ALRQS:]9Z1?V&D_:M=72-,U'^&7]D#_@M[_P5H_X)
M:2Q? SP5\5?$^G>#/AQ>7>CW?[,W[2/@:7Q-X=\'W/F+//H$>@^*K?1_B/\
M#R&VF=YSH'A;Q-X3MHIKJXFDLC)<2,W^@=_P7V_X+!?M#_\ !&OX=?L_:]\#
M_P!F;X??%CP3\69/%G@-?B!X^\4^);7P_P##?QOX3TO2;_PMX8U3PIX=AT_4
M-=3Q3X=DUO4]+DB\7:-(\?@[78)"C+#.WC7P/_X*)?\ !"__ (*Z_L7?"KXF
M?\%&M>_X)^:=\=;;P!8Z?\:O ?Q]UGX>_#+QYX!^(=E90:3XSD^%VH>//$=I
M\3K/P5K6JYU'P7J/@[Q;JMR='U'2=/O-5D\0V=Y;VX!!_P $1_\ @YG^%_\
MP4V^(VF?LM?';X8:7^SU^U/K&EZIJ?@D>&]<FU?X4?&.70],FUSQ'8^%6UD1
M^(?"/B^"PM=6UR+P?JUUXFBO]'TV^O+/Q9>7T,NG)\ ?\'=G_!)3]I7]ICQA
M\'/V]/V9?AGK_P 8D^'/PD?X,?''P1X%L[O7/'VB^&/#WBOQ3XX\%^/='\'V
M2S:CXIT:WN?&_BK2/%0\/6M[KFC1QZ!J$VFW>A)JFHZ#_-[^PA\,?A;K_P#P
M<?? ?PA_P3@U'6M:_9Y\)_MVZ1XI^%.M7_\ ;&LR+\ /AYXA;Q9\09SJ&JA]
M;O?#O_"O]%\7Z7H&M^()?[5U#1IM(O-8N7U.\FD?^OW_ (+U?\'"O[6O_!)?
M]I?PA\!?AO\ LJ?"GQ9X/\>?#SPS\2O!_P 8_B+XA\;WUGXFT]];O]$\<^%;
M+P[X=C\-66E^)?#E[I,L!N'\3:\EC9Z[X:US4-%F@OX]-N #^0/]CC_@YH_X
M*T_L5VFB^ ;WXMZ7^T+\-_"4>G:!#\-?VF?#+^,;_2-+T:4VL^CV?C_3KOPU
M\5K2YCLT.F01Z[XNURPTD6ULD6CE+>2VF_O_ /\ @BE_P7@^!7_!8#PUXO\
M"VG^"+[X'?M)_"S1=/UWQ[\'=2UNW\1Z1JGA>\NH]+3QQ\-_$\=GI-QKWAJV
MU26UTW7+'4=%TO6/"^H:CI=K=Q7]EJ.F:O?_ #!^TA\>O^#83_@HM^SU<_M
M_M*_$']AG4=0\3_#]-:U+4]2\6^"?AS^V/X6FNM,FU(>'7TKPUJFA?'F7QGH
M]['=06GAU;35K/4M1MIEM+35M+NF>Z_E'_X- O!GB?7/^"P&K^*? 5GKL_PZ
M\"_L\_&>Z\8:Q?Z?M$'AC7M1\-:#X0T_7;FR:?2['6]5\07&BWL-@EW)]J;1
M]6>P^T6^GW$T0!_J>5^+G_!Q'_RA9_;_ /\ LDFB?^K,\"5^T=?BY_P<1_\
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M(M[WXG^ M1TWXC?#6S>ZPWV,7WCCPEH-DUV59+>.X>25)(EDC;_.._X-U_\
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M=_6O]$/_ ()+?\HKO^":O_9@W['_ /ZS[\/:_P \_2?^5P67_M)SK7_ISOZ
M/]36BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH _G9_X*._\ !LK_ ,$Z?^"AWC[6_C5-8^-_V;?C
MKXIU)=5\9_$+X(7FDVND^/;\PS13W_C/X>>(]-U?PG<ZO>/(EWJ'B#PW;^%O
M$&KWT*76N:IJDCS>;^6OPZ_X,C?V3M'\2)?_ !2_;2^/WCSPO%JB7*>'?!W@
M3P#\-]1GTJ-D<:7?^(M3N/B,LLTVUH[G4;'1=-=H7(MK:TF"SK_;A10!\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>_\ !)7_ (.+OVVOV\_^"KM[^PK\7_A=^RQX<^$EM<_M"0IXB^&_@GXM:/\
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MP@_H"H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"?$71]0L98Y[*^TSQMX7TOQ)8W=I-$6BEMKBVU**6%XV*-&RE2010!_EX?\
M!-/_ )6S7_[2#_MZ_P#I'^TE7ZI_\'S/_(2_X)B_]>/[9/\ Z4?LM5\L?\$^
M/V$?VX/!?_!SFWQ\\8_L:_M6>$_@4?VYOVUO%P^-/B;]GCXNZ#\)?^$4\56G
M[0"^%_$__"QM4\(6O@[_ (1[Q(VLZ.N@:U_;/]FZPVK::-.N;DWUKYOZ4?\
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M\V_NO@U\>_!_A^ZU'Q)I<VBVMK::7J6IZO-H]GK^I:#I'C/PCXALM:6*WT0
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MRK+B*?3O#W@WXD>)+S6D7?L&F:G;;'GB:(_Z7P 4!5 "@      #   X  X
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MOV:?&=K%YB265MX%NHM4^&^8IBSF)_A+XC\#6_VF-FMI[^RU&.$QM;RVUO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_IJNZ /R-HHHH **** "BBB@ HHHH **** "BBB@ HHHH [/X<?\E#\!_\
M8Y^%_P#T^6-?K+7Y-?#C_DH?@/\ ['/PO_Z?+&OUEH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\"_:N_Y-<_:3_P"R!?&+_P!5WXCKWVO OVKO^37/VD_^
MR!?&+_U7?B.@#^)2BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z<_8M_Y
M.T_9T_[*]X(_]/=K7]IE?Q9_L6_\G:?LZ?\ 97O!'_I[M:_M,H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YGQK_P B;XM_[%G7O_35=UTU<SXU_P"1
M-\6_]BSKW_IJNZ /R-HHHH **** "BN%T3XH?#3Q-XV\:?#7PY\0_ WB#XC?
M#:/09?B)X!T3Q9H.J^-? 47BK3QJWAB7QGX6L;^?7/"\?B/2R-2T)];L;%=7
ML"+S3S<6Y\RNZH **** "BBB@ HHHH **** .S^''_)0_ ?_ &.?A?\ ]/EC
M7ZRU^37PX_Y*'X#_ .QS\+_^GRQK]9: "BBB@ HHHH **** "BBB@ HHHH *
M*** "O OVKO^37/VD_\ L@7QB_\ 5=^(Z]]KP+]J[_DUS]I/_L@7QB_]5WXC
MH _B4HHHH ***^?/VD_VF/AE^RQ\/9/B#\2[R\^SW%V-+\/^']'ACNM?\3ZR
MT,EPNF:3;S36ULK)!%)<7=Y>W-K8V=NA>><.\$4P!]!T5^ WP0_X+):'<_%C
MQ_!\9]*\46'PP\6^)]*?X;75M:^&[Y_A?H*6CVE_:>(8=%TC2]7UVVN[SR=4
MGOQ=Z]J-D'EL[6WGAA5YOWNT_4+'5K"RU33+NWO]-U*TMK_3[ZUE2>UO+*\A
M2XM;JVFC+)+!<021S0RH2LD;JRD@@T 6Z*^0/VSOVOO"_P"QY\-+#QKJNB1>
M,O$FOZ[:Z'X6\#)KZ^';O6VP;C6=0;4QH^OR66G:)IR-/<71TBYA>^N-,TQG
MMY=2AF3U[X ?%C_A>?P9^'?Q<_L#_A%O^$]\.P:]_P (]_:O]M_V3Y\T\7V3
M^UO[.TC[=M\G=Y_]FV>[=CR1MR0#V&BBOSN_:-_X*8? C]F+XGZA\)O'OA/X
MMZOXCTW2]'U:>]\(:#X.O]%>VUNT6]M4BN=9\>Z!?-/'$P6X5]-CC23(CDE7
MYZ /T1HK\>?^'V?[*O\ T('[07_A*_#G_P">O7Z/?L^_'3PE^TC\*/#GQA\#
M:=XCTKPSXGFUR"PL?%=IIECKL+Z!KNH^'[PWEMH^KZ[I\:RWNF7$ML8=3N"]
MJ\+RB&5GAC /:**** /IS]BW_D[3]G3_ +*]X(_]/=K7]IE?Q9_L6_\ )VG[
M.G_97O!'_I[M:_M,H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGQK_
M ,B;XM_[%G7O_35=UTU<SXU_Y$WQ;_V+.O?^FJ[H _(VBBB@ K\.O^"Z7_!2
M_P 9_P#!/3]GWP3I/P6&FK^T'^T!KFO>&_A_JFJ::NLV_@[PYX8L]-E\:>-K
M729E>QU/7M-G\1>&-(\.6&J1W&G'4M<&J7EAJMKI%QI5Y^XM?R6_\'47P7^(
M][X"_9+_ &I?!-O>SZ'\#/&'C?PMXMOK*UEO7\+W_CV;P/K7@7Q-=1F&XL[7
M24UKP+?:/=WM]&+9M7U7PYI[F5[Z&)@#\(]/^,G_  6!_8_^/O[5'[3EYXY\
M7V/Q@^&[_LQ:S^V3+XBNO"WB:"^TOXJ^%=-U3X+:-\3/"\D36-[I5KHEUIW@
MB[A\/16E_P"![C58M#T^^T:207<']]G[ W[66C?MP_LC_!?]IG2-,CT&X^(G
MARX'BCPY#)--!X<\<^&M6U#PKXWT6TFN52YGTRS\4:+JG]BW=PB37VB2:=?.
MH-S7\Q7_  2M_P""H?[+'QT_;U_;D^*G[4NH^ _@O/\ MD>$OV2=+\.>"?B:
MT6J^ ]8\:?![X?Q>"_%FGR>)=3TG_A$["UG\36-AK?A5/%DVDS7$%Y8PVYFU
M6QF5?Z]_%7AE)_AGXN\+^!K+3=*EU3P;XCTSPY;:0EMI&GPW^J:+>6VG/;-9
M+#;VD9NIX76XB"K&,2AOES0!_-K_ ,%_O^"ONC? 3X=ZG^R%^R[\4]3L?VE?
M%5]I1^(WCGX8^*+C2=:^!GA33[RRUB724\4:%,E[I'Q"\8B&WTX:=IE]:ZOH
M/A:YU/4+^;3+C4M!%[^B/_!";XE_$;XO?\$P/V>O'_Q8\?\ C;XH>/-:U3XS
M1ZSXV^(GBK7?&OB[5H]+^-WQ#TG3$U/Q)XEO]3UF_33M*LK+3+!;J]E6TT^T
MM;.W$=M;Q1I_-K^V;_P1&\&?\$^O^"7/QG^.GQ=\66GQ>_:KUOQ;\(K'_A)-
M+_M.'P9\-].USX@:#%XATKPDNHF'4/$>L:R9KBVUGQIKMG97-U8L++2]&T>.
M;5)M6_H4_P"#>+_E$E^S/_V%_CI_ZO[XFT ?M?7X^?\ !9[_ (*6W'_!-[]F
MO2_$'@6QTG6OCS\7]<OO!OPCTW6ECNM*T4Z;8)?^*OB!K.F-/!+JNE^$K:YT
MNT@TZ)FCN_$7B'P_#?*=+:_*_L'7\+?_  <Y^-=*\5?\%!_V2_@_XWU#^Q_A
MKX4^#_A/Q!XAU?S;E_[,L?B?\7O$^C^-=1^SVL,LT8L?#?@'2+GS+6.:ZG,1
M5(F:&%7 /#O%/QV_X.%OV;O@]X,_X*(_$KXM?%./X/>*]4\*:DVF>-==\%ZU
MX=.B^(KR&7PO/XM^"$216W@[PMXXDO8M+MY].T+P[K"I?V$;3:+<7.A7+?VN
M?L(?M6:'^VS^R9\%OVF-$T^/16^)/AB2;Q#X?BF>XC\.^-/#VJ7_ (7\:Z'#
M-(J3366G^*=%U6+3+F>..6\TO[%>.B_: *_F_P#&W_!S1^QKX_\ '=U\#?'O
M[%6I?$/]D%]5T72I/$_B^\\)>*+K4+#POKNGZAX=\27'P"\2>$;K0;C2]'U#
M2-+\1:/87OC<Z[82Z=87L=E!K%O'8P_U3_!35?A)XB^%?@7Q9\"8?",?PE\9
M>&])\7^!9O VDV&B>&;_ ,/^([*#4].U'3M,TVTL;>U%W;7$4DL+6D%Q%+OA
MNHHYXY(U /4J*** .S^''_)0_ ?_ &.?A?\ ]/EC7ZRU^37PX_Y*'X#_ .QS
M\+_^GRQK]9: "BBB@ HHHH **** "BBB@ HHHH **** "O OVKO^37/VD_\
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M'&BA41$4!41% 554!54   "@#\B/^"U7_)I_A#_LNWA'_P!0CXDU]<_L ?\
M)F?[._\ V3RP_P#2R^KV+XU_ ;X4?M$^$[/P-\8O"G_"8>%K#7K3Q-::7_;G
MB3P_Y6MV%CJ6FVE[]M\+:QHFHR>59:OJ,/V:6[>T?[1YDEN\L,$D77_#_P
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M_AQ_R4/P'_V.?A?_ -/EC7ZRU^37PX_Y*'X#_P"QS\+_ /I\L:_66@ HHHH
M**** "BBB@ HHHH **** "BBB@ KP+]J[_DUS]I/_L@7QB_]5WXCKWVO OVK
MO^37/VD_^R!?&+_U7?B.@#^)2BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#Z<_8M_Y.T_9T_[*]X(_P#3W:U_:97\6?[%O_)VG[.G_97O!'_I[M:_M,H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGQK_R)OBW_ +%G7O\ TU7=
M=-7,^-?^1-\6_P#8LZ]_Z:KN@#\C:*** "BBB@ HHHH **** "BBB@ HHHH
M**** .S^''_)0_ ?_8Y^%_\ T^6-?K+7Y-?#C_DH?@/_ +'/PO\ ^GRQK]9:
M "BBB@ HHHH **** "BBB@ HHHH **** "O OVKO^37/VD_^R!?&+_U7?B.O
M?:\"_:N_Y-<_:3_[(%\8O_5=^(Z /XE**** "BBB@ HHHH **** "BBB@ HH
MHH **** /IS]BW_D[3]G3_LKW@C_ -/=K7]IE?Q9_L6_\G:?LZ?]E>\$?^GN
MUK^TR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(*G_ ()9?]%\_;__ /#I_LZ__0JT ?O]_P /8O\ @EE_TDL_8 _\3(_9U_\
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M /AT_P!G7_Z%6@#Z9_X>-_\ !/3_ */P_8S_ /$H/@C_ /-Q1_P\;_X)Z?\
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M)D?LZ_\ SQJ/^'L7_!++_I)9^P!_XF1^SK_\\:OP!_X@J?\ @EE_T7S]O_\
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M /\ #I_LZ_\ T*M'_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6@#\DO^&M/V5?\
MHYG]GW_P\WPY_P#FDH_X:T_95_Z.9_9]_P##S?#G_P":2OUM_P"(*G_@EE_T
M7S]O_P#\.G^SK_\ 0JT?\05/_!++_HOG[?\ _P"'3_9U_P#H5: /R2_X:T_9
M5_Z.9_9]_P##S?#G_P":2C_AK3]E7_HYG]GW_P /-\.?_FDK];?^(*G_ ()9
M?]%\_;__ /#I_LZ__0JT?\05/_!++_HOG[?_ /X=/]G7_P"A5H _)+_AK3]E
M7_HYG]GW_P /-\.?_FDH_P"&M/V5?^CF?V??_#S?#G_YI*_6W_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JT?\ $%3_ ,$LO^B^?M__ /AT_P!G7_Z%6@#\DO\
MAK3]E7_HYG]GW_P\WPY_^:2C_AK3]E7_ *.9_9]_\/-\.?\ YI*_6W_B"I_X
M)9?]%\_;_P#_  Z?[.O_ -"K1_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H _)+
M_AK3]E7_ *.9_9]_\/-\.?\ YI*/^&M/V5?^CF?V??\ P\WPY_\ FDK];?\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M'_$%3_P2R_Z+Y^W_ /\ AT_V=?\ Z%6@
M#\DO^&M/V5?^CF?V??\ P\WPY_\ FDH_X:T_95_Z.9_9]_\ #S?#G_YI*_6W
M_B"I_P""67_1?/V__P#PZ?[.O_T*M'_$%3_P2R_Z+Y^W_P#^'3_9U_\ H5:
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M_!++_HOG[?\ _P"'3_9U_P#H5: /W^_X>Q?\$LO^DEG[ '_B9'[.O_SQJ/\
MA[%_P2R_Z26?L ?^)D?LZ_\ SQJ_ '_B"I_X)9?]%\_;_P#_  Z?[.O_ -"K
M1_Q!4_\ !++_ *+Y^W__ .'3_9U_^A5H _?[_A[%_P $LO\ I)9^P!_XF1^S
MK_\ /&H_X>Q?\$LO^DEG[ '_ (F1^SK_ //&K\ ?^(*G_@EE_P!%\_;_ /\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5_$6GK&MCK$NCV/C>_U>_O+J5;N5_AEX%C599-)LI;7]D?\ @J!_P3J\1?\
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MSPMXEOM!MM&?PO\ $_X4KIFM:AXFT[2-.74M<\0R:);V=U<F[A@&+ZV_,?\
MX;F_X/%_^D2W[#/_ (4FC?\ TQBO;?\ @Z7\0Z#X1\'_ /!)WQ7XIUG2_#GA
MCPQ_P53^ GB'Q'XAUN^MM+T70=!T72_$>I:OK.KZG>R0V>G:7I>GVUQ?:A?7
M<T5M:6D$UQ/(D4;L/V1_X>__ /!*3_I)+^PS_P")3?!;_P";.@#\T;#]L/\
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M:T'Q;^T_^S1K^KRPZ;X)^$?Q>\%:;=:K\0/ BW B6UTFRL]&LM1\*O$\@/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS1^9$SQOLD1EWQNZ-C*,RD$[5 '\UW[.G_*TG_P4)_[1O? 3_P!2CX65S/\
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MY<JNGFVMU!#<V\FW?#<0Q31LLD:,+%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[FTM+Q8TN[:
MWNDAN+>[A2YACG6*[M)DN+6YC656"7%M/&D]O,H$D,R))&RNH86*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9"F5N9'-T<F5A
M;0IE;F1O8FH*,3$T(# @;V)J"CP\+U1Y<&4@+UA/8FIE8W0*+U-U8G1Y<&4@
M+TEM86=E"B]7:61T:" V-C8*+TAE:6=H=" V-#4*+T-O;&]R4W!A8V4@+T1E
M=FEC95)'0@HO0FET<U!E<D-O;7!O;F5N=" X"B]&:6QT97(@+T1#5$1E8V]D
M90HO3&5N9W1H(#4T-S P/CX*<W1R96%M"O_8_^  $$I&248  0$   $  0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4AT._O/$WAGP=XFUG6M!M;+6KBWT>[N-5LK2*VU2>'3YG2[E2%OHF@ HHHH
M**** "BBO'_C7^T+\ OV:_"NG^.OVC/CC\'_ ( ^"=6\06OA/2_&/QK^)?@O
MX5^%=2\57VG:KK%CX9T_Q#XZUK0=(O/$%YI&A:YJEKHUO>2:C<:=HVJWT-L]
MMIUY+" >P45\ ?\ #V+_ ()9?])+/V /_$R/V=?_ )XU;OA;_@IS_P $V/''
MB;P[X*\%?\%"OV'?&'C+QAKND>%O"7A+PM^UC\!?$'B;Q3XF\0:A;Z3H/AWP
M[H.D^/KO5=;UW6]5N[33-(TC3+2ZU#4M0NK>RL[>:YFCC8 ^XJ*** "BBB@
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M+.RN]3E\"6&HZEX:\>R:78.D=]JMGX%\;:9X:\6ZAI5DTL/VO4[#1KFPMA-
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M:?M ^ /#_C_0;6Z0+YUMH7CC1_$.D0/(D4_EV:BXA@G$D* ']!GQB_X*A?\
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M[:^LI)$O+&Y22VO(()XWC7_/@_X+H?\ *U7_ ,$[_P#LH/\ P3>_]:3:L/\
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M4Z%KFNK9SZ@VBZ1J_CO7=!T_4M673[6ZOCIUE<3W@L[:>Y,/DPR.ORU\6_\
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M^L^ []/%=I?ZIJNF:EKC7=W)=>'=7\0ZA>Z?<>%&EVV O7A8 _M?_P"#F_\
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MOU?2_$6H:?XKO[B\619[G3[F>]:56F9P#]1_C9_P6<_X):_LZ?&*;X!?&?\
M;<^"7@?XLV.I+HVM^%;K6=3U:/PGJS)'(VF^.O$/A[2=7\+> KZ%)8WNK;QG
MK>A36:NINDA!%?46J?MH?L>:'\0_ ?PBUO\ :P_9JT;XL?%.P\+:I\,?A?JW
MQU^%^G?$3XC:9XYF>W\$ZCX$\$WGBF'Q+XNL?&%Q');^%[K0-,U"#Q!/&\6D
MR7<B,H_@+_X-T/\ @WZ_9J_X*2_LT_%+]L_]NJ?XC>.;;QM\3O%?@3X6^'M
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M[220-<:;J^ESW%I/Y%S#/:7<(D$]G>V]Q9W<4-U!-"G\KW_!/'_@F/\ LS?
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MU8W,=E?Z-XP^(6G:5>_#KP?JVGW4OD:AIOBCQ7I-Y820W2WD,!L[OR?X??\
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M^)NM6UE;^(/&NMV]JTR6JO;:=INB>'](^U7JZ#X7T;1=&%[?264M]=?S;?\
M!:W_ (-L/V@/CK^UE/\ \%$?^"7GQ*TGX8?M >(]>LO&?Q%\!W?CC6?A5JZ_
M$G3;,0K\5O@[\1]&B:/P[XJUY[6SE\2:-JMYX>M+C6I=1\46GB6.ZU&]TR4
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MVQ-$_P""F/\ P3&^,&C_  A_:NAO_"FN>-_#&N^)M3\#_P!J^-O!>FZ?X?\
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MS\2?@WX@_9#T;X=^-_ /@'0I?&7Q!U3]H*[_ .$F\(>']'BUKQ?H=W\*-'\
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M1_<3_P %+?C3X/\ A%_P39_;4^-&JZCIE[X9T?\ 9-^,VJ:1.;BWFTWQ%?\
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M/XGT_3]>O_#FC>*8/!OB^6W\3Z+HOB*]\)VFJZ5!K.GZIJ7AZ46MWIDWX_\
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MXN^)G_"[_P"S8_V8T^"Y@_X1L?"$^ _MQ\4J;\1_\+*\C^P,71N1J/\ Q*J
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M:Y_:[_X+:?LK_P#!23X;?$7]G'1/@;\#_&?[(OB+Q9X5\<>+OB;IOQ7U"R^
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M32XF=$=T62^6!&=$=E!)5&( /U/7+^./">G>/?!7C#P-K +:1XS\+>(/">J
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M-7\.:'?:%X=U;2]>UBTU/4K6?3-%U+3]4O8X+&\MYY #Z'_X/<?^3,OV-O\
MLYWQ!_ZJKQ%7]&?_  2?M((O^"1/_!/.W2-1#-^P%^S3+(@ VL]]\"?"-S<D
MC&"999Y7;(Y9B3DDFOPX_P"#P/\ 9I_:-_:9_9,_9/\ #?[-_P  /C9^T%XB
M\.?M$ZYK?B'0?@C\*O'7Q7UK0=%F^&NO6$6KZSI?@/0=>OM+TN6^FALH[^^@
M@M'NY8[=93,ZH?WT_P""9_@SQAX#_P""7W["'P_\<^%/$G@SQYX0_8>_9Q\)
M>+?!/BO0M4\.^+O"_BK0_@CX2TG6O#/B+PWK%K9ZSHGB#1]5MKG3-4T;4[*V
MU'3]0MY[.[MH;F*2-0#^*3_@Q])_X7W^WT,G!^$/P5)&>"1XS\:@$CH2 Q /
M;)QU-?Z+5?P7_P#!G;^Q]^UM^S'\;?VV]6_:3_9;_:+_ &>]+\5_"SX1Z=X6
MU+XX?!'XE_"?3_$NH:;XM\77.HV.@7GCWPQH%OK-YI]O<VUQ>VVG27,UK#<0
M2SI''+&S?WH4 ?YR'_!P3;PW?_!SU_P3LM;B-9;>YO?^"?5O/$ZADDAF_:E\
M3QRQNIR&5T9E92"""0>*_?'_ (.\D5_^"-OC1F4$Q_M ? ET)'*L=;U6,L/0
M[)'7/HQ'>ORA_P""X'['?[7'Q9_X.,OV"/C?\*_V6?VC?B7\%O!VH_L+OXN^
M+WP_^"'Q,\9?"_PJGA']I/Q!KOBM_$?C_P .>&-2\)Z&OAC1)H=9\0MJ>K6H
MT72I8M1U(VUI(DQ_;#_@Z3^"/QH_:#_X)/>,/AS\!/A#\4/C?\0KKXW?!?5K
M;P)\(? 'BOXE>,KC2M*UO4)=3U.#POX,TG6M;ET_3HG26_O([%K:SC=7N)(U
M8$@'3_\ !L'IMO9_\$)/V*T55?\ M"T_:3O;H[ OFR77[5?QV7#C+;BEND-O
MN)^=(E.%!"C^9?\ X,@O^3D_V[!V_P"%'?"O_P!3W6_\3^=?U<?\&[OPH^*7
MP3_X(Q_L<_"WXS?#7Q_\(_B;X8TKX[1^)?AU\3O!WB+P%X[\/2:Q^TI\:-=T
MF/7/"/BK3M)\0:2^J:'JNF:SIRW^GV[7NE:C8:C;"6SO+>:3^=7_ (,\OV.O
MVN?V9/V@?VSM:_:2_98_:._9\T?Q3\'/AKI?AC5OCA\$/B;\)],\1ZG8>-M8
MN[[3M!O_ !YX8T"UU>^L[66.YN[33Y;BXM[>1)IHTC=6(!XE^P[_ ,KG?[0W
M_94/VNO_ %2'B6N6_P"#H_\ Y6!_^"<W_9$OV//_ %L[X^5]9_L=?L@?M:>&
M/^#M/XZ_M'^)?V7?VBO#W[/&K_$;]J*^TGX]:Y\$_B5I/P8U2R\0?![Q!IF@
MWFG?%&_\,V_@>]M=;U*:'3](N+;798M2OI8K2R>:XD2,\W_P<>_L<_M=?'+_
M (+C?L%?%KX*?LK_ +1_Q@^%7@[X0?LJZ9XN^)GPM^!_Q-^('P^\+:EX=_:T
M^-OB3Q!I_B/QGX3\,:OX<T.^T+P[JVEZ]K%IJ>I6L^F:+J6GZI>QP6-Y;SR
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M$_\ P4Z\!_MT_MZ_"C6/A+^RO\*]4\'7&I#4_ ^N> / 5U\/_AYJUQXH\-_
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MR09-*N;&7:OF8H _I"HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP\_Z'SP9_P"%1H?_ ,G5^35% 'ZR_P#"Q_AY_P!#YX,_\*C0_P#Y.H_X6/\
M#S_H?/!G_A4:'_\ )U?DU10!^LO_  L?X>?]#YX,_P#"HT/_ .3J/^%C_#S_
M *'SP9_X5&A__)U?DU10!^LO_"Q_AY_T/G@S_P *C0__ ).H_P"%C_#S_H?/
M!G_A4:'_ /)U?DU10!^M=MX^\"WEQ;V=GXU\)75W=316UK:VWB/1Y[BYN)Y%
MB@M[>"*\>6:::5ECBBC5I))&5$4L0#UM?DU\./\ DH?@/_L<_"__ *?+&OUE
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y
MGQK_ ,B;XM_[%G7O_35=UTU<SXU_Y$WQ;_V+.O?^FJ[H _(VBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#L_AQ_R4/P'_ -CGX7_]/EC7ZRU^37PX_P"2
MA^ _^QS\+_\ I\L:_66@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KF?&O\ R)OBW_L6=>_]-5W735S/C7_D3?%O_8LZ]_Z:
MKN@#\C:*** "BBB@ HHHH **** "BBB@ HHHH **** .S^''_)0_ ?\ V.?A
M?_T^6-?K+7Y-?#C_ )*'X#_['/PO_P"GRQK]9: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "N9\:_P#(F^+?^Q9U[_TU7==-
M7,^-?^1-\6_]BSKW_IJNZ /R-HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH [/X<?\E#\!_P#8Y^%__3Y8U^LM?DU\./\ DH?@/_L<_"__ *?+&OUEH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGQK_
M ,B;XM_[%G7O_35=UTU<SXU_Y$WQ;_V+.O?^FJ[H _(VBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#L_AQ_R4/P'_ -CGX7_]/EC7ZRU^37PX_P"2A^ _
M^QS\+_\ I\L:_66@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KF?&O\ R)OBW_L6=>_]-5W735S/C7_D3?%O_8LZ]_Z:KN@#
M\C:*** "O#_VB_VD/@Q^R;\)O$/QR_: \9'P%\+?"MUH=EKWB<>'?%7BDV-S
MXDUNP\.Z+'_8G@O0_$?B&Z^V:QJ=E9[[/2;B.W\[[1=O!:QRSQ^NZUJUGH&C
MZMKNHN8M/T73+_5K^4;<QV>G6LMY=.-S*N4@A=AN95XY8#D?YI_[6OQ<_;3_
M ."GG@/]KK]O'QMX^U?2/V7/@/XV\"^&O#7PIN_$6HVWAC23X_\ '5GH/@/P
M;X9\%Z9*^@W_ (C\.:#K46O^.O&^JH-0O;N2S2.ZNUU"SM=( /\ 3!1UD1)$
M.4=5=3@C*L RG! (R"#@@$=P#3J_DA_X(R^.O^"@G[)?[<WQ+_X)V_M-Q?%G
MXM?!>SM=6M/"OQ,N]$\=^,OA[X!\5Z/X7MO''AN_T'XD:GHMQ%H?@OQ_X*E6
MT'A[6M7M--T[Q/)H5AIUM8:S=ZE!JOOW_!S5^U)\6?V>?V=/V<-!^"7QB^)'
MP8\=^/OC5K6KW&N?"KQ_XH^'?B?5?"7@?P+JEGJ^DW6K^$=6T?5;O03K'CCP
MU>7FFS7$FGR:A:Z3=30M<VEI)& ?TP45_GEZ=^RE_P ',.K:?8:KI_C+]OB>
MPU.RM=0LIS^VWJ$)FM+V!+FVE,,_Q[BGB,D,B/Y<T4<J;MLD:."H_J#^.7[5
M7QP_X)V_\$8O!OQ>^+D6N:S^U9X4^!WPM^'EXGQ$UT^--<E^/7BNRTSPS<ZS
MXRUZ75M5;Q9<>'=1FU/Q7K4QUJ^/B%=%GMQJ+B]%T #]L:*_SMO#/_!/7_@J
MG^TW^R?XI_X*F:I^TMXHN-9LM&\:?%KPOH>L?$SXBV7Q;\0^"_"TNHW?B?Q/
MX/ET>*/1O"J21:)>WGA'PSIUWIL.JZ9I]N-.BTRWDT:WN_Z=_P#@@3_P4 ^)
M/[=7[)?B*'XVZJ/$GQA^!'C*W\!^)/&,@M(M0\;>'-6TE-9\'>)=:M;.WM88
MM;,$>JZ!J5TD.-6FT#^V)G:^OKQ4 /W2HK^(G_@MO^T+^W1X\_X*O:!^R;^Q
M%\<_VA_#7B:+X0_#SPQ:?"GX,?'+Q?\ "_2M;\<7NG^,/BAJ>H7MAI/C+PKX
M9779/!FM:5+>:MJTL-U-I&F:;;273P6ME$OF?[.7[*O_  <8:)^T+\"-9^*?
MBC]N";X8:1\9OA?J?Q'A\0?MDW6OZ#+X#L/&^AW7B^+6]"_X7EJ7]MZ1)X>B
MU%=2TC^SK_\ M*S,UG]BNO.\B0 _O"HHHH [/X<?\E#\!_\ 8Y^%_P#T^6-?
MK+7Y-?#C_DH?@/\ ['/PO_Z?+&OUEH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@^!AJ">'9_&OA_1O%>G:1XA\.ZY>:?/<6D5O8:H!J5G()9;.98P#]HOV"?\
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M%'_#QS]M;_HO.O\ _A/^"/\ YF* /[#:*_CR_P"'CG[:W_1>=?\ _"?\$?\
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M?5&L[[[/&NJZ59O<*MN6FA5X=RK(QH _G=_X)<?\$YOVY/C!^VU+_P %.O\
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M-<_:3_[(%\8O_5=^(Z]]KP+]J[_DUS]I/_L@7QB_]5WXCH _B4HHHH ****
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M^"67_22S]@#_ ,3(_9U_^>-7X _\05/_  2R_P"B^?M__P#AT_V=?_H5:/\
MB"I_X)9?]%\_;_\ _#I_LZ__ $*M '[_ '_#V+_@EE_TDL_8 _\ $R/V=?\
MYXU'_#V+_@EE_P!)+/V /_$R/V=?_GC5^ /_ !!4_P#!++_HOG[?_P#X=/\
M9U_^A5H_X@J?^"67_1?/V_\ _P .G^SK_P#0JT ?O]_P]B_X)9?])+/V /\
MQ,C]G7_YXU'_  ]B_P""67_22S]@#_Q,C]G7_P">-7X _P#$%3_P2R_Z+Y^W
M_P#^'3_9U_\ H5:/^(*G_@EE_P!%\_;_ /\ PZ?[.O\ ]"K0!^_W_#V+_@EE
M_P!)+/V /_$R/V=?_GC4?\/8O^"67_22S]@#_P 3(_9U_P#GC5^ /_$%3_P2
MR_Z+Y^W_ /\ AT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M '[_?\
M#V+_ ()9?])+/V /_$R/V=?_ )XU'_#V+_@EE_TDL_8 _P#$R/V=?_GC5^ /
M_$%3_P $LO\ HOG[?_\ X=/]G7_Z%6C_ (@J?^"67_1?/V__ /PZ?[.O_P!"
MK0!^_P!_P]B_X)9?])+/V /_ !,C]G7_ .>-1_P]B_X)9?\ 22S]@#_Q,C]G
M7_YXU?@#_P 05/\ P2R_Z+Y^W_\ ^'3_ &=?_H5:/^(*G_@EE_T7S]O_ /\
M#I_LZ_\ T*M '[_?\/8O^"67_22S]@#_ ,3(_9U_^>-1_P /8O\ @EE_TDL_
M8 _\3(_9U_\ GC5^ /\ Q!4_\$LO^B^?M_\ _AT_V=?_ *%6C_B"I_X)9?\
M1?/V_P#_ ,.G^SK_ /0JT ?O]_P]B_X)9?\ 22S]@#_Q,C]G7_YXU>+?M)_\
M%2/^"9'B3]G7X^>'= _X*-_L&:QKNO\ P5^*>BZ)I&G_ +87[/%U?ZIJ^J^!
MM=L=-TZQMHOB*TEQ>7UY/#;6T$:L\LTJ1H"S 5^-7_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
MAT_V=?\ Z%6C_B"I_P""67_1?/V__P#PZ?[.O_T*M 'Y8_\ #2'[,W_1T/[+
MW_B2/P0_^;RC_AI#]F;_ *.A_9>_\21^"'_S>5^IW_$%3_P2R_Z+Y^W_ /\
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MLZ__ $*M '[_ '_#V+_@EE_TDL_8 _\ $R/V=?\ YXU'_#V+_@EE_P!)+/V
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M2K=RO\,O L:K+)I-E+:_LC_P5 _X)U>(O^"EW@SX1? S5OVC_B-\"OV==/\
M&NJ^(_VDO"'PMNIM-\3_ !^\(QZ7!;:!\+KK5_.2QTKPU-JKW.JZY=:E::];
MLEK;6T/AZZO)[?5=$ /FW_@F5_P65T3_ (*;_MQ?M^_!OX-:?X-U+]EO]E32
M?@_8_";XI:;:ZX/%OQ6\0^)K_P =:3X_\575]<ZW+H+^ 9M5\+PP?#R'3O#E
MCJ%WI$#^(M1U>^CUZTTO1?W7K^3?_@BE\"/A+^S'_P %L?\ @N+\ _@3X(T?
MX<_"7X8>#_V$_#G@KP=H4<B6&DZ<OPBN;VYD>6>2:[O]2U74[R^UG6]7OY[G
M4]:UK4-0U?5+JZU"]N;B7^LB@#\3?^"^/_!2'X[?\$M?V'M%_:4_9W\)?"CQ
MI\0=4^/?P]^%3:-\9-#\7^(/"7]A^+O#_CK5+ZZBL?!7COX=ZPNLQ7?AG3X[
M*X?7VL8X)KQ9["X>2&6W_)O_ (;F_P"#Q?\ Z1+?L,_^%)HW_P!,8KV?_@\0
MD2+_ ()1>"Y9&5(X_P!LWX'R2.QPJ(GA#XML[,3P%5023V S7[+_ /#W_P#X
M)2?]))?V&?\ Q*;X+?\ S9T ?G7\"_VG_P#@X<\0?L7_ +;GQ,_:._8O_9*^
M"W[5WPAT'PEXN_9/^&VGZ=K?C;P3\;M.TNU\2ZW\5O"VO:?X&_:^\;ZS#XJN
M=*TC2]'^'\X\9^$+6/Q)K-H-0T[7K![@V/W)_P $=O\ @I'X>_X*E_L-?#;]
MI>&TT'P[\3H9[_X??'WP#X?::/3_  +\8_"JVZ^(K#3M/OM7UW5M.\-^(K"\
MTCQMX-M=8U?4M5A\*>)=(MM4OKG5+:^<???P@^-7P@_:"\!:3\4_@3\4/ 'Q
MC^&>O3ZG:Z)\0/ACXMT/QQX-U>YT74KK1]8@TSQ+X<OM1TB^ETO5K*\TS4$M
MKN5K._M+FTG$=Q!)&O\ *#ID-O\ \$+?^"\5_:W=Y#X._P""<W_!8M[[4K6[
MO[DZ=X#^#'[6^CWDM]-;SW=W<P:-X>LM;\1:_<6]O_QZ6\FA?%33+91_9?PT
M9K8 _67_ (+1_P#!3WQ__P $]?AA\$/ O[,?@;P;\9/VY/VMOC%X9^$/[,WP
M<\:6NL:OH&L32ZQI$7C+Q9XGT3PUXK\%^([CP[HUMJND^'8;FP\2:5':>)_%
MOA^^U"X?1K#5XZ_7#X;)\0X?AYX'C^+U]X.U+XJ1^$O#X^)&H?#W1]8\.^ K
MKQP-*M3XIG\&Z'XB\0^+->TGPN^M?;3H=CK7B;7=3M]-^S)?:K>7(DF;^87_
M ()@>%-0_P""KO\ P4]_:%_X+1?$6WN=1_9N^ 6H>)/V2_\ @FAH.J1%])O=
M$\,3W^C_ !+_ &@-,L;F.2-;G7KG4-=M]$U>V=96N_&GB30[]!>> =(DM_W#
M_P""C'[)OQ0_;;_9KU+]G'X9?M&>,OV7(_'7C#PI'\2?B=\/!<_\)Q/\);&X
MN;CQSX)\,RVM[IIM=0\;V8MM DO;B_BL;*QNKRYOK36K6*70-5 /@7X)_P#!
M:KPA^U!_P6<\5_\ !-S]G<_#[Q[\%/A!^SI\0O&GQ8^,E@VJZKJ^I?';PEXQ
M\%Z-+X*^'^MZ?K\7A6X\'>$M*\1W&G^*]1ET36KK5O&'VC3])U+2K/PY<R:]
M],?\%5?^"@/Q_P#^"?/PQ^&'CS]GW]@3XP_\% =?\>^/+[PCKO@/X.:AXTT_
M6/ NCVGA^\UF/Q=JS^"?@M\:[V33;F]MH=&1;S1M'M1=74974Y)=MK)^%_[&
MG[$G[.__  3Y_P"#E3X=_LU?LR>"T\'?#OPU_P $=+W5+V:YG_M#Q+XS\6ZC
M\?+FWUWQUXVUMHXIM>\6ZZFGV,=]J#Q006]E8Z=H^E6FG:)I>F:;9_V/T ?Q
MG>)?^#H+_@H5X,\/:[XN\8?\&Y?[9?A3PGX7TC4?$'B7Q/XE\<_&[0O#WAW0
M=(M);_5M;UW6M4_8/M=-TC2-+L8)[W4=2U"YM[.RM(9;FYFBAC=U_H0_X)0_
MM]Z[_P %,_V+_ O[7VM_ /5/V<8_'_B+QKI>A^ -3\:7/Q!%YH7A/7[C0+3Q
M7IOBRY\!?#C^U-+UVXL[QK9K?PTEM"]K-#%?WVQI1^57_!=_XI>-?VKOC]^Q
MA_P0W^"'B'6=$US]M#Q39_%']L#Q)X7N+B#5/ _[&OP[U*^U;Q%I]U>V23-I
M(^(=SX4\2+:R7Z1:=JMQX/LO".I&>P\:-;7']('PU^''@?X/_#SP/\*/AIX:
MTKP;\//AOX4T#P1X(\*:):QV6D>'?"WAC3+;1]#T?3[6)52*UL-.M+>WC &Y
M@F]V9V9B =M1110 4444 %%%% !1110 4444 %%%% !1110!\"_\%'O^"CO[
M/'_!,/\ 9VU/]H3]H+4=3N8+G4X_"GPW^'/A:&&]\=_%CX@7MI<W>F>#/"%A
M/+#;BXEM[2XO=5U?4)K?2M#TNWGO;V<R&TM+O\&[?_@K7_P<8>+]'M_CIX"_
MX(3Z'#^SQ>:3/XET_P (^*OB[;6GQ\O_  [*B:AIDJ>&[WQ?X;\<P:M+I2ON
MT9?@)>:G=WD\"6=CO5+6ZT?C/HFD_M[_ /!T]\*?@3\285\3?![_ ()D_L<'
M]HK1_ =_'#?^&;CXX^,=9\$76G>)-8L;A9;<ZC9CXI?"G7M-B=$F%[\.-'NE
M#VINDD_K-H _*S_@E=_P5I^ G_!5#X9>,-=\ :'XE^$GQN^#VMKX4_:"_9M^
M(RBW^(WPB\3/=:E8VXO5:UL&UCP[J=YHVK6NF:VNG:;=1:AI>IZ+KVC:%KNG
M7FF1?IAXO\7^%?A_X5\1>.?'/B/1/"'@WPCHVH^(O%'BGQ)J5IHV@>'M!TBU
MDO=3U?6-5OY8++3].L+2&6XNKNYFCAABC9W< 5_*C^UUX8T[]A#_ (.9/^"=
M_P ?OA7';^%_#O\ P4Z^'/Q5^ G[1?A?3U-CI?C+QAX%T[38M$\;75O;/;VL
MGB"YUC7/@Z]S<W$5T]P_A2]F"KJ&O7MY)^K_ /P4[_X)<7O_  5!\1_L^> _
MB9^TA\3OAG^Q_P##N^\5^)/CW^S_ /"_4+G0;K]IC7Y=2\$W7P]T3Q=XEAN(
MTTOP?X6@T;Q8;^$66J:A<W'B.WN]#.@:[I>F^(]. /+O^"0G_!7F/_@J[\6?
M^"@LW@7PYX<TS]G7]F[XK?#3P+^SYXFM]+US3O'/Q!\+^(="\8CQ!XT\<-J7
MB'4=--OX@UWPDVL^";#3- \+WVC^%=3L['Q+;7NN+<RP?N'7\N?_  0!^&'P
M]^"O[<__  7K^$OPG\'Z#\/_ (:_#S]KSX/^%/!7@OPQ80Z9H/ASP_I'A7XE
MVUAING6<("QQ11KNDD<O/<SO+=74LUS-+*_]1E 'X0_\%Z/^"D_[5_\ P3<^
M#G[,'B']CKX<?!GXH_%S]HG]I_PY^SWIWA7XU:/XJU70[VY\6>%O$M]H-MHS
M^%_B?\*5TS6M0\3:=I&G+J6N>(9-$M[.ZN3=PP#%];?F/_PW-_P>+_\ 2);]
MAG_PI-&_^F,5[;_P=+^(=!\(^#_^"3OBOQ3K.E^'/#'AC_@JG\!/$/B/Q#K=
M];:7HN@Z#HNE^(]2U?6=7U.]DAL].TO2]/MKB^U"^NYHK:TM()KB>1(HW8?L
MC_P]_P#^"4G_ $DE_89_\2F^"W_S9T ?FC8?MA_\' 7AC_@F/^U?^TM\=/V.
MOV3?A7^V;\!_%?\ PF'P\^"4&A^,/'_@CXH_L[^&O#&C:S\0;ZST_P"&/[57
MCO7_ /A95BTOBF^\.6R>-K5-53PS'H \(2W6MV6M)^I__!,C]N[P1_P4C_8G
M^"/[6G@R*QTR\\?>'18?$7PC8S7$R> ?BQX;D_L;XB^#,WJI?-9Z5XBM[J?P
M_=WB++J_A:]T+7$WV^IPR/\ 7?PY^)7PU^-G@'0/B3\*?&_@[XI?#+QKI\U[
MX8\;^!]>TGQ=X,\4Z6+BYT^>[T;7M&N;[2-8L#=6UU9R36ES<6[2P30EBR.H
M_D<_9:U;0O\ @@E_P69^._['GCO6;+P#_P $Z/\ @HUH/BW]I_\ 9HU_5Y8=
M-\$_"/XO>"M-NM5^('@1;@1+:Z396>C66H^%7B>0'^Q+7X&6P+W5[<E@#]6_
M^"P/_!3[XS?L:^+/V1/V4OV*O ?PT^,'[=_[:7Q9LO"GPT\"?%73_&&L> ?"
M?PSTN98?&WQ,\;V/@7Q'X1UZ'2]/N+FUALIO^$DTN"'3-/\ &7B5UU*T\&ZC
MIT_[5Z4^J6'A[39/%NH:-/K5GHUF_B;5=*L[C1/#TVJ6]C&VM:AINGZGJFL7
M>D:-)=I<W-G9ZAK6J7%A8F."[U2^EBDNY?Y@/^"*GPS\4?\ !0/]L3]IW_@O
M+\==#O[;3/BEJ.N_L\_\$\?"7B*UDAN/ /[+W@75+W0-0\=VEI,56TU3QW>6
MUYIXF^SQ7-MJEU\4[BUGN-'\86K5^N/_  5!_82^(7_!13X'>$/V;_#7[3OQ
M"_9@^&FL_$S3]7_:(U?X5_NO'/Q2^#5IX6\5V&I_"'2M1EECLM)M?$_B74_#
M.HZO?:I#JVDOINAW&GZGX=\06-_/ILP!\B_L2?\ !:+PO^WO_P %5OVJ_P!C
M+X!1>!_%?[,W[-'P$M?$</QETZ'5+OQ!\1?C/I_Q&\.^%O%\GA37;?Q++X8O
MOA+I=EXC&B:3<)X674]<\0Z)J/B'3O$=UX6OM)CN?O#_ (*1_P#!0+X1?\$S
MOV5/&7[47Q>L=5\26FD:GHO@_P !_#SP[-;0^*OBC\2_%4TT'A?P)X;:Z#PI
M>7J6FHZQJ=V8;DZ5X;T37-86ROFT\6<_X,?\$R_V5?@1^Q7_ ,'#W[:'[./[
M-_@+3?AW\*?A]_P3.^ MGHVBV)DN+V_OKCQ5\+)]6\2>)-7N2^H>(O%7B"^,
MFHZ]K^J33W^I7LK/)(L20PQ?8'_!R'^SM\<?C!^R+\ /C1\"/A]JWQDUW]AW
M]LCX-_M@^+?@UH%N]]X@^(GP^^&5IXHL_%-EX?TV)+B;4]6TJWUV+4Y=/M;'
M4+Z?0(M>-A8WMXD-G<@'R_XI_P""U/\ P5J_9#\+^!?VI?\ @HW_ ,$KO"'P
ME_87\9:[X9L/&/B_X0_%Z'QI\:_V>]&\8W5KI/A[6OBAX+EU;4FU.2]U74=-
M4Z<FA^#9+1[E?#^ISZ=XLN-/T6]_J;\+^)_#_C;PSX=\9>$]7LM?\*^+="TC
MQ/X:U[39EN-.UOP_KVGV^JZ-J^GW"_+/9:EIUW;7EK,ORRP31N.&K^2;_@IG
M_P %Q_V%_P!OO_@GAXW_ &2_V%M?\1_M4_M;?MV>$+/X-?"C]FOPKX \9VWC
MWPYKGBN\T]_$.K^/AK'A^TT#PROP[TNVU36Y;R;6)=.N+G2(]7M-2'A2UU+Q
M1IO])W[#'P0\3_LT?L6_LF?L[^-M7AU_QC\#/V</@O\ ";Q3K%J[26=]XA^'
M_P //#WA?6);"1Y)7?3EO],GCT]GE=FLD@+,22: /JBBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#^4[XS:@/@!_P=G_LQ>,?&<$VG>$?VPO^">GB
M;X-_#[Q).,:5>?$7P?KWC'Q+J?ADSDL8M0BLO!/AR,(5BCENO&7A^WBDDGO6
MC']3NK:YHF@Q6D^N:QI>C0W^HV>D6,VK:A::=%>ZMJ,ODZ?I=I)>30I<ZC?S
M?NK.RA+W-U+^[@B=^*_(S_@LG_P2ZG_X*3?!'P#??"GQU;_!C]L?]F'QS;?&
M+]DKXX,DL1\(^/=.GTZ^NO#6MZA96MYJEEX3\67.B:#<7MYIUM=W&C^(?#WA
MCQ%_9NL0:/<:)J?\]/[8O[0__!9K]JK]FC4/V /V]?\ @@I\2OVA?&$MW8W-
MK\?OV>OVA/$/PU^'UYX]\%BYC\(?%:VN? 'A7QQX-@N;6ZN4\01Z#X@^(ECX
M7U+4"#<^$M.:UBTW3 #[C_X.$-1/QB_;]_X(*_L<>$(TU/Q]XD_;CTK]H77;
M9+B,-H'PX^$GB#P+-K&K7T,>^]2.^T(>/-0TZ5(?(F/@K5HI)HWC5E_JZK_/
MO_X)V?#7]L'_ ():?\%"/@%^U+_P7(^%/QZ^+/BCXT?!+X;_ ++'[+G[3&B^
M)$_:)T;]F3Q+KVJ2>#-+^$OQ>B\()K>J6?C;Q%9:Q9>%=)U_2M2\1F>Y\6^)
MY;.Z\=7_ (E\6:QX6_T$* /YD_\ @F9_RL)?\' O_8-_88_]4T:_ILK\+OV&
M?V./VC_@[_P6._X+!_M5?$?X<_\ ".? 7]J:Q_92A^!'CS_A+_ FK_\ "=2?
M#7X:'P_XU7_A%]"\4:IXS\,?V+J_^B9\8^'?#RZC_P ?&DF_M?WU?NC0!_*?
M_P 'B4,=Q_P2@\&P3+OBF_;,^"$,J99=T<G@_P"+:.NY2K+N5B,J0PSD$'FO
MK+_B%Q_X(4?]&,_^;,_MA_\ T05,_P"#DG]B3]I[]OK_ ()^>%O@A^R7\,O^
M%L?%#3?VG/A3\0[WPQ_PF?P]\">3X/\ #7AWXB6&M:O_ &U\2_%G@WP])]BN
M]=TJ+^SXM6DU2Y^U;[2RGC@N7A_H!H ^<_V4OV3/V?OV(?@AX7_9P_9?\ ?\
M*Q^#'@N\\1ZAX:\&_P#"5>-O&G]FW?BWQ#J7BKQ!-_PD/Q"\2>+/%=Y_:&O:
MOJ-_Y>H:Y=16GVC[+9);644%O%^('_!V/\/O!?B__@BM\?O%7B7P[IFL>(OA
M3\0?@!XQ^'FL7ENLE_X4\2:S\:O!'PXU75=(N.)+>?4/!7CCQ3X?NPK>7-8Z
MO.LB,ZQ/'_277XV?\%^OV4_CY^VQ_P $J?VD/V;?V8_ ?_"S/C3X^U3X)7/A
M/P9_PE'@SP9_:T/A#X\?#7QGXB?_ (2+X@^(O"GA.Q_L_P ->']7U+;J6NV;
MW?V3['8K<W\]M:S 'VC_ ,$^/A?X$^#'["_[(GPT^&GAVS\+>"_#/[.WPCCT
MG1K'S&CCEU/P3H^LZO?7,\SR7%[J>LZUJ.HZSJ^HW4LMWJ6JW]Y?W<LMQ<2R
M-]A5XY^SMX5U_P "?L_? OP1XJL/[*\4>#?@Y\,?"OB33/M5E??V;K_A[P3H
MFD:Q8?;=-N+S3KS['J-G<6_VJPN[JRN/+\VUN)X'CE;V.@#^9.^_Y6UM&_[0
MWR_^M":K7]-E?A==_L<?M'R_\'$&F?MTI\.=W[*]O_P33D_9_F^*7_"7^!!L
M^+C?&/4/%0\)?\(0?% ^(S9T">*__MY?"+>&?F^RG6OMJM;C]M?$\FLQ>&_$
M,OAVV-YX@CT/5I-"LQ+;0&ZUE+"X;3+837LL%G"9[T01"6[FAMHRV^>6.(.X
M /Y>?^",4=Q^V3_P5L_X++?\%+->C.I>'O!OQ6T_]@+]GF^OW%W+HW@WX0O:
MGX@)HJ@-;Z7IOB-/#7PR\6QQVKFXEN?%6LM=>7)<7!NOZHJ_"C_@W8_8=^/?
M[!'_  3GT_X6?M2^!F^'W[1'CKXX_&'XP?%70KCQ;X,\=:A+K'BC5M/T#1-7
MU3Q7X!\2>+?#6KWVK^#_  EX<OY)+37[ZXMTF2UOQ;WT-Q;1?NO0 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?R<_"V*+]G3_@[N_:4MO%5]%ING?MY
M_P#!/GPKXC^&ZZBOV;^W/%?PYT[X/>';C1]#NI\+?7-MH7[.OQ&U:[L;9G=8
M8S*ZJMJ@;^K#4]>T/1)=(@UG6=)TB?Q!JL>A:##J>HV=A+K>N2V=[J,6C:1'
M=S1/J6JRZ?INHWT>G68FNWL]/O;I83!:SO'^+7_!9O\ X)<>/OV[?#/P4^/W
M[*/Q'M_@?_P4"_8U\6R?$/\ 9E^*5S<RV&CZL9+BROM<^&7C.\@LM19?#WB&
M?3+*>RN+S3=5TRVO$O=)UG3+SPQXG\2VT_\ /E^WK\;/^"Q'_!0+]G[1/V,?
MVN_^" WQ?\1?'3P7J]IXU^'G[2GP+_:,\0?#SX?^ _C?X?T74?#>A_&/PM+H
M7AWQ?\.#>::OB+4;JPT'Q+\9-9T;R;V]:V$#6_VNQ /T'_X*W2Z?\<O^#@K_
M (((?L^>&)AJGB_X*:M\;?VD?'.GV/FW$WAOP=(WACQ/H>IZS]F5SIUKJ-Q^
MS[K]M;/>/'%/.;: _P#'[ )_ZP:_A,_X)6^$/VF_^"8?_!32T\<?\%IOAG\=
M?B9^T]^W-X#^#?[/'[,W[8^A:M>?M!_#7PO?7<FCZ!=? 7QE>>#]&NKKPIX[
MU.?2_!EEJGB=Y]4L%M?#^KZTTC>'=3\4^.]4_NSH _FN_P""*'_*2O\ X.'O
M^SW?AC_ZCOQ.K^E&OQ"_X)>?L@_M$_LZ_MP?\%EOC!\8_AY_PAWPZ_:N_:F\
M"?$?X!>(O^$M\#>(/^$]\&:-HOCJTU+6?[(\+>)M;UWPM]FN-9TV/^SO&FF>
M'-5F^T[[>QE2&=HOV]H _E"_X.L_ _A?XG?#7_@EI\-O'&E_VWX*^(7_  4_
M^"G@?QAHOVW4=-_M?POXLT#Q3H/B#2_[1TB[T_5M/_M#2=0N[3[;I=_9:C:^
M;Y]E=VUS'%,GU_\ \0N/_!"C_HQG_P V9_;#_P#H@JT?^"['[%G[3'[95E_P
M3@A_9M^&O_"QY/@)_P %$/@K\=/BPO\ PF/@#PA_PBGPK\)1:LOB'Q3GQYXJ
M\+KKO]GM<P#^Q/#1UCQ'=[\V.D7(5RO[VT >,?L\?L]_"#]E+X+?#_\ 9Y^
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ME6EU%O23RKBVL8(9H_,B9XWV2(R[XW=&QE&92"=J@#^:[]G3_E:3_P""A/\
MVC>^ G_J4?"RN9_X."_$'C_X[?'S_@E/_P $K=%\;^(/AQ\'O^"@?QZ\?O\
MM+:]X8U2XT?6/%?P?^"%GX$UC6OA1%>6S6LS:?XXL?%VKO>K%J,2IJNC^&UO
M-/UBPN+G3I_KKX+_ +(/[1/A/_@O=^V/^VGX@^'G]G_LS_%7]B;X1_"+P%\2
MO^$M\#77]O?$/PQKW@&]USP]_P (;9>)KGQ_I?V&VT34Y?[6UGPKIVAW/V;9
M9ZE<236Z2W?^"UW_  3]^.G[8?PV_9[^.?['/B#0?#7[;_["?QGLOC[^SC)X
MJO?[.\,>,)%.F?\ ";?##7+_ &!;6T\:VV@: \0N[JPTC4KK18-!UW4-,T;6
M;[5M/ /'?V_/^"$7_!.O6OV'OBMIO[//[,_PC_9C^-WP6^%WB+XB? 3X^_!O
MPS9_#SXK^#_B1\,/#=]XC\'ZMKWQ*\.2:3XQ\66UWJ.E0VFOW'BW7]6NY8KJ
M768KJ'7;/3]3M?K3_@AU^UKX_P#VX/\ @E9^Q_\ M'?%>\N]5^)OBGP/XB\(
M^/?$%\ELEWXL\4_"+XA>,/A#JOC.Z%E;6=C]L\93>!O^$HU!;*U@MH-0U:ZM
MHHHQ"47\;OCA^W3_ ,%R/^"@OP2\2?L*_#'_ ()#_$?]C3XM_&GPOJOPH^.7
M[4OQH^(-S;_ GX8^$?$EC+HGCCQ#\--7B\)Z7/XDN-;\/W&J0Z9<:#KGBO5O
M"\E[%#I.G>,K];;5HOZ1_P!B#]E7PC^Q!^R1\ /V3O ^H7.L>'O@;\.-%\%I
MKM[%%!=^(]9B$NH^*?$]S;P(D-M/XF\4:AK.O2VL2^7;/J)@5G$8=@#ZHHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *]U:6E]%Y%[:V]Y )
M;>X$-U#'<1">TN(KNTF\N573S;6Z@AN;>3;OAN(8IHV62-&%BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** *]S:6EXL:7=M;W20W%O=PI<PQSK%=VDR7%K<QK*K!+BVGC2>WF4"2
M&9$DC974,+%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MK\S?^&H_CK_T/1_\%5E_\9H_X:C^.O\ T/1_\%5E_P#&: /TRKYZ_P""@?\
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M1FEL=&5R("]$0U1$96-O9&4*+TQE;F=T:" Q.#0R/CX*<W1R96%M"O_8_^
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MT]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M%G_1-/!G_@BMO_B*/^%3_"S_ *)IX,_\$5M_\179T4 <9_PJ?X6?]$T\&?\
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M_P#%T?\ "V/BG_T4KQG_ .#RY_\ BZ /UEHK\FO^%L?%/_HI7C/_ ,'ES_\
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M(KLZ* .,_P"%3_"S_HFG@S_P16W_ ,11_P *G^%G_1-/!G_@BMO_ (BNSHH
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-.38Q,3@Q"B4E14]&"@$!

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>a18q1_10qx093xchart-08965.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-08965.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% #6&Y2!C/!&<XW*0RYQSC<!G%?B7\ O\
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M () _LI_!FX_9IUGP_JWQGU_QG^S5\6?VA/CS:?$3QQ\1E\5>//C-\:/VG_
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MH_X23P__ -!S1_\ P:6'_P D5^/WEQ?\\HO^_4?_ ,31Y<7_ #RB_P"_4?\
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MY-]^!?\ V1SX8?\ J$:%7LM !1110 4444 %%%% !1110 4444 %>#?M(_\
M)*M7_P"PGX?_ /3O;5[S7@W[2/\ R2K5_P#L)^'_ /T[VU 'YP4444 %%%%
M'UI^R9_R'O&?_8'T7_TX7]?<E?#?[)G_ "'O&?\ V!]%_P#3A?U]R4 %%%%
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M^LFOY-O^"KW_ ">IXX_[$KX9_P#J./0!^(/Q0^-'C?P3\>O@K\,[#P_X2LO
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MV]DUO;Q1P6]O9FWMX(4$<,%O!;>3!!#&O$<,$*)##&.$C1$'"B@#^XS]G/\
MY-]^!?\ V1SX8?\ J#Z%7LM>-?LY_P#)OOP+_P"R.?##_P!0?0J]EH ****
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MH_B,G\SXF)H _F9\R/\ YZ1?]_H?_CE'F1_\](O^_P!#_P#'*_IF_P"' ?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>a18q1_10qx093xchart-09340.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-09340.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O@_P#X*._MK77[ ?[,>J_M":=\(-4^.NL6_P 0_A)\-=!^
M&6C>,]&\ 7_B+Q#\7_B%H?PYT"&+Q3X@TW5='TP1:OK]F[O?VJ6SJ=L]W90^
M9=1?>%?AK_P<,^&/$GC+_@G7)X;\):GK^A>(=5_:L_8GMM,\1>&-(CUW7/#%
MS)^T_P##A8_%&G:7<6MY9W5SX<=EUJ&._@?3FELD2_!M6E! .#\4?\%R/%_P
M5\"_M:0?M7_L"?%C]FO]HS]E_P#9ETG]KFP^ WB#XS_"/XAZ1\7_ (*:C\2[
M;X37WB#P5\8?ADWB/PW8W7ASQI>V.F^(=+U;0S>V1O[)H8KGS)A!^VW@3XR?
M#CXAZ!JVO>'?&O@W4D\*I'#X\MM)\7^'M:;P!K"Z3#K&HZ#XQFTV_F3P[JVD
MVDIEO[/6ETZYMX$-S/!##EE_F?\ ^"F/_!-?4O@5_P $XO\ @II^TA\4?VD?
MV@?VVOVK/B'^QYI_P'L?B5\6M+\"Z7-X3^$>@?%;0O&R?#WX<_#WX2^$/#NC
M:3I^N>+[E?$GB.ZGBU?4=3OM-L)Q-9QQ7@N?DK]H'X;_  U_8C\9_P#!6;0/
M@=^QKX6\3_!36_\ @DS^P3K7C']GSPIX?^(O@WX>?$3Q%K7QH\:^ O'/C_Q_
M+\(;C1?'7B0^#?!/B74_'GQ;F\/ZY;^.O&7A70->@U;6&O-6U#4V /[#O#OQ
MX^"/B[PF?'GA3XP_"SQ/X'&O0>%O^$R\/?$3P=K7A4^)KF\M]/M_#W_"1:9K
M5UH_]N3W]W:V4.D&]&HRW=Q!;1VS331(]"X_:,_9_M='@\0W7QQ^#UOH%SI^
MG:K;ZY/\3_ T.CSZ9K'B*Z\(:3J,.IR:^ME+8ZIXKL;SPSIUY'.UM?>(;2YT
M6VEEU.WFM4_S\=&^'WA'QY\&/^"HOA'P'IO@[QO^S_\ %/\ :I_X(8>)_ -S
M\!/V1?'O[%WP%\<^#M>^*'B#P5\3/%'P.^!^KS7WB#3O"$.H:)J/A#6OB5!K
M%]JGC75M N/&>HZJ+K5+6ZE_1G_@I[^Q#^SS;_M6_P#!0;P+H/[,GP]D^'?[
M/?\ P;>^+]3_ &</"EC\-+:Z\&_"WXD:=\<_C_KFCZO\-=(BTZ;1M&\?:3J>
MH2:QH>HZ9$?$NF7>I:A>Z;+"=4U!KD _LDTSXF?#G6[KQM8Z-X]\%ZM??#6Z
M-E\1++3/%6@7]WX"O!92:D;3QI;6FH33>%;K^SHI+\V^OII\HLHWNB@@1Y%S
MO!WQB^$OQ#\(ZEX_\ _$_P"'?CCP+H[ZG'JOC/PAXW\+^)O">FOHL'VG64U#
MQ'HFK7VBV3Z3;YGU-;J^A-A"#+=B*/YJ_AI\7>"/!O[(6F_M'W'PU_9#T;QW
M\/?B!_P;O?L%>-_C/\'=/T#XF^%_#/Q?^)GC']I2#PG\2OBO\:]3^%$VC?$S
MQMKWA+PEXIUKQ_\ %RZM?$,7Q&\7^#_#^O:;J>K(E_?7T?COPR\,0:K\'_\
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MPSKFD:P]O?3S+^VM% 'YE:!_P2>_9?\ #GASX)^&-/U#XK-IOP$_;C\7?\%
M_ [7'C+3)+J;X[>-=5\>:OK%GKTR>%XEU'P MW\1-?%GX;@CL+^*%+".;7K@
MPSM==_\ MI_\$Z_@E^W3K'P'\2?%+Q;\;? _BC]FSQ)XU\:?"/Q7\#_B??\
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MMA_8MSH=_?\ Z244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'.O>,B.AT?12/_ ^_K[DKX;_ &3/^0]XS_[ ^B_^G"_K[DH **** "OY./\
M@JW_ ,GK^-/D\W_BCOA?^ZY_>_\ %/G]UQD_O/N< GYN.<5_6/7\FW_!5[_D
M]3QOU'_%%?#/!!((/_".-@@CD$=01R#R* /Y0_A7I_P]\+?';]JSPO\ %#QO
MK<R?%_PU\6_$4/[2WP]^*UZN@7_PVT2Z'BSQGX>\4V<,]];^&_'WPXT*_LO#
M]EK-CI=W9:!::1K7A'PW<V5]J;6DN7XC^'E_K7PG\$^%/!O@.;3/"GQQ^/\
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M::*W34_%<CR);:I;RS;5@\)S-\D0:5B5"A$;YMVU6_=;^SK#_GRM/_ 6W_\
MC5']FZ?_ ,^5I_X"V_\ \:H _E,_X?%_\$N/^CY?@7_X&>,__F-H_P"'Q?\
MP2X_Z/E^!?\ X&>,_P#YC:_JR_LS3O\ GQL__ 2W_P#C5']F:=_SXV?_ ("6
M_P#\:H _E-_X?%_\$N/^CY?@7_X&>,__ )C:/^'Q?_!+C_H^7X%_^!GC/_YC
M:_JR_LS3O^?&S_\  2W_ /C5']F:=_SXV?\ X"6__P :H _G9_9U_P""WG_!
M)?P;JWBBZ\0?MZ_ 2QCO=.TFWM?-U#Q?$9GAN[Z6;89O!\49$2M'O ?=^]0J
MK#>4^K?^'_W_  1P_P"D@GP _P#!MXE_^9BOUZ_LW3QTLK,?]NMO_P#&J/[.
ML/\ GRM/_ 6W_P#C5 'Y"_\ #_[_ ((X?])!/@!_X-O$O_S,4?\ #_[_ ((X
M?])!/@!_X-O$O_S,5^O7]G6'_/E:?^ MO_\ &J/[.L/^?*T_\!;?_P"-4 ?D
M+_P_^_X(X?\ 203X ?\ @V\2_P#S,5_.7_P46_X*@?\ !/SXN_M4>+/''PY_
M:P^%7BSPK?\ A3P'8VNM:3/XHN+*6[TO1'M;^W67_A&5S);3860 $*649W;E
M7^Z[^SK#_GRM/_ 6W_\ C5(=+TXG)L+(GU-I;$_^BJ /\V[_ (;T_8V_Z.+^
M'G_ES_\ S-T?\-Z?L;?]'%_#S_RY_P#YFZ_TD/[+TW_GPLO_  $MO_C5']EZ
M;_SX67_@);?_ !J@#_-O_P"&]/V-O^CB_AY_Y<__ ,S=1S?MY_L;M#,J_M%_
M#PLT,JJ!_P )/DLT;  ?\4WU)(%?Z2G]EZ;_ ,^%E_X"6W_QJC^R]-_Y\++_
M ,!+;_XU0!^''P1_X+Q_\$@_#/P8^$?AS6_V^?@+I^LZ!\,? .B:O83ZIXF2
M>RU/2O">D6%_:3H?# *36UW;S0R*1E70@\BO3_\ A_\ ?\$</^D@GP _\&WB
M7_YF*_7K^S=/'2RM/_ 6W_\ C5']G6'_ #Y6G_@+;_\ QJ@#Y&_90_X*!_L:
M?MR/XYC_ &3/VA/A]\=9/AHGAQ_':>!KS4KH^&4\7-K:^&VU,:AI>G>6-7;P
MYK8M/*\[<=-N=_E[5W_8U00VUO;[O(@AAWXW>5%''NVYQN\M5W8R<9SC)QU-
M3T %%%% !1110 4444 %%%% !7B/[0OQOTG]GSX8:G\0]1\.Z_XTU%M;\'>"
MO!?@/PH=*3Q/\0/B-\2/%VB^ ?AWX&T&;7=0TK0[*^\3^,?$6CZ9)J^N:GIV
M@^'["6]\0:]?V6C:7?7,?MU?-_[5/P,U+X_?"D>%O#'B+2O"'Q!\)>._AE\8
M/A7XKUW09?%&@:%\3_@WX]T#XC^"9_$GAVWU'1[O6O"FI:OX>30/%NG:=J^D
MZO<>&-8U<:)JVEZP+&_MP#P;3/VZM4\):#\>+3]H?X!>-/A=\6/@/\--$^,=
MS\,?A[KUA\?7^*'PZ\6W/BG1?">I_";7O"&D:'=:[J]SXR\&:]X(\2Z%XE\,
M>$IO!FM1Z=K.MW0\":UI/C"ZB^*?[=>J^#_V1/V<?VF/ GP;3QUXE_:<U/\
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MBZ]=@_;GUO\ X6)^S=\$-5_9]\:^&_C?^T)\%OB;\6;CPCXBUD:9X2^%FM>
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/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>a18q1_10qx093xchart-10113.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-10113.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %>#?M(_\DJU?_L)^'_\ T[VU>\UX-^TC_P DJU?_ +"?A_\
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MO;>LHSU_F>QQ^?G_  X!_P"".'_2/OX ?^"GQ+_\T]'_  X!_P"".'_2/OX
M?^"GQ)_\T] &/]JM?^?JT_\  RU_^/4?:K7_ )^K3_P,M?\ X]6S_P . O\
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MK?\ ^.T?VC8?\_MI_P"!5O\ _':_(7_AP#_P1P_Z1]_ #_P4^)?_ )IZ/^'
M/_!'#_I'W\ /_!3XE_\ FGH _7K^T;#_ )_;3_P*M_\ X[7\GW_!5N>"3]M+
MQN\<\#J?!7PT 9+B!AD>'7!Y$A'!']>E?J/_ ,. ?^".'_2/OX ?^"GQ+_\
M-/3A_P $ _\ @C@!C_AWU^S]^.C^(R?S/B8F@#^8C4],T?6H+:VU>RT[4[>S
MU32M;M8+X6MS%;ZOH=[%J6CZE$DCE4O-,OX(KNSG W0S(&&065LRW\(^"K/4
M;W6+3PGX,M-8U**]AU+5[7PYX9MM6U*#4MW]I0ZCJD%C'?W\.I;W_M&*\N9X
M[_>_VQ9][9_J*_X<!_\ !''_ *1]?L_?^";Q%_\ -+1_PX#_ ."./_2/K]G[
M_P $WB+_ .:6@#^7.X\&^!KN\T[4;KP?X(NM0TB.RBTC4+GPQX6N+_2(M-(;
M3HM)O9K![K2XM.8!M/BT^:VCL& :S6$@$=#<21^1<?O(N8)B?WT/4QOD_P"L
M[U_37_PX#_X(X_\ 2/K]G[_P3>(O_FEH_P"' ?\ P1Q_Z1]?L_?^";Q%_P#-
M+0!^BG[.NH6*_L_? Q6O+0,OP=^&((^U6^01X(T,$'][U!%>R?VC8?\ /[:?
M^!5O_P#':_(7_AP#_P $</\ I'W\ /\ P4^)!_+Q/1_PX!_X(X?](^_@!_X*
M?$O_ ,T] '[ 0W-O<;O(GAFV8W>5+')MW9QN\MFVYP<9QG!QT-3U\<_LH?\
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H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>a18q1_10qx093xchart-10263.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-10263.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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MI<WEY*UK_(O\ _V</A)\6XO^";WA6\7P5^TO^RO\7/\ @LG^T9X\T?P]X?\
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M%]%\9?$#^WE\">$]6\1Z3IOB;QJ?"FG1ZQXG'A+0KR]@U;Q(WAW2I8M4U_\
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M_P""_P >?B_XS\>>,?VD/VT+/X/_ !.^+/@7XW?%3]CC1/C7I*?LI_$?XA^
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MI_$5A./]%:Z\4_#*'P!I-U?XCNM8T[P+H"GS8M)3R@#]GU15  R .@!( '0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZQ_LF?\ (>\9_P#8'T7_ -.%_7W)7PW^R9_R'O&?_8'T7_TX7]?<E !1110
M5_)M_P %7O\ D]3QQ_V)7PS_ /4<>OZR:_DV_P""KW_)ZGCC_L2OAG_ZCCT
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MX<U&\?3C)+IL7B:[(;4K@7,?W'<DM#<L<9:*X9MH"KN9'8[5'"C).%'"C@
M"O._"_PD\ ^#+_PGJGA[1KFSO_ _PSA^#_AFXN-;US4VT_X>PZKIFM)HDG]I
MZA=_VA.VIZ/IMS-K>H_:M<N#:)'/J$D32(_H<_\ J)_^N$W_ **>@#^XC]G/
M_DWWX%_]D<^&'_J#Z%7LM>-?LY_\F^_ O_LCGPP_]0?0J]EH **** "BBB@
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# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>a18q1_10qx093xchart-10785.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-10785.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M.\510S^%/AOJ5M-K,=Q9^.?$<-_;3>'O!EVD>OZQ'>6\NF:9<+<1L_\ )_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YO_;#_9YTK]K/]E7]HO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKD?&_C/3/ 7A^Y\
M1ZO!?7%C:SV=O)%I\4,MT7OKE+6(HEQ<6T959) 9"900@)4,?E(!UU%?,O\
MPU5\/O\ H$>+O_ #2O\ Y=4?\-5?#[_H$>+O_ #2O_EU0!]-45\R_P##57P^
M_P"@1XN_\ -*_P#EU1_PU5\/O^@1XN_\ -*_^75 'TU17E/P\^+_ (;^)=WJ
M=EH=EK5K+I5M:W5PVJ6]G CQW<TT,8A-M?7;,X:%BX94 4@@DG ]6H ****
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M^MC+%- [0REH;F&>UN$BNH)H8_YZM7_8M_;2F\2?&G1/&/@_XC>.-&U_Q/\
M%G]H+Q#JWP_UO]E?3? .N_$74_$?[/OQ@^!D/[*5IXVT7_A.]"^*OA#XR_#O
M6K3XH>$?C9/!\&?'WPI\!^#_  #-<BRN_!MWH?ZU_L#?"KXF_"3]GZZTKXOM
MKD7CKQS\;?V@_C3J&E>*$\!0>)]!L?C)\6/$/CG2M*\46'PL4?#/1?%,UIJ
M\0>*/#GP_EO/!_AGQ#K^I^'M#U#4;73/MUR ?L+^R9_R'O&?_8'T7_TX7]?<
ME?#?[)G_ "'O&?\ V!]%_P#3A?U]R4 %%%% !7\FW_!5[_D]3QQ_V)7PS_\
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M_P"D?7[/_P#X*/$?_P TU'_#@+_@CA_TCZ_9_P#_  4>(_\ YIJ ,;[5:_\
M/U:?^!EK_P#'J/M5K_S]6G_@9:__ !ZMG_AP%_P1P_Z1]?L__P#@H\1__--1
M_P . O\ @CA_TCZ_9_\ _!1XC_\ FFH ^F?V3[VS37O&1:[LP#H^B@?Z7:D_
M\?\ J!Z"8GM_(=2,_<']HV'_ #^VG_@5;_\ QVOR&_X<!?\ !' _\X^OV?\
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MT ?HI^SKJ%BO[/WP,5KRT#+\'?AB"/M5OD$>"-#!!_>]017LG]HV'_/[:?\
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M@%\7Q\>/A7X:^*<?@7Q9\.[3Q0VLR:=X>\9W?@[4=6ETS3-<U'1]/\0VNI>
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M8>Y)_,D^]+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>a18q1_10qx093xchart-11273.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-11273.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M7L;2Z\32:(C+)JR^9?B.[D8-^^] !1110 4444 %%%% !1110 4444 %%%%
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M5?!7]MS]H/XF_MA?\$_O@C^TSX;_ &=OBC\:?@5_P4T_X*'_ +$?CSX\:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML=9^P?;!!;"Z^Q_;?L_VG[-;^?Y?F^1%O\M>SH **** "BBB@ HHHH ****
M"BBB@ KP7]I(!OA5JX8!A_:?A[A@&'_(7MNQ!%>]5X-^TC_R2K5_^PGX?_\
M3O;4 ?F[Y<7_ #RB_P"_4?\ \31Y<7_/*+_OU'_\33Z* &>7%_SRB_[]1_\
MQ-'EQ?\ /*+_ +]1_P#Q-/HH ^LOV2T1=?\ &95$4_V/HN=J*N?^)A?]=H&?
MQK[FKX;_ &3/^0]XS_[ ^B_^G"_K[DH **** "OY-O\ @J]_R>IXX_[$KX9_
M^HX]?UDU_)M_P5>_Y/4\<?\ 8E?#/_U''H _."BBB@ J*?\ U$__ %PF_P#1
M3U+44_\ J)_^N$W_ **>@#^XC]G/_DWWX%_]D<^&'_J#Z%7LM>-?LY_\F^_
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M?AOP+X2^$GC[XNMI_BO1Y-/N=!^+?C ^&O 7A;PUXHBAFO-.L?''A+P3K7Q
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M2OAO]DS_ )#WC/\ [ ^B_P#IPOZ^Y* "BBB@ K^3;_@J]_R>IXX_[$KX9_\
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M<>)Y&F\2^,KOPEX:TOP_<^*_$,S37!FUSQ'-ISZSJTIGF+W][<,9923(_H=
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>a18q1_10qx093xchart-11509.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-11509.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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MQ'INH^+_  -8^+!?'P[<>)M$MIWO-*35!IUT8!<QJ\16);I+=[JT6?\ +_\
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M^$FT;P+\5+^QFBTKXB>*8M>U_0O"$FEO:>&I-<OI]1TKTC_@H=_P5_\ VP?
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M) 'J2 /S-+7@_P"TB2/A7JY!(/\ :?A_D$@_\A>V[@@T >Z^9'_ST3_OI?\
M&CS(_P#GHG_?2_XU^-F]_P#GI)_W\?\ ^*HWO_STD_[^/_\ %4 ?LGYD?_/1
M/^^E_P :/,C_ .>B?]]+_C7XV;W_ .>DG_?Q_P#XJC>__/23_OX__P 50!^R
M@96SM96QUP0<?7!IU?#G[)K,=>\9;F9L:/HN-S,V/]/O^F2<?A7W'0 4444
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M[M9HKBWF0E)89$=258&M&O&OV=/^3??@7_V1SX8?^H1H5>RT %%%% !1110
M4444 %%%% !5>6[M8&V37$$3X#;9)HHVP<@':[J<'!P<8.#SQ5BOS\_:8_X)
M6_\ !/;]L;XC1?%S]IO]E+X5_&7XD0^'-*\(Q>+_ !C8:Q<ZNGAO1+C4+K2M
M'66QUJPA^QV5QJNH2PKY&\/=2EG8;0H!][?VC8?\_MI_X%6__P =KPC]H^_L
MG^%>KA;RS)_M/P^<?:[8=-7MO649Z_S/8X_/S_AP#_P1P_Z1]_ #_P %/B7_
M .:>C_AP#_P1P_Z1]_ #_P %/B3_ .:>@#'^U6O_ #]6G_@9:_\ QZC[5:_\
M_5I_X&6O_P >K9_X<!?\$</^D?7[/_\ X*/$?_S34?\ #@+_ ((X?](^OV?_
M /P4>(__ )IJ ,;[5:_\_5I_X&6O_P >H^U6O_/U:?\ @9:__'JV?^' 7_!'
M#_I'U^S_ /\ @H\1_P#S34?\. O^".'_ $CZ_9__ /!1XC_^::@#Z9_9/O;-
M->\9%KNS .CZ*!_I=J3_ ,?^H'H)B>W\AU(S]P?VC8?\_MI_X%6__P =K\AO
M^' 7_!' _P#./K]G_P#\%'B0?R\34G_#@'_@CA_TC[^ '_@I\2__ #3T ?KU
M_:-A_P _MI_X%6__ ,=H_M&P_P"?VT_\"K?_ ..U^0O_  X!_P"".'_2/OX
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MV'N2?S)/O2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>a18q1_10qx093xchart-12206.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-12206.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M_@;XV\;:C<QO')JGC+6OAUH$WBK50KJI\O5->74-1B8 K)%=)*C-&Z,WVW0
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M4)M%L[F?Q+%86&E:3=:3IEL ?87Q/_:L\(?"7XN?#OX4^)_AW\:[FR^(>O\
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MZ+_Z<+^ON2@ HHHH *_DV_X*O?\ )ZGCC_L2OAG_ .HX]?UDU_)M_P %7O\
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M "'O&?\ V!]%_P#3A?U]R5\-_LF?\A[QG_V!]%_].%_7W)0 4444 %?R;?\
M!5[_ )/4\<?]B5\,_P#U''K^LFOY-O\ @J]_R>IXX_[$KX9_^HX] 'YJSV%E
M<W6GWUQ:6\UYI+WTFF74L2O<:>^IV9T_46LY6!:W:_L&-E=F,C[1:DP2;DX#
MQ9V8<2BSM!*MW]O646EL)5O_ "_)_M!91%YBW_D_N?MP87?D_NO.\OY:L44
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MYQ]KMATU>V]91GK_ #/8X_/S_AP#_P $</\ I'W\ /\ P4^)?_FGH_X< _\
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M%>R?VC8?\_MI_P"!5O\ _':_(7_AP#_P1P_Z1]_ #_P4^)!_+Q/1_P . ?\
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+ %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>a18q1_10qx093xchart-12335.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-12335.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M_%'X\_'GXM>&_A#JGAKXD_$?P'\*/BAXIU3QAXT\"^$M;BNO$ERVG:-XA/\
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MF)NHKEW_ ):_V!OV9M<_:B_97_9M\"?L^_\ !+G4_#'[0WAS_@H%J_Q1O_\
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M\^/,OBB >$;'PSX6\1Z_X#A\#3R^.]7DL%TG5+NV\D\%?\%)/^"G?[0NO_\
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M"G3+VP2^^"/Q,NY?&=GK6LW.CVUK:_VX*,*.G<\#'!)(_'!Y/<Y/>@!U%%%
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MQE^%$>EZA;ZMI_@BQT?1M(TRV\)ZKX02?2M*LK:_%S(DMQ+^MU% 'Y2^,?\
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MXH _C[\8_LH_$#X<_P#!/O3_ (0>.?@I\9_@1\9/^"@O_!7K]C)]#\(?&?\
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M]^ 5U?RWVC316Z:GXKD>1+;5+>6;:L'A.9ODB#2L2H4(C?-NVJW[K?V=8?\
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MX(X?])!/@!_X-O$O_P S%?KU_9NGCI96G_@+;_\ QJC^SK#_ )\K3_P%M_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>a18q1_10qx093xchart-13246.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-13246.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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MBCP+XR\/Z:]D)H+W5O"VO6-O,\^EW:QZ&I_\%!/V%M'^#J?M":G^V+^S)9?
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M@/XO:-_P2&_:0\)?$/Q;KVA?"#PM-:Z3^V1_P0?\??#?Q/K'Q6\%>.O'%O\
M!/\ 8+^$7P4\&?'PS?$75]#\%^)M7NO!M_X/\3:783WWAOP?K7Q/A2?7=-\)
MVS:])IS?<?[,G[&GQY^%W[$'_!4#]ER[^ OA?P%XH^*7Q<_X*(ZM\!M>T/Q-
M\,8_#'QN\*_M+:K\4O%'P>U9+7PU)#=^ K;0-/\ &7A_X?7FB_$.VL+O0/[*
MECL(T\+VED(P#LOV4?\ @KY>_%/4_!</[7W[,5]^PCX6^+O[*-[^VC\%_BGX
M_P#V@?A%\1_A-XQ^!.AW?PS@\4:KXF\8>'F\.S?"[Q#H%K\8OAUJMSHWC;2+
M.UET_7)0-5BO[&2QD^]Y/V\_V)8I/A9%)^UQ^S8C_''Q+XC\'?!D/\;/ATB_
M%?Q1X1\47W@?Q+H?PZD?Q L?C'4-%\:Z==^#M0BT)[U8/%4:^'BYU>6&SD_#
M[7/^"(=EX(_X)'?%+X8_"?X;^)/$G_!0;XM?\$\? O[-/B'5/B?^T9XW^)D>
MB:V='^'FN>.?A'\.O$7Q.\=ZW\/?AC\,&^(7AN:_71O -MX;\(7W]A: %$FG
M:7HT5K-_P4-_X)O?M*^/OB;^T9X=^ 7[+OP;^,7P]_;6_8C^ O[('AWXB>)/
M&_PY^'5I^P#XA^%'C[XJ:[K/CW2_!FJ>'I==UGP)=CXH:5\4- LO@LTOBQOB
MQ\-M*M[W2;"VN=*\4:4 ?9:_\%C/!.M?M0_M!_ 'P1X)^%7B+PI^S9^U)^SS
M^RU\0_B9K/[77P4\!:I:>(?BQH.JZY\4/%<7PV\7&QU2?0_@G<:7?^$6T6QU
MZ^\8?$?Q_P"&_B#X0\.:'8ZAX!ULK]S?L/?MM_ G_@H+\ -'_:0_9XU]M;^'
M^L^*?'/A'R+VZT1_$.BZOX'\5:EX>GL_$^EZ)J^M)X=U'6=,M=)\::3HVHW<
M>K'P=XK\+ZM>VEK_ &K%$/Q5^)?_  2^_:'UO]H;XC>/_#WPG\"7GA_Q;_P6
MX_8/_;!NO$$NO?#K2]6\4?LU?!3]GGP;X)^+OB_7H(%M[N]U:7XAVOBW5;OP
M-?PC5_$FL:WKGB"RTVX;6[N]OOT'_P""+O[-WQ<_9!_89\.?LV_&SX1:3\*O
M&OPL^*WQQTV._P!!\0^!?$6B_%KPSX@^*/B3QIX3^+6F3>";JXETNSUSP_XE
MT_P[!H?C&&P\9Z7%X42'4K"UT\Z3& #]7Z*** "BBB@ HHHH **** "BBB@
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MQX4\3+X5\=Z;XC\0^%[[3[+6/"LEWIL.MVVK>'KBX74] U5(/K[XM_'?X(_
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MAU+1[^VU72=0BBN8I8X[W3-3L[34-.NT5;BQOK:WO+62*Y@BE2_110 4444
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M,Z1HK9+#"C !YKZ[H **** "BBD+*."P!]"0* %HIN]/[R_]]#_&C>G]Y?\
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M ";[\"_^R.?##_U!]"KV6O&OV<_^3??@7_V1SX8?^H/H5>RT %%%% !1110
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MD@;G1C@9.!G R>.: /R _P"'_P!_P1P_Z2"? #_P;>)?_F8KR/XW_P#!=O\
MX)">*OA[J>D:-^W[\ KJ_EOM&FBMTU/Q7(\B6VJ6\LVU8/"<S?)$&E8E0H1&
M^;=M5OW6_LZP_P"?*T_\!;?_ .-4?V;I_P#SY6G_ ("V_P#\:H _E,_X?%_\
M$N/^CY?@7_X&>,__ )C:/^'Q?_!+C_H^7X%_^!GC/_YC:_JR_LS3O^?&S_\
M 2W_ /C5']F:=_SXV?\ X"6__P :H _E-_X?%_\ !+C_ */E^!?_ (&>,_\
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M^!M!FUW4-*T.ROO$_C'Q%H^F2:OKFIZ=H/A^PEO?$&O7]EHVEWUS'[=7S?\
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M^*WC+XD:E<6TFH6=A?RVVG6WB6P\/V N[6)K73-%L;"!%L[2V ^E: "BBB@
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MBR31]-N[[Q7#XZ\;ZGX*L/@A::+H]C>?%SP-XJG^)?AR%=#\,ZS9I\]>/O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
AHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>a18q1_10qx093xchart-14374.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-14374.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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MA\'>);O4O ^@S2_$+PY?^(XOL&DQS7VJX_J"'0<8X''''MQQQTXXH 6BBB@
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MN;+4=+U.UBOM.U"SN(R4FM;VRN(+JWE0E9(948$@U_(%X$_8^_::_88^$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445'+-% ADFDCB
MC! +R.L: DX +.54$DX )Y/ YH DHJC_ &GIW_/]9_\ @7;_ /QVC^T]._Y_
MK/\ \"[?_P".T 7J*H_VGIW_ #_6?_@7;_\ QVC^T]._Y_K/_P "[?\ ^.T
M7J*KPW=M<%A!<03% "PBFBE*@Y +"-V(!((!.,]JL4 %%%% !117(ZOX_P#
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M3X@Z3I<,C3>"?B-XFT:Q\&:Q<ZE):Z)I]QJVG:CJMVEO:""X_'RRL_!WQ?\
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M*:BLJE=12X9IUOUN5E8N&- ']\7[.0"_L^? I5 51\&_A@ J@*J@>!]" "J
M  !P   !P!BO9J\:_9S_ .3??@7_ -D<^&'_ *@^A5[+0 4444 %%%% !111
M0 4444 %?GY^TQ_P52_X)[?L<_$:+X1_M-_M6_"OX-?$B;PYI7BZ+PAXQO\
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MQZW;>(([9-8'B)I_$/VP:Q<SWC_U^?V9IW_/C9_^ EO_ /&J/[,T[_GQL_\
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M;\8?%SXK>,OB1J5Q;2:A9V%_+;:=;>);#P_8"[M8FM=,T6QL($6SM+8#Z5H
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H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>a18q1_10qx093xchart-17408.jpg
<TEXT>
begin 644 a18q1_10qx093xchart-17408.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( -4# 2(  A$! Q$!_\0
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M)\// .N^(OAC\4-&U;6_'/A'X=^&-!O_ /A(=+&K_#GP]J%I+I6MW(!_0/\
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MT**ZMYM6^QPSQ._\[O[=_P"ROXK_ &6O&O[37[4WBK0O@'X"^ MC_P %-O\
M@F!^TE\$/A]\2?'/ACX7_!+XPVGP<_9+TG]GWQIX!\8^);+PYX@\!_L\I_PL
MN]FUKPOXZ^+FB:'\/E\7>"_"]]K.J6=EJ&E7S_%_PW_8_P#VEOVIOV,K?XY?
MLF_ ;2O%'CV;]N3_ (*]S_##Q5^SU^TA\$?#7PM\&^"_VAOBII.F:+8Z1X5^
M/GPCU_X#?M6?L1^+/%?P]&D>.8)-!\+^+[SP5X3T'6/A;HFH67B/5M'M #^Z
MNUNK:^MK>\LKB"[M+N&*YM;JVFCN+:YMYXUE@G@GB9XIH9HG26*6-VCDC971
MF5@3/7F_P=T'Q7X6^$OPP\,^/#X3/C?P[\._!&A>,6\!:2F@>!F\5:1X7TK3
MO$3>#="CAMTT7PH=8MKT^'-)6"%=-T;[%9+%$L C7TB@ HHHH **** "BBB@
M HHHH **** "OF[]H;]H_1/@%J'P"\.3>'=0\8>,OVCOV@O _P  ? 'AK2[Z
MSL)Y+_7=,\2>-O'/BR^N+I)S'H?PU^$O@/Q_\0M7CBMI)M37P[:^'K:6UO=;
MM;J'Z1K\IOV]]'N]!_:__P""1WQRU"YN(O 7P\_;!^)_PW\7;"OV+3]:_:3_
M &1_CA\(_A9K.J%HRD,-U\3;OP[X#T^=IH]VM^/=+L(TFGU"$( >A_"O_@IG
M^S)JOP+^$GQ9_:+^,7[-W[+GB?XJ^&Y_%-G\._%_[5GP+\9Q6^D'XD:G\,=/
MU#0_B%X6\3)X/\<:1?\ B*RM-/?6O"TUWIFGZY>S>';ZXBU32[](_KWXL_'K
MX'_ 70=-\4_'#XP_"_X.^&=:O[K2=(\0_%#QYX7\!Z)JFJ67A_6/%=WIFG:K
MXHU/3+&]U"W\,^'M=\02V=M/+<+HVCZGJ/E_9+*XE3^2;X<_\$9_VS[/]FC3
MOAUXW^"?P\OO&&B?\$*OVX_V-- L[_QY\,_$$6B?M6_&C]J/5/B1\,M(T:^N
M;J>QTY;_ ,"7[WS?$:SFM=)\/W,TFF76JVEXSBOVZ_:G_8\^*OQOTS_@DOI<
MO@?PWXTLOV7_ -JWX1_%GX_Z?XHU7PS?V.D>&/!_[+WQ=^'VIZS#;:])-;^+
MM0T[XB^*/#9LK;28;_49+@QZY:QB&QENX #V/XI_\%%OV3I/A#\5?'_P/^+G
M[,O[4'C[X,_!>W_:4TOX5Z#^TM\#/#=S=^#YDBB\,^,[[QOXKU^?PQ\-?#.J
M'5+>"V^(GB=[#1-,75; 7=Y;KJ]F+GRT?\%4M!_X7'_PJ#_A2^KBZ'_!1YO^
M"=XUO_A.=+^RC6U_8\_X:X_X6C]F_P"$>P-%^P8\$_\ ".?;//$__%2_V_\
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MI&H6VK:5>K!=1RQ+=Z;JEE9ZCI]R$$]E?VMM>6LD5S!%*EZB@ HHHH ****
M"BBB@#/U/2=+UJT-AK&G6&JV1N;&\-GJ5G;7]J;O2[ZVU/3;HV]W%-";C3]2
ML[34+*?9YMI>VMM=V[QW$$4B:%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%M__ (U1_9NG_P#/E:?^ MO_ /&J /Y3/^'Q?_!+C_H^7X%_^!GC/_YC:/\
MA\7_ ,$N/^CY?@7_ .!GC/\ ^8VOZLO[,T[_ )\;/_P$M_\ XU1_9FG?\^-G
M_P" EO\ _&J /Y3?^'Q?_!+C_H^7X%_^!GC/_P"8VC_A\7_P2X_Z/E^!?_@9
MXS_^8VOZLO[,T[_GQL__  $M_P#XU1_9FG?\^-G_ . EO_\ &J /YV?V=?\
M@MY_P27\&ZMXHNO$'[>OP$L8[W3M)M[7S=0\7Q&9X;N^EFV&;P?%&1$K1[P'
MW?O4*JPWE/JW_A_]_P $</\ I()\ /\ P;>)?_F8K]>O[-T\=+*S'_;K;_\
MQJC^SK#_ )\K3_P%M_\ XU0!^0O_  _^_P"".'_203X ?^#;Q+_\S%'_  _^
M_P"".'_203X ?^#;Q+_\S%?KU_9UA_SY6G_@+;__ !JC^SK#_GRM/_ 6W_\
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MWG^QNT,RK^T7\/"S0RJH'_"3Y+-&P '_ !3?4D@5_I*?V7IO_/A9?^ EM_\
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@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771476656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">cah<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CARDINAL HEALTH INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,063,302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771837040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 32,641<span></span>
</td>
<td class="nump">$ 32,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of products sold</a></td>
<td class="nump">30,969<span></span>
</td>
<td class="nump">30,449<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,672<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and employee severance</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Amortizationandotheracquisitionrelatedcosts', window );">Amortization and other acquisition-related costs</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation (recoveries)/charges, net</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings before income taxes</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings per common share attributable to Cardinal Health, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (in shares)</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Diluted (in shares)</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share</a></td>
<td class="nump">$ 0.4624<span></span>
</td>
<td class="nump">$ 0.4489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Amortizationandotheracquisitionrelatedcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Amortizationandotheracquisitionrelatedcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771913456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">40<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net unrealized gain/(loss) on derivative instruments, net of tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income, net of tax</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e557-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4613674-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569643-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772021152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">8,382<span></span>
</td>
<td class="nump">8,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">12,121<span></span>
</td>
<td class="nump">11,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,041<span></span>
</td>
<td class="nump">2,117<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">23,725<span></span>
</td>
<td class="nump">28,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,651<span></span>
</td>
<td class="nump">1,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangibles, net</a></td>
<td class="nump">14,926<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">681<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">41,940<span></span>
</td>
<td class="nump">40,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">19,202<span></span>
</td>
<td class="nump">17,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,270<span></span>
</td>
<td class="nump">1,988<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">22,407<span></span>
</td>
<td class="nump">21,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">9,068<span></span>
</td>
<td class="nump">9,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">3,758<span></span>
</td>
<td class="nump">2,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Authorized&#8212;500 thousand shares, Issued&#8212;none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Authorized&#8212;755 million shares, Issued&#8212;327 million shares and 327 million shares at September 30, 2017 and June 30, 2017, respectively</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">4,943<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common shares in treasury, at cost: 12 million shares and 11 million shares at September 30, 2017 and June 30, 2017, respectively</a></td>
<td class="num">(853)<span></span>
</td>
<td class="num">(731)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cardinal Health, Inc. shareholders' equity</a></td>
<td class="nump">6,678<span></span>
</td>
<td class="nump">6,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">6,695<span></span>
</td>
<td class="nump">6,828<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests and shareholders&#8217; equity</a></td>
<td class="nump">$ 41,940<span></span>
</td>
<td class="nump">$ 40,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6759541088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">755,000,000<span></span>
</td>
<td class="nump">755,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, issued</a></td>
<td class="nump">364,000,000<span></span>
</td>
<td class="nump">364,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common shares in treasury</a></td>
<td class="nump">44,000,000<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772203344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Impairments and loss on sale of other investments</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Increase in trade receivables</a></td>
<td class="num">(359)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(381)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase in accounts payable</a></td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other accrued liabilities and operating items, net</a></td>
<td class="nump">229<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="num">(6,139)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments', window );">Purchase of available-for-sale securities and other investments</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments', window );">Proceeds from sale of available-for-sale securities and other investments</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from Sale of Property, Plant, and Equipment</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,144)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PaymentofContingentConsideration', window );">Payment of contingent consideration obligation</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in short-term borrowings</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Purchase of noncontrolling interests</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Reduction of long-term obligations</a></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities', window );">Proceeds from interest rate swap terminations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net tax withholdings from share-based compensation</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities', window );">Excess tax benefits from share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common shares</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury shares</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(744)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rates changes on cash and equivalents</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net decrease in cash and equivalents</a></td>
<td class="num">(5,698)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at beginning of period</a></td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at end of period</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">$ 2,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PaymentofContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from a settlement payment of contingent consideration assumed in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PaymentofContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from purchases of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Purchaseofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=96864182&amp;loc=d3e11374-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3098-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3581-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with maturities (principal being due), prepayments and calls (requests of early payments) on securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82913847&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762595344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal 2018 and 2017 in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, 2018 and June 30, 2017, respectively.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. In addition, financial results presented for this fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recent Financial Accounting Standards</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In August 2017, the Financial Accounting Standards Board (the "FASB") issued&#160;accounting guidance which is intended to improve and simplify accounting rules around hedge accounting. The guidance will be effective for us in the first quarter of fiscal 2020 and early adoption is permitted. We are currently evaluating the impact of this standard on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In March 2016, the FASB issued amended accounting guidance that changed the accounting for certain aspects of share-based compensation to employees. The guidance requires all income tax effects of share-based awards to be recognized in the statement of earnings as awards vest or are settled. Additionally, the guidance increases the amount employers can withhold in shares to cover employee income taxes without requiring liability classification and allows a policy election for accounting for forfeitures. The primary impact of adoption resulted in the recognition of excess tax benefits in the statement of earnings on a prospective basis, rather than as a component of equity. The impact on the presentation in the condensed consolidated statement of cash flows is also prospective. We adopted this guidance in the first quarter of fiscal 2018. The impact of adoption on the provision for income taxes on our condensed consolidated statement of earnings was immaterial. The inclusion of excess tax benefits and deficiencies as a component of our income tax expense will increase volatility within our provision for income taxes as the amount of excess tax benefits or deficiencies from share-</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">based compensation awards depends on our stock price at the date the awards vest.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In May 2014, the FASB issued amended accounting guidance related to revenue recognition. This guidance is based on the principle that revenue is recognized in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the transfer of goods or services to customers. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The FASB also subsequently issued several amendments to the standard, including clarification on principal versus agent considerations, performance obligations and licensing, and certain scope improvements and practical expedients.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We continue to make progress on our evaluation of the amended revenue recognition guidance, including identification of revenue streams and customer contract reviews. Our revenue is primarily distribution revenue, which we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Although we are continuing to assess the impact of the amended guidance, we generally anticipate that the timing of recognition of distribution revenue will be substantially unchanged under the amended guidance.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6906855808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Acquisitions</font><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Patient Recovery Business</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">On July 29, 2017, we acquired the Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses (the "Patient Recovery Business") from Medtronic plc for </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$6.1 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in cash. The Patient Recovery Business manufactures </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">23</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> categories of medical products sold into multiple healthcare channels, and includes numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo. The acquisition further expands the Medical segment's portfolio of self-manufactured products. We closed the Patient Recovery Business acquisition in&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">28</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> principal countries on&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">July&#160;29, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and acquired control of, as described in GAAP, and the rights to, the net economic benefit from the entire Patient Recovery Business in the remaining countries at the closing. We are in the process of transitioning legal ownership in the remaining non-principal countries, which we expect to complete by the end of calendar 2018. The results for the entire Patient Recovery Business in all countries are included in the condensed consolidated financial statements beginning&#160;July 29, 2017. We funded the acquisition through </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$4.5 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in new long-term debt, the use of existing cash and borrowings under our existing credit arrangements. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Transaction and integration costs associated with the acquisition of the Patient Recovery business were </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$37 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and are included in amortization and other acquisition-related costs in the condensed consolidated statements of earnings. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Fair Value of Assets Acquired and Liabilities Assumed</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The allocation of the purchase price for the acquisition of the Patient Recovery Business is not yet finalized and is subject to adjustment as we complete the valuation analysis for this acquisition. The purchase price is subject to adjustment based on working capital requirements as set forth in the acquisition agreement. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The valuation of identifiable intangible assets utilizes significant unobservable inputs and thus represents a Level 3 nonrecurring fair value measurement. The estimated fair value of the identifiable intangible assets was determined using income-based approaches, which includes market participant expectations of the cash flows that an asset could generate over its economic life, discounted back to present value using an appropriate rate of return. The weighted- average discount rate used to arrive at the present value of the identifiable intangible assets was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">8.2 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and considers the inherent risk of each intangible asset relative to the internal rate of return and weighted-average cost of capital. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of the assets acquired and liabilities assumed as of the acquisition date for the Patient Recovery Business:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Patient Recovery Business</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,712</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trade names (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">186</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other (3)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total identifiable intangible assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,630</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(153</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(873</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total identifiable net assets acquired/(liabilities) assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,975</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,078</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The range of useful lives for customer relationships is </font><font style="font-family:Arial Narrow;font-size:8pt;">10</font><font style="font-family:Arial Narrow;font-size:8pt;"> to </font><font style="font-family:Arial Narrow;font-size:8pt;">18</font><font style="font-family:Arial Narrow;font-size:8pt;"> years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The useful life of trade names is </font><font style="font-family:Arial Narrow;font-size:8pt;">15</font><font style="font-family:Arial Narrow;font-size:8pt;"> years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The useful life of developed technology is </font><font style="font-family:Arial Narrow;font-size:8pt;">15</font><font style="font-family:Arial Narrow;font-size:8pt;"> years.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762600928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Restructuring and Employee Severance </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance costs:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs (2)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In September 2017, we entered into an agreement to transition the distribution of our Medical segment's surgeon gloves in certain international markets from a third-party distribution arrangement to a direct distribution model. The expected costs with this restructuring include </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$125 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, on a pre-tax basis, in contract termination costs. These costs are reflected in facility exit and other costs in the condensed consolidated statements of earnings during the three months ended September 30, 2017. The contract termination costs are expected to be paid before the end of fiscal 2018. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Related Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">34</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">127</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">161</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6911690944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Goodwill and Other Intangible Assets</font><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,939</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4,282</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7,221</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,156</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,157</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,951</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7,468</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,419</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:Arial Narrow;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in the Medical segment goodwill is primarily due to the Patient Recovery Business acquisition. Goodwill recognized in connection with the Patient Recovery Business acquisition primarily represents the expected benefits from certain synergies of integrating the business, the existing workforce of the</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">acquired entity, and the expected growth from new customers.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,046</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,659</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">697</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">212</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">485</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">346</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,050</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,446</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,111</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,507</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">509</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">195</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">314</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,925</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,452</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,986</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in definite-life intangibles is primarily due to the Patient Recovery Business acquisition. Total amortization of intangible assets was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$135 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$101 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> 2022</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$444 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$563 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$531 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$458 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$421 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762588688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale Securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Available-for-Sale Securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Available-for-Sale Securities</font><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. We held the following investments in marketable securities at fair value at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Treasury bills</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">International bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">U.S. agency bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">International equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In July 2017, we liquidated our marketable securities. There were no unrealized gains or loss at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and gross unrealized gains and losses were immaterial at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and 2016, gross realized gains and losses were immaterial and we did not recognize any other-than-temporary impairments.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=4738149<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2289146<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762665664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Disclosure [Text Block]</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;">6. Long-Term Obligations and Other Short-Term Borrowings </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had total long term obligations, including the current portion, of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$10.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$10.4 billion</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </font><font style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </font><font style="font-family:Arial Narrow;font-size:10pt;">$19.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In June 2017, we issued additional debt with the aggregate principal amount of </font><font style="font-family:Arial Narrow;font-size:10pt;">$5.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;"> to fund a portion of the acquisition of the Patient Recovery Business, to redeem the </font><font style="font-family:Arial Narrow;font-size:10pt;">$400 million</font><font style="font-family:Arial Narrow;font-size:10pt;"> </font><font style="font-family:Arial Narrow;font-size:10pt;">1.7%</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Notes due 2018</font><font style="font-family:Arial Narrow;font-size:10pt;"> and for general corporate purposes. In July 2017, we redeemed the </font><font style="font-family:Arial Narrow;font-size:10pt;">$400 million</font><font style="font-family:Arial Narrow;font-size:10pt;"> </font><font style="font-family:Arial Narrow;font-size:10pt;">1.7%</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Notes due 2018.</font><font style="font-family:Arial Narrow;font-size:10pt;"> The notes issued in June 2017 were </font><font style="font-family:Arial Narrow;font-size:10pt;">1.948%</font><font style="font-family:Arial Narrow;font-size:10pt;"> Notes due 2019, </font><font style="font-family:Arial Narrow;font-size:10pt;">2.616%</font><font style="font-family:Arial Narrow;font-size:10pt;"> Notes due 2022, </font><font style="font-family:Arial Narrow;font-size:10pt;">3.079%</font><font style="font-family:Arial Narrow;font-size:10pt;"> Notes due 2024, </font><font style="font-family:Arial Narrow;font-size:10pt;">3.410%</font><font style="font-family:Arial Narrow;font-size:10pt;"> Notes due 2027, </font><font style="font-family:Arial Narrow;font-size:10pt;">4.368%</font><font style="font-family:Arial Narrow;font-size:10pt;"> Notes due 2047, and floating rate Notes due 2022.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;"> revolving credit facility and a </font><font style="font-family:Arial Narrow;font-size:10pt;">$1.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;"> committed receivables sales facility program. At </font><font style="font-family:Arial Narrow;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;">no</font><font style="font-family:Arial Narrow;font-size:10pt;"> amounts outstanding under the revolving credit facility or the committed receivables sales facility program.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In November 2016, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through November 1, 2019. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers.  Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762594800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Income Taxes</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fluctuations in our provision for income taxes as a percentage of pretax earnings (&#8220;effective tax rate&#8221;) are due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">34.2 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">37.3 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The decrease in the effective tax rate was due to the impact of discrete items.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$410 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$417 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits, respectively. The </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> balances include </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$266 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$268 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits, respectively, that if recognized, would have an impact on the effective tax rate. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$97 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$99 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for income taxes in the condensed consolidated statements of earnings. These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service or other taxing authorities, possible settlement of audit issues, reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">zero</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a net decrease of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$35 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, exclusive of penalties and interest.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), which has been acquired by Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$144 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$142 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheets.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762625680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingent Liabilities and Litigation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Commitments, Contingent Liabilities and Litigation </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">July 2014</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">10 years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of both companies. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$45.6 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the remainder of the initial term.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Legal Proceedings</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We become involved from time to time in disputes, litigation, and regulatory matters.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We may be named from time to time in </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information could lead to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">From time to time, we may determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges, net in our condensed consolidated statements of earnings.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Opioid Lawsuits </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As of October 30, 2017, </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">98</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> counties and municipalities, one state attorney general and one tribal entity have filed lawsuits against pharmaceutical wholesale distributors (including us) relating to the distribution of prescription opioid pain medications. Many of the lawsuits also include pharmaceutical manufacturers and retail chains. We are also a defendant in a purported class action lawsuit brought on behalf of unions and other health and welfare funds that paid for certain opioid prescriptions on behalf of their members. These lawsuits, which have been filed in various federal, state and other courts, allege violations of controlled substance laws and various other statutes as well as common law claims, including negligence, public nuisance and unjust enrichment, and seek equitable relief and monetary damages. We are vigorously defending ourselves in these lawsuits. Since these lawsuits are in early stages, we are unable to predict their outcome or estimate a range of reasonably possible losses.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In September 2017, we, along with other distributors, received a request for information related to an investigation being conducted by a group of approximately </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">40</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> U.S. state attorneys general. We also have received civil investigative demands, subpoenas or requests for information from several individual state attorneys general offices. These investigations are focused on the distribution of opioid medication. We are currently evaluating and responding to their requests.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Product Liability Lawsuits</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As of October 30, 2017, we are named as a defendant in </font><font style="font-family:Arial Narrow;font-size:10pt;">90</font><font style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits filed in Alameda County Superior Court in California involving claims by approximately </font><font style="font-family:Arial Narrow;font-size:10pt;">1,030</font><font style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </font><font style="font-family:Arial Narrow;font-size:10pt;">15</font><font style="font-family:Arial Narrow;font-size:10pt;"> similar lawsuits involving claims by approximately </font><font style="font-family:Arial Narrow;font-size:10pt;">25</font><font style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.</font><font style="font-family:Arial Narrow;font-size:10pt;color:#5b9bd5;"> </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At September 30, 2017, we had a total of $</font><font style="font-family:Arial Narrow;font-size:10pt;">129 million</font><font style="font-family:Arial Narrow;font-size:10pt;">, net of expected insurance recoveries, accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits. While we have recorded accruals based on our assessment of these matters, because these lawsuits are in early stages, we are unable to estimate a range of reasonably possible losses in excess of this accrued amount.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762589952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Available-for-sale securities (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other investments (3)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration (4)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Available-for-sale securities (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other investments (3)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration (4)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The fair value of interest rate swaps, foreign currency contracts and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in the condensed consolidated balance sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. Observable Level 2 inputs such as quoted prices for similar securities, interest rate spreads, yield curves and credit risk are used to determine the fair value. See </font><font style="font-family:Arial Narrow;font-size:8pt;">Note 5</font><font style="font-family:Arial Narrow;font-size:8pt;"> for additional information regarding available-for-sale securities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds primarily invest in the equity securities of companies with large market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration represents the obligations incurred in connection with acquisitions. We do not deem the fair value of the contingent consideration obligations under any single acquisition to be significant. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding future business results, discount rates, discount periods, and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following table presents those liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Contingent Consideration Obligation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions from acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Changes in fair value of contingent consideration (1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payment of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">23</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amount is included in amortization and other acquisition-related costs in the   condensed consolidated statements of earnings.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762607008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. Our derivative and hedging programs are consistent with those described in the 2017 Form 10-K. The amount of ineffectiveness associated with these derivative instruments was immaterial for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, accounts payable, and other accrued liabilities at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,333</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,713</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,003</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,395</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762595344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the acquisition of a </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">71 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> ownership interest in naviHealth during fiscal 2016, we recognized redeemable noncontrolling interest with a fair value of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$119 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at the acquisition date. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The noncontrolling interests are redeemable at the option of the third-party noncontrolling interests holders at any time after the two-year anniversary of the closing.&#160;During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, certain third-party noncontrolling interest holders notified us of their intent to exercise their put right on the noncontrolling interest representing </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">16 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of naviHealth with a carrying value of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$103 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a redemption value of $</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">109 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Upon notification of the intent to exercise the put, the carrying value of the </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">16 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of naviHealth became mandatorily redeemable and was reclassified to other accrued liabilities in the condensed consolidated balance sheet.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The reconciliation of the changes in redeemable noncontrolling interests are as follows: </font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Redeemable Noncontrolling Interest</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">118</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net earnings attributable to redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net purchase of redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(103</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustment of redeemable noncontrolling interests to redemption value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2017, we settled the </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$103 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> mandatorily redeemable liability with cash, which resulted in our ownership interest in naviHealth increasing to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">98 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6609578560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Shareholders' Equity </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2.2 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$150 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$67.92</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We funded the repurchases with available cash and short-term borrowings.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">3.1 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$250 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$81.37</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We funded the repurchases with available cash </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The common shares repurchased are held in treasury to be used for general corporate purposes.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Currency</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Translation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(125</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(108</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(86</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Activity related to realized gains and losses on available-for-sale securities, as described in </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Note 5</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, was immaterial during the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. There were no unrealized gains and losses on available-for-sale securities at </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762580240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc.<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share Attributable to Cardinal Health, Inc.</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Earnings Per Share Attributable to Cardinal Health, Inc.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">316</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">318</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">322</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units, and performance share units that were antidilutive for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">5 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">3 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6630637904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Segment Information</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment and Corporate:</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">28,920</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">28,762</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,644</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,041</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,641</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,039</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance. The results attributable to noncontrolling interests are recorded within segment profit. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; other income, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation, and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. We encourage our segments and corporate functions to identify investment projects that will promote innovation and provide future returns. As approval decisions for such projects are dependent upon executive management, the expenses for such projects are often retained at Corporate. Investment spending within Corporate was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents segment profit by reportable segment and Corporate:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">467</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">534</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">596</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">661</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June 30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22,220</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">21,848</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18,055</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,688</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,665</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7,576</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41,940</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40,112</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762576432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">15. Share-Based Compensation </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The total tax benefit related to share-based compensation was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$6 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$8 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. As of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">July&#160;1, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, under ASU 2016-09, excess tax benefits, which are immaterial for the three months ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, are prospectively recognized within the provision for income taxes on our condensed consolidated statements of earnings and prospectively recognized as operating activity on our condensed consolidated statement of cash flows.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">76.72</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">79.53</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">71.60</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$117 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for  </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">ten years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">63.44</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">64.30</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">59.19</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$35 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">109</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td></tr></table></div><font style="font-family:Arial Narrow;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units vest over a </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">three</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">zero</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">200 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:51%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">77.83</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.43</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vested (1)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">71.57</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">75.39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)    Vested based on achievement of </font><font style="font-family:Arial Narrow;font-size:8pt;">133 percent</font><font style="font-family:Arial Narrow;font-size:8pt;"> of the target performance goal.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$18 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">two years</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> if the performance goals are achieved.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6907818496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. References to "we," "our," and similar pronouns in this Quarterly Report on Form 10-Q for the quarter ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">September&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal 2018 and 2017 in these condensed consolidated financial statements are to the fiscal years ending or ended June 30, 2018 and June 30, 2017, respectively.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. In addition, financial results presented for this fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2018</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recent Financial Accounting Standards</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In August 2017, the Financial Accounting Standards Board (the "FASB") issued&#160;accounting guidance which is intended to improve and simplify accounting rules around hedge accounting. The guidance will be effective for us in the first quarter of fiscal 2020 and early adoption is permitted. We are currently evaluating the impact of this standard on our condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In March 2016, the FASB issued amended accounting guidance that changed the accounting for certain aspects of share-based compensation to employees. The guidance requires all income tax effects of share-based awards to be recognized in the statement of earnings as awards vest or are settled. Additionally, the guidance increases the amount employers can withhold in shares to cover employee income taxes without requiring liability classification and allows a policy election for accounting for forfeitures. The primary impact of adoption resulted in the recognition of excess tax benefits in the statement of earnings on a prospective basis, rather than as a component of equity. The impact on the presentation in the condensed consolidated statement of cash flows is also prospective. We adopted this guidance in the first quarter of fiscal 2018. The impact of adoption on the provision for income taxes on our condensed consolidated statement of earnings was immaterial. The inclusion of excess tax benefits and deficiencies as a component of our income tax expense will increase volatility within our provision for income taxes as the amount of excess tax benefits or deficiencies from share-</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">based compensation awards depends on our stock price at the date the awards vest.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In May 2014, the FASB issued amended accounting guidance related to revenue recognition. This guidance is based on the principle that revenue is recognized in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the transfer of goods or services to customers. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The FASB also subsequently issued several amendments to the standard, including clarification on principal versus agent considerations, performance obligations and licensing, and certain scope improvements and practical expedients.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We continue to make progress on our evaluation of the amended revenue recognition guidance, including identification of revenue streams and customer contract reviews. Our revenue is primarily distribution revenue, which we recognize at a point in time when title transfers to customers and we have no further obligation to provide services related to such merchandise. Although we are continuing to assess the impact of the amended guidance, we generally anticipate that the timing of recognition of distribution revenue will be substantially unchanged under the amended guidance.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762680928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of the assets acquired and liabilities assumed as of the acquisition date for the Patient Recovery Business:</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Patient Recovery Business</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,712</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trade names (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">186</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other (3)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total identifiable intangible assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,630</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(153</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(873</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total identifiable net assets acquired/(liabilities) assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,975</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,103</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,078</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The range of useful lives for customer relationships is </font><font style="font-family:Arial Narrow;font-size:8pt;">10</font><font style="font-family:Arial Narrow;font-size:8pt;"> to </font><font style="font-family:Arial Narrow;font-size:8pt;">18</font><font style="font-family:Arial Narrow;font-size:8pt;"> years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The useful life of trade names is </font><font style="font-family:Arial Narrow;font-size:8pt;">15</font><font style="font-family:Arial Narrow;font-size:8pt;"> years.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The useful life of developed technology is </font><font style="font-family:Arial Narrow;font-size:8pt;">15</font><font style="font-family:Arial Narrow;font-size:8pt;"> years.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6913758880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Employee Severance</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance costs:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three months ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs (2)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">128</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">132</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated and duplicate payroll costs during transition periods.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</font></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Related Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">34</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">127</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">161</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762575632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2,939</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">4,282</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7,221</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,156</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,157</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,951</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7,468</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,419</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,046</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,659</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">697</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">212</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">485</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">346</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,050</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,446</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,111</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,507</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">509</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">195</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">314</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,925</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,452</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,986</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted- Average Remaining Amortization Period (Years)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,046</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,659</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">697</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">212</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">485</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">346</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,050</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,446</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6,111</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,604</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,507</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Intangible</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">999</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names, and patents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">509</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">195</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">314</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">916</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">304</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,925</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,452</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,466</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1,986</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6921448272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Available-for-sale Securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We held the following investments in marketable securities at fair value at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Treasury bills</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">International bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">U.S. agency bonds</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Asset-backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">International equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62557-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27198-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6908793360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Available-for-sale securities (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other investments (3)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration (4)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Available-for-sale securities (2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other investments (3)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">116</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration (4)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The fair value of interest rate swaps, foreign currency contracts and commodity contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in the condensed consolidated balance sheets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">We invest in marketable securities, which are classified as available-for-sale and are carried at fair value in the condensed consolidated balance sheets. Observable Level 2 inputs such as quoted prices for similar securities, interest rate spreads, yield curves and credit risk are used to determine the fair value. See </font><font style="font-family:Arial Narrow;font-size:8pt;">Note 5</font><font style="font-family:Arial Narrow;font-size:8pt;"> for additional information regarding available-for-sale securities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds primarily invest in the equity securities of companies with large market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Contingent consideration represents the obligations incurred in connection with acquisitions. We do not deem the fair value of the contingent consideration obligations under any single acquisition to be significant. The estimate of fair value of the contingent consideration obligations requires subjective assumptions to be made regarding future business results, discount rates, discount periods, and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of reaching various targets or of achieving certain milestones. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement. Changes in current expectations of progress could change the probability of achieving the targets within the measurement periods and result in an increase or decrease in the fair value of the contingent consideration obligation.</font></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following table presents those liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;padding-left:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Contingent Consideration Obligation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Additions from acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Changes in fair value of contingent consideration (1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Payment of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">23</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amount is included in amortization and other acquisition-related costs in the   condensed consolidated statements of earnings.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6917455632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,333</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,713</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">10,003</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,395</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6762594800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Reconciliation of the Changes in Redeemable Noncontrolling Interests</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The reconciliation of the changes in redeemable noncontrolling interests are as follows: </font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:77%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Redeemable Noncontrolling Interest</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">118</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net earnings attributable to redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Net purchase of redeemable noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(103</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustment of redeemable noncontrolling interests to redemption value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2017, we settled the </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$103 million</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> mandatorily redeemable liability with cash, which resulted in our ownership interest in naviHealth increasing to </font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">98 percent</font><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6915494464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Currency</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Translation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Accumulated Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Comprehensive</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Loss</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(125</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income/(loss), net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(108</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(86</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909320624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">316</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units, and performance share units</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">318</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">322</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6606144704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Revenue by Reportable Segment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table presents revenue for each reportable segment and Corporate:</font></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">28,920</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">28,762</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,724</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">3,279</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,644</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,041</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">32,641</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">32,039</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</font></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Segment Profit by Reportable Segment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">467</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">534</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">129</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">596</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">661</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(334</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">262</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">535</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Assets by Reportable Segment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:13pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June 30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">22,220</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">21,848</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Medical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18,055</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">10,688</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,665</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7,576</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">41,940</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">40,112</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6759535648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Total Share-based Compensation Expense by Type of Award</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under the Plans</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">63.44</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</font></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">64.30</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">59.19</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalStockOptionPlanDataTableTextBlock', window );">Schedule of Additional Data Related to Stock Option Activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">65</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">109</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">June 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">7</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">6</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Transactions Related to Restricted Share Units Under the Plans</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">76.72</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">79.53</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">71.60</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"></font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Transactions Related to Performance Share Units Under the Plans</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:51%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">77.83</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">66.43</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Vested (1)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">71.57</font></div></td><td style="vertical-align:bottom;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at September 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">75.39</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">(1)    Vested based on achievement of </font><font style="font-family:Arial Narrow;font-size:8pt;">133 percent</font><font style="font-family:Arial Narrow;font-size:8pt;"> of the target performance goal.</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;color:#000000;"></font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A disclosure of additional data related to all stock option activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6760741888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772564112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 29, 2017 </div>
<div>USD ($) </div>
<div>category </div>
<div>country</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,139<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash acquired</a></td>
<td class="nump">$ 6,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NumberofProductCategoriesManufactured', window );">Number of Product Categories Manufactured | category</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PrincipalCountries', window );">Number of principal countries | country</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_BusinessCombinationTransactionandintegrationcosts', window );">Transaction and integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Fair Value Inputs, Discount Rate</a></td>
<td class="nump">8.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_BusinessCombinationTransactionandintegrationcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred during the initial evaluation of a potential acquisition that primarily relate to costs to analyze, negotiate, and consummate the transaction, as well as due diligence activities. Also includes costs related to activities required to combine the operations of an acquired enterprise into our operations and to stand-up the systems and processes needed to support a global footprint.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_BusinessCombinationTransactionandintegrationcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NumberofProductCategoriesManufactured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Product Categories Manufactured</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NumberofProductCategoriesManufactured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PrincipalCountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PrincipalCountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772883408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Acquisition) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 10,419<span></span>
</td>
<td class="nump">$ 7,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Total identifiable intangible assets acquired</a></td>
<td class="nump">2,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and equivalents</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other accrued liabilities</a></td>
<td class="num">(153)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="num">(873)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets acquired/(liabilities) assumed</a></td>
<td class="nump">2,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total net assets acquired</a></td>
<td class="nump">6,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 1,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member] | Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets:</a></td>
<td class="nump">$ 732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary difference assumed at the acquisition date that are classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6925634112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring and employee severance</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771583408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee- Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6921363440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ContractTerminationAxis=cah_DistributorContractMember', window );">Medline [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ContractTerminationAxis=cah_DistributorContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ContractTerminationAxis=cah_DistributorContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771574352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 7,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired, net of purchase price adjustments</a></td>
<td class="nump">3,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">10,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired, net of purchase price adjustments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">4,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired, net of purchase price adjustments</a></td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 7,468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772367520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">6,050<span></span>
</td>
<td class="nump">3,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,604<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 4,446<span></span>
</td>
<td class="nump">1,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Intangible, Total other intangible assets</a></td>
<td class="nump">$ 6,111<span></span>
</td>
<td class="nump">3,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Intangible, Total other intangible assets</a></td>
<td class="nump">4,507<span></span>
</td>
<td class="nump">1,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember', window );">IPR&amp;D, trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">IPR&amp;D, trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">3,705<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 2,659<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember', window );">Trademarks, trade names, and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 697<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 1,648<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">346<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,302<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771522912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Three</a></td>
<td class="nump">531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">$ 421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771762864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale Securities (Schedule of Available-for-Sale Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_USTreasurySecuritiesMember', window );">Treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember', window );">International bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_MunicipalBondsMember', window );">U.S. agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember', window );">International equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26610-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772755104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Debt and Capital Lease Obligations</a></td>
<td class="nump">$ 10,395<span></span>
</td>
<td class="nump">$ 10,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 17,906<span></span>
</td>
<td class="nump">19,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A1.7Notesduefiscal2018Member', window );">1.7% Notes due fiscal 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member', window );">1.948% Notes due 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.948%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesduefiscal2022Member', window );">2.616% Notes due fiscal 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">2.616%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesduefiscal2024Member', window );">3.079% Notes due fiscal 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.079%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesduefiscal2027Member', window );">3.41% Notes due fiscal 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">3.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesduefiscal2047Member', window );">4.368% Notes due fiscal 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.368%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from Notes Payable</a></td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Committed Receivables Sales Facility Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember', window );">Short Term Credit Facilities Member | Committed Receivables Sales Facility Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of all debt, including all short-term borrowings, long-term debt, and capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A1.7Notesduefiscal2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A1.7Notesduefiscal2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A1.948Notesdue2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesduefiscal2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesduefiscal2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesduefiscal2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.079Notesduefiscal2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesduefiscal2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesduefiscal2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772692304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">34.20%<span></span>
</td>
<td class="nump">37.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 410<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, interest and penalties accrued</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Amount CareFusion is liable under tax matters agreement in the event amount must be paid to the taxing authority</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax years open for examination</a></td>
<td class="text">2008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax years open for examination</a></td>
<td class="text">2008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Tax years open for examination</a></td>
<td class="text">2008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IndemnificationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable from CareFusion related to certain pre-Spin tax exposures and transaction taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IndemnificationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6760936992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>organization </div>
<div>plaintiff </div>
<div>lawsuit</div>
</th>
<th class="th"><div>Jul. 31, 2014</div></th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyRequestForInformation', window );">Loss Contingency, Request for Information</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyAccrualNetofInsuranceRecoveries', window );">Loss Contingency Accrual, Net of Insurance Recoveries | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">1,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | organization</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersAxis=cah_CVSHealthMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_InitialtermofPharmaceuticalSourcingVenture', window );">Initial term of pharmaceutical sourcing venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_MaximumQuarterlyPayment', window );">Maximum quarterly payment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of lawsuits filed</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_InitialtermofPharmaceuticalSourcingVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial term of Pharmaceutical Sourcing Venture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_InitialtermofPharmaceuticalSourcingVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyAccrualNetofInsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Net of Insurance Recoveries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyAccrualNetofInsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_MaximumQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_MaximumQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyRequestForInformation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the type of information that the parties to the litigation have sought or provided, and when it was provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyRequestForInformation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=cah_CVSHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=cah_CVSHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_OpioidLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_OpioidLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772852272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 1,162<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent Consideration</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent Consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Total available-for-sale securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative Assets (Liabilities), at Fair Value, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent Consideration</a></td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26610-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82895926&amp;loc=d3e24584-111560<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6912198992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details) - Recurring - Contingent Consideration Obligation<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at beginning of period</a></td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions from acquisitions</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payment of contingent consideration</a></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at end of period</a></td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cah_ContingentConsiderationClassifiedasaLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cah_ContingentConsiderationClassifiedasaLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6910648448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Carrying amount</a></td>
<td class="nump">$ 10,003<span></span>
</td>
<td class="nump">$ 10,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 10,333<span></span>
</td>
<td class="nump">$ 10,713<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of all debt, including all short-term borrowings, long-term debt, and capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6761166320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Aug. 26, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestLineItems', window );"><strong>Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Carrying Amount</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_NaviHealthMember', window );">naviHealth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestLineItems', window );"><strong>Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership interest (as a percent)</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable Noncontrolling Interest, Equity, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent', window );">Decrease from purchase of interest</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Adjustment of redeemable noncontrolling interests to redemption value</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Carrying Amount</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Redeemable Noncontrolling Interest, Equity, Redemption Value</a></td>
<td class="nump">$ 109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | naviHealth</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestLineItems', window );"><strong>Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest percentage (for example, but not limited to redeeming or purchasing the interest of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Noncontrollinginterestdecreasefromredemptionsorpurchaseofinterestspercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569655-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4616395-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption value, as if currently redeemable, of redeemable noncontrolling interest classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 24(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6922165248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests (Changes in Redeemable Noncontrolling Interests) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at June 30, 2017</a></td>
<td class="nump">$ 118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at September 30, 2017</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cah_NaviHealthMember', window );">naviHealth</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at June 30, 2017</a></td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net earnings attributable to redeemable noncontrolling interests</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Adjustment of redeemable noncontrolling interests to redemption value</a></td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at September 30, 2017</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Noncontrolling Interest, Change in Redemption Value</a></td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569655-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4616395-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6911891072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details) - Treasury Shares - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (using cost method), shares</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share)</a></td>
<td class="nump">$ 67.92<span></span>
</td>
<td class="nump">$ 81.37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772916944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 6,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income, net of tax</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">6,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), before reclassifications</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income, net of tax</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gain/(Loss) on Derivatives, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), before reclassifications</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income, net of tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income/(loss), before reclassifications</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income, net of tax</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6922021408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8211;basic (in shares)</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted Average Number Diluted Shares Outstanding Adjustment</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8211;diluted (in shares)</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6909320624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6906520400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ProjectCostsOnInvestmentAndOtherSpending', window );">Project Costs On Investment And Other Spending | $</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ProjectCostsOnInvestmentAndOtherSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ProjectCostsOnInvestmentAndOtherSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6761305600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenue by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 32,641<span></span>
</td>
<td class="nump">$ 32,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">32,644<span></span>
</td>
<td class="nump">32,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">28,920<span></span>
</td>
<td class="nump">28,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">3,724<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6771653520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">$ 535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (334)<span></span>
</td>
<td class="num">$ (126)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6925601648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Assets by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 41,940<span></span>
</td>
<td class="nump">$ 40,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">22,220<span></span>
</td>
<td class="nump">21,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">18,055<span></span>
</td>
<td class="nump">10,688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,665<span></span>
</td>
<td class="nump">$ 7,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772003600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to share-based compensation</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">133.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ExercisablePeriodOfPlansInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The instrument's contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ExercisablePeriodOfPlansInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6919489232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6654300704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares) | shares</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares) | shares</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">66.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share) | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">64.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 59.19<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6922191552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details) - Stock Options - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of outstanding options at period end</a></td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of exercisable options at period end</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772435280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details) - Restricted Share Units<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 76.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">66.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">79.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 71.60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6761970624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details) - Performance Share Units<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="nump">133.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 77.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">66.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">71.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 75.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized | $</a></td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_RNPLX;N[?_V/@B*#OX=1?R"U!+ P04    " #E@F=+F5R<(Q &  "<)P
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M/+YL[']KC >4<KC!$>KQ@ZV&A-:'XRV>[3QFL^'-L/P@MG[CZB=02P,$%
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MGV"NYT#)7/P7N(+"\* $<Y1&N;B2<G#>Z)D%I6CQ,NVRB_LXW1S2&;8-X#.
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MXME.8S89WO3S#V++-RY^ E!+ P04    " #E@F=+8QWPV+4!  #2 P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q]4]MNVS ,_15!'U EBIL%@6V@
MZ3"LP H$';8^*S9]075Q)3EN_WZ4['K>9NQ%$BF>PT.*2@=C7UP#X,F;DMIE
MM/&^.S+FB@:4<#>F XTWE;%*>#1MS5QG0901I"3CF\V>*=%JFJ?1=[9Y:GHO
M6PUG2UROE+#O)Y!FR.B6?CB>VKKQP<'RM!,U? ?_HSM;M-C,4K8*M&N-)A:J
MC-YMCZ<DQ,> GRT,;G$FH9*+,2_!>"@SN@F"0$+A X/ [0KW(&4@0AFO$R>=
M4P;@\OS!_B76CK5<A(-[(Y_;TC<9/5!20B5ZZ9_,\!6F>FXIF8K_!E>0&!Z4
M8(["2!=74O3.&S6QH!0EWL:]U7$?QIO]88*M _@$X#/@$/.P,5%4_EEXD:?6
M#,2.O>]$>.+MD6-OBN",K8AW*-ZA]YIO][N470/1%',:8_@R9HY@R#ZGX&LI
M3OP?.%^'[U85[B)\]X?"9)T@625((D'RWQ+78F[_2L(6/55@ZSA-CA2FUW&2
M%]YY8.]X?)/?X>.T/PI;M]J1B_'XLK'_E3$>4,KF!D>HP0\V&Q(J'XZ?\&S'
M,1L-;[KI!['Y&^>_ %!+ P04    " #E@F=+U 1W8K0!  #2 P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q]4V%OVR 0_2N('U 2DJ519%MJ.DV;
MM$E1IZV?B7VV48'S ,?=OQ]@U_,V:U^ .^Z]>W<<V8#VQ;4 GKQJ95Q.6^^[
M$V.N;$$+=X<=F'!3H]7"!],VS'461)5 6C&^V1R8%M+0(DN^BRTR[+V2!BZ6
MN%YK87^>0>&0TRU]<SS)IO71P8JL$PU\!?^MN]A@L9FEDAJ,DVB(A3JG#]O3
M>1_C4\!W"8-;G$FLY(KX$HU/54XW41 H*'UD$&&[P2,H%8F"C!\3)YU31N#R
M_,;^(=4>:KD*!X^HGF7EVYP>*:F@%KWR3SA\A*F>=Y1,Q7^&&Z@0'I6$'"4J
MEU92]LZCGEB"%"U>QUV:M _CS>XPP=8!? +P&7!,>=B8*"E_+[PH,HL#L6/O
M.Q&?>'OBH3=E=*96I+L@W@7OK=@>#AF[1:(IYCS&\&7,',$"^YR"KZ4X\W_@
M?!V^6U6X2_#='PKOUPGVJP3[1+#_;XEK,<>_DK!%3S78)DV3(R7V)DWRPCL/
M[ -/;_([?)SV+\(VTCAR11]>-O6_1O00I&SNP@BUX8/-AH+:Q^-].-MQS$;#
M8S?](#9_X^(74$L#!!0    ( .6"9TNH:LK@M $  -(#   9    >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;'U3VV[<(!#]%<0'!)O=9-.5;2F;JFJE5EJE
M:OK,VF,;!3PNX'7Z]P7LN%9KY068X9PS%X9L1/-B6P!'7K7J;$Y;Y_HC8[9L
M00M[@SUT_J9&HX7SIFF8[0V(*I*T8CQ)[I@6LJ-%%GUG4V0X."4[.!MB!ZV%
M^7T"A6-.4_KF>))-ZX*#%5DO&O@.[D=_-MYBBTHE-7168D<,U#E]2(^G?<!'
MP+.$T:[.)%1R07P)QI<JITE("!24+B@(OUWA$90*0CZ-7[,F74(&XOK\IOXI
MUNYKN0@+CZA^RLJU.;VGI():#,H]X?@9YGIN*9F+_PI74!X>,O$Q2E0VKJ0<
MK$,]J_A4M'B==MG%?9QN>#K3M@E\)O"%<!_CL"E0S/RC<*+(#([$3+WO17CB
M],A];\K@C*V(=SYYZ[W7(KW[D+%K$)HQIPG#UY@%P;SZ$H)OA3CQ_^A\F[[;
MS' 7Z;MU]$.R+;#?%-A'@?V[)6Y@#O\6R58]U6":.$V6E#AT<9)7WF5@'WA\
MD[_P:=J_"=/(SI(+.O^RL?\UH@.?2G+C1ZCU'VPQ%-0N' _^;*8QFPR'_?R#
MV/*-BS]02P,$%     @ Y8)G2Z>XP<ZT 0  T@,  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL?5-A;]L@$/TKB!]0$N(V561;:EI-F[1)4:>MGXE]
MME'!N(#C[M_OP*[K=M:^ '?<>_?N.-+!V&?7 'CRJE7K,MIXWQT8<T4#6K@K
MTT&+-Y6Q6G@T;<U<9T&4$:05XYO-#=-"MC1/H^]D\]3T7LD63I:X7FMA_QQ!
MF2&C6_KF>)1UXX.#Y6DG:O@)_E=WLFBQF:64&EHG34LL5!F]VQZ.28B/ ;\E
M#&YQ)J&2LS'/P?A69G03!(&"P@<&@=L%[D&I0(0R7B9..J<,P.7YC?U+K!UK
M.0L']T8]R=(W&;VEI(1*],H_FN$K3/5<4S(5_QTNH# \*,$<A5$NKJ3HG3=Z
M8D$I6KR.NVSC/HPWU_L)M@[@$X#/@-N8AXV)HO('X46>6C,0._:^$^&)MP>.
MO2F",[8BWJ%XA]Y+OMWSE%T"T11S'&/X,F:.8,@^I^!K*8[\'SA?A^]6%>XB
M?/=!X6Z=(%DE2")!\M\2UV*23TG8HJ<:;!VGR9'"]&V<Y(5W'M@['M_D/7R<
M]A_"UK)UY&P\OFSL?V6,!Y2RN<(1:O"#S8:"RH?C'L]V'+/1\*:;?A";OW'^
M%U!+ P04    " #E@F=+($MU]K4!  #2 P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q]4]MNVS ,_15!'U E2MIT@6V@Z3!LP 8$'=8]*S9M"]7%
MD^2X^_M1LNMYF[$72:1X#@\I*ANL>_$M0""O6AF?TS:$[LB8+UO0PM_8#@S>
MU-9I$=!T#?.= U$ED%:,;S9W3 MI:)$EW]D5F>V#D@;.COA>:^%^GD#9(:=;
M^N9XDDT;HH,562<:^ KA6W=V:+&9I9(:C)?6$ =U3A^VQ],^QJ> 9PF#7YQ)
MK.1B[4LT/E4YW41!H* ,D4'@=H5'4"H2H8P?$R>=4T;@\OS&_B'5CK5<A(='
MJ[[+*K0YO:>D@EKT*CS9X2-,]=Q2,A7_&:Z@,#PJP1RE53ZMI.Q]L'IB02E:
MO(Z[-&D?QAO^;H*M _@$X#/@/N5A8Z*D_+T(HLB<'8@;>]^)^,3;(\?>E-&9
M6I'N4+Q'[[78'FXS=HU$4\QIC.'+F#F"(?N<@J^E./%_X'P=OEM5N$OPW1\*
M[]8)]JL$^T2P_V^):S&'OY*P14\UN"9-DR>E[4V:Y(5W'M@'GM[D=_@X[5^$
M:Z3QY&(#OFSJ?VUM )2RN<$1:O&#S8:".L3C <]N'+/1"+:;?A";OW'Q"U!+
M P04    " #E@F=+KW./=[4!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R,2YX;6Q]4V&/U" 0_2N$'W!TN]5=-VV3VS-&$TTV9SP_L^VT)0=,!;H]
M_[U >[5JXQ=@AGEOW@Q#/J)YMAV (R]*:EO0SKG^Q)BM.E#<WF$/VM\T:!1W
MWC0ML[T!7D>0DBQ-DK=,<:%IF4??Q90Y#DX*#1=#[* 4-S_/('$LZ(Z^.AY%
MV[G@8&7>\Q:^@OO67XRWV,)2"P7:"M3$0%/0^]WIG(7X&/ D8+2K,PF57!&?
M@_&I+F@2!(&$R@4&[K<;/("4@<C+^#%STB5E *[/K^P?8NV^EBNW\(#RNZA=
M5] C)34T?)#N$<>/,-?SAI*Y^,]P ^G#@Q*?HT)IXTJJP3I4,XN7HOC+M L=
M]W&Z.60S;!N0SH!T 1QC'C8EBLK?<\?+W.!(S-3[GH<GWIU2WYLJ.&,KXIT7
M;[WW5NX.QYS= M$<<YYBTG7,$L$\^Y(BW4IQ3O^!I]OP_:;"?83O_U#X;IL@
MVR3((D'VWQ(W8H[)7TG8JJ<*3!NGR9(*!QTG>>5=!O8^C6_R.WR:]B_<M$);
M<D7G7S;VOT%TX*4D=WZ$.O_!%D-"X\+QX,]F&K/)<-C//X@MW[C\!5!+ P04
M    " #E@F=+P$=IX,$!   W!   &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6QM5.UNVR 4?17$ Y08QUT5V9::3E4G;5+4:=MO8E]_J'QX@./N[0?8
M<;V,/X%[?>XYYP(W^:3TF^D +'H77)H"=]8.!T),U8%@YDX-(-V71FG!K MU
M2\R@@=6A2'!"=[M[(E@O<9F'W$F7N1HM[R6<-#*C$$S_.0)74X$3?$V\]FUG
M?8*4^<!:^ [VQW#2+B(K2]T+D*97$FEH"OR8'(Z9QP? SQXFL]DCW\E9J3<?
M?*D+O/.&@$-E/0-SRP6>@'-/Y&S\7CCQ*ND+M_LK^W/HW?5R9@:>%/_5U[8K
M\ -&-31LY/9532^P])-AM#3_%2[ '=P[<1J5XB;\HFHT5HF%Q5D1['U>>QG6
M:>&_EL4+Z%) ;PK(+!2<?V:6E;E6$]+SV0_,7W%RH.YL*I\,1Q&^.?/&92]E
M\I#DY.*)%LQQQM M9D40Q[Y*T)C$D?Y73N/E:=1A&LK3K7IZ'R?81PGV@6#_
M3XOTIL48)HV+9%&1+$*POQ&)8;(;$;*Y. &Z#4_6H$J-,HS+)KM.Q2,-%_\!
MGT?J&]-M+PTZ*^N>3[CD1BD+SLKNSGGIW!2O 8?&^NTGM]?S6YX#JX9E3,GZ
M7U'^!5!+ P04    " #E@F=+NE$VM[<!  #2 P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6QM4]MNG# 0_17+'Q#OLC2[60%2-E752HVT2M7VV0L#
M6/&%VF9)_CYC0RA->;$]XW/.7#S.!F.?70O@R8N2VN6T];X[,N;*%A1W-Z8#
MC3>UL8I[-&W#7&>!5Y&D)$LVFUNFN-"TR*+O;(O,]%X*#6=+7*\4MZ\GD&;(
MZ9:^.YY$T_K@8$76\09^@/_9G2U:;%:IA +MA-'$0IW3^^WQE 9\!/P2,+C%
MF81*+L8\!^-;E=--2 @DE#XH<-RN\ !2!B%,X\^D2>>0@;@\OZM_B;5C+1?N
MX,'(WZ+R;4X/E%10\U[Z)S-\A:F>3Y1,Q7^'*TB$ATPP1FFDBRLI>^>-FE0P
M%<5?QEWHN _CS3Z=:.N$9"(D,^$0X[ Q4,S\,_>\R*P9B!U[W_'PQ-MC@KTI
M@S.V(MYA\@Z]UV)[N,W8-0A-F-.(29:8&<%0?0Z1K(4X)?_1DW7Z;C7#7:3O
MEM%W=^L"Z:I &@72?TK<?RAQ#7/X$(0M>JK -G&:'"E-K^,D+[SSP-XG\4W^
MPL=I?^2V$=J1B_'XLK'_M3$>,)7-#8Y0BQ]L-B34/ASW>+;CF(V&-]WT@]C\
MC8LW4$L#!!0    ( .6"9TLQS0>TP0$  #<$   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;'54[8[;(!!\%<0#' Y)VKO(MG2YJFJE5HJNZO4WL=<V
M.CY<P/'U[0O8<:V4^Q/8]<SL++#)1VU>;0?@T)L4RA:X<ZX_$&*K#B2S=[H'
MY;\TVDCF?&A:8GL#K(XD*0C-L@]$,JYPF<?<R92Y'IS@"DX&V4%*9OX<0>BQ
MP!M\33SSMG,A0<J\9RW\ />S/QD?D46EYA*4Y5HA TV!'S>'XS[@(^"%PVA7
M>Q0Z.6O]&H*O=8&S8 @$5"XH,+]<X F$"$+>QN]9$R\E W&]OZI_CKW[7L[,
MPI,6OWCMN@+?8U1#PP;AGO7X!>9^]AC-S7^#"P@/#TY\C4H+&W]1-5BGY:SB
MK4CV-JU<Q76<]:^T-('.!'I#(%.AZ/P3<ZS,C1Z1F<Z^9^&*-P?JSZ8*R7@4
M\9LW;WWV4F[N'W)R"4(SYCAAZ!JS((A77TK05(DC_8].T_1MTN$VTK?KZKMW
M!'9)@5T4V*T%'K*;%E.8=YK<)XOL$P+TID@*L[TI0E87)\&T\<E:5.E!Q7%9
M99>I>*3QXO_!IY'ZSDS+E45G[?SSB9?<:.W 6\GNO)?.3_$2"&A<V'[T>S.]
MY2EPNI_'E"S_%>5?4$L#!!0    ( .6"9TO3E275T@$  )P$   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;&U4VVZ<,!#]%<L?$.^R0#8K0,HFBEJI
ME5:IVCQ[8;@HOA#;+.G?US:$DHU?L&=\YIP9,^-LE.I5MP &O7,F=(Y;8_H#
M(;IL@5-](WL0]J26BE-C3=40W2N@E0_BC$2;34HX[00N,N\[J2*3@V&=@)-"
M>N"<JK]'8'+,\19_.)Z[IC7.08JLIPW\ O.[/REKD86EZC@(W4F!%-0YOM\>
MCJG#>\"?#D:]VB-7R5G*5V=\KW*\<0D!@](X!FJ7"SP 8X[(IO$V<^)%T@6N
M]Q_L3[YV6\N9:GB0[*6K3)OC/485U'1@YEF.WV"N)\%H+OX'7(!9N,O$:I22
M:?]%Y:"-Y#.+3873]VGMA%_'Z239S6'A@&@.B): O=<ADY#/_)$:6F1*CDA-
M=]]3]XNWA\C>3>F<_BK\F4U>6^^EV-[%&;DXHAESG##1&K,@B&5?)**0Q#'Z
M$AZ%PW?!#'<^?+=6CY,P01PDB#U!_*G$Y*K$$"8-BR1!D21 <'LE$L+LPR)I
M4"0-$-Q=B80PUR)DU1T<5./G0J-2#L+/Y,J[C-Y]Y+OK/WR:VY]4-9W0Z"R-
M[5'?2;64!FPJFQM;<&N?BL5@4!NWO;5[-0W,9!C9SV\!61ZDXA]02P,$%
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MVQM@=21)06B2W!')N,)E'F-'4^9Z<((K.!ID!RF9^7L H<<"I_@2>.9MYT*
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M_HW6#GPIR8U?H<X_L,41T+A@WGO;3&LV.4[W\PLBRS,N_P%02P,$%     @
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MD=,G6.K98[04_P6NP"W<96(U2LFU_Z)RU$:*A<6F(MC;O':]7Z?Y)#DL8>$
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M<'?1'H70S @&#V8?%.9U[P><';7MIJ8OVR>N'6C1=,\WZO]#Y/\ 4$L#!!0
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MA>Q!/W&N0!L,'G2+:CWZI@V%DS++5*_%, "&C>+=.-O0-&"+OU!+ P04
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M5,IL$[T7T]N>#,7[>6RA97;F_P!02P,$%     @ Y8)G2V^VOD:' @  30D
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M6A-&8:JS09/-)+%K-K2.D<WP8Q)DZX!HL:,I=N;;'B,M9+RA.4!:R#BG/1A
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M?V,75FBX8:)K['@A[:^W.TO%RS:+IE+2]V;,*SM>V_RW,#@ MP&X"]"U_Q=
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M'<^,2:KXW)5BRM4):QB4]"SUHSH06+P[9G0#R9K^".4,Y[CL'U!+ P04
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MQ+?G>Q%;G82&#5LQ=$42Z"(!\S$R7"16'VH^#!]NC69D HU,@)'(,#*Q.OE
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MOK((D)I6U29M4M2IV[5#3@#5QLQV0O?OYP]"*7%O8OOPGO<Y!^*3#UR\R@9
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M.A"HI-YNU)[;<6 /DO7CI$/3N,W_ E!+ P04    " #E@F=+^U"NYO\"  #
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MDV0$$BTFFY58>81X$BF:1(J4.CWPU,HB31<)CI*A*)F%$L,"#Y"C ?+Y1[I
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MGL]#8 XD&Y;YAM8AF_\'4$L#!!0    ( .6"9TL4TEU4V $  %X$   9
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MH=\4]"3U,E)KWH[0=B-9W?T>./T_2O(/4$L#!!0    ( .6"9TO,7IS>;P(
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M-#;!KZ&' LF&UD%7%C2YS5;@=0>4-F#&H:XR+\;LY"!LP_$70BT05DD*T_:
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M59[O>2\/]5XJ>N/+_ ?,SN%!RX@B]>U@H^21Z?HY1L2>PXR(!Q*B*YGU%8)
M95P^H2OY?2G0B^7+6\J,I0=>-&;&$FWHI-55GOR$"6(OXG3Q:^79:<\[:G76
M6S3=5;<R(I[/45=+UO3(R>Y5"]R8^#*B)6ZE&Q\I/7"A7E^[[(4O]<;ZDS*'
MN0)UAL(U*.]"JR& DH3I> &LS5.!B*94/=#U?L6;26%40'(H((3T1TF6)NT(
M8QO$CJ9U$WQ[59#MSLS+X95Y,:?,DX!M2QAR$"Z1<_<\774/N3[:;D!/S8M
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M[HO.CU3J4/,N5 SYEVUD*E+@V1<[)0*"5*.TG)]- )_)D='Q4X1O:IT&H,>
M$!,%P]T#1KK\(\Q2D283NW01*BHC.^@@_$()GUSUP-P@%?&=4:(C1JA'L9UH
M+"&.&L'HD%;ADO2.7X!+Y,MHP=KP/>AFF-UAL2/[ ;&!JZ=6XKMT'H$5H&RS
M"A\HZW,K[TDBDQUS3"<[?ZS!!LY@MJN]#/M]8X:U%7GK*9W6$'@LKU$8" (
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MFZQP<)VOKV/Q&".Y&(X5$6BD$D/8D(@GF-%&U2DME)7;K:F*(D54@D/EKEN
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MQ,I@'=\ >?5D2O]>Z+HENGKHSJI;XKABC+@"(_01=_86L_5GDP$M=CR]Y'J
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M+G)E;'-02P$"% ,4    " #E@F=+9O,+8((   "Q    $
M@ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .6"9TO@^^\L[@
M "L"   1              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( .6"9TN97)PC$ 8  )PG   3              "  ;8"  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ Y8)G2TBEZ2AQ @  >P@  !@
M             ( !]P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( .6"9TO],USQE0,  $P0   8              "  9X+  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #E@F=+ELR<0UP"  #.
M!P  &               @ %I#P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ Y8)G2XUK]N3* P  RA$  !@              ( !^Q$
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( .6"9TO-.J7[
M  (  !$&   8              "  ?L5  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " #E@F=+%,I?QG4$  #H%@  &
M@ $Q&   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ Y8)G
M2U#WNYVU 0  T@,  !@              ( !W!P  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( .6"9TM>V79=M $  -(#   8
M      "  <<>  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" #E@F=+C%P_8[,!  #2 P  &               @ &Q(   >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ Y8)G2Y>@_9*T 0  T@,  !D
M             ( !FB(  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " #E@F=+#W >>;4!  #2 P  &0              @ &%)   >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .6"9TL>F (ZM@$
M -(#   9              "  7$F  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ Y8)G2P?V$-"T 0  T@,  !D              ( !
M7B@  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #E@F=+
MT*_@Q+0!  #2 P  &0              @ %)*@  >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( .6"9TO8U5O LP$  -(#   9
M      "  30L  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ Y8)G2V,=\-BU 0  T@,  !D              ( !'BX  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #E@F=+U 1W8K0!  #2 P
M&0              @ $*,   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( .6"9TNH:LK@M $  -(#   9              "  ?4Q  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ Y8)G2Z>XP<ZT
M 0  T@,  !D              ( !X#,  'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " #E@F=+($MU]K4!  #2 P  &0
M@ '+-0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( .6"
M9TNO<X]WM0$  -(#   9              "  ;<W  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ Y8)G2\!':>#! 0  -P0  !D
M         ( !HSD  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M    " #E@F=+NE$VM[<!  #2 P  &0              @ &;.P  >&PO=V]R
M:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .6"9TLQS0>TP0$  #<$
M   9              "  8D]  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
M4$L! A0#%     @ Y8)G2].5)=72 0  G 0  !D              ( !@3\
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #E@F=+)B<K
M/;8!  #2 P  &0              @ &*00  >&PO=V]R:W-H965T<R]S:&5E
M=#(V+GAM;%!+ 0(4 Q0    ( .6"9TM-<Y:2P0$  #<$   9
M  "  7=#  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
MY8)G2\6N(:FT 0  T@,  !D              ( !;T4  'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " #E@F=+&.Q:NK<!  #2 P  &0
M            @ %:1P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( .6"9TLC8Y /LP$  -(#   9              "  4A)  !X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ Y8)G2]SS-/BT 0
MT@,  !D              ( !,DL  'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " #E@F=+1W>"0],!  "<!   &0              @ $=
M30  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( .6"9TN.
M1/T#[@$  &8%   9              "  2=/  !X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ Y8)G2WH[2?/9 0  8 0  !D
M     ( !3%$  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .6"9TN-/DAC]P$  $<%   9              "
M 6=>  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ Y8)G
M2V^VOD:' @  30D  !D              ( !E6   'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " #E@F=+F/YT@:4#  !-$0  &0
M        @ %38P  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( .6"9TO](>T8+0(  %L&   9              "  2]G  !X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ Y8)G2\GGYBFI @  & P
M !D              ( !DVD  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " #E@F=+$$T:W"L#  "J#@  &0              @ %S;
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( .6"9TO*Z&6H
MPP(  "D+   9              "  =5O  !X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ Y8)G2[%]Q .+ @  TPD  !D
M ( !SW(  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #E
M@F=+^=&LY&H#  "4$0  &0              @ &1=0  >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( .6"9TN[?&Z?^0$  &(%   9
M          "  3)Y  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#
M%     @ Y8)G2_*F>5#< 0  X@0  !D              ( !8GL  'AL+W=O
M<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #E@F=+R41:/GT"   1
M"0  &0              @ %U?0  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM
M;%!+ 0(4 Q0    ( .6"9TN%., G*0(  +D&   9              "  2F
M  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ Y8)G2V_H
M)1@- @  >@4  !D              ( !B8(  'AL+W=O<FMS:&5E=',O<VAE
M970U,BYX;6Q02P$"% ,4    " #E@F=+^U"NYO\"  # #   &0
M    @ '-A   >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (
M .6"9TOR(3R@_P$  ' %   9              "  0.(  !X;"]W;W)K<VAE
M971S+W-H965T-30N>&UL4$L! A0#%     @ Y8)G2Q327538 0  7@0  !D
M             ( !.8H  'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"
M% ,4    " #E@F=+:4';-O4!   G!0  &0              @ %(C   >&PO
M=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( .6"9TN_H5%]<@(
M *\(   9              "  72.  !X;"]W;W)K<VAE971S+W-H965T-3<N
M>&UL4$L! A0#%     @ Y8)G2\Q>G-YO @  I0@  !D              ( !
M'9$  'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " #E@F=+
M\GN6#"@"   $!P  &0              @ '#DP  >&PO=V]R:W-H965T<R]S
M:&5E=#4Y+GAM;%!+ 0(4 Q0    ( .6"9TM^D%/,UP(  #8,   9
M      "  2*6  !X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%
M  @ Y8)G2_M.'E)' @  A0<  !D              ( !,)D  'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " #E@F=+:" ./G$"  !Z"
M&0              @ &NFP  >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+
M 0(4 Q0    ( .6"9TOFC7R;00(  !@'   9              "  5:>  !X
M;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ Y8)G2ZLV['9W
M @  : @  !D              ( !SJ   'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6Q02P$"% ,4    " #E@F=+O4^_':$"  !/"0  &0
M@ %\HP  >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( .6"
M9TN(C?7QZTP  %Q5 0 4              "  52F  !X;"]S:&%R9613=')I
M;F=S+GAM;%!+ 0(4 Q0    ( .6"9TLM%D$F:P(   ,.   -
M  "  7'S  !X;"]S='EL97,N>&UL4$L! A0#%     @ Y8)G2S&R*6'.!
MURH   \              ( !!_8  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( .6"9TO:N?=7+P(  #@G   :              "  0+[  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .6"9TLP;ZE,]0$  (\F
M   3              "  6G]  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !* $H .!0  (__      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>134</ContextCount>
  <ElementCount>248</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1014000 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Restructuring and Employee Severance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</Role>
      <ShortName>Restructuring and Employee Severance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Available-for-Sale Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AvailableForSaleSecurities</Role>
      <ShortName>Available-for-Sale Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Commitments, Contingent Liabilities and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Redeemable Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RedeemableNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2302302 - Disclosure - Acquisitions Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables</Role>
      <ShortName>Acquisitions Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</Role>
      <ShortName>Restructuring and Employee Severance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Available-for-Sale Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AvailableForSaleSecuritiesTables</Role>
      <ShortName>Available-for-Sale Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/AvailableForSaleSecurities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstruments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Redeemable Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RedeemableNoncontrollingInterests</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2316301 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2402403 - Disclosure - Acquisitions (Acquisition) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AcquisitionsAcquisitionDetails</Role>
      <ShortName>Acquisitions (Acquisition) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/AcquisitionsBusinessCombinationsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails</Role>
      <ShortName>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails</Role>
      <ShortName>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Restructuring and Employee Severance Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarrativeDetails</Role>
      <ShortName>Restructuring and Employee Severance Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2404404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Available-for-Sale Securities (Schedule of Available-for-Sale Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/AvailableForSaleSecuritiesScheduleOfAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Available-for-Sale Securities (Schedule of Available-for-Sale Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/AvailableForSaleSecuritiesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408401 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2410401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsReconciliationOfLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details</Role>
      <ShortName>Fair Value Measurements (Reconciliation of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails</Role>
      <ShortName>Financial Instruments (Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Redeemable Noncontrolling Interests (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RedeemableNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Redeemable Noncontrolling Interests (Changes in Redeemable Noncontrolling Interests) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RedeemableNoncontrollingInterestsChangesInRedeemableNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests (Changes in Redeemable Noncontrolling Interests) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RedeemableNoncontrollingInterestsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2415403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2416402 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2416403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Revenue by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2416404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Segment Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2416405 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Assets by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2417404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2417405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2417406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="cah-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cah-20170930.xml</File>
    <File>cah-20170930.xsd</File>
    <File>cah-20170930_cal.xml</File>
    <File>cah-20170930_def.xml</File>
    <File>cah-20170930_lab.xml</File>
    <File>cah-20170930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0000721371-17-000145-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-17-000145-xbrl.zip
M4$L#!!0    ( .6"9TM HA9VN@ ! &CC$  0    8V%H+3(P,3<P.3,P+GAM
M;.R]:9=:29(F_'GF5^2KSZ\R?5_J5.<<7ZM4DRDI)67UY*<^"&XHZ") Q:*4
MYM>/V04B(/RR!D1 B#[5*I6X<&US\\?,S<W^^K^^WO1^^%(-1]U!_S]>T!_)
MBQ^J?GO0Z?8__<>+W]^_=._#JU<O_M?/__.O_]_+E__'O_OEASAH3VZJ_OB'
M,*Q:XZKSPY_=\?4/_]FI1O_ZX6HXN/GA/P?#?W6_M%Z^G'[I\U^J*TI:'Q47
M5]8(*RKXHZK:YJHM.E9]O%+__]>_&"Y,)3Y2H3D7U95IF7:;<'-%KJZJCFJQ
M^L>^?ASVNG_!/W\ JONCO[1;U__QXGH\_OR7GW[Z\\\_?VRWAD!XJ_=C>W#S
M$R-4$\N!H=G#@TE_//QV^P7\G1]'5?O'3X,O/\T^K+_TDM"7G-Y^;3(<@D16
M?6_V:<,7.U6W^3OP 3XNEA^OOK:OFY_'3QI^O]O_4HW&S5^9?H9?XO>^-!H(
M1O62U.IO#H:?X''"?YH],?]"K]O_UYJG\>./K5$U?[S?ZK9'S335'S7PT1_T
M^Y.;YG=TQL.?QM\^5S_!0R_AJ6K8;=]^;_.7EK\PK*Y6<J)^@D_G#XZZ[686
MX -D@"XS,!I_'JYX'CYI^,)D]/)3J_7Y]CM7K=''FI#9!PU"@D^&@UXU:OQ.
M_4GSEU .S5^J/VGZTGA8?5HI)_L3?#Y_%#_HW#/R6WE./UQZ=-SXJ)P^.EY\
MM+O.0/NC<:O?OC6YKX6)_LGKIZFU]J?ZT]M'1YVF!^%GZ4__Y]=?WK>OJYO6
MW</=S0^_O*7FY__Y/_Z*[_K+J/[@777U0_WNOUS7=@>NZN7<(_T(=+R8?8IJ
M^(\7H^[-YQYP]!/^RM3-M0?]<?5U_$,72,X1OFI^H[]]B/B>^2/@A+OC;_@/
M\W_I=O#?KKK5\(>:C&J)@[E9AE?_^\7/!/Y/,\HU_>M/][]<O^.G^R^9O>,S
MK*E!9_&M(('A.,)>\//4G-"BYE^_^VSA"U6_L_"X?<G)W=LZ\X?G_W3[OOD_
MS"33+*I7M:38F_883/H$936UE_&4=4I@X=W^Y.R3O5FOK42?AY6HW:Q$'=A*
M\JM:5.(4Y;1D(40ML/UP"YFNCM-?&$O:/@S;ZN2UK8ZA;7WRVE;'T#88^7_-
MT-1_^<FHVZ]&(]?^]Z0[ZHXATG%?NZ/_@BWYO]ZVQET@]UW5'D 0]&W^Z*_5
MS<=J>/L+N=OOCJM?NE^JSJL^4/>I^[%7N=&H&H_\MU];_ST8AEX+7H"_.O].
MK+Y4O<'GJO.A:E_W![W!IV_ONI^NQ[/??C2EW+K?ZA-&;?4_3?^M V_^^KG7
M;7?'4YI^Z'3AD6DD.&/C+RN$]^)GD-Y?UDKOKS\UOF17 G:0_8N?YU_:(/QU
MI-UN27?R.B$O]O1V_6'8ZE2O6S?5Q9 ?P9#O2_MBN?M;;IB,QH.;:OBNZK7P
ME:/K[N>+$3^"$:\1_'=NS]^WW9VL@J>!M/C'I$]?PA^<7#3]E)J^GU]2N^67
MU$$S![-4W!\?XG<)HTX<Q9Q>*I+^8])C]N) 3F>KT"^9/6S2]0#^8 U&NGWF
M'?Q4M?2M7UM?NS>3F_.RD,?$D#N0=2O=NY<NB??[<%J'LN=GDOXZK^S3*1K2
M;PN&=-G\3@ ]GX)1/-%N"6^Z[);'VRT7Q?M]V//,G,, RS?&51X,QPOV=H T
M9ZL[_&>K-ZG\M]N__AWLJC5L7W_[!;>9)0._?>95__-D/*H?X.=E[D^?X=Q*
MY'=6OT;FC[D&[D*:+=; XN.GN@:^;X-]/N:QB -1Z0$^&[;:XP_5\*;;;RT9
M1.R.QL/NQ\D8-K798^=A#*CK%8Q-#6$E9]_'/MD4#+RK0"23]G@R[/8_A<%H
M[/H=^+=J^&49M27P*X-O5?4>/.L02RW/PR1N@=)Z-N\VDA5\7@QDDX'D5KO;
M V9#;P#N]=,S-8]&+K\3XYA5:UY<QZFXCD>H4;TH^S25??A*BGU6]L7G?R>K
M^J+H,US1BXI^/X:]'VF<![_OIR2/;J.^7ZM.M]WJG9=JU[(UC?F6^#I/93:@
M\LWZ?'O=&MZTVM5D_"S5VL3>=X+#]S*'R_)^/@9P'ZY=G,&C.H/'!&@7U3ZA
M:H\;9%U\]C-:IZ_ZG>IJAQ(*5.^KM^]B79-[TQK^:]3J=]Z,KZOA>6E[1[ZG
M^E_'^/FN[45S^$XO1EWN)3W4&- OW"T-U^^\!6_:?];UFN@15K-\GB;0$*)=
M7,*)NX23"_$>NJ%<BK^?6>N!!WJ5R][R:'O+R?D2M1!X7FSF)&WFV#V(]C6!
MRW9R&MO)T8UBUQS&TB7J>K&<ER7LG+M8NDB]P/#S4/\E0#GQ .7X3>KNC*%F
M_ ,VIWUS%:N/6#*1_CT!"M]7[<FP.^Y6RX9P_\/SLH$MN5VH_FID]WQ3V0]1
M?1@,/P^&@)'\H-_Y;BQ@+=?G:PA+.8>'7WMCJV_2_5JU1I-A?5*4A]6_)]B_
MO?GW%IX<O4-)#\^N!.T0U]G8L2[8K=)$ SEK5'&>*97[-K^K\_MUT@=>/[=Z
MZ :>N\]K8O;[5'L>#*ONI_[?\#YA'WG#+WTW>]]6W'^?AG$!0T\&AHY;K7/Q
M$&?K(4XK7*I3"[[5_E?U_?B'-3R?KQ$\9)NXI$N^VXWA]_<?AG44]?VH?S7+
MW^?JOYC L_ "#S&!"PIX)D;PD*W@DCPZ6_>_J'9D_U4?[Q@CH;=E,X[]J*AZ
M/1A7H\ZDNNJ.VJT>(XR=EYY+YJ85,NNY.T_%-M37K=(M_5'?YYV:9Z+9-;P=
M3Z\G5S&WN+N'8=7ICN?M 99\^+OJRZ#W!1L++#US[]QKA1F%P<U-=SRN.N^J
M=M7]TOK8JT;O6_#'_&?>#@>?AJTSZY5:2NMN%U@KK@,=;:TR[-VD_3P@R2K_
MQ7\DVA;>6YR7H:WT8&NY.\^]:7O%"EIPKI^-7E<S=[YJW;#3H%K?7P^&=4O+
MI<]OPZ?+/C/?9]!,-@CKLLL\FC.B/UIAY@L6OF//R\#6(.1&OIZM"]H*[)Z+
M5H\"3Y_#6KU$M&>U9K=1JOB1*W.?=?%<X.!:[LY3L;.9E[]]B*<X+_Y^DD8\
MY0C(HI?E\YC+]G0#T![SO.R9C 5ZNOD[CWS/_%6_/;BI/K2^NLD8PJO[P/ 5
M?'O8;_4 /U7]2?6^&G[IMJM7[][?BT^?B=J;I7%G QO$<: (]#+\:4]KK5N4
MN7[GEP$@AG],AMU1I]O&:WS?I[5N$,?%6I_66F>UM&$PZ8^']P^6OA,3;9+!
MQ2X//T+O37O,[T#:+]UQ]U-]OSFT1M5=Q]'AH#-ICW_IMC[6V9%?6G^.)MWQ
M_5ST^\G'47V;;)Q@%QQCK<BR%U[^_+P,MA3-K%WI6MD<R&172';!HS>)]M$,
MF9*7? =#7GK\* YV>HM_=F7_KJ]-^.?[OU>MWOCZO$ROY&9V\+#,SO?LMP:C
M$<YWZX)G[[>[U<A_>]T:3X;5FZN[?[X[7'OSN3OH=KY++[:UH*8FUB2IBT\[
MND\[A)%?-NW=S?VRF9^BX3]K$[U8PWIKD+_1=U7G3>M?[P>381M6[ 7D/8+B
MQ6X@KW[\D)C^_G'GI3/-I3/-O8=/H#/-<8_X#V#S_&+S![-Y?K'Y1[7Y[]5
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M,VF/PS38A_7^:ZL_N0)ZP9=UEN0R\TK_F/28/2S(??4Z+_IE3A5LX0#QG%$
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M>Y$Z'_PSRYC??!Y6UU@@\J5ZU6\/;BI,-;ZNQF^N/K2^[B9NS;/D6A.24I!
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M3>""V,2[=$E9)[*SPDE'<V":SG@G#(*@,^/]]_<?AO6VL/U2D-02PQF N$P
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MW5&[-\"T]O.MT9!61&TM"0QK,FQP5'E/@M!"X<B?HCA \RW-IT&*IRGZ)SO
MDR1F)JR/5CJII#!:4ZNY2$(DB.C6%5^>N<B?[+".<)VQU7Q2,DG/E6=@^LQI
M91D8=CP#D1]7/I8GB$)ED!R[/,CLD@BI;HC HG/Z%+W!<ZFJT!H$G#TU"<0=
MO'6"*JNL-C$$ET+9+(JJ(I5SYK)_NE**B,V>P2L0#N C!VM8U(1Q!9Y"^K+_
M\_,1^9-YXAB)L\F$9(V5$D"'-L8"W.-6*>/<NDK<$Q'YD4O>$HO91+RGRZ2
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M/(*G1F264S!>2M@^.".!B% W!,[6-<M#P+L>+I!IEOE5__?^\+8H#8"VK_K
MP'CT:O0./A_T 6!_>SL8C;!P>/V^NW&HYLIQ2!!<4F*]CD0JKQS$"]EI(V)P
MBC2T;6W @GLP\_C26)Z%N0IA.D\!'0.RC!!CI&BUE2IA39[3(:MUS7L.((;;
MJU'S^X);WB!;!_<MI77_"PWADM0XGE'QH&,4@)H,,P589$87B<%M*3L,-^LB
M@!B9MSZ(H'D$Z M_C]%82?'(Q"1?''!Q+8MCH/VX@="XW:UC!/A[KZJCX'YG
M<0;3SE$MQ2[1L$$S*Y0CB5*?L 4'N.E$<!AK>4VH <5NINOA?&R(?FV$'40
M#M=9$)6<2A(/YZCEBN;HBZH6B%P>SL>P^Z6%HY"FU;N+I;IW8+ZQ<OFY5!9R
MDZ1R >\^._#?S.,4\^05+ =M15YWPK^U]$Y3Y$]6Q\(A[DP\J0Q>E!HG.(NB
M%GDD/K(RR?Z2%<GH,Q?]D]6S,.NXQ085PFMA$\T.Y [_L=3F2-FZ-J(G(O+C
MRD=AWWD>\9IW4)1::SFMY6."9*ILDW("IOE<*@LSB4%!H"D=Q% B6I-S+7I.
M1&(BK*MN.W.1/V&O:F*8"A("_$RR)CGBX'H0N<*)Q&5GF^=G[4_FB 6#@-E'
M)7RV4MK@/:GW0(X#/E-:UW3R1$1^9-/T5 :1",!ZXH(DR8)#!OD("C#-T"+>
M.I1IIJNKJCU^<Y6^MJ\Q^,44Q)M^<\G;[N=O&M/LV@=/@)'D(4K6L[I"/)[?
M/ E^%^H.Q]6&N(5PR6F2-&09D;-DF<2X)8,KIPT=(XNHY6%<W9ZR0B"*WYQV
MUIJ B<VF\Q7G8U--B7L\\<50C.C E6#1).TU$8( 3G)"&\,CAWBY,:7%-;_/
MTS:T'8JC4DN+' D<\R"T3EDJ&;"W4Z;229J 1^U4\WD'%^S!',T'JU?#+]W9
M:/%BQO7K0?]+-1I7G7HR]^C#8-SJ+7Z.1[JO!^,_JO'=U=/U?NI04]XCDU9H
M2Z+U7)J8/0W<R!R-38)*4<3D95KO: (X62GO.DG>!(=3Y9*F0DD=B)&1 BRQ
M.$C7B-C08N(BX_V&U3N3 ==)RHF.$CRUS<H(3B27VGK+RKE2M,AAGK>HIT7J
M>3"<_1,^1U>YTOV=R1V*,4H9V#X$ #RI!+$L$$!]FK,8)2/AQ<]OV1^/(-Q&
MOL].XBL=RQT4P7ZFEG#JC9/1"A.554&KG)R ?S47>>\B[PU.YBZ?%QD+8-'.
M2RF%]CXX R 7T:!G,NGSDOK=45,>#FX6/YEUH=R]%%J+S$TV)G 023 RX%%Q
MD#C&!%/[90>4?9SN1KH?0Q*;CCBL4,HE<(3.).>59Y2A)+C$:=&V; /Q")+X
MVJY&H^6O-/]L[O;!]0#2=0B#&R:%;&$*(0=OB%(L *P4R?BLP_2L*E+BZ:J!
M?HL2> B]1V1\@^:=$#+&0!@1Q'.1"4G(.(TJ!(B"UR6>#\;QO0007BP<3/IU
ME<$2/S-V\)=[U1@GJ8P7O.(!&K8=+&^U*MICQ'+.F6<X-DSKD+-(P5@?M)4<
M5EIS2899B/;6R*I1I LYGO_LCJ]_[P\^CF"-8F7S]!=0)J";7G?>0FB:!@(=
M=F\S,]]VN^;8)-#;G[KK>8>*6=%NNWZH>]6M.JU1Z_:K3S:Q(!N/<)%!O EK
MGFFKI<36/XX%HVU1D$D:U'5,/1Q3\1.P?7C%2L?RW'2M68J.0=SKL,L'3T$J
M.M.UEL(406^15SB6 HZHY/?5>-R;BNE[4;,R,@7ELC.*:,]AIX/ +_-(9[T;
MBC0V/;:B%Y1P"%6/5KQFMQ+_<U9QDIP3PX7,-$GBB LV11*3L]+G( JO7;:V
M/8KLGT"Y*PZ*SEFY46&_!YZULQ%/2HT5!-VTIT+AG++-LS^.K]S5[7]=NSVY
MF?2P@'9U9=JF>^8*0"17@7AAP,9ML"IR3>$/8I(19<\(D$P1MNU.XQ$XW*MA
M,EIJW2SYIC7\U\CU.P#QT8 V]47QQF8(^R.-4A(\-R*9,L43 ',*_RF$5MX-
M.U^9S;^S3\]WJJ1BU#@JO90,*\4R)\J3[!D54A9UU%85*>KS%]R^;=:)=8DD
ME91265H>373!^."MU4)06YY6D>+V^M,+;UW=LF4Q>BG@3[ %6$8.QZ/2Z&2B
MP#$I?9$Z40X?TQ>QP 4U2GI.N+2..DT<PWI7AF=NNBQ=+Z<HG*_,'N*+LK(F
M.:IA^7@)*\CG+'&2H*00LS4=3!)Q@CO?0R6WKS/".7_21 LX*4ONP/(\H3(H
M)JU5MFR=QA]3> M?F>6$W\&JZO8!A;ZYRO75IS^J5O/,IS7- R)/UA@FDY,N
M$B<,7C/5%DL&N"O HA [.:<M:=Y?!/CM#,_NQK4 2(R]1&#;MM*PX!P7'F_#
M&Z^X)D5*6Y256ON1^4!&!Y,=U4LS=B?(T4,(#S:<#*=4Z:# N=+ 5'%I1I1W
M9O8C\V&,?K@>5CNJ-&;-M-;,:(_YB&Q$S$P2QF(0 ,P*3B4_@$IK.A_(ZI^#
MW1B5QA.'G?!T2C(;[A-L?5Q8HU4RK)P1*U49W^U#Y99L_FTX&#7T=E@7K1EO
MLH#M*4F=I _:Y*R,R; @<566#:PXM[OHKJ;HP=0_)OJA!A/I06H5C,1NGDJ+
MA!?%*)%,I]*6RSY4IRF/AR ;P56$_1C, X TA :&V>AP7+7&RSCE20.U.\7T
M)R"5?5&+5#BB@'%G,"3/SH!0$#5C+S#;,.S5TD<6S%IWIA.SV(O9LB#A62=#
MT SV+)^3C:$(CQ21Q?GRT:E_U,5/I$U.U$4'D@D+H4_ 28$^0.QH?6'G#=W\
M3E,>#UG\09 ,D0RS.'8W8\\E2ETTEE@K*,_%F02 N%V24R<@E7T7?Q3@^R)C
M,FKX?V:L=X#=#65!) !$98\\)7:!>+M(IO$FQKJ-GYD$@(V  ]!:"AT\(^ (
M.,08AE)=)LZH9;MH]=XUB3TH?\QU'VP2@&SP\IX'Y\V\PZ&Y5',:B16RB,0X
MW242>R)9/&3-&Z:2S=%BN;\,DMJ,-<#*$Z$S 7LIMC6["PIZ8H'LN]PA4O>6
M0<Q.P29@OW<4]D[!@J&9,59F$]5.B;$'"F5MR!U$4,'C\B8R).=C$D;FP#0%
MQU5Z<' "NZ"4AU/^F&M=1^S#E[31#/9XXZR-%KB57BLE!"_#<O.(?N\I]G="
MA<-CIQ"-AVA&&2N<-> 0!0[S+"_2,B4?<;$_U=[N<*AF=C91/,&5R6![8D9M
MTD$#/BSW=DZ.L]JG23LL4EQ(#TP+KE86:B]B?)8X"YY[DW P 7<^4Y6]38''
M+$A\\?-;RO_8BN9UE!R1F:,XAX4A*9Q0KP*U$7PC6+]1@@1O-1!@,KB#YRF?
MK1S&G8O0WF5AF:-@1$PSYSS%9(AA*#=QZD;TQP.%M-&'+*RVH#3!Y AQ$M 2
M"(K8I'P(1OD4\0(/98<5U-_@J5\@4'C3?]_J5:,W5[-D8K]3_^75S>=6=XA5
M).&Z-?RT3PTZ0..@ X==@D*TD 1-9-8%6 380,OI)O?]X*XD'I:]#97FPI(L
M/%ZQB-(:D@,L^ED38?":Y:C ET7^\Q#LU>L/#&SP2W<\:XI[5WFW>]-N KB4
M!&%-L%X"8@TISX:<6&QWM3U/:^DZ ",;E*-L-%0'%\$?$Z]9X%+,E".,,V5_
ME;):;B].1O@-4&4_?<6BLTEW=(V/O;G"QH,[J\/AK4F1F<G2..V$U$&"'PW:
M>4=2.7_N'O5KB7D@Y9OD+UADF9A$I>9>B\@$1\H)P^VQG(O;;$C;,S"; KQ;
MK[T0-2,1=F['?7V&P0GWW# A\/9U* H6-"N/%.=OWIJ:V\VA;CB)[,QO;[RO
M/M4U@[<XY->JTVVW>IO:2X.[@2A:@$\5$E/)'/!FDB&0D*Q4!1>"F=+6C\C%
M6W!>-ZUV-1EOP4PT3#JA/&;%I./.91:U)B&F*%S#*0JSY<C%W9A9%_]R[K)F
MUG) P5+1C#5.R0NO/=B*$&7'/R+HP\EY^ V@U18?2,9<E09G(C2(%R"&!VAF
M!82U6I;]&&G9D'U_?@YE\=X$DF1V42DM'6!NV+*\XL%YP%" EHIU*U21/CTF
M%SM9/(30P$[$<01>8I]T)ZD-/EC8<#,M!UTR*W=R0O-!Z7&"-;Y3'+@[UHE.
M&0J!*D-CD<E%PV5*5LF<8#LM:VS [:\BLHF@AQ)^<!,#UPE;+8M<DB"#4(Z)
MH+&7*2%89E-<(.4- SI.A.'=_"_6$@OA#0$[]#$9&IG.7J>('6G*0H65IK@M
MTWDPK+J?^J'NX=K^!J%W?S2-*.?X:X\KH)08JS%1R25CW'@395).":NE=65+
M)[&2B\W4'9:G@]MQPN"+9I(X\.Z(<2I#-$F=@8",4%(&*>5%X#.0Q4XFSKBT
M 8(U9@1!6.V]C8"JHV**9/BDA*:',@\\EGL['%QU=X\$@A1,TQ@5Q6Z\B@2+
M5;48F$&DQD6QY=%YJG61ZKOW;TW6)I@/>Y'%3<$1*T6$S<O"BXVV">B3H< 3
M5.D2>S:3->W^A#*<7JXOVS_YZ@KD?]LEJAK]VNT/AMWQMWE;=PBDEW\%^WOA
M'9_Q-5XZQ;X/*RX);HK+<)()Q#5$VJP]8=:H-,MLT)C+ <E8NGB/ZT=D[V2D
MNFEH+,'):=@2S3BTJ A!XRQFMTZ8AO[:!:H[6:G"!HC7J]IU/X%M[(TM>BR\
M#H5%OI&;'%04UL\6OX7PR-T3S.*P5JMWD<T2D0?EK]3\(G\R8<8<O(AW6,B;
ME<4AB*AXG82\C^<7^>/J"/S5/0CJ;U>=NR_/9ZL]2).99:R;!"?!@P#_ ?&M
MF6D2MF-MUVAR):<[D'LDGM=K5ZGLA7, -I24Q!C)W&Q9@YK-_58DVVGW03S#
M$[,JV5FCCWW2I(EKG3/L?PQ;QV6E9FE2V*3O+TCL)+?"_Q>D[$7MQDT: DS&
M(HA<",4H5S6UZ%>)9^6)I"KPSG;$+O5P>-5W[;J3Q^AMZUNK& "RA9 A\LHQ
M&*L@[!+*"R.CF;6P45DW#*'51>IE(U$/Y&"3X".IK\.9@-,= R.&F^F@!0A'
M>)F^I<P60>0#6< -JS^&#6Z/\QN+-2J ZYPQ0<O #75JJH  H6%Y#X&5(]S7
M$O0 RC=-U\3KB3%*X;E@/&9- .5/)UPP0T0Y?](TF?R^E-<C2F9>J?]I-KBP
MJ%'80@$FT.P395P!*T;'7!=/UPIP(M*BU,X4.9?MB3L42QLT(UW.46'88HB6
M.DK<':::49G3AK[WY?"10S'UKFI7W?I>_.YK@R0C-:, 50&K"LN])6+FG))6
MHF'J]!8K>X&@!U"^00,II,BEYSSZ3*(U43LY<TJ!)%=FMLJBG1TH[\ ^L?*D
M.GV=C:E=G7A=5XGJ81OF"D>B,25C!-H]DP[G38!SHKFPI:9];3?Z#L[;;8YC
MPZ^MK#"X*U79E/5PC"J:',X/P[HT ZC "9(CF(&GY6CJ4Q/6NF,:+Y+D)GAG
M80%Z6)*$1A,SIOX2H(<B'#]!WO8V!$Q_O7K[+MX90FLV)&O3M5G*: P*?!>)
M$L"L,=XJC;DP^ ]Q!3@YM- :2M8?Z ^D#0K<+&PNF4C#A4V <XV03@,*@,BR
MO @LBV34=G0=@I.U]VNBTCRY0#0S4F+NUD0;>0#<*ZE@!7Y1M,Q1/IP3V$ ?
MJ!$#NV%2"4>;.JF=-SJDC/,_E(_>E "&6M.P36ZFZN%<K-6&PP'.&J)7$V1R
MV>%1D A!N90T(/GR/BYI &(/YN)VJ/M^Q0Y1)D.I-* $+$P&I\\<_)7!2B&4
ME,@+MM5MN"BH>C@7ZW6!S7Z3IH3!4HC"YTB)RX9Q1BG$MF63(,NV,:E-;-2I
MP7W[\@)"3&!"V,O):^TE&,\\74 3XT7]?WE=_QX%.Q&W<1H@$4 <5O5G)X./
M@)]FV0'X7R4P: J5UA WC9F^K9J\M>9^,>>$TY (1*"2P$X.[^4L60I!D96%
M"Z04S;B@[.[UVY.UMB(DQ$RL T*P;,+ 'D.P]XO3GB=!RI@8-MFR9F@=6;/L
M\FTW+\QT]0;8T.OYCD;TG-*40M!2&1F9]A0V#1>BR."BF&G0=<.27B>Z$Q+R
MD\W@@K4M@S"&RPC.2 (RH@Q'!$4*SLF5TTO/4;A/-F4K>4\=(4J'J&1VQJ1L
MI$I:98==5@LG^I3"/?*\,6%PT)@'_A$O$:,%2\G 7A=42K%(C#SJ6GXN(PS!
M3;)@I>4B"6DE<\DFXT-.V(I--6V.YROD)W.8P7HG%$Z;UTE&JTR6CF>E*1/6
MZK*OU#D*]\D<9G99<4!X27@M,Q<N>&YI%HQ"D)OMTSC,)QE R%46A!$%@1F7
M> ;L?%+66*RY ^Q8MDAYR%I>'$W8GTY;N1[T.M5P-*URV#&DA*@^ <"5T5 )
M,-=P3ZQA6N!D26^+8D%!:'FS>1-)#R-_+99WTB8(($6B6G*1'5-4)LJ9(5F9
MLE\AL#4+S!Y._K1D;,>82&=&?; Y44MDA)T62V]5 B0GP/&+\D".-EQ8*(G8
ME<1U,H5U'(+!:ATJ)./" .RD&=8YQ<-05N1*&!-EFF$3B?WJS5485IWN&-Y9
M-RN^-?LW5^X&3T??@(>#(!\C^O7K?/EW[HTE^C+H?<$#I:5G[KE,O(KRJC\:
M#R>X !>Z3M_<=,?CJK-P-%+?\IK_S-OAX-.P=;/ITCG%FRDB*4&]3T1%YCR
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MJ^\F,LM%##RJW_3B9WF?B[7T/(3R>P?1]RK3'?9(5PH0A\I4*L\AE)I5IBM
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MUP#-B!0R,V$!H1& C29G%Y,N;AU1VK!1[$[D49@\;%L7 J Y85-T2[2D()?
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MIJX.X'_8 &EL@GH*BD^WHC2.0\]S5N =CJ#; ;L2V1J/!N..,1J:V$U2ZPX
MP'JO/[2&FF%T^SLC6R7%[,LX<IFP7PV[_"4\I:=H3\<&=D/+[/0-TQST,,T.
M=,!.KZV/)OWN;E6\1(!N.4>98/J4Q%%L^U/>HR1T_<AU3O8+[<F$W95P;0PG
MXPDVA =F,.E;O4YGT.]B_R/@#49OHUYS2\N5RB!P(3"_;OP?#V:S/S;:UFBB
M8_5X7YT,U+$.; &L_H%E#?6-2MY.Z2+_W%#>$U+;TR9[U.MT._W.H&>9DUZW
M-S#5CM'I6YAL/QCL#LA4 Z?R5:,#X+-/=>RT>Q: R.IVAP 9O3T8#CIFQ\2F
M4</QN+<M;+C1JJXI\#E.=5S#JA7'J:5;W=$(\U6'($<F5A>X7-\8:>H(%,K.
M3E.FHY>3GW#<T6H!S3V*N-75.F/+Z@"#ZIGMOFIU.X8%)LS Q'$+ZY6K!6@:
M]WHU6%@:-*/#E']6B?+80X';[O8,K6^9F*W;,:V1:JC=L6E-K)%1DO)8ZAE+
MA>[>+)TW@5;OJKHY@'_:;0VDBM5K]T8FB!5@!]WA1-OIG#HV0:F\$VX ]N%U
M2GE8?VNQ5N0+OBN"%SOP*;SM/%Y!<]P%C;*-XSO:IJJ:/1,;E7>';6 5PY%5
MY!4^B1)0+^_U=?=1V6>_#'#_WZG S?UXN*>5)WZVO[N+9/%:W' TT/O=P<0P
M#: "M3?J3?H=':C!G'2TE6Y4Z25HFSQ%7L+.2W#]UR\!+%:M@\.IU2Z@OM6S
M^KV1U37[1F\T&!N]SI9+V,+8:WD)FYZQ5?-"/8\=.^H:X]$$H#H&U-8FW8%E
MFL.>,3"''<L"+65+*?96S;@2$%P*T%58LI.Q@5G;XQ&.O\8A#MI0ZX]-8.QJ
MISOJ;K2TV6')-@G.:Z+Z"UO8KD]]ON#U )/$]K ?Z/9*_-=YSB'ERVU#PY9M
M7:W;4<U^?VQIPPDP]4ZO:VJ:-<0"T\YZ@>EY#U\[V)=6.@[LQ (@JUJW;^)H
M50O8>&_4'ZN385\U-..Z8+_;LMKU>JU"O-<Z6A?'J.K 78"5=_KFR+3T;F^H
MF?IP/,%2]&Z)L#_A\+6#?6EX;QB=45?M#<<C"ZS[07?0ZPS::/*/!J#3CX<U
M@SV>A,]S'5&S0VYF<2VN<,S,Q#T^<*8/K>[ [ TZ';UO&IIJ#4<]RQBJ(Q""
M%G"%5P)G1V]PXWCSP)NR,.+!\>-<JV,<J6P!.4W:([/=Z?;5H=8>]/LC$T<L
MZAM#+CI6>]-UN+&'8W>XMX?IR!Q/]/8 E+8^SE&W+&T\PH;PP_;8'(XW>DIW
M.MTW[_"4X3+'P;UM#+!_&D@/=6AV3;T_&HR& [6GMR>Z!;2U"7?M@%.=LN\S
M0:(9 [*&;1T(0-4'0W5@@!XU[K4[9E_O#>&_@\F6@9SJYMRT&[F6<X_&&EJ@
MU@Y'IM[6=4OO3-H#P\*KP=A91]L<:;>EO](U7TPU([%&ZE"=@&FG#@;8:-#H
M=OL= ?2N.>QN=(JZ4S?''C8'[/O$D-KM=H:6KFK6>&B.0-QK8UWO=KN6VNUK
M'7W3ONWTF@V)9C#L;MO4U9'1&1BH)PP[EMFS>L >AI8UF0S&&PUD[]1#])>K
MO)9S,VRKT[&PG^IDW.OC!*V!WH9_.OU.#Z.#@\UFMILI.M=\,=4P;&,\ 8M,
MZXP'8]74K7&O8QFJ.E M4&FP _L&/5B;_L[2H?XM9':4A"^T,DV""C,C#OLQ
MIK&U5[LU'P;:E=>]TG7":&O]SG@\TLR>J:$FH8^ZD_[$:&/CY<G.)@66>J\7
M$M0//6 Y0%F+6)0.%!4L$*,+&-2SVJ;:[O2PA]T(YP>/S*XZT7<&1KOW/:U$
MH' 3>)/8.GOL*FL,IBP6&V#W"1#-;7W0'_3U\:@[@O]L36(U-OC.EET<O<E]
MNH0V&&N&V3':(]72!L,A%N_Q38[;_<G*6(YLDQL=38_?9'H'YR&SE=HI7>T/
M.FV@,DRVT4=JK]_KC0:]P: ]Z8,A;VXYL9A-O_? Z8E./G@5I+1Z<$T?C?5^
MU^Q-QF9OK/;;(]TTQST=E$<#U)1MF:KK56.G''QWJN@>#5?O3WH35=/&'5/O
M#P=:;S#2C?%P,!BBSK31_U??**G:W,*Q&]Q'-MA.T$+:,:V!.0'I!C:@VM'5
ML8H#.-:+S8%)FQLFX+$;3.&,_.IG%L^WI=570CPKV<YCD%)C'5G V 0MUU([
M;4V?J&,3%-SNYI"$U 3;>^[-D[T=$I50TTJBXW@X-K0^V%[==A<8O#FQU$$?
M.T9U0<O9G(.HOAT2__!#Y@2/OOMO-OUF?Q\PG\W<]3%GKY+6J#<P+$OMHVBR
M3+,WL(#U]75CU.MAG<_F.*R-CLL[]G'25O<1F05&[:BC]>#_0/Y6I]?70(0:
M5K<[,3KCT>901'4#Q*=OE4_%AC]\9K[MQ2[5*J0:)9@R8;+.Q%^#O-73.H/A
M!(ZCC4UC:/1 U*I#HV^@BV^R:1_V-M+8W[#5RDZ\[P+-86^(K5C- :BT_1[6
M)H/Z9@RLB66U!]I&QD/O4%0KZ<3?YG;\6Y!XTX^+)>QW/)LQ!SO:PU>^ +\X
M,GQA=4U0[=HF.@-'_3ZFFQJCSK@[&1JF9FV(!*VS8?V?MLTJ#KJW.M!J=[N#
MH=E1>[TNL,!.O]U#LARV002 R-X\Z(9=]_:#KL7?>)[WR/42+"(EO:00K,O=
M/D>WTA^-^ZH!"I+9U_I@PHX,W;0ZXTE7&QL@[-L'E?><N-=*COM*_'#8;H."
M:$PZ6A>TK9%IC$!9IN-VAM90W5;,?K;C?IKM6N3H6^UW)A.SW^V-QW")FJY9
M/;!Z^(0/8%1;56%]TR=TY"Y+/>!K8S_&$U4=M<?#CCKHCGJ@IHX-,?VV/])[
MHZU&S@8_*O^ &\\,[,AUCKZ_@:498++UM)YI "5VAO"#F"HW:%O=;07*^N:0
MEJ/V6.+A7KD[K0/VF-DW1WH')[3"O[4)O[M>>]2SMM_=!HL]^G"./?_0GTYI
M+KKM%:+]GSW;']FQ_8U\;'"2@0>?[3Y6803W:&*: Q 30WTP:O?-,7D^T+>@
M6GVU_>[/_^W%/TW=)R6*7SSVIW<S6/)N9B]<[^7#-W?!(N47]JQ\"1:V_Q-]
M%H' ^*"VE_%/[_[[,?YI[7'/]=G=G,[]0=7:?_AI:4_QB'</01P'BP_&\OM/
MN.4[VW,?_0_(>-S9R\Z5\>_;=M8/7=M3?K'#,'A>?]@)O"#\\'_X9?"EOLV9
M,@L\+WA&0B9'9:0LP^#)G3+%S@ .V!#;KJ>$C#SD2AS NQ'. 4^Y^(!;^A%?
ME^[O1SAZ]5 HK)PNY+%9_*&=+N/Z4^#>]'OQU3[F*'O9R^-@B0M_SQ<F2"@.
M\SSQG3^] [L>?X] ^*>_'X\9S^XTGL./</*'()RR\ XNQ;.7$?N0_E \/QZF
ML*DP^PEU7=R*_Z=WUCL%[IK_K&;?_3&>YC^&6U<0N^=;,JT__+2R4/Z"K8NN
M/Z^^\?'>15^O7?;PW;.^_A5\ )9,<],$"G+"_&F%O#0@E2+M%'\7A%S\4T@T
MAW]Y=9L%@EXG@YR2K#<P0GR65@;Y%O#*_@\),(D0V0-?];WK*["$AXSMA[V,
M;?5.LN/H[_;#4E"^@)2Z_*[0/#PEY<P5P'H_?+&>@84E0IA^>^:\]B'PIGRQ
MKVP9D]_JO^W%\J?_ VK!3WJ[I:!&=028:X:F 6QD!O+SP]R=@JPY6F"[_IR%
M;KS]N0Q.$@U/04-Z]J^)STY'N).8Y8/M_/X8!L!7[H3.Y=#_+LM%-Y6I4N#;
M?WP,V2,Z:MRTFD1YHJ!%,%."@IDH=$7%CI4E[[S#_.DE"7_G-0G*(+5P@RSJ
M(<.V<]C_*@N<KV+P/K!6 #U"_LK!US$KA]\94*L$N0///82*XS$[_-,[/_#9
MNQ\S()P#NVY8?$LNM_ZL9&K'0$MM]R03*X.)G:;YG5^GKK<"R/)JS#<K@-E!
MM0M8-D?8,8U35EX!U[50=/.(MW;:R:V2H!"M'4ER)PO1'RFFLO7[,E9TIEB1
M48M8D7;A:,V1L289+WD]7O("_.&H8$G#!/$%@R6*C)&<U\ER6]B7Q4B.QC,9
M&GD-K&F:TYW-\YR4,.W$0@E*HA6+XKFS7<&2AGA<F^ =V\YF2^.J-4+LAK%;
MB9K'8:)T3%;#?K>X*F]"I3B3N_)Z8=DP?EL[^%7-60]&O:.]5>G/?_SQR 3U
M8L)^_\EV/?QT$H1?;8]]94X"Z."RZ)A\]O%D;&JF:O7[ZG!DMC7+T+IIK;PY
M'EGGSF?/W&IGS6?_C2ESYDV5>"6OW:6IK-1C7L'D3CO\G7&O793!&J-2,]L-
M1>C*CDO+:;>DGU+FM,N<=IG3+G/:FYQ,+-VT9]=C)?;)5/:SI1FF#4^4!^"3
MI5G^I69LU@-:VQEA+;(T:V)U;H<0IUQ+4[7J?:?7DC_2(/94.^EY:WQ)LJ%M
MSVK5U[1<"[.Y>2.2GJ5.5;XM&C\\!/[T&&7HX 31AB6 GDVD7PLQU8]N:B>@
MKY56Z%E=$H0TOX_ EV$0+M%YR:H3.:4"\Q9DT=5K? TBO^9*KVLA.R[6VI*X
MI#EU!,+\X_[KO6(_XH ?:4Q)8TH:4Y<61PVC%6E,26/J:'SI1Q&+[_"\;%K(
M<9/:70UDTM7K?0TBP^9*L6LANW+%V]73EK2I\-G5$!7CP]*K%7,-(RMI84D+
M2UI81[ 451)$&1;62AZN=F]N9.(>IK>HM2KW/4O^Y+<@A@?LM!;L;A:$=Y&]
M4J)4FI;TZBV5FAW6V"LI+Y?L[631\-:DY[.N3P?U370U/1<'OSP#KYW^)'GR
M)=-Y;YX%T[-5-8V5C':/_GQL+X$C&@,4^PC@L+SHTZSO. #S&##T,P#6>>'_
M/J:5@#'$OQNJ.C:U_K#3[UK&F+<2&/6U]L"X1"N!(A&^WEI >TMK 6VCM0#_
M$%=(J^PW])GU^EM$&+X%NA;L+_,Y9!'S8_I\+Q8= 9K+3 W\E(2(1B!5(SYU
MF4B8)@/.7-_V'5PM2J>:8\\%QTNFC+HRV!P]"2*VYRD+^Y\!(/7+7?#LP_-!
MR'OS!)Z'H:OD(7*GKAT"SK<4VY_2(Q$<U9T!2X+#N.@*=((%,(D7)0YM/P(,
MYEW&\=L+_JZY_<24!\9\A7GN K8(6[U7@ 18R'P'\#4.E'?/K/5.>1<D(?P'
M'X[@FYX=XCA$'Y:AUA'Q'.[R[XD=PEN]%UAA&82Q$O@*D.A"4=MW?U? <*.#
M_HM_"WN<PTDV+KRDJSAFIE9)KU3>$Q3>94=^]X,2(B@1BD,[!/R$Y?Z'V5X\
M;RD??>>>P(D3U@^^;"7Q/19%!$C!L. =-'\>, ?^&CZ[$;MO/AG-W A$*_5/
M14R)$)=$-\9U!!5?18Y- ,4[YC@)?.4H>K1#A@M2DY3\_1%NP,7>@RG2%MM"
M\G>N-(ILP95$2SX%VWNY@LLX!H8Y2UF&; D0G>)=('<+I_!MICR[\9Q 3!E@
M7PN-9@".X^_.W/8?F3(,%@LWBH!C*>_??1T/@99</XK#1' QN*9U=A.M\ANB
MK0*#=?T9RBA\G#Z;P@U[090@Y0@2FBH/+RDCQ@M?AK" N\39KX_,9R$P6?H<
M><M4H)CR#]_%W[XB""+8[%_Z_<^P6V1WQ(3=10%0(>T4UKY7<,0L!Q'?$_#]
M'4("H8Y[QV@.00]?D9-]0M!8V+\SA0%*+&@?Q.6C*%F(V1+QW(X5FV:S9]R?
M;R8_R5&D@NL[0L @K/P 7GNO]'GON/05"_L% #U#)C@+@X6@R72;F2"Z!W:H
M@(11@J7KPWY;),_L;,QXI/@,J#VRPQ<"K,U;$BT+F@/"[]A#Y+@J$ 6$'V @
M7"_ +D40>)AY$7L&WLHR49>A&=]IE#CSE>TB)T%!KG"]B, 5(JJ'!"L[!K2C
M0R.)QW3B(I)$B1='Z?%P]R0[X;V"+54EPI"?528>4VH0,TX01( TV<W"DO"5
M*:@OR#?3ZTQA0?B+V/0 Z/,=F6L&%F#6"=S!FL1 .%=UE*W])BH#'+&*$R19
MXMO)E'@38%]+L&  B_?24J)YD'A3!&;([*G@,?],?.*N.8M.%SB,'Z13L(D5
MD'IBNSYG+TC;?=]'UK"I&_YO?I&K=UBA?GA@RY 254.FO*N0;*O;>G9+[WZX
MW[R._9;Z8:;W%F.]:!/V_>G7W+)96^O(;H"ZUC9-4QL/M.Y0'XR-L3X:IM/M
MQVUS>&X3_O4>>/I;=#H]OU/&M*YFO,UD5^^5K58[4?_79+% ^0R?%:Y+R>]+
M22]L/Q9)!\CM& O2 2(=(-(!(AT@=;\,Z0"1#A#I )$.$.D D0X0Z0"1#I!;
M-UV_,&SDJTPR0BA8^5]Q5!<H^_O3<NNE]HGJ&:6?/,+J0H=%C-U_0F40P'\$
M;D_Z7P>HI('.P:8Y916TJ<?$%1K@W 5QZ48D$8C*07]Q%V!/ M\7%N;2@T,6
M=;$P037,IL0A9<ZFCZSP*=>F\A>X( ]04)"^@]($&4P2I8K.S WAF*DA2HJ7
M,"&T-FT ^ ]J>E,^[P>W"D(+]"\RCW]CQ%Y1F ,6P/<8SH:P:9>D:().!%H6
M"3!X,A+@0HX7'*=,-\ET2''H9SN$RP44Z@@4 KP06 ':'K_N;4A! IXK_].B
M0P2_A+?GL!#%"2AF*/S)31+-X1[N'FP.R\42H,I504 G!A@4O#!425=0(].:
M46T#K2]8P*OM[P)5-I:UGPG184$2E4[PZ,.),XTYNRH:%&6'.$0J0MU1/(?S
M1=!L1'R)6!Q[B#_]:3H/!B5Q7-P=; C;33-NX'/E.#T*V*&.S67S'-@3;H%V
M2KMS,*TU.W3A8/ Q/A$DJ9\ X>FY]H/KH3GA>& DD,\HLXML'(\")U"6Y*8&
MY9=QK8 4[]5+@7]FS$5E-DH-&I>\H#D-9$3$-;D<=@*:J>[.OCODV("[> !;
M:^;&T7XHXW;1!Y5:VLH#.A3!]K;1#8+XY---$&H ZQ:/4U4@WVRZ2?Z6%6-B
MOT6TLB''CN;*C&#F(EI%07%7G%T@# BMX1N%RWZ%&:G6ZCX+P,SV'#RY47HY
M*[>^G]ML!^DSP,M=H&6&A"Y>CI91M.>2R):&'QV7^>3>W@0Z;J1(:]^15 6;
M3E%>>0I >^18B1@KE,8])[17J&3'[N"AE<V1%<HIO"J-:0M#$NQ@RI:I+PO/
M%N$X*"09!P<+T6'P=OBI<@;2)"FP!1PD$UX0G8WC)$)J3@!["]D3\Y,5GH'8
MN4)-D<(!GY&&\-UPR9*NX$9K;!RY!,<@\;V91X) D'_D3EF8216NN< C@-B(
MJ-P23>4#_='CR[+4D96:-N2#GW$*?PR"*:%FQ,(G5[@Q';@.0.YP76(11\G%
M5B8\"@XLQ7Y !H^OX:Z%EC@3 !S=^H\\1@#F'1>B,86I4I#@1P4F!I9X1/P=
M*27=5#89$1@L]Y7@5XH!AW\FT\?<%.2')PZ^^H&-+4A6[H"_)XAX/ 25*KKR
MX('$/0J9Q)LAI["S37 ($1X1=-!##@#BVIC K(CA=$>/8QA_OW#MI@I9\20@
M!\-<# 9^BCZP "P3@>J(O;KB58P 6(!:2%Y%O*C@ <C*SH,L(#V! 6303Q68
MR F6+%5W<\ L\6"83T](-76;IO]MG[J&-^8BDJ4>2CCU8XA<6O# 5'?.'7@I
M2]A"\QE1%*_.Q;%GA;O+$3N*0;(L!$*N(S)^RV7/0&WHX2ZP!Z["H#<*""P.
MW8=$J"_TC9;@ <\%=1"9-ZI++L7=D.30QF'X4^SEE+]*Y;0K6(5\D'X 6!Z2
MWI)C$7Z=Q-^4Y8RBP!3)Z0A+(:U-,>JC]#W4]!YI=V2B<.B381(0Z8G04=%$
MR2&>0Q>>+SB\81$DA5BP4N)FQ%8XL%?4N&TPR^PQI-,8EZ-U@1T)=9^F4FW=
MRGX*V)EQ<5+^Q$H>!J@\/D!K&"P>7-Y28I2QVV,R+GJ6,=(&0VT\-H;M\:C3
M[QEJ.G]QH$Y&E\BX*#I>FI6!H6&  21AY&Z?PWOA[4GW&&WA,_P!A>471F;I
MBY)24[/%V2>,0 /?TGIIF!?9K",BA\B]TH,/;53!1HPME5\92(1O<]!Q'@(R
M3Y'M_Y+$8:K%??2C9"8,E!?E04 *(XGD5ML)2PPQHN;T,YO&8>"[CK+T'-(V
MJ[)K_JMSK](4K&UY.N4%B4@7Y1K>SL.#+N$G,QS4'6[+IRK+K;[9@*JL8X*R
MPAX#RN@ H;E@4]+\0-I/$[0G(N[@0:4I\6*R8N:4-^*06 >QZ3-/(),(74:*
MGX R$)"7<PH4$;[<><PF%>D!-) I?)V'*2-EB"'WEY;ROR!L010#JB)X6TH_
M?(23T:K_"Y+9#H. 7X2=,]U,40$U%5<EQ/]9'"!BI.K_7]"B@C">@80-R*/&
MO-E=X<JFV4G)/2*BK/'>&R]NP?7W5%J7=?G5!4)SVX)T$8X%9S@2<J_\+2D;
MJ^IM(B\MY8\BH0G0H47!=18YH"=R8QGS&?C7R3&(?!^59>XN\%FL #;XP0)X
MG/#K9,D$9'.'^_ F\S8NP/@B4R^#N=!E$?THAB <^V[F6R-W$BK)J,$3ZI'W
ME#T"'#!3*XSF[G+S#2 )[[;<<<%TX'X#[KA= '7C>(,7<9XI=RIZ2)MAP0N8
M1L)3A\(A)T<G=^&\(<L2'4[)^7A@CZZ/)\R1:$4@$@1G"8_HK'&-&$0@6B:5
M"2?CWCR'</)!&?<"5,M8N  L?H@YEB81XRY(L'\(R]"A@AC]$.#JY%[E9@Y9
MO=G7@#0 G6$': GQH$]I6N1EU*1O>;*ID$\@ZH0+C;MYP! - +<0S_),@P*N
M"+-T [-3Y0@H"#"Y,DS2N^E,Y,H0:9J$:;00"(,Q90'/S*/KRXD50F"-\=@+
M3(+[=QYSHLS5(@[<I7Z.U#%X4#@F*D8SWD!';VT@L0](&W84K3;!=+9?;2\A
M+M+G3M)^*CL11'\3,3MDY'U,[&/3AO,)I'K/"YP5[]\R07]6Q$18)!5VA["'
M7/!%E%CV HH#RC&/W,S$BB)T0?U3B-X\7P\5DF>6RV)</O=+VK#$"]8J9%EX
MA=V(L.?JKG>^)XM0/ ?A[UQ,+-V84O[HJH4[.,)@,;X.F*- _2( [$=@&?C5
MQHN*%3C#O::^7.QN@H(#A**+/XJH08+QP7\# 10##XD?/*![5#RS3(1#/9XG
ME.+*78$8D_P;>V*>HJ-^EN=B4B+I$U'>@B8]"\CBWO(\U<*W!/J]LM5GTG%1
M2: 4N(1"*CQ\F:86+$'#M)UYKAAFEMS"#G\'!%C:(?>\8A( :8PBNI"FNN9!
M&Y[>Z_.WH\H']B/WX (Z4VX !D,S-=IS9ZQ% 214#C'OV79^Y_YF@I8X*M\U
M+HM[!=S&U?B2Z/@%4T[@/^=G;'JGV!AU>639VOSK2<1=UH 8&*D7BO?JRPZ'
M:U7"RKK7,*"#N5W5RL,TBB2<\=AN".$0NM'O7((1,JP>G7O^$7HBC.7R;L?>
MVH6(N(*XC_0Z4(QRNX+X37F,H[/FJ>Q<C)', DQ<(;6*<">B@CQB%_$KM"QP
MRR[*6Z\@;VTN;Y$QIT\4V#'%[%-!M5,J?:@)Q MO6FD=E[F87=2Q^._%K0@W
M</'-*GXG6YA#W6&>)[[SIW?M=_1[M+2=]/?CHQS/[C2>?^A9]]V.:>A:NV?1
M#W](^X4!.GCV,F(?TA\VU+=\B\6.M5D/,6-KD^'#>][R#7;-/[S>I&QK(S7^
MO/JVQS7]K*^_^8;SZ]$/LNV17OBJ[T%M$T9D],/^&.;V9MKZ:X,>5OKL;?;+
MJP#6^^&+4I.%)4)XNZ%T6FQ)C@@Z&> ?]^IC^Z7:J;A=EU:R6\!?K_:Q-\^&
MZ=EAFMO#561@N7-W&2GOU6,X;^D@JQ& 2FN76]VQJYG>T.JJ6EEGO\(.M%(
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M!GBJEKAG8(/5U"1P^;Q%)%>#N-ONYB3)>T%Y5,U%E)987@(QE*+R7"YA?3N
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M N#*!$C%7;ZV^T/^@CWM7$?Y&B0ABESE5S@63D"B1K+#7[\J_T-]T@%!PJ4
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M=!U(3."]8-?@_A#+!8.A:37IRI'M(6<6XY >7O)#I5.?^??23/*73._"%O3
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M!6QOFX$%[I2I',6(3)@=ZU,NX=*S_4AY[V"2L/#9\C+U BO\C-]9888I@WL
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M^KZ0A_)#GHBR-?7$CJO.+#D )V\VD40MIS&@T;EH)HGZUKZ$E^TK* \O#]^
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MLB^ 0VKSH4T(RF6R6/+/^9L7]I05U!5A:CX@9V$1+A(E'IJ0J[9PX7<PH-T
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M2]WN'XY5BE:>5]_VN/;&YX]\_.9+L.1<^#7XEC[VEG[;:%]0T#2'*P+L4R;
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M,"3N,!.\6&+=?!)83P2.D@56(?V;\:J%M )@NA;D1/W$"Y"S(42*"?\Y$11
M]A#@EDBD4^52R$7_6NWZ!CG:<6G9PJ^;#C(Y>"WT9962'&SHETT.[ESV]9=]
MNRDSH\\9'I&9T9?)C#Y&_Y&]O/&Y:B?V7#T:'J.ERO2Z4X [WJ)X7I*6FYQ^
M7W74_LKS\;>#3VVW=+V\L/U-)^DWB.W53BI+3B<+C=X"+>!C757RL0N63%20
M1EAKU6ZXZN8[Q0(Y+BN[')A>,"M[IP;2;I\M<?!::+1YY%@[E>-6R3#3^WL5
MU4=<+]4=E)5[MHTU(S)74L#-C0I1O*Q-%'/I$8S ;>O<EV6I1/:"^BNE'5?=
M*$H8;U@EVBE2>Q]*?4%G#947I]U&TS4+34G3-HI;^DUI*_VF]F/69K;D84F/
MQ3S)OP3!]-GUO+X__>C'MO_HPI;[4<1.39<T!OU.OS/J=JW!L#OH='75&(ET
MR;9J# R9+KDOX\2X5](;(9S^1/B5WXS"KV8#+RZ\[<TDB)O,%TJO[@KX[OZ,
M"">O^XXW4XB053^F6/R 75L?J2H5$1J?P,H+F=-PN9P&52LGJ<&X;%S_PJ^_
MZ-O5]BT?_KROEQD=,J/C'*'TSW,;9(S#$@)!6<:U=-5(1%M[]F<VE1@F,>R<
MR6G?4.<_P4_6]*R@BNI\96].&3*_<,A<:_7T7N40NXF(>8-86^TDKV1CDHV]
M!5I&2[-DEV')QB0;JP\;VVY"2+[V)O!U6YJF2D97!J.[>8?P2K"3]Y$*<9ZW
MSRCVMTQ"9XYCJ'BS&-[GY/5N"3?49[TT0KP6DJH?]=1.1;AJ@M!;JKG9S482
MA22*VR2*[3H<4DEI/MYKH9(KBA94H:9-@A#0R,_;^\6A[4>>: ::JV9Y"FT5
MY/=:W.NJYG>HY=E9IX+M6HB[,@!)V2F)=[LFVKXX;DKBE<0KB;<4C=F0HKA.
M==WWYOZ,)SFEYRQ3>EZ[AD-C3$V%>56S>O; ]2IC2EJK9U;$8+?!\B:"2Y<A
MY0H9:NU4)\DI):<\?_3=Z%B24TI.*3FEY)224^YOZ&2HY2662U:Y9KL?WWEF
M7_N TW=7:HF_6E$;!-=W0H:93*+1@:B<RSH:9%T.W$C,YH(7%69F*)_MV,4O
M?F$.<O<799!$+I^>E$_?*_3\".%[CSYLBSHE.('OXUB(P,\F+!VV8F$SA1XS
M-,OB.PZ:P"8XS&<S%P=T8;>:=!I9].*S\!$GM=# IY@]8LTOMH& 9Q_$FUIB
M)3>BCYZ#\/=9$#I,S-W<N/8C,#Z[R,K&JJ39:C@3S(U?^,":%<@\PD( ;(*+
MSYX5!_ M6+"PO$DGS>YR<FA/FJ8W/8GRKB=9GZ?LS#:=&;N;.)X=R2DM1=!?
MH*.)44I'DS./"MEX_,)38BY[>.N6#]_LF^]=94.5VIGC^78OT6:@?DT%2IAX
MTQ!4E+U]KJTAQE_"(#I893[_]G+MOBQ/C.3?DBA>P[J^XR2+A":AUY<T^HL
M[NS?Q"XE<4CB.!?>_<+V3XF0\N+:2*)N9'"XDGHFK/N-_L"F=TH?@&0_,N4+
M6]BNCRZ\(IM6/L/%!%/E_?]C=GBX'BLKBXYE E,V ^C'[,YS9ZS@+HWV.T=/
ME01G!'7S^45]\+)V@),8)S%.8EPC %<;8#4-XR3@3@'<S?N'N6+W^0N!#O\9
MM;""?,IPJM%I1>.EPZX>D-JN$Y>6%E@=',Z3U]>1/8^D!^3B;1$EJV@ J^"H
M8FFJ5AJN2)XA>8;D&5?,,Z1ZT?P 0K-82?W@=W:B^^7'?J6&]&%NB:MN&L&3
MTW%ZCN+N#J^<XGE\M7%,F3ZAPR%=![PN3YC<=J/L"[L=K[<P5Q+Q1:Q(2<V2
MFB4U2Y$LB5B:@S4&W-79@9?'O;1<MPOK7!P/#TX>N4R.2*U@)?%*XI7$*XE7
M38&5Q"L)JWIDL=53H3U+5'4DRQCJ2M8UPLK: 4YBG,0XB7&- %QM@-4TC).
M.YL">$UZ'CT[%(T<E9#Q^7?1W%W*F<2[M&"]U6V;99'FK<1/;IW3W!R5J*VV
M(2<72RJ15+)_4E#'+*VINZ22FZ&2FL'G_-)%ES[><E*HLYIE4;^L^/:"1;S]
M^]*.L4%^%=S[NL=K=GKEC2B\]OF9#:+%VHD!26Y<BU(U26Z2W"2YG6EXM%6:
M^TN2FR2WQ@/NVJR?JS-R1NR)><&23968.7,?T.7QY:0638<+@,L.FCB7B[=C
M5#2\]88+36I7/E\[N2"I<"4<65Z81=*@I$%)@R=)0KU=G@M"4J&DPJN$W_GI
M\F"BE'UXWF!?\3X\L@O/F8)+K;;9KMR-(JO^9>N.IGG*FT7':JO3-B0=2SJ6
M=-QH.C9:1HDN&$G';S!I:A04JATI7PM@KRW:M@IZ[=[<;ZA?M36Y_0*X>4FQ
MNH)9J=A1Q(Y*3BSS&DJ79#6#>6D-U ^'ZYG!>"YC757+:]'W*BREEE 9*=^2
MVB\YI>24S7:'2$XI.:7DE))37B.G-%IFN[SZ(LDIZ\0I)3.\:E_2:1VA?XSM
M!X]M_7[AY\*Y/-=G=VF?1:W]AW7(60"GPMG_F42Q.WO9B4"%E5?NJ)TN@R-X
M?/Y[\=5^$"YL;^4:5?Q.MC"=2W&8YXGO_.E=^QW]#I?FI+]O ?PW=\$BY1?V
MK'P)%O8&ZC^[TW@./\+)!=H!'GCV,F(?TA]^6N=&^::*KKL<?[2M@8?#O7]\
M3X;^A]<Q="M5B3.]\7'CHJ_7+GOXWBT?_KPWWY#"D]J)T'R[:KT3:QU@^"PL
M.Y/LKXG/<KCI[9:BM=6#==V&(%UU=A>M/&5.$%(?MP\)R.40)3)?];WK*["$
MARW>?C@%*5]M9WG^E--+8.E?PB#:'W@ZYVX^9B&QLE1UR8<ERJ\]VW><9)%X
M=LRFM4'\_B* &_DWL3J)^A+U*T*S7UA<&Y0_GM?+_E?'>6@^[IXF+*<<7-R'
M6!^\K!W@),9)C),85W_ E9 D6K-:SBI*"C]^_D*@Q7]&HC4EM:D\J6]+Z2I_
MC2!56E2]NF.7'5OCF96EI57>2@Q;BBS)"*Z0$7!$L#15*PT3)$>0'$%RA,9R
M!*D:G-$+>-4%:?0LKS]S=SL&3[&994%U^=0JBZ<OZ(6YWAQ_2;/GT+DE\4KB
ME<0K!6YS:+8AZ8;K))G6!71AG?J0YVLQI,N$BFH%*XE7$J\D7DF\:@2L9-[9
M<7EG(YEU5E<66".LK!W@),9)C),85W_ -<16K3B2,TPBV"<+E9!Y5#82S=UE
M)>&;-T>.+^ 74EN]3FF-;*_%R5,_&JD78[EVHNAU2FNU(TE"DL15D$2O)TE"
M>CN.P)AO6?J^2.57?'O!X!=,YE_:,?./:N1\F9C>I<G.;)=&=G+L=GU(K[FR
MZZJH2^W)H?:2NB1U54-=NEK]I*MKH2[IJL-G1^R)><&23968.7,?;OKQY:3:
MS^LVQ53IL)/>">F=*(J:\J8(2)*0)'$-)-$Y? [VK9"$+(A[BSOO O.^SSF@
ML-;9^WI+[U4T4>P(L-Y$@G_-IV;*HAW)%@K)&T9YR1N2+4BV(-G"=;"%GE9>
M8$.RA=)-"CG]^97""#G]N3E]@FYF,)^PQ RS-,>*G,-W04*])25*\D')!QMC
M>DH^*/F@Y(.2#S:$#_8LR0<K,ZIW3\$]V\8*0'MMQ*ZQ/&K$[I$X1P\+'TMZ
MXV0LSS$2YX3,CO"'W3$ZQ8V49>@N[!#>HDP3IL2! C:V\MF.709[^<(<9-DO
MRB")X*A1I-C.OQ(W<K%L\E[A5KE=F,"E!+--^UQYMB-E Z0E'?:_5-U,YQE6
M]0Y*.:ON &VU\@/,@I N-IZ'C"D+>& >*<R?LNK.]94M8[9X8&$NF'>.\FS"
M/<'&-_EZ26NWE)!%2^;$[A/S7NZ5,?")!8[9@Q/YR4$TEMYPR!8V=JD-\6LS
M-P*94B5(K,KN$E U2![GE:VOM;5-OTU9BP-CM?%./%!VHP_5\0[#,*KF':WJ
M=F]V]";O7J^<;U>X>\.TJM]]I7+3T"J'__U^#57\_,<?D^CNT;:7'_X2!--G
MV%+?G^9#&OO$H$? BKT@2D+V#13"@1<XO__Y/__CC^F3'WTG6+!O]O<MWP/-
MW4<M\@N;_>G=9(1<]^_JW[^-WBGN%/Y@._'=I-TS0+ :774T'DXF@W;?&@SZ
M^GC4';>!1^CO_KRFN1:!\LU=@"[X"WM6O@0+>[=5?H3B:[VJ^.IO47SU_+H8
MT[J:(3[$%3[X0;BPO<U TOI<;%3W^1:Z]PJ'OP(7\$KJ6NVU_XF7.''"&YN@
M]A\D(2CYP1-H[: [H)K@\K/&>%844[:R9"&.*K4?&6H-RY#!9PK81#Z<)E+>
MIXV>M?9/;#;C:@H^K@ D6?:A^M,/BAVRU(YPYH#_C+;@XA14G[:$N@PPA7_<
M?[V'L\+CRN:*$6I#B1?#RY59&"SH" ^I!;)PO],24R 4V"@8-*!F1OLIM?:7
M-DI"/*U4T6NLHN/E;")KI<:M;MQK*7$V\D;T[KU>]0'6C2=T?P";S]P?>^ZM
MX/)P%TL0I,C^KHJQ]&/)/0Y<_*^)S\YWE);RS)2Y7:5^K+:;[1@SU&[E!P!Z
M3_P0E,)''[XW)?;PP'PV<^-H&V.1Q%1'8E(>;,_V'=(V'2^95G=/_Z5U.LVF
M*JU3N>%_!%6A6F7'BCM3\J\#:PP2;PK<$>2U[6>B>9<HO]\$EI31DJTT04;W
MJI=PE3*37J]Z)^(JN[ =)TR I:3QCJ7]LL!0)0^*,/ARS!N*,=_V8I><"1Z%
M4D#1W\.4GN>N,\?[SKZ1V@Y[G"?B&TX 9KH?,2Q.\"D$3R\D_P9N+L+=I>X4
MTB/ ,LE$%OI,'L, @ZN+(,%O/S!X$[*^EY5-TKGPVT+(345PEX4A_5STZJ0]
M,A3/M1]<SR5([-^NV) 2S1F+HZ8SU8\Q!F'0" Q\^\%[498 80J8D<!!V" D
M4,X\ *B%NRH%$;^)O7),>7;CN?BZ#\=35"WUV@BSTD:DY9"'A?![Y/;ZR+UA
MGO*%/3$?OOJ5A4\N !ZPB]\9O :]0782SX.0%FCEVX]8''LLQ7D[F;IXTBAA
M)%DQ&AA%Z:?LNQN1&VWW*009L>]+-\S"BXBY2<SW[;D+-^;NQ'OE-_BFB$UF
M< 09['/'(5%+NL\<H*> T$4JB)\9\RMC7O]F85 IU[7A4''NB@  5<:'J\^!
M: &* ->)4/%"'W'&7O&D*>=MN+,$L'OF>JS 2H&BXB3T,]9)!#QC4Q;"NO],
M0C>:N@[21DMYLD,W2**B:[OX!='G,OT6,G@XV>I7@+Z (&#]9P0VJ&[\.1!*
MR/6CY.&?( >)LQ#5/[QLX10DI$3<_P5D3@0:4MM*H^F<_R<@, !@A6\U_^(0
M0C9H V'\0A"BVP,^!8@)./H8,LXRD>,H0_CR)"&1/@S"I0@(*>_?Y1^\^R%5
M">8VLB+@0Y3ZA)(6X#Z B\!+'[G.[R[(4)\N=QB I>*_W"O_H 0,\N9OVT6K
MN /@=,$# "O543!Y8^$#T!2.)HK#PMA&_,.8S/<EQ08YV<7 >2.;<$?(_25@
M5XBK8,A$W"]HR&TE6KK^73";(>WF+^<^C?2-KL/A -R:N4^89U=QYE;UR0L5
M9VX96O4'D,9A78W#-<,$Y6"THIMS;4XD:!VE?!^9=[ O>V UR^ )I#29)!_]
M$7N(^_[T9SO\G5%6[1CX6_SRE8%\(%$"'PXY[\'6S<#D=V8R')"A,#+[NM4S
MNEU#&W?'/:T_&JMIAH(UTKHR0V%?AH)YK_2?;-?#:[H#H7#WU?;0<$BOZLU(
M7O)^2S,>VY?2)UPB%:3:148@8'NE $^U U0[' ](',0GIFN"8%ZYIPCO*;7;
M'7@_?0MT+]L-01GT$G:D50Y;FS,P6O$1GE^("J";$_;.+:^]UH[W#Y4KE99V
M4>E* 4UVUZB0^/SWXJL%&A:K153\3K8P/['#/$]\YT_OVN_H]VAI.^GOQ_.7
M9W<:S^%'.+FHMP"<\>QEQ#ZD/_RT7C^1;ZK8!B"KP;"V]H0XO)$ WY)I_>'U
M(H^M]2;B2&]\O'?1UVN7/7SWK*^_^8; Z\(F01L+V0-?]3VR/:Z+1S_L5Y].
MG"3W2M^3"F"]'[Z84\/"$B&\(=]7K01EIT8M.X[B<]7.,;QZ[#O&A),#>$X!
M[C?T0R?AB_( ?+*TKCDGU4!7V[Z_&D987D'T:QAW:!?ARY4Z;X=0F@JN:L?P
MP--@=2VUS0UB3[63GK?&ER0;VO9LB:T-KYW9W+P1R5-#5LJ1'@)_*J<_GU&D
M7PLQU8]N:B>@KY56>&V3) AI?A^!+VFJ":M.Y%S+N$!I7DKSLD'2ZUK(CHNU
MMB0N:4X=@3"4\&H_,M]YD<:4-*:D,75I<=0P6I'&E#2FCL872D6]P_-BH=WN
M/$BIW4FC2AI5391BUT)VY8JWJZ<M:5/ALZLA*D:%&16+N8:1E;2PI(4E+:PC
M6$IIXZ*OA2 J&M4HY\/OX,UB6L1F>=1)<NV-MU1J=EACK^2,,W[>DFW6A.$_
MY[.N3P?U30P+.A<'OSP#KYW^)'GR)=-Y;YX%T[.=B@:=2T:[1W^64]G6'M[6
MD,Y7_IIX+U301CV=//=?B2CRQVX]6VOVJ4%/R.#K\"^?-S"$76,CM4?;]:E]
MFT>M Z^J30SOIL*;(FX<&3_",[.(@\5=8#LZ>D&%4#AO<YE[Y;8F0N#DAI:X
M\".N&SX"0IH"<_6#N-"Y$SMG4O.=NWAN^W=P),R\#%^HE; ;4I^,XWOL5-,[
MI]B?YV?7QS9N+Q]%/[W36NUH_>&X/^IWA[K54<V1;IG]4=9J1^OV9:N=L[2N
MN9B8 0SQ&>\*1^WNJ*%I/K>3VH96QD&Z:N4#2X)GGX71W%WF'7]=7_'M)_=_
M@'7 @:><=^;][SJME<Z^4_AQRMB"A"W</))4&'B>2YUTQ)($.KO8,:?*!IZJ
M6GDG946T:RVBPO0*VJ=C"\,=E\B;*Q<N6X @6*:$P.6K&T[O>.O(G0O-@6M0
M$\>8]V4&-JG8LSAM\_@<W&$?39S7Z8(Y$:&P$<LC!X>U[G.1>C.RO94WKWP=
MQAF(09;S;EI)VCC9#>E;/C4_9=^!O[@1$Q\L$Y#\B)+I@(!=RX=L"?^%1?"O
M59U8[53/_F9%7B?8%+86>\&#G8%5M2N?VBG:)R/A+CBI9L?:])>4=7/MRCEP
MP[OL_F,)%\&)T[&+#'0[;2)E\JEIF\@95SA*Y^PD^, <&Z0!:,L@3@.:I5X4
M.6BDV&C6%/H$8H=>WAQ4C#,XL4U_PS'JVYQK9;X#9U]!J<+TR-=U-2[F]PY<
M+@<L&TV/&M[8<&&'CZ[/-VDG<9#^@0<KZ"\5]#XT2NE]V#UO_[V-YH-O;1\H
MV_\=Y=R7[?_6X'NF]G]?<N[[RRKW39U4)\0+9$7#YK,#(=?!P$1?<RVZ+<KH
M:AG-DAH3.U55JW)XW5IH]#:E-3W["XOS(?)V'(?N0\(U63!_#M#J3Q'C,G-7
M9N[>NB:!=+=,0C"A^=2Q"Y':515PO5?;U==P;6+5L9"Y+.(=;'B5D'I_%@OL
MPC7.4W3#I;,<#W&#";E:])E70MD5W,3%";RBO,'=T)%4?D#6I2RO.=114_ ?
M5#>RX;7;N34GP_:KJ"JG^^8RNK>#5]4N#M];\V+L3O!N5+SQHZ]\<N( .6.6
MALWG:4\K#4F?)6=B1_PYC2R_\%01QX[FZ? Z4!H3+Q:S*I/P]<0ZUZ=9UI2\
M%%0&K9Y5=0#_V-S? _)RBVF\O[#GON/@!'F U.<P\.%'AR;_1I^!4S@O_-_'
MY/1V1]:@U^[K@Z'9&?7Z74,=B)S>T: SMK1SY_2VUV3[ZW,:M;?0L[9QC_S#
M$W-\OS#$+F7B^J RX1OSZU*^QDA'X2MM#.O%ZE+FUD\>877!VY"A[3^A,@C@
M/\I[_.:[2?_KX-T/BAM%"9OF*8)V_MPCEJN@BLFY!PV[C7G.(LZM7BS#X(GG
MNT3PBX<CK M/AXF',RA)FBIS-GUDA4_Y(.K\!< JE0>FL-F,#]BE0=A)EAHS
M<T,XYK\2.\0$3#".LU1?K4T; (D'7-">BD1/V"IPE(4; [.C$9HTC9./08?O
M,;24[3C-R<0B 2?FF2CP9"3 A?F%R"5WY.7,,E#3\/<#:@SJB4,_VR%<+D^:
M)A0"O!!8H=@+?MW;D"*>@^7!TW:F(L\X^U)QC+E-0Y,ILS.:PSW</=@<EHLE
M0)4G 6$F&6!0\,)$"53^FI#1%'; )$ 1E^8>\\GHA"H;R]K/A.BPX,-* KA
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M _B[XGB7K@ZXUNZ_LA2(GLVJ4,K /YFRNQ?6G^<VJ%H.2P@*ER1JF8USLS5
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MXCXB%(YS!XN;.VB82@H=6_U":_V,;HT+'8U.C5\>JSSSC4,77>59DWJ[>S\
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M.?.-N/6[G7O_]/<?WXG[.._%?__T_P%02P,$%     @ Y8)G2]N&P)M*$
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M'B!WM]PN(Z'N[OJJU;BG[8>6\RUUN6_\9GU%JNZ)QYE' VK4-CE-R)F1E-]
M!1"!!"121"^+>C R?Z(!_.=?C:ON([R]8H5>M["54-_K9M5-$C=0.$:12*ML
MQ&.ES2JS9V)3HC>ZNGO8>FP)QZBV<UT/W+F=W;-M9]?WG.;M='_&5/R*@XA\
M(5@WG\F;RQ)J%W8G%[:]:8V##!#*(S6=ANSB[>!<2J+B9?ALJ3PI"O7=Z\,:
M ES>[)=5C 6O4;5[M+=M'"]Q ;23NZ'/%1EEDDV"Z:9!J@_2NX,HTRG>/VSF
M2&ZE=3Z06R@]5U/NY]C])N'7-\;[DH@G/5)>,XB?\H8\D6!_'5[W!NH5>N9"
M]KO4,Q?3#*M+8I6'L#DH,IJCO.HHUAWM&.W1_H];)\Y:OEK2X8)PIQ8]2VJQ
MU!D:F#FD1W*NF50BJI8XV&3=>8/M,9CIJ: <3L,IJ+NL4 K+/7KNV>*ZC:+&
M+PS8&CL[3'4E%0WU2G8N";OA;/A(1'C;#Y*3$3HCNU4C/97B0NE[%UP(_JPG
M/FN@_A6T*72>Q=!K=Y[<V:],.S2;)VH-VPK40#D=3=IHM$1&S;C 5-&M+Z9M
M7#'$+D=P1]@]6X2U<]Z\^/H+Y_XS#8*T9UV#)6Q(H1GB25!9=@IQG'&W>V")
MNREDKD--49,YVI:IK(7KAN3*N,X1MGL ?W68;'RT+N)A^M156O)B<D_TFR'T
MH/5 AGH,6S/WE>HL](N%M*V<7^2?^,HD^A,T500EFFP=QTWB_)U7\Y9E%16Z
MR$)R5MU%%FYOO<)&5K7DJR2:,Q'K'E@2L7+\-B\OBX]]/>*7\ASE1=S9U@=+
MMA5+(R/>S':NFT"Y(-P#W@?+TPMY'AJ?$U5; BA+6$54=U\ZMO0ELR[P6+0N
M\#B[+K"E=3WK3*^P;-0]MB2OM4C>]N)"1JHE)K6PW6G*L25-J4EV\_*6>^(3
M$FJSOW*(9$S!72@UA*2.@&'E%Y2*@=P[.?N6<7F*B69!48:ZI6K:PI<CR,.)
MO&:%)2L.T:]0LWO9?]\RLRSA#&@G40115J9\,Y.T0H[J)M;5@0N]8"&*E_*"
MAF?AA3Q4"]EEX=R[.ON6*%V*S";&9+W%Y:E('P;2C]J$XX!/"'D@3T3$'P@H
MRUP1D'NN9(_).<SXT9T$%66P6ZZF37SNP4!$U>2>!'I'^I$72ESR.A'Z==5P
M3[?L W6QG^C7HL9JH40O?0J[E*31KJG#>P%S^5=T2,D]JEOV-ZI&9;VD^LL'
MWU2G0F>TY(YEG#%_4'.J9/Q=IE((4U6WGFGELGYF616XT$<6-KU+,9S5L^77
M1D/5Q+(<G'OYQYY8ENGOS<LLDWWW&D]^6R3=ZSE'EMPQ 6GH4]Z+31AOEZY^
M+*0&LGOF?730/2Q!'N1O\8;O]G2'@^6Z0:\$4B&+"VFYE<6&KY<L-O0]! D6
MD=?HF<70A:0NI+=64I.*MGW3171RY4[P 56O07?9"@I)7\A7K:2G%^/ZMMR[
MN*^6K"Z5=R]['EFR4RMS#4Q&]3/X%QBD]2L7")/5$E*[M#LIM1W^,$!M@X3R
M4(UGHG;>4@[-/>+93G L8VJ;P%A;//?9#]\W5>'@$U8X6P)^4-S[?CLV9R/6
MPG&M&@O]8'$FLM0/9CXVDJF M [Y%6:C!DKTV+J,E< @R)'U*#"4\$Q[?6,^
M$7<!7K_/5*BRT&D6TZ5R3A,$,]Z!\FH@HP=2(X*,,EO/64)COM&ROG]'A$EW
MS'N- >(;:/2JSK2*%H7^=5S?OV9<*C<JY51+WD]DE-MZW2I>9U:"J:??*?I^
M3E=.B4*?.UJ_STTUV[I<59=[Y H']D)7+_HGN9AH,/"+9W"E-?M:S=H+G6QQ
M<:F4DQEUEI=-5-(+$J9]M5MJM;:>-6VDBNL1+@SWFH3MP/1REANZ,#'B 8R!
M\NK/B*I))5)F)=T+$K;GZ/,@?T<Q3*-;/SM=?.YY41B9X&6.\5M>[W[#9:VH
MOI8*W8.K[7%9&]<SIYAU#,YID3R^8'OE/-K1JC3TE6"+'*ZT>N5&*J39OG*U
M0/-VU6JNI6M$0)N\._K9GFJV\_-_'?E^[KQ(_Q2/QY0-N+Z47&",Q]J;:_H2
M">(/*N ^S!5@#G'64B(B+<.AAT=_G/=VC[]R1:0?@2X2#-GK]CY\(6&?B!9B
M."1GK8(R-# ?FDV19015415I-7X1/!J?M5[Z(J"G5)&PA108<=9BG+$H//5Y
MB"F[AAO:MA:*"XZ)H-Q_- 7]2"0["YTJ-IT<?$@U!EU/%NQ9=G_S;-G;/>H=
MS;?^WMZ<146E-L^N_=WN\<F"Q@=S=A65VD2[#GH+"A\OF.4LM'E6'>SN'WV8
MU_A@WJRB4N]F5V9'MJV06ZS6JR1ZD\%$C$?RHBX"N)<954ED!0M5"K.RD2$7
MBO[7E,/,YSKIQ!Z$16D,$?$"DL?-\Z&)D95$ZA@97PDY@U1)3.9-[,=?M@/[
M2)^JNH9?1)(R(B4DV'W(-N8V(L NRA09QC@SYM<1W+1&6-9U+W]]B%^(/]M7
M%R]OW* 3?UH4_$Y_,)J:=RA+_2%[^1GK5S2KR9W@0$HX9UA5J0VT._V*JOX&
M%H6TUD!<!EA*.J#$QQ*G3SM,YHVO([J1+:"OZT?\D_YX_D)EWDK[[7*6^.K4
MIZ&>?W.C^FSWU&OJ;/@&)GTR;><P*BNP<03!_"O^^ 87J=ZSCN@JL'G6.#Z,
M=I[(9(:5*UL_.JSF?JE)5R]$>%1J'>Z,Z.W ; 9=LW\3++*>5%RLOB&IFJN:
MDH[;5R]4I6\;N<Q';U>!OTJ4OKZ[_P0IAT]"++Y+G%@QVZ<*RKQ[<GW-0#4&
M8<9+SDJG\3<SP%'@/8BB3"K,E-LF2( A38)!F0_N1AAZND<B\\'E!QY!WV'#
M7Z%\)')&5I!X_]ZEEYVSK,&;G'N>B'#PE2@^N&8R,@];Z:]B/ $NR;I<9:E7
MI-<3Q*_-[Q?\0L,H_%>$!3 63.[P1-]/[5Q^^Z\RL'R!Q@'7FQU)YB]N7$3^
MBI^H;=9BN?[NPQYX_5APCQ ?O.U%/V^LUZ+U*ZD&@H=2+T[W]<ZL-W-..K&G
MGNRF.5_6%#/O :'):T!\ ET4K- F05\E87QTDXLQ#(<CN,$':5$)-7JY_K=.
MP%J. EZ2(*SL)I%V6 @)@ON1IRZQ(D.N1\<OF$4#K!]W)7YF=\G"]1W!K&@0
MX;+*,7PNZ[>W8\JI?X.?9425G.V[2^YMW-AS!Q)P/PE?DW1M:-:8HD+O/BHE
MD8H/EBP)3 TI+/<NL;L6<S/9UAQA]GOOSQ/,]CPZQL$ECV"@R^58UCOOU>&G
MZL;1RH0G',!(BY\P-3K!-%A?D?I#:.8U&NE",F5/,!(G'Y-*;5L59M-"X%*?
MC$?P;-'-/C86EMH /^7_(1")]+SZEEUG7&3O_X3\1"<N.8O*EM\T*C.3LVRB
MGH_7%O_+#+C92U\O#6RR$&,^[9CW[N)B&Y<$3-=9P&$AV&MF9HUREG@[>^*#
M'](;@2X??_@?4$L#!!0    ( .6"9TOTUAE>4!T  *H_ 0 4    8V%H+3(P
M,3<P.3,P7V-A;"YX;6SM?5MS&SF2[OO\"A_O,]JXHVIB>C9LV9YQA+OE8\G;
M^U:!JU1G*%);5;2M_?4G421E72BRR*H"*4]'.&2*PB7Q(3.1"202?_O/[U>3
M%U]]59>SZ:\OR2_XY0L_M3-73B]^??GE#+T^._GPX>5__OTO?_L_"/WWF\\?
M7[R=V?F5GS8O3BJO&^]>?"N;RQ=_.%__ZT6H9E<O_IA5_RJ_:H06E5ZT'R;E
M]%]_C3^,KOV+[W7YU]I>^BO]<69UT_9]V337?WWUZMNW;[]\-]7DEUEU\8IB
MS%[=UGJR1/P-K8JA^!4B%#'RR_?:O7P!(YS6;=\=.ED5__ZH_#?6EB9YGK]J
M_WI;M"[7%81FR:O__NWC63M.5$[K1D^M?_GWO[QXL8"CFDW\9Q]>Q/^_?/YP
MKQ&K*Y@#/?G%SJY>Q0*O7MO_F9=U&<&JH>NVA<O*AU]?6GT)@R8*YPS'(?_'
MNJ+-S;7_]65=7EU/8)"OAJ#BSN>WOM'E9!>ZGJX\ J5OYG4Y]75],KLR4*K]
M[ER;B=^%XNV-C$#Y[[JJH*NO?G>$GZHZ%)5?H=$X_/>SZDQ/_)FW\PIZWH[I
MUHJC4QAETLTG_C0\7:8CX$/V,?JXN_%\Q^H#4?M&UV5]&CY5OH95I16KUU-W
M-K^ZTM7-:3@K+Z9E**V>-J^MG<VG#2Q-GV:3TF[GM"&:/H)1W@KR9V^A\GMH
M>6I+/?E1\@R6%@=]=F3:PQ!S!$@FX)N1^ <6G:NRB787K#]MA_#Q8ZE-.6E%
M$^C["!\N6F*W#&^OM@XQCF[<W*?)P48UK6'>7;2'W^A)M//.+KUOMI.^I=[8
M]'W2%8!UZ1O@YLF^Q*YM9 3*0;$TOIWGTW"BZ\OWD]FW71#>6']L>F=7UY6_
M]-,:5.<'\+"N_+Z4/]U2^C&<Z(FEPPWD7G,CC^:=KJ:@*_9EH(?5!Z)VY5V#
MTGH'NJRY^3 -L^JJBUKO4G4@*E>#_^2KLTN0_M=-4Y5FWD3[\'QVLBS_3Z\G
MS27,[!;"]VSM,&/9T2$;J/7#C!5,O!D8=Y.RY:%68J]FT[9F_:7V#JJ #,\;
M'PTF"WSWMIS ;^[==4=#]&#T' ;/3NY7KS8'&M=[75;_I2=S_YO7];Q:Z+PM
M=&^L,R9=MU^"IUW78(^T!M^M^;<LZDZGGZ,C6P&VK7W?C4-'['%,3!Y*RAKJ
M7C<_AO& T"\U?/HRG9G:5U\C?WV8@E35'_U7/V$]<$M'U9C8=I+B#C6'HG'E
M@7^8UDTU[R2J&ZJ,2-6.2^<N38Q(]:W;_ZYNRJMH!MX1_X^SZ<6YKZY.S63I
M8$9=< K.$"CO6=7$O[V95=7L6U3I^X][/")&1*Z;H&RM.!"%_YC-W+=R,EE!
M\V':Z.E%"3TM=/@6.KM63T3MCK*T;W.)1O-CKWQ5\LW-9W\-O!LYX<Q?1+88
M9J3[=)4<A8=_&7KH6]I/--Y.^F&W1@:B?+$;<:Z_;R5O3<GA:=A1V#O4'(C&
MW5:>+63OU]A!1M)M'HYA7=Z-ADX2V:?)@4;UV3OOKV++OX-#,9LV\"TT<P'*
MP5>^WKJ8=ZZ?BMZ32U!JOOXPW5JR&^N-UV$J1';4>7NWEVH\G41KQU8&HSU:
MWK:91U<[[AY#>[,;#\;05U^U,4O;J.Y8/Q6]KRU,=-F 73>)KM+Y;&N-D]D.
MHI6D]U18W3THK>L9>&) \Q]E<]EUG)U#90Y!2BH4=]96>[:7:CP=M=5.K0Q$
M^])%ZWXN]G2%T2A:N"9[^[#[-SC:B'9D\.X-C$;Q9^#"Z=P/. F=6QQM3,MO
M/E6S4#8#CFS'=D<;7R>ULZW:4-3%P[<WNO8N'BKZ:=U)UVRL-"IENTKH3HV,
M2OF=2%GGVMAE/7FK&WUK0)TU,_NOT^O6U>PSNCX=I4)@,KE#Q#DLH[6V+3U?
MILY7GR9Z, AV[RD=!G?)N9V=3[YJ1;X-/(,FODS+9@Q8!NC\P$BUEEEI8\A2
M<J!VZCL13N>S1D_6%WKW/7Z$1?T<2(%1?8/&AP&H7Z>C(M-MG>U0=4@J+V<3
MX)+ZW?_,P7GN0MO:"J-1=+MC]MK:^=6\Y?9VTW--'./'6;V+E W9SVCCW\>^
MZ-3 :!1WY_(-U9ZDSNJ)C;,#,O$1?E\6CZ3L<9%OT8O_WGC0E&[X?K;=MKOM
M.?:[ZGDRL_>P6_;67IP,NC;M-<=YC2ZTOGX507WE)TV]^J:%&6&RO(?Y'\NO
MBS77Z&)<T,6T_%_O/CBP[,M0ZMOSO9;RRKL[YX#W]XGF5][][IO5>";:^,FO
M+X'V8N0>"QB?\Y(J1)DE2#)ED: N(.^I-XI)HVAV'^9)O.TZJY;S>Y0XI\/W
M25R]E-YPD:%,8(R"E1D25FAD!<U%SI0,3G3!]8[DO*[LBUD%,O[K2_+RQ3=?
M7EPV[<=%*[JRCP3J_OW@98E7=0S$B2VBLO%7J_KQWO,1\MSLV.8)4'QVO/\P
MX*!=B\]AD5[-52+)V$I'X;4(V J!,NHM8I@P9 AV,"G&<4D)S;+\)Y6;87AT
M1'D98_:>MS35R>6F+A2UE@H8H<PT15D&VI-*SY G&<%22Y]S_^\D(0-S91+Y
MV6<6GZ.DQ!N*\5 -BGS5D[LAVB,+S..."Z$I4PS4)L&6(LF#0LS!KUPPE5-'
M)%9N?[FASTYNCFEE&62ZGJ. ?)A^A?*SZB;90K+LKW">,IYC"8""9E2YY4A:
MT(R"!*$#)YA3LK\XL#_%X4"S]!REX&1>Q=OWBY*?*G^M2[?<7EY%9=Z_H##V
MZM&5GH(1(W+#P*H0DJ"0PP_"C$:>6:LX$1C<V?VEB/\I14<ZB\]1RCY5LVM?
M-3?Q#*M9KK;7,0HAD50]V7_!O7 *8X64Y!8Y9@T2SCC$-&.&&)9S8O>7(O&G
M%!W)K#U'J5EJD3M_:#5'VI7H8>]%!A!+1QW2DH+[J$2.HB.+J,XX5U9D(:C]
M)4;^D!CTI\@<<-*>H\"\]<'#^-VY_G[GC_$NP *61)*SC8PB"!XR22S**/P(
MD@3@&T$19M3H/% 1 MY?A-2?(G1DLY=*ECH<J=SN3.9,P]JI/:**:"2\-"BS
M&;AWVH4\P )*.-V?!X]Z3VK44\(> /]@D[^]6A>[,'!00]>$O..%56P.:1FX
MWXYI<U/UNG=^VU0$CL\*P^67/1ZZ^N9W/9Z1I$#Z9/]4J@<D),'$=<QLFC#N
M[#X8;>C[V@#2-3;'MJH%$;FS!JP^0Y1'L/@:I'">(>,Y_$GE.1>=(B]&'_G)
M5C_B<6&P%SWETH+YD.& ',8&V<P[Q%4NM0:[@AM^[*?FPT[A; 3,4MG8J_0-
M;[V)>U(G^KIL].2CU[6_D]&A Z/LTDY!F-::<8\RIQS".-?(N$P#D4QB'935
M^.ACD_I.\T.N&1G 5 RU. VPMII[MY.JV5RQ # QQH"M"@00S7*"%.4<.0WN
MAV1,.--CDR&-@S<PRPR.6"H>65IG]2=]$ZWR[;RQOD*AM*)&@#NJF+"(:,=!
M"AC F!L;J).:RAZ!*&E.W@?FB<&0.JX%J/?*4P29:2RP0TX8B0C+!<KS !@[
M+&VN&0E]S);D^F,$LV4L'%-QTIV=SM6I]*[;YEV;*)AQ3O*,(!"B'&58Q4 2
M@^.^&,M@_66"/R?-,SPWC8AD*G[:EGYI>4%/5]5-S'AR%?7N!M[:I[G",I-S
M*F.PGO2(>HI11N%'S@ <&W*>DQXARFFB8D;ELT2HIN*YQ^A\F-K)W+4;654[
M??<2P*\?] 8N'*8#L"TY9SRG**?.@8%IVS@?B51. _-$,J_8L<>9C,J7!\/Y
M<)RZ$]<5W!"1!261")B#MN<.>>T8<AGV) "VS)ECWP(XQ"1OY;,]D$W%,Y^J
MI5704MWF*]_ -&M*%SP827(!UF>.!7BR5B$O- :H J,\SUE01[]QU'?*9F/
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M;WD,@^N^MMV"[V?AQ],D,= ?Z*N>BE'H4JV@T@42XK.9$EN49X"8S'.[,!M
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MU.5@K_;8L4_#I/NRUN/4$$<,>S)/8)4)HY/^7E.ZR+.8$BH72,5@7(ZI1GG
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MQ*.0.P:P8T:TP-;)HT]1,A83#8U<TL/PWV?3V7U<MINYFRL6% ;%# U(Q4Q
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M&HNFX1N2LOBNL0(IBQ&$!#LA;+7F6R3;%PT8[6Z2H:R:81",B$&U*U3C=R0
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MZ89)H6-TY</L)KO:++*WU]63^NY]]B4OUJ5^/NQ<]ZG#@E77FH3VOGLV,8Q
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MA823()IH2+]J/1K]Z!FOJ",?)V0](^IQQEL2S:BW-  %B:#4(0W)86;#2%]
M&EI__'AZG&0P&".8M\_T-<]\4Q(62 F0-1YQ Z"!7FE<X8&PP'%'. ;1?'-V
M]8CH'TR+,J)QB02;AEAFLUKGMUGQL)I8O:-[HE6B"1* (A;6!$8HM5HC?U@.
MF)+QN2R#:3(?"K66<:Y[AULMK]ZEZS+C]&24ZWB#A&,!PJI/M77&.,*Y9;#J
ML%!.Q1?:&%K-O0(VWHG'K]DB_Y)=?<QF-\M\D7^^>S__?'."%PU;)HY8(A#7
MQ".B HFY9-4FF+%$M4_M'>YFF9'F@7Z1B\ $^6MQ.F6IKFGB$9::6B8,!)PZ
M@H@[(&E\E#?8#^F<]XQ7! Q1L]GFMKQ2)KM2MWFQGO_/=@5LQYDC+TL8,<$!
M!41[C#4EWAM_F&$!9NV#I5,L28.RJ!\$(^#5FVS=CD.A88(,U$A"Q0$1S&-?
MWOM;24L<:F_"3+%"#<J7\]&*@!OOLQ+3LC;! XKO\H-A.]*<>F,"#?>4"B:0
M@PPS'\SY_:DM; GL$%8>[L:PB=C4(XR3I^(.7M_AU3+\F'U,OXWUE6BN\@J]
M,45V-5^;T*.[ZUTV>)/]L-,-$XDEY!(2@SV &"G@**0>"BB<-@(U*L8RHL1U
M.U_'&R7$>8N#MZF)L0(()03'E:3*.AK+3E=?"GN:7] 7,E'O:>V&[N%$\>M2
MB_4W@IUHE5 K&#*\O#[',VD%%E)5X  V:I6-L_:L^M#W=PD&?<$T7K;*LSUN
MD.UXHEW"N%60.V@QEL9Y;!4GE:S:2A3W?E,O6FS&C$YXO6R.1+E3%!\UIJ1$
MF$'59GV3%_/U7:,%Y&F#!'KFC*6 0 9->=K!4%M)1T '$@Q\'=A@:T='A*;3
M?\/9X/LF"9<N2.B=0I1XPY7C#%420@?I)2P6[=56RX).*+U$/D2\,$Q/@ZG4
MO\Z*9;IXGWW-EIOL0U9\G<^R5^\_U&X+UK1,A#<N3*$N3*6>&VNL$P=YG:6C
MWO#6-*.YJ^J^XT*?$(U%B:T]4]:!#2I9_'^;8KZZFL]*'=12HJ9E0JCB05C&
MG<%0&(L1._CWD+#V\\. IR1ZID2_$(T6?-]75L@WRW5Q5U]S_9G'$^6I1  [
M;7S QWG)S,$<=H1%F";0N_)[P&4LC;]/EY^S&L_@\$QBD4("*2V89DZ4N<&6
M53)(J=OG#@Y\2^, SD!;4$95;.T(?O!4(&B8AB10P8O%#F#.C.8')+1V<5OY
M+?3QG$8[87&YNHW28A]7I=.H\M< Z>WFME:9CYY+H"%E$2P/.56$&T8\.%@/
M#JL(;>Y6FLC[PV T?:;?FNGSX7,)$E BCB0//H)&5BBK[;V# "+,O>U%GQTP
M&$N?[OHZF^TN;MT;B>^#85]>N#I?;N;+SV^#%5)[F4CSER1:6EX6*'.:.FZ-
M PZ "@7&^:BAE69,&&BO=S#,QF+.;^7E*?GGY?Q_LF!J?M/9,JAE?8HF1UHD
MVB%!N--$(0\ 5L([4<DG((WPLIF!.-$/0!,3X.--NOY'OEE<O;K]DL[6!Y[O
M&7X^/VI>F"@&&$*4.F"XPU ##F6%#I:^_?F=P1SR<>G3+WX3L^LP6[[+ENFB
MO-M)+:^V\<ELM5:S6;')3I6G[?#6!%L*-=,0.TJ5!=+2 %HU#0O;OE328/F2
MX_)L !#'.U0T*\J[NEXMC\FV>A_^GB_33XN[=_EJ-3^=XM;J?4F 7$@FC+0>
M(J&44?XP$*GW[6TC>F$$&P.^L:@5[+AEZ/E_9>DI=^G!4XD&EDC/*3?EW98:
M4,KNW0VFVSM+[,)HT!Z4EL=-R^H\M\OY]7R7__(^FV7SKT>R64\^G[#@T&$H
M-$(::Z.A<>80T&' M;_DA5^(#ON$9_"<^=?Y\O/'K+A]<%5CE3[_X28OUN7?
M=%X4^>_!,1LRJ_V\CDR=[_[XJM37#1+=C[1(@'"(!&-3 H>5M09IPR3F!!%#
M 2,35L!^W..ZU/9GGDX\M(8ZR:R $'O&#59X+QL6U+:?SGO.:>^LFY,7Z;;!
M(NHL]MUDZ=-9><5L7>[A]P\GQI8WOA(A*-?2>X1)N1;MH/"P0TATX)SU3FI]
M6E^B*RRC%1UYU-':Q++G'D^P1Q0:A312 1]IG?#\ )( ,.[MQRZJ.JGU3NB\
M)/U'N44YM=HGVG_.ON:+K\'$>MSG^AWI4^T2SQ 3!$E)P@SIM.,0Z4I6BCLD
MEPRV]=%-94_WJGL$IZ5_=["A'W5A>S_\B9I"-:T21459:L!*YXC74EGDV:'K
M!+9/"!ML^Z(7O?8/34NMFOSV=KY>9U?W#N;J0QK^40GXKL@_%^GQ/>OS7Y+(
MX+4*:Y1"GE"F-/3<5X)I3<>TWFITWJN:\I$ &VNBKVZSW5[)MIHW.(9ZI$6"
M"$/$<NV A"),6-KK"D)"H6Y?3&'@8T1]FO/]8#.E[G<W\]77I*QMFS"+*)$8
M B(M@)A32V$ELR4D\KN].VNR 3/ZP.O'X$J4GD%\%.G%F'B7AG5QN0Z+6OXU
M*^ZJ7IV^*/Q4FX12+YWB0DG*'022E8GR^VY+3R*\6Z5'5>3#H#36N"_C\>M@
M-Y6KY,?PY1KCX+G'DP /0X!KH3%15DK'U$$R3V&T9PKZM QZ &8JE=?.[\\W
M2"P%S$IA"9,@&+[20&8JZ<I:47$; -T45J/]3@B]-!Y$N;C'H/ZI,H$>SGHU
M\_WW#R=<VK L.NEX\'.A8:4G74GEJ&J?PW-^DMADLWUG6*91=J/;"(XU220U
MUI41-(F%8QI2B@^CPRGIXY[ONZCLI/8[(_02N1#EG!\#!7IQX13\,W^3K[/5
MU29@N)JEB_"(..G!G6J24&FP4=@#II7 AC%B#RAP1-K']P=SX+KCGP^"37N%
M2B*J/H0_RSIE/OMXPF!YB([!X*L"3!73@A^\5D<Z7&TUV$9-WXKL Y>V2D1_
M#M]Y2B2$3JOR9*.$E67.?'D+"82^K/,K *HZ+B")L!YVOPKM$YVV:L5_!EQ^
MUP=R6JTG&R6**$F#S2DU8EP)[L,D4V6<$<?:7T([V$&+?M7:)SKMU4K@=UW@
M=5H]WB;!6 B(27 >D4":&JIQM<%/A>#ME3K8X8:^E=H;.&UU2OZ,F7C:!U*C
MU).-$N(U=[Z\ST-C7%8Q0.;0\8!$>W=WL+,*_6JU3W0N*/W!&2,(\%AZ0CCA
M0A('[P4S[8]<#G:\H5>U#XK66 [OW]-B7O:\/ -:$^=Z^F@B#.6$R&#U TNL
M$-)P4DEDPI(TXF0^692K(RA3J+DVHO']PPGFW!', <4>.VG+HE[@8&YX&_D^
M1GLEG=!V)V1>BMZCC&%-J>X8PI;OLZOL]LO][31G[5\\USCQR"(.A0-.6.<,
ME\2K2FI&9?O<E/,-O$CV,WJ *0YRG!G??KYY0C103  %%;%><J2D.DA.@S,3
M]_K0IVK/8DTG]'XD_D2YSL1.FVGH<EZM58#"8JJ8YX9Z@ 00CAS.E6K'V@=O
MS_<A)UM9VJ(QJD;/*L3I@DTD&/<6(4\9Q%S1@QQ,X,A/.;;0QXF*G.VPN%S=
M1CE5CZO2:53YKLAG67:U\D'Z;3#R77I74ZG@6).$"V.H4%0(ZKBPF&#F#DL+
MY>U#>R/M=K_N7+B@)VC&.ZSZ);TK)5^]O2ZA.#68GSR:\&"=(&<!XX@19974
MM I^:DQ\]#OBW97=$9)I+/&JJ%H9G=A>Q' 5K,-9^$/ZN7EUDE,O28"A2!(C
MF 28 2*,/)SBT(SA,9/6)R+&8&"-EL <('A[_>2P]:XB\:&$D$F_A+^L[TZ0
MYIS7)% :Y@!16F$B%/'.'PZ2:F%5^Z#A2#OWW6DS(%Q3$L>G\^+OZ6(3_J!N
MRVL_WF[6JW6ZO KBG$F>4Z]*&"400HZI\L)XYXB!U1*K _#M"312EL P!.H1
MLGL215%+;?#;R,L 2G9;?N5-OBSK187?AK:?JPE]TF^;F]*U6+U:UCXY=:FW
MN@Z^;E#\K?$[$F\(-PH;HI RB@"&89FY!H.1C6C#:WBFP4'?O<X^IPNW7(=A
M6U<M[OR7)0Q0;,M;(;#0W'I!@--[9( TME&AO#&*R0V@Z^\,]X'!2V.N/M=?
MX0H55B49@.?$!8<'(L*(V8,"M1%C9K>?%88=4O\-ZUJ<!]W+J%6@RYPH$_P:
MR;%B6 M!<35<O><F[OAN9TV>7;2@'5X_!E>BC!?'1Y%>LD3?I%_G?\O2Q?KF
M9![HT\<2*31AWE+G.8&&E7GG_K \<S.FP=%;]8K&@.>] 3/6@'ZUW%7.OZ^@
M_S&[_9(7:7'G @;KN_=AE?2[XMXGQO8YKTDDM!X0"@#CJCR<H)@&%1)6Z1@O
M:QO<.AT0P/'V%4Z#M)-C6RT^_'87E^C@[#SWN@0"B*@I<=&:!LN-2^(J9#B"
M$<X^PRC^3-^G!RS'8MF;;+V[-^9U'J;L];J8?]JL2\D^YG52GB!;A[<FC#ID
M>=",IQ9APQ2BU<3.)&7MK98A+_<>GG/C03H6]7Z=+[>785?=K. K]WWO\ZY.
M^=0-WY"4)Z29Y58K@J337 7;H9*?<-L^B7;(*\.'I]0P\$U%GUTP=Q?+W?5\
M&[(_@SY'WI!XYZTI+4VO"618:,?*+6F!M!4>H?8&UG"WIPYN8 V#W>"[([6!
M_C=AT4[+V_E^K(@_8T ;!ZUE%%$'B/.B'.*(668008T6W9<9\?=A<J4>0H@!
M#3^*X+2R/3+:(#;FA;D]1?P;Z[I[Q/\\\**.^'_8?%IE_]J$S[FO9=YQ?37*
M(RT2(#G5DBJ,*(8.:.MD&<D*2ZN4%JCVU^W&%_%OK/]\".C&LD2>Z6UM]/9H
MF\122+$,0]10HD'I*FZ34I "06;D6-P1_LZ:JV=")YQ>)B>BC.3'0X4H*%";
MZO_L\PGDP9EC G,95F>.!=:B]-V1T=QX[B*,[O:@I].:;X7,E%MZ+:^T\!K[
M\C"3U<C \JR#\X?%T^/V)_,&OM)B1#NA'^A>QFZO#Z3GA&HDD! ,*<T=KF3F
M =6X[8;.FCQ[V[<=7C\&5Z*T)^*CR*29 >5=W+@\4V<@$80 SW=F5-DYI_&8
M@8G>,@,: WXJ,^ \8*8*5[_]?9D5JYOYE_N#+/KN75ID)W=QSWA+8K@GBE'G
M@W%%K,,B0'*(\] .![PCR MH&\,:#K^XT@(.)Q8Z9P0<WI24(Q(I3)W##G"H
M'/"HPL,JWG[1B& ;9*B8:#<,VZXHC[HRWW?E:K^[5\)4W._NY<6733&["7_(
MKZM'5U]VH^'84M37^Q.D()"66(:E%E*$_R-0P5%>2A'?QNQPE)H2V9>WY:^$
M86&8400\,)08&49:D!\;1ZUT=,Q[0"9GUK#8Q;7P#9L/9SDE%AOK!""4.4TA
MKTQ+HR2/\'AD+$M@)R#CHECS!)-6[TLL$HPRKKA41D#H)72NPH8IW+XHQ& U
MG6,A63<DIT\^&>$T;GE0>K;>%.507%ZYVR^+_"[+/F1?LR)=SK(IOZUFZ_G7
MK18798&',J^QIH7)HSB:^Z"798]"3\/OLN)K]KI1CDY]\\1CQ:0SC&#JB3&8
M&"[*%=D1#3VDC0X)#K3)-;O)KC:+[.WU4VWMU;C545U>SAEO24B0V%O '6$"
M TZI5GZ'A7*(B#$WQ&H2<OI4[-,=L<$ &R@)YTCI_# 'IK-M38(P69S8*SOQ
M=&(P"(L',E1Q)S"#SA-1R6< CO8$[2 ZS/O&JV4,XIF/']VW./E\8I#'%@L%
M=1@24@23 ?%]=[U".M("Z+THX+0R.^$3O5JCVH**1YO3.$:F##<MYE?;GFY7
MKIJ<AN<;),!X3<ORC0$FJ56PR1FII&/4M5?ZP"D-0T[5O4(V'2%J=Z6/-2DI
M;RF6E#I) \4))%17$L)@%L4YP?>EMEH6=$+I)?(AJI4A-AI,E.I8EF0LO8!J
MB__#SBFH6R9.MDN$X%)331%4T'-D*56RDA5[,>;UDM&M%GTB-QI+=EVLSX-^
M^%PBO(;( ZZQ1<%;UEQM<P-W0PBYR)>'GO3T5/L]('396H]R$8A!V?&D*[;+
M>B8"6(,ILSBLE P; ^T!)6M)^]-1YV_<1C?I]X/9RTAA)<X)HQPQ'F*#'-;4
M[\>!!@HC'O>RT%F39^>RML/KQ^!*E(M)?!29:E/^Z#Y*W5U'IULF80ZV'!A,
MD/-(.,H]))6\PM#VI^H&OD5UC*6F7^S&XDIYUNP)*K73Q]$VB0U>.W60L?*0
M&82"<T4K&3U2-.XEIC<-YL/B]3*Y$>62$A\E(EA2WBW2.E_EV><3+C3DV"/D
MC09,68GT 2WI6/OSF0-?S3KZ\M$2L<G84#LM'&F12$( Q1(Q%CQS8(R@ILKF
M ,BJ2+>J>])9'0,Z8?3RN!#_ C$9!:91_:ZZXB&$][K42'T8ZT2KQ" KB686
MH/)^&$D\@::24],.A7X&OF%UC 6B/]PFYD?M!'&R7<(9 !0 XR0V6D!'*:+W
MLIK(?8Q>M-B,&9WP>MD<B7(IB8\:TU!B>_.6R6^_%-E-"=W7K"KCVVA]:=(\
M(4)PC"G1W 80K)9.Z4IRRVC[A49<_D(S ("Q4*=V6FGV@D26%_,PABSGCC*C
M-;I/0D>.1[[#WJ^"SV1/)P1_-!Y%N4Y= GV.T6:P<VHUYZY>S]-/Y<68\VRE
M5JM\-B_GZG_,US=-SWB%AC_"L2WN,"%AP3+<2L.4)D*6R=P$(DB]DXU.<@Z4
ME#/ZL2T'@ 2,!\.,"RZ!!=Z+/1;$*3_F953=CVTU5FR'8UOG 79YQ[:0E&7=
M1Q[^34 P_[W?)C)MY3,8^A$),9C1VEB'#8YMG8?7Y.=[B!7$NB UL8:Q(#_$
MI.HNY2C2BPI[44"C@S[M\(E>K5'9>/%H,X+=C%Y39S@S<'O=N0">80NUM*J2
MEWL@6],@HH-<YT[>PV!WF>D1SA-6%MV@7I1UA!37QE<R8H!]G+-_[QILG"?1
M#J^7R8VHEI!X*3$-%;[SZ&O+VA]ID4! G14RK+62J3"_2H1P)9^FXT:+FI4Y
MZD%7^1#8C*5[G\[*J,^="?YED+U6\\\^GPAH.,9",,&%1-!;32JLJ#8/;AR+
MIHQH_WKO YE)C,C]E/>^T2W&-2T3JCA7U@"C)=#8$RVW]Q9NY:7:1GB[[*#!
MH7[AFI(>9W(B4=" ,(8L%(H%5TQ0R5TE&8%VU%RI%D3HHJL&'#@3GLF<R[/\
MR55B!!9.2>V@I$PHR8+-5$D%)1G3A8Q)Z6W &4OE[]*[[7'6(/"C/I]0_+$F
MB;7<!7N9.(Z(YUAHSP\24MSA"HH!2S\/H_Z>()I^6S"BNU.'W]N3UD@.@XK"
MZHY!6-B#C<85=HY;XH1O-'V]E+T]79:%%D(+II@2!EH<L-EA$?P6,N9U,MWW
M]AHKML/>WGF 7=[>GH58*B\\8D(#8ZD.ILM>/HP]&//JD<'"PXUUV&!O[SR\
M)M\$4HQ)Y@0QTDJFC40.\JJ[/(R6.*.[O2B@T6Y0.WRB5VM4@=EXM-F+%NT\
MS#?S3YN :-63D]>!'7T^(<Z X"0PJ4._@TG*,=ZM7YH:!>"H.[2G#>N>8,_[
M1Z6E$JNPGOLV+TV+??;?\Y[QR><3[10W3G"@/ )*2Q(<B,H(05ZV=XZG#8V=
M:UOU"=+T_M'@Y?WWE:)>+:_SXG8[ED;]F%JMLO5*W[W/ON3%NA2V*ETUL3^X
M[\:N7]L+%PY];N(/-FF>($*A1<IB"00N;R[TFNI 1N^0X+;9A4-#^X,G!-%W
M^S\V]PL;ORW!VF 2UEWIC82&VS#Y@CTV'&F#1IS-3OJ'_2KZJ'\X%' #^8EQ
ME9 .,[QPB$A $0U+.;5.J I^0] %N)8#J+]9*>GSH!LKJ-QGZ6!!M+?*4.L1
M)H!Y7Q[6J,8F$C).Q[0OM36M(=P.I9?(AZ@\VMAH,(WZWX8Y-2VGQ:IV:FV:
MR9$68?8DP<G# %"JG?/62\(J^9PB$3G"_:GJZ?FS7J 9;^0784E,U^7U:/L.
MURK_:)M$(,>D$\)XY3'1E FG*QD5T!'N+_>N_K[ &8L PY21!XX1JCC50CC'
M&)1(NDI6A'G[.EVCY:H/;S'VB>!H;&E56)P+)*TB$#J+K7?<<<@/LD <><&5
MGO1TLL)X.X0N6^M1&H(Q*+N7N/B[FS1,5[-LLY[/TL7)?8WG'DVLE=P+"Z22
M@&G!RXY6G:08M+\1=S!+KB7(>:] M-36K]E5K9H>/9,H2"P7 &#B(! >"8T/
MK@D3HYX&&TT_71 8:Z[<!>1/3)*[!Q+.@]7/L/(<0F8DP!;+JO?:N @3L0>-
MU+9"9?#MI>_W6QKFVPVSV?,^^YHM-]D/NMN#&2:!0X@*ZY "(%!M/]X-\^'G
MZ79[WF>S?%GNF&Y[7"8R;?7DPQ"JS(>/^;VGF5W5;?BT>V$"*6)62<L)=X!(
M9K3<#SX3H+)CAMZZ[_DT5O=WF=TC8/=#;/LXC(T5UH35F-,P>1LJ#I PS\:D
MTUE._- ,:+;S<QYZEQCIYY YY[%''ACMM3#$@P-@2D9:;J0OM34-^;=#Z27R
M(4J'/Q8:7/K.#Z$^X"5D<.D$ ZZ,GNM*/BA-^R/&X^_\-%95PYV?\Z"YS)T?
MXT@8%QYPCPUS"BF)#C*"\.OXPA&]J[\O<"Y[YX<&":$!%A)-R@QP9(+G7J$G
M)!R1"#$;C7V"&/<V #;4.>YHF/LX!)YHJU E"\4<QFTE]J2GD_L![1"Z;*U'
M:0O&H.PH-G^HD>7A#P< P)0QK?E])[D1$=8):@ERW>;/>4",MOECC>(<"RDE
M01@! CFS56S,41^AM=5=/UT0&*\^Q]9H.'W0??=(@H(MB0A4.EB&S@.'K<6'
M^*8!$3I, X=M6^$RP1;0_C?OBOQZOKZ O9B#91LT%E3D\^+@J.YD>)VO5@_L
MW,=F;IOMFYZ^F&!GC6:.,V(10T8;1?9^DQ(B&-OQ[/B<EJ_C[L_Y+T\,<5)3
MK:GB$JG@FO J445Q).V8"_A9.T&C,Z=F\VAPZ'^(C21,F/,((AT6:A.6!N^)
MJ2"QA(V92]0I)C D&YIM*IV'Y"5N(DBKF8'*&BHQ*JN"8^$K";4D(.YP05>U
M-=U-:(?22^1#E(&$6&APZ9M*VB(;)/* @. A F MX ? T$5M*C565<--I?.@
MN<Q-)8*555H'+]\*0S1@DM_+Z/V8>PE3J;\O<"Y[4PEK[LJK1@T"V',$J/*X
MDA5;W#ZS8.1-I1$-R#X!C7NK 1!A,/-<"L0--)09<Q@(Y1F^N"W&GO1T<L^A
M'4*7K?4H[<(8E!W%!I.FU$*I!?*<>^^-=Y@>.HGYJ&7OVFQ@- :Y;H/I/"!&
MVV"2Q&&&/1!,A9\L]+PZTZH$1J[]Z!II@ZF-?KH@,+IK5=UINSIYD?GW3R<"
M&&T)=)A(B9W0E$!9R04-CK#*76PQXNZH3K!I-7P=O#"[93I=E?5Z;[^$]7#P
M6GC/?C":>NC/=T^%WBT_[TR N_M']N7H55G3_G63#;?.+T^\T9XZ(H);:JU#
MWCG*(/5>.1$6'M6H/MQ R-W78*@3<W5,SC,JZG7[1H(!0(@#Z\OK0AAFT$BS
MQY%Y+,>,3Y[>:1N1,L>K\(T*=M1[:SNI0C]K B./GDLL*4L0*"O#"D, (AY:
M=@! B#&/6+2MJS(6!9X>,.Z XVB><&ML[J5;7KU;I&$9O,WJ'>H!/I< 2R1B
M974CX[6"QDB-*V2=)#;N:$Q+ECR=\.(!]@_J]H=PE"&E"V;L-$P]E A?Y[-_
MOOU2RMG\/M6G;1(LB:06"V"E\0YR8CRJ9!3.C;H]W="=GE35QRYC[0CL> F^
MY64'LW5VM>WQ;T%MJ_<??JLET,EVB:?808VT4L:6@]9R:@_H:=:>1,-%VV(B
M49_@CD6D=UFQC<TL9]D6I_H<B2,M$JXTE! SK@SW&"F@5#50N%*X?2&AP2[U
MBXH\_< ZVOQ30E3C,1Z>2<H[<559J=@;BQ0C0FA>R4 (BO8LYO3>8EL,1^5!
M_:IS_U3"PL @U#J-G!6886JL/@1O",-Q^V4M]/&<1CMA<;FZC=)Q&5>ETZCR
MUP#I[>:V5IF/GDL48@Y %.P4SQE'V"FE*ED@1:/ZH0TOHFJCB;P_#$;39_JM
MF3X?/I<([1V2Q&MA%>*,H>":5[)@*ML?QAGNUNT^]-D!@]%C 5GQ=;XW +^S
M-CZFWW2V#/BORTWEAW]QW\H?3^TS]?.!1$L9:&\Q4#X@YPCCX+#S0C6/L1CO
M=-M-DV >39SUI.OT]^ IEVD263'/K^ )WO;YF81SIX(O!I1A&D'!.="D0M)V
MJ0LV77ACP,W2Z9"/:M9]DR^_!F&RG5RKC_DZ73S\>WD=Y9M\_5_9NLP'^KR<
M_T^95])M(F[SS<0"K"@%&'CF!<:8>W3 V#O=WOB>+OXR\=P\@AHNGNJ[$>[S
M8O^K\KE3$_JX'4D\#].-5%!QQ[S'GEAX,/>X;5:K^=E!0?X8%./JIF7*L?N6
M%;/YJ@S"[7KQ]KH,V*Y>+?\K2XMCES/7M"K+\7#.J!<"&.6]99A7")O@(_K6
MM*(OB%;] SFJ<?NI'JQ/IVR?]_//-^M5D'H6_II^/ID%.,3W$@D-1MPHR*@H
MM<4X]P=L:8=J!^P%D30F%0R?COTLOO>['.KJ:OO6=&'3=?H^6VR/_^4/-L57
M?Z0SG^:?Q0@1A"@4U. PFR&(Y5;C7B%E:*,#17^D,V>))5AQP4C $R-+R[/$
MO,+1>QI/X: 1*3-8.O-Y8+_ =&;CN<'$"A=48;2%"'-3 4 \;70(X;+3F1M3
MX&0Z\WDX1A.KO("<4$N<<%1J)H/MH*Q1CI,*60I5Y(?+6[)DC.30=L#^0=W^
M$(XR*^""&?L2TIFME5IBY@D67!KCK*0'&:&7,9[+GU35C=.9SP/VC_#TL"%0
M)802SCAA@NWOK"=<8L@ P)X@0%R,]<VG\W>BULW%CY1)]BQE6%8]I$21X&Z0
M\M"0X"7&4 +-&6N?,Q[SCGQT_#]3#='8OL>@WH<JWV[6JW6ZO-I6R%@7\V#X
MS?Z>+C:UD?@AOID #X!UB@1G6@#!M0NK;Z5U#4A[*SCF[?G6H:U(U!#]AM->
MW@?;;(_EK<VM&N2CB:$. XF5AA )P@6T5!_T+EW[7)28M]T[D3T&/5P*VQ^,
M[G]DY99;6.V^9D7Z.7N?E<H.OS=Y0"*=K3?IXF-6W*(!AT&+WB1,,.N,UI1Y
MX*BG2'M8Z050VK[X5<SY U.-C^$5="D#Y\%,T1")D=:/IKU)%%5*EW>?*4/"
ME":<QJS2"P/H9>8T1+"P#*2@Z3,>%HL',;*/ 9E5D*84_K=EX,4V5^ETRL-P
M)>0>]?)AUPZ)&4_/#&]/G#?M>,0.W$BY&@ J11G!"CG)H?/(&$J=L, @%X:;
M^R-7H]G>L488"L0U\N45:2A,4-I4.,JPAKZ@7(W&E!DL5^,\L%]BK@:D5A,7
MED-JRZN-!0P_[0'P8-13J1/E:C2FP.E<C;-PC";H=P$;WMH&+80Y@E !;#"(
MA&:@0M9(=%FY&DU9,L;.=SM@_Z!N?PA?0J[&)3%V&J;V5_0)2<T4$UY(A61P
M[Z2WNI(/8'B)&]B#JKEAT:?S8(T^_!35L1CFJ$,2,V, ,<X@XXDZ8!OT=X&4
M'=!OB4 %T:S?QV!V_]K,UW>OEJO@66UGD+?KFZSX>),N]X&TPZ;\^WRQ\'E1
M-AHBM-&J(TE8% /V5"+K&%"!&ZY, -]I@P 0XQTK$P^(6'7S@D;*FTV-13):
M'Q*(#!/"*\VT(%! R!3:Z0 #*#N438IOP1B8I../I58JO/QA]-?PBO7JU7*7
MV3C)*'K<A<1ZYI1BQE+O@G&+(2.RTD"93OF"%IF7,H@Z:?#RQ]#?MRJ:= P]
M[D(""7'2(&V(M(!#@XW;>YD8*M#A0']\*80O90QUTN#ECZ&@F.ML/O4P^JX7
M"2%$.L:0LAHP"YR66%=Z(%"W/UX47W[B2QE)795X^8/IH*@GR3C;==JFZ\RG
M\V*;^!E-F.&<GB:4E^HSP 6;G&D, O%,I4_KU<LL8!=Q'&) Y?U(@S'R$9@$
MG]A;!#4$GB(OL'#.'Z91[,:L?1'/6C@,]R,<PV>J__('[F.O-L[1>V8?$P)$
MT!;R)BP@6C@ +3H0T,%F=^B^N.#*A0_A83EP^>/XL6<=YS@^LX^)D(YS@3@R
MB$%JB'-(W.L0M]]IB,\"_F'&\; <N/QQO/?K-T6VBG,0G]/!A NC >/$$\R\
M<T3P>^TI -H7!K[DP-*%C^ !"?!'U9 VY2J@9@I@CZADP5_1E#E?[>8B'HR?
M%S3(N@>*8E'#Q5,]\E)2C(6YTGMJ&&1($V*,MY4V4*#.BSQ2'MV@Z$,W,1R*
M??:XZ8/[C<LW_'':]"RNFL ! I"REG*/&-&<[FK!>RN1M(WRCO\X;9HES'+!
M,:?,4D*X!1!YL<=1*,?:F]CQG39M3)G!3IN>!_8+/&WJ6?##D;<F."+<:.@9
MMA4 F&C]\D^;-J; R=.FY^$835CC H[L04.<\!Q9")D-9K?1UE23A#'\HDZ;
M-F;)&&?WV@'[!W7[0_@"3IM>%&.G8>H#MZ$LM;-U&]Y_^*W^9OE3[1**B*9
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MFO(T$Y5EZ*LIYYY.@YKD4%1A7S$=/_R:_F=1XFU:M;L5HCB&B>>C@.F]'Q-
M78)[%(D3N3(2J]NV88T]:=3;<XU:8<>3]@B(Z>J<Y,L)ZWC>C6BI)($#8FHJ
M%,M04V/>%=.\T%KU](CA0WJ;=3L^",)Q''O4A@"1(*&QC]$1"90Z?<>$_=EU
M]<)J<%L-<(LC5]SO920Z6O36>&!T:ZY*3.;0X9>(5=?B46'Z(?1XG(=RFJR!
M39$YL'>?/B=?RW23W:;E[U7:U2'[%=:A:V/@$D)] &R;AC3T>W/8=H5J!J.-
MF%;83Y__>WI[]R_)A54?(#8UP(*#%)]U&<?DZQ-:DY$HJ88'_IZ#>WU/A&86
MQ>>K)F-3=8ZJFUEJYX[6655U,T3Y]>&DWUWVS?I]5WS;9IOKS-I7V=6>SR-9
M&SYW5=SQ62+^$?;[F_VZ9NII55EYGZ\S_F7WD^;)[)]UMK[9Y?_89\V_\EOV
MH_MF:HJ?')RQ/F$SZ73RJ.YW+YJFPEK.KMH>@!U!Y3OVZW?,-?XKS)_\>M?,
MBSW!=0*$_Y1/?IU J%[!T$ H\^L;?O/-NIE:8Y!NRF)_?6.5V77.Z[ ]MO38
MS/ECK_GL7/NHFL_%9M\9\16_3X?QV7[^LCN9P-HQ(;ZPJH?;RV++?Z<1",YV
M1VE5/VRS<?-Q0Z_EF3DX+6_R_/-N>MPH-+=PN0'.T5QGAH:V%\: LJ<['O"I
MPXSV9EQ7;".Y\L-_A,2ISIS8R,(H:7*)\@AEI@.TGG(QT--7IFT9W7AU^(6F
MU\=8H?G]81.0"YR8,LMNZ,383R@(_%[","3(-U1M%@<P>VEDQ,9$,Q'17GTV
M$PS])6B1.,Q=B'XOL)O1:&B6H9UF752O2ZORJ4F#"1\7\*59_=*/56@3"EV(
M[!A#$,2>A]V^%H-MZNJ<[9,W;EA[/V3U23/7*JT*1&N15;,<*TOJN242;PYX
MK1[P3XN2UF=\JLNJ>FA^"$D=X9Z<G([E47YE&GUMX09P(PPB&_@P]'T;!9 !
MZ0&0R%9<E3;:[(0KTJC1U6CC R FKC-Q+R>K&FDWO +M-1*%5I]IB\0R5-2$
M8V=7G6GF3N)>:^$U&K$/:0*9-0>$$!(W=L"A&^RY<2AYM[4VNX:U\Y6&>_EP
M.O<N?>^U/O;%=',NXN6$4XKS61:<2? XH)TFHK$,\33BV?,KL0VQIT$^7UQ.
M 0(_LMT$4S? MH,=BF*O1^%ZH>1!1[JMR[1GI?.0AIOU\T5,VM14+1BC%=5X
M%'2JZF+6D$D2JB:OHT*S>(D=YYVXS&I@4?@6J7U5%[=9^3EKEWU4-_E=/TD6
M S>TH>NS#K(/($SBV*6'OK&/Y&[G'6''<$^TAV:5I]@DKY4:0Z.8($[%H)SX
M'<A[!&NNJZ7.4S0@9SJ(789T:?'DZ053VM@16<9ZG*A'N\VGM#ZY12_P0IN-
MU&&<$(P)"(+$=WIC(2)"QTJ--&%8B([(NJ4XS4JU;FG>78M4? 7F&"J'%6E"
M%I67YO!S5SI8TD>>CV%.?.7J1 RJK5O]>I,M9B5FMS25(3H^:IM=\R-@.4+K
MNDQW-<-W^=!\Z+I@@ZA=O^25?Z?XMFO/&>/_:-M1NQ+U;EOD-7MZLR1WU_I3
M,GS]>M2K]E]9F1>;YO=SUGNO[K)U?I6W!K?IMW$+1<^_!6>6B6IX;>9?)*K#
MB4)K4Y+K-2?MRNQL\Y4OMRZVQ?7#YZ:U=%8)2$#H!C&@+D L%P:1W^]CQ@E
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ML(]<V!<E_ CZ4M,_)G%,L( X2TN^N:5B6GR$SD^^+(^2L7LL&7D'7W)-L=&
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M\,%JG>@O@6UN%^P]X?<[GOIB_=9X<W[/P6S1%,N*"PND7,*;*H:&[I<;R_Q
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MP3KZ8*65U7JQS(0C1+QB;M$;U.6G$<W^2F0,$TSKK&FM'!BS<14,DMB+?"]
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M7A8R C3"F$Q[.L4EOO F+<MVD^EML1]82&.$27$MFHA"!4GBG;P.FM5@LT[
M32]'YXEZ194T,+P<<=+AS L:I8TC4:GZ2U%LON7;+3/\;E>S=R^_W'9=NF/.
M^YI]KV/&P.\K$ :^2VT0> GP0.P ZCLM"#\(8"AUL)MFTX8[5#W:ICFVFSJ/
MJ+M1FYRVZ:9>3.MF9%U.^QX1_HSJDQZ9]1N':S5X)Q[NRI$YH(^&HK(,O33E
M7#')FRVGI^0?^[Q^.!S<YCA.G+C0=Q-,DH2"A!#D4Y>XD8=C[(M.+D@^U5RC
M;(',=B;B8QX&VI,B8<MH+ZK@GUY9/H8#X;/BUS?99K_-/EY]J5FKBA_P-JVZ
ME7$X9F.H./0AQ-0+W, . >PM$BAY4_@(.X9[!CTTOH.@ <?OS&C@O;IP53^E
M8GHR%9MRXC*"2#.'Z9]G:4!Z='"[#!W2XLG3 _&UL2-]FT6KAWP;2+'C:S>:
M]6PP 30!!!/7!CZA#H HZ&V"() Z\VV<)=,%X39S'T$IK9D=2::@.DW&HU+G
M1YQ"LU=\O,3.D"YI874ARJ3'EW.7=6A@2&Z\<##5K1Y+_ @$+K*3**(>)';D
M(*^W!5$DM99+S<+$:J2XBE61/9E!ETGBQLG/3"M27Z3EU:&8*HW+T)N1/KPX
M,!O'B*B^?"V;J?B'IK?5+0F+@LAQ7.(G3D <'!+'AMU($#AQ[$FMGU=YOF%M
MZ2&U]Q9*%F65^!+3$]-4R:G)D:5FI#7/8M 7*!E0DC$$+D-'1GE0Z'N=) _I
MX$.T;L#V_K!D!\,8A+87^91 UR>!FR"GL^5B"A(9%5&S8%A'VLK#H1:AOG92
MD3\Q53%/G9RNJ+!FY@R-EX@94)=Q1"Y#7T;Z\/3$# V,*/53VL2-UJR?5&:;
M%0* ]89B.XIM!!&&GD?#@\682DTZC[$S5;^E:F!9:8?+>K.O^/J9=5'5UFU6
MWQ2;GRZZ#XWHW,B2K-#),<COF,[.1=<SO+!Z:#/V>AYS)-K[461V&2JEQ9.A
MWM H=I04JUT)W1G$K*'^VK335>!&%$80QR0@-$2^&R2)3T'L.0G B2.UTEB+
M0<,:UMUK75E716E]SN[8QV[XBK7VGN3;8M>VP!&RI<RT@GY-0?(X(>LWC708
M+RR.TFIASBAJ9X@35;>QO"]0YD:[-*1W>OA2$K[>:G=5/3?^*2L; 5Z%O&OH
M.B&T08!#%$4NL7O=!;X3*HO?&*,S=>(NK+0%:]V5^9K]F97M1ZPW^<[:5YOC
M=WX:H8ZCPJ&@D%-%8E1MZZB.'<Q6)1G0MB,XHU .\"<JECI"L$#!U.+6D&CJ
MXTU4.#]G5<T:?YUM&@!_V^5U]?G+W[K:'84><6(W1@@GM@MH$L#$@90B$OHD
M]FT9M1QGR;!$'L&US<]JX,F)WD@JQ91N.A;EY.V4P$;@&F36&X:M^FFF2OX@
M5P-2IH?C9>B7)E\*$V^AG%(Q(60#N-N4N=V.I3MK 8J=R/'\ .& >BZR$7([
M:P%"GB^C4:HV3(]@C[#4Y4F9/S%AFH(Z.4EZQEHUDPZ=H69 @<:2N0SM&>U%
MH?<5D^P9L7<I:U99>0 0Y(884)RXR =A& ?]\P%P':E>D/!33?=X.!"E]982
MQ CV:8QP(ME_$:'#3"^E]WZH1R+-T#(40 'WTYZ&HN=2K;S3$=]G3X<)B5V2
MA)[O09S$O848^)YT.Q=\[C0M76DQHQ0]$JW= #-*[7V6U8HG#+S6YB5Y6E"K
MET7^4KM7\EZTY?^:[_+;_6UG [D^L1V7C51HX >N1Q!"O0T'NE(KA^2>;+CU
M=V#DFKTD-V(-WQPM<DV_PS'38. 1"P/-7XVM90B (O9"Q_LB*0+I]Q,;84QY
M.97&88+<P/== .S>A@<CJ9EQN2>;%H$6C*0(R'$C* +&:)$4@1;'7")PRL*0
M""BQM1 14,/^5 1&,""\W^GV;EL\9-F7K+S/N]I"G%9\VOKV+MM5S6$W7]/O
M<;;+KO*:,E=/?T*^\R^S51Q%3(H2SVYNJR7 #VR_!P?C0&IJ>2)(IB>>T^_6
M98O0*K-M<_1?7;0SRF\ON3O-'8,]:LE]5A-%34S7%A@P.4'L'; Z#]J2:1>E
M4Z@7_$I"J_/#XNW^T8^MSI6)-X!IH7] B2>.[S(D?&JGG^Y)FX-SX2W\+Z)!
M9<D'KGR]8?QP_$BW!!%]2\M-\\??LZKF=Z%G95YLG%40$.0YT$;8CUTG# ([
M!CW$!$52AXU/"LQP FD@6?<M)KX:B8%J%B<]9&E922Y*FC9B8FECL<&22Q[G
M<H5UX@D_..7T<YTW5N/)1?N7U7EDM2Y-?(B!QE@,9))90KZ,?#*/ZT]/5)B/
M_]=RRSJ]69'O6;G.*W[X3&ODX]4GUM:J=[O_X)JW@C@* A_2,+0QHC3QO:#/
M9MCUB-#MBCKL&%;^$WB][A=7UAU'*)T M- ZK.=3,RK9MS]/YH75DSDAEYMB
MW9QYW;2\Q7#Z")7X&/<F8Q3VIWC_<\5&M+OF<+M]NK78BW_[LV@68_XVJ<F.
M/+M)3 ($O)!G=-(V;]K0ZDFA_Z52&#!<OIYW+H?RSN?\^J:N&.HU?U&OLU7D
M8,\-,')\&+J4\'-"Z0$K]*6*3O,@-%Z#*J^SFLO>83'8=<&:YINTLE+^;8Y3
M920Q?2@EAA2+CN+,8XO6MPOKZ-T,XPS= 7IMP#';"[&@D<=\'+PT!)DY(L)I
M:W]99?_8\Q/H[MD?7]DO-\NQ["B <021YT+/(7:<D A'7N!&)(H2&TEM#5&U
M83AU'&%9#2Z+ U,[HE*51$')GX _2=%6H<Z,VK[,S9!>CF1S(8HWUHNGFJ6%
ME1&JTQ])!QWH17:,,02Q'<.$4I_;0S:S[Q*I[1[J5N91'J4EG".H5%8? RQJ
MT9]9EGN>Y4=.@R0Y7:P*R?KQN@XI,:.H1-U"%">([<@/O2#RL1MXH1>'E-O"
M<8!I0*2VA*A9F%B!1FF.*&E*>F. KY%:,\^:LA=I$9<821H7*2^R/@Q+BQ(C
M$JO/BS*O'][M6.-D [J/WW:LD=[D=\<!7?SPB8T!=_4*!Q0@'Q+*= PDQ M=
M!H8A\!.?#^RD[BS1:=>P!!V@67D'=E313BOC8DHU%]ER^O6!M34^9U%LM[P\
MUH.]L(X!..+EE;86\>3+YD6I'%I/:R @RU!"(YX]7Y!OB#WQTTHV67;+)VX>
MO[0]HO84\^-5NF'HNR[R("$>L0,'$9NZ/8H$!5*[>G3;-JR>1[C6V0;>0CZ]
M5%KVQ!/-X1"3U3DC(2>MFH-@Z)04*38'U-547):AL,:\>W:VBDD6198@/;;;
M=[XVV9H?595Q9DJ&\?:NN0.X*/L#-8NK_J-5UT-;N<BQHP0DOA?%812R_UR[
MQV:'B="ZUFD1&5;EI(/<KIL_/8JT1RJ^#&?", WK\G(C)*?6N\<2G1\D>O,H
M:B>.,-5Y,8A5/T999#3%EU\M,ZIJ"[4.32_?66<BW4>-CW/>\-."L^_I[=TV
MN[ N]S7[I=K:YK=YMXNI;'2:__KQ)>#_JIL%8=T#V3OQQ%:S^>FFV+)LQ1??
M5=6^69/"/MB=SOGFP-U/?+#%'\<>\?8;^YWM@U6P/O?&JO:75;[)T_*!(^$?
MN6NZW1;[C]_'Q+$7S7W@]4VZL]9I=7/1W%F=,D\>+M/U[R\9%#'7M(#N0R]1
M6/TT;KV;MC?NS,JXZ=_H^=?0S>!S,:>&F!A3XK0L']AWT6VQ9U"2 (+$PPD)
M;0!]$D,GP#T4%,E=T6D$P()&ESURJX6^Q-'-8W)'#W$48_4CC7-4750:[(SB
M4Z\.?#YH53OZ2MS0AWZ @@CAT'%HY!#28_&1)[7^U@R"!2G!$;JY:I-T@'36
MG$S&QESE23@L,RKT$V9'2[1JI'XDC5;V44FDQS$J?%9'6NZ8Z:H_%AU=5LUN
MFU42NRZ$,(9)2"& "0Q([+A!&. PB4(LNIA)^?GFFG(/Z7@Y@/5;#VOJ>W;/
ML#/0'$<3NHP6-]Z-IX<;Z.%%M-V@7<U&\-M]G=]G7[+UOLSK/*O(]_5VO\DV
M_=$)^[:F\O'J&;JVYT5\$D2LSY4X@*\M9P.RR.^P$6)[4L.>:1 9[OU\*FI>
M<DEYK:1WQLKZHU2JYB3\HAW:7ECE\8S\]IJ5?7-&/J_+G&Y/.OU9?9/6UC>F
MLNQ31[J:';!M]49R$<1$KX&8UB[O#9 3YE/\UM$!J_?@>#A.YP,ONCU7\XM9
M!L9:R!_0_6F#NXPD,;'/Q9S-22[]Q/RZT*RJ&(++?-<@J X9#V#H(^!&*$8)
M##W'LV.;+[0+ 84V%3Z":Y0-<RK1P[).<<W6@QLB:: U:^%V&8U4CRN%@7=O
M=)-*\FJ]+:I]F7W-OM<Q\_KW%?5C@!V0>*'MA@0DON_%O7&,DDBFRZ;)I.$^
M67.)5I4W,9#K'>FB5%FO3+,Y7KFL(T3K-P[2:E#.KV(O4">G9V.X7ZRRC7+J
M=8T;SYGP-ISLFD_Y?\[NBI+O?G[)<AR',?)B!$&8>-@.?1H%[!N$DAC[/I"2
M.AWV#.M<!]%ZMVN&CO(GJ&KA5$SKIJ933NAZ)@_PEJ%R J0-2)Q.RI>A;UH]
M>KKW1SM;HLKV;K<N;K,O;%C6'/UPZ#5"#'S/==S0AM!+0N#:.&GN^T0.=2(H
M>MV*ZN/-M;86D76 --M8Z PU VUJ+)G+:$>CO2CTOF*2/8'>SE<^([7"2>QZ
M81(&(02)$\11XCB]$4H3J9*TY*--Y_=C VGPR.[[E^1),)&;HT@R9PNS8R8W
M/^)A* VK$;8,I5 %_S2YCN% 6A>^K+-=6N9%<SP)\#%VDPBAV \@H,1W8=#;
M F$L=:6+F@73*M%A43N72(TS2:DP1I>D8@@R958O3LD0D0TE\A:F'FH^G!.1
M$8P(:TEGXF^[ZBY;YU=YMND.&8$VM ,4$R\ H>=A$GH^/?1ID"-W[)FRE8DT
MY<(Z@:9Z_) ZE8(R,PF+:E(C2: 9Y3G'SY#ZC.9T(0HTWH^G*J2)&>E>S?M\
ME[UC7U8KA&,;04@IB"@,B.<YSL&0&\92F]H5'C_=J(=CLAI0JMT:"=(D^S1F
M^%(> HE09;9?<R!$I%,CS]Y"]&2$ ^>Z,ZI<B.]KN,]V^XP]/L"NZ]D.7T88
M^X[OA@[N'^^Y.);;JB#X4,-JT>&8>L5ZZ_S FR[-SS+>;WG8SY:**_DM^B[C
MHJH_7OVE*#;5EV*[65$;(1( A%CF]7T284!(;R5)8"#S2LL^V_";S>$TMW24
MQ6:_KBNK8J#DTJ T6V(YT"11<@FPYZC!8GT9(LB($#QA8D /5#E;ABPHHR_T
MO#ER(O&7LJBJ3V5QE=<K!T*(;<\A& 1QF,11B-V##,6NNZJ+.MV*"83,<Z7$
MX0!!^,5OH%BW:7F=2\[Y2Y$CI@>F>)'3@I:2%L:T*G#B_X "J+"TC-:OA+P8
M_X[(M?J/=UF9\IG[[MK/D^67B ;4H30D48 </PKM^* RM@^EQLOJ5@QW%P[
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M@"G%L4N3D "G-8I=QPVDKM$=:<IPYZ5I0KPOTN&S&H"G-Y1-WY3.L_5*D])
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M:>["Z@!;!\16#UGR\%"M41#3S]D"(*>@.KDW<_RH!(\#*FHD',O043.N/3W
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MZ / F6\N>YNQL^O1VNBV0ZET.O1BK5DS5Z)J]JTN<E;G/1[))DUI&KH!]L(
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M5]C471)0MHE\">^7RO]>U=_8GS2?KDY-*O)2TL]<B GP(0E\SPL#"OA;G/T
MF?BI*[6-2I--TT-5#M/I</+9I=,S\I+;K70Q+J:!2Y M.7X5Y7F1,:T@?^?V
M:6F.@!V"J-VKY[NZC+"F41:'BM-U$T*#((#4HX" E&08#O8]/W&)9F$4M/K3
M2J,HZ]K$T0#AQN1QD2&P,(?3)%(R#C^,2,KZ)2^32LR)"N7O7_?'-/<&AX(5
MLFHU23-^0YN/$YI&@9?T8W&,<8"DE'&"&<-2N#]A?%ENMY)Z-X4\,8&;B3<Y
M1?O]JW,XEWTD7XL,=4\S=$:O--!JAT#I<*32WN0D9^>JNBBO=W^M'HIZQX?.
M7 =?V,Z [R$_B$.?0)J!)":^W]G&09007VZ=58M%P\+4[5K>=:]JY5OGLMIM
M)-5)$Z^"4W6S4RHY5]?C<PX ^TIL<?T2(N[<7)U6XNU0-<T^/9^M,\"8^-6&
M]5U5YVV!6']^89- /X QIDD"0!!1Y/K$[6TF/LV0U!UATRP9UK8].!5=F\BA
MF)[-1Y^<CAV8X\"6EZ^S/)V1+3W\VB%7FGQY<76A/H:$I\WN=^6ZO,NWW.9H
MBF) *2%1"N(HC1,WPZBO^C!U8>Q)+8PJ&3 L1K__Y>M?G/RZVX6@($=JG G.
M;YFF2W(J:X33B<]2DO,:*>?FIJ9P:(? 3'/A^8S3=#Z$+^9JFJ)%^?H?Q4L!
M@VZ*DBC$E" /^JZ/4QIW%@GV"9,VJ4NX)M@Q+"X=M'>7'3:G49Q7G\2CF-+,
M1:&<X#QA;_%:YPQ'9_1'![-VR) 63YY?<Z6-'5%1>CZ]/AA+H1O#$!&01IF?
MNEE*(] 9HU&0H5CJS4Q%$[-.*/4GJY4E295%,36:@4 Y(7IEL6X1"7J=F#/J
M,Y%).X1GJA.5UM:E_\SEAW)7O&^+VX9AB!.2A"A+?>(3R%_A#,=%/AQ1J1D@
MO98-BY/$.4".V>E &SB *1$*,2E;+@IR"J<Y (N=QMQS>484S<3$#JTTY)O"
MR4Q5!H5'ER<MK](LR$!" ?OXP(,09AGV1X-N!K/50U%?5L+#2W5#,OWU&)/X
M]H7NOIW\98=5'FM.8%5PJ#D/G9(CS7.2-_,P\R0_YT:9TTFU0[]T./)\C*F+
M&U%E.CR5]NF*W]M<[)INV/6EZ.YSQE73-MTC:RAOBLWG_+$[,/"M^-XB1L4_
M5MTN+^2E61)"'R4A\"**8$ S&J<)]A(Y^3*-QKC&=>#>=>B<8P?DA,UX4,34
MSZ9HR$GD 3FO$8^Q.P-XIT-_T3]5^>ZR"]CH@?,']\'IG)BY;)Q(^1G5G2N8
M=DCS;-Y6RW09R8$]M]BU\6-,L*Y9G^E.@*''PZ\,H."?>;WI_N]O1=.6N^LO
MY?5-VWPN6(_;M?EUL8IIQ))/$&/LAIAB'V<AC"@@+O:I&P%73OJ7P3A30KA\
MD1"<(\^<R\?7=,CI/+OH_^,,'CJ]BQ?.P<F9![8FXG1N +QHN[!#S1;FX/F
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M^FQTRF5W=2:-:-8YELX(EA9R[5 K/:Y4!AJ?FD[AZO9R>.+S2[&NKG?EO]@
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M8",8SA];O#1Q,,^"C51$E*ZF@KO-E_X"4;ANRX=NOP2\9+^0K]N5B_T0131
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MXJ8KT,4B!=$);F2D1Y)-2V5'UHNW)$>)%5&Y^587>7-?/Q[96T$?!1$D.$Q
M$&2)"R(_&BT!-Y(ZD*SR^7/*C%/NG'; *"<U2LR)R8QITN0D9D3S5&3F%9=7
M&#DC+%/XLT-4)GE0Z6M-<F+2/7U[OV[OZW)W#7>;X8G4X;G#LFA>>V$,QQ&A
M+B(A3B.< "]S0]Q#@9@(7DUL%(!A.7J"V<EW&X?>WFVKQZ)POA8/1;>6(*=,
M9L(@)EV+1T!.VUZ2/S[K>T!LQ^.'*L2>D4BC<;)#0\VZ6,W8[B6?_N8Z?U-M
M&;T-_>=]V3Y^K-KB-?M13"#U8@_Z,,-1&$:I/Y24&(3 E]IYK,^J8;WM,N
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M!L^HGOXHV*%^!ORJ3+=?.35\OWLHAOM@7S-*O23S81:%44A#+XL(P>EH-$9
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MCUO=!_;5__X?XW?8_UWF3?&__\?_!U!+ P04    " #E@F=+J@"B7P)\  "
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MJG\79"A[0#K*50W>7[>.WK;']:'+[J]\I#,+I.:(:TNLYMI;3I5 T@FN(#+
MGF^D/ZXM*P&^N]'_\.1O2R=V#P+'-A6,MDQBI2(>2D#H8:1_A8HVG/U H[\V
M0<I>,7^T ]VR\&-:GZIOQ6P/O39E G,(2FVQ%A1J:8WW' FDH-)&& SX9?&F
M.Q67[0#<*TE^R^^^Y--#-%F5"AI  )5#C"CB#70>8+^60R(BZ&41Y03];6/
M2=CUQ8'?BDEQM[@[R(+OR@6&F9.>6"JM\$IQRRU;RF*B9\5I+4?[E?'@6"V6
M[>'7&Q>R;_6X\+1<T-08QHE 0 &)@/ F#HJE+,A)[&JY8CNX@"Z4"PWPZXL+
M/O)UGK\MON97SZ/Y]<-OV7^54S/.XLRYW\4XHI6@J%,<"DZ(=%%XR.,T6\VR
M0L(F3L@ >=2;$]*="@9 Q<?^O\ON<EO>9<7D-#IN:RE@[;A#PCMNB$, ,\MX
MA0<5BES6--<)4^JSL04-],5(LYC-R[M\NCQ/3^/UMKB?'9PV]]0* B .:)Q"
M+"<6<B,]W8QN!JGZ89C6C 5E5XCWQ:S/T^PJ3Y(?IM/SHL%IAAWDA%+)'0%2
M,6$KB9273:S5 "?0OCC4$.:^B&-3AH7R/IW)C6XGY;B\>?A8W-S.#_/H0,U
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MJ4N9:!FD$,#D;6"SOD$0C301ZGR&8(=Z]FFECH5HTFQ@!J:;8)J).*LAI0V
MHD)+8=MKLL4^?(@VB/,\B4I_^ _>BFRRH7_,1RG.(K8\&179^+'DIWDVN8K?
M//O%F+;MC@<:QB6T]I9!IXA!7BGJ8=0K9E9+=SZ[\R[_XTF_I^4D_CA:Q:J\
MGYK;;'*3OYD\+;%,BS#.#UV&:=1NL-RG,!L+XJ2L$(N@85;AY1V\L&BW-HA3
MG@_^OI;(NV5RV73\H*[*^QJ98(]H)3 IB9 I63V16CC(#? 5#@Z"1D]B#8^&
M/7&F-E.;ZN-,O%RC,ONN^P=WI^LW$C!A%I+H!4#(N%9(22@K%*3V%[:BZX0?
M^SG8'OCG-XW[AVZ=O>W&;0>(@5>.1Z  !1(A93VH,-.8-'D398 Q*D,SH]UH
MZ<341#X;I<R0#^Y;,:\R/YH]*8AVE@_I1%(J*JE#<2P:QBC8=-<*<V&!ZCVJ
MMVP?_<$O32]NHTL9"@6&T920J":F%<-\M75 '06J5EA@IQM=S_K^L/KSB"VM
M PT$KHFV2&DD"!>$*9)B8=8(&(1J+;E?CWUH@PK;MZ[:Q7D #M&Q?#NVJ6 9
M=HY%'2(1S:SFB$E5(8((;L*\ ;H['3"O8\1[F8U,>7=7K ZB3+D4)/[X-#%V
M2I,]+VZ639]MVGG2RY2'J>IHTN)C J8:,]%1[01MF,78Z.@M<(L<P-+IE;J\
M9YJ?\>7(6G+4,1K'-124YSCRE\J4O1%Z+A01%2(.R0M;TG?$EA=QUAVJ8'@V
MY-Q')N<Q)9!S:(2@4'D&!-5$*,"<PX@08( [HREY6\YFW_7^T(G)]@K!6(>\
M81!SQK%44GF$*@FM(Q>V!]V1]LL.H.[+E7W16?WP+DM)Z-]?/_[Z4#J3^HT$
M!(TC#DJ0XKXUCR90F@T*QEY8CK"F5#C$K+9P/@_;UIT_>.EZ3ZU@A0=(6*(Y
M)EI+B*U3E9P"-;H_]AKXU (!]G*L"=@G;N*^OR_*(@+^QVQ1S/>_@;>M:%"I
M-YX0KJ5S6BE,%*LZR2"_L/27K:BK;!72$_6^?A&E\D ?:C%@?Z4@G#58 ZT(
M7I[2:4S%!@%)S&5MEK3-A5;![37+AUG,YN5=!+Q.(IGO"@?*!4OO[:CT K$2
M'@.QX;K@H,EB>?"4:>R@-,:SMQW<["[.F=]U]Z ;LK-.$$8KY"-FRA"IJ:6,
MPDK&%)]]65-.$R4_WXMM"=(3IQSSMT]_S;/Q_';O'/.L5. <..LIHA)X0 GU
M&.&J:]@W>OMJ@-IN045E6UCVMDS9['N9;)8?6OR^*!SBC,J-Y@9&N*F)EC3.
MOAMD1".W8X!)+=I>Y#;%\SPL2=>>#Z]D=U0)EA%#A.#"2*\L5(":C2\5?U_K
MZLCKL2E-5+R7+2<C^I(SKQ7-4R!X[3[_I\67V3*MYMQ]C7\D" X8[1TU O>.
M NPHQ<09S[P *87U4CX(5:.,D0.\/-^RY6X'U#.2YJ#]WEDG"" T5A!JPQ&W
MSGL%*@\88J<N+""HL:8/,^<D7,_$G8/Q]UO+A[@8$5X8)Y04$%D@)>"5;-S0
M"SM\:T''^UES$JIG.V=[6R,X?G>E0 1W&N"H!L\A(C[.];J24G)\80_I=GV.
M=BJN)^X[O)E$ERVN@O/I77G]X3:;WF6C?#$O1MGX4[F8CF*__A9164RWG>@?
MUT"05 L$A"<*X!2>+9FH3K$A=>3")J8V-%OV@/.)Q/DM^U;<+>[^SR*;QCZ-
M'SYD#RF:80=+=I0.!C!(*)>,<LN,E,:1C;V%%C69=U[#%G<S2K0#ZKD.W/,_
MS#@K[F:^&.=7[Q8'W)8:M0.7Q 'K 5,)2R-U_&,SW;I&MUA?PU[7Z63J#N0S
MD>MC\L5F<U].WTRNRV@JGP8?'V;7UNH!. P5($@[1E'*>J.B974NA6WJ=&GM
MPA?DK=.K#93/9;R68^']]8<X/.(OKZ_KN\Y;Z@;JK9".1_]1$^X4)4S;"E#'
MR*5[T.T;KJ80G^@3/>N&&HVFBVS\+I^7UV\FL\4TFXQ23IB4<GU[OL/C&PE&
M&"L$T<I0AN,/"H$43<&4)"D!5Y-);X!I75OVH#K%NJ?0^<FL'!=7V3R_TMDX
M=?C3;9[/SQ<?_RF*L;S#]/YZD_GH0SDKEN0Z'!9?IWK0Q#G(N7)$6&\0!5"F
M1S&(410(YVL]?-F-]*M'W>O<:?VN8$ ZBA))%041WB-AE5651)CB7E.0]; !
MUZJ2MZ7X/A79OAR*52?-8IK@JDV79^6#2Z=>$ (!*<?2R71%H)(-XGKIMEX/
M:TY5[%9^-(.R+YJ8;':;[H?$_Z3\GE^S\?+&R-QDT^E#VO))[^[MH4VM^H'&
M"=)P@X&CG&L0046FDMVY1F_K#)9&)^O_^>V[#A#NBUTI/V'L<4J1''V>-2)[
MV+2U?$!000^X@Y9*)@W !-%*-L]9DU>H![B'URY[VD"T+[:DE,.3J+J'V-,]
M)'E:+"B4#C^8,%!39 BVT/!*DG1)_K*VY-KE1@,@^Z+$,E'.=U+O(<;+PL$@
M9[PB!GNA'/4.>VO74D$:3>1E;:FU2X_&<)[%U:WKX@:!L(\SIG162(8D4U15
MWEV$I]&"Z/@]L7*>C5\1-9H@V1<K/DS+^WPZ?_@P3HFJ5NGK[].2</_LLJ]:
M2%!)YG7*;$ LL\GI>I2TT8W>P7HBC9=#+2+:GR<RSR8W1?2:5AC$GKZ9C,:+
MJ^AO_Z4LK_XHQN.]'LKAZ@$3;+B,V-D()*8NQ794DAN$FW!IL)Y+8RYU@.P9
M7)EWY61TC#?S6#X@K 6'!"G,D= D+O0DJ&2SI%'LY6 =FL:L:0/*?IV9@UY,
M@,X2(TATQ)14.-U(<YO><]4HUFFP[DM+.W-'8M??'9NG^8@^S<O1/V[+<=3(
M;/7R3HU-W+I-A+B^PRF':=HR<HA'WUUL''D/=9-G 0;HR'1Z&M 1YF=@7?W#
M@MV5@H'6*(?3 ]XDCDT=Q:R6%$Q@TN0]V0%N];:O_-WL:H9T;_/7*M_D[$/V
MD'8=:ZS*MU8(E$1;#"BQ)OIOC%A)G%Y+QPT"%W9>V8::G\]U;>#:7_C3Y.9S
M/KU;/S5GLOLBN11Y-LO??QFOK_S5V.(YJITX*!$4!F(N.(.>0\=HM?CD+J)^
M6;-@!QSK$NY^UV4I,"=JZ@5$!Q=HNRH&GDP\EU *0@"% AK/-@/-R":YF0:X
MON^ 7*WB>SYWZB@W*A"+G+<.<^>H0-HXHBL_@1.BFT1J'K^^[WQ9UX5):HKI
ML*:\QG-=8)HI!I6&"'EO*>5L R37\((GN8X<\BY0[XMS=JVLS]FWZA62)X#5
MVI:LVT2(WB3E5EIF+85QY&EDT6:VUZJ))1OV_-<-[SK"O;](H*L\OTL+D=35
M<C*/V,:/W+R91-WDL_D*I2JF2=VEI<O>0*'CFPL2>D(DY!X(CS@7!F.W\1@
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M2+_'1X9/#9NOWW*@DD(#J/8", 2(YEB["C/I8*,+;Z_( M6F3IT@SL[@O^Q
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MU "-6-=$V&[D&L-^3BOWL9C]XP1;5E4+%%AD(<0*IFP%@F/C>26I0ZS)(GZ
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MV&(O(.<^.AS2X;5>*.7U<FR\GJC8(7+V-$T,F*7Q\WO#F$YK,1 E74)'$N6
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M@ YI2#:C'B-]87$-71"D_@6-AN /@(1';J<<V5*(4XX$R!J/N '00*\TKO!
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M$7&;D6N\O+ E9;LDJ,^P4[ > +O4:+2X6XQ3?.C3? 6G\6U'8X$1$P=RRJ.
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M4S0O:@4B011)1&-(HJ.((#*"5K(:(2XLS*<C'AQ.&G8BWL,+Y3F.;[5;"T1
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M&;Z9\VV4+)N/,JX\%5H(@LH<8HWH>-:(:QSY-K7%=2S?IAFL8]F'?MMIO@U
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M4SY>T6;S6$_X2 _"O;6]WLQ_S#<_S]"A<U]>:"M]+$]>O70<B=!![Q<<1D!
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M$N2J(SLL#4\>3F608RXM.'8LY6:?4Y#_6!;K"M@CU&_QUH(:0[VD3E"O 7D
M*/_<B\GQR=VX'!77\PGN$OV@3/Y/H8)TQ')91E#."^F$/)@*%#S/[<_<S71&
MI0<#BG,,EK^EB;\W"4$;:1+H42LBG.,&JO ,E#9M2M\VS_@LZY.]' ;W()]7
MS_Q7C\X'0A2SZ;^4Q@@Q:;FLT$O 3K#/TJ@8/H@4!\HH^^-JM4HO^C&[U%0Q
M6NX',PDL^!@"BA!CLC0L,L.]\U#KU+7W^Q0EH=Q/7U*\0:'"QT\5WDGCG 8I
M/7+%%-%"5G.-4K19]4:X;76NH)^_M] 2T,M.XI)!8!#11T8$Q&2'I%757(52
M;1:5$9*G$ZDW2M%JAN]EI6@%,"(M9208@SRMHX9:7LU-6C.QU):.Y%PK1:L9
MLKE8\W$UNUK?K7YN=>?DR?H3GRZ,,I2R"(&J2+V.E,B]M1;4M=ML&R%C6LIV
MV36>N7BR-:I[$UOG-/O)SQ=>.J&3APX8)8.H6+!T/S?FTT(_K7/I/E:F+G =
MQ+;LRJ#9ZZ0_24)U;<RO3Q56B*1;CAA'K+1><H[Z,$^'$RN+W%+6QVQ-*UP'
MX<^VJ4$UX/):Z-]GFZ]'>]?7>;Q0S* TTKNH(FH+3(4 *!RG0?A V^R3C] B
M]<BH;@ >A%K5J/>]-,K!OY_M*NK4I=>15Q2ZQ)-1+8E07EMC6"05O )HF^)(
M(\PG[)%BW8$\T!;<P-7=SMUX,Z@T.*:8<]%$F\2GW/ZV>^!&C6+CK>8UV3.*
M.)SUYD)*B4XX0:T!+ZP)M"ILS0)&/C%/Y5S"/+N!EP/T&D9@_Q?E/\KZ$__^
M;_\/4$L! A0#%     @ Y8)G2T"B%G:Z  $ :.,0 !               ( !
M     &-A:"TR,#$W,#DS,"YX;6Q02P$"% ,4    " #E@F=+VX; FTH0  #*
ML@  $               @ 'H  $ 8V%H+3(P,3<P.3,P+GAS9%!+ 0(4 Q0
M   ( .6"9TOTUAE>4!T  *H_ 0 4              "  6 1 0!C86@M,C Q
M-S Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( .6"9TLNPBWQX%   -U.!  4
M          "  >(N 0!C86@M,C Q-S Y,S!?9&5F+GAM;%!+ 0(4 Q0    (
M .6"9TO%#-OY"KX  #?G"0 4              "  ?1_ 0!C86@M,C Q-S Y
M,S!?;&%B+GAM;%!+ 0(4 Q0    ( .6"9TNJ *)? GP  ("'!@ 4
M      "  3 ^ @!C86@M,C Q-S Y,S!?<')E+GAM;%!+!08     !@ & (0!
(  !DN@(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
